carbamazepine has been researched along with Aura in 2372 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As a new-generation aromatic antiepileptic drug, oxcarbazepine (OXC) is often used for epilepsy treatment." | 9.41 | Pharmacogenomics of oxcarbazepine in the treatment of epilepsy. ( Ran, YW; Yan, X; Yuan, Y; Zhang, L; Zhang, S, 2023) |
| "Gabapentin as monotherapy probably controlled seizures no better and no worse than comparator AEDs (lamotrigine, carbamazepine, oxcarbazepine, and topiramate)." | 9.41 | Gabapentin monotherapy for epilepsy: A review. ( Abakumova, T; Hoyle, CHV; Ziganshina, LE, 2023) |
| "To assess tolerability and efficacy of lacosamide in adults with cerebrovascular epilepsy etiology (CVEE)." | 9.34 | Lacosamide in patients with epilepsy of cerebrovascular etiology. ( Bozorg, A; Brandt, C; Dimova, S; Ferrò, B; Holmes, GL; Kälviäinen, R; Rosenow, F; Steiniger-Brach, B; Zhang, Y, 2020) |
| "A large-scale, double-blind trial (SP0993; NCT01243177) demonstrated that lacosamide was noninferior to controlled-release carbamazepine (carbamazepine-CR) in terms of efficacy, and well tolerated as first-line monotherapy in patients (≥16 years of age) with newly diagnosed epilepsy." | 9.30 | Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy. ( Ben-Menachem, E; Biton, V; Brock, M; De Backer, M; Gasalla, T; Grebe, HP; Jensen, L; Li, T; Steiniger-Brach, B; Terada, K, 2019) |
| "The antioxidant activity of reamberin was investigated in children with epilepsy: 16 patients received intravenous reamberin once daily for 5 days in addition to carbamazepine." | 9.30 | [The effect of reamberin on the antioxidant status in children with epilepsy]. ( Dorovskikh, VA; Nosal', LA; Shtarberg, MA; Simonova, NV, 2019) |
| "In this phase 3, randomised, double-blind, non-inferiority trial, patients from 185 epilepsy or general neurology centres in Europe, North America, and the Asia Pacific region, aged 16 years or older and with newly diagnosed epilepsy were randomly assigned in a 1:1 ratio, via a computer-generated code, to receive lacosamide monotherapy or controlled-release carbamazepine (carbamazepine-CR) twice daily." | 9.24 | Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. ( Baulac, M; Brock, M; De Backer, M; Li, T; Rosenow, F; Terada, K; Toledo, M; Werhahn, KJ, 2017) |
| "To systematically evaluate the medication safety and effectiveness of Oxcarbazepine (OXC) and carbamazepine (CBZ) for the treatment of post-stroke epilepsy (PSE)." | 9.22 | Oxcarbazepine versus Carbamazepine for the Treatment of Post-Stroke Epilepsy: A Systematic Review and Meta-Analysis. ( Guo, CA; Li, PW; Lu, XM; Wan, DJ; Zhang, YJ, 2022) |
| " One study compared clonazepam to carbamazepine as monotherapy for participants with newly diagnosed psychomotor epilepsy (a condition corresponding to what is now termed mesial temporal lobe epilepsy)." | 9.22 | Clonazepam monotherapy for treating people with newly diagnosed epilepsy. ( Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2022) |
| "This post-hoc subgroup analysis of data from an unblinded, randomized, 52-week superiority study (KOMET) compared the effectiveness of levetiracetam (LEV) with extended-release sodium valproate (VPA-ER) and controlled-release carbamazepine (CBZ-CR) as monotherapy in patients aged ≥ 60 years with newly diagnosed epilepsy." | 9.22 | Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. ( Marson, AG; Noack-Rink, M; Pohlmann-Eden, B; Ramirez, F; Tofighy, A; Trinka, E; Werhahn, KJ; Wild, I, 2016) |
| "This Phase I, open-label, dose-escalation study investigated the effects of steady-state brivaracetam on the pharmacokinetics of carbamazepine in patients with epilepsy, with and without valproate co-administration." | 9.22 | Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration. ( Brodie, MJ; Sargentini-Maier, ML; Stockis, A, 2016) |
| "IV carbamazepine administered as multiple 30- or 15-min infusions every 6 h, and as a single rapid infusion, was well tolerated as a short-term replacement in adults with epilepsy receiving stable dosages of oral carbamazepine." | 9.20 | Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials. ( Bekersky, I; Biton, V; Cloyd, J; Dheerendra, S; Halford, JJ; Kalu, U; Klein, P; Lee, D; Peng, G; Tolbert, D, 2015) |
| "In this phase 1, open-label study, adult patients with epilepsy on a stable oral carbamazepine dosage (400-2,000 mg/day) were converted to intravenous carbamazepine (administered at 70% of the oral dosage)." | 9.20 | Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy. ( Bekersky, I; Biton, V; Cloyd, J; Drummond, R; Lee, D; Tolbert, D; Walzer, M; Wesche, D, 2015) |
| "Oral loading of oxcarbazepine tablet is effective and well tolerated to adequately achieve the therapeutic levels of its active metabolite, 10,11-dihydro-10-hydroxy-carbazepine (monohydroxy derivative, MHD) in epilepsy patients." | 9.17 | Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. ( Cho, JY; Chu, K; Gu, N; Jang, IJ; Kim, DW; Lee, H; Lee, SK; Na, HJ; Yoon, SH; Yu, KS, 2013) |
| "The aim of the study was to investigate immunoglobulin levels in patients with epilepsy using the antiepileptic drugs (AED) levetiracetam (LEV), carbamazepine (CBZ), or lamotrigine (LTG)." | 9.17 | Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine. ( Frøland, SS; Luef, G; Mochol, M; Mushtaq, U; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2013) |
| "The aim of this study was to evaluate the association of genetic variants in the major genes involved in carbamazepine (CBZ) metabolism and transport with its pharmacokinetics in epilepsy patients." | 9.17 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. ( Ahmed, G; Birnbaum, AK; Cloyd, JC; Lamba, JK; Leppik, IE; Marino, SE; Puranik, YG; Remmel, RP, 2013) |
| "Eighty-one patients participated in the study: 51 patients with chronic epilepsy (G1) treated with carbamazepine (CBZ) or valproic acid (VPA), and 30 patients with newly diagnosed epilepsy (G2)." | 9.16 | The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid. ( Bochyńska, A; Graban, A; Gugała-Iwaniuk, M; Lechowicz, W; Lipczyńska-Łojkowska, W; Lipska, B; Restel, M; Ryglewicz, D, 2012) |
| "This study aimed to evaluate the effects of monotherapy with valproate or oxcarbazepine on the linear growth of children with idiopathic epilepsy." | 9.16 | The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy. ( Bideci, A; Camurdan, O; Cansu, A; Cinaz, P; Hirfanoglu, TL; Karaoglu, A; Serdaroglu, A; Yesilkaya, E, 2012) |
| " This study was done to evaluate the effect of levetiracetam (LEV) on subjective sleep quality and sleep architecture in patients with epilepsy, and the results were compared with the effects of carbamazepine-CR (CBZ-CR)." | 9.15 | The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy. ( Cho, YW; Kim, DH; Motamedi, GK, 2011) |
| "To investigate the effect of topiramate on bone mass and metabolism in premenopausal women with epilepsy." | 9.15 | The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. ( Heo, K; Kim, WJ; Lee, BI; Lee, HW; Lee, SA; Rhee, Y; Shin, DJ; Song, HK; Song, K, 2011) |
| "An international trial comparing remacemide hydrochloride with carbamazepine was undertaken in individuals with newly diagnosed epilepsy using a novel double-blind, parallel-group, double triangular sequential design." | 9.14 | The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. ( Dean, AD; Edgar, C; Wesnes, KA; Wroe, SJ, 2009) |
| " The present study aimed at evaluating the effect of piperine on the steady-state pharmacokinetics of a single dose of carbamazepine in poorly controlled epilepsy patients on carbamazepine monotherapy." | 9.14 | Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. ( Hota, D; Kharbanda, P; Pandhi, P; Pattanaik, S; Prabhakar, S, 2009) |
| "We performed an observational retrospective study on patients with brain tumor-related epilepsy: 35 who had assumed oxcarbazepine monotherapy and 35 patients who had undergone treatment with traditional antiepileptic drugs." | 9.14 | The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. ( Carapella, MC; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Pompili, A; Vidiri, A, 2009) |
| "During an international double-blind trial evaluating the efficacy and tolerability of lamotrigine and carbamazepine in patients aged >or=65 with newly diagnosed epilepsy, the comparative effects of the drugs on health-related quality of life were investigated based on screening and 12-, 28-, and 40-week data, using the modified Side Effect and Life Satisfaction (SEALS) Inventory and the Liverpool Adverse Event Profile." | 9.14 | Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age. ( Abdelnoor, M; Gjerstad, L; Isojärvi, J; Perucca, E; Saetre, E; Taubøll, E, 2010) |
| "For a retrospective observational investigation based on real clinical practice of relative efficacy of valpoic acid (VPA), carbamazepine (CBZ) and topiramate (TPM) we have selected 106 patients with age of seizure onset before 17 years with a undoubted diagnosis of symptomatic or cryptogenic occipital lobe epilepsy (OLE), who had received treatment according to ILAE recommendations, and observation time since the last treatment change was from 2 to 10 years." | 9.14 | [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children]. ( , 2010) |
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 9.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| " In this study, FA profiles were determined in 56 patients with epilepsy who participated in a 12-week double-blind randomized trial of omega-3 FA supplementation (1 g eicosapentaenoic acid and 0." | 9.13 | Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? ( Bell, GS; Browning, L; Flugel, D; Koepp, MM; Patsalos, PN; Sander, JW; Yuen, AW, 2008) |
| "To explore effectiveness, tolerability and changes in quality of life in patients with epilepsy converting to topiramate (TPM) from carbamazepine (CBZ) or oxcarbazepine (OXC) due to insufficient effectiveness and/or tolerability." | 9.13 | Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy. ( Adam, H; Bogdanow, M; Kowalik, A; Kühn, F; Rimpau, W; Schauble, B; Schreiner, A; van Oene, J, 2008) |
| "The aim of the study described here was to investigate the efficacy, tolerability, and side effects of oxcarbazepine (OXC) monotherapy in newly diagnosed, previously untreated adult and elderly patients with partial epilepsy." | 9.13 | Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. ( Aktekin, B; Bilgen, R; Dogan, EA; Senol, Y; Usta, BE, 2008) |
| " All patients with epilepsy between the ages 3-18 years, taking carbamazepine as monotherapy, were studied and blood samples were obtained for ANA and other tests." | 9.13 | Antinuclear antibodies in children with epilepsy treated by carbamazepine. ( Asadi-Pooya, AA; Asadi-Pooya, K, 2008) |
| "ABCB1 polymorphisms were previously demonstrated to be associated with the metabolism and resistance of carbamazepine (CBZ) in epilepsy, but the results still remained controversial." | 9.12 | Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis. ( Fan, YX; He, GH; Huang, YH; Meng, JR; Meng, R; Wang, P; Yin, SJ; Zhang, Z; Zhou, T, 2021) |
| " This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin, carbamazepine, phenobarbital, and valproate) and two newer (lamotrigine and levetiracetam) AEDs during pregnancy." | 9.12 | Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications. ( Demir, O; Kaplan, YC, 2021) |
| "CYP3A4 (rs2242480), CYP3A5 (rs776746) and SCN1A (rs3812718 and rs2298771) gene polymorphisms were previously indicated to be associated with carbamazepine (CBZ) metabolism and resistance in epilepsy." | 9.12 | Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis. ( Cai, WK; He, GH; Shen, ML; Wang, P; Zhang, Z; Zhao, GX, 2021) |
| "This study was performed to evaluate carnitine deficiency in a large series of epilepsy children and adolescents treated with old and new antiepileptic drugs with or without ketogenic diet." | 9.12 | Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. ( Auricchio, G; Coppola, G; Epifanio, G; Federico, RR; Pascotto, A; Resicato, G, 2006) |
| "To compare the behavioural side effects associated with two commonly used antiepilepsy drugs-phenobarbital and carbamazepine-in children in Bangladesh." | 9.12 | Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. ( Banu, SH; Ferdousi, S; Jahan, M; Khan, NZ; Koli, UK; Neville, B, 2007) |
| "We report the results of a prospective study of the efficacy and tolerability of levetiracetam, a new antiepileptic drug with a unique mechanism of action, in comparison with controlled-release carbamazepine as first treatment in newly diagnosed epilepsy." | 9.12 | Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. ( Ben-Menachem, E; Brodie, MJ; Meencke, HJ; Perucca, E; Ryvlin, P, 2007) |
| "This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy." | 9.12 | Oxcarbazepine improves mood in patients with epilepsy. ( Bria, P; Della Marca, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G, 2007) |
| "To assess the comparative effectiveness, efficacy, and tolerability of lamotrigine (LTG) and sustained-release carbamazepine (CBZ) in the treatment of newly diagnosed epilepsy in the elderly." | 9.12 | An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. ( Gjerstad, L; Isojärvi, J; Perucca, E; Saetre, E, 2007) |
| "To determine whether levetiracetam (LEV) affects plasma concentrations of carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy." | 9.12 | Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. ( De Smedt, H; Otoul, C; Stockis, A, 2007) |
| " The aim of this study was to evaluate thyroid function in 78 girls taking carbamazepine (CBZ), oxcarbazepine (OXC), or valproate (VPA) monotherapy for epilepsy and after withdrawal of the treatment." | 9.11 | Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. ( Isojärvi, JI; Knip, M; Mikkonen, K; Myllylä, VV; Pakarinen, AJ; Rättyä, J; Vainionpää, LK, 2004) |
| "In a novel double-blind trial, topiramate was compared with the investigator's choice of carbamazepine or valproate as first-line therapy in patients as young as 6 years of age with newly diagnosed epilepsy." | 9.11 | Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. ( Neto, W; Wang, S; Wheless, JW, 2004) |
| "This randomized, open-label study was designed to compare the efficacy and tolerability of lamotrigine monotherapy with those of valproate and carbamazepine monotherapy in patients with epilepsy whose seizures were uncontrolled on their prestudy antiepileptic drug monotherapy." | 9.11 | Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. ( Fakhoury, TA; Hammer, AE; Messenheimer, JA; Vuong, A, 2004) |
| "This two-part, open-label study evaluated the pharmacokinetics, safety, and tolerability of oxcarbazepine as combination therapy in 112 children 2 to 12 years old with inadequately controlled epilepsy." | 9.11 | Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. ( Bulteau, C; D'Souza, J; Dulac, O; Markabi, S; Motte, J; Pons, G; Rey, E; Sturm, Y; Tran, A, 2004) |
| "In a double-blind, randomized, parallel-group, placebo-controlled trial, we assessed the effect of add-on melatonin (6-9 mg/day for 14 days) on the antioxidant enzymes glutathione peroxidase (GPx) and glutathione reductase (GRd) in 31 children with epilepsy receiving CBZ monotherapy, who were seizure free at least for the last 6 months." | 9.11 | Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial. ( Agarwal, S; Aneja, S; Gupta, M; Gupta, YK; Kalaivani, M; Kohli, K, 2004) |
| "A proportion of patients undergoing epilepsy surgery, and receiving carbamazepine (CBZ), experience significant elevations in CBZ plasma concentrations, some with associated CBZ toxicity." | 9.11 | Risk factors for carbamazepine elevation and toxicity following epilepsy surgery. ( Bingaman, W; Hiremath, GK; Hovinga, C; Kotagal, P; Morris, H; Nelson, D; Wyllie, E, 2005) |
| "To determine the relative tolerability and efficacy of two newer antiepileptic drugs, lamotrigine (LTG) and gabapentin (GBP), as compared to carbamazepine (CBZ) in older patients with epilepsy." | 9.11 | New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. ( Boardman, KD; Carter, GS; Collins, JF; Felicetta, J; Frederick, T; Marks, W; Pryor, F; Ramsay, RE; Rowan, AJ; Spitz, M; Tomyanovich, ML; Towne, A; Uthman, BM, 2005) |
| "The authors conducted a 3-month, prospective, open-label study assessing the effects of switching from immediate-release carbamazepine formulations to an equal total daily dose of carbamazepine extended-release capsules (CBZ-ERC) in adolescents and adults with epilepsy." | 9.11 | Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. ( Ficker, DM; Glauser, T; Kanner, A; Krauss, G; Moore, JL; Privitera, M, 2005) |
| "To compare topiramate (TPM) with investigator's choice of carbamazepine (CBZ) or valproate (VPA) for initial treatment in patients with newly diagnosed epilepsy." | 9.10 | Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. ( Brodie, MJ; Chadwick, DW; Mattson, RH; Neto, W; Privitera, MD; Wang, S, 2003) |
| "Remacemide hydrochloride is a low-affinity, non-competitive NMDA receptor channel blocker under investigation for the treatment of epilepsy." | 9.10 | Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen. ( Blume, WT; Guberman, A; Holdich, TA; Jones, MW; Lee, MA; Pillay, N; Veloso, F; Weaver, DF, 2002) |
| "Remacemide hydrochloride is a low-affinity, non-competitive N-methyl-D-aspartic acid (NMDA) receptor channel blocker, under investigation in epilepsy." | 9.10 | Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen. ( Betts, TA; Boddie, HG; Chadwick, DW; Crawford, PM; Holdich, TA; Lindstrom, P; Newman, PK; Soryal, I; Wroe, S, 2002) |
| "The authors assessed the effect of concomitant antiepileptic therapy on steady-state plasma concentrations of the new antiepileptic drug (AED) topiramate and the potential relation between topiramate plasma levels and side effects in a cohort of 116 patients with epilepsy." | 9.10 | Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. ( Albani, F; Avoni, P; Baruzzi, A; Contin, M; Riva, R, 2002) |
| "The efficacy of remacemide hydrochloride (REM) as an antiepileptic drug (AED) was tested in a double-blind, add-on trial in patients with refractory epilepsy." | 9.09 | Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy. ( Jamieson, V; Lucas, SB; Mawer, GE; Wild, JM, 1999) |
| "To compare the cognitive and behavioural effects of clobazam versus standard monotherapy in the treatment of childhood epilepsy." | 9.09 | The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy. ( Bawden, HN; Camfield, CS; Camfield, PR; Cunningham, C; Darwish, H; Dooley, JM; Gordon, K; Ronen, G; Stewart, J; van Mastrigt, R, 1999) |
| "In a multicentre, double-blind trial 150 elderly patients (mean age 77 years) with newly diagnosed epilepsy were randomised in a 2:1 ratio to treatment with lamotrigine (LTG) or carbamazepine (CBZ)." | 9.09 | Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. ( Brodie, MJ; Giorgi, L; Overstall, PW, 1999) |
| "5-18 yrs with intractable epilepsy and comedicated with carbamazepine or valproate." | 9.09 | Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy. ( Jović, NJ; Majkić-Singh, N; Milovanović, DD; Mirković, D, 1999) |
| "Both examined antiepileptic drugs, vigabatrin and carbamazepine, cause acquired color vision defects." | 9.09 | Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. ( Kälviäinen, R; Mäntyjärvi, M; Nousiainen, I, 2000) |
| "Changes in body weight were evaluated in 349 patients from a study comparing efficacy of add-on therapy with tiagabine (TGB), carbamazepine (CBZ) or phenytoin (PHT)." | 9.09 | Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin. ( Bertrand, ME; Deaton, RL; Hogan, RE; Sommerville, KW, 2000) |
| "This prospective observational study explored the efficacy and tolerability of topiramate (TPM) in patients with refractory epilepsy attending a single outpatient clinic." | 9.09 | Topiramate in refractory epilepsy: a prospective observational study. ( Brodie, MJ; Sills, GJ; Stephen, LJ, 2000) |
| " The primary aim of the study was to evaluate lamotrigine add-on therapy and consecutive monotherapy in patients with epilepsy whose seizures were not controlled by carbamazepine or valproate." | 9.09 | Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy. ( Jozwiak, S; Terczynski, A, 2000) |
| "To evaluate the efficacy, safety, and cognitive effects of initial vigabatrin monotherapy compared with initial carbamazepine monotherapy in patients with newly diagnosed epilepsy." | 9.08 | Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. ( Aikiä, M; Kälviäinen, R; Mervaala, E; Riekkinen, PJ; Saukkonen, AM, 1995) |
| " Use of the drug as monotherapy was investigated in a double-blind, randomised, parallel-group comparison with carbamazepine in newly diagnosed epilepsy." | 9.08 | Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. ( Brodie, MJ; Richens, A; Yuen, AW, 1995) |
| "To assess the effects of carbamazepine vs valproate sodium on cognitive functioning in patients with epilepsy compared with normal control subjects." | 9.08 | Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. ( Cattanach, L; Collins, JF; Cramer, JA; Delaney, RC; Mattson, RH; Prevey, ML, 1996) |
| "Our objective was to evaluate the patterns of malformations in children exposed in utero to phenytoin (DPH) and carbamazepine (CBZ) monotherapy, and to compare them prospectively with matched mother-child pairs exposed to nonteratogens, and to separate the effects of antiepileptic drugs (AEDs) from those of epilepsy by collecting groups of untreated epileptics and those treated with DPH and CBZ for conditions other than epilepsy." | 9.08 | Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. ( Chitayat, D; Farkas, LD; Koren, G; Nulman, I; Scolnik, D, 1997) |
| " This paper presents an analysis of body weight data gathered during a randomized trial comparing valproate with carbamazepine in 260 children aged 4-15 years with newly-diagnosed epilepsy." | 9.08 | Weight gain with valproate or carbamazepine--a reappraisal. ( Easter, D; O'Bryan-Tear, CG; Verity, C, 1997) |
| "We have analyzed the records retrospectively and interviewed 70 adult patients attending an epilepsy clinic on VPA mono- or polytherapy followed over a median of 27 months (range 3-189), as well as 20 patients on carbamazepine (CBZ) monotherapy." | 9.08 | Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. ( Corman, CL; Guberman, AH; Leung, NM, 1997) |
| "Patients with newly diagnosed localization-related epilepsy who participated in a VGB-carbamazepine (CBZ) monotherapy trial were included." | 9.08 | A comparison of the neuropathological effects of vigabatrin and carbamazepine in patients with newly diagnosed localization-related epilepsy using MR-based cerebral T2 relaxation time measurements. ( Connelly, A; Duncan, JS; Van Paesschen, W, 1998) |
| "To compare the effectiveness of monotherapy clobazam (CLB) to carbamazepine (CBZ) and phenytoin (PHT) in children with epilepsy." | 9.08 | Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. ( , 1998) |
| "To examine the effect of grapefruit juice on the bioavailability of carbamazepine in patients with epilepsy." | 9.08 | Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. ( Bhargava, VK; Garg, SK; Kumar, N; Prabhakar, SK, 1998) |
| "We measured the levels of estradiol (E2), total testosterone (TT) and free testosterone (FT) in 24 male patients with epilepsy receiving phenytoin (DPH), 21 male patients with epilepsy receiving cabamazepine (CBZ), 23 male epileptics receiving no treatment, and in 10 healthy age-matched male controls." | 9.07 | [Effects of phenytoin and cabamazepine on sex hormones in male patients with epilepsy: a controlled study]. ( Ma, S; Zhou, S, 1994) |
| "Sixty-four new cases of childhood epilepsy were randomly assigned to either carbamazepine, phenytoin or sodium valproate, and were assessed with behavioural measures before medication and after one and six months of treatment." | 9.07 | Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial. ( Berg, I; Butler, A; Ellis, M; Foster, J, 1993) |
| "Sixty-four new cases of childhood epilepsy were randomly assigned to either carbamazepine, phenytoin or sodium valproate, and were assessed with cognitive tests before medication and three subsequent times over a year." | 9.07 | Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. ( Berg, I; Butler, R; Forsythe, I; McGuire, R, 1991) |
| "At present, 34 patients aged 15 to 63 years with newly diagnosed epilepsy have been randomly assigned to vigabatrin (n = 17) or carbamazepine (n = 17)." | 9.07 | Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. ( Aikiä, M; Kälviäinen, R; Mumford, J; Partanen, J; Riekkinen, PJ; Saksa, M; Sivenius, J, 1991) |
| "Taltrimide was compared with valproate and placebo in 17 patients with intractable epilepsy being on carbamazepine monotherapy." | 9.06 | A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy. ( Allonen, H; Iivanainen, M; Neuvonen, PJ; Parantainen, J; Tamminen, M; Tokola, O; Waltimo, O, 1990) |
| "Progabide, an experimental GABA-ergic antiepileptic drug, was given in a placebo-controlled double-blind cross-over trial to 19 adult patients with chronic partial epilepsy refractory to previous high-dose antiepileptic drug therapy." | 9.06 | Progabide for refractory partial epilepsy: a controlled add-on trial. ( Schmidt, D; Utech, K, 1986) |
| "To conduct a literature review of the impact on cognition and mood status of lacosamide (LCM) in people with epilepsy." | 9.05 | The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy. ( Chang, YP; Huang, LC; Li, KY; Yang, YH, 2020) |
| " One study compared clonazepam to carbamazepine as monotherapy for participants with newly diagnosed psychomotor epilepsy (a condition corresponding to what is now termed mesial temporal lobe epilepsy)." | 9.01 | Clonazepam monotherapy for treating people with newly diagnosed epilepsy. ( Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2019) |
| "To review the time to treatment failure, remission and first seizure with carbamazepine compared with phenytoin when used as monotherapy in people with focal onset seizures (simple or complex focal and secondarily generalised), or generalised onset tonic-clonic seizures (with or without other generalised seizure types)." | 9.01 | Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C, 2019) |
| "Lamotrigine is used in pregnancy to control epilepsy and mood disorders." | 8.95 | Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. ( Adams-Webber, T; Barzilay, E; Leibson, T; Nulman, I; Pariente, G; Shulman, T, 2017) |
| "Carbamazepine (CBZ) is a commonly used drug for epilepsy that is associated with troublesome adverse events including dizziness, double vision, drowsiness, poor co-ordination and unsteadiness." | 8.93 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Rigby, A; Saunders, M, 2016) |
| "The efficacy and safety of vigabatrin (VGB) as an add-on therapy for refractory epilepsy have been well established." | 8.91 | Vigabatrin versus carbamazepine monotherapy for epilepsy. ( Gan, L; Luo, H; Luo, M; Wang, J; Xiao, Y, 2015) |
| "The efficacy and safety of vigabatrin (VGB) as an add-on therapy for refractory epilepsy has been well established." | 8.88 | Vigabatrin versus carbamazepine monotherapy for epilepsy. ( Gan, L; Luo, H; Luo, M; Wang, J; Xiao, Y, 2012) |
| "To determine the efficacy of immediate-release carbamazepine (IR CBZ) versus controlled-release carbamazepine (CR CBZ) in patients with newly diagnosed epilepsy." | 8.86 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Saunders, M, 2010) |
| "There is moderate evidence indicating that oxcarbazepine is effective as an alternative treatment for partial or generalized epilepsy in children and adults who were refractory to previous treatment." | 8.85 | Oxcarbazepine for refractory epilepsy: systematic review of the literature. ( Atallah, AN; Prado, GF; Puga, ME; Saconato, H, 2009) |
| " The present study aims to determine the distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its possible impact on the metabolism of valproic acid (VPA) and carbamazepine (CBZ) in patients with epilepsy from Khyber Pakhtunkhwa region of Pakistan." | 8.84 | Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy. ( Ali, N; Almarshad, F; Alshahrani, AM; Jamil, A; Saleh Faisal, M, 2024) |
| " Controlled trials in elderly patients with epilepsy demonstrate efficacy and tolerability comparable to gabapentin." | 8.84 | Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. ( Nanry, K; Ramsay, E; Sajatovic, M; Thompson, T, 2007) |
| "This paper briefly reviews and comments on the development of lamotrigine as a treatment for bipolar disorder." | 8.84 | Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. ( Ascher, JA; Bowden, CL; Calabrese, JR; DeVeaugh-Geiss, J; Evoniuk, G; Weisler, RH, 2008) |
| "To review the best evidence comparing oxcarbazepine and phenytoin when used as monotherapy in patients with epilepsy." | 8.83 | Oxcarbazepine versus phenytoin monotherapy for epilepsy. ( Marson, AG; Muller, M; Williamson, PR, 2006) |
| " However, a particular association of valproate and carbamazepine with neural tube defects (NTDs)--specifically, with spina bifida aperta (SB)--has been identified." | 8.82 | Management issues for women with epilepsy: neural tube defects and folic acid supplementation. ( Yerby, MS, 2003) |
| "To check for an association between carbamazepine (CBZ) use by the mother during pregnancy and congenital eye malformations (i." | 8.81 | Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child? ( Cornel, MC; Kroes, HY; Reefhuis, J, 2002) |
| "To provide an overview of the evidence comparing carbamazepine (CBZ) and valproate (VPA) monotherapy for epilepsy, investigating whether existing data support the current practice of preferring CBZ for partial-onset and VPA for generalized-onset seizures." | 8.81 | Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. ( Chadwick, DW; Clough, H; Hutton, JL; Marson, AG; Williamson, PR, 2002) |
| "Carbamazepine and valproate are drugs of first choice for epilepsy." | 8.80 | Carbamazepine versus valproate monotherapy for epilepsy. ( Chadwick, DW; Clough, HE; Hutton, JL; Marson, AG; Williamson, PR, 2000) |
| "More than two-thirds of patients with WHO grade 2 glioma related epilepsy treated with levetiracetam first line achieve seizure freedom within 2 years and it is a reasonable first-choice agent." | 8.31 | Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure. ( Chumas, P; Fairclough, S; Goodden, J; Maguire, M; Mathew, R, 2023) |
| "Several studies have reported an association between certain human leukocyte antigen (HLA) alleles and carbamazepine (CBZ)-induced hypersensitivity reactions in patients with epilepsy." | 8.31 | Next-generation sequencing-based HLA typing reveals the association of HLA-B*46:01:01 and HLA-DRB1*09:01:02 alleles with carbamazepine-induced hypersensitivity reactions in Vietnamese patients with epilepsy. ( Bui, TP; Le, NTT; Le, PL; Nguyen, LTT; Nguyen, TD; Trinh, TH; Van Nguyen, AT; Van Nguyen, L, 2023) |
| "To investigate the antiseizure medication (ASM) doses required to achieve seizure freedom and their correlation with the World Health Organization's defined daily doses (DDDs) in patients aged 16 years or older with newly diagnosed epilepsy." | 8.31 | Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy. ( Hersi, H; Peltola, J; Raitanen, J; Saarinen, JT, 2023) |
| "A prospective longitudinal study was conducted to assess the Apo B100/A1 ratio as a marker of cardiovascular risk in children with epilepsy aged 5-14 years on long-term anti-seizure medication monotherapy with either sodium valproate, oxcarbazepine, or levetiracetam." | 8.31 | Change in Apo B100/A1 Ratio in Children With Epilepsy on Monotherapy With Sodium Valproate, Oxcarbazepine or Levetiracetam. ( Dhama, A; Kaushik, JS; Lekhwani, S, 2023) |
| "Carbamazepine may cause clinical effects such as dizziness and nystagmus." | 8.31 | Assessment of vestibulo-ocular reflex with video head impulse test in epilepsy patients undergoing carbamazepine monotherapy. ( Adiguzel, A; Demir, I, 2023) |
| "Carbamazepine is a medication used to treat a variety of neurological and psychiatric conditions including seizure disorders, neuropathic pain syndromes, and bipolar disorder." | 8.12 | Neurologic toxicity of carbamazepine in treatment of trigeminal neuralgia. ( Birdsong, S; Bridwell, RE; Brown, S; Clerkin, S; Long, B, 2022) |
| "Investigations on the effects of newly constructed glucose-PEG2000-DSPE modified carbamazepine nano system on oxidative stress damage and cell apoptosis in epilepsy." | 8.12 | Glucose-PEG2000-DSPE modified carbamazepine nano system alleviated cell apoptosis and oxidative stress in epilepsy. ( Wu, C; Xiao, K; Zhao, F, 2022) |
| "Background and Objectives: Hyponatremia is one of the most common adverse effects in patients treated with oxcarbazepine (OXC)." | 8.12 | Oxcarbazepine and Hyponatremia. ( Čiauškaitė, J; Gelžinienė, G; Jurkevičienė, G, 2022) |
| "This study aimed to investigate the factors affecting the plasma concentration of monohydroxylated derivative (MHD) of oxcarbazepine (OXC) in children with epilepsy." | 8.12 | Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy. ( Huang, A; Huang, S; Song, H; Yao, N, 2022) |
| " The efficacy evaluation of NPs/KCZ was evaluated in a kainic acid (KA)-induced mice model of epilepsy with carbamazepine (CBZ) treatment." | 8.12 | Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy. ( Fu, J; Lv, K; Sun, W; Wang, J; Yin, X; Zhang, J, 2022) |
| "Epilepsy is one of the most prevalent neurological conditions and carbamazepine is a commonly used anti-seizure drug (ASD), especially in developing nations." | 8.02 | Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: A cross-sectional study. ( Aghoram, R; Balachandran, M; Indira Priya, D; Jain, S; Meher, R; Nair, PP; Nandwani, S; Sreekumaran Nair, N; Wadwekar, V; Wagh, S, 2021) |
| "The study is aimed at comparing effects of older drugs like carbamazepine (CBZ) and newer agent like levetiracetam (LEV) on polycystic ovarian syndrome (PCOS) in women with epilepsy (WWE)." | 8.02 | Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy. ( Alabi, A; Makanjuola, A; Oboh, D; Ogunjimi, L; Ogunniyi, A; Olawale, O; Olusola-Bello, M; Osalusi, B; Yaria, J, 2021) |
| "We performed an observational study, collecting data between 2017 and 2019 on serum sodium levels and adverse effects retrospectively in people with epilepsy while receiving treatment with either carbamazepine (CBZ) or oxcarbazepine (OXC)." | 8.02 | Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. ( Berghuis, B; de Haan, GJ; Hulst, J; Koeleman, BPC; Lindhout, D; McCormack, M; Sander, JW; Sonsma, A, 2021) |
| "To evaluate the efficacy and tolerability of extended release carbamazepine (finlepsin-retard and tegretol CR) in adult patients with new-onset focal epilepsy (FE) with the assessment of epileptiform activity index (EAI)." | 8.02 | [The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index]. ( Karlov, VA; Kozhokaru, AB; Orlova, AS; Vlasov, PN, 2021) |
| "56 G > A rs17183814 on the response to lamotrigine monotherapy in patients with focal epilepsy in Herzegovina area, Bosnia and Herzegovina." | 7.91 | Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina. ( Basic, S; Bozina, N; Markovic, I; Pejanovic-Skobic, N, 2019) |
| "This study evaluated the effect of androsterone (AND), a metabolite of testosterone, on the ability of selected classical and novel antiepileptic drugs to prevent seizures caused by maximal electroshock (MES), which may serve as an experimental model of human generalized tonic-clonic seizures in mice." | 7.91 | Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice. ( Aebisher, D; Bartusik-Aebisher, D; Buszewicz, G; Kołodziejczyk, P; Mróz, K; Mróz, T; Tutka, P; Łuszczki, JJ, 2019) |
| " Therefore, we conducted a prospective longitudinal study to evaluate the effects of LEV and carbamazepine (CBZ) treatment on lipid profile and thyroid hormone levels in patients newly diagnosed with epilepsy." | 7.91 | Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study. ( Iijima, K; Ishida, Y; Maruyama, A; Nagase, H; Nakagawa, T; Nishimura, N; Nishiyama, M; Nozu, K; Takami, Y; Tanaka, T; Tokumoto, S; Tomioka, K; Toyoshima, D; Yamaguchi, H, 2019) |
| "The aims of this study were to identify the influencing factors such as gender, age, dose and combinations of other antiepileptic drugs (AEDs), especially in triple combinations on the pharmacokinetic of Lamotrigine (LTG) in epilepsy patients of Northwest Chinese Han population." | 7.91 | The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy. ( Han, X; Huang, J; Lv, J; Ma, L; Nie, X; Peng, L; Wang, J; Xia, L; Zan, X, 2019) |
| "This study investigates the neuronal protective effect of SXC combined with carbamazepine (CBZ) on epilepsy and cognitive impairment in kainic acid-kindled SD rats." | 7.91 | Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats. ( Chen, M; Jia, C; Jiao, H; Wei, L; Yang, H; Yin, W; Zhang, R, 2019) |
| "To assess the association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy." | 7.91 | [Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy]. ( Chen, H; Huang, J; Huang, L; Huang, Q; Liu, G; Qian, Z; Tang, X, 2019) |
| "We constructed a Markov model in a hypothetical cohort of adult Asian patients with epilepsy in the United States being considered for carbamazepine to investigate the cost-effectiveness of two alternative strategies: (1) no HLA-B*1502 gene allele screening and using carbamazepine and (2) HLA-B*1502 gene allele screening and starting levetiracetam in the case of a positive screen." | 7.91 | Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States. ( Choi, H; Mohit, B, 2019) |
| "Carbamazepine (CBZ) with piperine, the active ingredient in black pepper, which is omnipresent in food and may be potentially used for epilepsy control owing to its anticonvulsant effects, can be coadministered to epileptic patients." | 7.91 | Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats. ( Cheng, Y; Hu, M; Ren, T; Xiao, M; Xu, H; Yan, X; Yang, M; Zhang, C; Zhang, Y; Zhao, J; Zuo, Z, 2019) |
| "To assess the effect of monotherapy with Carbamazepine (CBZ) and Sodium valproate (VPA) on serum 25-OH Vitamin D levels in children with epilepsy compared to controls." | 7.88 | Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy. ( Devadathan, K; Mohammed Kunju, PA; Muthubeevi, S; Pillai, JP; Sasidharan, B; Sreedharan, M; Vasumathy Amma, MA, 2018) |
| "The goal of our study was to investigate the incidence of Stevens-Johnson syndrome (SJS), the frequency of SJS diagnosis, and the association between SJS and prior use of allopurinol, carbamazepine or phenytoin." | 7.88 | Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study. ( Cheng, CY; Cheng, FJ; Chuang, PC; Huang, YS; Pan, HY; Syu, FK, 2018) |
| "This study evaluated cochlear function in patients with idiopathic epilepsy and treated with carbamazepine (CBZ)." | 7.88 | Cochlear Function in Adults with Epilepsy and Treated with Carbamazepine. ( Hamed, SA; Oseilly, AM, 2018) |
| "Phenytoin (PHE) and carbamazepine (CBZ) are first rank causative drugs that can induce drug rash with eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)." | 7.88 | Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS/TEN in epilepsy patients. ( Kumkamthornkul, P; Srinoulprasert, Y; Tansit, T; Tuchinda, P; Udnaen, S, 2018) |
| "The objective of the EPICON Project is to develop a set of recommendations on how to adequately switch from carbamazepine (CBZ) and oxcarbazepine (OXC) to eslicarbazepine acetate (ESL) in some patients with epilepsy." | 7.88 | EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy. ( Bathal, H; Ojeda, J; Parra, J; Rocamora, RA; Rodríguez-Uranga, JJ; Serrano-Castro, PJ; Villanueva, V; Viteri, C, 2018) |
| "To ascertain possible determinants of carbamazepine (CBZ)- and oxcarbazepine (OXC)-induced hyponatremia in a large cohort of people with epilepsy." | 7.85 | Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. ( Berghuis, B; de Haan, GJ; Koeleman, BPC; Lindhout, D; Sander, JW; van der Palen, J, 2017) |
| "The aim of the study is to investigate the effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on plasma oxcarbazepine (OXC) concentrations and therapeutic efficacy in Han Chinese patients with epilepsy." | 7.85 | Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy. ( Ding, M; Ding, Y; Guo, Y; Liu, Z; Shen, C; Tang, Y; Wang, S; Zhang, B; Zhang, Y, 2017) |
| " The interactions among UGT1A4, UGT1A6, UGT1A9, and UGT2B15 genetic polymorphisms, monohydroxylated derivative (MHD) of oxcarbazepine (OXC) plasma concentrations, and OXC monotherapeutic efficacy were explored in 124 Chinese patients with epilepsy receiving OXC monotherapy." | 7.85 | Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy. ( Fang, Y; Lu, Y; Ma, C; Wang, Y; Wu, X; Xu, L, 2017) |
| "The PPK model, using the power scaling of body weight, effectively elucidated the topiramate serum concentration profile ranging from pediatric to adult patients." | 7.85 | Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data. ( Ikeda, A; Ito, S; Matsubara, K; Sugimoto, M; Takeuchi, M; Yamamoto, S; Yano, I; Yonezawa, A, 2017) |
| "The aim of the study was to develop a population pharmacokinetic (PPK) model of oxcarbazepine and optimize the treatment of oxcarbazepine in Chinese patients with epilepsy." | 7.83 | Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy. ( Hao, G; Lv, C; Xu, W; Yu, Y; Zhang, Q, 2016) |
| "This retrospective longitudinal study included 85 VPA-treated and 93 carbamazepine (CBZ)-treated (as a reference) young patients with epilepsy." | 7.83 | Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain. ( Ishitsu, T; Kajiwara, A; Nakagawa, K; Noai, M; Oniki, K; Saruwatari, J; Soraoka, H; Tanamachi, Y, 2016) |
| "To identify the factors influencing topiramate pharmacokinetics (PK) in a large population of adult patients with epilepsy using population PK analysis." | 7.83 | Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis. ( Bae, EK; Jang, IJ; Kim, TJ; Lee, J; Lee, KJ; Lee, SK; Moon, J; Shin, D; Shin, JW; Shin, YW, 2016) |
| "Studies of the effect of oxcarbazepine (OXC) on body growth of children with epilepsy are rare and their results are controversial." | 7.83 | Weight gain in children on oxcarbazepine monotherapy. ( Attilakos, A; Garoufi, A; Katsarou, E; Koemtzidou, E; Kossiva, L; Soldatou, A; Tsentidis, C; Vartzelis, G, 2016) |
| "Although it has been reported that some antiepileptic drugs have inducing or inhibiting effects on lamotrigine (LTG) clearance, whether they have the same effects in Asian epilepsy patients as in those in other countries has not been clarified, especially in children." | 7.83 | The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy. ( Abe, S; Azuma, Y; Ishihara, N; Ito, Y; Itomi, K; Kidokoro, H; Kojima, S; Kurahashi, H; Kurahashi, N; Maruyama, K; Natsume, J; Negoro, T; Okumura, A; Suzuki, M; Takeuchi, T; Tsuji, T; Watanabe, K; Yamada, K; Yamamoto, H, 2016) |
| "The aim of this study was to compare the risk of metabolic syndrome (MS) and evaluate related factors for MS among people with epilepsy treated with valproate (VPA) or carbamazepine (CBZ)." | 7.83 | Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine. ( Haldre, S; Kõks, S; Rakitin, A, 2016) |
| " Here, we suggest that triggering limbic seizures with low doses of PTZ in pilocarpine-treated marmosets might provide a more effective basis for the development of AED." | 7.83 | Seizures triggered by pentylenetetrazol in marmosets made chronically epileptic with pilocarpine show greater refractoriness to treatment. ( Blanco, MM; Cinini, SM; Lima, TZ; Mello, LE; Pontes, JC; Queiroz, CM, 2016) |
| "To prospectively evaluate the long-term impact of valproate (VPA) versus carbamazepine (CBZ) on anthropometric, hormonal, and metabolic parameters in young male patients treated for epilepsy." | 7.81 | Endocrine Effects of Valproate versus Carbamazepine in Males with Epilepsy: A Prospective Study. ( de Vries, L; Goldberg-Stern, H; Itzhaki, T; Landau, Z, 2015) |
| "2%) patients (8 valproate-treated, 6 carbamazepine-treated, 3 combination therapy, and 1 other) complained of inter-ictal headache." | 7.81 | [Effects of topiramate on headache in children with epilepsy]. ( Aihara, M; Kanemura, H; Sano, F; Sugita, K; Tando, T, 2015) |
| "Routine testing for HLA-A*31:01 in order to reduce the incidence of cutaneous adverse drug reactions in patients being prescribed carbamazepine for epilepsy is likely to represent a cost-effective use of health care resources." | 7.81 | Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. ( Alfirevic, A; Hughes, DA; Marson, AG; Pirmohamed, M; Plumpton, CO; Yip, VL, 2015) |
| "To examine the effects of cytochrome P450 3A4 (CYP3A4), cytochrome P450 3A5 (CYP3A5) and ATP-binding cassette sub-family B member 1 (ABCB1) genetic polymorphisms on carbamazepine (CBZ) plasma concentrations in Chinese patients with epilepsy using CBZ as monotherapy and bitherapy with phenytoin (PHT), phenobarbital (PB), or valproic acid (VPA)." | 7.81 | Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. ( Liu, DQ; Ma, HY; Sheng, YH; Wang, C; Wang, P; Yin, T; Zhou, BT, 2015) |
| " At the same time, the patient was diagnosed with hyperthyroidism and was given carbimazole and propranolol." | 7.80 | Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. ( Hui-Ping Khor, A; Lim, KS; Lo, YL; Ng, CC; Yeap, LL, 2014) |
| " The aim of this study is to determine the effect of oxcarbazepine (OXC) monotherapy on biochemical markers of bone metabolism and BMD in epilepsy patients." | 7.80 | Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. ( Han, SW; Hong, SB; Hwang, KJ; Joo, EY; Kim, JY; Koo, DL; Lee, HW; Seo, DW; Shin, WC, 2014) |
| "Lacosamide (LCM), a new antiepileptic drug (AED) approved as adjunctive therapy for the treatment of patients with partial-onset seizures, has limited pharmacokinetic and drug interaction data." | 7.80 | Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs. ( Duncan, JS; Markoula, S; Patsalos, PN; Ratnaraj, N; Sander, JW; Teotonio, R, 2014) |
| "The aims of this study were to characterize the alterations in total and free carbamazepine (CBZ) and in total and free carbamazepine-epoxide (CBZ-EPO) clearances during pregnancy, to calculate the change in free fractions of CBZ and CBZ-EPO during pregnancy, and to determine whether seizure worsening is associated with a low ratio to nonpregnant baseline concentration of total or free CBZ or CBZ-EPO." | 7.80 | Carbamazepine clearance and seizure stability during pregnancy. ( Johnson, EL; Knight, B; Newman, ML; Newport, DJ; Pennell, PB; Ritchie, JC; Stowe, ZN, 2014) |
| "The aims of this study were to characterize a lamotrigine-resistant kindled model of epilepsy in mice, to study the anticonvulsant effect of carbamazepine (CBZ) and valproic acid (VPA), and to probe into the mechanism for resistance." | 7.80 | Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms. ( Mehndiratta, M; Pillai, KK; Singh, E, 2014) |
| "This study explored the association between the risk of carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and CBZ dose, dose-adjusted concentration, and ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms in patients of Han ethnicity with epilepsy who were living in northeastern China." | 7.80 | Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. ( He, XJ; He, XL; Jian, LY; Sun, XJ; Tang, M; Wu, Y; Xu, YY; Zhao, LM, 2014) |
| "This study was to establish the population pharmacokinetic (PPK) model of pharmacologically active metabolite of oxcarbazepine (OXC) and to estimate PPK parameters for the optimal individuation administration of OXC in Chinese children with epilepsy." | 7.80 | Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy. ( Liu, ZS; Peng, J; Wang, Y; Xu, H; Zhang, HN, 2014) |
| "To investigate biochemical cardiovascular risk factors and vascular endothelial function and structure in children with epilepsy on antiepileptic drugs (AEDs), particularly sodium valproate (VPA) and carbamazepine (CBZ)." | 7.80 | Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine. ( Keenan, N; Sadlier, LG; Wiltshire, E, 2014) |
| "To investigate whether single nucleotide polymorphisms (SNPs) of rs2298771 and rs3812718 of the sodium channel α-subunit type 1 (SCN1A) gene affect the efficacy of carbamazepine (CBZ) treatment for seizures in Chinese Han epileptic patients." | 7.80 | Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients. ( Liu, Z; Sheng, Y; Tang, B; Wang, P; Zhou, B; Zhou, Q, 2014) |
| "To develop a population pharmacokinetics model of oxcarbazepine in Chinese pediatric patients with epilepsy, and to study the interactions between oxcarbazepine and other antiepileptic drugs (AEDs)." | 7.80 | Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy. ( Chen, YJ; Gao, P; Liu, MC; Niu, CH; Peng, J; Wang, Y; Xu, H; Zhang, HN, 2014) |
| "To facilitate therapeutic monitoring of antiepileptic drugs (AEDs) by healthcare professionals for patients with epilepsy (PWE), we applied a GC-MS assay to measure three AEDs: carbamazepine (CBZ), phenytoin (PHT) and valproic acid (VPA) levels concurrently in one dried blood spot (DBS), and validated the DBS-measured levels to their plasma levels." | 7.80 | Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy. ( Ho, PC; Kong, ST; Kumar, PK; Lee, WB; Lim, SH; Ng, YL; Wang, HY; Wong, PS, 2014) |
| "The present study aimed to evaluate the effects of SNPs of major transporter and metabolizing enzyme genes on carbamazepine (CBZ) metabolism in Chinese patients with epilepsy." | 7.80 | Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. ( Guo, Y; Qiu, F; Sun, X; Yun, W; Zhao, L; Zhu, X, 2014) |
| "Oxcarbazepine is an antiepileptic agent that has been used during pregnancy, although its safety during pregnancy has not been sufficiently established." | 7.79 | In utero oxcarbazepine and a withdrawal syndrome, anomalies, and hyponatremia. ( Klinger, G; Merlob, P; Rolnitsky, A, 2013) |
| "We report a stillborn, GA/LMP = 37 weeks, delivered by an epileptic woman, who received in the first four months of pregnancy phenobarbital (PH) 0." | 7.79 | Sirenomelia after phenobarbital and carbamazepine therapy in pregnancy. ( Brailoiu, CG; Cernea, N; Tica, AA; Tica, OS; Tica, VI, 2013) |
| "The pharmacokinetics and pharmacodynamics of carbamazepine (CBZ) vary widely among patients with epilepsy." | 7.79 | Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. ( Ge, Y; Guo, Y; Hu, C; Luo, X; Meng, H; Wang, J; Xue, P; Yun, W; Zhang, F, 2013) |
| " The patient also used carbamazepine 600 mg BID for epilepsy." | 7.79 | [Pulmonary embolism due to interaction between rivaroxaban and carbamazepine]. ( Risselada, AJ; van Roon, E; Visser, MJ, 2013) |
| "We studied 107 patients with epilepsy who received monotherapy with valproic acid drugs (58) and carbamazepine (49)." | 7.79 | [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy]. ( Avakian, GG; Avakian, GN; Bogomazova, MA; Delger, AB; Khromykh, EA; Lagutin, IuV; Oleĭnikova, OM, 2013) |
| "The participants included 53 epilepsy patients who received either valproic acid (VPA, n=26) or oxcarbazepine (OXC, n=27)." | 7.79 | Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. ( Arga, M; Arhan, E; Biberoglu, G; Cansu, A; Emeksiz, HC; Gulbahar, O; Hasanoglu, A; Serdaroglu, A, 2013) |
| " Carbamazepine (CBZ) is widely used in MS to control pain." | 7.78 | Comparison of carbamazepine rash in multiple sclerosis and epilepsy. ( Alvestad, S; Brodtkorb, E; Espeset, K; Hovdal, H; Lydersen, S; Shirzadi, M, 2012) |
| "We conducted a prospective, observational study to verify the efficacy, tolerability and impact on quality of life, mood and global neurocognitive performances of oxcarbazepine monotherapy in patients with brain tumor-related epilepsy (BTRE)." | 7.78 | Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. ( Dinapoli, L; Fabi, A; Maschio, M; Muti, P; Pace, A; Sperati, F; Vidiri, A, 2012) |
| "Individualization of carbamazepine (CBZ) dosage regimen in patients with epilepsy based on based on therapeutic drug monitoring (TDM) followed by estimation of pharmacokinetic (PK) parameters can help in better control of epilepsy." | 7.78 | Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. ( Bewernitz, M; Derendorf, H; El Desoky, ES; Hamdi, MM; Sabarinath, SN, 2012) |
| "Similar to valproic acid, carbamazepine increases the risk of neural tube defects; however, it does not increase the risk of other malformations." | 7.78 | Is carbamazepine safe to take during pregnancy? ( Koren, G; Matlow, J, 2012) |
| "The aim of this study was to investigate the genetic polymorphisms of UGT1A3, UGT1A6, and UGT2B7 in Chinese epilepsy patients and their potential influence on the pharmacokinetics of valproic acid (VPA)." | 7.78 | Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. ( Chu, XM; Hao, HP; Wang, GJ; Zhang, LF; Zhang, SN; Zhou, JH, 2012) |
| "An open pilot study to evaluate the effect of pregabalin (PGB) as add-on therapy on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy (BTRE)." | 7.78 | Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. ( Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A, 2012) |
| "The effects of ALAC administered per os were evaluated by standard protocols against audiogenic seizures in Genetic Epilepsy Prone Rats (GEPR-9 rats), maximal electroshock (MES)-induced seizures in rats, pilocarpine-induced seizures in mice, spontaneous chronic seizures in mice exposed to pilocarpine-induced status epilepticus (SE), and absence seizures in WAG/Rij rats." | 7.77 | Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. ( Citraro, R; De Fazio, S; De Sarro, G; Mainardi, P; Perucca, E; Raggio, R; Russo, E; Scicchitano, F, 2011) |
| "We describe the association of the HLA-B*1502 allele in 27 epilepsy patients (19 Malays, 8 Chinese) treated with carbamazepine (CBZ) at the UKM Medical Center (UKMMC), 6 with CBZ-Steven Johnson Syndrome (CBZ-SJS), 11 with CBZ-induced rash, 2 with suspected phenytoin-induced rash and 8 negative controls." | 7.77 | Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. ( Jamal, R; Rani, ZZ; Ratnaningrum, S; Raymond, AA; Then, SM, 2011) |
| "We present an implementation of a method we previously reported allowing the newer antiepileptic drugs (AEDs) rufinamide (RFN) and zonisamide (ZNS) to be simultaneously determined with lamotrigine (LTG), oxcarbazepine's (OXC) main active metabolite monohydroxycarbamazepine (MHD) and felbamate (FBM) in plasma of patients with epilepsy using high performance liquid chromatography (HPLC) with UV detection." | 7.76 | Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. ( Albani, F; Baruzzi, A; Candela, C; Contin, M; Mohamed, S; Riva, R, 2010) |
| "The aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (LEV), compared with patients taking carbamazepine (CBZ) or lamotrigine (LTG)." | 7.76 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. ( Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2010) |
| "We evaluated the serum leptin and insulin as predictors of weight gain in children receiving long-term treatment with valproate (VPA), carbamazepine (CBZ), lamotrigine (LTG)." | 7.75 | States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain. ( Fida, NM; Hamed, EA; Hamed, SA, 2009) |
| " The aim of the present work was to assess the involvement of P-glycoprotein in carbamazepine and phenobarbital hippocampal pharmacokinetics in an experimental model of epilepsy, induced by repetitive MP administration." | 7.75 | Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid. ( Girardi, E; Gonzalez, NN; Höcht, C; Lazarowski, A; Mayer, MA; Opezzo, JA; Taira, CA, 2009) |
| "The study includes 40 patients (31 boys, 9 girls) with epilepsy who had been treated with carbamazepine." | 7.75 | Cardiac effects of carbamazepine treatment in childhood epilepsy. ( Akaln, N; Arhan, E; Ayçiçek, S; Güven, A; Köse, G, 2009) |
| "Previous studies found a strong association between HLA-B*1502 and carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS) in Han Chinese, but not in Caucasian populations." | 7.74 | Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. ( Desudchit, T; Hirankarn, N; Kangwanshiratada, O; Korkij, W; Limotai, C; Locharernkul, C; Loplumlert, J; Shotelersuk, V; Suphapeetiporn, K; Tongkobpetch, S, 2008) |
| " This retrospective study of children with epilepsy, aged <12 years at enrollment, examined weight gain associated with valproic acid or carbamazepine monotherapy." | 7.74 | Lack of valproic acid-associated weight gain in prepubertal children. ( Baumann, RJ; Espinosa, PS; Mendiondo, MS; Robertson, WC; Salazar, JC; Yu, L, 2008) |
| "To determine the influence of valproate (VPA) treatment on acylcarnitines in children with epilepsy." | 7.74 | Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. ( Gerstner, T; Koenig, SA; Kohlmueller, D; Longin, E; Mehlem, P; Schulze, A; Teich, M; Treiss, I; Werner, T, 2007) |
| "Ecto-nucleotidases, one of the main mechanisms involved in the control of adenosine levels in the synaptic cleft, have shown increased activities after the pilocarpine model of epilepsy." | 7.74 | Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases. ( Bogo, MR; Bonan, CD; Bruno, AN; Cognato, Gde P; da Silva, RS; Sarkis, JJ, 2007) |
| "The present study evaluated the effectiveness of intraperitoneal (IP) injections and oral administration of carbamazepine (CBZ) in food on the frequency of spontaneous motor seizures in rats with kainate-induced epilepsy." | 7.74 | Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols. ( Clark, S; Dudek, FE; Grabenstatter, HL, 2007) |
| "OBJECTIVES - While carbamazepine (CBZ) decreases thyroid hormone concentrations it rarely causes hypothyroidism." | 7.74 | Carbamazepine and risk of hypothyroidism: a prospective study. ( Horacek, J; Simko, J, 2007) |
| "Carbamazepine treatment of paediatric patients with epilepsy resulted in an induction of CYP3A4/5 and a concomitant increase in plasma 4beta-hydroxycholesterol." | 7.74 | Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. ( Bertilsson, L; Diczfalusy, U; Larsson, H; Wide, K, 2008) |
| "To compare the temporal pattern of seizures after acute withdrawal of oxcarbazepine (OXC) and phenytoin (PHT) in the epilepsy monitoring unit (EMU)." | 7.74 | Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring. ( Abou-Khalil, BW; Azar, NJ; Song, Y; Wang, L, 2008) |
| "This is the first report demonstrating an association between the SCN1A polymorphism and carbamazepine-resistant epilepsy." | 7.74 | Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. ( Abe, T; Hori, M; Ishitsu, T; Nakagawa, K; Nakagawa, T; Seo, T, 2008) |
| "The aim of the study was to obtain pharmacokinetic data for carbamazepine (CBZ) and its fractions not bound with proteins in bitherapy with lamotrigine (LTG), topiramate (TPM), vigabatrin (VGB) or valproic acid (VPA) in children and adolescents treated for epilepsy." | 7.73 | Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents. ( Steinborn, B, 2005) |
| "A very simple and fast method has been developed and validated for simultaneous determination of the new generation antiepileptic drugs (AEDs) lamotrigine (LTG), oxcarbazepine's (OXC) main active metabolite monohydroxycarbamazepine and felbamate in plasma of patients with epilepsy using high-performance liquid chromatography (HPLC) with spectrophotometric detection." | 7.73 | Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. ( Albani, F; Balboni, M; Baruzzi, A; Callegati, E; Candela, C; Contin, M; Riva, R, 2005) |
| "We measured the brain-to-plasma partition of 10,11-dihydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide (10-OHCBZ) in epilepsy patients undergoing surgery to alleviate drug-resistant seizures and administered with different oral doses of oxcarbazepine (OXC)." | 7.73 | A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. ( Baumgartner, C; Caccia, S; Czech, T; Guiso, G; Janigro, D; Marchi, N; Novak, K; Pirker, S; Rizzi, M; Vezzani, A, 2005) |
| " We describe two patients with idiopathic generalized epilepsy in whom nonconvulsive status epilepticus, aggravated by carbamazepine, was misdiagnosed as psychiatric disorder." | 7.73 | Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. ( D'Arcangelo, G; Guerrini, R; Marini, C; Masi, G; Parmeggiani, L, 2005) |
| "We studied total serum levels of carbamazepine (CBZ) serially, before and after five PEX cycles, in an epilepsy patient who underwent PEX for myasthenia gravis." | 7.73 | Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy. ( Ahmed, SN; Holt, A; Siddiqi, ZA, 2005) |
| "Authors presented the data on the efficacy and tolerability of the new anticonvulsant drug topiramate (topamax) in the treatment of 110 children aged from 6 months to 16 years with pharmacoresistant types of epilepsy including 42 patients with tuberous sclerosis." | 7.73 | [The efficacy of topiramate (topamax) in the treatment of resistant epilepsy in children]. ( Belousova, ED; Dorofeeva, MIu; Ermakov, AIu, 2005) |
| "The authors examined sodium concentrations from 97 oxcarbazepine-treated (OXC) and 451 carbamazepine-treated (CBZ) patients with epilepsy using cross-section and follow-up studies." | 7.73 | Hyponatremia from oxcarbazepine and carbamazepine. ( Dong, X; Leppik, IE; Rarick, J; White, J, 2005) |
| "To determine potential changes in the plasma concentrations of oxcarbazepine (OXC) and its metabolites during pregnancy and puerperium." | 7.73 | Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. ( Atakli, D; Gatti, G; Mazzucchelli, I; Neve, AL; Onat, FY; Ozkara, C; Perucca, E; Specchio, LM, 2006) |
| "A 70-year-old patient treated with oxcarbazepine experienced severe hyponatremia." | 7.73 | [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine]. ( Gumbrevicius, G; Sveikata, A, 2006) |
| "The aim of the study was to compare the effects of carbamazepine (CBZ) and oxcarbazepine (OXC) on the reproductive endocrine function in women with epilepsy." | 7.73 | Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. ( Isojärvi, JI; Koivunen, R; Löfgren, E; Pakarinen, A; Tapanainen, JS, 2006) |
| "We assessed the concentration of the oxcarbazepine metabolite 10-hydroxycarbazepine (MHD) in nine pregnancies among seven women before, during, and after pregnancy." | 7.73 | Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy. ( Christensen, J; Sabers, A; Sidenius, P, 2006) |
| " Following pilocarpine-induced status epilepticus interrupted after 4h, rats were continuously videorecorded for onset and recurrence of spontaneous convulsive seizures." | 7.73 | Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat. ( Bentivoglio, M; Chakir, A; Fabene, PF; Ouazzani, R, 2006) |
| "Epileptic patients receiving medications such as phenytoin or phenobarbital have been noted to have an exceedingly low incidence of myocardial infarction, but children treated with carbamazepine have shown alteration of their serum lipid profile that could predispose them to atherosclerosis." | 7.72 | Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine. ( de Chadarévian, JP; Katsetos, CD; Legido, A; Miles, DK, 2003) |
| "To investigate the pharmacokinetic profile of carbamazepine (CBZ) in Chinese epilepsy patients." | 7.72 | Population pharmacokinetics of carbamazepine in Chinese epilepsy patients. ( Hu, M; Jiao, Z; Shi, XJ; Zhang, JH; Zhong, MK, 2003) |
| "Prolonged antiepilepsy drug treatment can result in secondary carnitine deficiency." | 7.72 | Serum carnitine levels during oxcarbazepine and carbamazepine monotherapies in children with epilepsy. ( Dirik, E; Iscan, A; Kurul, S, 2003) |
| "We report a rare case of severe hyponatremia with coma induced by the use of oxcarbazepine after one month of treatment, in pos-operatory of neurosurgery." | 7.72 | [Hyponatremic coma induced by oxcarbazepine: case report]. ( da Silva, JA; Holanda, MM; Quinino, SC, 2003) |
| "A 70-year-old woman under anticonvulsive therapy with carbamazepine and valproate was diagnosed as polymyalgia rheumatica." | 7.72 | [A case of polymyalgia rheumatica with improved steroid-responsibility after discontinuing carbamazepine]. ( Katada, S; Kobayashi, H; Sato, A; Sato, M, 2004) |
| "This study addresses the question of epileptogenesis by investigating the effects of carbamazepine (CBZ) on the silent period of the pilocarpine model of epilepsy." | 7.71 | Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy. ( Capella, HM; Lemos, T, 2002) |
| "In order to investigate the possible role of valproic acid therapy in the development of obesity, hyperinsulinism and polycystic ovaries (PCOs), we have studied metabolic parameters and ovarian morphology in epileptic women." | 7.71 | Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. ( Abraham, I; Alge, A; Bauer, G; Haslinger, M; Lechleitner, M; Luef, G; Seppi, K; Trinka, E; Unterberger, I; Windisch, J, 2002) |
| " The boy was exposed to phenytoin, in combination with carbamazepine, during pregnancy." | 7.71 | Chondrodysplasia punctata (CDP) with features of the tibia-metacarpal type and maternal phenytoin treatment during pregnancy. ( Annerén, G; Brandberg, G; Larsson, M; Lönnerholm, T; Wester, U, 2002) |
| "While severe hyponatremia is reported to be more frequent in adults treated with oxcarbazepine (OXC) than with carbamazepine (CBZ), there is not sufficient data about the incidence of hyponatremia in childhood during treatment with OXC." | 7.71 | Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children. ( Boenigk, HE; Holtmann, M; Korn-Merker, E; Krause, M; Opp, J; Tokarzewski, M, 2002) |
| " We report the case of a patient with a history of epilepsy (taking carbamazepine, Tégrétol LP) and Addison's disease (treated by hydrocortisone (HDC) 30 mg/d, Dectancyl 0,5 mg/d, Florinef 50 mg/d)." | 7.71 | [Generic carbamazepine-induced subacute adrenal insufficiency?]. ( Estour, B; Guy, C; Millot, L; Mounier, C; Vergely, N, 2002) |
| "It is not known whether polytherapy with carbamazepine (CBZ) and valproate (VPA) increases the risk of thrombocytopenia." | 7.71 | Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate. ( Finsterer, J; Hess, B; Pelzl, G, 2001) |
| " This study aimed to evaluate thyroid function in men taking carbamazepine (CBZ), oxcarbazepine (OCBZ), or valproate (VPA) for epilepsy." | 7.71 | Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. ( Isojärvi, JI; Kotila, M; Myllylä, VV; Pakarinen, AJ; Rättyä, J; Turkka, J, 2001) |
| "Carbamazepine efficacy in the children with epilepsy is significantly lower in the presence of parietal theta rhythm." | 7.71 | [Parietal theta rhythms in carbamazepine therapy of children with epilepsy]. ( Kudriavtseva, EP; Vorob'eva, OV, 2001) |
| "Dynamics of carbamazepine and valproic acid concentrations in the middle of follicular and lutein menstrual cycle phases has been studied in women with epilepsy, aged 21-30 years." | 7.71 | [Pharmacokinetic aspects of carbamazepine and valproic acid using in reproductive-age women with epilepsy]. ( Karlov, VA; Sokolov, AV; Tishchenkova, IF; Vlasov, PN, 2002) |
| "To report a case of transient cholestatic hepatitis occurring in an infant between the third and seventh weeks of life, most likely due to carbamazepine exposure during pregnancy and breast feeding." | 7.71 | Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. ( Braegger, CP; Frey, B; Ghelfi, D, 2002) |
| "We report the case of a 12-year-old girl with severe clinically relevant hyponatremia (118 mmol/l) and hypochloremia (81 mmol/l) during treatment with oxcarbazepine (OCBZ)." | 7.70 | Hyponatremia induced by oxcarbazepine in children. ( Boenigk, HE; Borusiak, P; Holert, N; Korn-Merker, E, 1998) |
| "The last premortem serum concentrations of phenobarbital (PB), phenytoin (PHT), carbamazepine (CBZ) and its CBZ-10,11-epoxide metabolite (CE) were compared with the corresponding postmortem serum concentrations in 16 adult patients of an epilepsy centre." | 7.70 | Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy. ( Jürgens, U; May, T; Rambeck, B; Schnabel, R, 1999) |
| "Forty girls taking valproate (VPA), 19 girls taking carbamazepine (CBZ), and 18 girls taking oxcarbazepine (OXC) for epilepsy and 49 healthy control girls participated in the study, which included a cross-sectional clinical examination when the girls were 8 to 18 years old and a longitudinal growth analysis from the age of 1 year." | 7.70 | The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. ( Isojärvi, JI; Knip, M; Lanning, P; Rättyä, J; Vainionpää, L, 1999) |
| "Carbamazepine produces dose-related anticonvulsant effects in epilepsy models including the genetically epilepsy-prone rat (GEPR) model and the rat maximal electroshock model." | 7.70 | Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. ( Birkhahn, D; Burk, A; Dailey, JW; Graumlich, JF; Jobe, PC; McLaughlin, RG; Shah, N, 1999) |
| "We determined serum levels of triiodothyronine (T3), thyroxine (T4), free thyroxine (FT4), thyroxine-binding globulin (TBG), and thyroid-stimulating hormone (TSH) in 148 healthy children and 141 children with epilepsy who had been receiving CBZ (61 patients), VPA (51 patients), or PB (29 patients) for 12-161 months." | 7.70 | Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. ( Castro-Gago, M; Del Río-Garma, M; Del Río-Garma, MC; Eirís-Puñal, J; Lojo-Rocamonde, S; Novo-Rodríguez, I, 1999) |
| "A comparative study was conducted to evaluate the efficacy and tolerability of oxcarbazepine administration in patients with a diagnosed intractable epilepsy with simple partially and complex seizures secondarily generalised." | 7.70 | [Oxcarbazepine in the treatment of drug-resistant epilepsy in children and adolescents: preliminary study]. ( Kluczyński, A, 2000) |
| "25 of Pynnönen (Method 2) to predict the unbound serum carbamazepine (CBZ) concentration in 50 serum samples from 28 polytherapy pediatric patients with epilepsy." | 7.69 | Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy. ( Fujii, I; Kodama, H; Kodama, Y; Kuranari, M; Takeyama, M, 1995) |
| "We evaluated the effects of carbamazepine (CBZ) on serum androgen levels and sexual function prospectively for 5 years in 11 men with epilepsy and in 25 patients receiving either CBZ (14 patients) or phenytoin (PHT) (11) monotherapy for > 5 years." | 7.69 | Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. ( Isojärvi, JI; Lukkarinen, O; Myllylä, VV; Pakarinen, AJ; Repo, M, 1995) |
| "Urinary excretions of carbamazepine, carbamazepine-10,11-epoxide, carbamazepine-10,11-trans-diol, 9-hydroxyacridan and 2- and 3-hydroxycarbamazepine were measured at various stages of pregnancy, and in the post-natal period, in ten epileptic women, six of whom took no other enzyme-inducing anticonvulsant and four of whom took such co-medication." | 7.69 | Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy. ( Bernus, I; Dickinson, RG; Eadie, MJ; Hooper, WD, 1995) |
| "The case of a patient who developed thrombocytopenia during treatment with carbamazepine (CBZ) is described." | 7.69 | Carbamazepine-induced thrombocytopenia and carbamazepine-10,11-epoxide: a case report. ( Kimura, M; Maeoka, Y; Suzuki, N; Yoshino, K, 1995) |
| "The interaction between clearance of phenytoin, valproic acid, phenobarbital and carbamazepine, and changes in body weight was determined in a 19-year-old obese woman with epilepsy (body weight 93 kg, BMI 36." | 7.69 | Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study. ( Ashikari, Y; Chiba, S; Kodama, Y; Kuranari, M; Sakata, T; Takeyama, M, 1996) |
| "The purpose of the study was to assess whether there was an increased rate of congenital anomalies or significant developmental delay in infants of women with epilepsy who had been treated with carbamazepine during pregnancy." | 7.69 | Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. ( Cohen, E; Ornoy, A, 1996) |
| "The case history of a patient developing tubulointerstitial nephritis (TIN) during carbamazepine therapy is described." | 7.69 | Carbamazepine-associated acute tubulointerstitial nephritis. ( Buurke, EJ; Eijgenraam, JW; van der Laan, JS, 1997) |
| "Nineteen children with epilepsy were tested on two occasions, first during treatment with carbamazepine (CBZ) and then 6 months later without treatment." | 7.69 | Motor impairments in children with epilepsy treated with carbamazepine. ( Braathen, G; Theorell, K; von Bahr, L, 1997) |
| "The antiepileptic drug carbamazepine produces dose related anticonvulsant effects in genetically epilepsy-prone rats (GEPRs) and most other animal seizure models." | 7.69 | Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. ( Dailey, JW; Jobe, PC; Li, MY; Reith, ME; Yan, QS, 1997) |
| "The effect of ketoconazole (200 mg/d orally for 10 days) on the plasma concentrations of carbamazepine (CBZ) and its active metabolite carbamazepine-10,11-epoxide (CBZ-E) was assessed in eight patients with epilepsy stabilized on CBZ therapy." | 7.69 | Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy. ( Arena, D; Fazio, A; Perucca, E; Pisani, F; Scordo, MG; Spina, E, 1997) |
| "Very little data are available on the usefulness of oxcarbazepine in young children with epilepsy." | 7.69 | Oxcarbazepine in the treatment of early childhood epilepsy. ( Gaily, E; Granström, ML; Liukkonen, E, 1997) |
| "We examined the anticonvulsant effects of BW1003C87 (5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine ethane sulphonic acid), which is structurally related to the new antiepileptic drug, lamotrigine, and compared its effects to those of the conventional antiepileptic drugs, phenytoin and carbamazopine, using the rat amygdala-kindling model of epilepsy." | 7.69 | BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. ( Morimoto, K; Sato, H; Sato, K; Sato, S; Yamada, N, 1997) |
| " The first patient was a boy with epilepsy, whose symptoms first appeared following treatment with carbamazepine." | 7.68 | Carbamazepine hypersensitivity and rickettsiosis mimicking Kawasaki disease. ( Garoufi, A; Karpathios, T; Parha, S; Theodoridis, C; Yiallouros, P, 1993) |
| "The purpose of the present study was to compare the pharmacokinetic parameters of two carbamazepine (CBZ) tablet formulations (conventional (CBZ-CO) and controlled-release (CBZ-CR)) in patients with epilepsy receiving the drug as monotherapy or polytherapy." | 7.68 | Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy. ( Bonneton, J; Dravet, C; Genton, P; Iliadis, A; Mesdjian, E; Viallat, D, 1993) |
| "In order to investigate the mechanism of action of anticonvulsant drugs, we examined the effects of carbamazepine (CBZ) and antiepilepsirine (AE) on convulsions and on brain biogenic amines in genetically epilepsy-prone rats (GEPR)." | 7.68 | Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. ( Bettendorf, AF; Burger, RL; Dailey, JW; Jobe, PC; Mishra, PK; Yan, QS, 1992) |
| "Information from standardised tests of intelligence, school attainments, attention, memory and visuomotor function, together with parent and teacher questionnaire information about various aspects of behaviour, was obtained for 63 schoolchildren with newly diagnosed epilepsy before treatment with sodium valproate or carbamazepine, and again at intervals for a total period of 12 months." | 7.68 | Psychological effects of sodium valproate and carbamazepine in epilepsy. ( Stores, G; Styles, E; Williams, PL; Zaiwalla, Z, 1992) |
| "The effect of aging on carbamazepine (CBZ) plasma level/dose ratio was evaluated retrospectively in 15 children who were receiving CBZ monotherapy and who were followed up for at least 3 years." | 7.68 | A within-subject analysis of carbamazepine disposition related to development in children with epilepsy. ( Albani, F; Baruzzi, A; Contin, M; Riva, R, 1992) |
| "We retrospectively collected plasma level assessments performed in 96 adult patients with epilepsy on stable monotherapy, including 9 patients on clobazam (CLB), 34 on carbamazepine (CBZ), 24 on phenobarbital (PB), 9 on phenytoin (PHT), and 20 on valproate (VPA); these results were compared to those obtained in 54 adult patients on stable bitherapy with the association of CLB with either CBZ (n = 17), PB (n = 17), PHT (n = 5), or VPA (n = 15)." | 7.68 | Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. ( Bonneton, J; Dravet, C; Genton, P; Mesdjian, E; Roger, J; Sennoune, S, 1992) |
| "We report the first comparison of Chewable and Regular Carbamazepine (CBZ) tablets in children with epilepsy." | 7.68 | The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy. ( al-Quadah, AK; Camfield, C; Camfield, P; Fraser, A; Hwang, P; Soldin, S, 1992) |
| "We report the cases of four patients who were taking the anticonvulsant drugs phenytoin or carbamazepine and in whom skin lesions developed that showed histologic features suggestive of mycosis fungoides." | 7.68 | Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. ( Kruyswijk, MR; Meijer, CJ; Rijlaarsdam, U; Scheffer, E; Willemze, R, 1991) |
| "Four young patients who developed weight gain induced by carbamazepine therapy are described." | 7.68 | Weight gain, increased appetite, and excessive food intake induced by carbamazepine. ( Eshel, Y; Lampl, Y; Rapaport, A; Sarova-Pinhas, I, 1991) |
| "We report a 3-week-old boy with cholestatic hepatitis, most likely due to carbamazepine exposure during pregnancy and breastfeeding." | 7.68 | Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. ( Frey, B; Musy, JP; Schubiger, G, 1990) |
| "A total of 64 problem patients with epilepsy (42 retrospective evaluations, 22 prospective cases) was treated with the combination of carbamazepine and valproic acid." | 7.67 | [Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic]. ( Fröscher, W; Hoffmann, F; Stoll, KD, 1984) |
| "Ninety children with epilepsy were treated with carbamazepine (CBZ) alone or with other anticonvulsant drugs." | 7.67 | Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy. ( Brett, EM; Elyas, AA; Lascelles, PT; Schoeman, JF, 1984) |
| "One hundred seventy-six children treated with carbamazepine for epilepsy were monitored over a 12-month period to determine the effects of carbamazepine on the hematologic system." | 7.67 | Hematologic monitoring in children with epilepsy treated with carbamazepine. ( Evans, OB; Gay, H; Parks, B; Swisher, A, 1989) |
| "Carbamazepine clearance was studied in Black paediatric epilepsy patients, 90 receiving monotherapy and 17 on combination therapy." | 7.67 | Carbamazepine clearance in paediatric epilepsy patients. Influence of body mass, dose, sex and co-medication. ( Summers, B; Summers, RS, 1989) |
| "To assess the most efficient means of monitoring thyroid status in an epilepsy clinic, total thyroxine (T4), free thyroxine stimulating hormone (TSH) were measured in 71 adult patients treated long-term with either phenytoin (DPH), carbamazepine (CBZ) or sodium valproate (VAL)." | 7.67 | The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. ( Borsey, DQ; Browning, MC; Connacher, AA; Davidson, DL; Jung, RT, 1987) |
| "A 36-year-old woman on long-term anticonvulsant therapy with carbamazepine (Tegretol) sustained superficial facial and corneal burns after using a photocopier for 2 h." | 7.67 | Carbamazepine-induced facial burns caused by a photocopier. ( Ward, DJ, 1987) |
| "Simultaneous steady-state serum total and free (non-protein-bound) concentrations of carbamazepine and carbamazepine-10,11-epoxide were measured in 68 patients under the age of 21 years with epilepsy (44 males, 24 females; mean age, 11." | 7.67 | Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy. ( Agbato, OA; Brett, EM; Elyas, AA; Lascelles, PT; Patsalos, PN, 1986) |
| "Sixty patients receiving carbamazepine and 61 age-matched controls were studied to determine the prevalence of hyponatremia." | 7.67 | Hyponatremia during carbamazepine therapy. ( Lahr, MB, 1985) |
| "Carbamazepine (20 mg/kg, 40 mg/kg or 60 mg/kg) given three times a day, has been demonstrated to have a significant anti-epileptic effect in rats with chronic limbic epilepsy induced by injecting tetanus toxin bilaterally into their hippocampi." | 7.67 | Antiepileptic and antiamnesic effect of carbamazepine in experimental limbic epilepsy. ( Brown, J; Hawkins, CA; Mellanby, J, 1985) |
| " A case of non-hereditary acute porphyria, similar to acute intermittent porphyria, following treatment of epilepsy with carbamazepine is reported." | 7.66 | Carbamazepine-induced non-hereditary acute porphyria. ( Brodie, MJ; Goldberg, A; Macphee, GJ; Moore, MR; Philip, MF; Rapeport, WG; Thompson, GG; Yeung Laiwah, AA, 1983) |
| "IgA, IgG and IgM concentrations were determined in sera and nasal washings from 20 patients with epilepsy on single-drug treatment with carbamazepine, in 20 patients on single-drug treatment with phenobarbital and in 26 healthy subjects." | 7.66 | Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital. ( Aarli, JA; Gilhus, NE; Strandjord, RE, 1982) |
| "Carbamazepine serum levels have been determined by gas-liquid chromatography in 24 children and 26 adults with epilepsy on chronic carbamazepine treatment." | 7.66 | Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy. ( Kumps, AH, 1981) |
| "We describe a procedure for determining 2-ethyl-2-phenylmalonamide (I) in serum of epilepsy patients dosed with primidone (II) for seizure control, by extracting the sample with chloroform under basic conditions, with use of an internal standard, 2-ethyl-2-(p-tolyl)malonamide, and without derivative formation." | 7.66 | Monitoring 2-ethyl-2-phenylmalonamide in serum by gas-liquid chromatography: application to retrospective study in epilepsy patients dosed with primidone. ( Haidukewych, D; Rodin, EA, 1980) |
| "Many anticonvulsants are known to cause osteomalacia, however, carbamazepine has not previously been studied in this regard." | 7.66 | Biochemical evidence for osteomalacia with carbamazepine therapy. ( Callaghan, N; Duggan, B; O'Driscoll, D; O'Hare, JA, 1980) |
| "Serum levels and seizure control were investigated in a prospective study when carbamazepine was given as a single drug to 32 patients with a variety of seizures." | 7.66 | Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. ( Callaghan, N; Duggan, B; Feely, M; O'Callaghan, M, 1978) |
| "The plasma concentrations of carbamazepine and its 10,11-epoxide were measured in 37 children and 13 adults with epilepsy during maintenance therapy." | 7.65 | Carbamazepine and its 10,11-epoxide in children and adults with epilepsy. ( Frey, H; Iisalo, E; Pynnönen, S; Sillanpää, M, 1977) |
| " Thirteen ambulant patients suffering from partial epilepsy with complex symptomatology, who were already being treated with phenytoin in optimal doses (plasma level 14-20 mug/ml) were also given carbamazepine." | 7.65 | Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy. ( Bertilsson, L; Eichelbaum, M; Lund, L; Palmér, L; Sjöqvist, F, 1976) |
| "Relapse of seizures can have major adverse psychosocial consequences and also may carry a risk of morbidity and mortality." | 7.01 | Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy? ( Asadi-Pooya, AA; Mesraoua, B; Perucca, E; Tomson, T, 2023) |
| " The stable-labeled intravenous dosing methodology enabled the estimation of the CBZ clearance (CL) and volumes of distribution." | 6.78 | Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy. ( Ahmed, GF; Birnbaum, AK; Brundage, RC; Cloyd, JC; Leppik, IE; Marino, SE; Pennell, PB; Ramsay, RE, 2013) |
| "Temozolomide treatment did not affect TPM plasma concentrations in chronically treated patients." | 6.73 | Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. ( Albani, F; Baruzzi, A; Contin, M; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Zarabla, A, 2008) |
| " There was no significant difference between the two groups with respect to premature discontinuation due to adverse events." | 6.71 | Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. ( Beydoun, A; D'Souza, J; Kutluay, E; McCague, K, 2003) |
| " Patients were converted during an carbamazepine, phenytoin, or valproate) to lamotrigine via a protocol-specified dosing algorithm or to conventional therapy via standard dosing guidelines." | 6.71 | Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. ( Hammer, AE; Kaminow, L; Schimschock, JR; Vuong, A, 2003) |
| "25 for each of the pharmacokinetic parameters for CBZ and for the summation of CBZ and CBZ-epoxide (CBZ-E)." | 6.69 | Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy. ( Belendiuk, GW; Couch, RA; Garnett, WR; Levy, B; McLean, AM; Pellock, JM; Rudnic, EM; Zhang, Y, 1998) |
| "Oxcarbazepine appears to be an effective and well-tolerated drug for children and adolescents with intellectual disability and epilepsy." | 6.69 | Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. ( Gaily, E; Granström, ML; Liukkonen, E, 1998) |
| "Study was conducted to compare the pharmacokinetic profile of conventional and slow-release carbamazepine formulations in Indian epileptic patients." | 6.69 | A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation. ( Agarwal, A; Garg, RK; Nag, D, 1998) |
| " The median elimination half-life (t1/2) in patients receiving concomitant valproate (VPA) was 43." | 6.68 | Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. ( Boreus, L; Eriksson, AS; Hoppu, K; Nergårdh, A, 1996) |
| " Both dosage regimens of lamotrigine were well tolerated." | 6.68 | A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. ( Dam, M; Reunanen, M; Yuen, AW, 1996) |
| " for 10 days) on the steady-state plasma concentrations of Oxcarbazepine (OXC), its active metabolite 10, 11-dihydro-10-hydroxy-carbazepine (MHD) and the corresponding diol (DHD) were studied in a randomized, double-blind cross-over placebo-controlled trial in 6 epileptic patients stabilized on a fixed dosage of OXC." | 6.67 | Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. ( Artesi, C; Di Perri, R; Fazio, A; Oteri, G; Perucca, E; Pisani, F; Xiao, B, 1994) |
| "The in-vitro dissolution profiles of two carbamazepine formulations (Tegretol and a generic carbamazepine) have been assessed and the bioavailability of carbamazepine compared in 12 epileptic children at steady-state." | 6.67 | Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy. ( Aleksandrowicz, J; Bowmer, CJ; Cawood, A; Forsythe, WI; Hartley, R, 1991) |
| " The bioavailability of CBZ from the two preparations was similar." | 6.67 | Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Kaski, M; Sivenius, J; Tuominen, J, 1991) |
| " The twice-a-day dosage should result in better compliance and consequently in a better quality of treatment in the long term." | 6.67 | [Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults]. ( Remy, C, 1990) |
| "Epilepsy is one of the most common neurological disorders, affecting approximately 50 million people worldwide." | 6.66 | Current role of carbamazepine and oxcarbazepine in the management of epilepsy. ( Beydoun, A; DuPont, S; Lagae, L; Matta, M; Nagire, V; Zhou, D, 2020) |
| " In the dosage used, l-tryptophan was tolerated well by these children, and seizure frequency, as a whole, remained unaltered." | 6.65 | l-Tryptophan in hyperactive child syndrome associated with epilepsy: a controlled study. ( Ghose, K, 1983) |
| "Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures." | 6.50 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Saunders, M, 2014) |
| "Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures." | 6.50 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Rigby, A; Saunders, M, 2014) |
| "Phenobarbital was associated with a higher rate of drug withdrawal although there was no evidence to suggest that phenobarbital caused more adverse events compared to carbamazepine, valproic acid or phenytoin." | 6.47 | Side effects of phenobarbital in epilepsy: a systematic review. ( Li, YP; Zeng, LN; Zhang, LL, 2011) |
| "Levetiracetam has a novel structure and unique mechanisms of action." | 6.47 | Spotlight on levetiracetam in epilepsy. ( Lyseng-Williamson, KA, 2011) |
| "Carbamazepine is a widely used drug." | 6.43 | Carbamazepine-induced acute liver failure as part of the DRESS syndrome. ( Holt, AP; Mutimer, DJ; Naisbitt, DJ; Pirmohamed, M; Syn, WK, 2005) |
| "Lamotrigine is a relatively new AED which is licensed in many countries for use as an initial monotherapy." | 6.43 | Lamotrigine versus carbamazepine monotherapy for epilepsy. ( Gamble, CL; Marson, AG; Williamson, PR, 2006) |
| "Oxcarbazepine was generally well tolerated during monotherapy and adjunctive therapy; 2." | 6.42 | Oxcarbazepine: a review of its use in children with epilepsy. ( Bang, L; Goa, K, 2003) |
| "Carbamazepine is a major antiepileptic drug which is primarily used to treat epileptic patients suffering from partial seizures with or without secondary generalization, but which also has applications in those suffering from primary generalized tonic-clonic seizures." | 6.40 | Carbamazepine in the treatment of epilepsy in people with intellectual disability. ( Alvarez, N; Waisburg, H, 1998) |
| "Plasma concentrations of lamotrigine, an antiepileptic drug obtained in three adult controlled clinical trials conducted in the United States were pooled and analyzed using NONMEM, a population pharmacokinetic computer program, to facilitate development of dosing guidelines." | 6.40 | Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy. ( Chen, C; Cox, E; Fiedler-Kelly, J; Grasela, TH; Risner, ME; Womble, GP, 1999) |
| " Other topics were: psychotropic effect of antiepileptic drugs, folic acid and vitamin D administration in epilepsy, and EEG investigations." | 6.15 | Controlled trials in epilepsy: a review. ( Bentsen, KD; Flachs, H; Gram, L; Parnas, J, 1982) |
| "Lacosamide (LCM) is a third-generation antiepileptic drug (AED) that affects sodium channel inactivation." | 5.72 | Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting. ( Eguchi, Y; Ishikawa, N; Izumo, H; Kobayashi, Y; Okada, S; Tateishi, Y, 2022) |
| "Drug-resistant epilepsy is a problem worldwide." | 5.62 | Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients. ( Kong, FC; Lang, LQ; Ma, CL; Zhong, MK, 2021) |
| "This study aimed to develop a pharmacokinetic (PK) model of oxcarbazepine (OXC) and analyse the relationship between monohydroxylated derivative (MHD), an active metabolite of OXC, and the adverse events of OXC." | 5.62 | Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy. ( Chu, K; Jang, IJ; Jang, Y; Kim, TJ; Lee, S; Lee, SK; Yoon, S; Yu, KS, 2021) |
| "The present study aims to evaluate the efficacy of selenium (Se) alone or combined with carbamazepine (CBZ) against the adverse effects induced by the chemoconvulsant pentylenetetrazole (PTZ) in the cortex of adult male rats." | 5.56 | Electrophysiological and Neurochemical Assessment of Selenium Alone or Combined with Carbamazepine in an Animal Model of Epilepsy. ( Aboul Ezz, HS; Ali, MA; Mohammed, HS; Zedan, A, 2020) |
| "Carbamazepine was ineffective, and seizures were exacerbated with levetiracetam (LEV)." | 5.56 | Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome. ( Goji, A; Kagami, S; Mori, T; Tayama, T; Toda, Y, 2020) |
| "Lacosamide is a novel anticonvulsant that acts by enhancing sodium channel slow inactivation." | 5.56 | Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range. ( Araki, Y; Fukushima, Y; Imai, K; Kagawa, Y; Takahashi, Y; Terada, K; Yamamoto, Y, 2020) |
| "Oxcarbazepine (OXC) is an antiepileptic drug metabolised to active 10-monohydroxy derivative (MHD) following oral administration." | 5.51 | Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens. ( Jiao, Z; Li, XW; Lin, WW; Lin, XH; Rao, X; Wang, CL; Zeng, DY; Zhang, J, 2019) |
| "Almost all seizure durations were >20 seconds." | 5.51 | Effect of carbamazepine on spontaneous recurrent seizures recorded from the dentate gyrus in rats with kainate-induced epilepsy. ( Dudek, FE; Grabenstatter, HL, 2019) |
| "Epigenetics underlying refractory epilepsy is poorly understood." | 5.51 | Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. ( Cui, L; Lv, Y; Shi, M; Wang, Z; Zheng, X, 2019) |
| "LEV provides similar seizure control to that of the older AEDs, and it is more effective and better than LTG." | 5.48 | Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine. ( Escartin Siquier, A; Forcadas Berdusan, M; Martin Moro, M; Martinez Ferri, M; Peña Mayor, P; Perez López-Fraile, I, 2018) |
| " For pharmacokinetic analysis, NONMEM software with implementation of ADVAN 1 subroutine was used." | 5.43 | CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy. ( Djordjevic, N; Jakovljevic, M; Jankovic, S; Milovanovic, D; Milovanovic, DD; Milovanovic, JR; Obradovic, S; Radosavljevic, I; Radovanovic, M, 2016) |
| "Valproic acid (VPA) follows a non-linear pharmacokinetic profile in terms of protein-binding saturation." | 5.42 | A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation. ( Ding, J; Jiao, Z; Li, X; Lin, W; Miao, L; Wang, C; Wang, Y; Zhao, L; Zhao, Z, 2015) |
| " Patients were on stable TPM dosing regimen for at least 7 days; therefore, steady-state was assumed." | 5.42 | Application of Counter-propagation Artificial Neural Networks in Prediction of Topiramate Concentration in Patients with Epilepsy. ( Erić, S; Grabnar, I; Jovanović, M; Kuzmanovski, I; Miljković, B; Prostran, M; Sokić, D; Vovk, T; Vučićević, K, 2015) |
| "As a new-generation aromatic antiepileptic drug, oxcarbazepine (OXC) is often used for epilepsy treatment." | 5.41 | Pharmacogenomics of oxcarbazepine in the treatment of epilepsy. ( Ran, YW; Yan, X; Yuan, Y; Zhang, L; Zhang, S, 2023) |
| "Gabapentin as monotherapy probably controlled seizures no better and no worse than comparator AEDs (lamotrigine, carbamazepine, oxcarbazepine, and topiramate)." | 5.41 | Gabapentin monotherapy for epilepsy: A review. ( Abakumova, T; Hoyle, CHV; Ziganshina, LE, 2023) |
| "To establish using dried blood spot (DBS) as a surrogate to plasma for therapeutic drug monitoring (TDM) of carbamazepine (CBZ), we compared the population pharmacokinetic (PPK) estimates from concurrent DBS and plasma levels." | 5.40 | Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication. ( Chan, E; Ho, PC; Kong, ST; Lim, SH, 2014) |
| "Oxcarbazepine (OXC) is an effective anticonvulsant used for treatment of partial and secondarily generalized seizures." | 5.40 | Use of oxcarbazepine for treatment of refractory status epilepticus. ( Berning, S; Kellinghaus, C; Stögbauer, F, 2014) |
| "Carbamazepine levels were measured at 6 months." | 5.39 | Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy. ( Aggarwal, A; Chillar, N; Faridi, MM; Kumar, V; Mittal, H; Sharma, S, 2013) |
| " Forty adult patients were studied and oxcarbazepine was administered orally at a single loading dosage of 30 mg/kg." | 5.38 | Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy. ( Cho, JY; Chu, K; Gu, N; Jang, IJ; Kim, DW; Kim, HS; Lee, SK; Oh, J; Yoon, SH; Yu, KS, 2012) |
| "Carbamazepine is a widely prescribed antiepileptic drug." | 5.38 | Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. ( Birnbaum, AK; Brundage, RC; Cloyd, JC; Conway, JM; Gross, CR; Leppik, IE; Marino, SE; Mishra, U; Musib, LC; Pennell, PB; Ramsay, RE; Rarick, JO; White, JR, 2012) |
| "Curcumin was co-administered with sub-therapeutic dose of valproate 60min before PTZ injection." | 5.37 | Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. ( Gupta, YK; Mehla, J; Pahuja, M; Reeta, KH, 2011) |
| "Valproic acid (VPA) is an anticonvulsant and mood-stabilizing drug for the long-term treatment." | 5.37 | Valproic Acid related metabolic syndrome in patients with epilepsy. ( Kasradze, S; Mania, M; Okujava, N, 2011) |
| "Epilepsy is a syndrome of episodic brain dysfunction characterized by recurrent unpredictable, spontaneous seizures." | 5.35 | Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract. ( Abraham, PM; Krishnakumar, A; Paul, J; Paulose, CS, 2009) |
| "To assess tolerability and efficacy of lacosamide in adults with cerebrovascular epilepsy etiology (CVEE)." | 5.34 | Lacosamide in patients with epilepsy of cerebrovascular etiology. ( Bozorg, A; Brandt, C; Dimova, S; Ferrò, B; Holmes, GL; Kälviäinen, R; Rosenow, F; Steiniger-Brach, B; Zhang, Y, 2020) |
| " We evaluated serum lipid profiles in adults with newly diagnosed epilepsy, following randomization to lacosamide (LCM) or carbamazepine (CBZ) monotherapy." | 5.34 | Effects of lacosamide and carbamazepine on lipids in a randomized trial. ( Chellun, D; De Backer, M; Dimova, S; Mintzer, S; Roebling, R; Steiniger-Brach, B; Zhang, Y, 2020) |
| "The aim of this study was to investigate the effects of sodium valproate (SV) and carbamazepine (CBZ) on neuromuscular transmission using single-fibre electromyography (SFEMG) in patients with epilepsy." | 5.34 | An investigation on the effects of carbamazepine and sodium valproate on neuromuscular transmission. ( Ay, H; Ethemoğlu, Ö, 2020) |
| "Oxcarbazepine (OXC; Timox) is a new antiepileptic drug (AED) chemically related to carbamazepine (CBZ), with comparable efficacy but superior safety according to controlled clinical trials." | 5.34 | [Oxcarbazepine in the treatment of epilepsy]. ( Freidel, M; Krause, E; Kuhn, K; Peper, R; Vogel, H, 2007) |
| "Epilepsy is one of the most important features of the syndrome, in addition to the characteristic facial appearance, cardiac anomaly, dysphagia, deafness, mental retardation and growth delay." | 5.34 | [Effect of carbamazepine on epilepsy with 1p36 deletion syndrome]. ( Imai, K; Kagitani-Shimono, K; Kamio, N; Kurosawa, K; Nabatame, S; Nagai, T; Okinaga, T; Ozono, K, 2007) |
| "Population models can be important extensions of therapeutic drug monitoring (TDM), as they allow estimation of individual pharmacokinetic parameters based on a small number of measured drug concentrations." | 5.33 | Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy. ( Carlsson, KC; Glauser, T; Hoem, NO; Vinks, AA, 2005) |
| "Carbamazepine has also been shown to induce the hepatic synthesis of sex hormone-binding globulin, thus reducing free serum testosterone levels and possibly causing erectile dysfunction (ED) in some men; these effects have not been observed with oxcarbazepine." | 5.33 | Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience. ( Sachdeo, R; Sathyan, RR, 2005) |
| " VPA was not found to have any clinically significant influence on TPM pharmacokinetic and metabolic profiles." | 5.33 | A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. ( Bialer, M; Britzi, M; Doose, DR; Gatti, G; La Neve, A; Levy, RH; Maryanoff, BE; Mimrod, D; Perucca, E; Soback, S; Specchio, LM; Specchio, N, 2005) |
| "To investigate the relationship between the serum concentration of the mono-hydroxy-derivative (MHD) of oxcarbazepine (OXC) and adverse effects (AEs) in epileptic patients on high-dose OXC therapy." | 5.33 | Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. ( Bilo, L; Di Nocera, P; Fasiello, C; Italiano, D; Pisani, F; Ruosi, P; Striano, P; Striano, S, 2006) |
| "Men with epilepsy are known to have reduced fertility." | 5.32 | Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. ( Bjørnenak, T; Gjerstad, L; Haugen, TB; Røste, LS; Saetre, ER; Taubøll, E, 2003) |
| "Oxcarbazepine was generally well tolerated during monotherapy and adjunctive therapy; 2." | 5.32 | Spotlight on oxcarbazepine in epilepsy. ( Bang, LM; Goa, KL, 2004) |
| " Adjusting the maintenance dosage of H(2)-histamine antagonists has been recommended in elderly patients since age-related reduction in renal plasma flow, glomerular filtration rate and renal tubular function may be present, which can in turn elevate histamine levels in plasma and cerebrospinal fluid." | 5.31 | H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. ( Bergemann, N; Diebold, K; Mundt, C; Roesch-Ely, D; Sartor, K; von Einsiedel, RW, 2002) |
| " Everyone received a drug dosage which gave an adequate therapeutic plasma concentration and satisfactory seizure control." | 5.31 | [Bimodal evoked potentials during long-term therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and adolescents with epilepsy]. ( Zgorzalewicz, M, 2000) |
| "Tiagabine may cause various mild extrapyramidal side effects." | 5.31 | Transient dystonias in three patients treated with tiagabine. ( Grabowska-Grzyb, A; Wolańczyk, T, 2001) |
| "Carbamazepine and depakine treatment during at least 6 months does not predispose to ovary polycystosis syndrome." | 5.31 | [The pharmacological and hormonal effects of carbamazepine and valproic acid in the treatment of reproductive age women with epilepsy]. ( Karlov, VA; Kushlinskiĭ, NE; Vlasov, PN, 2001) |
| "A large-scale, double-blind trial (SP0993; NCT01243177) demonstrated that lacosamide was noninferior to controlled-release carbamazepine (carbamazepine-CR) in terms of efficacy, and well tolerated as first-line monotherapy in patients (≥16 years of age) with newly diagnosed epilepsy." | 5.30 | Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy. ( Ben-Menachem, E; Biton, V; Brock, M; De Backer, M; Gasalla, T; Grebe, HP; Jensen, L; Li, T; Steiniger-Brach, B; Terada, K, 2019) |
| "The antioxidant activity of reamberin was investigated in children with epilepsy: 16 patients received intravenous reamberin once daily for 5 days in addition to carbamazepine." | 5.30 | [The effect of reamberin on the antioxidant status in children with epilepsy]. ( Dorovskikh, VA; Nosal', LA; Shtarberg, MA; Simonova, NV, 2019) |
| "We evaluated seven patients with oral motor apraxia and ocular motor apraxia." | 5.30 | Carbamazepine responsive epileptic oral motor and ocular motor apraxia. ( D'Cruz, OF; Greenwood, RS; Naqvi, SZ, 1998) |
| "Carbamazepine (CBZ) is an effective anticonvulsant agent." | 5.30 | Exacerbation of epileptic seizures by carbamazepine: report of 10 cases. ( Fraticelli, E; Parmeggiani, A; Rossi, PG, 1998) |
| " PB was also the most toxic drug, followed by CBZ and by PHT." | 5.30 | Anticonvulsant and neurotoxic effects of intracerebroventricular injection of phenytoin, phenobarbital and carbamazepine in an amygdala-kindling model of epilepsy in the rat. ( Alós, M; Barcia, JA; Belda, V; Rubio, P; Serralta, A, 1999) |
| "Tiagabine has comparable anticonvulsant action to carbamazepine in rats and has anticonvulsant effects in non-human primates supporting the potential use of inhibitors of GABA uptake as therapy for epilepsy." | 5.29 | The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. ( Chapman, AG; Meldrum, BS; Parvez, NS; Smith, SE, 1995) |
| "Treatment with carbamazepine slow-release tablets in children with epilepsy can be replaced by carbamazepine suppositories in 25% higher dosage, with good clinical effect and appropriate pharmacokinetic values, when it is unsuitable to use the common oral route of administration." | 5.29 | Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy. ( Arvidsson, J; Flesch, G; Nilsson, HL; Sandstedt, P; Steinwall, G; Tonnby, B, 1995) |
| "Carbamazepine (CBZ) has been reported to have an antidiuretic action, though it is not known how it produces this effect." | 5.29 | Fluid retention and cardiomegaly associated with carbamazepine in an epileptic child. ( Atalay, S; Gürer, YK; Karademir, S; Oner, A, 1993) |
| " This study compares the pharmacokinetics of CBZ-CO against CBZ-CR in patients with epilepsies chronically treated with CBZ in monotherapy or CBZ-PB in bitherapy, the effect of PB on CBZ-CO and CBZ-CR pharmacokinetic parameters, and the effect of the two formulations of CBZ on PB pharmacokinetic parameters." | 5.29 | Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy. ( Barra, Y; Bonneton, J; Genton, P; Iliadis, A; Mesdjian, E; Sennoune, S, 1996) |
| "However, hyponatremia is supposed to occur even more often than with CBZ." | 5.28 | Hyponatremic coma under oxcarbazepine therapy. ( Paulus, W; Steinhoff, BJ; Stodieck, SR; Stoll, KD, 1992) |
| " Dosing was single blind." | 5.28 | Carbamazepine-10,11-epoxide in epilepsy. A pilot study. ( Almkvist, O; Bertilsson, L; Nilsson, BY; Svensson, JO; Tomson, T, 1990) |
| "Carbamazepine (CBZ) is a widely used antiepileptic drug (AED)." | 5.28 | The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy. ( Finnerty, G; Patsalos, PN; Russell-Jones, D; Sander, JW; Shorvon, SD, 1990) |
| "Pregnant women with epilepsy on one or more of the following AEDs: lamotrigine, carbamazepine, phenytoin or levetiracetam." | 5.27 | AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. ( Bagary, M; Coleman, J; D'Amico, M; Denny, E; Dodds, J; Eldridge, S; Greenhill, L; Hard, K; Kelso, A; Khan, KS; Marlin, N; McCorry, D; Middleton, L; Moss, N; Newton, S; Pirie, A; Pullen, A; Rikunenko, R; Roberts, T; Rogozińska, E; Thangaratinam, S; Weckesser, A, 2018) |
| "To assess the association, if any, between brivaracetam (BRV)-induced elevated carbamazepine-10,11-epoxide (CBZ-E) and toxicity and efficacy in patients with epilepsy." | 5.27 | Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program. ( Brodie, MJ; Colson, AO; Elmoufti, S; Fakhoury, T; McDonough, B; Stockis, A; Whitesides, J, 2018) |
| "Standard lipid fractions, lipoprotein(a), and C-reactive protein (CRP) were examined in a subset of those participating in the STEP-ONE trial, in which elderly patients with new epilepsy were randomized to treatment with carbamazepine, lamotrigine, or levetiracetam." | 5.27 | Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly. ( Chervoneva, I; Kraemer, G; Mintzer, S; Trinka, E; Werhahn, KJ, 2018) |
| "Side effects of carbamazepine (CBZ), valproate (VPA) and clonazepam (CZP) are rare during long-term use but rather common and usually transient during the early phases of treatment." | 5.27 | Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. ( Keränen, T; Sivenius, J, 1983) |
| "Praziquantel was ineffective and hazardous, causing some known and some previously unreported responses and reactions." | 5.27 | Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. ( Bhatt, M; Desai, S; Wadia, N, 1988) |
| " The pharmacokinetic parameters have been found to be important for specifying the causes of dissociation between the level of blood anticonvulsant and the therapeutic effect when the attacks cannot be controlled or there were signs of intoxication." | 5.27 | [Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment]. ( Antadze, ZI; Chankvetadze, BG; Okudzhava, VM; Vetrogon, FG, 1987) |
| "Carbamazepine was given to 152 patients who were receiving multiple drug therapy for uncontrolled seizures." | 5.26 | Role of carbamazepine in reducing polypharmacy in epilepsy. ( Maheshwari, MC; Padmini, R, 1981) |
| "Phenytoin produced a lower serum level than the same dose of its sodium salt." | 5.25 | Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy. ( Gamstorp, I; Lilienberg, G; Norell, E, 1975) |
| "In this phase 3, randomised, double-blind, non-inferiority trial, patients from 185 epilepsy or general neurology centres in Europe, North America, and the Asia Pacific region, aged 16 years or older and with newly diagnosed epilepsy were randomly assigned in a 1:1 ratio, via a computer-generated code, to receive lacosamide monotherapy or controlled-release carbamazepine (carbamazepine-CR) twice daily." | 5.24 | Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. ( Baulac, M; Brock, M; De Backer, M; Li, T; Rosenow, F; Terada, K; Toledo, M; Werhahn, KJ, 2017) |
| "To systematically evaluate the medication safety and effectiveness of Oxcarbazepine (OXC) and carbamazepine (CBZ) for the treatment of post-stroke epilepsy (PSE)." | 5.22 | Oxcarbazepine versus Carbamazepine for the Treatment of Post-Stroke Epilepsy: A Systematic Review and Meta-Analysis. ( Guo, CA; Li, PW; Lu, XM; Wan, DJ; Zhang, YJ, 2022) |
| " One study compared clonazepam to carbamazepine as monotherapy for participants with newly diagnosed psychomotor epilepsy (a condition corresponding to what is now termed mesial temporal lobe epilepsy)." | 5.22 | Clonazepam monotherapy for treating people with newly diagnosed epilepsy. ( Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2022) |
| "Despite a dramatic increase in treatment options over the past 30 years, Carbamazepine (CBZ) is still considered the standard of care and the most prescribed initial treatment for focal epilepsy." | 5.22 | The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review. ( Boughrara, W; Chentouf, A, 2022) |
| "We sought to assess the anti-seizure efficacy of carbamazepine (CBZ) and retention rate (RR) in randomized, controlled trials (RCTs) in epilepsy." | 5.22 | Anti-seizure efficacy and retention rate of carbamazepine is highly variable in randomized controlled trials: A meta-analysis. ( Hoppe, C; Olaciregui-Dague, K; Schmid, M; Surges, R; Weinhold, L, 2022) |
| " Participants had "failed" initial monotherapy for partial epilepsy and were randomized to substitution monotherapy with levetiracetam or an older AED (carbamazepine or valproate sodium)." | 5.22 | Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health. ( Christie, J; Gorelik, A; Hakami, T; Kantor, S; O'Brien, TJ; Petty, SJ; Sakellarides, M; Seibel, MJ; Todaro, M; Wark, JD; Yerra, R, 2016) |
| "This post-hoc subgroup analysis of data from an unblinded, randomized, 52-week superiority study (KOMET) compared the effectiveness of levetiracetam (LEV) with extended-release sodium valproate (VPA-ER) and controlled-release carbamazepine (CBZ-CR) as monotherapy in patients aged ≥ 60 years with newly diagnosed epilepsy." | 5.22 | Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. ( Marson, AG; Noack-Rink, M; Pohlmann-Eden, B; Ramirez, F; Tofighy, A; Trinka, E; Werhahn, KJ; Wild, I, 2016) |
| "This Phase I, open-label, dose-escalation study investigated the effects of steady-state brivaracetam on the pharmacokinetics of carbamazepine in patients with epilepsy, with and without valproate co-administration." | 5.22 | Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration. ( Brodie, MJ; Sargentini-Maier, ML; Stockis, A, 2016) |
| "IV carbamazepine administered as multiple 30- or 15-min infusions every 6 h, and as a single rapid infusion, was well tolerated as a short-term replacement in adults with epilepsy receiving stable dosages of oral carbamazepine." | 5.20 | Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials. ( Bekersky, I; Biton, V; Cloyd, J; Dheerendra, S; Halford, JJ; Kalu, U; Klein, P; Lee, D; Peng, G; Tolbert, D, 2015) |
| "In this phase 1, open-label study, adult patients with epilepsy on a stable oral carbamazepine dosage (400-2,000 mg/day) were converted to intravenous carbamazepine (administered at 70% of the oral dosage)." | 5.20 | Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy. ( Bekersky, I; Biton, V; Cloyd, J; Drummond, R; Lee, D; Tolbert, D; Walzer, M; Wesche, D, 2015) |
| " No clinically relevant differences were found for using body surface area or weight to explain between-patient variability, therefore the final model included the effects of body weight on apparent clearance (CL/F) and apparent volume of distribution (V/F) of MHD, and in addition, the effect of 3 concomitant anti-epileptic drugs (carbamazepine, phenobarbital and phenytoin) on CL/F of MHD." | 5.20 | Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities. ( Bouillon, T; Fink, M; Hirota, T; Sugiyama, I; Suzuki, H; Yamaguchi, M, 2015) |
| "Oral loading of oxcarbazepine tablet is effective and well tolerated to adequately achieve the therapeutic levels of its active metabolite, 10,11-dihydro-10-hydroxy-carbazepine (monohydroxy derivative, MHD) in epilepsy patients." | 5.17 | Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy. ( Cho, JY; Chu, K; Gu, N; Jang, IJ; Kim, DW; Lee, H; Lee, SK; Na, HJ; Yoon, SH; Yu, KS, 2013) |
| "The aim of the study was to investigate immunoglobulin levels in patients with epilepsy using the antiepileptic drugs (AED) levetiracetam (LEV), carbamazepine (CBZ), or lamotrigine (LTG)." | 5.17 | Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine. ( Frøland, SS; Luef, G; Mochol, M; Mushtaq, U; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2013) |
| "The aim of this study was to evaluate the association of genetic variants in the major genes involved in carbamazepine (CBZ) metabolism and transport with its pharmacokinetics in epilepsy patients." | 5.17 | Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy. ( Ahmed, G; Birnbaum, AK; Cloyd, JC; Lamba, JK; Leppik, IE; Marino, SE; Puranik, YG; Remmel, RP, 2013) |
| "Eighty-one patients participated in the study: 51 patients with chronic epilepsy (G1) treated with carbamazepine (CBZ) or valproic acid (VPA), and 30 patients with newly diagnosed epilepsy (G2)." | 5.16 | The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid. ( Bochyńska, A; Graban, A; Gugała-Iwaniuk, M; Lechowicz, W; Lipczyńska-Łojkowska, W; Lipska, B; Restel, M; Ryglewicz, D, 2012) |
| "Carbamazepine clearance was not associated with body weight or any parameterization of body size nor was age or race or any marker of hepatic or renal function in community dwelling elderly patients." | 5.16 | Population pharmacokinetics of carbamazepine in elderly patients. ( Birnbaum, AK; Brundage, RC; Collins, JF; Macias, FM; Punyawudho, B; Ramsay, ER, 2012) |
| "The extent of lamotrigine interactions was investigated dependent on age, gender, weight and dose of concomitant carbamazepine and/or valproic acid in 65 patients with epilepsy." | 5.16 | Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics. ( Brzaković, BB; Martinović, ZJ; Miljković, BR; Pokrajac, MV; Prostran, MŠ; Vezmar Kovačević, SD; Vučićević, KM, 2012) |
| "This study aimed to evaluate the effects of monotherapy with valproate or oxcarbazepine on the linear growth of children with idiopathic epilepsy." | 5.16 | The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy. ( Bideci, A; Camurdan, O; Cansu, A; Cinaz, P; Hirfanoglu, TL; Karaoglu, A; Serdaroglu, A; Yesilkaya, E, 2012) |
| "The aim of this study is to investigate the effects of epilepsy, valproic acid and oxcarbazepine on nitric oxide levels, lipid peroxidation and xanthine oxidase levels in newly diagnosed epileptic children and healthy controls." | 5.15 | Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy. ( Arhan, E; Kurt, N; Kutsal, E; Ozcelik, A; Ozturk, B; Ozturk, HS; Serdaroglu, A; Sevinc, N, 2011) |
| " This study was done to evaluate the effect of levetiracetam (LEV) on subjective sleep quality and sleep architecture in patients with epilepsy, and the results were compared with the effects of carbamazepine-CR (CBZ-CR)." | 5.15 | The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy. ( Cho, YW; Kim, DH; Motamedi, GK, 2011) |
| "To investigate the effect of topiramate on bone mass and metabolism in premenopausal women with epilepsy." | 5.15 | The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. ( Heo, K; Kim, WJ; Lee, BI; Lee, HW; Lee, SA; Rhee, Y; Shin, DJ; Song, HK; Song, K, 2011) |
| "An international trial comparing remacemide hydrochloride with carbamazepine was undertaken in individuals with newly diagnosed epilepsy using a novel double-blind, parallel-group, double triangular sequential design." | 5.14 | The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy. ( Dean, AD; Edgar, C; Wesnes, KA; Wroe, SJ, 2009) |
| " The present study aimed at evaluating the effect of piperine on the steady-state pharmacokinetics of a single dose of carbamazepine in poorly controlled epilepsy patients on carbamazepine monotherapy." | 5.14 | Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. ( Hota, D; Kharbanda, P; Pandhi, P; Pattanaik, S; Prabhakar, S, 2009) |
| "To investigate the comparative effects of carbamazepine (CBZ) and lamotrigine (LTG) on electrocardiography (ECG) parameters in elderly patients with newly diagnosed epilepsy." | 5.14 | Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine. ( Abdelnoor, M; Amlie, JP; Anfinsen, OG; Gjerstad, L; Isojärvi, J; Perucca, E; Saetre, E; Taubøll, E; Tossebro, M, 2009) |
| "We performed an observational retrospective study on patients with brain tumor-related epilepsy: 35 who had assumed oxcarbazepine monotherapy and 35 patients who had undergone treatment with traditional antiepileptic drugs." | 5.14 | The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine. ( Carapella, MC; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Pompili, A; Vidiri, A, 2009) |
| " The present study investigated reproductive and sexual function in patients with epilepsy (aged 18-45) treated with levetiracetam (LEV: 30 men/26 women), carbamazepine (CBZ: 63 men/30 women), or lamotrigine (LTG: 37 men/40 women) monotherapy and in healthy controls (36 men/44 women)." | 5.14 | Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults. ( Bertelsen, M; Gjerstad, L; Lossius, A; Luef, G; Mørkrid, L; Rauchenzauner, M; Sandvand, F; Svalheim, S; Taubøll, E, 2009) |
| "During an international double-blind trial evaluating the efficacy and tolerability of lamotrigine and carbamazepine in patients aged >or=65 with newly diagnosed epilepsy, the comparative effects of the drugs on health-related quality of life were investigated based on screening and 12-, 28-, and 40-week data, using the modified Side Effect and Life Satisfaction (SEALS) Inventory and the Liverpool Adverse Event Profile." | 5.14 | Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age. ( Abdelnoor, M; Gjerstad, L; Isojärvi, J; Perucca, E; Saetre, E; Taubøll, E, 2010) |
| "5 years), with predominantly focal forms of epilepsy treated with trileptal (oxcarbazepine)." | 5.14 | [Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents]. ( , 2010) |
| "For a retrospective observational investigation based on real clinical practice of relative efficacy of valpoic acid (VPA), carbamazepine (CBZ) and topiramate (TPM) we have selected 106 patients with age of seizure onset before 17 years with a undoubted diagnosis of symptomatic or cryptogenic occipital lobe epilepsy (OLE), who had received treatment according to ILAE recommendations, and observation time since the last treatment change was from 2 to 10 years." | 5.14 | [Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children]. ( , 2010) |
| "We investigated the prevalence of this multidrug resistance 1 gene (MDR1) polymorphism in drug-responsive versus drug-resistant epilepsy patients treated with carbamazepine (CBZ), which is a substrate of this protein." | 5.13 | Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey. ( Bebek, N; Cine, N; Gul, G; Ozgon, GO, 2008) |
| "To evaluate the response to albendazole treatment in patients who had SSECTL and new onset seizures treated with antiepileptic drugs (AED) in a prospective clinical trial." | 5.13 | Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. ( Chattopadhyay, A; Khandelwal, N; Sawhney, IM; Thussu, A, 2008) |
| " In this study, FA profiles were determined in 56 patients with epilepsy who participated in a 12-week double-blind randomized trial of omega-3 FA supplementation (1 g eicosapentaenoic acid and 0." | 5.13 | Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations? ( Bell, GS; Browning, L; Flugel, D; Koepp, MM; Patsalos, PN; Sander, JW; Yuen, AW, 2008) |
| "To explore effectiveness, tolerability and changes in quality of life in patients with epilepsy converting to topiramate (TPM) from carbamazepine (CBZ) or oxcarbazepine (OXC) due to insufficient effectiveness and/or tolerability." | 5.13 | Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy. ( Adam, H; Bogdanow, M; Kowalik, A; Kühn, F; Rimpau, W; Schauble, B; Schreiner, A; van Oene, J, 2008) |
| "The aim of the study described here was to investigate the efficacy, tolerability, and side effects of oxcarbazepine (OXC) monotherapy in newly diagnosed, previously untreated adult and elderly patients with partial epilepsy." | 5.13 | Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. ( Aktekin, B; Bilgen, R; Dogan, EA; Senol, Y; Usta, BE, 2008) |
| " All patients with epilepsy between the ages 3-18 years, taking carbamazepine as monotherapy, were studied and blood samples were obtained for ANA and other tests." | 5.13 | Antinuclear antibodies in children with epilepsy treated by carbamazepine. ( Asadi-Pooya, AA; Asadi-Pooya, K, 2008) |
| " Cannabidiol (CBD) is increasingly used to treat epilepsy." | 5.12 | Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. ( Główka, AK; Główka, FK; Karaźniewicz-Łada, M; Mikulska, AA, 2021) |
| "ABCB1 polymorphisms were previously demonstrated to be associated with the metabolism and resistance of carbamazepine (CBZ) in epilepsy, but the results still remained controversial." | 5.12 | Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis. ( Fan, YX; He, GH; Huang, YH; Meng, JR; Meng, R; Wang, P; Yin, SJ; Zhang, Z; Zhou, T, 2021) |
| " This paper aims to undertake a comprehensive review regarding the possible risks of four classical (phenytoin, carbamazepine, phenobarbital, and valproate) and two newer (lamotrigine and levetiracetam) AEDs during pregnancy." | 5.12 | Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications. ( Demir, O; Kaplan, YC, 2021) |
| "CYP3A4 (rs2242480), CYP3A5 (rs776746) and SCN1A (rs3812718 and rs2298771) gene polymorphisms were previously indicated to be associated with carbamazepine (CBZ) metabolism and resistance in epilepsy." | 5.12 | Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis. ( Cai, WK; He, GH; Shen, ML; Wang, P; Zhang, Z; Zhao, GX, 2021) |
| "The gene polymorphisms of ABCB1, EPHX1, and SCN1A were found to influence carbamazepine (CBZ) metabolism and resistance in epilepsy patients, but the relevance remains controversial." | 5.12 | ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. ( Bai, ZF; Chen, XF; Chen, XL; Li, WX; Tang, JF; Wang, XY; Xiao, XH; Zhang, H; Zhang, ML; Zhang, SQ; Zhao, X; Zhao, YL, 2021) |
| "This study was performed to evaluate carnitine deficiency in a large series of epilepsy children and adolescents treated with old and new antiepileptic drugs with or without ketogenic diet." | 5.12 | Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. ( Auricchio, G; Coppola, G; Epifanio, G; Federico, RR; Pascotto, A; Resicato, G, 2006) |
| "We conducted a study to assess the effect of phenobarbital, carbamazepine, and valproate on serum lipid profiles and lipoprotein (a) in 64 children with epilepsy (aged between 1 and 15 years) admitted to the child neurology outpatient clinic between July 2000 and July 2002." | 5.12 | Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes. ( Aslan, A; Demir, E; Orem, A; Orhan, F; Sonmez, FM; Topbas, M; Yildirmis, S, 2006) |
| "Quantitative EEG (QEEG) effects of therapeutic doses of carbamazepine (CBZ), oxcarbazepine (OXC), valproate (VA) and lamotrigine (LA) monotherapy were investigated in patients with beginning epilepsy." | 5.12 | Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings. ( Altmann, A; Bessenyei, M; Clemens, B; Hollódy, K; Jerney, J; Kollár, K; Ménes, A; Piros, P; Rosdy, B; Rózsavölgyi, M; Steinecker, K, 2006) |
| "The aim of the present study was to assess serum lipid levels before and after treatment with oxcarbazepine (OXC) in children with epilepsy." | 5.12 | Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children. ( Cecconi, I; Franzoni, E; Garone, C; Gualandi, S; Malaspina, E; Marchiani, V; Moscano, FC; Sarajlija, J, 2006) |
| "To compare the behavioural side effects associated with two commonly used antiepilepsy drugs-phenobarbital and carbamazepine-in children in Bangladesh." | 5.12 | Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. ( Banu, SH; Ferdousi, S; Jahan, M; Khan, NZ; Koli, UK; Neville, B, 2007) |
| "We report the results of a prospective study of the efficacy and tolerability of levetiracetam, a new antiepileptic drug with a unique mechanism of action, in comparison with controlled-release carbamazepine as first treatment in newly diagnosed epilepsy." | 5.12 | Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. ( Ben-Menachem, E; Brodie, MJ; Meencke, HJ; Perucca, E; Ryvlin, P, 2007) |
| "This study prospectively examined whether continued add-on treatment with oxcarbazepine (OXC) is associated with quantitative improvement in mood and anxiety symptoms in adult patients with partial epilepsy." | 5.12 | Oxcarbazepine improves mood in patients with epilepsy. ( Bria, P; Della Marca, G; Di Nicola, M; Janiri, L; Martinotti, G; Mazza, M; Mazza, S; Pozzi, G, 2007) |
| "To assess the comparative effectiveness, efficacy, and tolerability of lamotrigine (LTG) and sustained-release carbamazepine (CBZ) in the treatment of newly diagnosed epilepsy in the elderly." | 5.12 | An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. ( Gjerstad, L; Isojärvi, J; Perucca, E; Saetre, E, 2007) |
| "To determine whether levetiracetam (LEV) affects plasma concentrations of carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy." | 5.12 | Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. ( De Smedt, H; Otoul, C; Stockis, A, 2007) |
| "To compare clinicians' choice of one of the standard epilepsy drug treatments (carbamazepine or valproate) versus appropriate comparator new drugs." | 5.12 | A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. ( Appleton, R; Baker, GA; Chadwick, DW; Doughty, J; Eaton, B; Gamble, C; Jacoby, A; Marson, AG; Shackley, P; Smith, DF; Tudur-Smith, C; Vanoli, A; Williamson, PR, 2007) |
| " The aim of this study was to evaluate thyroid function in 78 girls taking carbamazepine (CBZ), oxcarbazepine (OXC), or valproate (VPA) monotherapy for epilepsy and after withdrawal of the treatment." | 5.11 | Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. ( Isojärvi, JI; Knip, M; Mikkonen, K; Myllylä, VV; Pakarinen, AJ; Rättyä, J; Vainionpää, LK, 2004) |
| "In a novel double-blind trial, topiramate was compared with the investigator's choice of carbamazepine or valproate as first-line therapy in patients as young as 6 years of age with newly diagnosed epilepsy." | 5.11 | Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy. ( Neto, W; Wang, S; Wheless, JW, 2004) |
| "This randomized, open-label study was designed to compare the efficacy and tolerability of lamotrigine monotherapy with those of valproate and carbamazepine monotherapy in patients with epilepsy whose seizures were uncontrolled on their prestudy antiepileptic drug monotherapy." | 5.11 | Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. ( Fakhoury, TA; Hammer, AE; Messenheimer, JA; Vuong, A, 2004) |
| "This two-part, open-label study evaluated the pharmacokinetics, safety, and tolerability of oxcarbazepine as combination therapy in 112 children 2 to 12 years old with inadequately controlled epilepsy." | 5.11 | Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. ( Bulteau, C; D'Souza, J; Dulac, O; Markabi, S; Motte, J; Pons, G; Rey, E; Sturm, Y; Tran, A, 2004) |
| "Clinical effects and pharmacokinetics of once-a-day pediatric zonisamide (ZNS) monotherapy were investigated in 72 children (range, 3 months to 15 years; mean age, 8 years and 3 months) with cryptogenic localization-related epilepsies with simple, complex, or secondarily generalized partial seizures; none had prior epilepsy treatment." | 5.11 | Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies. ( Miura, H, 2004) |
| "In a double-blind, randomized, parallel-group, placebo-controlled trial, we assessed the effect of add-on melatonin (6-9 mg/day for 14 days) on the antioxidant enzymes glutathione peroxidase (GPx) and glutathione reductase (GRd) in 31 children with epilepsy receiving CBZ monotherapy, who were seizure free at least for the last 6 months." | 5.11 | Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial. ( Agarwal, S; Aneja, S; Gupta, M; Gupta, YK; Kalaivani, M; Kohli, K, 2004) |
| "A proportion of patients undergoing epilepsy surgery, and receiving carbamazepine (CBZ), experience significant elevations in CBZ plasma concentrations, some with associated CBZ toxicity." | 5.11 | Risk factors for carbamazepine elevation and toxicity following epilepsy surgery. ( Bingaman, W; Hiremath, GK; Hovinga, C; Kotagal, P; Morris, H; Nelson, D; Wyllie, E, 2005) |
| "To determine the relative tolerability and efficacy of two newer antiepileptic drugs, lamotrigine (LTG) and gabapentin (GBP), as compared to carbamazepine (CBZ) in older patients with epilepsy." | 5.11 | New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. ( Boardman, KD; Carter, GS; Collins, JF; Felicetta, J; Frederick, T; Marks, W; Pryor, F; Ramsay, RE; Rowan, AJ; Spitz, M; Tomyanovich, ML; Towne, A; Uthman, BM, 2005) |
| "The authors conducted a 3-month, prospective, open-label study assessing the effects of switching from immediate-release carbamazepine formulations to an equal total daily dose of carbamazepine extended-release capsules (CBZ-ERC) in adolescents and adults with epilepsy." | 5.11 | Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. ( Ficker, DM; Glauser, T; Kanner, A; Krauss, G; Moore, JL; Privitera, M, 2005) |
| "Subjects were 85 men with localization-related epilepsy (25 on carbamazepine [CBZ], 25 on phenytoin [PHT], 25 on lamotrigine [LTG], and 10 untreated for at least 6 months [no AED]) and 25 controls." | 5.11 | Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. ( Bromfield, EB; Drislane, FW; Dworetzky, BA; Farina, EL; Frye, CA; Herzog, AG; Pennell, PB; Schomer, DL, 2005) |
| "Body mass index (BMI) and fasting serum concentrations of insulin and lipids were measured in 102 men with epilepsy who were treated with VPA, carbamazepine (CBZ), or oxcarbazepine (OXC) monotherapy." | 5.10 | Fasting serum insulin and lipid levels in men with epilepsy. ( Isojärvi, JI; Knip, M; Kotila, M; Myllylä, VV; Pakarinen, AJ; Pylvänen, V; Rättyä, J; Turkka, J, 2003) |
| "To compare topiramate (TPM) with investigator's choice of carbamazepine (CBZ) or valproate (VPA) for initial treatment in patients with newly diagnosed epilepsy." | 5.10 | Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. ( Brodie, MJ; Chadwick, DW; Mattson, RH; Neto, W; Privitera, MD; Wang, S, 2003) |
| "Serum triglycerides, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), vitamin B12 and folic acid levels were studied in 16 children with epilepsy who had been receiving carbamazepine (CBZ), and in 16 healthy children." | 5.10 | Effect of long-term carbamazepine therapy on serum lipids, vitamin B12 and folic acid levels in children. ( Caksen, H; Deda, G; Içağasioğlu, D, 2003) |
| "We studied serum calcium, phosphorus, alkaline phosphatase (ALP), thyroid hormones (total thyroxine [TT4], free thyroxine [FT4], thyroid-stimulating hormone [TSH]), parathyroid hormone (PH), and osteocalcine levels in children with epilepsy who had been receiving long-term carbamazepine (CBZ) therapy to determine whether there was any effect of CBZ therapy on these hormones." | 5.10 | Evaluation of thyroid and parathyroid functions in children receiving long-term carbamazepine therapy. ( Atas, B; Caksen, H; Cesur, Y; Dulger, H; Odabas, D; Tuncer, O, 2003) |
| "Remacemide hydrochloride is a low-affinity, non-competitive NMDA receptor channel blocker under investigation for the treatment of epilepsy." | 5.10 | Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen. ( Blume, WT; Guberman, A; Holdich, TA; Jones, MW; Lee, MA; Pillay, N; Veloso, F; Weaver, DF, 2002) |
| "Remacemide hydrochloride is a low-affinity, non-competitive N-methyl-D-aspartic acid (NMDA) receptor channel blocker, under investigation in epilepsy." | 5.10 | Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen. ( Betts, TA; Boddie, HG; Chadwick, DW; Crawford, PM; Holdich, TA; Lindstrom, P; Newman, PK; Soryal, I; Wroe, S, 2002) |
| "The authors assessed the effect of concomitant antiepileptic therapy on steady-state plasma concentrations of the new antiepileptic drug (AED) topiramate and the potential relation between topiramate plasma levels and side effects in a cohort of 116 patients with epilepsy." | 5.10 | Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. ( Albani, F; Avoni, P; Baruzzi, A; Contin, M; Riva, R, 2002) |
| "The efficacy of remacemide hydrochloride (REM) as an antiepileptic drug (AED) was tested in a double-blind, add-on trial in patients with refractory epilepsy." | 5.09 | Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy. ( Jamieson, V; Lucas, SB; Mawer, GE; Wild, JM, 1999) |
| "To compare the cognitive and behavioural effects of clobazam versus standard monotherapy in the treatment of childhood epilepsy." | 5.09 | The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy. ( Bawden, HN; Camfield, CS; Camfield, PR; Cunningham, C; Darwish, H; Dooley, JM; Gordon, K; Ronen, G; Stewart, J; van Mastrigt, R, 1999) |
| "In a multicentre, double-blind trial 150 elderly patients (mean age 77 years) with newly diagnosed epilepsy were randomised in a 2:1 ratio to treatment with lamotrigine (LTG) or carbamazepine (CBZ)." | 5.09 | Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. ( Brodie, MJ; Giorgi, L; Overstall, PW, 1999) |
| "One-hundred eighty patients with partial or idiopathic generalized nonabsence epilepsy, aged 6 to 65 years, requiring initiation of treatment with carbamazepine (CBZ), valproate (VPA), phenytoin (PHT), phenobarbital (PB), or primidone (PRM) were randomly allocated to two groups according to an open, prospective parallel-group design." | 5.09 | A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy. ( Bartoli, A; Cian, P; Fattore, C; Gatti, G; Jannuzzi, G; Monaco, F; Perucca, E, 2000) |
| "Our objective was to determine, in three separate studies, the effects of controlled-release carbamazepine (CBZ-CR), lamotrigine (LTG), and gabapentin (GBP) on nocturnal sleep in epilepsy." | 5.09 | Effect of anticonvulsants on nocturnal sleep in epilepsy. ( Diomedi, M; Gigli, GL; Marciani, MG; Placidi, F; Romigi, A; Scalise, A, 2000) |
| "5-18 yrs with intractable epilepsy and comedicated with carbamazepine or valproate." | 5.09 | Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy. ( Jović, NJ; Majkić-Singh, N; Milovanović, DD; Mirković, D, 1999) |
| "Both examined antiepileptic drugs, vigabatrin and carbamazepine, cause acquired color vision defects." | 5.09 | Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy. ( Kälviäinen, R; Mäntyjärvi, M; Nousiainen, I, 2000) |
| "Changes in body weight were evaluated in 349 patients from a study comparing efficacy of add-on therapy with tiagabine (TGB), carbamazepine (CBZ) or phenytoin (PHT)." | 5.09 | Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin. ( Bertrand, ME; Deaton, RL; Hogan, RE; Sommerville, KW, 2000) |
| "This prospective observational study explored the efficacy and tolerability of topiramate (TPM) in patients with refractory epilepsy attending a single outpatient clinic." | 5.09 | Topiramate in refractory epilepsy: a prospective observational study. ( Brodie, MJ; Sills, GJ; Stephen, LJ, 2000) |
| "A clinical pharmacological study (270 patients) was made to optimize therapy of epilepsy with carbamazepines (finlepsin and its retard form)." | 5.09 | [The optimization of epilepsy therapy with finlepsin]. ( Gromov, SA; Khorshev, SK; Mikhaĭlov, VA, 2000) |
| " The primary aim of the study was to evaluate lamotrigine add-on therapy and consecutive monotherapy in patients with epilepsy whose seizures were not controlled by carbamazepine or valproate." | 5.09 | Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy. ( Jozwiak, S; Terczynski, A, 2000) |
| "We compared the cognitive effects of randomly prescribed phenytoin (PHT) and carbamazepine (CBZ) therapy on newly diagnosed patients with epilepsy in a 2-year parallel group follow-up study." | 5.08 | Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up. ( Jokelainen, M; Pulliainen, V, 1995) |
| "To evaluate the efficacy, safety, and cognitive effects of initial vigabatrin monotherapy compared with initial carbamazepine monotherapy in patients with newly diagnosed epilepsy." | 5.08 | Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. ( Aikiä, M; Kälviäinen, R; Mervaala, E; Riekkinen, PJ; Saukkonen, AM, 1995) |
| " Use of the drug as monotherapy was investigated in a double-blind, randomised, parallel-group comparison with carbamazepine in newly diagnosed epilepsy." | 5.08 | Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. ( Brodie, MJ; Richens, A; Yuen, AW, 1995) |
| "We determined serum levels of total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), and triglycerides (TGs) in 125 healthy children and in 119 children with epilepsy who had been receiving carbamazepine (58 children), phenobarbital (22 children), or valproic acid (39 children) for 7 months to 10." | 5.08 | Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy. ( Bravo, M; Castro-Gago, M; Del Río, MC; Eirís, JM; Lojo, S; Novo, I; Pavón, P, 1995) |
| "Using a randomized parallel group study design, we compared the cognit ive effects of carbamazepine (CBZ), phenobarbital (PB), and valproate (VPA) in children with epilepsy." | 5.08 | Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study. ( Chen, YJ; Kang, WM; So, WC, 1996) |
| "To assess the effects of carbamazepine vs valproate sodium on cognitive functioning in patients with epilepsy compared with normal control subjects." | 5.08 | Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. ( Cattanach, L; Collins, JF; Cramer, JA; Delaney, RC; Mattson, RH; Prevey, ML, 1996) |
| "Our objective was to evaluate the patterns of malformations in children exposed in utero to phenytoin (DPH) and carbamazepine (CBZ) monotherapy, and to compare them prospectively with matched mother-child pairs exposed to nonteratogens, and to separate the effects of antiepileptic drugs (AEDs) from those of epilepsy by collecting groups of untreated epileptics and those treated with DPH and CBZ for conditions other than epilepsy." | 5.08 | Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. ( Chitayat, D; Farkas, LD; Koren, G; Nulman, I; Scolnik, D, 1997) |
| "The aim of the authors' study was to investigate the factors affecting carbamazepine (CBZ) clearance (CL) in children with epilepsy." | 5.08 | Carbamazepine population pharmacokinetics in children: mixed-effect models. ( Delgado Iribarnegaray, MF; Domínguez-Gil, A; Falcão, AC; García Sánchez, MJ; Otero, MJ; Santo Bueldga, D, 1997) |
| " This paper presents an analysis of body weight data gathered during a randomized trial comparing valproate with carbamazepine in 260 children aged 4-15 years with newly-diagnosed epilepsy." | 5.08 | Weight gain with valproate or carbamazepine--a reappraisal. ( Easter, D; O'Bryan-Tear, CG; Verity, C, 1997) |
| "To compare the bioavailability of three generic brands of carbamazepine tablets with that of a proprietary brand in adult patients with epilepsy." | 5.08 | Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients. ( Amornpichetkoon, M; Kaojarern, S; Silpakit, O, 1997) |
| "We have analyzed the records retrospectively and interviewed 70 adult patients attending an epilepsy clinic on VPA mono- or polytherapy followed over a median of 27 months (range 3-189), as well as 20 patients on carbamazepine (CBZ) monotherapy." | 5.08 | Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. ( Corman, CL; Guberman, AH; Leung, NM, 1997) |
| "Patients with newly diagnosed localization-related epilepsy who participated in a VGB-carbamazepine (CBZ) monotherapy trial were included." | 5.08 | A comparison of the neuropathological effects of vigabatrin and carbamazepine in patients with newly diagnosed localization-related epilepsy using MR-based cerebral T2 relaxation time measurements. ( Connelly, A; Duncan, JS; Van Paesschen, W, 1998) |
| "To compare the effectiveness of monotherapy clobazam (CLB) to carbamazepine (CBZ) and phenytoin (PHT) in children with epilepsy." | 5.08 | Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. ( , 1998) |
| "To examine the effect of grapefruit juice on the bioavailability of carbamazepine in patients with epilepsy." | 5.08 | Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. ( Bhargava, VK; Garg, SK; Kumar, N; Prabhakar, SK, 1998) |
| "The drug encorat, an analogue of valproic acid (Sun, India) was given to 16 children aged from 4 month to 5 years suffering from resistant forms of early infantile epilepsy." | 5.07 | [The enkorat treatment of infantile spasms and the Lennox-Gastaut syndrome]. ( Badalian, LO; Iskander, MB; Kharlamov, DA; Medvedev, MI; Mukhin, KIu; Temin, PA; Veselov, NK, 1994) |
| "We measured the levels of estradiol (E2), total testosterone (TT) and free testosterone (FT) in 24 male patients with epilepsy receiving phenytoin (DPH), 21 male patients with epilepsy receiving cabamazepine (CBZ), 23 male epileptics receiving no treatment, and in 10 healthy age-matched male controls." | 5.07 | [Effects of phenytoin and cabamazepine on sex hormones in male patients with epilepsy: a controlled study]. ( Ma, S; Zhou, S, 1994) |
| "A group of 51 patients with chronic cryptogenic or symptomatic localized epilepsy refractory to therapy with barbiturates underwent progressive substitution with phenytoin or carbamazepine, in standardized and randomized fashion." | 5.07 | Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function. ( Antoniuk, SA; Bigarella, MM; Bittencourt, PR; da Costa, JC; Doro, MP; Ferreira, AS; Fonseca, LC; Gonçalves e Silva, GE; Gorz, AM; Marcourakis, T, 1993) |
| "Sixty-four new cases of childhood epilepsy were randomly assigned to either carbamazepine, phenytoin or sodium valproate, and were assessed with behavioural measures before medication and after one and six months of treatment." | 5.07 | Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial. ( Berg, I; Butler, A; Ellis, M; Foster, J, 1993) |
| " Fourteen patients with refractory epilepsy on a twice daily regimen of modified-release carbamazepine (CBZ-MR." | 5.07 | Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients. ( Blacklaw, J; Brodie, MJ; Carswell, A; Gillham, RA; McKee, PJ, 1993) |
| "Sixty-four new cases of childhood epilepsy were randomly assigned to either carbamazepine, phenytoin or sodium valproate, and were assessed with cognitive tests before medication and three subsequent times over a year." | 5.07 | Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. ( Berg, I; Butler, R; Forsythe, I; McGuire, R, 1991) |
| "At present, 34 patients aged 15 to 63 years with newly diagnosed epilepsy have been randomly assigned to vigabatrin (n = 17) or carbamazepine (n = 17)." | 5.07 | Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. ( Aikiä, M; Kälviäinen, R; Mumford, J; Partanen, J; Riekkinen, PJ; Saksa, M; Sivenius, J, 1991) |
| "Taltrimide was compared with valproate and placebo in 17 patients with intractable epilepsy being on carbamazepine monotherapy." | 5.06 | A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy. ( Allonen, H; Iivanainen, M; Neuvonen, PJ; Parantainen, J; Tamminen, M; Tokola, O; Waltimo, O, 1990) |
| "Thirty three children with poorly controlled epilepsy, and six new patients, were treated with slow release carbamazepine." | 5.06 | Slow release carbamazepine in treatment of poorly controlled seizures. ( Bowmer, CJ; Forsythe, I; Hartley, R; Haworth, M; Ryan, SW, 1990) |
| "We investigated the neuropsychological effects of carbamazepine, phenobarbital, and phenytoin in 15 partial complex epilepsy patients treated with each drug for 3 months, using a randomized double-blind, triple crossover design." | 5.06 | Comparative cognitive effects of anticonvulsants. ( Gallagher, BB; Huh, K; King, DW; Loring, DW; Meador, KJ, 1990) |
| "A clinical and pharmacokinetic study was carried out progressively substituting a new anticonvulsant oxcarbazepine for its congener carbamazepine in a group of patients with refractory epilepsy." | 5.06 | Hyponatraemia during oxcarbazepine therapy. ( Eadie, MJ; Moses, DK; Pendlebury, SC, 1989) |
| " All the patients had epilepsy that had previously been untreated, and had been randomly assigned to receive carbamazepine, phenytoin, or sodium valproate." | 5.06 | Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study. ( Callaghan, N; Garrett, A; Goggin, T, 1988) |
| "A prospective, double-blind, placebo-controlled investigation of possible withdrawal symptoms from phenytoin, carbamazepine and sodium valproate is reported in patients with active epilepsy, on combination therapy." | 5.06 | Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate. ( Duncan, JS; Shorvon, SD; Trimble, MR, 1988) |
| "Progabide, an experimental GABA-ergic antiepileptic drug, was given in a placebo-controlled double-blind cross-over trial to 19 adult patients with chronic partial epilepsy refractory to previous high-dose antiepileptic drug therapy." | 5.06 | Progabide for refractory partial epilepsy: a controlled add-on trial. ( Schmidt, D; Utech, K, 1986) |
| "The effect of an additional dose of 400 mg carbamazepine (CBZ) on a series of simple psychomotor tests was investigated in 8 patients with epilepsy receiving chronic CBZ monotherapy in a balanced randomised double-blind placebo controlled cross-over study." | 5.06 | Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients. ( Brodie, MJ; Butler, E; Macphee, GJ; McPhail, EM, 1986) |
| "To conduct a literature review of the impact on cognition and mood status of lacosamide (LCM) in people with epilepsy." | 5.05 | The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy. ( Chang, YP; Huang, LC; Li, KY; Yang, YH, 2020) |
| "In double blind crossover 4 month trials, carbamazepine was compared to phenytoin as sole treatment for 45 patients with uncontrolled partial and generalized epilepsy." | 5.04 | Carbamazepine and the electroencephalogram of epileptics: a double blind study in comparison to phenytoin. ( Dodrill, CB; Troupin, AS; Wilkus, RJ, 1978) |
| "Two preparations of carbamazepine, as tablets and in syrup, were given for 8 weeks to 20 patients with epilepsy in a randomized crossover study." | 5.04 | Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients. ( Gerna, M; Monaco, F; Morselli, PL; Recchia, M; Riccio, A, 1975) |
| "We conducted this meta-analysis to evaluate effects of second-generation anti-epileptic drugs (AEDs; levetiracetam, lamotrigine) compared to first-generation AEDs (valproic acid, carbamazepine) on bone metabolism in epilepsy patients." | 5.01 | Effects of Second-Generation Antiepileptic Drugs Compared to First-Generation Antiepileptic Drugs on Bone Metabolism in Patients with Epilepsy: A Meta-Analysis. ( Chen, Y; Fu, J; Li, J; Peng, L; Tao, T, 2019) |
| " One study compared clonazepam to carbamazepine as monotherapy for participants with newly diagnosed psychomotor epilepsy (a condition corresponding to what is now termed mesial temporal lobe epilepsy)." | 5.01 | Clonazepam monotherapy for treating people with newly diagnosed epilepsy. ( Bragazzi, NL; Brigo, F; Igwe, SC; Lattanzi, S, 2019) |
| "To review the time to treatment failure, remission and first seizure with carbamazepine compared with phenytoin when used as monotherapy in people with focal onset seizures (simple or complex focal and secondarily generalised), or generalised onset tonic-clonic seizures (with or without other generalised seizure types)." | 5.01 | Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. ( Marson, AG; Nevitt, SJ; Tudur Smith, C, 2019) |
| " The point estimates of carbamazepine and lamotrigine efficacy showed their superiority with respect to all comparator antiepileptic drugs for the treatment of newly diagnosed focal epilepsy." | 4.98 | Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis. ( Crescioli, G; De Masi, S; Guerrini, R; Ilvento, L; Lucenteforte, E; McGreevy, KS; Mugelli, A; Pugi, A; Rosati, A; Virgili, G, 2018) |
| "Carbamazepine (CBZ) is used for the treatment of epilepsy and other neurological and psychiatric disorders." | 4.98 | Carbamazepine adverse drug reactions. ( Fricke-Galindo, I; Jung-Cook, H; LLerena, A; López-López, M, 2018) |
| "Lamotrigine is used in pregnancy to control epilepsy and mood disorders." | 4.95 | Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis. ( Adams-Webber, T; Barzilay, E; Leibson, T; Nulman, I; Pariente, G; Shulman, T, 2017) |
| " Oxcarbazepine and lamotrigine were associated with increased occurrence of autism." | 4.95 | Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. ( Cogo, E; D'Souza, J; Finkelstein, Y; Hemmelgarn, BR; Hutton, B; Kealey, R; MacDonald, H; Reynen, E; Rios, P; Soobiah, C; Straus, SE; Thavorn, K; Tricco, AC; Veroniki, AA; Yazdi, F, 2017) |
| "The objectives were to determine the influence of oxcarbazepine (OXC) monotherapy on the serum levels of total homocysteine (tHcy), vitamin B12 and folate in patient with epilepsy pooling together case-control or interventional studies." | 4.95 | Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis. ( Abdulahi Abdurahman, A; Djafarian, K; Rezaei, S; Shab-Bidar, S, 2017) |
| "Although carbamazepine is one of the oldest anticonvulsant drugs, it is still heavily utilized for treatment of epilepsy in children." | 4.95 | Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children. ( Djordjevic, N; Jankovic, SM; Milovanovic, JR, 2017) |
| "Carbamazepine (CBZ) is a commonly used drug for epilepsy that is associated with troublesome adverse events including dizziness, double vision, drowsiness, poor co-ordination and unsteadiness." | 4.93 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Rigby, A; Saunders, M, 2016) |
| " Antiepileptic drugs (AED) such as phenytoin are often used in clinical practice with the hopes of preventing post-traumatic epilepsy." | 4.91 | Pharmacological treatments for preventing epilepsy following traumatic head injury. ( Abel, H; Campbell, LA; Pohlmann-Eden, B; Thompson, K, 2015) |
| "This literature review is devoted to the use of the antiepileptic drug zonisamide in the initial monotherapy of symptomatic and cryptogenic partial epilepsy." | 4.91 | [New possibilities of monotherapy of symptomatic and cryptogenic partial epilepsy]. ( Belova, YA; Rudakova, IG, 2015) |
| "The efficacy and safety of vigabatrin (VGB) as an add-on therapy for refractory epilepsy have been well established." | 4.91 | Vigabatrin versus carbamazepine monotherapy for epilepsy. ( Gan, L; Luo, H; Luo, M; Wang, J; Xiao, Y, 2015) |
| "The developmental quotient (DQ) was lower in children exposed to carbamazepine (CBZ) (n = 50) than in children born to women without epilepsy (n = 79); mean difference (MD) of -5." | 4.90 | Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. ( Adab, N; Bromley, R; Greenhalgh, J; Marson, AG; McKay, AJ; Sanniti, A; Tudur Smith, C; Weston, J, 2014) |
| "The efficacy and safety of vigabatrin (VGB) as an add-on therapy for refractory epilepsy has been well established." | 4.88 | Vigabatrin versus carbamazepine monotherapy for epilepsy. ( Gan, L; Luo, H; Luo, M; Wang, J; Xiao, Y, 2012) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: monotherapy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs (lamotrigine or levetiracetam) for drug-resistant epilepsy; and hemispherectomy for drug-resistant epilepsy." | 4.88 | Epilepsy (generalised). ( Maguire, M; Marson, AG; Ramaratnam, S, 2012) |
| "Long-term use of phenytoin (PHT) causes gingival hyperplasia; however, little is known about the oral side effects of other antiepileptic drugs (AEDs)." | 4.87 | The effects of antiepileptic drugs on oral health. ( Aragon, CE; Burneo, JG; Cornacchio, AL, 2011) |
| "To determine the efficacy of immediate-release carbamazepine (IR CBZ) versus controlled-release carbamazepine (CR CBZ) in patients with newly diagnosed epilepsy." | 4.86 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Saunders, M, 2010) |
| "To identify specific major congenital malformations associated with use of carbamazepine in the first trimester of pregnancy." | 4.86 | Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. ( de Jong-van den Berg, L; Dolk, H; Garne, E; Jentink, J; Loane, MA; Morris, JK; Wellesley, D, 2010) |
| "In this systematic review we present information relating to the effectiveness and safety of the following interventions: monotherapy using carbamazepine, gabapentin, lamotrigine, levetiracetam, phenobarbital, phenytoin, sodium valproate, or topiramate; addition of second-line drugs (lamotrigine or levetiracetam) for drug-resistant epilepsy; and hemispherectomy for drug-resistant epilepsy." | 4.86 | Epilepsy (generalised). ( Maguire, M; Marson, AG; Ramaratnam, S, 2010) |
| " It is unclear whether or not monotherapy with the new AEDs offers higher efficacy and/or lower side effects compared to classic AEDs (phenobarbital, phenytoin, carbamazepine, or valproate) thereby significantly improving the quality of life in children with epilepsy." | 4.85 | [Role of monotherapy with new antiepileptic drugs in the treatment of childhood epilepsy]. ( Legido, A; Valencia, I, 2009) |
| "Studies have confirmed that the elimination of lamotrigine and the active metabolite of oxcarbazepine is enhanced during pregnancy." | 4.85 | Managing antiepileptic drugs during pregnancy and lactation. ( Sabers, A; Tomson, T, 2009) |
| "There is moderate evidence indicating that oxcarbazepine is effective as an alternative treatment for partial or generalized epilepsy in children and adults who were refractory to previous treatment." | 4.85 | Oxcarbazepine for refractory epilepsy: systematic review of the literature. ( Atallah, AN; Prado, GF; Puga, ME; Saconato, H, 2009) |
| " The present study aims to determine the distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its possible impact on the metabolism of valproic acid (VPA) and carbamazepine (CBZ) in patients with epilepsy from Khyber Pakhtunkhwa region of Pakistan." | 4.84 | Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy. ( Ali, N; Almarshad, F; Alshahrani, AM; Jamil, A; Saleh Faisal, M, 2024) |
| "The data on therapeutical efficacy of the new antiepileptic drug trileptal (oxcarbazepine) and results of the own observations of 38 patients with partial epilepsy who received trileptal as mono- or polytherapy are presented." | 4.84 | [The use of the antiepileptic drug trileptal in the clinical practice]. ( Eroshina, ES; Gromov, SA; Lipatova, LV, 2008) |
| " The USA guideline for epilepsy treatment recommends that patients with newly diagnosed epilepsy can be treated with gabapentin, lamotrigine, topiramate, and oxcarbazepine." | 4.84 | [Newer antiepileptic drugs]. ( Matsuura, M, 2007) |
| " Controlled trials in elderly patients with epilepsy demonstrate efficacy and tolerability comparable to gabapentin." | 4.84 | Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. ( Nanry, K; Ramsay, E; Sajatovic, M; Thompson, T, 2007) |
| " After excluding a possible interaction by long-term Carbamazepine treatment, the diagnosis of the Ictal bradycardia syndrome was made in view of the simultaneous occurrence of severe bradycardia and epileptic activity recorded on electro-encephalography." | 4.84 | [The ictal bradycardia syndrome: a case report and review of the literature]. ( Aissi, K; Bagnères, D; Demoux, AL; Francès, Y; Granel, B; Mechulan, A; Rossi, P; Sbragia, P; Somma-Mauvais, H, 2007) |
| "This review analyses the concept of extended-release (ER) formulations in epilepsy and evaluates ER formulations of carbamazepine, valproic acid and a modified-release (MR) formulation of oxcarbazepine." | 4.84 | Extended-release formulations for the treatment of epilepsy. ( Bialer, M, 2007) |
| " As the result of the detailed analysis of the literature the author recommends lamotrigine, carbamazepine and oxcarbazepine as first choice antiepileptic drug for epileptic patients suffering from depressive disorder, too." | 4.84 | [Effects of antiepileptic drugs on mood of people with epilepsy]. ( Rajna, P, 2007) |
| "This paper briefly reviews and comments on the development of lamotrigine as a treatment for bipolar disorder." | 4.84 | Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. ( Ascher, JA; Bowden, CL; Calabrese, JR; DeVeaugh-Geiss, J; Evoniuk, G; Weisler, RH, 2008) |
| "To review the best evidence comparing oxcarbazepine and phenytoin when used as monotherapy in patients with epilepsy." | 4.83 | Oxcarbazepine versus phenytoin monotherapy for epilepsy. ( Marson, AG; Muller, M; Williamson, PR, 2006) |
| " However, a particular association of valproate and carbamazepine with neural tube defects (NTDs)--specifically, with spina bifida aperta (SB)--has been identified." | 4.82 | Management issues for women with epilepsy: neural tube defects and folic acid supplementation. ( Yerby, MS, 2003) |
| "Lamotrigine and oxcarbazepine demonstrated efficacy in randomized active-control trials in patients with newly diagnosed epilepsy and in substitution trials in patients refractory to conventional AEDs." | 4.82 | Monotherapy in epilepsy: role of the newer antiepileptic drugs. ( Vazquez, B, 2004) |
| "To check for an association between carbamazepine (CBZ) use by the mother during pregnancy and congenital eye malformations (i." | 4.81 | Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child? ( Cornel, MC; Kroes, HY; Reefhuis, J, 2002) |
| "The introduction of these new antiepileptic drugs, from felbamate to levetiracetam, raised hope of control of epilepsy with fewer adverse effects and improved quality of life." | 4.81 | New antiepileptic drug therapies. ( Bergin, AM; Connolly, M, 2002) |
| " The terms used individually and in combination were oxcarbazepine, carbamazepine, epilepsy, and seizures." | 4.81 | Oxcarbazepine, an antiepileptic agent. ( Huff, NA; Kalis, MM, 2001) |
| "Carbamazepine (CBZ) has been extensively used in the treatment of epilepsy, as well as in the treatment of neuropathic pain and affective disorders." | 4.81 | Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. ( Ambrósio, AF; Carvalho, AP; Carvalho, CM; Soares-Da-Silva, P, 2002) |
| "To provide an overview of the evidence comparing carbamazepine (CBZ) and valproate (VPA) monotherapy for epilepsy, investigating whether existing data support the current practice of preferring CBZ for partial-onset and VPA for generalized-onset seizures." | 4.81 | Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. ( Chadwick, DW; Clough, H; Hutton, JL; Marson, AG; Williamson, PR, 2002) |
| "The antiepileptic drug hypersensitivity syndrome (AHS) is an adverse drug reaction associated with the aromatic antiepileptic drugs (AEDs) phenytoin (PHT), carbamazepine (CBZ), phenobarbital (PB), and primidone." | 4.80 | Antiepileptic drug hypersensitivity syndrome. ( Schlienger, RG; Shear, NH, 1998) |
| "Carbamazepine and valproate are drugs of first choice for epilepsy." | 4.80 | Carbamazepine versus valproate monotherapy for epilepsy. ( Chadwick, DW; Clough, HE; Hutton, JL; Marson, AG; Williamson, PR, 2000) |
| "Vigabatrin is among the most promising of the new anti-epilepsy drugs, but two unrelated complications have been noted in patients receiving vigabatrin for chronic refractory epilepsy." | 4.79 | Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective. ( Schmidt, D, 1995) |
| "The major established drugs used in the management of epilepsy are carbamazepine, valproic acid, phenytoin, phenobarbital, primidone, ethosuximide and benzodiazepine drugs." | 4.79 | Established antiepileptic drugs. ( Perucca, E, 1996) |
| "Trial reports on carbamazepine or valproate monotherapy (Medline-search), and data from the Nijmegen Epilepsy Research Group were analyzed." | 4.79 | Adverse effects in epilepsy therapy. Wait and see or go for it? ( Deckers, CL; Hekster, YA; Keyser, A; Lammers, MW; Meinardi, H; Renier, WO, 1997) |
| "Carbamazepine, a drug used for the treatment of epilepsy and neuralgias, may exert hazardous effects on the cardiac conduction system." | 4.79 | Carbamazepine-induced sinus node dysfunction. ( Jiménez, JE; Johnson, CD; Rivera, H, 1997) |
| "This article provides an analysis of the degree of agreement between in vivo interaction studies performed in patients with epilepsy and healthy individuals, and in vitro studies which identified the cytochromes P450 (CYP) inhibited by felbamate and those involved in its metabolism." | 4.79 | Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. ( Banfield, CR; Glue, P; Levy, RH; Mather, GG; Perhach, JL; Racha, JK, 1997) |
| "A 14-year-old female developed systemic lupus erythematosus (SLE)-like symptoms, rash, fever, leukopenia and positive anti-nuclear antibody (ANA) two weeks after administration of carbamazepine (CBZ; Tegretol) used against benign Rolandic epilepsy." | 4.78 | Carbamazepine-induced systemic lupus erythematosus-like disease. ( Kanno, T; Kasukawa, R; Kazuta, Y; Miyata, M; Nishimaki, T; Sato, Y, 1992) |
| "The author reviews the use of carbamazepine in the treatment of epilepsy." | 4.77 | Carbamazepine and mood: evidence from patients with seizure disorders. ( Trimble, MR, 1988) |
| "Carbamazepine is an antiepileptic drug used in the treatment of epilepsy, trigeminal neuralgia, and bipolar disorder." | 4.31 | Acute lymphocytic leukemia in a patient with long-term carbamazepine exposure: Acute lymphoblastic leukemia that develops in a patient who has been using carbamazepine for a long time. ( Bagci, M; Sayin, S, 2023) |
| "More than two-thirds of patients with WHO grade 2 glioma related epilepsy treated with levetiracetam first line achieve seizure freedom within 2 years and it is a reasonable first-choice agent." | 4.31 | Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure. ( Chumas, P; Fairclough, S; Goodden, J; Maguire, M; Mathew, R, 2023) |
| "Several studies have reported an association between certain human leukocyte antigen (HLA) alleles and carbamazepine (CBZ)-induced hypersensitivity reactions in patients with epilepsy." | 4.31 | Next-generation sequencing-based HLA typing reveals the association of HLA-B*46:01:01 and HLA-DRB1*09:01:02 alleles with carbamazepine-induced hypersensitivity reactions in Vietnamese patients with epilepsy. ( Bui, TP; Le, NTT; Le, PL; Nguyen, LTT; Nguyen, TD; Trinh, TH; Van Nguyen, AT; Van Nguyen, L, 2023) |
| "To investigate the antiseizure medication (ASM) doses required to achieve seizure freedom and their correlation with the World Health Organization's defined daily doses (DDDs) in patients aged 16 years or older with newly diagnosed epilepsy." | 4.31 | Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy. ( Hersi, H; Peltola, J; Raitanen, J; Saarinen, JT, 2023) |
| "Findings from this explorative study strengthen the evidence for the warning against the use of valproate in pregnancy and raise concern of risks of specific psychiatric disorders associated with topiramate and levetiracetam." | 4.31 | Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. ( Alvestad, S; Bjørk, MH; Christensen, J; Cohen, JM; Dreier, JW; Furu, K; Gissler, M; Igland, J; Leinonen, MK; Sun, Y; Tomson, T; Zoega, H, 2023) |
| "A prospective longitudinal study was conducted to assess the Apo B100/A1 ratio as a marker of cardiovascular risk in children with epilepsy aged 5-14 years on long-term anti-seizure medication monotherapy with either sodium valproate, oxcarbazepine, or levetiracetam." | 4.31 | Change in Apo B100/A1 Ratio in Children With Epilepsy on Monotherapy With Sodium Valproate, Oxcarbazepine or Levetiracetam. ( Dhama, A; Kaushik, JS; Lekhwani, S, 2023) |
| "A patient with epilepsy on carbamazepine developed a rapidly progressive cerebellar syndrome." | 4.31 | Progressive multifocal leukoencephalopathy associated with carbamazepine-induced immune dysfunction and recovery after carbamazepine cessation. ( Counsell, CE; Khan, QI; Macleod, AD; Perrott, S, 2023) |
| "This study revealed the higher risk of cardiac arrhythmias persists long term in people with epilepsy, especially among those using carbamazepine and valproic acid." | 4.31 | Epilepsy and long-term risk of arrhythmias. ( Cai, J; Feng, Z; Huang, P; Liu, P; Lu, J; Lu, Y; Tang, H; Wang, J; Yang, G; Yang, Y; Yu, Q; Yuan, H, 2023) |
| "Carbamazepine may cause clinical effects such as dizziness and nystagmus." | 4.31 | Assessment of vestibulo-ocular reflex with video head impulse test in epilepsy patients undergoing carbamazepine monotherapy. ( Adiguzel, A; Demir, I, 2023) |
| "The purpose of this study was to detect the changes of P-Glycoprotein (P-GP) expression in rat brain microvessel endothelial cell line RBE4 after the action of Tetramethylpyrazine (TMP) on Carbamazepine (CBZ), so as to clarify the potential mechanism of TMP combined with CBZ against intractable epilepsy drug resistance." | 4.31 | Study on the reversal of epileptic drug resistance by tetramethylpyrazine in combination with carbamazepine through modulation of P-Glycoprotein expression in rat brain microvessel endothelial cell. ( Deng, Y; Li, Y; Liu, J; Liu, W; Qian, X; Wang, J; Xiao, G; Yan, J; Ye, J; Zhong, N, 2023) |
| "A261T) identified in two patients with mild, carbamazepine-responsive, focal epilepsy." | 4.12 | Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants. ( Cellini, E; Guerrini, R; Gurnett, CA; Mei, D; Miceli, F; Nappi, M; Parmeggiani, L; Soldovieri, MV; Taglialatela, M, 2022) |
| "Carbamazepine is a medication used to treat a variety of neurological and psychiatric conditions including seizure disorders, neuropathic pain syndromes, and bipolar disorder." | 4.12 | Neurologic toxicity of carbamazepine in treatment of trigeminal neuralgia. ( Birdsong, S; Bridwell, RE; Brown, S; Clerkin, S; Long, B, 2022) |
| "To explore developmental processes of epileptogenesis/ictogenesis and pathophysiology of carbamazepine-resistant epilepsy, we determined effects of high-frequency-oscillation (HFO) on glutamatergic tripartite-synaptic transmission, astroglial expression of connexin43, and intracellular Erk- and Akt-signalling, using genetic rat model (S286L-TG) of autosomal-dominant sleep-related hypermotor epilepsy(ADSHE), which bears rat S286L-mutant Chrna4(corresponding to human S284L-mutant CHRNA4)." | 4.12 | High frequency oscillations play important roles in development of epileptogenesis/ictogenesis via activation of astroglial signallings. ( Fukuyama, K; Okada, M, 2022) |
| "Investigations on the effects of newly constructed glucose-PEG2000-DSPE modified carbamazepine nano system on oxidative stress damage and cell apoptosis in epilepsy." | 4.12 | Glucose-PEG2000-DSPE modified carbamazepine nano system alleviated cell apoptosis and oxidative stress in epilepsy. ( Wu, C; Xiao, K; Zhao, F, 2022) |
| "Background and Objectives: Hyponatremia is one of the most common adverse effects in patients treated with oxcarbazepine (OXC)." | 4.12 | Oxcarbazepine and Hyponatremia. ( Čiauškaitė, J; Gelžinienė, G; Jurkevičienė, G, 2022) |
| "Carbamazepine (CBZ), a drug prescribed to prevent seizures in people with epilepsy, has a narrow therapeutic range such that patients would greatly benefit from personalized drug dosage recommendations." | 4.12 | Comparison of signal enhancement strategies for carbamazepine detection in undiluted human saliva using an electrochemical sensor with stencil-printed carbon electrodes. ( Downs, C; Fu, E; Wentland, L, 2022) |
| " The patient was treated with Carbamazepine and Clonazepam achieving the disappearance of seizures." | 4.12 | Expanding the genetic and clinical characteristics of Protocadherin 19 gene mutations. ( Dell'Isola, GB; Di Cara, G; Fattorusso, A; Imperatore, V; Mencaroni, E; Prontera, P; Striano, P; Tascini, G; Verrotti, A, 2022) |
| "This study aimed to investigate the factors affecting the plasma concentration of monohydroxylated derivative (MHD) of oxcarbazepine (OXC) in children with epilepsy." | 4.12 | Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy. ( Huang, A; Huang, S; Song, H; Yao, N, 2022) |
| " The efficacy evaluation of NPs/KCZ was evaluated in a kainic acid (KA)-induced mice model of epilepsy with carbamazepine (CBZ) treatment." | 4.12 | Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy. ( Fu, J; Lv, K; Sun, W; Wang, J; Yin, X; Zhang, J, 2022) |
| "The present study identifies a significant positive association between ASM and LUTI incidence and antibiotic prescriptions in patients with epilepsy treated with pregabalin, whereas a protective effect was found for carbamazepine in women only." | 4.12 | Association between anti-seizure medication and the risk of lower urinary tract infection in patients with epilepsy. ( Ehrenberg, C; Gremke, N; Kalder, M; Kostev, K; Möller, L; Printz, M, 2022) |
| "To describe levetiracetam pharmacokinetic variability in patients with epilepsy in real clinical practice." | 4.12 | Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware? ( de la Fuente, E; de Toledo, M; de Toledo, MP; Ferreiros-Martinez, R; Lagares, A; Muro, I; Ovejero-Benito, MC; Ramos, C; Sobrado, M; Vieira Campos, A, 2022) |
| "Epilepsy is one of the most prevalent neurological conditions and carbamazepine is a commonly used anti-seizure drug (ASD), especially in developing nations." | 4.02 | Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: A cross-sectional study. ( Aghoram, R; Balachandran, M; Indira Priya, D; Jain, S; Meher, R; Nair, PP; Nandwani, S; Sreekumaran Nair, N; Wadwekar, V; Wagh, S, 2021) |
| "The study is aimed at comparing effects of older drugs like carbamazepine (CBZ) and newer agent like levetiracetam (LEV) on polycystic ovarian syndrome (PCOS) in women with epilepsy (WWE)." | 4.02 | Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy. ( Alabi, A; Makanjuola, A; Oboh, D; Ogunjimi, L; Ogunniyi, A; Olawale, O; Olusola-Bello, M; Osalusi, B; Yaria, J, 2021) |
| " The aim of our study was to investigate the effects of valproic acid and carbamazepine monotherapy used in the treatment of epilepsy patients on serum adiponectin and carnitine levels." | 4.02 | The correlation between carbamazepine and valproic acid monotherapy with serum adiponectin and carnitine. ( Ceylan, M; İyigün, İ; Kızıltunç, A; Şimşek, F, 2021) |
| " In this study, we examined the effect of both acute and chronic treatment with moclobemide on seizures and the action of first-generation antiepileptic drugs: valproate, carbamazepine, phenobarbital and phenytoin." | 4.02 | Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice. ( Banach, M; Borowicz-Reutt, KK, 2021) |
| "We performed an observational study, collecting data between 2017 and 2019 on serum sodium levels and adverse effects retrospectively in people with epilepsy while receiving treatment with either carbamazepine (CBZ) or oxcarbazepine (OXC)." | 4.02 | Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. ( Berghuis, B; de Haan, GJ; Hulst, J; Koeleman, BPC; Lindhout, D; McCormack, M; Sander, JW; Sonsma, A, 2021) |
| " Exanthema as especially clinically relevant adverse drug event was rightly chosen for carbamazepine by 18 (8%) and for lamotrigine by 12 (5%) participants." | 4.02 | Knowledge of epilepsy among German pharmacists. ( Bertsche, A; Bertsche, T; Herziger, B; Jeschke, S; Müller, RM; Neininger, MP, 2021) |
| "Carbamazepine (CBZ)-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are strongly associated with the HLA-B*15:02 allele." | 4.02 | Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model. ( Cavallari, LH; Hao, J; Kristin, E; Mahasirimongkol, S; Mitropoulou, C; Patrinos, GP; Prahasto, ID; Prayuni, K; Shin, JG; Snyder, SR; Suyatna, FD; Williams, MS; Yuliwulandari, R, 2021) |
| "To evaluate the efficacy and tolerability of extended release carbamazepine (finlepsin-retard and tegretol CR) in adult patients with new-onset focal epilepsy (FE) with the assessment of epileptiform activity index (EAI)." | 4.02 | [The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index]. ( Karlov, VA; Kozhokaru, AB; Orlova, AS; Vlasov, PN, 2021) |
| "39 years) with epilepsy, well controlled by monotherapy with levetiracetam, valproic acid, ethosuximide, oxcarbazepine or carbamazepine and 45 age/sex-matched controls." | 4.02 | Effects of antiseizure monotherapy on visuospatial memory in pediatric age. ( Coppola, G; Di Bonaventura, C; Donadio, S; Operto, FF; Padovano, C; Pastorino, GMG; Scuoppo, C; Vivenzio, V, 2021) |
| " Carbamazepine- or oxcarbazepine-induced maculopapular exanthema occurred earlier (median: one week) than that induced by other antiseizure medications (median: three weeks) (p=0." | 4.02 | Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment. ( Bettinotti, MP; Braatz, VL; de Paola, L; Iglehart, B; Lohr, A; Rodrigues, M; Silvado, CES; Tensini, FS; Tensini, TS; Von Glehn, CQC, 2021) |
| " In epilepsy after trauma, levetiracetam had the highest retention rate at 80% (95% confidence interval [CI] = 65-89), exceeding that of the most commonly prescribed ASM, carbamazepine (p = ." | 4.02 | Potential for improved retention rate by personalized antiseizure medication selection: A register-based analysis. ( Garcia-Ptacek, S; Håkansson, S; Karlander, M; Larsson, D; Mahamud, Z; Zelano, J; Zelezniak, A, 2021) |
| "Epilepsy patients were followed up at the Antalya Training and Research Hospital Department of Neurology, Epilepsy Outpatient Clinic who were at high risk for osteoporosis (use of valproic acid [VPA] and enzyme-inducing drugs, using any AED for over 5 years, and postmenopausal women) and were evaluated using a screening protocol." | 4.02 | Management of bone metabolism in epilepsy. ( Abidin, E; Fatma, G; Uçan Tokuç, FE; Yasemin, GB, 2021) |
| "Carbamazepine and topiramate both have established potentials for causing teratogenesis, and it is possible that replacement of carbamazepine with a less teratogenic AED, for example levetiracetam, might result in any subsequent depression that occurs in pregnancy being inappropriately attributed to the newly introduced agent." | 3.96 | Antiepileptic drugs and depression during pregnancy in women with epilepsy. ( Eadie, MJ; Graham, JE; Hitchcock, AA; Horgan, D; Lander, CM; Mitchell, J; O'Brien, TJ; Vajda, FJE, 2020) |
| "56 G > A rs17183814 on the response to lamotrigine monotherapy in patients with focal epilepsy in Herzegovina area, Bosnia and Herzegovina." | 3.91 | Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina. ( Basic, S; Bozina, N; Markovic, I; Pejanovic-Skobic, N, 2019) |
| " Under carbamazepine monotherapy, the patient presented hypoparathyroidism accompanied by severe hypocalcemia." | 3.91 | Familial congenital choanal atresia with GATA3 associated hypoparathyroidism-deafness-renal dysplasia syndrome unidentified on auditory brainstem response. ( Kita, M; Kuwata, Y; Usui, T, 2019) |
| "This study evaluated the effect of androsterone (AND), a metabolite of testosterone, on the ability of selected classical and novel antiepileptic drugs to prevent seizures caused by maximal electroshock (MES), which may serve as an experimental model of human generalized tonic-clonic seizures in mice." | 3.91 | Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice. ( Aebisher, D; Bartusik-Aebisher, D; Buszewicz, G; Kołodziejczyk, P; Mróz, K; Mróz, T; Tutka, P; Łuszczki, JJ, 2019) |
| " Therefore, we conducted a prospective longitudinal study to evaluate the effects of LEV and carbamazepine (CBZ) treatment on lipid profile and thyroid hormone levels in patients newly diagnosed with epilepsy." | 3.91 | Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study. ( Iijima, K; Ishida, Y; Maruyama, A; Nagase, H; Nakagawa, T; Nishimura, N; Nishiyama, M; Nozu, K; Takami, Y; Tanaka, T; Tokumoto, S; Tomioka, K; Toyoshima, D; Yamaguchi, H, 2019) |
| "Lamotrigine and levetiracetam have higher retention rates than carbamazepine in poststroke epilepsy." | 3.91 | Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study. ( Åsberg, S; Kumlien, E; Larsson, D; Zelano, J, 2019) |
| " None of the clinical factors appeared to affect seizure outcomes significantly except that treatment with carbamazepine was a protective factor against uncontrolled seizures (OR = 0." | 3.91 | Factors predicting uncontrolled seizures in epilepsy with auditory features. ( Chen, L; Zhang, L; Zhu, X; Zou, X, 2019) |
| "A hundred and one children with epilepsy using valproic acid or carbamazepine and 58 healthy children were included in this study." | 3.91 | Effects of antiepileptic drugs on dynamic thiol/disulphide homeostasis in children with idiopathic epilepsy. ( Arhan, E; Aydin, K; Kurt, ANC; Neselioglu, S; Serdaroglu, A; Uçar, HK; Yerel, O, 2019) |
| "The aims of this study were to identify the influencing factors such as gender, age, dose and combinations of other antiepileptic drugs (AEDs), especially in triple combinations on the pharmacokinetic of Lamotrigine (LTG) in epilepsy patients of Northwest Chinese Han population." | 3.91 | The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy. ( Han, X; Huang, J; Lv, J; Ma, L; Nie, X; Peng, L; Wang, J; Xia, L; Zan, X, 2019) |
| "Newly diagnosed rats with epilepsy were treated with carbamazepine (CBZ) during a 4-week baseline period to establish their baseline seizure rate in the presence of 50% adherence." | 3.91 | Correction of medication nonadherence results in better seizure outcomes than dose escalation in a novel preclinical epilepsy model of adherence. ( Hill, AC; Newell, TG; Thomson, KE; White, HS, 2019) |
| "This study investigates the neuronal protective effect of SXC combined with carbamazepine (CBZ) on epilepsy and cognitive impairment in kainic acid-kindled SD rats." | 3.91 | Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats. ( Chen, M; Jia, C; Jiao, H; Wei, L; Yang, H; Yin, W; Zhang, R, 2019) |
| "To assess the association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy." | 3.91 | [Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy]. ( Chen, H; Huang, J; Huang, L; Huang, Q; Liu, G; Qian, Z; Tang, X, 2019) |
| "We constructed a Markov model in a hypothetical cohort of adult Asian patients with epilepsy in the United States being considered for carbamazepine to investigate the cost-effectiveness of two alternative strategies: (1) no HLA-B*1502 gene allele screening and using carbamazepine and (2) HLA-B*1502 gene allele screening and starting levetiracetam in the case of a positive screen." | 3.91 | Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States. ( Choi, H; Mohit, B, 2019) |
| "Carbamazepine (CBZ) with piperine, the active ingredient in black pepper, which is omnipresent in food and may be potentially used for epilepsy control owing to its anticonvulsant effects, can be coadministered to epileptic patients." | 3.91 | Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats. ( Cheng, Y; Hu, M; Ren, T; Xiao, M; Xu, H; Yan, X; Yang, M; Zhang, C; Zhang, Y; Zhao, J; Zuo, Z, 2019) |
| "Due to the significant risk of developing Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), the use of carbamazepine is not recommended in patients carrying the human leukocyte antigen B (HLA-B) *15:02 allele." | 3.88 | External quality assessment for laboratory testing of HLA-B*15:02 allele in relation to carbamazepine therapy. ( Han, Y; Li, J; Lin, G; Xie, J; Zhang, K, 2018) |
| "Intrauterine exposure to anti-epileptic drugs, particularly carbamazepine, may be associated with an increased risk of foetal death during pregnancy." | 3.88 | Anti-epileptic drug exposure and risk of foetal death in utero. ( Eadie, MJ; Graham, J; Hitchcock, AA; Lander, CM; O'Brien, TJ; Vajda, FJE, 2018) |
| "The aim of this study was to investigate the effect of carbamazepine (CBZ) and sodium valproate (VPA) monotherapy on sexual functions, sex hormones, and semen analysis and quality in male patients with epilepsy." | 3.88 | Evaluation of sex hormones and sperm parameters in male epileptic patients. ( Colak, A; Köse, C; Ocek, L; Sarıteke, A; Tarhan, H; Uludağ, FI; Zorlu, F; Zorlu, Y, 2018) |
| "To assess the effect of monotherapy with Carbamazepine (CBZ) and Sodium valproate (VPA) on serum 25-OH Vitamin D levels in children with epilepsy compared to controls." | 3.88 | Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy. ( Devadathan, K; Mohammed Kunju, PA; Muthubeevi, S; Pillai, JP; Sasidharan, B; Sreedharan, M; Vasumathy Amma, MA, 2018) |
| "A total of 304 patients with epilepsy, aged 18-70 years, were divided into a lamotrigine monotherapy group and groups receiving lamotrigine with AEDs that act as enzyme inducers, enzyme inhibitors, or both." | 3.88 | Effect of antiepileptic drug comedication on lamotrigine concentrations. ( Božina, N; Čajić, I; Klarica Domjanović, I; Lovrić, M; Petelin Gadže, Ž, 2018) |
| " The frequency of number of seizures/week was higher in the carbamazepine cohort compared to valproic acid cohort." | 3.88 | Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients. ( Ali, N; Nazish, H; Shakir, S, 2018) |
| "The goal of our study was to investigate the incidence of Stevens-Johnson syndrome (SJS), the frequency of SJS diagnosis, and the association between SJS and prior use of allopurinol, carbamazepine or phenytoin." | 3.88 | Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study. ( Cheng, CY; Cheng, FJ; Chuang, PC; Huang, YS; Pan, HY; Syu, FK, 2018) |
| "This study evaluated cochlear function in patients with idiopathic epilepsy and treated with carbamazepine (CBZ)." | 3.88 | Cochlear Function in Adults with Epilepsy and Treated with Carbamazepine. ( Hamed, SA; Oseilly, AM, 2018) |
| "Phenytoin (PHE) and carbamazepine (CBZ) are first rank causative drugs that can induce drug rash with eosinophilia and systemic symptoms (DRESS) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)." | 3.88 | Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS/TEN in epilepsy patients. ( Kumkamthornkul, P; Srinoulprasert, Y; Tansit, T; Tuchinda, P; Udnaen, S, 2018) |
| "In our personal experience, headache is a frequent complaint in Persons with epilepsy (PWE) receiving antiepileptic drugs (AEDs), carbamazepine (CBZ) in particular." | 3.88 | New-onset interictal headache in Persons with epilepsy (PWE): A case-control study. ( Aghoram, R; Nair, PP; Sahu, J; Wadwekar, V, 2018) |
| "We measured serum levels of 25-OHD and osteocalcin (OCLN) in normal controls (n=30) and in epilepsy patients taking carbamazepine (CBZ) (n=50) in monotherapy for a period of at least twelve months." | 3.88 | Effect of Long-term Carbamazepine Therapy on Bone Health. ( Mahmutbegovic, N; Mehicevic, A; Suljic, EM, 2018) |
| "The objective of the EPICON Project is to develop a set of recommendations on how to adequately switch from carbamazepine (CBZ) and oxcarbazepine (OXC) to eslicarbazepine acetate (ESL) in some patients with epilepsy." | 3.88 | EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy. ( Bathal, H; Ojeda, J; Parra, J; Rocamora, RA; Rodríguez-Uranga, JJ; Serrano-Castro, PJ; Villanueva, V; Viteri, C, 2018) |
| "7% of enrolled males with epilepsy; there is any association between sexual dysfunctions and various AEDs in the treatment, except for carbamazepine (CBZ); there is not any association between sexual dysfunctions and frequency of seizures; hormonal changes are associated with sexual dysfunction in males with epilepsy treated with AEDs but not with the orgasmic dysfunction; there is not any association between hormonal changes and type of AEDs, except for CBZ; depression is associated with sexual dysfunctions." | 3.85 | Relation between sexual dysfunctions and epilepsy, type of epilepsy, type of antiepileptic drugs: a prospective study. ( Fierro, B; Giacalone, N; Pavone, C; Urso, L; Vella, M; Zummo, L, 2017) |
| "A hybrid model of a decision tree and Markov model was developed to evaluate three strategies for treating newly diagnosed epilepsy among adults: (i) carbamazepine initiation without HLA-B*15:02 screening (current practice); (ii) universal HLA-B*15:02 screening prior to carbamazepine initiation; and (iii) alternative treatment [sodium valproate (VPA)] prescribing without HLA-B*15:02 screening." | 3.85 | Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia. ( Apalasamy, YD; Cavallari, LH; Chaiyakunapruk, N; Chong, HY; Dahlui, M; Hao, J; Mohamed, Z; Shabaruddin, FH; Snyder, SR; Tan, LL; Williams, MS; Wu, DBC, 2017) |
| "Female patients with epilepsy and an older age, AED polytherapy, and carbamazepine treatment had a higher risk of low fT4." | 3.85 | Effects of antiepileptic drugs on thyroid hormone function in epilepsy patients. ( Chuang, MJ; Chuang, YC; Fu, TY; Lu, YT; Shih, FY; Tsai, MH; Tsai, WC, 2017) |
| "The results from this pilot investigation suggest that nonadherence to carbamazepine is associated with significant negative but reversible effects on seizure control in an animal model of epilepsy." | 3.85 | The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy. ( Glauser, TA; Modi, AC; Rausch, JR; Steve White, H; Thomson, KE, 2017) |
| "To ascertain possible determinants of carbamazepine (CBZ)- and oxcarbazepine (OXC)-induced hyponatremia in a large cohort of people with epilepsy." | 3.85 | Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. ( Berghuis, B; de Haan, GJ; Koeleman, BPC; Lindhout, D; Sander, JW; van der Palen, J, 2017) |
| "A limited number of anti-epileptic drugs accounted for the treatment of a majority of new patients with epilepsy (carbamazepine, lamotrigine and valproate accounted for more than 70%)." | 3.85 | Patterns of antiepileptic drug prescription in Sweden: A register-based approach. ( Berggren, F; Berling, P; Bolin, K; Gauffin, H; Landtblom, AM; Morberg, S, 2017) |
| "Phenytoin monotherapy may cause a significant increase in the levels of serum homocysteine and a significant decrease in the serum folate and vitamin B12 levels in children with epilepsy, and the significant changes in above mentioned parameters occur early in the course of treatment." | 3.85 | Homocysteine Metabolism and Hematological Parameters in Early Stage of Phenytoin Treated Epileptic Children. ( Sharma, TK; Sitaraman, S; Vardey, SK, 2017) |
| "The aim of the study is to investigate the effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on plasma oxcarbazepine (OXC) concentrations and therapeutic efficacy in Han Chinese patients with epilepsy." | 3.85 | Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy. ( Ding, M; Ding, Y; Guo, Y; Liu, Z; Shen, C; Tang, Y; Wang, S; Zhang, B; Zhang, Y, 2017) |
| "In this cross-sectional observational study we enrolled consecutive children aged 2-12 years with epilepsy who had received phenytoin or carbamazepine monotherapy for >6 months." | 3.85 | Hyperhomocysteinaemia in children receiving phenytoin and carbamazepine monotherapy: a cross-sectional observational study. ( Attri, SV; Chandrasekaran, S; Patil, S; Sahu, JK; Sankhyan, N; Singhi, P; Suthar, R; Tageja, M, 2017) |
| " The interactions among UGT1A4, UGT1A6, UGT1A9, and UGT2B15 genetic polymorphisms, monohydroxylated derivative (MHD) of oxcarbazepine (OXC) plasma concentrations, and OXC monotherapeutic efficacy were explored in 124 Chinese patients with epilepsy receiving OXC monotherapy." | 3.85 | Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy. ( Fang, Y; Lu, Y; Ma, C; Wang, Y; Wu, X; Xu, L, 2017) |
| "To investigate the risk and genetic association of oxcarbazepine-induced cutaneous adverse reactions (OXC-cADRs), including Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), in Asian populations (Chinese and Thai)." | 3.85 | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians. ( Chang, PY; Chang, WC; Chang, YC; Chen, CB; Chen, DP; Chen, MJ; Chen, YJ; Chiu, TM; Chu, CY; Chung, WH; Ho, HC; Hsiao, YH; Hsih, MS; Hsu, CK; Hsu, CN; Hui, RC; Hung, SI; Jorns, TP; Kao, PH; Kuo, KL; Kuo, TT; Lee, HE; Lin, CY; Lin, JY; Lin, YJ; Lu, CW; Ng, CY; Su, SC; Sukasem, C; Sun, PL; Tassaneeyakul, W; Weng, YC; Wu, CY; Wu, T; Wu, TL; Yang, CH; Yang, CS; Yang, CY, 2017) |
| "The PPK model, using the power scaling of body weight, effectively elucidated the topiramate serum concentration profile ranging from pediatric to adult patients." | 3.85 | Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data. ( Ikeda, A; Ito, S; Matsubara, K; Sugimoto, M; Takeuchi, M; Yamamoto, S; Yano, I; Yonezawa, A, 2017) |
| "The aim of the study was to develop a population pharmacokinetic (PPK) model of oxcarbazepine and optimize the treatment of oxcarbazepine in Chinese patients with epilepsy." | 3.83 | Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy. ( Hao, G; Lv, C; Xu, W; Yu, Y; Zhang, Q, 2016) |
| "This retrospective longitudinal study included 85 VPA-treated and 93 carbamazepine (CBZ)-treated (as a reference) young patients with epilepsy." | 3.83 | Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain. ( Ishitsu, T; Kajiwara, A; Nakagawa, K; Noai, M; Oniki, K; Saruwatari, J; Soraoka, H; Tanamachi, Y, 2016) |
| " Patient suffered from tumor-related epilepsy, treated pharmacologically with carbamazepine." | 3.83 | Toxic epidermal necrolysis in patient with malignant astrocytoma. ( Bartnik, P; Kacperczyk, J; Kaczmarska-Turek, D; Krasnodębska-Kiljańska, M; Olszewska, M; Orlewski, J, 2016) |
| "To identify the factors influencing topiramate pharmacokinetics (PK) in a large population of adult patients with epilepsy using population PK analysis." | 3.83 | Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis. ( Bae, EK; Jang, IJ; Kim, TJ; Lee, J; Lee, KJ; Lee, SK; Moon, J; Shin, D; Shin, JW; Shin, YW, 2016) |
| "Carbamazepine is one of the three most frequently prescribed antiepileptic drugs in pregnancy." | 3.83 | Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs. ( Brozmanova, H; Grundmann, M; Kacirova, I, 2016) |
| "Studies of the effect of oxcarbazepine (OXC) on body growth of children with epilepsy are rare and their results are controversial." | 3.83 | Weight gain in children on oxcarbazepine monotherapy. ( Attilakos, A; Garoufi, A; Katsarou, E; Koemtzidou, E; Kossiva, L; Soldatou, A; Tsentidis, C; Vartzelis, G, 2016) |
| "Although it has been reported that some antiepileptic drugs have inducing or inhibiting effects on lamotrigine (LTG) clearance, whether they have the same effects in Asian epilepsy patients as in those in other countries has not been clarified, especially in children." | 3.83 | The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy. ( Abe, S; Azuma, Y; Ishihara, N; Ito, Y; Itomi, K; Kidokoro, H; Kojima, S; Kurahashi, H; Kurahashi, N; Maruyama, K; Natsume, J; Negoro, T; Okumura, A; Suzuki, M; Takeuchi, T; Tsuji, T; Watanabe, K; Yamada, K; Yamamoto, H, 2016) |
| "The aim of this study was to compare the risk of metabolic syndrome (MS) and evaluate related factors for MS among people with epilepsy treated with valproate (VPA) or carbamazepine (CBZ)." | 3.83 | Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine. ( Haldre, S; Kõks, S; Rakitin, A, 2016) |
| "The alterations observed in body composition with valproic acid in contrast to other AEDs like levetiracetam, carbamazepine and phenytoin could affect treatment response in epilepsy especially in subjects with already altered body composition status like obese and thin frail patients, which needs to be established by prospective studies (CTRI/2013/05/003701)." | 3.83 | Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs. ( Gupta, YK; Kakkar, AK; Sarangi, SC; Tripathi, M, 2016) |
| "337T > C) and CYP3A4*22 genes involved in carbamazepine (CBZ) metabolism and pharmacoresistance among 118 Tunisian patients with epilepsy under maintenance dose of CBZ." | 3.83 | Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients. ( Ben Ammou, S; Ben Amor, S; Ben Salem, C; Chbili, C; Fathallah, N; Hassine, A; Laouani, A; Nouira, M; Saguem, S, 2016) |
| " Here, we suggest that triggering limbic seizures with low doses of PTZ in pilocarpine-treated marmosets might provide a more effective basis for the development of AED." | 3.83 | Seizures triggered by pentylenetetrazol in marmosets made chronically epileptic with pilocarpine show greater refractoriness to treatment. ( Blanco, MM; Cinini, SM; Lima, TZ; Mello, LE; Pontes, JC; Queiroz, CM, 2016) |
| "We compared persistence of antiepileptic drugs (AEDs) including carbamazepine, oxcarbazepine, gabapentin, lamotrigine, topiramate, valproic acid, and phenytoin in an Asian population with epilepsy." | 3.83 | Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study. ( Hsieh, CY; Huang, CW; Lai, EC; Lin, SJ; Setoguchi, S; Su, CC; Yang, YK, 2016) |
| "To examine the 30-day risk of hospitalization with hyponatremia associated with carbamazepine, valproic acid (V), phenytoin (P), or topiramate (T) use compared to nonuse in the outpatient setting among older adults." | 3.83 | Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies. ( Burneo, JG; Gandhi, S; Garg, AX; Hackam, DG; Mamdani, MM; McArthur, E; McLachlan, RS; Weir, MA, 2016) |
| "Carbamazepine monotherapy may cause a significant increase in the levels of homocysteine and a significant decrease in the levels of serum folate and vitamin B12 in children with epilepsy, significant changes in above mentioned parameters occurring early in the course of treatment." | 3.83 | Serum Homocysteine, Folate, and Vitamin B12 Levels in Carbamazepine Treated Epileptic Children. ( Sharma, TK; Sitaraman, S; Vardey, SK, 2016) |
| " This compound was effective in delaying onset of PTZ-evoked seizures at the dose of 5mg/kg in kindled animals and significantly reduced oxidative stress better than standard drug phenobarbital (PB)." | 3.81 | Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents. ( Kumari, S; Mishra, CB; Tiwari, M, 2015) |
| "To prospectively evaluate the long-term impact of valproate (VPA) versus carbamazepine (CBZ) on anthropometric, hormonal, and metabolic parameters in young male patients treated for epilepsy." | 3.81 | Endocrine Effects of Valproate versus Carbamazepine in Males with Epilepsy: A Prospective Study. ( de Vries, L; Goldberg-Stern, H; Itzhaki, T; Landau, Z, 2015) |
| "2%) patients (8 valproate-treated, 6 carbamazepine-treated, 3 combination therapy, and 1 other) complained of inter-ictal headache." | 3.81 | [Effects of topiramate on headache in children with epilepsy]. ( Aihara, M; Kanemura, H; Sano, F; Sugita, K; Tando, T, 2015) |
| " VPA and CBZ proved to be equally effective in Rett patients who presented seizures within the typical age range (4-5 years), while Lamotrigine (LTG) was effective for patients in whom epilepsy started later." | 3.81 | Antiepileptic drugs in Rett Syndrome. ( Baglietto, MG; Calevo, MG; Canevini, M; Giacomini, T; Giordano, L; Hayek, Y; Pintaudi, M; Renieri, A; Russo, S; Traverso, M; Veneselli, E; Vignoli, A, 2015) |
| "Routine testing for HLA-A*31:01 in order to reduce the incidence of cutaneous adverse drug reactions in patients being prescribed carbamazepine for epilepsy is likely to represent a cost-effective use of health care resources." | 3.81 | Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. ( Alfirevic, A; Hughes, DA; Marson, AG; Pirmohamed, M; Plumpton, CO; Yip, VL, 2015) |
| "To examine the effects of cytochrome P450 3A4 (CYP3A4), cytochrome P450 3A5 (CYP3A5) and ATP-binding cassette sub-family B member 1 (ABCB1) genetic polymorphisms on carbamazepine (CBZ) plasma concentrations in Chinese patients with epilepsy using CBZ as monotherapy and bitherapy with phenytoin (PHT), phenobarbital (PB), or valproic acid (VPA)." | 3.81 | Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy. ( Liu, DQ; Ma, HY; Sheng, YH; Wang, C; Wang, P; Yin, T; Zhou, BT, 2015) |
| "The present study aimed to evaluate the effects of gene variants in key genes influencing pharmacokinetic and pharmacodynamic of carbamazepine (CBZ) on the response in patients with epilepsy." | 3.81 | Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients. ( Beretta, G; Daci, A; Govori, V; Krasniqi, S; Norata, GD; Shala, A; Vllasaliu, D, 2015) |
| " At the same time, the patient was diagnosed with hyperthyroidism and was given carbimazole and propranolol." | 3.80 | Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis. ( Hui-Ping Khor, A; Lim, KS; Lo, YL; Ng, CC; Yeap, LL, 2014) |
| " Here we provide updated results from the UK Epilepsy and Pregnancy Register of the risk of MCMs after monotherapy exposure to valproate, carbamazepine and lamotrigine." | 3.80 | Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. ( Campbell, E; Craig, J; Delanty, N; Hunt, SJ; Irwin, B; Kennedy, F; Liggan, B; Morrison, PJ; Morrow, J; Parsons, L; Russell, A; Smithson, WH, 2014) |
| " The aim of this study is to determine the effect of oxcarbazepine (OXC) monotherapy on biochemical markers of bone metabolism and BMD in epilepsy patients." | 3.80 | Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy. ( Han, SW; Hong, SB; Hwang, KJ; Joo, EY; Kim, JY; Koo, DL; Lee, HW; Seo, DW; Shin, WC, 2014) |
| "Lacosamide (LCM), a new antiepileptic drug (AED) approved as adjunctive therapy for the treatment of patients with partial-onset seizures, has limited pharmacokinetic and drug interaction data." | 3.80 | Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs. ( Duncan, JS; Markoula, S; Patsalos, PN; Ratnaraj, N; Sander, JW; Teotonio, R, 2014) |
| "At the blood-brain barrier, overexpression of the drug efflux transporter ABCC2 (also known as MRP2) has been proposed as a mechanism for impaired carbamazepine (CBZ) treatment response in epilepsy." | 3.80 | A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine. ( Arlanov, R; Bonnett, L; Dickens, D; Johnson, MR; Lang, T; Marson, AG; Pirmohamed, M; Rädisch, S; Schwab, M, 2014) |
| "Women with epilepsy using LTG in combination with valproate (VPA; n=7), carbamazepine (CBZ; n=3) or oxcarbazepine (OXC; n=1) were evaluated during two periods of 28 days cyclic OC use, monitoring antiepileptic drug (AED) levels every other day with the dried blood spot sampling method." | 3.80 | Effect of oral contraceptives on lamotrigine levels depends on comedication. ( Lambrechts, DA; Lindhout, D; Sander, JW; Wegner, I; Wilhelm, AJ, 2014) |
| "The aims of this study were to characterize the alterations in total and free carbamazepine (CBZ) and in total and free carbamazepine-epoxide (CBZ-EPO) clearances during pregnancy, to calculate the change in free fractions of CBZ and CBZ-EPO during pregnancy, and to determine whether seizure worsening is associated with a low ratio to nonpregnant baseline concentration of total or free CBZ or CBZ-EPO." | 3.80 | Carbamazepine clearance and seizure stability during pregnancy. ( Johnson, EL; Knight, B; Newman, ML; Newport, DJ; Pennell, PB; Ritchie, JC; Stowe, ZN, 2014) |
| "The aims of this study were to characterize a lamotrigine-resistant kindled model of epilepsy in mice, to study the anticonvulsant effect of carbamazepine (CBZ) and valproic acid (VPA), and to probe into the mechanism for resistance." | 3.80 | Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms. ( Mehndiratta, M; Pillai, KK; Singh, E, 2014) |
| "This study explored the association between the risk of carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) and CBZ dose, dose-adjusted concentration, and ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms in patients of Han ethnicity with epilepsy who were living in northeastern China." | 3.80 | Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy. ( He, XJ; He, XL; Jian, LY; Sun, XJ; Tang, M; Wu, Y; Xu, YY; Zhao, LM, 2014) |
| "This study was to establish the population pharmacokinetic (PPK) model of pharmacologically active metabolite of oxcarbazepine (OXC) and to estimate PPK parameters for the optimal individuation administration of OXC in Chinese children with epilepsy." | 3.80 | Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy. ( Liu, ZS; Peng, J; Wang, Y; Xu, H; Zhang, HN, 2014) |
| "To investigate biochemical cardiovascular risk factors and vascular endothelial function and structure in children with epilepsy on antiepileptic drugs (AEDs), particularly sodium valproate (VPA) and carbamazepine (CBZ)." | 3.80 | Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine. ( Keenan, N; Sadlier, LG; Wiltshire, E, 2014) |
| "To investigate whether single nucleotide polymorphisms (SNPs) of rs2298771 and rs3812718 of the sodium channel α-subunit type 1 (SCN1A) gene affect the efficacy of carbamazepine (CBZ) treatment for seizures in Chinese Han epileptic patients." | 3.80 | Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients. ( Liu, Z; Sheng, Y; Tang, B; Wang, P; Zhou, B; Zhou, Q, 2014) |
| "We enrolled 19 patients with epilepsy who had discontinued oxcarbazepine because of skin rash despite an initial good response and then became refractory to other antiepileptic drugs along with an individual with paroxysmal kinesigenic dyskinesia with a similar situation." | 3.80 | Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study. ( Kang, ES; Lee, B; Lee, J; Lee, M; Yu, HJ, 2014) |
| "1249G>A GA genotype were significantly associated with carbamazepine/oxcarbamazepine (CBZ/OXC)-resistant epilepsy (p =0." | 3.80 | Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy. ( Hong, Z; Ma, CL; Wu, XY; Wu, ZY; Zheng, J; Zhong, MK, 2014) |
| "Maternal epilepsy treated with carbamazepine and migraine were found to be associated with higher risk of ventricular septal defect; panic disorders were associated with higher risk of hypoplastic left heart; type I diabetes mellitus was associated with higher risk of coarctation of the aorta; chronic hypertension was associated with higher risk of ventricular septal defect, common atrioventricular canal and common truncus; and paroxysmal supraventricular tachycardia was associated with higher risk of atrial septal defect secundum, common atrioventricular canal and ventricular septal defect." | 3.80 | Association of certain chronic maternal diseases with the risk of specific congenital heart defects: a population-based study. ( Czeizel, AE; Gerencsér, B; Szabó, I; Vereczkey, A, 2014) |
| "To develop a population pharmacokinetics model of oxcarbazepine in Chinese pediatric patients with epilepsy, and to study the interactions between oxcarbazepine and other antiepileptic drugs (AEDs)." | 3.80 | Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy. ( Chen, YJ; Gao, P; Liu, MC; Niu, CH; Peng, J; Wang, Y; Xu, H; Zhang, HN, 2014) |
| " Here, we report a case of a 12-year-old child with epilepsy who was also diagnosed with CML and given imatinib in addition to an enzyme-inducing antiepileptic drug, carbamazepine." | 3.80 | Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia. ( Endo, F; Jono, H; Kouroki, M; Ohmura, T; Saito, H; Taguchi, K, 2014) |
| "To facilitate therapeutic monitoring of antiepileptic drugs (AEDs) by healthcare professionals for patients with epilepsy (PWE), we applied a GC-MS assay to measure three AEDs: carbamazepine (CBZ), phenytoin (PHT) and valproic acid (VPA) levels concurrently in one dried blood spot (DBS), and validated the DBS-measured levels to their plasma levels." | 3.80 | Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy. ( Ho, PC; Kong, ST; Kumar, PK; Lee, WB; Lim, SH; Ng, YL; Wang, HY; Wong, PS, 2014) |
| "A 54-year-old woman with known epilepsy developed convulsions after using rifampicin and flucloxacillin, despite the use of maintenance treatment in the form of carbamazepine, valproic acid and clonazepam." | 3.80 | [Convulsions due to an interaction between anti-epileptic drugs and rifampicin]. ( Hanrath, MA; Swart, EL, 2014) |
| "The present study aimed to evaluate the effects of SNPs of major transporter and metabolizing enzyme genes on carbamazepine (CBZ) metabolism in Chinese patients with epilepsy." | 3.80 | Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy. ( Guo, Y; Qiu, F; Sun, X; Yun, W; Zhao, L; Zhu, X, 2014) |
| "We report two cases of drug rash with eosinophilia and systemic symptoms (DRESS) associated with the use of carbamazepine and phenytoin in Brazilian boys tested for human leukocyte antigen (HLA) class I and II alleles." | 3.79 | HLA typing in Brazilian boys with aromatic antiepileptic drug-induced DRESS. ( Cuman, RK; Gaeti, WP; Moliterno, RA; Obreli-Neto, PR; Schiavon, GB, 2013) |
| "Carbamazepine (CBZ) is broadly used for the treatment of epilepsy, neuropathic pain and other neurological diseases, owing to its effectiveness and low price." | 3.79 | Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand. ( Jitpimolmard, J; Jitpimolmard, S; Sawanyawisuth, K; Tiamkao, S, 2013) |
| "Oxcarbazepine is an antiepileptic agent that has been used during pregnancy, although its safety during pregnancy has not been sufficiently established." | 3.79 | In utero oxcarbazepine and a withdrawal syndrome, anomalies, and hyponatremia. ( Klinger, G; Merlob, P; Rolnitsky, A, 2013) |
| "We report a stillborn, GA/LMP = 37 weeks, delivered by an epileptic woman, who received in the first four months of pregnancy phenobarbital (PH) 0." | 3.79 | Sirenomelia after phenobarbital and carbamazepine therapy in pregnancy. ( Brailoiu, CG; Cernea, N; Tica, AA; Tica, OS; Tica, VI, 2013) |
| "There is strong evidence of an association between the presence of the human leukocyte antigen (HLA)-B*15:02 and two severe adverse drug reactions-Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)-in patients taking carbamazepine (CBZ), a common treatment for patients with epilepsy and neuropathic pain." | 3.79 | Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand. ( Koopitakkajorn, T; Mahasirimongkol, S; Praditsitthikorn, N; Rattanavipapong, W; Teerawattananon, Y, 2013) |
| "The pharmacokinetics and pharmacodynamics of carbamazepine (CBZ) vary widely among patients with epilepsy." | 3.79 | Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy. ( Ge, Y; Guo, Y; Hu, C; Luo, X; Meng, H; Wang, J; Xue, P; Yun, W; Zhang, F, 2013) |
| " The patient also used carbamazepine 600 mg BID for epilepsy." | 3.79 | [Pulmonary embolism due to interaction between rivaroxaban and carbamazepine]. ( Risselada, AJ; van Roon, E; Visser, MJ, 2013) |
| "We studied 107 patients with epilepsy who received monotherapy with valproic acid drugs (58) and carbamazepine (49)." | 3.79 | [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy]. ( Avakian, GG; Avakian, GN; Bogomazova, MA; Delger, AB; Khromykh, EA; Lagutin, IuV; Oleĭnikova, OM, 2013) |
| "The participants included 53 epilepsy patients who received either valproic acid (VPA, n=26) or oxcarbazepine (OXC, n=27)." | 3.79 | Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. ( Arga, M; Arhan, E; Biberoglu, G; Cansu, A; Emeksiz, HC; Gulbahar, O; Hasanoglu, A; Serdaroglu, A, 2013) |
| " Carbamazepine (CBZ) is widely used in MS to control pain." | 3.78 | Comparison of carbamazepine rash in multiple sclerosis and epilepsy. ( Alvestad, S; Brodtkorb, E; Espeset, K; Hovdal, H; Lydersen, S; Shirzadi, M, 2012) |
| "The aim of this study is to evaluate the carotid intima media thickness and serum lipids in pediatric patients with epilepsy treated with oxcarbazepine." | 3.78 | Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children. ( Doğan, M; Yiş, U, 2012) |
| "We conducted a prospective, observational study to verify the efficacy, tolerability and impact on quality of life, mood and global neurocognitive performances of oxcarbazepine monotherapy in patients with brain tumor-related epilepsy (BTRE)." | 3.78 | Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life. ( Dinapoli, L; Fabi, A; Maschio, M; Muti, P; Pace, A; Sperati, F; Vidiri, A, 2012) |
| "Individualization of carbamazepine (CBZ) dosage regimen in patients with epilepsy based on based on therapeutic drug monitoring (TDM) followed by estimation of pharmacokinetic (PK) parameters can help in better control of epilepsy." | 3.78 | Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. ( Bewernitz, M; Derendorf, H; El Desoky, ES; Hamdi, MM; Sabarinath, SN, 2012) |
| "Similar to valproic acid, carbamazepine increases the risk of neural tube defects; however, it does not increase the risk of other malformations." | 3.78 | Is carbamazepine safe to take during pregnancy? ( Koren, G; Matlow, J, 2012) |
| "The aim of this study was to investigate the genetic polymorphisms of UGT1A3, UGT1A6, and UGT2B7 in Chinese epilepsy patients and their potential influence on the pharmacokinetics of valproic acid (VPA)." | 3.78 | Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients. ( Chu, XM; Hao, HP; Wang, GJ; Zhang, LF; Zhang, SN; Zhou, JH, 2012) |
| "Based on epidemiological data it is advised to whenever possible avoid valproic acid during pregnancy." | 3.78 | Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes. ( Boersma, C; de Jong-van den Berg, LT; Jentink, J; Postma, MJ, 2012) |
| "The purpose of this study was to compare age and comedication as factors contributing to pharmacokinetic variability between 4 newer AEDs (lamotrigine, levetiracetam, oxcarbazepine, and topiramate) among patients with refractory epilepsy." | 3.78 | Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. ( Baftiu, A; Johannessen Landmark, C; Johannessen, SI; Larsson, PG; Rytter, E; Tysse, I; Valsø, B, 2012) |
| "Asians who carry the HLA-B*1502 allele have an elevated risk of developing Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) when treated with the antiepileptic drugs (AEDs) carbamazepine (CBZ) and phenytoin (PHT)." | 3.78 | Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. ( Dong, D; Finkelstein, EA; Sung, C, 2012) |
| "To study the effects of delayed and missed doses (poor compliance) on the pharmacokinetics of carbamazepine (CBZ) and its main active metabolite carbamazepine-10,11-epoxide (CBZE) in Chinese epilepsy patients using Monte Carlo simulation." | 3.78 | The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation. ( Ding, JJ; Jiao, Z; Wang, Y; Zhang, YJ, 2012) |
| "An open pilot study to evaluate the effect of pregabalin (PGB) as add-on therapy on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy (BTRE)." | 3.78 | Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study. ( Carapella, CM; Dinapoli, L; Fabi, A; Maschio, M; Pace, A; Pompili, A; Sperati, F; Vidiri, A, 2012) |
| "Many investigators agree that appropriate rational utilization of therapeutic drug monitoring (TDM) with Bayesian feedback dosage adjustment facilitates epilepsy treatment with carbamazepine (CBZ) and/or valproate (VPA) by increasing the seizure control and safety, as well as by reducing treatment costs." | 3.77 | Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy. ( Andreeva, OV; Bondareva, IB; Bondareva, KI; Jelliffe, RW, 2011) |
| "The effects of ALAC administered per os were evaluated by standard protocols against audiogenic seizures in Genetic Epilepsy Prone Rats (GEPR-9 rats), maximal electroshock (MES)-induced seizures in rats, pilocarpine-induced seizures in mice, spontaneous chronic seizures in mice exposed to pilocarpine-induced status epilepticus (SE), and absence seizures in WAG/Rij rats." | 3.77 | Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. ( Citraro, R; De Fazio, S; De Sarro, G; Mainardi, P; Perucca, E; Raggio, R; Russo, E; Scicchitano, F, 2011) |
| "To determine the frequency of malformations among infants born to women who had taken lamotrigine or carbamazepine as part of polytherapy during the first trimester of pregnancy." | 3.77 | Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. ( Hernandez-Diaz, S; Holmes, LB; Mittendorf, R; Shen, A; Smith, CR, 2011) |
| "Relationships between reproductive hormone levels, bone turnover marker levels, bone mineral density, and rates of bone loss were evaluated in premenopausal women with epilepsy taking enzyme-inducing antiepileptic drugs (EIAEDs: phenytoin or carbamazepine) or lamotrigine." | 3.77 | Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs. ( McMahon, DJ; Morrell, MJ; Pack, AM; Shane, E, 2011) |
| "The aim of the present study was to build population pharmacokinetic models for the clearance of carbamazepine (CBZ) in two separate populations of Serbian patients with epilepsy, children and adults." | 3.77 | Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis. ( Jankovic, SM; Milovanovic, JR, 2011) |
| "Twenty-four patients who had developed carbamazepine-induced SCAR (7 Stevens-Johnson syndrome (SJS), 17 drug hypersensitivity syndrome (HSS)), 50 carbamazepine-tolerant controls from the Korean Pharmacogenetic Adverse Drug Reaction Research Network and data of 485 Korean general population from a previously published study were recruited." | 3.77 | Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. ( Chang, YS; Cho, SH; Jee, YK; Kang, HR; Kim, SH; Lee, KW; Lee, SM; Min, KU; Park, HW; Park, SH; Song, WJ, 2011) |
| "Valproic acid, which current guidelines suggest should be avoided in pregnancy, was most notable in terms of strength and breadth of its associations." | 3.77 | Use of antiepileptic medications in pregnancy in relation to risks of birth defects. ( Ahrens, KA; Anderka, MT; Bosco, JL; Gilboa, SM; Holmes, LB; Mitchell, AA; Werler, MM, 2011) |
| "We describe the association of the HLA-B*1502 allele in 27 epilepsy patients (19 Malays, 8 Chinese) treated with carbamazepine (CBZ) at the UKM Medical Center (UKMMC), 6 with CBZ-Steven Johnson Syndrome (CBZ-SJS), 11 with CBZ-induced rash, 2 with suspected phenytoin-induced rash and 8 negative controls." | 3.77 | Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients. ( Jamal, R; Rani, ZZ; Ratnaningrum, S; Raymond, AA; Then, SM, 2011) |
| "Our study was carried out to ascertain the role of valproic acid for inducing metabolic disorders like hyperinsulinemia, insulin resistance and metabolic syndrome." | 3.77 | Fasting insulin and HOMA-index changes in patients treated with valproic acid. ( Javashvili, L; Kasradze, S; Mania, M; Okujava, N, 2011) |
| "This prospective study was designed to investigate whether or not monotherapy with sodium valproate (VPA) or oxcarbazepine (OXC) affects plasma levels of fatty acylcarnitine esters in children with epilepsy." | 3.77 | Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine. ( Biberoglu, G; Cansu, A; Ezgu, FS; Hasanoglu, A; Hirfanoglu, TL; Serdaroglu, A; Tumer, L, 2011) |
| " Two years later she developed epilepsy secondary to brain trauma and as a result, she started receiving oxcarbamazepine treatment." | 3.77 | [The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma]. ( Kedzia, A; Krysiak, R; Okopień, B, 2011) |
| "Carbamazepine (CBZ) is frequently used for treating epilepsy, but this drug causes cutaneous adverse drug reactions (cADRs) that may range from mild to severe." | 3.76 | HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. ( Aihara, M; Fujiwara, T; Ikeda, H; Kaniwa, N; Kashiwagi, M; Muramatsu, M; Saito, Y; Takahashi, Y; Yamazaki, E, 2010) |
| "We present an implementation of a method we previously reported allowing the newer antiepileptic drugs (AEDs) rufinamide (RFN) and zonisamide (ZNS) to be simultaneously determined with lamotrigine (LTG), oxcarbazepine's (OXC) main active metabolite monohydroxycarbamazepine (MHD) and felbamate (FBM) in plasma of patients with epilepsy using high performance liquid chromatography (HPLC) with UV detection." | 3.76 | Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. ( Albani, F; Baruzzi, A; Candela, C; Contin, M; Mohamed, S; Riva, R, 2010) |
| "Young adult outpatients with epilepsy on monotherapy for no less than 6 months with carbamazepine (CBZ), valproic acid (VPA), oxcarbazepine (OXC) and topiramate (TPM) were examined." | 3.76 | Effects of the antiepileptic drugs on peripheral nerve function. ( Boylu, E; Domaç, FM; Misirli, H; Saraçoğlu, M; Senol, MG, 2010) |
| "The study comprised 40 children and adolescents with idiopathic epilepsy on either valproate or carbamazepine." | 3.76 | Growth hormone levels in children and adolescents with epilepsy. ( Al-Badani, AK; Aly, GS; El-Khayat, HA; Mamdouh, RM; Mohamed, EI; Tomoum, HY, 2010) |
| "In this study of older adults with epilepsy, lamotrigine was the most effective AED as measured by 12-month retention and seizure freedom, with levetiracetam a close second." | 3.76 | Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. ( Arif, H; Bazil, CW; Buchsbaum, R; Hirsch, LJ; Pierro, J; Resor, SR; Sims, J; Whalen, M, 2010) |
| "The aim of the study was to investigate risk factors for cardiovascular disease in patients with epilepsy using the new antiepileptic drug levetiracetam (LEV), compared with patients taking carbamazepine (CBZ) or lamotrigine (LTG)." | 3.76 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine. ( Gjerstad, L; Luef, G; Mørkrid, L; Rauchenzauner, M; Svalheim, S; Taubøll, E, 2010) |
| " The purpose of this study was to determine the allele and genotype frequencies of such genetic variants in patients with epilepsy from North India administered first-line antiepileptic drugs, such as phenobarbitone, phenytoin, carbamazepine and valproic acid, and compare them with worldwide epilepsy populations." | 3.76 | Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment. ( Baghel, R; Bala, K; Brahmachari, SK; Giddaluru, S; Gourie-Devi, M; Grover, S; Gupta, M; Kaur, H; Kaur, K; Kukreti, R; Narayanasamy, K; Sharma, A; Sharma, S; Talwar, P; Varma, B, 2010) |
| " The influence of age and concomitant medications on the dose/concentration ratio of levetiracetam was examined in 103 children with epilepsy." | 3.76 | Age and comedications influence levetiracetam pharmacokinetics in children. ( Dahlin, MG; Ohman, I; Wide, K, 2010) |
| " The carbamazepine concentration in breast milk of one epilepsy maternal patient was assayed by high performance liquid chromatography, and the literature was reviewed to find the nursing evidence in the use of cabamazepine." | 3.76 | [A case report of monitoring on carbamazepine in breast feeding woman]. ( Wei, Y; Xiong, X; Yang, L; Zhai, SD; Zhao, M; Zhou, Y, 2010) |
| " Between 1999 and 2004, we enrolled pregnant women with epilepsy who were taking a single AED (carbamazepine, lamotrigine, phenytoin, or valproate)." | 3.76 | Effects of breastfeeding in children of women taking antiepileptic drugs. ( Baker, GA; Browning, N; Clayton-Smith, J; Cohen, M; Combs-Cantrell, DT; Kalayjian, LA; Kanner, A; Liporace, JD; Loring, DW; Meador, KJ; Pennell, PB; Privitera, M, 2010) |
| "We evaluated the serum leptin and insulin as predictors of weight gain in children receiving long-term treatment with valproate (VPA), carbamazepine (CBZ), lamotrigine (LTG)." | 3.75 | States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain. ( Fida, NM; Hamed, EA; Hamed, SA, 2009) |
| "An intravenous formulation of carbamazepine (CBZ) was administered to 113 (60 male; 53 female) persons with epilepsy aged 19-87 years." | 3.75 | Safety of an IV formulation of carbamazepine. ( Birnbaum, AK; Cloyd, JC; Conway, JM; Eugene Ramsay, R; Leppik, IE; Musib, L; Pennell, PB; Rarick, JO; White, JR, 2009) |
| "Between 1999 and 2004, we enrolled pregnant women with epilepsy who were taking a single antiepileptic agent (carbamazepine, lamotrigine, phenytoin, or valproate) in a prospective, observational, multicenter study in the United States and the United Kingdom." | 3.75 | Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. ( Baker, GA; Browning, N; Clayton-Smith, J; Cohen, M; Combs-Cantrell, DT; Kalayjian, LA; Kanner, A; Liporace, JD; Loring, DW; Meador, KJ; Pennell, PB; Privitera, M, 2009) |
| " The aim of the present work was to assess the involvement of P-glycoprotein in carbamazepine and phenobarbital hippocampal pharmacokinetics in an experimental model of epilepsy, induced by repetitive MP administration." | 3.75 | Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid. ( Girardi, E; Gonzalez, NN; Höcht, C; Lazarowski, A; Mayer, MA; Opezzo, JA; Taira, CA, 2009) |
| " We point out that during the pregnancy 4 of these 5 women with epilepsy had taken valproates, and the other one--carbamazepine." | 3.75 | [Fetal malformations in women with epilepsy]. ( Bozhinov, P; Bozhinova, C; Markova, C, 2009) |
| "Stable-labelled carbamazepine was administered intravenously on three occasions during the deinduction period to 15 patients with epilepsy for whom carbamazepine therapy was being discontinued." | 3.75 | Characterization of the time course of carbamazepine deinduction by an enzyme turnover model. ( Birnbaum, AK; Cloyd, JC; Leppik, IE; Marino, SE; Pennell, PB; Punyawudho, B; Ramsay, RE; White, JR, 2009) |
| "The study includes 40 patients (31 boys, 9 girls) with epilepsy who had been treated with carbamazepine." | 3.75 | Cardiac effects of carbamazepine treatment in childhood epilepsy. ( Akaln, N; Arhan, E; Ayçiçek, S; Güven, A; Köse, G, 2009) |
| "This substudy of the Neurodevelopmental Effects of Antiepileptic Drugs investigation enrolled pregnant women with epilepsy on AED monotherapy (carbamazepine, lamotrigine, and valproate)." | 3.75 | A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. ( Gaillard, WD; McVearry, KM; Meador, KJ; VanMeter, J, 2009) |
| "(1) Numerous follow-up studies of pregnancies in women with epilepsy show that valproic acid is more teratogenic than other antiepileptics." | 3.75 | Valproic acid: long-term effects on children exposed in utero. ( , 2009) |
| "Previous studies found a strong association between HLA-B*1502 and carbamazepine (CBZ)-induced Stevens-Johnson syndrome (SJS) in Han Chinese, but not in Caucasian populations." | 3.74 | Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. ( Desudchit, T; Hirankarn, N; Kangwanshiratada, O; Korkij, W; Limotai, C; Locharernkul, C; Loplumlert, J; Shotelersuk, V; Suphapeetiporn, K; Tongkobpetch, S, 2008) |
| " Hyperhomocysteinemia was defined as fasting total Hcy above 12 micromol/L and/or post-methionine load concentrations above 38 micromol/L." | 3.74 | Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins. ( Apeland, T; Frøyland, ES; Kristensen, O; Mansoor, MA; Strandjord, RE, 2008) |
| " This retrospective study of children with epilepsy, aged <12 years at enrollment, examined weight gain associated with valproic acid or carbamazepine monotherapy." | 3.74 | Lack of valproic acid-associated weight gain in prepubertal children. ( Baumann, RJ; Espinosa, PS; Mendiondo, MS; Robertson, WC; Salazar, JC; Yu, L, 2008) |
| " We describe a 14-year-old boy with localization-related epilepsy, who developed severe adverse cutaneous and systemic reactions after 3 weeks of carbamazepine administration." | 3.74 | Carbamazepine-induced drug-induced hypersensitivity syndrome in a 14-year-old Japanese boy. ( Fukuda, M; Ishii, E; Ishikawa, M; Suzuki, Y; Tohyama, M; Yasukawa, M, 2008) |
| "8 yrs, range 5-21 yrs) with childhood epilepsy who were converted from carbamazepine to oxcarbazepine overnight between January 2003 and December 2005." | 3.74 | Overnight transition from carbamazepine to oxcarbazepine in children and adolescents. ( Neft, RA; Vaisleib, II, 2008) |
| "To determine the influence of valproate (VPA) treatment on acylcarnitines in children with epilepsy." | 3.74 | Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. ( Gerstner, T; Koenig, SA; Kohlmueller, D; Longin, E; Mehlem, P; Schulze, A; Teich, M; Treiss, I; Werner, T, 2007) |
| "Ecto-nucleotidases, one of the main mechanisms involved in the control of adenosine levels in the synaptic cleft, have shown increased activities after the pilocarpine model of epilepsy." | 3.74 | Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases. ( Bogo, MR; Bonan, CD; Bruno, AN; Cognato, Gde P; da Silva, RS; Sarkis, JJ, 2007) |
| " It identifies lamotrigine as a cost-effective alternative to carbamazepine for the treatment of focal epilepsies, but confirms valproate as the most effective drug for the treatment of generalized or unclassified epilepsy." | 3.74 | Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients. ( Chadwick, D; Marson, T, 2007) |
| "Carbamazepine is one of the most commonly used anticonvulsants for the treatment of epilepsy and its plasma concentrations must be monitored periodically to obtain a useful and safe clinical effect." | 3.74 | [Saliva and plasma levels of carbamazepine have a poor correlation: a pilot study]. ( Godoy, CG; León, MD; Mennickent, S; Vega, M, 2007) |
| "A previous study conducted in Taiwan found a 100% association between HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome (SJS) in Han Chinese subjects, with an extremely high odds ratio compared with carbamazepine-tolerant subjects (odds ratio = 2,504)." | 3.74 | Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. ( Baum, L; Cheng, AS; Kwan, P; Lau, KM; Man, CB; Ng, MH; Yu, E, 2007) |
| "Using the mouse maximal electroshock-induced seizure model, indicative of tonic-clonic seizures in humans, the present study was aimed at characterizing the interaction between remacemide and valproate, carbamazepine, phenytoin, and phenobarbital." | 3.74 | Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock. ( Borowicz, KK; Czuczwar, SJ; Luszczki, JJ; Malek, R; Patsalos, PN; Ratnaraj, N, 2007) |
| "The present study evaluated the effectiveness of intraperitoneal (IP) injections and oral administration of carbamazepine (CBZ) in food on the frequency of spontaneous motor seizures in rats with kainate-induced epilepsy." | 3.74 | Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols. ( Clark, S; Dudek, FE; Grabenstatter, HL, 2007) |
| "OBJECTIVES - While carbamazepine (CBZ) decreases thyroid hormone concentrations it rarely causes hypothyroidism." | 3.74 | Carbamazepine and risk of hypothyroidism: a prospective study. ( Horacek, J; Simko, J, 2007) |
| " The goal of this study is to describe three patients diagnosed with migraine and epilepsy (both under control) who evolved into status migrainosus after the introduction of oxcarbazepine (OXC), as part of a switch off from carbamazepine (CBZ)." | 3.74 | Uncontrolled headache induced by oxcarbazepine. ( Amaral, VC; Crippa, A; de Paola, L; Della Colleta, MV; Di Stani, F; Piovesan, EJ; Silvado, CE; Teive, HG; Werneck, LC, 2007) |
| "To report an interaction between carbamazepine and clarithromycin, we present a study that includes three regular attenders at the epilepsy department of Montpellier and seven cases reported by the French national drug safety center." | 3.74 | [Carbamazepine and clarithromycin: a clinically relevant drug interaction]. ( Coubes, P; Crespel, A; Gélisse, P; Halaili, E; Hillaire-Buys, D; Jean-Pastor, MJ; Vespignan, H, 2007) |
| " A total of 25 children with idiopathic epilepsy (8 valproate, 11 carbamazepine, and 6 oxcarbazepine) and 10 healthy children were included in the study." | 3.74 | Homocysteine levels in epileptic children receiving antiepileptic drugs. ( Kurul, S; Unalp, A; Yiş, U, 2007) |
| "Carbamazepine treatment of paediatric patients with epilepsy resulted in an induction of CYP3A4/5 and a concomitant increase in plasma 4beta-hydroxycholesterol." | 3.74 | Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy. ( Bertilsson, L; Diczfalusy, U; Larsson, H; Wide, K, 2008) |
| "To compare the temporal pattern of seizures after acute withdrawal of oxcarbazepine (OXC) and phenytoin (PHT) in the epilepsy monitoring unit (EMU)." | 3.74 | Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring. ( Abou-Khalil, BW; Azar, NJ; Song, Y; Wang, L, 2008) |
| " We previously reported biochemical evidence of increased bone turnover in premenopausal women with epilepsy on phenytoin monotherapy compared with those on carbamazepine, lamotrigine, and valproate." | 3.74 | Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. ( McMahon, DJ; Morrell, MJ; Pack, AM; Randall, A; Shane, E, 2008) |
| "This is the first report demonstrating an association between the SCN1A polymorphism and carbamazepine-resistant epilepsy." | 3.74 | Association between SCN1A polymorphism and carbamazepine-resistant epilepsy. ( Abe, T; Hori, M; Ishitsu, T; Nakagawa, K; Nakagawa, T; Seo, T, 2008) |
| " We studied premenopausal women with epilepsy receiving antiepileptic drug monotherapy (phenytoin, carbamazepine, valproate, and lamotrigine)." | 3.73 | Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. ( Doñe, S; Flaster, E; Holloway, L; Marcus, R; Morrell, MJ; Pack, AM; Randall, A; Seale, C; Shane, E, 2005) |
| "To assess the influence of aging on the pharmacokinetics of phenobarbital (PB) at steady state in patients receiving long-term therapy." | 3.73 | Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data. ( Battino, D; Croci, D; Mamoli, D; Messina, S; Perucca, E; Ratti, S, 2005) |
| " Serum interleukin-5 levels were measured with enzyme-linked immunosorbent assay technique in 68 children with epilepsy receiving sodium valproate monotherapy and compared with the levels of 60 healthy controls and 14 children with epilepsy receiving carbamazepine." | 3.73 | Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5. ( Bourantas, KL; Kateri, MD; Makis, AC; Papadopoulou, ZL; Tzoufi, M, 2005) |
| "Across a range of assumptions used, the risk of hospitalization for Stevens-Johnson syndrome or toxic epidermal necrolysis in new users is low for carbamazepine, lamotrigine, phenytoin, phenobarbital, and valproic acid." | 3.73 | Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. ( Messenheimer, J; Mockenhaupt, M; Schlingmann, J; Tennis, P, 2005) |
| "A 32-year-old epileptic patient with a lengthy history of multiple-drug abuse and psychotic disorders was found to have an elevated serum carbamazepine concentration of 40." | 3.73 | Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA). ( Gagnieu, MC; Lardet, G; Moulsma, M; Parant, F, 2005) |
| "We report a 63-year-old Japanese man with epilepsy who developed skin eruptions, liver dysfunction, high fever, leukocytosis and atypical lymphocytosis 4 weeks after he had started taking carbamazepine." | 3.73 | Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. ( Goshima, J; Hara, H; Kobayashi, M; Matsunaga, A; Shimizu, H; Suzuki, H; Tochigi, M; Yokoyama, A, 2005) |
| "The aim of the study was to obtain pharmacokinetic data for carbamazepine (CBZ) and its fractions not bound with proteins in bitherapy with lamotrigine (LTG), topiramate (TPM), vigabatrin (VGB) or valproic acid (VPA) in children and adolescents treated for epilepsy." | 3.73 | Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents. ( Steinborn, B, 2005) |
| "A very simple and fast method has been developed and validated for simultaneous determination of the new generation antiepileptic drugs (AEDs) lamotrigine (LTG), oxcarbazepine's (OXC) main active metabolite monohydroxycarbamazepine and felbamate in plasma of patients with epilepsy using high-performance liquid chromatography (HPLC) with spectrophotometric detection." | 3.73 | Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy. ( Albani, F; Balboni, M; Baruzzi, A; Callegati, E; Candela, C; Contin, M; Riva, R, 2005) |
| "We measured the brain-to-plasma partition of 10,11-dihydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide (10-OHCBZ) in epilepsy patients undergoing surgery to alleviate drug-resistant seizures and administered with different oral doses of oxcarbazepine (OXC)." | 3.73 | A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. ( Baumgartner, C; Caccia, S; Czech, T; Guiso, G; Janigro, D; Marchi, N; Novak, K; Pirker, S; Rizzi, M; Vezzani, A, 2005) |
| " We describe two patients with idiopathic generalized epilepsy in whom nonconvulsive status epilepticus, aggravated by carbamazepine, was misdiagnosed as psychiatric disorder." | 3.73 | Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents. ( D'Arcangelo, G; Guerrini, R; Marini, C; Masi, G; Parmeggiani, L, 2005) |
| "We studied total serum levels of carbamazepine (CBZ) serially, before and after five PEX cycles, in an epilepsy patient who underwent PEX for myasthenia gravis." | 3.73 | Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy. ( Ahmed, SN; Holt, A; Siddiqi, ZA, 2005) |
| "Authors presented the data on the efficacy and tolerability of the new anticonvulsant drug topiramate (topamax) in the treatment of 110 children aged from 6 months to 16 years with pharmacoresistant types of epilepsy including 42 patients with tuberous sclerosis." | 3.73 | [The efficacy of topiramate (topamax) in the treatment of resistant epilepsy in children]. ( Belousova, ED; Dorofeeva, MIu; Ermakov, AIu, 2005) |
| "The authors examined sodium concentrations from 97 oxcarbazepine-treated (OXC) and 451 carbamazepine-treated (CBZ) patients with epilepsy using cross-section and follow-up studies." | 3.73 | Hyponatremia from oxcarbazepine and carbamazepine. ( Dong, X; Leppik, IE; Rarick, J; White, J, 2005) |
| "To determine potential changes in the plasma concentrations of oxcarbazepine (OXC) and its metabolites during pregnancy and puerperium." | 3.73 | Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. ( Atakli, D; Gatti, G; Mazzucchelli, I; Neve, AL; Onat, FY; Ozkara, C; Perucca, E; Specchio, LM, 2006) |
| "Thirty patients were enrolled: 10 on gabapentin, 10 on lamotrigine and 10 on carbamazepine monotherapy for epilepsy." | 3.73 | Measuring the effects of antiepileptic medications on balance in older people. ( Blum, D; Fife, TD; Fisher, RS, 2006) |
| "A 70-year-old patient treated with oxcarbazepine experienced severe hyponatremia." | 3.73 | [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine]. ( Gumbrevicius, G; Sveikata, A, 2006) |
| "The aim of the study was to compare the effects of carbamazepine (CBZ) and oxcarbazepine (OXC) on the reproductive endocrine function in women with epilepsy." | 3.73 | Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. ( Isojärvi, JI; Koivunen, R; Löfgren, E; Pakarinen, A; Tapanainen, JS, 2006) |
| "We assessed the concentration of the oxcarbazepine metabolite 10-hydroxycarbazepine (MHD) in nine pregnancies among seven women before, during, and after pregnancy." | 3.73 | Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy. ( Christensen, J; Sabers, A; Sidenius, P, 2006) |
| "Morning urine samples were collected from children with epilepsy receiving VPA (n = 25), carbamazepine (n = 16), or clobazam (n = 12) for > or = 4 weeks and from age-matched control subjects (n = 39)." | 3.73 | Oxidative stress in children receiving valproic acid. ( Abbott, FS; Chang, TK; Farrell, K; Michoulas, A; Teng, XW; Tong, V, 2006) |
| " Following pilocarpine-induced status epilepticus interrupted after 4h, rats were continuously videorecorded for onset and recurrence of spontaneous convulsive seizures." | 3.73 | Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat. ( Bentivoglio, M; Chakir, A; Fabene, PF; Ouazzani, R, 2006) |
| "In order to evaluate the results of epilepsy treatment in children and adolescents the influence of two antiepileptic drugs (AED) carbamazepine (CBZ) and valproates (VPA) on cognitive functions of epileptic children and adolescents was analyzed." | 3.73 | [Long latency auditory evoked potentials in schoolchildren and adolescents with epilepsy]. ( Zgorzalewicz, M, 2006) |
| "A 7-year-old boy began to complain that his pitch perception was decreased just after oral medication with carbamazepine was initiated for the treatment of epilepsy." | 3.72 | Carbamazepine-induced abnormal pitch perception. ( Abe, T; Yoshikawa, H, 2003) |
| "Epileptic patients receiving medications such as phenytoin or phenobarbital have been noted to have an exceedingly low incidence of myocardial infarction, but children treated with carbamazepine have shown alteration of their serum lipid profile that could predispose them to atherosclerosis." | 3.72 | Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine. ( de Chadarévian, JP; Katsetos, CD; Legido, A; Miles, DK, 2003) |
| "To investigate the pharmacokinetic profile of carbamazepine (CBZ) in Chinese epilepsy patients." | 3.72 | Population pharmacokinetics of carbamazepine in Chinese epilepsy patients. ( Hu, M; Jiao, Z; Shi, XJ; Zhang, JH; Zhong, MK, 2003) |
| "The database of a large TDM service was used to identify retrospectively steady-state serum CBZ concentrations in 157 elderly patients with epilepsy (65 years and older) treated with CBZ alone or in combination with phenobarbital (PB)." | 3.72 | Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. ( Battino, D; Croci, D; Mamoli, D; Messina, S; Perucca, E; Rossini, A, 2003) |
| "A group of 105 women (54 of whom were, and had only ever been, taking valproate for at least a year, and 51 who had only ever taken either lamotrigine or carbamazepine, for at least a year) were compared with a group of 50 women who did not have epilepsy: any oral contraceptive taken at the time of testing was recorded and blood levels of follicle stimulating hormone (FSH), luteinising hormone (LH), testosterone and prolactin were estimated from days 2 to 6 of the menstrual cycle (day 1 being the first day of bleeding) and an MRI scan made of their pelvis." | 3.72 | A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. ( Betts, T; Dutton, N; Greenhill, L; Rolfe, T; Yarrow, H, 2003) |
| " The paper is about the evolution of these changes in EEG and the assessment of disease recurrence in the course of treatment and upon therapy termination in patients taking valproic acid preparations (VPA) during idiopathic generalized epilepsy (IGE) and those taking carbamazepine (CBZ) preparations during cryptogenic focal epilepsy (CFE)." | 3.72 | [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy]. ( Marszał, E; Szwed-Białozyt, B, 2003) |
| "Prolonged antiepilepsy drug treatment can result in secondary carnitine deficiency." | 3.72 | Serum carnitine levels during oxcarbazepine and carbamazepine monotherapies in children with epilepsy. ( Dirik, E; Iscan, A; Kurul, S, 2003) |
| "We report a rare case of severe hyponatremia with coma induced by the use of oxcarbazepine after one month of treatment, in pos-operatory of neurosurgery." | 3.72 | [Hyponatremic coma induced by oxcarbazepine: case report]. ( da Silva, JA; Holanda, MM; Quinino, SC, 2003) |
| "0803 * INDI, in which CBZ indicates co-administration of carbamazepine, VPADD the daily dose of VPA and INDI uncontrolled epilepsy." | 3.72 | Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients. ( Cosson, V; EL Desoky, ES; EL Din Amry, S; Fuseau, E, 2004) |
| "To investigate the effect of antiepileptic drugs, especially carbamazepine and valproate, on intelligence in prenatally exposed children of mothers with epilepsy." | 3.72 | Normal intelligence in children with prenatal exposure to carbamazepine. ( Bardy, A; Gaily, E; Granström, ML; Hiilesmaa, V; Isoaho, M; Kaaja, E; Kantola-Sorsa, E; Kotila, M; Matila, R; Nylund, T, 2004) |
| "A 70-year-old woman under anticonvulsive therapy with carbamazepine and valproate was diagnosed as polymyalgia rheumatica." | 3.72 | [A case of polymyalgia rheumatica with improved steroid-responsibility after discontinuing carbamazepine]. ( Katada, S; Kobayashi, H; Sato, A; Sato, M, 2004) |
| " Twenty-eight patients were taking carbamazepine (CBZ); five, lamotrigine (LTG); 12, oxcarbazepine (OXC); and 25, valproate (VPA) as monotherapy for epilepsy." | 3.72 | Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy. ( Isojärvi, JI; Mikkonen, K; Päivänsalo, M; Pakarinen, AJ; Tapanainen, P; Vainionpää, LK, 2004) |
| " Anthropometric measurements, staging of pubertal maturation, and clinical manifestations of hyperandrogenism were assessed, as well as measurement of serum levels of testosterone, dehydroepiandrosterone sulfate (DHEAS), sex hormone-binding globulin (SHBG), and free androgen index (FAI)." | 3.72 | Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. ( Abd El-Basset, FZ; El Barbary, NS; El-Khayat, HA; Hakky, SM; Mohamed, MS; Nassef, NM; Tohamy, SM; Tomoum, HY; Zaky, AA, 2004) |
| " After adjustment for prior fracture, use (ever) of corticosteroids, comorbidity, social variables, and diagnosis of epilepsy, carbamazepine [CBZ; odds ratio (OR), 1." | 3.72 | Fracture risk associated with use of antiepileptic drugs. ( Mosekilde, L; Rejnmark, L; Vestergaard, P, 2004) |
| " We investigated and compared the toxic effects of two dibenz[b,f]azepine derivatives with anticonvulsant activity, 10,11-dihydro-10-hydroxyimino-5H-dibenz[b,f]azepine-5-carboxamide (BIA2-024) and (S)-(-)-10-acetoxy-10,11-dihydro-5H-dibenz[b,f] azepine-5-carboxamide (BIA2-093), with the structurally related compounds carbamazepine (CBZ) and oxcarbazepine (OXC), both in current use for the treatment of epilepsy." | 3.72 | Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093. ( Ambrósio, AF; Araújo, IM; Carvalho, AP; Carvalho, CM; Leal, EC; Malva, JO; Soares-da-Silva, P; Verdasca, MJ, 2004) |
| "This study addresses the question of epileptogenesis by investigating the effects of carbamazepine (CBZ) on the silent period of the pilocarpine model of epilepsy." | 3.71 | Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy. ( Capella, HM; Lemos, T, 2002) |
| "In order to investigate the possible role of valproic acid therapy in the development of obesity, hyperinsulinism and polycystic ovaries (PCOs), we have studied metabolic parameters and ovarian morphology in epileptic women." | 3.71 | Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. ( Abraham, I; Alge, A; Bauer, G; Haslinger, M; Lechleitner, M; Luef, G; Seppi, K; Trinka, E; Unterberger, I; Windisch, J, 2002) |
| "The purpose of this study was to determine if there are any correlations between carbamazepine serum levels of epileptic mothers during pregnancy and the brainstem auditory evoked potentials in their infants as an index of drug neurotoxicity in newborns exposed prenatally." | 3.71 | Effects of prenatal exposure to carbamazepine on brainstem auditory evoked potentials in infants of epileptic mothers. ( Belmont, A; Garza, S; Ibarra, J; López, V; Poblano, A; Rosas, Y; Sosa, J, 2002) |
| " The boy was exposed to phenytoin, in combination with carbamazepine, during pregnancy." | 3.71 | Chondrodysplasia punctata (CDP) with features of the tibia-metacarpal type and maternal phenytoin treatment during pregnancy. ( Annerén, G; Brandberg, G; Larsson, M; Lönnerholm, T; Wester, U, 2002) |
| "The aim of this study was to obtain a pharmacokinetic calculation for valproic acid (VPA) and its free fraction in 50 children and adolescents (4-18 years) treated for epilepsy in VPA monotherapy and bitherapy with carbamazepine (CBZ)." | 3.71 | Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents. ( Galas-Zgorzalewicz, B; Steinborn, B, 2002) |
| " A cohort study comparing life expectancy of males and females with cerebral palsy and a systematic review of five trials comparing two anti-epileptic drugs, carbamazepine and sodium valproate, are used for illustration." | 3.71 | Aggregate data meta-analysis with time-to-event outcomes. ( Hutton, JL; Marson, AG; Smith, CT; Williamson, PR, 2002) |
| "To study the markers of bone turnover in epilepsy patients in the different stages of the pubertal growth before and after the beginning of carbamazepine (CBZ) monotherapy." | 3.71 | Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. ( Chiarelli, F; Greco, R; Latini, G; Morgese, G; Verrotti, A, 2002) |
| "While severe hyponatremia is reported to be more frequent in adults treated with oxcarbazepine (OXC) than with carbamazepine (CBZ), there is not sufficient data about the incidence of hyponatremia in childhood during treatment with OXC." | 3.71 | Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children. ( Boenigk, HE; Holtmann, M; Korn-Merker, E; Krause, M; Opp, J; Tokarzewski, M, 2002) |
| " We report the case of a patient with a history of epilepsy (taking carbamazepine, Tégrétol LP) and Addison's disease (treated by hydrocortisone (HDC) 30 mg/d, Dectancyl 0,5 mg/d, Florinef 50 mg/d)." | 3.71 | [Generic carbamazepine-induced subacute adrenal insufficiency?]. ( Estour, B; Guy, C; Millot, L; Mounier, C; Vergely, N, 2002) |
| " This prospective study investigated the relation between the daily intake of the antiepileptic drug carbamazepine and both its trough plasma and hair concentrations in a highly supervised inpatient population of patients with epilepsy during a period of 6 months." | 3.71 | Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant inpatient epileptic population. ( Mei, Z; Patsalos, PN; Richens, A; Schapel, G; Williams, J; Wilson, JF, 2001) |
| "To document the population pharmacokinetics of carbamazepine in patients with epilepsy living in Singapore, the majority of whom are of Chinese origin and others of minority races." | 3.71 | Population pharmacokinetics of carbamazepine in Singapore epileptic patients. ( Chan, E; Hue, SS; Lee, HS, 2001) |
| "To evaluate changes in serum electrolyte balance and underlying regulatory mechanisms in 10 male patients with epilepsy 2 and 6 months after replacing long-term carbamazepine (CBZ) monotherapy with oxcarbazepine (OCBZ) monotherapy." | 3.71 | The regulation of serum sodium after replacing carbamazepine with oxcarbazepine. ( Huuskonen, UE; Isojärvi, JI; Myllylä, VV; Pakarinen, AJ; Vuolteenaho, O, 2001) |
| "It is not known whether polytherapy with carbamazepine (CBZ) and valproate (VPA) increases the risk of thrombocytopenia." | 3.71 | Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate. ( Finsterer, J; Hess, B; Pelzl, G, 2001) |
| " Epilepsy was present in 21 patients, predominantly partial seizures and the drug of choice was carbamazepine (15 patients)." | 3.71 | [Rett syndrome: retrospective and prospective study of 28 patients]. ( Antoniuk, SA; Bruck, I; Bruyn, LR; Facchim, D; Halick, SM; Koneski, J; Rodrigues, M; Spessatto, A, 2001) |
| "Carbamazepine and valproic acid are effective antiepileptic drugs for treating many types of epilepsy." | 3.71 | Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. ( Basciani, F; Chiarelli, F; Morgese, G; Morresi, S; Verrotti, A, 2001) |
| " This study aimed to evaluate thyroid function in men taking carbamazepine (CBZ), oxcarbazepine (OCBZ), or valproate (VPA) for epilepsy." | 3.71 | Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. ( Isojärvi, JI; Kotila, M; Myllylä, VV; Pakarinen, AJ; Rättyä, J; Turkka, J, 2001) |
| "Long-term treatment with valproate (VPA) or carbamazepine (CBZ) may induce reproductive endocrine disorders in patients with epilepsy." | 3.71 | Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. ( Isojärvi, JI; Knip, M; Myllylä, VV; Pakarinen, AJ; Rättyä, J; Repo-Outakoski, M, 2001) |
| "A 42-year-old woman presented with acute bullous skin lesions and angio-oedema that had developed 3 months after initiation of treatment with carbamazepine for epilepsy." | 3.71 | Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria. ( Alfei, B; Bianco, A; Biolcati, G; Di Rocco, P; Gasbarrini, G; Grieco, A; Griso, D; Miele, L; Vecchio, FM, 2001) |
| "The authors examined the ratio between the plasma and the cerebrospinal fluid (CSF) concentration of topiramate in 14 adults with epilepsy." | 3.71 | Plasma concentration of topiramate correlates with cerebrospinal fluid concentration. ( Christensen, J; Dam, M; Højskov, CS; Poulsen, JH, 2001) |
| "To examine bone development in children and adolescents who have uncomplicated idiopathic epilepsy and had received monotherapy with carbamazepine or valproic acid for at least 1 year." | 3.71 | Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine. ( Herkenrath, P; Rauch, F; Rieger-Wettengl, G; Schauseil-Zipf, U; Schoenau, E; Stabrey, A; Tutlewski, B, 2001) |
| "Carbamazepine efficacy in the children with epilepsy is significantly lower in the presence of parietal theta rhythm." | 3.71 | [Parietal theta rhythms in carbamazepine therapy of children with epilepsy]. ( Kudriavtseva, EP; Vorob'eva, OV, 2001) |
| "Dynamics of carbamazepine and valproic acid concentrations in the middle of follicular and lutein menstrual cycle phases has been studied in women with epilepsy, aged 21-30 years." | 3.71 | [Pharmacokinetic aspects of carbamazepine and valproic acid using in reproductive-age women with epilepsy]. ( Karlov, VA; Sokolov, AV; Tishchenkova, IF; Vlasov, PN, 2002) |
| " We present four patients with severe refractory epilepsy in whom introduction of levetiracetam led to disabling symptoms compatible with carbamazepine toxicity requiring either carbamazepine dose reduction or levetiracetam withdrawal." | 3.71 | Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction. ( Patsalos, PN; Sander, JW; Sisodiya, SM, 2002) |
| "To report a case of transient cholestatic hepatitis occurring in an infant between the third and seventh weeks of life, most likely due to carbamazepine exposure during pregnancy and breast feeding." | 3.71 | Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. ( Braegger, CP; Frey, B; Ghelfi, D, 2002) |
| "Children due to receive carbamazepine for epilepsy were recruited into the study." | 3.70 | Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test. ( Choonara, I; Parker, AC; Preston, T; Pritchard, P, 1998) |
| "We report the case of a 12-year-old girl with severe clinically relevant hyponatremia (118 mmol/l) and hypochloremia (81 mmol/l) during treatment with oxcarbazepine (OCBZ)." | 3.70 | Hyponatremia induced by oxcarbazepine in children. ( Boenigk, HE; Borusiak, P; Holert, N; Korn-Merker, E, 1998) |
| "The last premortem serum concentrations of phenobarbital (PB), phenytoin (PHT), carbamazepine (CBZ) and its CBZ-10,11-epoxide metabolite (CE) were compared with the corresponding postmortem serum concentrations in 16 adult patients of an epilepsy centre." | 3.70 | Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy. ( Jürgens, U; May, T; Rambeck, B; Schnabel, R, 1999) |
| "Forty girls taking valproate (VPA), 19 girls taking carbamazepine (CBZ), and 18 girls taking oxcarbazepine (OXC) for epilepsy and 49 healthy control girls participated in the study, which included a cross-sectional clinical examination when the girls were 8 to 18 years old and a longitudinal growth analysis from the age of 1 year." | 3.70 | The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy. ( Isojärvi, JI; Knip, M; Lanning, P; Rättyä, J; Vainionpää, L, 1999) |
| "Carbamazepine (CBZ) is widely used in the treatment of epilepsy." | 3.70 | Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies. ( Barra, Y; Bourgarel-Rey, V; Charvet, B; Desobry, A; Mesdjian, E; Mirrione, A; Sérée, E, 1999) |
| "Carbamazepine produces dose-related anticonvulsant effects in epilepsy models including the genetically epilepsy-prone rat (GEPR) model and the rat maximal electroshock model." | 3.70 | Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats. ( Birkhahn, D; Burk, A; Dailey, JW; Graumlich, JF; Jobe, PC; McLaughlin, RG; Shah, N, 1999) |
| "Video monitoring studies were undertaken to determine if the anticonvulsant, carbamazepine (CBZ), could prevent seizures in infant rats that had been intrahippocampally injected with tetanus toxin (TNTX)." | 3.70 | Insights into the tetanus toxin model of early-onset epilepsy from long-term video monitoring during anticonvulsant therapy. ( Anderson, AE; Hrachovy, RA; Lee, I; Rashid, S; Swann, JW, 1999) |
| "We determined serum levels of triiodothyronine (T3), thyroxine (T4), free thyroxine (FT4), thyroxine-binding globulin (TBG), and thyroid-stimulating hormone (TSH) in 148 healthy children and 141 children with epilepsy who had been receiving CBZ (61 patients), VPA (51 patients), or PB (29 patients) for 12-161 months." | 3.70 | Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. ( Castro-Gago, M; Del Río-Garma, M; Del Río-Garma, MC; Eirís-Puñal, J; Lojo-Rocamonde, S; Novo-Rodríguez, I, 1999) |
| "A comparative study was conducted to evaluate the efficacy and tolerability of oxcarbazepine administration in patients with a diagnosed intractable epilepsy with simple partially and complex seizures secondarily generalised." | 3.70 | [Oxcarbazepine in the treatment of drug-resistant epilepsy in children and adolescents: preliminary study]. ( Kluczyński, A, 2000) |
| "Our data indicate that not only fasting but also 6h-PML tHcy levels should be determined in order to identify hyperhomocysteinemia among patients on AEDs." | 3.70 | Homocysteine concentrations and methionine loading in patients on antiepileptic drugs. ( Apeland, T; Kristensen, O; Mansoor, MA; Strandjord, RE, 2000) |
| "Twenty epileptic women were treated with valproate only during pregnancy and two were treated with valproate and carbamazepine." | 3.70 | Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. ( Ebbesen, F; Holsteen, V; Hoseth, E; Joergensen, A; Kaad, PH; Moeller, M; Rix, M, 2000) |
| "25 of Pynnönen (Method 2) to predict the unbound serum carbamazepine (CBZ) concentration in 50 serum samples from 28 polytherapy pediatric patients with epilepsy." | 3.69 | Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy. ( Fujii, I; Kodama, H; Kodama, Y; Kuranari, M; Takeyama, M, 1995) |
| "We evaluated the effects of carbamazepine (CBZ) on serum androgen levels and sexual function prospectively for 5 years in 11 men with epilepsy and in 25 patients receiving either CBZ (14 patients) or phenytoin (PHT) (11) monotherapy for > 5 years." | 3.69 | Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy. ( Isojärvi, JI; Lukkarinen, O; Myllylä, VV; Pakarinen, AJ; Repo, M, 1995) |
| "We determined changes in serum concentrations of thyroid hormones during carbamazepine (CBZ) therapy during a 5-year prospective follow-up study of 20 patients with newly diagnosed epilepsy." | 3.69 | Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine. ( Airaksinen, KE; Isojärvi, JI; Mustonen, JN; Myllylä, VV; Pakarinen, AJ; Pelkonen, O; Rautio, A, 1995) |
| "Axial (second, third, and fourth lumbar vertebrae) and appendicular (distal third of radius) bone mineral density was measured by dual-energy x-ray absorptiometry in 27 healthy children and 26 children with uncomplicated idiopathic epilepsy treated with either carbamazepine (n = 13) or valproate (n = 13) for more than 18 months." | 3.69 | Effect of carbamazepine and valproate on bone mineral density. ( Bodensteiner, JB; Hobbs, GR; Jacob, JC; Penney, S; Riggs, JE; Sheth, RD; Wesolowski, CA, 1995) |
| "Urinary excretions of carbamazepine, carbamazepine-10,11-epoxide, carbamazepine-10,11-trans-diol, 9-hydroxyacridan and 2- and 3-hydroxycarbamazepine were measured at various stages of pregnancy, and in the post-natal period, in ten epileptic women, six of whom took no other enzyme-inducing anticonvulsant and four of whom took such co-medication." | 3.69 | Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy. ( Bernus, I; Dickinson, RG; Eadie, MJ; Hooper, WD, 1995) |
| "We report the clinical findings on all 260 epileptic in- and out-patients of a Dutch epilepsy centre ever treated with oxcarbazepine on a named-patient basis." | 3.69 | Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis. ( Meinardi, H; Van Parys, JA, 1994) |
| "The in vivo serum protein binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide, which was the main metabolite of carbamazepine in plasma, were assessed in sera from 30 adult patients with epilepsy on carbamazepine monotherapy." | 3.69 | In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients. ( Fujii, I; Kodama, H; Kodama, Y; Kuranari, M; Okamoto, T; Takeyama, M; Tsutsumi, K; Yasunaga, F, 1994) |
| "The pharmacokinetics, tolerability, and efficacy of carbamazepine (CBZ) and the pharmacokinetics of carbamazepine-10, 11-epoxide (CBZE) were studied after chronic administration of a conventional tablet formation or of the controlled-release (CR) formulation of CBZ 400 mg (Tegretol 400) to 20 patients with epilepsy treated with carbamazepine and complaining of intermittent adverse effects." | 3.69 | Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects. ( Bareggi, SR; Guizzaro, A; Monza, CG; Parisi, A; Pirola, R; Tata, MR, 1994) |
| "The authors describe the case of an epileptic patient in chronic therapy with carbamazepine, and with plasma concentration of the drug in therapeutical range, who suffers from persistent sinus tachycardia." | 3.69 | [Cardiac effects of carbamazepine therapy]. ( Checchini, M; Magni, M; Scaglione, M; Vaccarella, A, 1995) |
| "To evaluate the population pharmacokinetics of valproic acid in children, 97 steady-state serum valproate concentration measurements were gathered during normal, routine, outpatient care of 52 children with epilepsy (1." | 3.69 | A model for estimating individualized valproate clearance values in children. ( Botha, JH; Gray, AL; Miller, R, 1995) |
| " We studied the pharmacokinetic and pharmacodynamic aspects of an oral 15-mg dose of midazolam in 6 patients with epilepsy who are also taking carbamazepine (CBZ) or phenytoin (PHT)." | 3.69 | Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin. ( Backman, JT; Laaksovirta, H; Neuvonen, PJ; Ojala, M; Olkkola, KT, 1996) |
| "The case of a patient who developed thrombocytopenia during treatment with carbamazepine (CBZ) is described." | 3.69 | Carbamazepine-induced thrombocytopenia and carbamazepine-10,11-epoxide: a case report. ( Kimura, M; Maeoka, Y; Suzuki, N; Yoshino, K, 1995) |
| " The mother had taken clonazepam, a benzodiazepine, and carbamazepine during the entire pregnancy for epilepsy." | 3.69 | Paralytic ileus in a fetus-neonate after maternal intake of benzodiazepine. ( Haeusler, MC; Hoellwarth, ME; Holzer, P, 1995) |
| "The interaction between clearance of phenytoin, valproic acid, phenobarbital and carbamazepine, and changes in body weight was determined in a 19-year-old obese woman with epilepsy (body weight 93 kg, BMI 36." | 3.69 | Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study. ( Ashikari, Y; Chiba, S; Kodama, Y; Kuranari, M; Sakata, T; Takeyama, M, 1996) |
| " In this paper we describe two patients with comorbid epilepsy, major depression, and panic disorder, whose serum citalopram levels increased and antidepressant response changed when concurrent carbamazepine treatment was substituted with oxcarbazepine." | 3.69 | Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases. ( Koponen, H; Leinonen, E; Lepola, U, 1996) |
| "Oxcarbazepine has been proven to be a promising new antiepileptic drug for the treatment of human epilepsy." | 3.69 | Pharmacokinetics of oxcarbazepine in the dog. ( Frey, HH; Schicht, S; Wigger, D, 1996) |
| "The purpose of the study was to assess whether there was an increased rate of congenital anomalies or significant developmental delay in infants of women with epilepsy who had been treated with carbamazepine during pregnancy." | 3.69 | Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. ( Cohen, E; Ornoy, A, 1996) |
| "The case history of a patient developing tubulointerstitial nephritis (TIN) during carbamazepine therapy is described." | 3.69 | Carbamazepine-associated acute tubulointerstitial nephritis. ( Buurke, EJ; Eijgenraam, JW; van der Laan, JS, 1997) |
| "Twenty-three patients resident at the Chalfont Centre for Epilepsy, who have been prescribed carbamazepine either as monotherapy or in combination with other antiepileptic drugs have been monitored for a period of 6 months." | 3.69 | Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy. ( Patsalos, PN; Williams, J; Wilson, JF, 1997) |
| "We report the effects of two new dihydropyridine derivatives, isradipine (4-(4'-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedic arboxylic acid methylisopropylester) and niguldipine (1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid 3-(4,4-diphenyl-1-piperidinyl)-propyl methyl ester hydrochloride), and of dantrolene (1-[(5-[p-nitrophenyl]furfurylidene)-amino]hydantoin sodium, an inhibitor of Ca2+ release from intracellular stores) on the protective efficacy of antiepileptic drugs against maximal electroshock-induced seizures." | 3.69 | Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. ( Borowicz, KK; Czuczwar, SJ; Gasior, M; Kleinrok, Z, 1997) |
| " Eighty patients presenting with epilepsy received monotherapies of valproic acid, phenytoin, or carbamazepine; 18 patients did not receive antiepileptic drug therapy." | 3.69 | Color vision tests for early detection of antiepileptic drug toxicity. ( Bayer, AU; Dichgans, J; Kuehn, M; Paulus, W; Ried, S; Schmidt, D; Thiel, HJ; Zrenner, E, 1997) |
| "Nineteen children with epilepsy were tested on two occasions, first during treatment with carbamazepine (CBZ) and then 6 months later without treatment." | 3.69 | Motor impairments in children with epilepsy treated with carbamazepine. ( Braathen, G; Theorell, K; von Bahr, L, 1997) |
| "The antiepileptic drug carbamazepine produces dose related anticonvulsant effects in genetically epilepsy-prone rats (GEPRs) and most other animal seizure models." | 3.69 | Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships. ( Dailey, JW; Jobe, PC; Li, MY; Reith, ME; Yan, QS, 1997) |
| "A 7-year-old girl developed pure red cell aplasia during carbamazepine (CBZ) monotherapy for epilepsy." | 3.69 | Pure red cell aplasia during carbamazepine monotherapy. ( Fujii, F; Itagaki, Y; Sumi, K; Tagawa, T; Uno, R; Yamaguchi, H, 1997) |
| "Basic haematologic parameters and serum gamma-glutamyl-transferase (GGT) activity were evaluated in a five-year prospective follow-up study of 25 patients with newly diagnosed epilepsy starting treatment with carbamazepine." | 3.69 | Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy. ( Isojärvi, JI; Myllylä, VV; Pakarinen, AJ, 1997) |
| "This single case reports an open trial of lamotrigine in the treatment of self-injurious behavior (SIB) and epilepsy in an 18-year-old female diagnosed with generalized seizure disorder, stereotypic movement disorder, and compulsive SIB in the context of profound mental retardation." | 3.69 | Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. ( Davanzo, PA; King, BH, 1996) |
| "Serum lipids were determined in 10 untreated patients with recently diagnosed epilepsy, 21 patients treated with carbamazepine (CBZ), 10 patients treated with valproate (VPA) and in 15 healthy children." | 3.69 | The effects of long-term anticonvulsive treatment on serum lipid profile. ( Hassanzadeh, A; Mawlud, K; Yalçin, E, 1997) |
| "Serum total cholesterol (TC), high-density lipoprotein (HDL-C), low-density lipoprotein (LDL-C) and very low-density lipoprotein cholesterol, triglyceride, apolipoproteins A1 and B levels were studied in 57 healthy children and in 39 children with epilepsy who had been receiving carbamazepine (CBZ) (23 children) for 1." | 3.69 | Serum lipids in epileptic children treated with carbamazepine and valproate. ( Arpaci, B; Atakil, D; Baybas, S; Dogu, O; Sözüer, DT, 1997) |
| "Auditory event related potentials were recorded in 40 patients with idiopathic generalized epilepsy, 20 on monotherapy with sodium valproate (VPA), 20 on monotherapy with carbamazepine and 20 age and sex matched controls." | 3.69 | Auditory event related potentials in patients with epilepsy on sodium valproate monotherapy. ( Karageorgiou, CL; Panagopoulos, GR; Tagaris, G; Thomaides, T, 1997) |
| "The effect of ketoconazole (200 mg/d orally for 10 days) on the plasma concentrations of carbamazepine (CBZ) and its active metabolite carbamazepine-10,11-epoxide (CBZ-E) was assessed in eight patients with epilepsy stabilized on CBZ therapy." | 3.69 | Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy. ( Arena, D; Fazio, A; Perucca, E; Pisani, F; Scordo, MG; Spina, E, 1997) |
| " The multiple peak approach has been used to evaluate the effect of age, total body weight, dose, gender and comedication (carbamazepine-induced change) on population estimates of valproic acid relative clearance." | 3.69 | Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening. ( Aoyama, T; Higuchi, S; Honda, T; Ohdo, S; Yukawa, E, 1997) |
| "Very little data are available on the usefulness of oxcarbazepine in young children with epilepsy." | 3.69 | Oxcarbazepine in the treatment of early childhood epilepsy. ( Gaily, E; Granström, ML; Liukkonen, E, 1997) |
| "5 months of pregnancy then carbamazepine 400 mg LP x 2/day, raised to 600 mg LP x 2/day at the 25th week of gestation because of epileptic crisis." | 3.69 | [Carbamazepine and vigabatrin in epileptic pregnant woman and side effects in the newborn infant]. ( Aboulghit, H; Beust, M; Kayemba Kay'S, S; Mourtada, A; Voisin, M, 1997) |
| "We examined the anticonvulsant effects of BW1003C87 (5-(2,3,5-trichlorophenyl)-2,4-diaminopyrimidine ethane sulphonic acid), which is structurally related to the new antiepileptic drug, lamotrigine, and compared its effects to those of the conventional antiepileptic drugs, phenytoin and carbamazopine, using the rat amygdala-kindling model of epilepsy." | 3.69 | BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. ( Morimoto, K; Sato, H; Sato, K; Sato, S; Yamada, N, 1997) |
| "Nonlinear mixed effects modeling (NONMEM) was used to estimate the effects of drug-drug interaction on valproic acid relative clearance values using 792 serum levels gathered from 400 pediatric and adult patients with epilepsy (age range, 0." | 3.69 | Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics. ( Aoyama, T; Higuchi, S; Ohdo, S; To, H; Yukawa, E, 1997) |
| " We studied the changes in arrhythmia profile and heart-rate variability, during abrupt withdrawal of carbamazepine and phenytoin treatment in 10 patients with side effects on these drugs." | 3.69 | Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death. ( Bergfeldt, L; Ericson, M; Kennebäck, G; Tomson, T, 1997) |
| "We studied the CSF amino acid levels of 42 patients with newly diagnosed epilepsy before treatment with antiepileptic medication and during monotherapy with either vigabatrin or carbamazepine." | 3.68 | Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies. ( Halonen, T; Kälviäinen, R; Pitkänen, A; Riekkinen, PJ, 1993) |
| " The first patient was a boy with epilepsy, whose symptoms first appeared following treatment with carbamazepine." | 3.68 | Carbamazepine hypersensitivity and rickettsiosis mimicking Kawasaki disease. ( Garoufi, A; Karpathios, T; Parha, S; Theodoridis, C; Yiallouros, P, 1993) |
| "Carbamazepine (CBZ) is known to have beneficial effects in the treatment of epilepsies and in the prophylaxis of affective disorders." | 3.68 | Calcium-antagonistic effects of carbamazepine in epilepsies and affective psychoses. ( Bingmann, D; Düsing, R; Grunze, H; Liu, Z; Mayer, A; Schirrmacher, K; Walden, J, 1993) |
| "We prospectively investigated the effects of rate of carbamazepine (CBZ) withdrawal and CBZ level on seizure type and frequency in 12 epilepsy patients withdrawn completely from antiepileptic drugs prior to entering an investigational monotherapy trial." | 3.68 | Carbamazepine withdrawal: effects of taper rate on seizure frequency. ( Blaxton, TA; Malow, BA; Stertz, B; Theodore, WH, 1993) |
| "A multiparametric investigation of daytime sleepiness was carried out in 10 patients with a generalized epilepsy treated by phenobarbital, 10 with a cryptogenic partial epilepsy treated by carbamazepine and 10 healthy controls." | 3.68 | Daytime sleepiness in epileptic patients on long-term monotherapy: MSLT, clinical and psychometric assessment. ( Galimberti, CA; Manni, R; Morini, R; Perucca, E; Ratti, MT; Tartara, A, 1993) |
| "Cases reported as loss of efficacy (secondary failure) of carbamazepine (CBZ) for epilepsy were analysed to determine the cause." | 3.68 | Investigation and management of loss of efficacy of an antiepileptic medication using carbamazepine as an example. ( Jain, KK, 1993) |
| "The purpose of the present study was to compare the pharmacokinetic parameters of two carbamazepine (CBZ) tablet formulations (conventional (CBZ-CO) and controlled-release (CBZ-CR)) in patients with epilepsy receiving the drug as monotherapy or polytherapy." | 3.68 | Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy. ( Bonneton, J; Dravet, C; Genton, P; Iliadis, A; Mesdjian, E; Viallat, D, 1993) |
| "Serum thyroid hormone and thyrotropin levels were assayed and the myocardial function was evaluated by measuring systolic time intervals both in 30 patients with epilepsy on long-term carbamazepine monotherapy and in 19 healthy volunteers." | 3.68 | Carbamazepine, serum thyroid hormones and myocardial function in epileptic patients. ( Airaksinen, KE; Isojärvi, JI; Myllylä, VV; Pakarinen, AJ; Repo, M; Salmela, P, 1993) |
| "In order to investigate the mechanism of action of anticonvulsant drugs, we examined the effects of carbamazepine (CBZ) and antiepilepsirine (AE) on convulsions and on brain biogenic amines in genetically epilepsy-prone rats (GEPR)." | 3.68 | Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats. ( Bettendorf, AF; Burger, RL; Dailey, JW; Jobe, PC; Mishra, PK; Yan, QS, 1992) |
| "Carbamazepine (CBZ) used in the treatment of epilepsy, is metabolized in man to an active metabolite: carbamazepine 10-11 epoxide (CBZ-E)." | 3.68 | Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients. ( Bonneton, J; Genton, P; Mesdjian, E, 1992) |
| "A 20-year-old man is described with drug-induced lupus erythematosus (DILE) induced by carbamazepine prescribed for epilepsy." | 3.68 | [Disseminated lupus erythematosus induced by carbamazepine (Tegretol)]. ( Boon, DM; Swaak, AJ; van Parys, JA, 1992) |
| "Sixteen epileptic patients suffering from focal epilepsy who underwent antiepileptic drug treatment with carbamazepine (CBZ) for the first time were studied." | 3.68 | Effect of carbamazepine treatment on EEG changes induced by different cortical activation patterns in newly referred epileptic patients. ( Bernardi, G; Gigli, GL; Grazia Marciani, M; Sabbadini, M; Stefani, N; Stefanini, F, 1992) |
| "A patient with epilepsy controlled by carbamazepine developed a carbamazepine neurotoxic reaction after being given an increased dosage of diltiazem hydrochloride as adjunctive therapy." | 3.68 | Carbamazepine neurotoxic reaction after administration of diltiazem. ( Grossman, E; Maoz, E; Rosenthal, T; Thaler, M, 1992) |
| "Information from standardised tests of intelligence, school attainments, attention, memory and visuomotor function, together with parent and teacher questionnaire information about various aspects of behaviour, was obtained for 63 schoolchildren with newly diagnosed epilepsy before treatment with sodium valproate or carbamazepine, and again at intervals for a total period of 12 months." | 3.68 | Psychological effects of sodium valproate and carbamazepine in epilepsy. ( Stores, G; Styles, E; Williams, PL; Zaiwalla, Z, 1992) |
| "The effect of aging on carbamazepine (CBZ) plasma level/dose ratio was evaluated retrospectively in 15 children who were receiving CBZ monotherapy and who were followed up for at least 3 years." | 3.68 | A within-subject analysis of carbamazepine disposition related to development in children with epilepsy. ( Albani, F; Baruzzi, A; Contin, M; Riva, R, 1992) |
| "Carbamazepine (CBZ) is used in neurology for the treatment of epilepsies and trigeminal neuralgia and in psychiatry for the prophylactic treatment of affective and schizoaffective psychoses." | 3.68 | Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies. ( Bingmann, D; Düsing, R; Grunze, H; Liu, Z; Walden, J, 1992) |
| "We retrospectively collected plasma level assessments performed in 96 adult patients with epilepsy on stable monotherapy, including 9 patients on clobazam (CLB), 34 on carbamazepine (CBZ), 24 on phenobarbital (PB), 9 on phenytoin (PHT), and 20 on valproate (VPA); these results were compared to those obtained in 54 adult patients on stable bitherapy with the association of CLB with either CBZ (n = 17), PB (n = 17), PHT (n = 5), or VPA (n = 15)." | 3.68 | Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. ( Bonneton, J; Dravet, C; Genton, P; Mesdjian, E; Roger, J; Sennoune, S, 1992) |
| "Thirteen patients with newly diagnosed epilepsy performed a battery of psychomotor function tests before and during the first 12 weeks of carbamazepine (CBZ) therapy." | 3.68 | Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients. ( Brodie, MJ; Larkin, JG; McKee, PJ, 1992) |
| "The effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites were investigated in eight patients with epilepsy or trigeminal neuralgia." | 3.68 | Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites. ( Boas, J; Dam, M; Flesch, G; Jensen, PK; Jórgensen, L; Mogensen, PH; Vesterager, A, 1992) |
| "We report the case of a young man suffering from epilepsy who developed chronic calcified pancreatitis after ten years of therapy with the anticonvulsant drugs carbamazepine and phenytoin." | 3.68 | Anticonvulsant-induced chronic pancreatitis. A case report. ( Billi, P; Broccoli, PL; Fontana, G; Melandri, R; Pezzilli, R, 1992) |
| "We report the first comparison of Chewable and Regular Carbamazepine (CBZ) tablets in children with epilepsy." | 3.68 | The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy. ( al-Quadah, AK; Camfield, C; Camfield, P; Fraser, A; Hwang, P; Soldin, S, 1992) |
| "This paper reports the results of a 12-month prospective follow-up study on the effects of carbamazepine (CBZ) medication on serum sex and pituitary hormone concentrations in 21 male patients with recently diagnosed epilepsy." | 3.68 | A prospective study of serum sex hormones during carbamazepine therapy. ( Isojärvi, JI; Myllylä, VV; Pakarinen, AJ, 1991) |
| "We report the cases of four patients who were taking the anticonvulsant drugs phenytoin or carbamazepine and in whom skin lesions developed that showed histologic features suggestive of mycosis fungoides." | 3.68 | Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy. ( Kruyswijk, MR; Meijer, CJ; Rijlaarsdam, U; Scheffer, E; Willemze, R, 1991) |
| "In newly diagnosed adult patients with epilepsy followed prospectively on monotherapy, carbamazepine and phenytoin were associated with a fall in plasma uric acid, but sodium valproate and phenobarbitone were associated with a rise in plasma uric acid." | 3.68 | Plasma uric acid in patients receiving anticonvulsant monotherapy. ( Heller, AJ; Johnson, AL; Marshall, WJ; Reynolds, EH; Ring, HA, 1991) |
| "The effects of antiepileptic drugs (AED) on infants during pregnancy and delivery were studied in a total of 82 epileptic mothers on various monotherapies; 29 cases receiving valproic acid (VPA), 20 receiving phenytoin (PHT), 18 on carbamazepine (CBZ) and 15 on phenobarbital (PB)." | 3.68 | [Effects of antiepileptic drugs on delivery and early childhood--comparison among mono-therapies of valproic acid, phenytoin, carbamazepine and phenobarbital]. ( Ishikawa, S; Izumi, M; Okada, H; Takeda, A; Tanaka, H, 1991) |
| "Methsuximide was added to the therapeutic regimens of 25 children with intractable epilepsy." | 3.68 | Methsuximide for intractable childhood seizures. ( Greenwood, RS; Miles, MV; Tennison, MB, 1991) |
| "Carbamazepine, a first-line drug for the treatment of epilepsy and neuralgia, may exert hazardous effects on the cardiac conduction system." | 3.68 | Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system. ( Bergfeldt, L; Edhag, O; Kennebäck, G; Tomson, T; Vallin, H, 1991) |
| "A girl was born to a mother who had undergone treatment for epilepsy with carbamazepine during pregnancy." | 3.68 | Teratogenic effect of carbamazepine. ( Vestermark, S; Vestermark, V, 1991) |
| "Four young patients who developed weight gain induced by carbamazepine therapy are described." | 3.68 | Weight gain, increased appetite, and excessive food intake induced by carbamazepine. ( Eshel, Y; Lampl, Y; Rapaport, A; Sarova-Pinhas, I, 1991) |
| "Oxiracetam, a nootropic drug, could be of potential use in the treatment of memory disturbances in patients with epilepsy who are using antiepileptic drugs." | 3.68 | Pilot study to determine the interaction of oxiracetam with antiepileptic drugs. ( Meijer, JW; van Emde Boas, W; van Wieringen, A; Vermeij, TA, 1990) |
| "Free and total carbamazepine (CBZ) and carbamazepine-epoxide (CBZ-EP) plasma levels were obtained on 113 patients with epilepsy (18-61 years old) controlled on either monotherapy or coadministration with either phenobarbital (PB), phenytoin (PHT), valproic acid (VPA), or all three." | 3.68 | Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy. ( Briggle, TV; Guterman, A; McManus, DQ; Perchalski, R; Ramsay, RE; Vazquez, D; Wong, P; Yost, RA, 1990) |
| "39 adult patients with intractable epilepsy were successfully treated with high-dose monotherapy, using carbamazepine or phenytoin." | 3.68 | [High-dose monotherapy in intractable epilepsy]. ( Peng, SM; Wu, JZ, 1990) |
| "A man developed acne keloidalis-like lesions in the scalp during treatment with diphenylhydantoin and carbamazepine for epilepsy." | 3.68 | Acne keloidalis-like lesions on the scalp associated with antiepileptic drugs. ( Ben-Dor, D; Grunwald, MH; Halevy, S; Livni, E, 1990) |
| "We report a 3-week-old boy with cholestatic hepatitis, most likely due to carbamazepine exposure during pregnancy and breastfeeding." | 3.68 | Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. ( Frey, B; Musy, JP; Schubiger, G, 1990) |
| "Using an open substitution study design, conventional carbamazepine (Tegretol, CBZ-C and a chewable carbamazepine formulation (Tegretol Chewtabs, CBZ-CHEW) were compared in 12 patients with severe intractable epilepsy." | 3.68 | A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients. ( Patsalos, PN, 1990) |
| " Fifty-two children had been exposed to phenytoin monotherapy, 19 to carbamazepine monotherapy, 27 to drug combinations including barbiturates, 29 to other drug combinations, and 17 children had not been exposed to antiepileptic drugs (AEDs) during pregnancy." | 3.68 | Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background. ( Bardy, AH; Gaily, EK; Granström, ML; Hiilesmaa, VK, 1990) |
| "Serum concentrations of the main vitamin D metabolites and of calcium, phosphate, and alkaline phosphatase were determined in each of the three trimesters of pregnancy and in simultaneously obtained maternal and cord blood at delivery in 22 epileptic women treated with diphenylhydantoin or carbamazepine alone or with a combination with one other drug." | 3.67 | Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood. ( Aarskog, D; Aksnes, L; Markestad, T; Strandjord, RE; Ulstein, M, 1984) |
| "A total of 64 problem patients with epilepsy (42 retrospective evaluations, 22 prospective cases) was treated with the combination of carbamazepine and valproic acid." | 3.67 | [Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic]. ( Fröscher, W; Hoffmann, F; Stoll, KD, 1984) |
| "A method of measuring carbamazepine-10,11-epoxide (CBZ-10,11-EPOX) has been developed and used to monitor plasma concentrations in children suffering from various forms of epilepsy." | 3.67 | Altered ratio of carbamazepine-10,11-epoxide/carbamazepine in plasma of children: evidence of anticonvulsant drug interaction. ( Brett, EM; Elyas, AA; Lascelles, PT; Schoeman, JF, 1984) |
| "Ninety children with epilepsy were treated with carbamazepine (CBZ) alone or with other anticonvulsant drugs." | 3.67 | Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy. ( Brett, EM; Elyas, AA; Lascelles, PT; Schoeman, JF, 1984) |
| "We evaluated the therapeutic efficacy and toxicity of high-dose monotherapy, using carbamazepine or phenytoin, in patients with previously uncontrolled seizures." | 3.67 | High-dose monotherapy in treatment of intractable seizures. ( Dinner, DS; Lesser, RP; Lüders, H; Pippenger, CE, 1984) |
| "The effects of carbamazepine monotherapy on thyroid function were evaluated in patients with epilepsy." | 3.67 | Thyroid function in epileptic patients treated with carbamazepine. ( Isojärvi, JI; Myllylä, VV; Pakarinen, AJ, 1989) |
| "One hundred seventy-six children treated with carbamazepine for epilepsy were monitored over a 12-month period to determine the effects of carbamazepine on the hematologic system." | 3.67 | Hematologic monitoring in children with epilepsy treated with carbamazepine. ( Evans, OB; Gay, H; Parks, B; Swisher, A, 1989) |
| "Carbamazepine clearance was studied in Black paediatric epilepsy patients, 90 receiving monotherapy and 17 on combination therapy." | 3.67 | Carbamazepine clearance in paediatric epilepsy patients. Influence of body mass, dose, sex and co-medication. ( Summers, B; Summers, RS, 1989) |
| "In six patients with epilepsy and fibrocystic breast disease the concentration in serum of antiepileptic drugs was obtained before, during, and after danazol therapy." | 3.67 | Clinically significant danazol-carbamazepine interaction. ( Haidukewych, D; Lichten, EM; Zielinski, JJ, 1987) |
| "To assess the most efficient means of monitoring thyroid status in an epilepsy clinic, total thyroxine (T4), free thyroxine stimulating hormone (TSH) were measured in 71 adult patients treated long-term with either phenytoin (DPH), carbamazepine (CBZ) or sodium valproate (VAL)." | 3.67 | The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic. ( Borsey, DQ; Browning, MC; Connacher, AA; Davidson, DL; Jung, RT, 1987) |
| "In a survey of the red cell folate status of 200 patients with epilepsy, compared to 72 controls, we found that median red cell folate levels were reduced significantly in patients treated with phenytoin (p less than 0." | 3.67 | A comparative study of the relative effects of anticonvulsant drugs and dietary folate on the red cell folate status of patients with epilepsy. ( Baker, M; Bissessar, A; Callaghan, N; Crowley, M; Goggin, T; Gough, H, 1987) |
| "Neural tube, craniofacial, and other congenital abnormalities have been described in infants born to mothers with epilepsy who were treated with valproic acid (VPA) during pregnancy." | 3.67 | Congenital abnormalities in two sibs exposed to valproic acid in utero. ( Anderson, L; Chitayat, D; Farrell, K; Hall, JG, 1988) |
| "The Comprehensive Epilepsy Program of Minnesota database was searched for patients who had no dose change of carbamazepine (CBZ), phenytoin (PHT) or valproate (VPA) for 3 consecutive visits." | 3.67 | Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population. ( Leppik, IE, 1988) |
| "A battery of psychometric tests was administered to 85 patients with epilepsy, of whom 26 were untreated, 40 received carbamazepine monotherapy and 19 took carbamazepine with another anticonvulsant." | 3.67 | Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. ( Brodie, MJ; Butler, E; Gillham, RA; Larkin, JG; Wiedmann, K; Williams, N, 1988) |
| "A 36-year-old woman on long-term anticonvulsant therapy with carbamazepine (Tegretol) sustained superficial facial and corneal burns after using a photocopier for 2 h." | 3.67 | Carbamazepine-induced facial burns caused by a photocopier. ( Ward, DJ, 1987) |
| "Appropriate use of carbamazepine for the treatment of epilepsy is based on correct identification of the patient's seizure type." | 3.67 | How to initiate and maintain carbamazepine therapy in children and adults. ( Porter, RJ, 1987) |
| "Simultaneous steady-state serum total and free (non-protein-bound) concentrations of carbamazepine and carbamazepine-10,11-epoxide were measured in 68 patients under the age of 21 years with epilepsy (44 males, 24 females; mean age, 11." | 3.67 | Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy. ( Agbato, OA; Brett, EM; Elyas, AA; Lascelles, PT; Patsalos, PN, 1986) |
| "The incidence of grand mal seizures, distribution of drug levels relative to the therapeutic range and the incidence of side effects were monitored before and after the provision of same-day preconsultation assay results (phenytoin and carbamazepine) to an epilepsy clinic." | 3.67 | Availability of drug assay results and dosage advice improves antiepileptic care in a specialist neurology outpatient clinic. ( Gilligan, BS; Harrison, PM; Heinzow, U; Horne, M; Ioannides-Demos, LL; McLean, AJ; Tong, N; Wodak, J, 1985) |
| " The mother had received carbamazepine therapy for epilepsy." | 3.67 | Persistent right umbilical vein--case report and review of literature. ( Bell, AD; Gerlis, LM; Variend, S, 1986) |
| "Sixty patients receiving carbamazepine and 61 age-matched controls were studied to determine the prevalence of hyponatremia." | 3.67 | Hyponatremia during carbamazepine therapy. ( Lahr, MB, 1985) |
| " Occurrence of psychotic syndromes in epilepsy may be relevant to kindling, atypical psychoses unrelated to epilepsy, and the psychotropic effect of carbamazepine." | 3.67 | Psychotic syndromes in epilepsy. ( Kane, JM; McKenna, PJ; Parrish, K, 1985) |
| "Carbamazepine (20 mg/kg, 40 mg/kg or 60 mg/kg) given three times a day, has been demonstrated to have a significant anti-epileptic effect in rats with chronic limbic epilepsy induced by injecting tetanus toxin bilaterally into their hippocampi." | 3.67 | Antiepileptic and antiamnesic effect of carbamazepine in experimental limbic epilepsy. ( Brown, J; Hawkins, CA; Mellanby, J, 1985) |
| "An 8 1/2-year-old girl was treated with carbamazepine because of headaches and electroencephalogram findings compatible with multifocal epilepsy." | 3.67 | Carbamazepine-induced hair loss. ( Shuper, A; Stahl, B; Weitz, R, 1985) |
| " A case of non-hereditary acute porphyria, similar to acute intermittent porphyria, following treatment of epilepsy with carbamazepine is reported." | 3.66 | Carbamazepine-induced non-hereditary acute porphyria. ( Brodie, MJ; Goldberg, A; Macphee, GJ; Moore, MR; Philip, MF; Rapeport, WG; Thompson, GG; Yeung Laiwah, AA, 1983) |
| "A total of 20 children with various types of epilepsy were treated with valproate, 11 with monotherapy and 9 with valproate in combination with phenobarbitone, phenytoin, or carbamazepine." | 3.66 | Plasma concentrations of valproate during maintenance therapy in epileptic children. ( Boréus, LO; Lundberg, B; Nergårdh, A, 1982) |
| " The present study comprised 31 patients with newly diagnosed epilepsy, commencing treatment with either carbamazepine or valproate." | 3.66 | Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. A controlled study. ( Bentsen, KD; Gram, L; Veje, A, 1983) |
| "For a period of 8 years, carbamazepine (CBZ) and its two major metabolites carbamazepine-10,11-epoxide (CBZE) and 10,11-dihydroxy-carbamazepine (CBZH) were monitored in plasma of black and white patients visiting outpatient epilepsy clinics." | 3.66 | Carbamazepine and its major metabolites in plasma: a summary of eight years of therapeutic drug monitoring. ( Aucamp, AK; Hundt, HK; Müller, FO; Potgieter, MA, 1983) |
| "IgA, IgG and IgM concentrations were determined in sera and nasal washings from 20 patients with epilepsy on single-drug treatment with carbamazepine, in 20 patients on single-drug treatment with phenobarbital and in 26 healthy subjects." | 3.66 | Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital. ( Aarli, JA; Gilhus, NE; Strandjord, RE, 1982) |
| "Serum IgA, IgG and IgM concentrations were determined in 30 patients with partial epilepsy before and during carbamazepine therapy." | 3.66 | The effect of carbamazepine on serum immunoglobulin concentrations. ( Aarli, JA; Gilhus, NE; Strandjord, RE, 1982) |
| "Carbamazepine serum levels have been determined by gas-liquid chromatography in 24 children and 26 adults with epilepsy on chronic carbamazepine treatment." | 3.66 | Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy. ( Kumps, AH, 1981) |
| "We describe a procedure for determining 2-ethyl-2-phenylmalonamide (I) in serum of epilepsy patients dosed with primidone (II) for seizure control, by extracting the sample with chloroform under basic conditions, with use of an internal standard, 2-ethyl-2-(p-tolyl)malonamide, and without derivative formation." | 3.66 | Monitoring 2-ethyl-2-phenylmalonamide in serum by gas-liquid chromatography: application to retrospective study in epilepsy patients dosed with primidone. ( Haidukewych, D; Rodin, EA, 1980) |
| "Many anticonvulsants are known to cause osteomalacia, however, carbamazepine has not previously been studied in this regard." | 3.66 | Biochemical evidence for osteomalacia with carbamazepine therapy. ( Callaghan, N; Duggan, B; O'Driscoll, D; O'Hare, JA, 1980) |
| "Phenobarbital and carbamazepine concentrations were determined by the EMIT technique in tears, saliva, cerebrospinal fluid (CSF), and plasma of patients with epilepsy." | 3.66 | Tears as the best practical indicator of the unbound fraction of an anticonvulsant drug. ( Mastropaolo, C; Monaco, F; Mutani, R; Tondi, M, 1979) |
| "Serum levels and seizure control were investigated in a prospective study when carbamazepine was given as a single drug to 32 patients with a variety of seizures." | 3.66 | Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control. ( Callaghan, N; Duggan, B; Feely, M; O'Callaghan, M, 1978) |
| "A 25-year-old Oriental woman developed systemic lupus erythematosus during a course of treatment with carbamazepine for long-standing idiopathic epilepsy." | 3.65 | IgA deficiency and systemic lupus erythematosus. Occurrence in an oriental woman with idiopathic epilepsy. ( Imamura, S; Kanoh, T; Takahashi, C; Takigawa, M, 1976) |
| "The plasma concentrations of carbamazepine and its 10,11-epoxide were measured in 37 children and 13 adults with epilepsy during maintenance therapy." | 3.65 | Carbamazepine and its 10,11-epoxide in children and adults with epilepsy. ( Frey, H; Iisalo, E; Pynnönen, S; Sillanpää, M, 1977) |
| "The influence of clonazepam on steady-state serum levels of diphenylhydantoin, phenobarbital and carbamazepine was studied in 22 patients with epilepsy receiving one or two of these drugs." | 3.65 | Lack of effect of clonazepam on serum levels of diphenylhydantoin, phenobarbital and carbamazepine. ( Johannessen, SI; Munthe-Kaas, AW; Strandjord, RE, 1977) |
| " Thirteen ambulant patients suffering from partial epilepsy with complex symptomatology, who were already being treated with phenytoin in optimal doses (plasma level 14-20 mug/ml) were also given carbamazepine." | 3.65 | Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy. ( Bertilsson, L; Eichelbaum, M; Lund, L; Palmér, L; Sjöqvist, F, 1976) |
| "Two patients with intractable epilepsy who had been treated with various combinations of anticonvulsant drugs developed phenytoin encephalopathy." | 3.65 | Choreo-athetosis and encephalopathy induced by phenytoin. ( McLellan, DL; Swash, M, 1974) |
| "Epilepsy is a chronic disease of the central nervous system characterized by recurrent epileptic seizures." | 3.01 | Second Generation of Antiepileptic Drugs and Oxidative Stress. ( Czuczwar, SJ; Kamieniak, M; Kośmider, K; Miziak, B, 2023) |
| "Relapse of seizures can have major adverse psychosocial consequences and also may carry a risk of morbidity and mortality." | 3.01 | Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy? ( Asadi-Pooya, AA; Mesraoua, B; Perucca, E; Tomson, T, 2023) |
| "Seizures are among the most common clinical signs in people with glioblastoma." | 3.01 | The complexities underlying epilepsy in people with glioblastoma. ( Cole, AJ; Dietrich, J; Sokolov, E, 2023) |
| "People with epilepsy are at increased risk for neuropsychological dysfunction due to multiple factors, of which the most amendable are antiseizure medications (ASMs)." | 2.90 | Comparative neuropsychological effects of carbamazepine and eslicarbazepine acetate. ( Boyd, A; Falco-Walter, J; Le, S; Loring, DW; Meador, KJ; Razavi, B; Seliger, J, 2019) |
| "The aims of the study were to develop a population pharmacokinetic model of orally administered brivaracetam in paediatric patients and to provide dosing suggestions." | 2.84 | Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years. ( Schoemaker, R; Stockis, A; Wade, JR, 2017) |
| "Carbamazepine and phenytoin were the drugs most strongly associated with decreases in T4 and T3 levels while topiramate had the greatest elevating effect on TSH." | 2.82 | Side effects of long-term oral anti-seizure drugs on thyroid hormones in patients with epilepsy: a systematic review and network meta-analysis. ( Cai, M; Guo, X; Han, Y; Lin, W; Yang, J; Zhong, R, 2022) |
| "The phenytoin treatment causes cerebellar defect and anemia." | 2.82 | The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches. ( Agrawal, M; Dhurandhar, Y; Panda, SP, 2022) |
| "Epilepsy is one of the most common neurological disorders worldwide." | 2.82 | Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis. ( Amos, A; Escheu, G; Harrison, W; Hauke, P; Kaducu, J; Keller, L; Matuja, W; Ngowi, BJ; Ovuga, E; Pfausler, B; Richter, V; Schmidt, V; Schmutzhard, E; Stelzle, D; Welte, TM; Winkler, AS, 2022) |
| "The LTG population pharmacokinetic model developed in this study may be a reliable method for individualising the LTG dosing regimen in paediatric and young adult patients on combination therapy during therapeutic drug monitoring." | 2.79 | Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients--nonlinear mixed effects modelling approach. ( Brzaković, B; Kovačević, SV; Martinović, Ž; Miljković, B; Pokrajac, M; Prostran, M; Vučićević, K, 2014) |
| " The stable-labeled intravenous dosing methodology enabled the estimation of the CBZ clearance (CL) and volumes of distribution." | 2.78 | Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy. ( Ahmed, GF; Birnbaum, AK; Brundage, RC; Cloyd, JC; Leppik, IE; Marino, SE; Pennell, PB; Ramsay, RE, 2013) |
| "Carbamazepine is a widely used anticonvulsive agent." | 2.76 | Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication. ( Breton, H; Demoly, P; Gelisse, P; Hillaire-Buys, D; Mathieu, O; Picot, MC, 2011) |
| "Leptin is a hormone that plays a major role in the regulation of feeding and energy expenditure." | 2.74 | The effect of carbamazepine treatment on serum leptin levels. ( Kose, S; Kulu, U; Sener, U; Uludag, IF; Zorlu, Y, 2009) |
| "Temozolomide treatment did not affect TPM plasma concentrations in chronically treated patients." | 2.73 | Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. ( Albani, F; Baruzzi, A; Contin, M; Dinapoli, L; Fabi, A; Jandolo, B; Maschio, M; Pace, A; Zarabla, A, 2008) |
| "Drug-induced osteopenia was evident in 3 patients with z scores of bone-mineral density less than -2." | 2.73 | Evaluation of bone turnover in epileptic children using oxcarbazepine. ( Camurdan, O; Cansu, A; Cinaz, P; Gücüyener, K; Gülbahar, O; Hirfanoğlu, TL; Serdaroğlu, A; Yesilkaya, E, 2008) |
| " The relationship between chronic use of carbamazepine and vitamin D levels has been studied, but no comprehensive review to inform practitioners and policymakers is currently available." | 2.72 | Impact of carbamazepine on vitamin D levels: A meta-analysis. ( Brennan, L; LoPinto-Khoury, C; Mintzer, S, 2021) |
| "In Morocco, epilepsy is one of the major neurological health conditions, with an estimated prevalence of 1." | 2.72 | Epilepsy in Morocco: Realities, pitfalls and prospects. ( Cherkaoui Rhazouani, O; Khramaz, M; Kissani, N; Mebrouk, Y; Meryem, C; Ouazzani, R; Souirti, Z, 2021) |
| "Epilepsy is the tendency to have unprovoked seizures." | 2.72 | Epilepsy: A Clinical Overview. ( Milligan, TA, 2021) |
| "Carbamazepine (CBZ) is a wildly used anti-epileptic drug (AED)." | 2.72 | Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis. ( Hu, T; Liu, J; Tian, T; Zeng, X, 2021) |
| " The aims of our study were to evaluate whether color vision and macular function are impaired in epileptic adolescents, to study if the monotherapy with valproic acid (VPA) and carbamazepine (CBZ) can affect color vision and macular function and to determine the possible relationship between color vision, retinal function and antiepileptic drugs (AEDs) dosage and their serum concentrations." | 2.72 | Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine. ( Chiarelli, F; Gallenga, PE; Iannetti, P; Lobefalo, L; Spalice, A; Tocco, AM; Verrotti, A, 2006) |
| "The objective of this study was to compare the efficacy and safety of a chronotherapeutic dosing schedule of phenytoin and carbamazepine versus a conventional dosing schedule for the treatment of tonic-clonic epileptic patients." | 2.72 | Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. ( Mahesh, SD; Sangle, S; Yegnanarayan, R, 2006) |
| " There was no significant difference between the two groups with respect to premature discontinuation due to adverse events." | 2.71 | Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. ( Beydoun, A; D'Souza, J; Kutluay, E; McCague, K, 2003) |
| "The incidence of adverse events, which were mild in severity, was similar between all treatment groups, including the placebo group." | 2.71 | Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans. ( Almeida, L; Soares-da-Silva, P, 2003) |
| " Patients were converted during an carbamazepine, phenytoin, or valproate) to lamotrigine via a protocol-specified dosing algorithm or to conventional therapy via standard dosing guidelines." | 2.71 | Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy. ( Hammer, AE; Kaminow, L; Schimschock, JR; Vuong, A, 2003) |
| " Reduction in VPA dosage in the third patient produced no improvement." | 2.71 | Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. ( Clough, P; Duncan, S; Easterford, K; Fallon, K; Kellett, M, 2004) |
| " Based on the lack of clinically relevant in vitro and in vivo effects, adjustment of carbamazepine dosing should not be required with concomitant zonisamide administration." | 2.71 | Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients. ( Bergen, D; Garnett, W; Grundy, JS; Levy, RH; Mather, G; Ragueneau-Majlessi, I; Rosenfeld, W; Shah, J, 2004) |
| "Carbamazepine treatment alters the serum lipid profile of children in such a way that it could potentially facilitate the development of atherosclerosis." | 2.71 | Serum lipid levels during carbamazepine therapy in epileptic children. ( Iranpour, R; Mahmoudian, T; Messri, N, 2005) |
| "Carbamazepine was prescribed at normal dosages (16." | 2.71 | Early alteration in bone metabolism in epileptic children receiving carbamazepine monotherapy owing to the induction of hepatic drug-metabolizing enzymes. ( Attilakos, A; Dimou, S; Garoufi, A; Katsarou, E; Mastroyianni, S; Skardoutsou, A; Voudris, KA, 2005) |
| "The aim of this study was to define the pharmacokinetic profile of free carbamazepine (F-CBZ) in adult Omani epileptic patients in order to improve on dosing schedules through population pharmacokinetic analysis using the NONMEM program." | 2.70 | Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients. ( Aarons, L; Ahmed, IA; Deleu, D, 2001) |
| "The present study evaluates effect of pharmacokinetic interaction between caffeine (300 mg) in three divided doses with sodium valproate (400 mg) and carbamazepine (200 mg) given as single doses, in normal human volunteers, using a open cross over design." | 2.69 | Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers. ( David, J; Joseph, T; Kulkarni, C; Vaz, J, 1998) |
| "25 for each of the pharmacokinetic parameters for CBZ and for the summation of CBZ and CBZ-epoxide (CBZ-E)." | 2.69 | Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy. ( Belendiuk, GW; Couch, RA; Garnett, WR; Levy, B; McLean, AM; Pellock, JM; Rudnic, EM; Zhang, Y, 1998) |
| "hr/L, and terminal elimination half-life from 14." | 2.69 | Feasibility and pharmacokinetics of carbamazepine oral loading doses. ( Cohen, H; Devinsky, O; Goldfrank, LR; Hoffman, RS; Howland, MA; Kutt, H; Leung, LK; Luciano, DJ; Rubin, RN, 1998) |
| "In this study our aim was to assess pharmacokinetic effects and adverse cognitive effects of switches between generic and branded formulations of carbamazepine (CBZ)." | 2.69 | Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates. ( Aldenkamp, AP; Diepman, L; Doelman, J; Franken, M; Hulsman, J; Majoie, M; Olling, M; Rentmeester, T; Schellekens, A, 1998) |
| "Oxcarbazepine appears to be an effective and well-tolerated drug for children and adolescents with intellectual disability and epilepsy." | 2.69 | Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability. ( Gaily, E; Granström, ML; Liukkonen, E, 1998) |
| "The most important factor determining seizure recurrence was continued therapy, which was the case for barbiturates, phenytoin and valproate." | 2.69 | Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study. ( Chadwick, D, 1999) |
| " Two analyses of adverse events are presented: tolerability and safety." | 2.69 | Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. ( Bernstein, P; Faught, RE; Holmes, GL; Magnus-Miller, L; McLean, MJ; Morrell, MJ; Privitera, MD; Rose-Legatt, A; Willmore, LJ, 1999) |
| "To evaluate plasma homocysteine (Hcy) concentrations in children receiving sodium valproate (VPA) and carbamazepine (CBZ), monotherapy, in comparison with healthy control subjects and to determine the possible relationship between Hcy levels and dosage and plasma concentrations of the antiepileptic drugs." | 2.69 | Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. ( Chiarelli, F; Giuva, T; Morgese, G; Pascarella, R; Trotta, D; Verrotti, A, 2000) |
| " The population half-life was 5." | 2.69 | Population pharmacokinetics of tiagabine in epileptic patients on monotherapy. ( Aarons, L; Groes, L; Ingwersen, SH; Nielsen, KK; Pedersen, PC, 2000) |
| "Study was conducted to compare the pharmacokinetic profile of conventional and slow-release carbamazepine formulations in Indian epileptic patients." | 2.69 | A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation. ( Agarwal, A; Garg, RK; Nag, D, 1998) |
| "Plasma carbamazepine (CBZ) and carbamazepine-10,11-epoxide (CBZ-E) concentrations were measured in 160 epileptic patients in order to determine the effect of factors such as age, daily dosing schedule, formulation, and combination with other antiepileptic drugs on these concentrations in relation to the daily dose." | 2.68 | Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults. ( Bonato, PS; Campos, GM; Lanchote, VL; Rodrigues, I, 1995) |
| "LTG, lamotrigine is a new antiepileptic agent chemically unrelated to any established drugs in use." | 2.68 | [Lamotrigine: first experience in Italy]. ( de Romanis, F; Sopranzi, N, 1995) |
| "In order to assess whether doses or serum levels are predictive for the efficacy and adverse effects of antiepileptic drugs (AEDs), measures for exposure to drug combinations have to be used." | 2.68 | Neither dosage nor serum levels of antiepileptic drugs are predictive for efficacy and adverse effects. ( Hekster, YA; Keyser, A; Lammers, MW; Meinardi, H; Renier, WO; van Lier, H, 1995) |
| " The current study investigates the pharmacokinetic or pharmacodynamic mechanisms responsible for this observation." | 2.68 | Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. ( Alloul, K; Ebrahim, Z; Shutway, F; Varin, F; Whalley, DG, 1996) |
| " The median elimination half-life (t1/2) in patients receiving concomitant valproate (VPA) was 43." | 2.68 | Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy. ( Boreus, L; Eriksson, AS; Hoppu, K; Nergårdh, A, 1996) |
| "l-1 and the dosage of CBZ should simultaneously be decreased in steps by more than 50% to minimize the change in CBZ plasma concentration." | 2.68 | Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children. ( Chiron, C; d'Athis, P; Dulac, O; Olive, G; Pous, G; Renard, F; Rey, E; Tran, A; Vauzelle-Kervroedan, F, 1996) |
| " When PB in the dosage of 30-60 mg/d was used in combination with PHT the above mentioned changes were not observed." | 2.68 | Brainstem auditory evoked potentials in epileptics on different anti-epileptic drugs. ( Gupta, HL; Mukhopadhyay, S; Panjwani, U; sel Vamurthy, W; Singh, SH; Thakur, L, 1996) |
| "Lamotrigine (LTG) is a new antiepileptic drug (AED), chemically unrelated to the drugs in current use." | 2.68 | Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication. ( Jürgens, U; May, TW; Rambeck, B, 1996) |
| " Both dosage regimens of lamotrigine were well tolerated." | 2.68 | A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. ( Dam, M; Reunanen, M; Yuen, AW, 1996) |
| "Omeprazole was given as a single oral dose before and after 3 weeks of treatment of five patients with CBZ (400-600 mg daily)." | 2.68 | Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. ( Bertilsson, L; Chang, M; Tomson, T; Tybring, G; Widén, J, 1997) |
| " for 10 days) on the steady-state plasma concentrations of Oxcarbazepine (OXC), its active metabolite 10, 11-dihydro-10-hydroxy-carbazepine (MHD) and the corresponding diol (DHD) were studied in a randomized, double-blind cross-over placebo-controlled trial in 6 epileptic patients stabilized on a fixed dosage of OXC." | 2.67 | Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. ( Artesi, C; Di Perri, R; Fazio, A; Oteri, G; Perucca, E; Pisani, F; Xiao, B, 1994) |
| "On treatment with carbamazepine (n = 27) and phenytoin (n = 8), the excretion of alpha 1-microglobulin was significantly increased, as compared with the healthy controls." | 2.67 | Renal tubular dysfunction following treatment with anti-epileptic drugs. ( Korinthenberg, R; Wehrle, L; Zimmerhackl, LB, 1994) |
| " Each patient received an individualized loading dose and maintenance dosage targeted at a 60-ng/ml plasma FNR concentration." | 2.67 | Flunarizine for treatment of partial seizures: results of a concentration-controlled trial. ( Drake, ME; Mikati, M; Olson, L; Pellock, JM; Pledger, GW; Sackellares, JC; Sahlroot, JT; Treiman, DM; Tsay, JY; Wright, FS, 1994) |
| " Consequently, the controlled trial was designed to account for this interaction by reducing the phenytoin dosage by approximately 20% during the felbamate treatment period and using matching placebo capsules to maintain the blind." | 2.67 | Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria? ( Pledger, GW; Sahlroot, JT, 1994) |
| " Median AUCs of CBZ, VPA and PHT during a dosage interval did not differ significantly after treatment with OXC and placebo." | 2.67 | A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. ( Blacklaw, J; Brodie, MJ; Connelly, D; Forrest, G; Gillham, RA; McKee, PJ; Walker, SM, 1994) |
| "Felbamate is a novel antiepileptic drug that is now available in the United States." | 2.67 | Effect of felbamate on carbamazepine and its major metabolites. ( Graves, NM; Leppik, IE; Remmel, RP; Wagner, ML, 1993) |
| "Carbamazepine OROS was dosed every 12 h at the same corresponding daily dose." | 2.67 | Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients. ( Garnett, WR; Kochak, GM; Levy, RH; Mangat, S; Thakker, KM, 1992) |
| "In order to compare the multiple-dose bioavailability of carbamazepine (CBZ) from 2 slow-release preparations, Neurotol slow and Tegretol Retard, a single-blind, randomized, cross-over study was carried out." | 2.67 | Comparative bioavailability of carbamazepine from two slow-release preparations. ( Anttila, M; Heinonen, EH; Nyman, L; Reunanen, M, 1992) |
| " Each patient received 90-day supplies of Epitol or Tegretol and placebo, which replaced the usual dosage of the alternate product." | 2.67 | Therapeutic bioequivalency study of brand name versus generic carbamazepine. ( Anderson, RL; Dean, JC; Oles, KS; Penry, JK; Riela, AR; Smith, LD, 1992) |
| "The in-vitro dissolution profiles of two carbamazepine formulations (Tegretol and a generic carbamazepine) have been assessed and the bioavailability of carbamazepine compared in 12 epileptic children at steady-state." | 2.67 | Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy. ( Aleksandrowicz, J; Bowmer, CJ; Cawood, A; Forsythe, WI; Hartley, R, 1991) |
| "01) in serum CBZ concentration were substantially less with CBZ-CR and were similar to those calculated during a 6 or 8 hourly dosage interval with conventional CBZ (fluctuation 33 +/- 3%, variation 42 +/- 5%)." | 2.67 | Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients. ( Blacklaw, J; Brodie, MJ; Butler, E; Gillham, RA; McKee, PJ, 1991) |
| " The bioavailability of CBZ from the two preparations was similar." | 2.67 | Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Kaski, M; Sivenius, J; Tuominen, J, 1991) |
| " dosing schedule of the controlled-release (CR) preparation without a detrimental effect on seizure frequency or adverse effects." | 2.67 | A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine. ( Bruni, J; Dhalla, Z; Sutton, J, 1991) |
| " The twice-a-day dosage should result in better compliance and consequently in a better quality of treatment in the long term." | 2.67 | [Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults]. ( Remy, C, 1990) |
| " The daily dose and dosing frequency of CBZ were kept the same as before the study." | 2.67 | Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine. ( Ben-Menachem, E; Bengtsson, E; Heinonen, E; Persson, LI, 1990) |
| "The bioavailability of carbamazepine from two products (Ethical Generics and Ciba-Geigy) and their efficacy with regard to seizure control and incidence of side-effects were compared in 23 children with tonic-clonic or complex partial seizures." | 2.67 | Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability? ( Aleksandrowicz, J; Bowmer, CJ; Forsythe, WI; Hartley, R; McLain, B; Ng, PC, 1990) |
| " There was no significant difference in bioavailability between the 2 preparations." | 2.67 | Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation. ( Anttila, M; Heinonen, E; Hokkanen, E; Järvensivu, P; Lehto, H; Reunanen, M, 1990) |
| "Epilepsy is one of the most common neurological disorders, affecting approximately 50 million people worldwide." | 2.66 | Current role of carbamazepine and oxcarbazepine in the management of epilepsy. ( Beydoun, A; DuPont, S; Lagae, L; Matta, M; Nagire, V; Zhou, D, 2020) |
| "Haloperidol was administered in standardized doses of ." | 2.66 | Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies. ( Aman, MG; Teehan, CJ; Turbott, SH; Vaithianathan, C; White, AJ, 1989) |
| "Safety and efficacy studies of new antiepileptic drugs require strict adherence to prescribed dosage regimens." | 2.66 | Compliant populations: variability in serum concentrations. ( Graves, NM; Holmes, GB; Leppik, IE, 1988) |
| "The previously described anti-spastic effect of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine was found accidentally in 2 patients undergoing a double-blind comparative study for evaluation of antiepileptic effect." | 2.66 | Oxcarbazepine and spasticity: further observations. ( Bittencourt, PR, 1988) |
| "Both carbamazepine and phenytoin were associated with significantly lower incidences of intolerable side effects than were primidone or phenobarbital." | 2.66 | Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. ( Collins, JF; Craft, B; Cramer, JA; Mattson, RH; Novelly, RA; Smith, DB, 1987) |
| "Decreased libido and impotence were more common in patients given primidone." | 2.66 | Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. ( Browne, TR; Collins, JF; Cramer, JA; Delgado-Escueta, AV; Mattson, RH; McCutchen, CB; McNamara, JO; Smith, DB; Treiman, DM; Williamson, PD, 1985) |
| " In the dosage used, l-tryptophan was tolerated well by these children, and seizure frequency, as a whole, remained unaltered." | 2.65 | l-Tryptophan in hyperactive child syndrome associated with epilepsy: a controlled study. ( Ghose, K, 1983) |
| "The effect of once daily dosage of carbamazepine on fit frequency, electroencephalogram (EEG), behaviour and 24-hour drug levels were compared with those following 2 to 3 divided daily doses treatment." | 2.65 | Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study. ( Christofides, JA; Dawson, M; Fry, DE; Ghose, K, 1981) |
| " Absolute bioavailability of IM PB was 101 +/- 11%." | 2.65 | Kinetics of phenobarbital in normal subjects and epileptic patients. ( Comfort, CP; Friel, PN; Kaluzny, SP; Levy, RH; Wilensky, AJ, 1982) |
| "Carbamazepine (CBZ) was found to be effective in most cases." | 2.61 | Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10. ( Albaradie, R; Alhazmi, R; Alkhaldi, H; Chaudhary, M; Housawi, Y; Mir, A, 2019) |
| "Therefore, in children with a seizure disorder on long-term valproate therapy, 25-OH-Vit D levels should be monitored and appropriate supplementation implemented if levels are deficient." | 2.61 | Valproate decreases vitamin D levels in pediatric patients with epilepsy. ( Chen, F; Guo, H; Hu, Y; Jing, X; Li, G; Lu, XP; Sun, F; Sun, J; Wang, T; Wen, X; Xu, Z, 2019) |
| "Oxcarbazepine (OXC) is a drug that has a similar structure of carbamazepine." | 2.58 | Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis. ( Liu, Y; Nie, X; Wang, X; Yu, Y; Zhao, L, 2018) |
| "Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.55 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017) |
| "Epilepsy is a common neurological condition with a worldwide prevalence of around 1%." | 2.55 | Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. ( Marson, AG; Nevitt, SJ; Sudell, M; Tudur Smith, C; Weston, J, 2017) |
| "Lamotrigine was preferred in patients with co-morbid depression." | 2.55 | Epilepsy treatment in adults and adolescents: Expert opinion, 2016. ( Chimato, N; Frank, RD; Karceski, SC; Shih, JJ; Vargas, E; Whitlock, JB, 2017) |
| "Epilepsy is the commonest clinical presentation, though it may also present with headache, symptoms of raised intracranial tension, hydrocephalus and ocular symptoms depending upon the localisation of the parasitic cysts." | 2.52 | Antiepileptic drugs for seizure control in people with neurocysticercosis. ( Mathew, A; Sharma, M; Singh, T, 2015) |
| "Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures." | 2.50 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Saunders, M, 2014) |
| "Drug-induced hypersensitivity or Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) is a severe adverse drug-induced reaction." | 2.50 | Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review. ( Abourazzak, S; Atmani, S; Chaouki, S; E L omairi, N; Hida, M, 2014) |
| "Epilepsy is defined as the tendency to spontaneous, excessive neuronal discharge manifesting as seizures." | 2.50 | Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. ( Marson, AG; Powell, G; Rigby, A; Saunders, M, 2014) |
| "Seizures and intracranial hemorrhage are possible medical diseases that any obstetrician may encounter." | 2.49 | Seizures and intracranial hemorrhage. ( Alexander, JM; Wilson, KL, 2013) |
| " Consequences of these pharmacokinetic (PK) properties may include adverse events (AEs) and breakthrough seizures, potentially leading to poor adherence." | 2.49 | Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations. ( Hovinga, CA; Leppik, IE, 2013) |
| " When prescribing these drugs to patients of this age bracket, treatment should be based not only on the diagnosis and seizure type but also on the propensity of the drugs for adverse effects and their drug-drug interactions." | 2.48 | Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects. ( Dostic, M; Jankovic, SM, 2012) |
| "54; strength of evidence: low) or adverse events (RR 0." | 2.48 | Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. ( Ashaye, A; Baker, EL; Baker, WL; Coleman, CI; Kluger, J; Phung, OP; Scholle, JM; Talati, R; White, CM, 2012) |
| "Phenobarbital was associated with a higher rate of drug withdrawal although there was no evidence to suggest that phenobarbital caused more adverse events compared to carbamazepine, valproic acid or phenytoin." | 2.47 | Side effects of phenobarbital in epilepsy: a systematic review. ( Li, YP; Zeng, LN; Zhang, LL, 2011) |
| "Levetiracetam has a novel structure and unique mechanisms of action." | 2.47 | Spotlight on levetiracetam in epilepsy. ( Lyseng-Williamson, KA, 2011) |
| "Studies on mechanisms of seizure generation and propagation have identified new potential targets for AEDs." | 2.45 | New antiepileptic drugs: molecular targets. ( Mula, M, 2009) |
| " Measuring antiepileptic drug levels in body fluids (therapeutic drug monitoring) is frequently used to optimise drug dosage for individual patients." | 2.44 | Therapeutic monitoring of antiepileptic drugs for epilepsy. ( Dahl, ML; Kimland, E; Tomson, T, 2007) |
| "Phenytoin has been causally implicated in three human cancers: lymphoma, myeloma and neuroblastoma, the latter specifically in the setting of foetal hydantoin syndrome." | 2.43 | Cancer risk in people with epilepsy: the role of antiepileptic drugs. ( Driever, PH; Sander, JW; Singh, G, 2005) |
| "Carbamazepine is a widely used drug." | 2.43 | Carbamazepine-induced acute liver failure as part of the DRESS syndrome. ( Holt, AP; Mutimer, DJ; Naisbitt, DJ; Pirmohamed, M; Syn, WK, 2005) |
| "Oxcarbazepine is a newer AED that is indicated for use as monotherapy and adjunctive therapy in children (United States 4 years of age, Europe 6 years of age) with partial epilepsy." | 2.43 | Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience. ( Bourgeois, BF; D'Souza, J, 2005) |
| "Lamotrigine is a relatively new AED which is licensed in many countries for use as an initial monotherapy." | 2.43 | Lamotrigine versus carbamazepine monotherapy for epilepsy. ( Gamble, CL; Marson, AG; Williamson, PR, 2006) |
| " For drugs that are eliminated renally completely unchanged (gabapentin, pregabalin and vigabatrin) or mainly unchanged (levetiracetam and topiramate), the pharmacokinetic variability is less pronounced and more predictable." | 2.43 | Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed? ( Johannessen, SI; Tomson, T, 2006) |
| "Agents introduced for the treatment of epilepsy have also been usedsimultaneously for psychiatric indications." | 2.43 | [Anticonvulsants treatment of psychiatric disorder in elderly patients]. ( Bidzan, L, 2006) |
| "Neural tube defects (NTDs), including spina bifida and anencephaly, are common congenital malformations that occur when the neural tube fails to achieve proper closure during early embryogenesis." | 2.42 | Pathobiology and genetics of neural tube defects. ( Finnell, RH; Gould, A; Spiegelstein, O, 2003) |
| "Oxcarbazepine was generally well tolerated during monotherapy and adjunctive therapy; 2." | 2.42 | Oxcarbazepine: a review of its use in children with epilepsy. ( Bang, L; Goa, K, 2003) |
| "The pharmacokinetic properties of a drug are the primary deter-minant of the extent and duration of drug action, and influence susceptibility to clinically important drug interactions." | 2.42 | The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? ( Johannessen, SI; Perucca, E, 2003) |
| " Although few studies are available, extrapolations from research in young people and elderly patients without dementia provide several recommendations for the management of seizures in patients with dementia: exclude symptomatic causes of seizures before committing to antiepileptic drug therapy; treat after a first seizure if there is evidence of focal neurological involvement or a risk of recurrent seizures; use antiepileptic drugs with minimal cognitive adverse effects, such as carbamazepine, valproic acid, gabapentin and lamotrigine; and use the lowest possible dosage and monitor antiepileptic drug levels, where possible." | 2.42 | Seizures in elderly patients with dementia: epidemiology and management. ( Lim, G; Mendez, M, 2003) |
| " In recent years, several rating scales have been developed that focus on both common adverse effects and various aspects of HRQOL that are more relevant to this patient population." | 2.42 | Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial. ( Ficker, DM; Privitera, M, 2004) |
| "Although antiepileptic drugs (AEDs) are commonly used to control and prevent seizures, their long-term use carries a considerable risk of morbidity." | 2.41 | Antiepileptic drug therapy for adults: when to initiate and how to choose. ( Sirven, JI, 2002) |
| " The concepts of bioavailability and bioequivalence require further consideration." | 2.41 | Is generic prescribing acceptable in epilepsy? ( Besag, FM, 2000) |
| " However, on rare occasions, they can progress to more severe cutaneous disorders, including Stevens-Johnson syndrome and toxic epidermal necrolysis." | 2.41 | Therapeutic safety monitoring: what to look for and when to look for it. ( Harden, CL, 2000) |
| "Minimal requirements: seizure-prevention outcome given as fraction of cases; AED or control assigned by random or quasi-random mechanism." | 2.41 | Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. ( Temkin, NR, 2001) |
| " Rates of metabolism in children may be much faster than in nonelderly adults, requiring dosing adjustments to ensure enough medication is used to control seizures." | 2.41 | Treatment of epilepsy in 3 specialized populations. ( Leppik, IE, 2001) |
| "Oxcarbazepine also has approval for monotherapy in partial seizures." | 2.41 | Newer therapies in the drug treatment of epilepsy. ( Biederman, TS; McAuley, JW; Moore, JL; Smith, JC, 2002) |
| "Felbamate, however, has been linked with substantially increased incidence of aplastic anemia, and the other new AEDs have been studied for relatively short periods of time." | 2.40 | Pharmacologic and dietary therapies in epilepsy: conventional treatments and recent advances. ( Chapman, DP; Giles, WH, 1997) |
| " The first appears to involve a nonspecific manifestation of drug intoxication; seizure-worsening in this context is usually reversible by dosage reduction or elimination of unnecessary polypharmacy." | 2.40 | Antiepileptic drugs as a cause of worsening seizures. ( Avanzini, G; Dulac, O; Gram, L; Perucca, E, 1998) |
| "Carbamazepine is a major antiepileptic drug which is primarily used to treat epileptic patients suffering from partial seizures with or without secondary generalization, but which also has applications in those suffering from primary generalized tonic-clonic seizures." | 2.40 | Carbamazepine in the treatment of epilepsy in people with intellectual disability. ( Alvarez, N; Waisburg, H, 1998) |
| "Plasma concentrations of lamotrigine, an antiepileptic drug obtained in three adult controlled clinical trials conducted in the United States were pooled and analyzed using NONMEM, a population pharmacokinetic computer program, to facilitate development of dosing guidelines." | 2.40 | Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy. ( Chen, C; Cox, E; Fiedler-Kelly, J; Grasela, TH; Risner, ME; Womble, GP, 1999) |
| " Because dosing is often modest, cost should rarely be the overriding factor in choosing a drug for a patient with newly diagnosed epilepsy in the developed world." | 2.40 | Monostars: an aid to choosing an antiepileptic drug as monotherapy. ( Brodie, MJ, 1999) |
| "Oxcarbazepine (OXC) was developed to provide a compound chemically similar enough to CBZ to mimic its efficacy and overall safety while improving its side-effect profile." | 2.40 | Oxcarbazepine. ( Tecoma, ES, 1999) |
| "Epilepsy is one of the most common neurological disorders." | 2.39 | Newer antiepileptic drugs. Towards an improved risk-benefit ratio. ( Patsalos, PN; Sander, JW, 1994) |
| "Oxcarbazepine (OCBZ) is a keto homologue of carbamazepine (CBZ) with a completely different metabolic profile." | 2.39 | Oxcarbazepine: pharmacokinetic interactions and their clinical relevance. ( Albani, F; Baruzzi, A; Riva, R, 1994) |
| "Once epilepsy is diagnosed, long-term treatment with AEDs is recommended, beginning with monotherapy." | 2.39 | Standard approach to antiepileptic drug treatment in the United States. ( Pellock, JM, 1994) |
| " TPM was added to the baseline antiepileptic drug (AED) at a dosage of up to 800 mg/day, after which the baseline drug was discontinued, when possible." | 2.39 | Drug interaction profile of topiramate. ( Bourgeois, BF, 1996) |
| "Antiepileptic drugs (AEDs) in broad use today have a number of pharmacokinetic liabilities, including a propensity for clinically meaningful drug interactions." | 2.39 | Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs. ( Perucca, E, 1996) |
| "We also present an overview of the psychiatric disorders in which carbamazepine has been found, or suggested, to be efficacious." | 2.39 | Carbamazepine clinical pharmacology: a review. ( Albani, F; Baruzzi, A; Riva, R, 1995) |
| " Adverse effects of antiepileptic treatment may affect the patient's quality of life to an even greater extent than the occurrence of seizures." | 2.39 | Adverse effects of established and new antiepileptic drugs: an attempted comparison. ( Gram, L; Rogvi-Hansen, B, 1995) |
| " However, the pharmacokinetic properties of an AED determine its ease of use, i." | 2.39 | Important pharmacokinetic properties of antiepileptic drugs. ( Bourgeois, BF, 1995) |
| " A drug concentration, however, can only be regarded as a guide around which to alter the dosage according to the patient's clinical condition." | 2.39 | Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring. ( Yukawa, E, 1996) |
| "This article surveys the pharmacokinetic parameters for the new antiepileptic drugs (AEDs): felbamate, gabapentin, lamotrigine, oxcarbazepine, tiagabine, topiramate, and vigabatrin." | 2.39 | Pharmacokinetics of new antiepileptic drugs. ( Gram, L, 1996) |
| "Vigabatrin is an irreversible inhibitor of GABA transaminase." | 2.39 | [Antiepileptic drugs: mechanism of action]. ( Mercadé Cerdá, JM, 1996) |
| " Specific indications and dosage schedules have been provided." | 2.39 | New antiepileptic drugs. ( Brodie, MJ; Wilson, EA, 1996) |
| "Epilepsy is a disorder of the central nervous system in which the clinical symptoms are recurrent seizures." | 2.38 | Advances in pharmacotherapy: recent developments in the treatment of epilepsy. ( Graves, NM; Leppik, IE, 1993) |
| " The usual phenytoin (PHT) dosage in adults is 4-6 mg/kg per day, but children may need a dosage three to five times higher." | 2.38 | Metabolism of antiepileptic medication: newborn to elderly. ( Leppik, IE, 1992) |
| "Epilepsy is a chronic disease that requires long term therapy, and most of the established antiepileptic drugs (the exception is phenobarbital) must be administered several times daily." | 2.38 | Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications. ( Bialer, M, 1992) |
| "Rare, serious adverse effects of antiepileptic drugs (AEDs) include hepatotoxicity and bone marrow suppression." | 2.38 | Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy. ( Wyllie, E; Wyllie, R, 1991) |
| " In order to use these effectively, the critical care nurse must be aware of the indications and controversies surrounding their use, the patho-physiologic conditions that impact on the disposition, and appropriate dosing and monitoring of these agents in the critical care setting." | 2.38 | Anticonvulsants: pharmacotherapeutic issues in the critically ill patient. ( Dupuis, RE; Miranda-Massari, J, 1991) |
| " The findings of this study are comparable with those of other series assessing carbamazepine-associated adverse reactions in children and adults." | 2.37 | Carbamazepine side effects in children and adults. ( Pellock, JM, 1987) |
| " Drug-drug interactions with carbamazepine include several types." | 2.37 | Clinically significant carbamazepine drug interactions: an overview. ( Pippenger, CE, 1987) |
| " New antiepileptic drugs have improved medical management, and technical and theoretical advances in pharmacokinetics have permitted physicians to design balanced dosing for individual patients." | 2.36 | Recent developments in the diagnosis and therapy of epilepsy. ( Crandall, PH; Engel, J; Sterman, MB; Troupin, AS; Wasterlain, CG, 1982) |
| " Using this fact we aimed to develop an MHD population pharmacokinetic (PPK) model in Chinese adult epileptic patients to facilitate the clinical implementation of model-guided individualised drug therapy." | 1.91 | Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients. ( Dai, H; Hu, Y; Li, X; Yang, Q; Zhang, X, 2023) |
| "Perampanel (PER) is an oral antiepileptic drug and its concomitant use with carbamazepine (CBZ) leads to decreased PER concentrations." | 1.91 | Population Pharmacokinetic Analysis of Drug-Drug Interactions Between Perampanel and Carbamazepine Using Enzyme Induction Model in Epileptic Patients. ( Fujita, Y; Hirota, T; Ieiri, I; Matsunaga, N; Murai, M; Muraki, S; Suetsugu, K; Tsuchiya, Y, 2023) |
| "Carbamazepine (CBZ) is an anticonvulsant characterized by poor water solubility, nanonization can improve its bioavailability." | 1.91 | Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development. ( Bonaccorso, A; Di Martino, P; Gigliobianco, MR; Lombardo, R; Mancuso, A; Musumeci, T; Pellitteri, R, 2023) |
| "97%), switching to or adjusting carbamazepine dosage (27." | 1.91 | The impact of a newly established specialized pediatric epilepsy center in Tanzania: An observational study. ( Aricò, M; Di Noia, SP; Kalolo, A; Mabusi, MS; Mastrangelo, M; Pisani, F, 2023) |
| "Seizure relapses are the leading cause of admission to emergency rooms (ER) in people with epilepsy." | 1.72 | Factors involved in time reduction between seizure relapses in patients with epilepsy attending emergency rooms in Medellín, Colombia. ( Bernal Cobo, R; Giraldo Castrillón, YM; Giraldo Tapias, LM; Gómez Escobar, T; Rojas-Gualdrón, DF; Rueda Cárdenas, LF; Vásquez Trespalacios, EM; Zapata Berruecos, JF, 2022) |
| "Treatment with carbamazepine was initiated." | 1.72 | A woman in her sixties with epilepsy and syncope. ( Engelsen, BA; Gradek, G; Midelfart-Hoff, J; Wendelbo, Ø, 2022) |
| "Menthol is a natural compound that evokes cold sensations by activating TRPM8 channels in peripheral sensory receptors." | 1.72 | Menthol exerts TRPM8-independent antiepileptic effects in prefrontal cortex pyramidal neurons. ( Spyrka, A; Szulczyk, B, 2022) |
| "We hypothesized that poor seizure control is associated with new-onset MHC diagnoses and/or new prescription drugs for MHCs." | 1.72 | Incidence of mental health conditions by seizure control among adults with epilepsy in the United States. ( Ferrari, L; Hauser, WA; Schabert, VF; Stern, S; Wade, CT; Willke, RJ, 2022) |
| " VPA showed a relatively short half-life in both mice and rats, which correlated with a sharp decline in efficacy." | 1.72 | Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach. ( Johnson, K; Mensah, JA; Metcalf, CS; Reilly, CA; Rower, JE; Wilcox, KS, 2022) |
| "When selecting an antiseizure medication, consideration should be given to the individual patient's risks of adverse consequences on other organ systems." | 1.72 | Long-Term Effects of Antiseizure Medications. ( LoPinto-Khoury, C, 2022) |
| "The association between autism spectrum disorders (ASD) and epilepsy has been extensively documented, and the estimated prevalence varies depending upon the selected population and the clinical characteristics." | 1.72 | Autism with Epilepsy: A Neuropsychopharmacology Update. ( Canitano, R; Palumbi, R; Scandurra, V, 2022) |
| "Lacosamide (LCM) is a third-generation antiepileptic drug (AED) that affects sodium channel inactivation." | 1.72 | Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting. ( Eguchi, Y; Ishikawa, N; Izumo, H; Kobayashi, Y; Okada, S; Tateishi, Y, 2022) |
| "Since arrhythmia often accompanies seizures, patients suffering from epilepsy are frequently co-treated with antiepileptic and antiarrhythmic drugs." | 1.72 | Ranolazine Interacts Antagonistically with Some Classical Antiepileptic Drugs-An Isobolographic Analysis. ( Banach, M; Borowicz-Reutt, K, 2022) |
| "Epilepsy is the most common childhood neurological disorder in Nigeria." | 1.62 | Serum folate levels in children on long-term anti-seizure medication in a Nigerian tertiary center-Implications for practice and public health. ( Aronu, AE; Bisi-Onyemaechi, AI; Chikani, UN; Ojinnaka, NC; Uwaezuoke, NA, 2021) |
| "Epilepsy is a common chronic neurological condition characterized by recurrent seizures." | 1.62 | ( Miyata-Nozaka, Y; Omar, H; Raymond, AA; Tan, HJ; Wong, SW; Zain, SM, 2021) |
| "Carbamazepine can cause hypersensitivity reactions in ~10% of patients." | 1.62 | Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. ( Carr, DF; Maggs, JL; Marson, AG; Meng, X; Park, BK; Pertinez, H; Pirmohamed, M; Yip, VLM, 2021) |
| "Drug-resistant epilepsy is a problem worldwide." | 1.62 | Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients. ( Kong, FC; Lang, LQ; Ma, CL; Zhong, MK, 2021) |
| "Carbamazepine was associated with a decreased cancer risk (OR Model I: 0." | 1.62 | Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients. ( Hamer, HM; Kostev, K; Lang, JD; Mueller, TM; Reindl, C; Stritzelberger, J; Westermayer, V, 2021) |
| "This study aimed to develop a pharmacokinetic (PK) model of oxcarbazepine (OXC) and analyse the relationship between monohydroxylated derivative (MHD), an active metabolite of OXC, and the adverse events of OXC." | 1.62 | Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy. ( Chu, K; Jang, IJ; Jang, Y; Kim, TJ; Lee, S; Lee, SK; Yoon, S; Yu, KS, 2021) |
| "Epilepsy is the third most frequent neurological disorder in aged patients after stroke and dementia." | 1.62 | [Epilepsy in the aged : Challenges in diagnostics and treatment]. ( Rohracher, A; Trinka, E, 2021) |
| "The antiseizure drug, carbamazepine (CBZ), and the antiabsence drug, ethosuximide (ETX), were administered separately to determine if they selectively suppressed unilateral- versus bilateral-onset SWDs, respectively." | 1.62 | Sensitivity of unilateral- versus bilateral-onset spike-wave discharges to ethosuximide and carbamazepine in the fluid percussion injury rat model of traumatic brain injury. ( Barth, DS; Dudek, FE; Poulsen, DJ; Smith, ZZ; Tatum, S; Taylor, JA, 2021) |
| "Carbamazepine (CBZ) is an anticonvulsant drug that usually is used for the treatment of seizures." | 1.62 | Exercise Improved the Anti-Epileptic Effect of Carbamazepine through GABA Enhancement in Epileptic Rats. ( Barzroodi Pour, M; Bayat, M; Karimzadeh, F; Navazesh, A; Soleimani, M, 2021) |
| "Carbamazepine was the second most common drug followed by lamotrigine and valproic acid." | 1.62 | Post-stroke epilepsy and antiepileptic drug use in men and women. ( Linnér, L; Loikas, D; Sundström, A; von Euler, M; Wettermark, B, 2021) |
| " Similar dose-related responses were seen following the week-long dosing protocol for carbamazepine, phenobarbital, and phenytoin, and these responses were associated with drug levels that were in the human therapeutic range." | 1.62 | Chronic limbic epilepsy models for therapy discovery: Protocols to improve efficiency. ( Bertram, EH; Edelbroek, P, 2021) |
| "The present study aims to evaluate the efficacy of selenium (Se) alone or combined with carbamazepine (CBZ) against the adverse effects induced by the chemoconvulsant pentylenetetrazole (PTZ) in the cortex of adult male rats." | 1.56 | Electrophysiological and Neurochemical Assessment of Selenium Alone or Combined with Carbamazepine in an Animal Model of Epilepsy. ( Aboul Ezz, HS; Ali, MA; Mohammed, HS; Zedan, A, 2020) |
| "Levetiracetam was the only antiseizure medication that led to slight improvements in executive functioning; whereas carbamazepine led to deteriorations in cognitive functioning." | 1.56 | Effects on executive functions of antiepileptic monotherapy in pediatric age. ( Carotenuto, M; di Bonaventura, C; Marotta, R; Mazza, R; Operto, FF; Pastorino, GMG; Roccella, M; Verrotti, A, 2020) |
| "Nodding syndrome is a highly debilitating, generalized seizure disorder, affecting children in subregions of sub-Saharan Africa." | 1.56 | Dried Blood Microsampling-Based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children With Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo. ( Colebunders, R; Delahaye, L; Hotterbeekx, A; Idro, R; Mandro, M; Ogwang, R; Stove, CP; Velghe, S, 2020) |
| "Five groups of each of 12 female rats were orally dosed daily for 8 weeks with either carbamazepine (CBZ) (60 mg/kg), eslicarbazepine (ESL) (80 mg/kg), valproic acid (VPA) (300 mg/kg), levetiracetam (LEV) (50 mg/kg) or saline (control (CTL))." | 1.56 | Effects of carbamazepine, eslicarbazepine, valproic acid and levetiracetam on bone microarchitecture in rats. ( Andersen, NB; Diemar, SS; Ding, M; Eiken, P; Ellegaard, M; Jørgensen, NR; Sejling, AS, 2020) |
| "Carbamazepine was ineffective, and seizures were exacerbated with levetiracetam (LEV)." | 1.56 | Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome. ( Goji, A; Kagami, S; Mori, T; Tayama, T; Toda, Y, 2020) |
| " This study was to investigate the herb-drug interactions of GR and CBZ, an AED, through pharmacokinetic approach in rats." | 1.56 | Herb-drug interaction of gastrodiae rhizoma on carbamazepine: A pharmacokinetic study in rats. ( Chook, P; Koon, CM; Leung, H; Leung, PC; Leung, TWH; Mok, VCT; Schachter, S; Yip, KL; Zhou, X, 2020) |
| "Epilepsy is very difficult to treat and often involves the combination of two or more AEDs." | 1.56 | Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database. ( Hayashi, T; Noguchi, Y; Tachi, T; Takaoka, M; Teramachi, H, 2020) |
| "Metabolic syndrome was more frequent in patients with epilepsy compared with healthy participants (32." | 1.56 | Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy. ( Ataklı, D; Balçık, ZE; Baslo, SA; Öztürk, O; Söylemez, E, 2020) |
| "Levetiracetam has replaced sodium valproate as the most frequently prescribed ASM in pediatric patients." | 1.56 | Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018. ( Dai, H; Feng, J; Yu, L; Yu, Z, 2020) |
| "Lacosamide is a novel anticonvulsant that acts by enhancing sodium channel slow inactivation." | 1.56 | Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range. ( Araki, Y; Fukushima, Y; Imai, K; Kagawa, Y; Takahashi, Y; Terada, K; Yamamoto, Y, 2020) |
| "Eight years after the index seizure, 31 % of the children were on AEDs, and this was more common among children with any of the comorbidities studied (OR; 4." | 1.56 | Childhood-onset seizures: A long-term cohort study of use of antiepileptic drugs, and drugs for neuropsychiatric conditions. ( Åmark, P; Åndell, E; Carlsson, S; Pihlström, N; Tedroff, K; Tomson, T, 2020) |
| "To study the risk of intellectual disability and delayed development in childhood milestones among children of women who used valproate or other AEDs during pregnancy." | 1.56 | Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones. ( Christensen, J; Daugaard, CA; Dreier, JW; Pedersen, L; Sun, Y, 2020) |
| "Children with Congenital Zika Syndrome and microcephaly are at high risk for epilepsy; however, the risk is unclear in normocephalic children with prenatal Zika virus (ZIKV) exposure [Exposed Children (EC)]." | 1.56 | Epilepsy surveillance in normocephalic children with and without prenatal Zika virus exposure. ( Abdel Baki, S; Blackmon, K; Burgen, KS; Chari, G; Cudjoe, N; Dlugos, D; Donald, T; Evans, R; Grossi-Soyster, EN; Jayatilake, P; Krystosik, AR; LaBeaud, AD; Landon, B; Macpherson, C; Noël, T; Oyegunle, V; Patel, AA; Pedraza, O; Thesen, T; Waechter, R, 2020) |
| "22) with evidence of a dose-response relationship for carbamazepine." | 1.56 | Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study. ( Kristensen, KB; Pedersen, SA; Pottegård, A; Schmidt, SAJ, 2020) |
| "Epilepsy was present in 29." | 1.51 | [Epilepsy in children with congenital hemiparesis secondary to perinatal ictus]. ( Alonso, X; Campistol, J; Escofet, C; Fons, C; Macaya, A; Revilla Orías, MD, 2019) |
| "Severe hyponatremia was defined as a serum sodium level < 130 mEq/L." | 1.51 | Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study. ( Imai, K; Inoue, Y; Kagawa, Y; Ohta, A; Takahashi, Y; Yamamoto, Y, 2019) |
| "Oxcarbazepine (OXC) is an antiepileptic drug metabolised to active 10-monohydroxy derivative (MHD) following oral administration." | 1.51 | Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens. ( Jiao, Z; Li, XW; Lin, WW; Lin, XH; Rao, X; Wang, CL; Zeng, DY; Zhang, J, 2019) |
| "Almost all seizure durations were >20 seconds." | 1.51 | Effect of carbamazepine on spontaneous recurrent seizures recorded from the dentate gyrus in rats with kainate-induced epilepsy. ( Dudek, FE; Grabenstatter, HL, 2019) |
| " The MHD plasma concentration was detected by high-performance liquid chromatography and then standardized through dosage and body weight." | 1.51 | Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms. ( Chen, X; Fang, S; Gong, Z; Ma, H; Qian, L; Wei, J; Xu, Z; Yan, Y; Yang, X; Zeng, S, 2019) |
| "Epigenetics underlying refractory epilepsy is poorly understood." | 1.51 | Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. ( Cui, L; Lv, Y; Shi, M; Wang, Z; Zheng, X, 2019) |
| "Epilepsy is a common worldwide neurological disorder." | 1.51 | Self-reported attitudes about medication in Lebanese people with epilepsy. ( Al-Hajje, A; Boumediene, F; Jost, J; Mroueh, L; Preux, PM; Ratsimbazafy, V; Salameh, P, 2019) |
| "Levetiracetam was the most frequently prescribed AED (62/124, 50%)." | 1.48 | Safety of antiepileptic drugs in children and young people: A prospective cohort study. ( Choonara, I; Egunsola, O; Sammons, HM; Whitehouse, WP, 2018) |
| "Usually, no adverse effects are observed in breastfed infants whose mothers are treated with the anti-epileptic carbamazepine." | 1.48 | Maternal Carbamazepine Therapy and Unusual Adverse Effects in a Breastfed Infant. ( Antonucci, R; Cherchi, C; Cuzzolin, L; Locci, C; Manconi, A; Oggiano, AM, 2018) |
| "Carbamazepine was the most chosen antiepileptic drug for secondary prophylaxis, followed by valproate acid, and levetiracetam." | 1.48 | [A nationwide multi-center questionnaire survey on the management and treatment of post-stroke seizure and epilepsy in Japan]. ( Abe, S; Fukuma, K; Higashida, K; Ihara, M; Nagatsuka, K; Okuno, Y; Tanaka, T; Tomari, S; Toyoda, K; Yamagami, H, 2018) |
| "Carbamazepine was the most commonly used first AED, with a retention rate of 52%." | 1.48 | Treatment of epilepsy in multiple sclerosis. ( Burman, J; Dagiasi, I; Kumlien, E; Vall, V; Zelano, J, 2018) |
| "Evidence for the comparative teratogenic risk of antiepileptic drugs is insufficient, particularly in relation to the dosage used." | 1.48 | Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. ( Battino, D; Bonizzoni, E; Craig, J; Lindhout, D; Perucca, E; Sabers, A; Thomas, SV; Tomson, T; Vajda, F, 2018) |
| "Psychiatric disorders are more common in patients with epilepsy than in the general population." | 1.48 | Psychiatric comedication in patients with epilepsy. ( Bosak, M; Cyranka, K; Dudek, D; Kowalik, M; Mołek, P; Słowik, A, 2018) |
| "Some comorbidities [e." | 1.48 | A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities. ( Balzer, N; Domingo-Fernández, D; Güldenpfennig, A; Hofmann-Apitius, M; Hoyt, CT, 2018) |
| "Carbamazepine (CBZ) is a widely used antiepileptic drug with large interindividual variability in serum concentrations." | 1.48 | Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients. ( Huang, YT; Lu, Q; Qu, J; Qu, Q; Shu, Y; Xiang, DX; Xu, P, 2018) |
| " Inclusion criteria included residency in a nursing home for at least 2 months, age 65 years or older, a stable dosing regimen of CBZ for at least 4 weeks (considered steady state), available CBZ concentration, and complete information regarding all co-medications." | 1.48 | Iron supplements in nursing home patients associated with reduced carbamazepine absorption. ( Ahn, JE; Bathena, SPR; Birnbaum, AK; Brundage, RC; Conway, JM; Leppik, IE, 2018) |
| " Taking into consideration that GSH conjugation is, in general, a detoxification pathway, these results suggest that under hyperoxia/oxidative stress conditions the bioavailability of the parent drug may be compromised." | 1.48 | The first-line antiepileptic drug carbamazepine: Reaction with biologically relevant free radicals. ( Antunes, AMM; Charneira, C; Marques, MM; Martins, IL; Morello, J; Nunes, J; Pereira, SA; Telo, JP, 2018) |
| "LEV provides similar seizure control to that of the older AEDs, and it is more effective and better than LTG." | 1.48 | Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine. ( Escartin Siquier, A; Forcadas Berdusan, M; Martin Moro, M; Martinez Ferri, M; Peña Mayor, P; Perez López-Fraile, I, 2018) |
| "Carbamazepine (CBZ) is a commonly used anti-epileptic in rural hospitals in India." | 1.46 | Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings. ( Alexander, M; Das, S; Fleming, DH; Mathew, BS; Prabhakar, AT; Winston A, B, 2017) |
| " This study compared adverse event (AE) reporting rates for brand vs." | 1.46 | Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS). ( Alatawi, Y; Berg, RL; Cheng, N; Hansen, RA; Page, D; Peissig, PL; Plotkina, AV; Qian, J; Rahman, MM, 2017) |
| "Oxcarbazepine is an antiepileptic drug with an activity mostly due to its monohydroxy derivative metabolite (MHD)." | 1.46 | Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children. ( Chiron, C; Comets, E; Dulac, O; Jullien, V; Pons, G; Rey, E; Rodrigues, C, 2017) |
| "Epilepsy is a spectrum of neurological disorders with many causal factors." | 1.46 | Inhibitory synapse deficits caused by familial α1 GABA ( Chen, X; Durisic, N; Keramidas, A; Lynch, JW, 2017) |
| "Epilepsy is one of the most common neurological diseases in childhood and adolescence." | 1.46 | Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children. ( Hadzagic-Catibusic, F; Hasanbegovic, E; Melunovic, M; Uzicanin, S; Zubcevic, S, 2017) |
| "Catamenial epilepsy is defined as an increase in the frequency of seizures during a particular phase of the menstrual cycle." | 1.46 | Catamenial Epilepsy: The Menstrual Cycle as a Clue to Predict Future Refractory Seizures. ( Khishfe, BF, 2017) |
| "The number of seizure-free patients in the last 4 weeks was overall CBZ/VPA/LTG/LEV=60%/79%/67%/67%, for generalized epilepsy was CBZ/VPA/LTG/LEV=67%/89%/65%/94%, and for localization-related epilepsy was CBZ/VPA/LTG/LEV=59%/71%/67%/57%." | 1.46 | Efficacy and tolerability of anti-epileptic drugs-an internet study. ( Baker, G; Wieshmann, UC, 2017) |
| "Antiepileptic drugs do cause adverse effects, affecting patients' quality of life, adherence and seizures." | 1.46 | Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications. ( Danesi, M; Fadare, J; Godman, B; Ogunleye, O; Olusanya, A, 2017) |
| "Valproic acid (VPA) was the most prescribed single therapy in young patients (<15years), whereas carbamazepine (CBZ) was preferred by clinicians in older patients." | 1.46 | Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome. ( Canevini, MP; La Briola, F; Nowbut, MS; Peron, A; Savini, MN; Turner, K; Vignoli, A, 2017) |
| " This improvement is more pronounced if the OXC-related AEs are most evident following morning dosing of OXC." | 1.46 | Transition from oxcarbazepine to eslicarbazepine acetate: A single center study. ( Mäkinen, J; Peltola, J; Rainesalo, S, 2017) |
| "Levetiracetam was independently associated with anger/aggression, nervousness/agitation, upset stomach, depression, and sleep disturbance; lamotrigine with nervousness/agitation, upset stomach, and difficulty concentrating; and valproic acid with upset stomach and shaky hands." | 1.43 | Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study. ( Fidzinski, P; Gaus, V; Holtkamp, M; Kowski, AB; Losch, F; Weissinger, F, 2016) |
| " For pharmacokinetic analysis, NONMEM software with implementation of ADVAN 1 subroutine was used." | 1.43 | CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy. ( Djordjevic, N; Jakovljevic, M; Jankovic, S; Milovanovic, D; Milovanovic, DD; Milovanovic, JR; Obradovic, S; Radosavljevic, I; Radovanovic, M, 2016) |
| "Oxcarbazepine (OXC) is a widely used antiepileptic drug for the treatment of partial seizures that was developed through structural variation of carbamazepine." | 1.43 | HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption. ( Byun, JI; Chu, K; Jang, IJ; Jeon, D; Jung, KH; Jung, KY; Kim, TJ; Lee, SK; Lee, ST; Lim, JA; Moon, J; Park, KI; Sunwoo, JS; Yu, KS, 2016) |
| " The dosage of PB was ranked first followed by that of CBZ and finally by the VPA." | 1.43 | [Therapeutic drug monitoring of three antiepileptic drugs - Back on twenty years of experience]. ( Badrane, N; Bencheikh, RS; Moussa, LA; Ouammi, L; Serragui, S; Tanani, DS; Zalagh, F, 2016) |
| "Carbamazepine-treated patients showed mean serum thyroid hormone levels significantly lower than baseline evaluation and the control group." | 1.42 | Evaluation of thyroid hormones in children receiving carbamazepine or valproate: a prospective study. ( Arapoglu, M; Dalgıç, N; Kafadar, İ; Kılıç, BA; Yalçın, K, 2015) |
| " Our data suggest that valproate has adverse effects on renal tubular functions." | 1.42 | Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy? ( Buyan, N; Demir, E; Gücüyener, K; Gülbahar, Ö; Gürkaş, E; Havali, C; Serdaroğlu, A; Yılmaz, Ü, 2015) |
| "The present study aimed to establish population pharmacokinetic model for phenobarbital (PB), examining and quantifying the magnitude of PB interactions with other antiepileptic drugs concomitantly used and to demonstrate its use for individualization of PB dosing regimen in adult epileptic patients." | 1.42 | Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients. ( Golubović, B; Jovanović, M; Kovačević, SV; Martinović, Ž; Miljković, B; Prostran, M; Vučićević, K, 2015) |
| "Valproic acid (VPA) follows a non-linear pharmacokinetic profile in terms of protein-binding saturation." | 1.42 | A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation. ( Ding, J; Jiao, Z; Li, X; Lin, W; Miao, L; Wang, C; Wang, Y; Zhao, L; Zhao, Z, 2015) |
| "Carbamazepine was started without clinical response despite high plasmatic level." | 1.42 | Cardiac asystoles misdiagnosed as epileptic seizures. ( Canevini, MP; Chiesa, V; Vignoli, A, 2015) |
| "Epilepsy is common in individuals with autism spectrum disorder (ASD) and intellectual disabilities (ID)." | 1.42 | Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities. ( Katz, N; Moses, L; Weizman, A, 2015) |
| "Patients who began treatment or whose treatment for dyslipidemia was modified during the study period were excluded from the analysis." | 1.42 | Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests. ( Jiménez-Conde, J; Ley, M; Principe, A; Rocamora, R, 2015) |
| " Furthermore, two interactions between these genes were associated with the lnCDR and the maintenance dosage of CBZ, respectively." | 1.42 | Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy. ( Hong, Z; Jiao, Z; Ma, CL; Wu, XY; Wu, ZY; Zhong, MK, 2015) |
| "To evaluate the relationship between serum concentrations of mono-hydroxy-carbazepine (MHD), the main metabolite of oxcarbazepine (OXC), and the occurrence of adverse effects (AE) in a large group of patients on OXC monotherapy." | 1.42 | Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy. ( May, TW; Sattler, A; Schaefer, M, 2015) |
| "Oxcarbazepine was most widely used, followed by valproic acid." | 1.42 | Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012. ( Ah, YM; Cho, YS; Jung, AH; Kim, KJ; Lee, JY, 2015) |
| " Patients were on stable TPM dosing regimen for at least 7 days; therefore, steady-state was assumed." | 1.42 | Application of Counter-propagation Artificial Neural Networks in Prediction of Topiramate Concentration in Patients with Epilepsy. ( Erić, S; Grabnar, I; Jovanović, M; Kuzmanovski, I; Miljković, B; Prostran, M; Sokić, D; Vovk, T; Vučićević, K, 2015) |
| "To establish using dried blood spot (DBS) as a surrogate to plasma for therapeutic drug monitoring (TDM) of carbamazepine (CBZ), we compared the population pharmacokinetic (PPK) estimates from concurrent DBS and plasma levels." | 1.40 | Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication. ( Chan, E; Ho, PC; Kong, ST; Lim, SH, 2014) |
| "Oxcarbazepine (OXC) is an effective anticonvulsant used for treatment of partial and secondarily generalized seizures." | 1.40 | Use of oxcarbazepine for treatment of refractory status epilepticus. ( Berning, S; Kellinghaus, C; Stögbauer, F, 2014) |
| "CNS inflammation is characterized by a disturbance of glial cell functions." | 1.40 | Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation. ( Dambach, H; Faustmann, PM; Haase, CG; Hinkerohe, D; Hufnagel, A; Moinfar, Z; Prochnow, N; Stienen, MN, 2014) |
| "For patients with mental retardation or developmental delay, 25(OH)D3 levels were lower than the levels in patients with normal intelligence quotient levels (p=0." | 1.40 | Vitamin D levels in children and adolescents with antiepileptic drug treatment. ( Baek, JH; Eun, BL; Kim, GH; Kim, MK; Seo, YH, 2014) |
| "She was seizure-free after the surgery." | 1.40 | Peri-ictal headache due to epileptiform activity in a disconnected hemisphere. ( Delalande, O; Dvorak, J; Jahodova, A; Komarek, V; Kršek, P; Kyncl, M; Tichy, M; Vydrova, R, 2014) |
| "The four classic categories of paroxysmal dyskinesias are kinesigenic, nonkinesigenic, exercise-induced and hypnogenic." | 1.40 | A rare paroxysmal movement disorder: mixed type of paroxysmal dyskinesia. ( Arpaci, B; Atakli, D; Guresci, B; Sen, A, 2014) |
| "Early treatment of epilepsy is warranted to avoid possible severe consequences." | 1.39 | Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle. ( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013) |
| " Age was a significant factor contributing to pharmacokinetic variability in individuals using LTG, OXC, and CBZ with increasing clearance as a function of bioavailability (Cl/F) over age 18, a maximum Cl/F at 33years (CBZ) and 36 years (LTG and OXC), and a gradual decrease of Cl/F towards older age." | 1.39 | The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study. ( Lindhout, D; Sander, JW; Wegner, I; Wilhelm, AJ, 2013) |
| " The mean dosage of AED for valproate was 498 mg/day and carbamazepine was 555 mg/day." | 1.39 | Malformation in index pregnancy in women with epilepsy is not followed by recurrence in subsequent pregnancy. ( Begum, S; Sarma, SP; Thomas, SV, 2013) |
| "Carbamazepine use was associated with a nearly 10-fold increase in severe cutaneous drug reactions in Korean elderly patients." | 1.39 | Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study. ( Choi, NK; Jung, SY; Kim, JY; Ko, YJ; Lee, J; Park, BJ; Shin, JY, 2013) |
| " In addition, there appeared to be a dose-response relationship between stroke risk and PHT prescriptions." | 1.39 | Comparative stroke risk of antiepileptic drugs in patients with epilepsy. ( Hsieh, CY; Lai, EC; Lin, SJ; Yang, YH, 2013) |
| "Carbamazepine levels were measured at 6 months." | 1.39 | Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy. ( Aggarwal, A; Chillar, N; Faridi, MM; Kumar, V; Mittal, H; Sharma, S, 2013) |
| " Forty adult patients were studied and oxcarbazepine was administered orally at a single loading dosage of 30 mg/kg." | 1.38 | Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy. ( Cho, JY; Chu, K; Gu, N; Jang, IJ; Kim, DW; Kim, HS; Lee, SK; Oh, J; Yoon, SH; Yu, KS, 2012) |
| "Carbamazepine (CBZ) is an antiepileptic orally administered drug, but due to its low solubility in water, its gastrointestinal absorption is slow and irregular, leading to delayed brain uptake with consequent peripheral side actions." | 1.38 | Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa. ( Hanan, R; Kamal, el T; Samia, O, 2012) |
| "ADMS rats dominantly exhibited myokymia, neuromyotonia and generalized tonic-clonic seizures." | 1.38 | Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures. ( Baulac, S; Ishida, S; Kaneko, S; Kuwamura, M; Mashimo, T; Nishio, T; Ohno, Y; Sakamoto, Y; Serikawa, T; Takizawa, A, 2012) |
| "Carbamazepine is a widely prescribed antiepileptic drug." | 1.38 | Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex. ( Birnbaum, AK; Brundage, RC; Cloyd, JC; Conway, JM; Gross, CR; Leppik, IE; Marino, SE; Mishra, U; Musib, LC; Pennell, PB; Ramsay, RE; Rarick, JO; White, JR, 2012) |
| "Quinolinic acid was not detected in the brain of patients who received antiepileptic drugs other than carbamazepine prior to surgery or in brain endothelial cultures obtained from a control patient." | 1.38 | A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain. ( Alexopoulos, AV; Ghosh, C; Gonzalez-Martinez, J; Hossain, M; Janigro, D; Marchi, N; Rasmussen, P; Yang, H, 2012) |
| "Phenytoin was used in 56 patients (22%) with the majority (n= 43) receiving intravenous phenytoin." | 1.38 | Seizure management at Auckland City Hospital Emergency Department between July and December 2009: time for a change? ( Bergin, P; Jones, P; Rosemergy, I; Walker, E, 2012) |
| "This paper describes the determination of carbamazepine (CBZ) in human plasma using ion chromatography combined with online electrochemical derivatization and fluorescence detection." | 1.38 | Ion chromatography combined with online electrochemical derivatization and fluorescence detection for the determination of carbamazepine in human plasma. ( Chen, D; Li, L; Subhani, Q; Wu, S; Xu, W; Yang, B; Zhu, Y, 2012) |
| "Phenobarbital has been in clinical use as an antiepileptic drug (AED) since 1912." | 1.38 | How did phenobarbital's chemical structure affect the development of subsequent antiepileptic drugs (AEDs)? ( Bialer, M, 2012) |
| "For unclassified epileptic seizures, no significant differences were found among the three AEDs." | 1.37 | Retrospective analysis of the effectiveness of first-line antiepileptic drugs for generalized onset and unclassified epileptic seizures in Chinese children. ( Ding, CH; Ding, YX; Fang, F; Ma, MS; Meng, LL; Wang, Y; Zou, LP, 2011) |
| "Eslicarbazepine acetate (ESL) was labelled for add-on treatment of adults with focal epilepsies in 2009." | 1.37 | [Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate]. ( Steinhoff, BJ; Trinka, E; Wendling, AS, 2011) |
| "Pretreatment with levetiracetam failed to exert any antiepileptogenic effect." | 1.37 | Protein kinase inhibitor as a potential candidate for epilepsy treatment. ( Gajda, Z; Horváth, Z; Kéri, G; Orfi, L; Szántai-Kis, C; Szente, M; Török, R, 2011) |
| "Approximately one third of newly treated epilepsy patients do not respond to antiepileptic drugs (AEDs)." | 1.37 | Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy. ( Haerian, BS; Lim, KS; Mohamed, EH; Mohamed, Z; Raymond, AA; Tan, CT; Tan, HJ; Wong, CP; Wong, SW, 2011) |
| "Curcumin was co-administered with sub-therapeutic dose of valproate 60min before PTZ injection." | 1.37 | Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. ( Gupta, YK; Mehla, J; Pahuja, M; Reeta, KH, 2011) |
| "Valproic acid (VPA) is an anticonvulsant and mood-stabilizing drug for the long-term treatment." | 1.37 | Valproic Acid related metabolic syndrome in patients with epilepsy. ( Kasradze, S; Mania, M; Okujava, N, 2011) |
| "Epilepsy was confirmed in 58 cases." | 1.37 | [Epilepsy in elderly]. ( Kotov, AS; Rudakova, IG, 2011) |
| " To demonstrate a case of a 15 year old girl suffering from refractory epilepsy with underlying focal cortical dysplasia (FCD), whose seizure deterioration was most probably associated with drug-drug interactions between prescribed common antiepileptic drugs, namely valproic acid, phenobarbital or the prodrug primidon and carbamazepine." | 1.37 | Antiepleptic drug interactions: a clinical case demonstration. ( Klapková, E; Komárek, V; Tesfaye, H; Tesfayeová, A, 2011) |
| "Antiepileptic drugs (AEDs) have been widely used in patients with epilepsy but the adverse effects in adult Chinese patients have not been investigated." | 1.36 | Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. ( Wang, X; Xi, Z; Yan, Y; Zeng, K, 2010) |
| "There were no serious adverse drug reactions reported during this study." | 1.36 | Safety profile of oxcarbazepine: results from a prescription-event monitoring study. ( Buggy, Y; Fogg, C; Layton, D; Shakir, SA, 2010) |
| "Weight gain was seen in 66." | 1.36 | Modification in body weight associated with antiepileptic drugs. ( Gaspari, CN; Guerreiro, CA, 2010) |
| "Epilepsy is associated with the presence of cataract." | 1.36 | Prevalence of Epilepsy among Cataract Patients. ( Hanhart, J; Kaiserman, I; Levartovsky, S; Nemet, A; Vinker, S, 2010) |
| " Piperine (20 mg/kg orally) was administered along with curcumin to enhance the bioavailability of the latter up to 20-fold more." | 1.36 | Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats. ( Jyothy, A; Munshi, A; Nehru, B; Sharma, V, 2010) |
| " Results of our study show the positive correlation between dosage and serum concentration of CBZ." | 1.36 | Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy. ( Bauer, S; Islami, H; Krasniqi, S; Neziri, B, 2010) |
| "Carbamazepine was incorporated into N-succinyl chitosan (NSC)/alginate hydrogel beads by ionic interaction." | 1.36 | Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery. ( Li, P; Liu, HJ; Wei, Q, 2010) |
| "The aim of the present study was to build population pharmacokinetic models for the clearance of valproate (VPA) in 2 separate populations of Serbian patients with epilepsy, children and adults." | 1.36 | Factors influencing valproate pharmacokinetics in children and adults. ( Jankovic, S; Jankovic, SM; Milovanovic, JR, 2010) |
| "Valproic acid was the most frequently prescribed drug, followed by carbamazepine and lamotrigine." | 1.35 | Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands. ( Brouwer, OF; de Jong-van den Berg, LT; de Vries, TW; van de Vrie-Hoekstra, NW; van den Berg, PB, 2008) |
| "Epilepsy is a multifaceted chronic disorder which has diverse and complex effects on the well-being of the patient." | 1.35 | Quality of life in seizure-free patients with epilepsy on monotherapy. ( Andelman, F; Auriel, E; Blatt, I; Chistik, V; Gandelman-Marton, R; Gross, B; Landov, H; Margolin, N; Neufeld, MY; Parmet, Y; Theitler, J, 2009) |
| "The purpose of this study was to perform population pharmacokinetic (PPK) analysis on carbamazepine and to determine the population model of clearance of this drug in terms of individual patient characteristics." | 1.35 | Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients. ( Jankovic, SM; Jovanovic, D; Milovanovic, JR, 2008) |
| " These findings showed that with a much lower dosage of the drugs, which is suggested in texts can lead to an appropriate blood level of CBZ and VPA for controlling the epileptic seizures." | 1.35 | An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks. ( Nobahar, M; Samaei, A; Vafaei, AA, 2009) |
| "Epilepsy is a syndrome of episodic brain dysfunction characterized by recurrent unpredictable, spontaneous seizures." | 1.35 | Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract. ( Abraham, PM; Krishnakumar, A; Paul, J; Paulose, CS, 2009) |
| "Epilepsy is a considerable source of stigma and misery for sufferers in Nigeria." | 1.35 | Pattern and presentation of epilepsy in Nigerian Africans: a study of trends in the southeast. ( Abadom, TR; Aguwa, EN; Ejim, EC; Ezeala-Adikaibe, B; Illo, CK; Ndukuba, K; Onodugo, OD; Onwuekwe, IO; Onyejizu, C, 2009) |
| "A total of 344 patients became seizure-free with the first prescribed antiepileptic drug." | 1.35 | Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy. ( Ding, CH; Ding, YX; Fang, F; Ma, MS; Ying, W; Zou, LP, 2009) |
| " TDM requests, interpretation and dosage adjustment recommendations were mainly responsible by residents." | 1.35 | Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. ( Faroongsarng, D; Kaewpibal, P; Ratanajamit, C; Setthawacharavanich, S, 2009) |
| "Temporal lobe epilepsy is one of the most common types of epilepsy." | 1.35 | Effect of oxcarbazepine pretreatment on convulsive activity and brain damage induced by kainic acid administration in rats. ( Ayala-Guerrero, F; Campos-Sepúlveda, E; González-Maciel, A; Mexicano, G; Reynoso-Robles, R; Romero, RM, 2008) |
| "Oxcarbazepine intoxication was regarded as a possible cause of death." | 1.35 | An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases. ( Hansen, SH; Linnet, K; Sabers, A; Simonsen, KW; Steentoft, A, 2008) |
| "Oxcarbazepine (OXC; Timox) is a new antiepileptic drug (AED) chemically related to carbamazepine (CBZ), with comparable efficacy but superior safety according to controlled clinical trials." | 1.34 | [Oxcarbazepine in the treatment of epilepsy]. ( Freidel, M; Krause, E; Kuhn, K; Peper, R; Vogel, H, 2007) |
| " Carbamazepine (CBZ) and phenobarbital (PHB) during pregnancy should be used at the lowest dosage compatible with maternal disease." | 1.34 | Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy. ( Carta, M; Cimador, M; Corsello, G; De Grazia, E; Di Pace, MR; Giuffrè, M; Sergio, M, 2007) |
| "In phenobarbital-treated patients, serum levels in 73% of the patients were in therapeutic range of 10-40 microg/ml, and about 44% of phenytoin-treated patients had serum levels in therapeutic range of 10-20 microg/ml." | 1.34 | Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients. ( Babaei, A; Eslamai, MH, 2007) |
| "Interindividual variability in intestinal absorption and bioavailability might contribute to inadequate control of seizures under treatment with carbamazepine and phenytoin." | 1.34 | Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition. ( Fried, M; Fritschy, JM; Kullak-Ublick, GA; Mueller, S; Pauli-Magnus, C; Simon, C; Stieger, B; Wieser, HG, 2007) |
| "Metabolic syndrome was more frequently associated with VPA-treated patients (41." | 1.34 | Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. ( Kim, JY; Lee, HW, 2007) |
| "Epilepsy is one of the most important features of the syndrome, in addition to the characteristic facial appearance, cardiac anomaly, dysphagia, deafness, mental retardation and growth delay." | 1.34 | [Effect of carbamazepine on epilepsy with 1p36 deletion syndrome]. ( Imai, K; Kagitani-Shimono, K; Kamio, N; Kurosawa, K; Nabatame, S; Nagai, T; Okinaga, T; Ozono, K, 2007) |
| "The carbamazepine treatment was stopped and laboratory parameters improved." | 1.34 | [Carbamazepine hepatoxicity--a case report]. ( Gawlikowski, T; Hydzik, P, 2007) |
| "The aim of this study was to define a population pharmacokinetic model that could estimate the clearance of valproate (VPA) in a Serbian epileptic population." | 1.34 | Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients. ( Jankovic, SM; Milovanovic, JR, 2007) |
| " There is an ongoing debate whether this can be attributed to chronic use of antiepileptic drugs or to the epilepsy itself." | 1.33 | Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy. ( Bjørnenak, T; Gjerstad, L; Mørkrid, L; Mørland, T; Røste, LS; Saetre, ER; Taubøll, E, 2005) |
| " These results provide evidence of a drug target polymorphism associated with the clinical use of AEDs and set the stage for a prospective evaluation of how pharmacogenetic diagnostics can be used to improve dosing decisions in the use of phenytoin and carbamazepine." | 1.33 | Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. ( Cavalleri, GL; Depondt, C; Goldstein, DB; Sander, JW; Schorge, S; Sen, A; Shorvon, SD; Sisodiya, SM; Soranzo, N; Tate, SK; Thom, M; Wood, NW, 2005) |
| "Oxcarbazepine (OZC) is a second-generation antiepileptic drug (AED) that also may be used as a mood stabilizer." | 1.33 | Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine. ( Cacciola, M; D'Arrigo, C; La Torre, D; Migliardi, G; Pacetti, M; Rosaria Muscatello, M; Spina, E; Zoccali, R, 2005) |
| "Population models can be important extensions of therapeutic drug monitoring (TDM), as they allow estimation of individual pharmacokinetic parameters based on a small number of measured drug concentrations." | 1.33 | Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy. ( Carlsson, KC; Glauser, T; Hoem, NO; Vinks, AA, 2005) |
| "Carbamazepine has also been shown to induce the hepatic synthesis of sex hormone-binding globulin, thus reducing free serum testosterone levels and possibly causing erectile dysfunction (ED) in some men; these effects have not been observed with oxcarbazepine." | 1.33 | Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience. ( Sachdeo, R; Sathyan, RR, 2005) |
| " VPA was not found to have any clinically significant influence on TPM pharmacokinetic and metabolic profiles." | 1.33 | A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. ( Bialer, M; Britzi, M; Doose, DR; Gatti, G; La Neve, A; Levy, RH; Maryanoff, BE; Mimrod, D; Perucca, E; Soback, S; Specchio, LM; Specchio, N, 2005) |
| " The effects on dopamine and serotonin levels are therefore proposed as pharmacodynamic markers for the anticonvulsant activity of these compounds." | 1.33 | Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine. ( Clinckers, R; Ebinger, G; Meurs, A; Michotte, Y; Smolders, I, 2005) |
| "Lamotrigine (LTG) was prescribed in 29 patients as add-on therapy." | 1.33 | The use of lamotrigine and other antiepileptic drugs in paediatric patients at a Malaysian hospital. ( Ab Rahman, AF; Ibrahim, MI; Ismail, HI; Seng, TB, 2005) |
| "Oxcarbazepine is an antiepileptic drug widely used to treat partial seizures in children and adults." | 1.33 | Possible precipitation of myoclonic seizures with oxcarbazepine. ( Holmes, GL; Kaddurah, AK, 2006) |
| "A 6-year-old girl had water reflex epilepsy occurring at lower temperature than the core temperature." | 1.33 | Hot water epilepsy occurring at temperature below the core temperature. ( Auvin, S; Bastos, M; Derambure, P; Lamblin, MD; Pandit, F; Vallée, L, 2006) |
| " The number or dosage of AEDs were more often increased in pregnancies with seizures (OR: 3." | 1.33 | Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry. ( , 2006) |
| " Brain AED concentrations were determined to ascertain any pharmacokinetic contribution to the observed antiseizure effect." | 1.33 | Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. ( Andres, MM; Cioczek-Czuczwar, A; Czuczwar, P; Czuczwar, SJ; Luszczki, JJ; Patsalos, PN; Ratnaraj, N, 2006) |
| "The correct diagnosis proved to be juvenile absence epilepsy (JAE) in six patients, juvenile myoclonic epilepsy (JME) in four, epilepsy with grand mal on awakening (EGMA) in two and childhood absence epilepsy (CAE) in two." | 1.33 | Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. ( Genton, P; Thomas, P; Valton, L, 2006) |
| "To investigate the relationship between the serum concentration of the mono-hydroxy-derivative (MHD) of oxcarbazepine (OXC) and adverse effects (AEs) in epileptic patients on high-dose OXC therapy." | 1.33 | Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy. ( Bilo, L; Di Nocera, P; Fasiello, C; Italiano, D; Pisani, F; Ruosi, P; Striano, P; Striano, S, 2006) |
| "Mebendazole was applied in treatment." | 1.33 | The cerebral form of toxocarosis in a seven-year-old patient. ( Bierzyńska-Macyszyn, G; Jamroz, E; Kazek, B; Kluczewska, E; Mandera, M; Marszał, E, 2006) |
| "Women with epilepsy have a higher risk of having dysmorphic child." | 1.33 | A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect. ( Batukan, C; Ceylaner, G; Ceylaner, S; Guven, MA; Uzel, M, 2006) |
| " In that control group, TDM was performed in the same pharmacokinetic (PK) laboratory, using the same sampling strategy as in the present study, and the same PK population modelling software was used for data analysis." | 1.33 | Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage. ( Belousov, YB; Bondareva, IB; Guekht, AB; Gusev, EI; Jelliffe, RW; Melikyan, EG, 2006) |
| "Oxcarbazepine was prescribed as monotherapy in 15 patients and as first-line therapy in 73% patients." | 1.33 | Oxcarbazepine therapy in very young children: a single-center clinical experience. ( Hardison, HH; Khurana, DS; Kothare, SV; Legido, A; Melvin, JJ; Mohsem, B; Mostofi, N; Valencia, I, 2006) |
| "Carbamazepine (CBZ) is a commonly used antiepileptic drug known to block voltage-gated sodium channels." | 1.33 | Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouse. ( Josephsson, A; Klason, T; Lavebratt, C; Ohman, I; Olson, L; Persson, AS; Schalling, M; Spenger, C; Trifunovski, A; Wang, FH, 2006) |
| "A 9-year-old girl with akinetic-rigid parkinsonism with tremor is described." | 1.33 | Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child. ( Cantú-Martínez, L; Flores, Lde L; González, HC; Martínez, HR; Onofre-Castillo, J; Villarreal, HJ, 2006) |
| "Carbamazepine (CBZ) was used in seven patients at the onset of AS." | 1.32 | Absence seizures in patients with localization-related epilepsy. ( Hayakawa, F; Nakai, Y; Negoro, T; Okumura, A; Sofue, A; Toyota, N; Watanabe, K, 2003) |
| "Men with epilepsy are known to have reduced fertility." | 1.32 | Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy. ( Bjørnenak, T; Gjerstad, L; Haugen, TB; Røste, LS; Saetre, ER; Taubøll, E, 2003) |
| "The incidence of birth defects in relation to specific AEDs was: valproate (16." | 1.32 | The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months. ( Graham, J; Hitchcock, A; Lander, C; O'Brien, TJ; Vajda, FJ, 2003) |
| "With pentylenetetrazol (PTZ) induced seizures pre-treated by CBZ, or SR-3, both CBZ and SR-3 were equally effective in providing seizure control and both were superior to the saline control." | 1.32 | Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). ( Mostofsky, DI; Rabinovitz, S; Yehuda, S, 2004) |
| "Oxcarbazepine was generally well tolerated during monotherapy and adjunctive therapy; 2." | 1.32 | Spotlight on oxcarbazepine in epilepsy. ( Bang, LM; Goa, KL, 2004) |
| "One hundred seventy-eight men had focal epilepsy (117 of these had temporal lobe epilepsy [TLE]) and 22 idiopathic generalized epilepsy (IGE)." | 1.32 | Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. ( Bauer, J; Blumenthal, S; Reuber, M; Stoffel-Wagner, B, 2004) |
| "Men with epilepsy have reduced fertility, and antiepileptic drugs may affect semen quality." | 1.32 | Effect of epilepsy and antiepileptic drugs on male reproductive health. ( Isojärvi, JI; Juntunen, KS; Löfgren, E; Päivänsalo, M; Pakarinen, AJ; Rautakorpi, I; Tuomivaara, L, 2004) |
| "We report on a 50-year-old man with mental retardation and right-sided hemi-paresis." | 1.32 | [Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient]. ( Huber, B; Seidel, M; Tomka-Hoffmeister, M, 2004) |
| "The average annual cost of outpatient treatment of epilepsy was found to be 47 US dollars per patient." | 1.32 | Cost of epilepsy in patients attending a secondary-level hospital in India. ( Kapoor, SK; Krishnan, A; Sahariah, SU, 2004) |
| " However, there is no information available on the number of therapeutic abortions, or the different types of epilepsy or drug dosage in the two treatment groups." | 1.32 | Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. ( Källén, B; Wide, K; Winbladh, B, 2004) |
| " It is also recommended to avoid saliva collection within 8 hours after OXC dosing to allow complete absorption and transformation of the parent drug." | 1.32 | Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD). ( Baumann, RJ; DeGrauw, TJ; Fakhoury, TA; Grim, SA; Miles, MV; Ryan, MA; Strawsburg, RH; Tang, PH, 2004) |
| "The aims of our study were to evaluate whether deficits in color vision exist in epileptic adolescents, to study if monotherapy with valproic acid (VPA) and carbamazepine (CBZ) can affect color vision, and to determine the possible relationship between abnormal color vision tests and AEDs dosage and their serum concentrations." | 1.32 | Color vision in epileptic adolescents treated with valproate and carbamazepine. ( Chiarelli, F; Gallenga, PE; Lobefalo, L; Morgese, G; Priolo, T; Rapinese, M; Trotta, D; Verrotti, A, 2004) |
| " Two hours after a documented overdosage of more than 100 tablets oxcarbazepine, the serum level of the parent compound was 10-fold higher than the therapeutic dosage (31." | 1.32 | Severe overdosage with the antiepileptic drug oxcarbazepine. ( Cilissen, J; De Heer, F; Janknegt, R; L'Ortije, WH; Nel, JE; van Opstal, JM, 2004) |
| "We describe the incidence of newly treated epilepsy in primary care and patterns of antiepileptic drug prescription, numbers of patients who remain on initial therapy and health service utilisation." | 1.32 | The outcome of initiation of antiepileptic drug monotherapy in primary care: a UK database survey. ( Buchan, S; Kerr, MP; Morgan, CL, 2004) |
| " A small dosage of carbamazepine was remarkably effective in stopping the attacks." | 1.32 | Kinesigenic attacks with ictal electroencephalographic abnormalities. ( Akiyama, T; Kobayashi, K; Ohtsuka, Y; Oka, E, 2004) |
| "The purpose of this study was to investigate the relationship of changes in the enzyme-inducing anticonvulsant daily dosage (drug score) to variations in urinary D-glucaric acid excretion and gamma-glutamyltransferase and beta-glucuronidase serum activities." | 1.31 | Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. ( Fernández, MP; Hermida, J; Tutor, JC, 2002) |
| " Adjusting the maintenance dosage of H(2)-histamine antagonists has been recommended in elderly patients since age-related reduction in renal plasma flow, glomerular filtration rate and renal tubular function may be present, which can in turn elevate histamine levels in plasma and cerebrospinal fluid." | 1.31 | H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures. ( Bergemann, N; Diebold, K; Mundt, C; Roesch-Ely, D; Sartor, K; von Einsiedel, RW, 2002) |
| " The mean values of pharmacokinetic parameters were: level/dose ratio (L/D) = 0." | 1.31 | Effect of vigabatrin on the pharmacokinetics of carbamazepine. ( Llopis, P; López, E; Quintana, MB; Rodríguez, I; Sánchez-Alcaraz, A, 2002) |
| "Determining antiepileptic drug (AED) concentration in biological fluids and calculating its dosage on this basis is a long-term method in the treatment of epilepsy." | 1.31 | [Therapeutic antiepileptic drug monitoring: thirteen years of experience in the Laboratory of Clinical Neuropharmacology in the Chair and Department of Developmental neurology]. ( Galas-Zgorzalewicz, B; Steinborn, B, 2000) |
| " Everyone received a drug dosage which gave an adequate therapeutic plasma concentration and satisfactory seizure control." | 1.31 | [Bimodal evoked potentials during long-term therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and adolescents with epilepsy]. ( Zgorzalewicz, M, 2000) |
| " In this study, we examined the anticonvulsant and adverse effects of the three clinically established AEDs carbamazepine (CBZ), phenobarbital (PB), and valproate (VPA) once per month in the same two groups of amygdala-kindled rats over a period of 9 (group 1) or 6 (group 2) consecutive months." | 1.31 | Repeated acute testing of anticonvulsant drugs in amygdala kindled rats: increase in anticonvulsant but decrease in adverse effect potential. ( Fiedler, M; Löscher, W, 2000) |
| " The difference in the pharmacokinetic parameters found after administration of individual MHD enantiomers compared with the administration of MHD in a racemic form suggests the possibility of interaction between the two enantiomers." | 1.31 | Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs. ( Bialer, M; Volosov, A; Yagen, B, 2000) |
| "Carbamazepine treatment alters the serum lipid profile of the children in such a way that it facilitates the development of atherosclerosis." | 1.31 | Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children. ( Demircioğlu, S; Dirik, E; Soylu, A, 2000) |
| "All patients with seizures or epilepsy were submitted to standard EEG and brain MRI with gadopentetate dimeglumine." | 1.31 | Seizures in multiple sclerosis. ( Dragutinovic, G; Drulovic, J; Dujmovic, I; Ercegovac, M; Levic, Z; Mesaros, S; Peric, V; Sokic, DV; Stojsavljevic, N, 2001) |
| " To avoid complex pharmacokinetic interactions among multiple antiepileptic drugs, the data on serum concentrations in the current study were collected from patients who were co-administered only one additional antiepileptic drug (phenobarbital-carbamazepine, phenobarbital-valproic acid, or carbamazepine-valproic acid) or who received monotherapy." | 1.31 | Pharmacokinetic interactions among phenobarbital, carbamazepine, and valproic acid in pediatric Japanese patients: clinical considerations on steady-state serum concentration-dose ratios. ( Aoyama, T; Higuchi, S; Hokazono, T; Ohdo, S; Satou, M; Yukawa, E, 2000) |
| " We used a linear one-compartmental model with oral absorption and found the pharmacokinetic parameter values of CBZ behaviour to be in good agreement with those reported earlier." | 1.31 | Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage. ( Bondareva, IB; Jelliffe, RW; Sokolov, AV; Tischenkova, IF, 2001) |
| " The half-life of MHD was 10." | 1.31 | [Pharmacokinetic variability of oxcarbazepine in epileptic patients]. ( Bercellini, MA; Rubio, MC; Saidón, P; Viola, MS, 2000) |
| "Tiagabine may cause various mild extrapyramidal side effects." | 1.31 | Transient dystonias in three patients treated with tiagabine. ( Grabowska-Grzyb, A; Wolańczyk, T, 2001) |
| "Oxcarbazepine (OXC) is a new antiepileptic drug derived from carbamazepine (CBZ)." | 1.31 | [Oxcarbazepine]. ( Arroyo, S, 2001) |
| "Carbamazepine and depakine treatment during at least 6 months does not predispose to ovary polycystosis syndrome." | 1.31 | [The pharmacological and hormonal effects of carbamazepine and valproic acid in the treatment of reproductive age women with epilepsy]. ( Karlov, VA; Kushlinskiĭ, NE; Vlasov, PN, 2001) |
| "Remacemide is a potential anticonvulsant drug with an active metabolite, desglycinyl-remacemide (DGR)." | 1.31 | Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal slice. ( Brodie, MJ; Santangeli, S; Sills, GJ; Stone, TW, 2002) |
| " Blood and saliva samples were taken simultaneously at 0 hours and 24 hours of CBZ dosing from 31 epileptic patients, receiving CBZ monotherapy for three or more months." | 1.31 | Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring. ( Puri, V; Tripathi, KD; Vasudev, A, 2002) |
| "Treatment with carbamazepine decreased plasma OE1S levels from a mean value of 810." | 1.30 | Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients. ( Berntsen, H; Engelsen, BA; Geisler, J; Geisler, S; Lønning, PE, 1997) |
| "After generalized or partial seizures, transient lesions may appear on magnetic resonance (MR) images." | 1.30 | Reversible MRI lesions after seizures. ( Aktan, S; Aykut-Bingol, C; Ince, D; Tekin, S, 1997) |
| " Our data indicate the possible use of hair testing as a marker of the dosage history of patients under long-term treatment with CBZ." | 1.30 | Carbamazepine levels in the hair of patients under long-term treatment: a preliminary study. ( Kourtopoulos, H; Paritsis, N; Psillakis, TK; Tsatsakis, AM; Tzatzarakis, M, 1997) |
| " AWD 140-190 thus presents an orally active and safe anticonvulsant agent, which is structurally unrelated to anticonvulsants currently used." | 1.30 | AWD 140-190: a new anticonvulsant with a very good margin of safety. ( Bartsch, R; Engel, J; Rostock, A; Rundfeldt, C; Tober, C; Unverferth, K; White, HS; Wolf, HH, 1997) |
| " Thus the performance of the Bayesian dosing program is acceptable when two feedback concentrations are known, and seems able to help the clinician adjust carbamazepine dosage in an outpatient population." | 1.30 | Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): a retrospective evaluation in an outpatient population. ( Boulieu, R; Fischer, C; Gaulier, JM; Mauguiere, F, 1997) |
| "Invasive or complex treatments for epilepsy with partial and generalized tonic-clonic seizures should not be used until at least two AEDs have failed to control seizures." | 1.30 | If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug? ( Camfield, CS; Camfield, PR; Dooley, JM; Gordon, K, 1997) |
| "Epilepsy is a relatively common problem in children, adults and the elderly." | 1.30 | Treatment of the epileptic patient in the dental office. ( Haller, JS; Kennedy, BT, 1998) |
| "05) change in the serum concentrations of either CBZ or its epoxide metabolite when LTG was added either to the group as a whole or to the nine patients who experienced adverse CNS effects." | 1.30 | Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction? ( Berry, DJ; Besag, FM; Newbery, JE; Pool, F; Subel, B, 1998) |
| " Patients received phenobarbitone as monotherapy or in combination with either of the antiepileptic drugs carbamazepine or valproic acid." | 1.30 | Detection of a drug-drug interaction on population-based phenobarbitone clearance using nonlinear mixed-effects modeling. ( Aoyama, T; Higuchi, S; Ohdo, S; To, H; Yukawa, E, 1998) |
| "We evaluated seven patients with oral motor apraxia and ocular motor apraxia." | 1.30 | Carbamazepine responsive epileptic oral motor and ocular motor apraxia. ( D'Cruz, OF; Greenwood, RS; Naqvi, SZ, 1998) |
| "Carbamazepine was also effective against decreasing of phytogemagglutinin-induced blastogenic response." | 1.30 | [Changes in the blastogenic lymphocyte transformation during kindling induced by picrotoxin in rats]. ( Brusentsov, AI; Godlevskiĭ, LS; Moroz, VV; Pomazanova, TN; Shandra, AA; Suprun, SA, 1998) |
| "Digestive epilepsy is a rare disease, poorly recognized by gastroenterologists." | 1.30 | [A case of digestive epilepsy with late diagnosis: a disease not to be disregarded]. ( Mendler, MH; Pillegand, B; Ravon, R; Sautereau, D, 1998) |
| " We propose that individual dosage adjustment in VPA + CBZ polytherapy should be combined with monitoring of relevant enzyme activities in serum." | 1.30 | Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children. ( Cepelak, I; Lenicek, J; Mandusić, A; Rekić, B; Zanić Grubisić, T, 1998) |
| " Both CBZ and CBZ-epoxide (CBZ-E) blood levels were elevated, and the symptoms resolved quickly when CBZ dosage was reduced and CLB discontinued." | 1.30 | Carbamazepine intoxication with negative myoclonus after the addition of clobazam. ( Genton, P; Mesdjian, E; Nguyen, VH, 1998) |
| "Her carbamazepine clearance was markedly decreased." | 1.30 | Carbamazepine-induced sinus node dysfunction and atrioventricular block in elderly women. ( Fujito, T; Hayashi, T; Hisauchi, I; Hoshi, K; Inoue, T; Kase, M; Maekawa, Y; Morooka, S; Nishimura, N; Sakai, Y; Takayanagi, K; Watanabe, J, 1998) |
| "Physicians treating epilepsy must be aware that CBZ can exacerbate seizures, and cause developmental regression in children." | 1.30 | Seizure exacerbation and developmental regression with carbamazepine. ( Nagarajan, L; Prasad, AN; Stefanelli, M, 1998) |
| "The aim of our work was to define the kinetic profile of carbamazepine (CBZ), in order to improve on dosing schedules through a Bayesian approach." | 1.30 | Kinetic profile of carbamazepine in an adult Portuguese outpatient population. ( Almeida, AM; Caramona, MM; Costa, IM; Falcão, AC; Leitão, F; Sales, F; Santos, J, 1998) |
| "Carbamazepine (CBZ) is an effective anticonvulsant agent." | 1.30 | Exacerbation of epileptic seizures by carbamazepine: report of 10 cases. ( Fraticelli, E; Parmeggiani, A; Rossi, PG, 1998) |
| " In those patients who use these drugs at increased dosage levels or for long periods, the possibility of tubular dysfunction may be increased, and these dysfunctions may manifest in clinical symptoms." | 1.30 | N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs. ( Cenani, A; Cengiz, M; Cengiz, S; Seven, M; Yüksel, A, 1999) |
| " PB was also the most toxic drug, followed by CBZ and by PHT." | 1.30 | Anticonvulsant and neurotoxic effects of intracerebroventricular injection of phenytoin, phenobarbital and carbamazepine in an amygdala-kindling model of epilepsy in the rat. ( Alós, M; Barcia, JA; Belda, V; Rubio, P; Serralta, A, 1999) |
| "In 1993, 27% of patients were being treated for epilepsy and in 1995/6, 30." | 1.30 | The management of epilepsy in a hospital for people with a learning disability. ( Carvill, S; Cassidy, G; Clarke, D, 1999) |
| " Valproate, when the proper therapeutic dosage was belatedly realized, was seen as a superior treatment for generalized and partial epilepsies." | 1.30 | Clinical experience with new antiepileptic drugs: antiepileptic drugs in Europe. ( Loiseau, PJ, 1999) |
| "In sera of 29 patients under the chronic administration of carbamazepine (CBZ, dose: 10." | 1.29 | 9-Hydroxymethyl-10-carbamoylacridan in human serum is one of the major metabolites of carbamazepine. ( Eto, S; Noda, A; Noda, H; Tanaka, N, 1995) |
| " On the basis of pharmacokinetic parameters, mean optimal dosages sufficient for maintenance of effective and safe carbamazepine concentrations were calculated." | 1.29 | [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome]. ( Dubrovina, LIu; Ivanova, ES; Kholodov, LE; Kopanev, IuA; Postnikov, SS; Prityko, AG; Sokolov, AV; Tatarinov, PA; Tishchenkova, IF; Veselov, NK, 1995) |
| "Carbamazepine treatment resulted in prolongation of peak latencies of waves I-III-V and interpeak intervals I-III and I-V." | 1.29 | Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children. ( Cenani, A; Dirican, A; Keskin, G; Senocak, D; Sozuer, D; Yalcin, E; Yuksel, A, 1995) |
| "Phenytoin-treated patients had a significant reduction in the mean IgA and IgG levels compared to healthy and epileptic controls (P < 0." | 1.29 | Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients. ( Başaran, N; Ciğer, A; Hincal, F; Kansu, E, 1994) |
| "Tiagabine has comparable anticonvulsant action to carbamazepine in rats and has anticonvulsant effects in non-human primates supporting the potential use of inhibitors of GABA uptake as therapy for epilepsy." | 1.29 | The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. ( Chapman, AG; Meldrum, BS; Parvez, NS; Smith, SE, 1995) |
| "Carbamazepine (CBZ) has been successfully employed in a variety of neurological and psychiatric disorders." | 1.29 | Signs and symptoms of carbamazepine overdose. ( Schmidt, S; Schmitz-Buhl, M, 1995) |
| "Treatment with carbamazepine slow-release tablets in children with epilepsy can be replaced by carbamazepine suppositories in 25% higher dosage, with good clinical effect and appropriate pharmacokinetic values, when it is unsuitable to use the common oral route of administration." | 1.29 | Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy. ( Arvidsson, J; Flesch, G; Nilsson, HL; Sandstedt, P; Steinwall, G; Tonnby, B, 1995) |
| "Trends in treatment of epilepsy in an institution for handicapped patients with epilepsy were investigated in a retrospective longitudinal study." | 1.29 | [Changes in drug therapy and in seizure frequency in an institution for epilepsy patients between 1971 and 1986]. ( May, T; Wohlhüter, M; Wolf, P, 1994) |
| "Carbamazepine was preferred to phenobarbital and phenytoin." | 1.29 | Neuroleptic and antiepileptic treatment in the mentally retarded. ( Brodtkorb, E; Sand, T; Strandjord, RE, 1993) |
| " A review of published studies involving small numbers of elderly subjects or patients given phenytoin sodium, valproic acid, or carbamazepine demonstrates decreased protein binding and intrinsic clearance and increased half-life with advancing age." | 1.29 | Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. ( Cloyd, JC; Lackner, TE; Leppik, IE, 1994) |
| " The usually administered dosage of OCBZ is approximately 50% higher than that of CBZ." | 1.29 | Oxcarbazepine: clinical development program. ( Schwabe, S, 1994) |
| "A retrospective study of 113 patients treated with a sustained-release form of valproate (SRF-VPA), known as the "chrono" formulation in most European countries, led to the following conclusions: Patients treated with the old VPA formulation could immediately receive the same daily dosage of SRF-VPA without loss of seizure control when administered as a single evening dose." | 1.29 | A retrospective study of 113 epileptic patients treated with sustained-release valproate. ( Despland, PA, 1994) |
| "Carbamazepine (CBZ) is a first-line drug in the treatment of epileptic seizures and neuralgia." | 1.29 | [Effects of carbamazepine on heart conduction in young patients: a serial study using ambulatory ECG]. ( Borgia, MC; Curione, M; Fanari, F; Matteoli, S; Puletti, M; Trappolini, M, 1994) |
| "Oxcarbazepine (OCBZ) has been accepted for registration as a first-line antiepileptic drug (AED) in several countries." | 1.29 | Clinical development outlook of oxcarbazepine. ( Schwabe, S, 1994) |
| " The recommended dosage of OCBZ as monotherapy for adults with epilepsy is 600-1,200 mg orally per day but may be higher in patients with refractory seizures and in patients requiring combination therapy." | 1.29 | Practical aspects of oxcarbazepine treatment. ( Dam, M, 1994) |
| " The 266 serum concentration data at steady-state after repetitive oral administration were analyzed using the nonlinear mixed effects model (NONMEM) program designed for estimation of population pharmacokinetic parameters." | 1.29 | Population analysis of the dose-dependent pharmacokinetics of zonisamide in epileptic patients. ( Hashimoto, Y; Hori, R; Odani, A; Okuno, T; Tanigawara, Y; Yasuhara, M, 1994) |
| "Carbamazepine (CBZ) has been reported to have an antidiuretic action, though it is not known how it produces this effect." | 1.29 | Fluid retention and cardiomegaly associated with carbamazepine in an epileptic child. ( Atalay, S; Gürer, YK; Karademir, S; Oner, A, 1993) |
| "Phenytoin is a potent inducer of carbamazepine metabolism." | 1.29 | Unmasking the significant enzyme-inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawal. ( Abou-Elkair, M; Chapron, DJ; LaPierre, BA, 1993) |
| "The latter 2 cases had been treated as epilepsy." | 1.29 | [Five cases of paroxysmal sleep disturbances]. ( Ikeno, T; Nagai, H, 1993) |
| "Carbamazepine was extracted from the hair by enzymatic hydrolysis and quantified by gas chromatography-mass spectrometry." | 1.29 | Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring? ( Kintz, P; Mangin, P; Marescaux, C, 1995) |
| "D-Cycloserine (DCS) is a high-efficacy partial agonist at the strychnine-insensitive glycine modulatory site within the N-methyl-D-aspartate (NMDA)-receptor/ionophore complex." | 1.29 | Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice. ( Czuczwar, SJ; Roliński, Z; Wlaź, P, 1996) |
| "Treatment with carbamazepine raised serum total cholesterol levels, C-HDL, phospholipid and A-I apoprotein in all groups, low density lipoproteins in females and B apoprotein males." | 1.29 | [The effects of phenobarbital, valproic acid and carbamazepine on the serum lipids and lipoproteins in a pediatric population]. ( Braga Hernández, S; Crespo Hernández, M; de Juan Frigola, J, 1996) |
| " With increasing carbamazepine dosage (1) carbamazepine overall plasma apparent clearance (CL/F), (2) plasma clearance of carbamazepine to urinary carbamazepine-10,11-epoxide, (3) plasma clearance of carbamazepine-10,11-epoxide to urinary unconjugated carbamazepine-10,11-trans-diol and (4) plasma clearances of carbamazepine to urinary 2- and 3-hydroxy carbamazepine all increased." | 1.29 | Dose-dependent metabolism of carbamazepine in humans. ( Bernus, I; Dickinson, RG; Eadie, MJ; Hooper, WD, 1996) |
| " A patient was only considered twice if his comedication or OCBZ dosage had been changed." | 1.29 | Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients. ( May, TW; Rambeck, B; Sälke-Kellermann, A, 1996) |
| " Routine clinical pharmacokinetic data (N = 1,010) collected from 466 patients receiving carbamazepine were analyzed according to a simple steady-state pharmacokinetic model with the use of NONMEM, a computer program designed for population pharmacokinetic analysis that allows pooling of data." | 1.29 | Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data. ( Aoyama, T; Yukawa, E, 1996) |
| " During this pregnancy the patient took a reduced dosage of carbamazepine." | 1.29 | Fetal malformations in an epileptic pregnant woman treated with carbamazepine. ( Caradonna, F; Caruso, G; Ceci, O; Clemente, R; Ferreri, R; Loizzi, P, 1996) |
| " This study compares the pharmacokinetics of CBZ-CO against CBZ-CR in patients with epilepsies chronically treated with CBZ in monotherapy or CBZ-PB in bitherapy, the effect of PB on CBZ-CO and CBZ-CR pharmacokinetic parameters, and the effect of the two formulations of CBZ on PB pharmacokinetic parameters." | 1.29 | Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy. ( Barra, Y; Bonneton, J; Genton, P; Iliadis, A; Mesdjian, E; Sennoune, S, 1996) |
| " Therapy was started with a dosage of 400 mg carbamazepine b." | 1.28 | EEG changes in patients during the introduction of carbamazepine. ( Besser, R; Hornung, K; Krämer, G; Rothacher, G; Theisohn, M, 1992) |
| "Cerebral cavernous angioma (cavernoma) has previously been treated by resection for all presentations when surgically resectable." | 1.28 | Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases. ( Churchyard, A; Grainger, K; Khangure, M, 1992) |
| " Regular 2 weekly follow up for a minimum period of 2 months was done, after altering the drug dosage and bringing plasma level(s) within therapeutic range." | 1.28 | "An analysis of epileptic patients nonresponsive to drugs". ( Joshi, MV; Karande, SC; Kshirsagar, NA; Shah, PU, 1992) |
| " Since praziquantel, the drug used to treat neurocysticercosis, undergoes extensive liver first-pass metabolism, we carried out a prospective study to verify whether there was a decrease in oral bioavailability induced by carbamazepine and phenytoin." | 1.28 | Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. ( Bittencourt, PR; Diekmann, HW; Fernandes, AG; Gracia, CM; Jung, W; Martins, R, 1992) |
| "However, hyponatremia is supposed to occur even more often than with CBZ." | 1.28 | Hyponatremic coma under oxcarbazepine therapy. ( Paulus, W; Steinhoff, BJ; Stodieck, SR; Stoll, KD, 1992) |
| " Carbamazepine and both metabolites showed significant differences in mean 4h post-dose plasma concentrations between day and night dosing (p less than 0." | 1.28 | Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children. ( Forsythe, WI; Hartley, R; Lucock, MD; McLain, B; Ng, PC, 1991) |
| "007) and a significantly shorter plasma half-life (mean values +/- SD = 4." | 1.28 | Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. ( Fazio, A; Martines, C; Pisani, F; Spina, E; Tomson, T; Trio, R, 1991) |
| " In order to define the minimal dosage of fentanyl required, the MD was titrated according to increases or decreases in the heart rate and/or mean arterial pressure exceeding 15 per cent of baseline ward values." | 1.28 | Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy. ( Modica, PA; Spitznagel, EL; Tempelhoff, R, 1990) |
| " Eighty-four patients had been established on treatment with a single anticonvulsant drug (35 carbamazepine (CBZ), 30 sodium valproate (VPA), 19 phenytoin (PHT)) at unaltered dosage for the previous 3 months." | 1.28 | Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. ( Brodie, MJ; Butler, E; Gillham, RA; Larkin, JG; Wiedmann, KD; Williams, N, 1990) |
| "When phenytoin was given with carbamazepine percentage (mean +/- SEM) protein binding was 87." | 1.28 | Serum protein binding of antiepileptic drugs in Sri Lankans. ( Joice, PD; Karunanayake, EH; Meijer, JW; Meinardi, H; Peiris, JB, 1990) |
| " Dosing was single blind." | 1.28 | Carbamazepine-10,11-epoxide in epilepsy. A pilot study. ( Almkvist, O; Bertilsson, L; Nilsson, BY; Svensson, JO; Tomson, T, 1990) |
| "Carbamazepine (CBZ) is a widely used antiepileptic drug (AED)." | 1.28 | The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy. ( Finnerty, G; Patsalos, PN; Russell-Jones, D; Sander, JW; Shorvon, SD, 1990) |
| "Carbamazepine (CBMZP) has been implicated as an inhibitor of the activities of 5-aminolaevulinic acid dehydratase (ALA-D) and uroporphyrinogen I synthetase (URO-S)." | 1.28 | Protoporphyrinaemia and decreased activities of 5-aminolevulinic acid dehydrase and uroporphyrinogen I synthetase in erythrocytes of a Vitamin B6-deficient epileptic boy given valproic acid and carbamazepine. ( Carson, R; Haust, HL; Peter, F; Poon, HC; VanDeWetering, C, 1989) |
| "Phenytoin treatment may impair the validity of the caffeine liver function test." | 1.28 | Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism. ( Büchsel, R; Kohl, D; Kreiten, K; Matern, S; Wietholtz, H; Zysset, T, 1989) |
| " These results support the increased use of dosing aids for PHT that may help clinicians more accurately choose PHT doses and estimate time to steady state." | 1.28 | Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients. ( Privitera, MD, 1989) |
| " We found a noticeable relationship between conduction velocity slowing and daily dosage for CBZ only." | 1.27 | Anticonvulsant therapy and its possible consequences on peripheral nervous system: a neurographic study. ( Faedda, MT; Geraldini, C; Sideri, G, 1984) |
| " Pharmacokinetic interactions between antiepileptic drugs may lead to considerable fluctuation in plasma drug concentration, and monotherapy is often preferable." | 1.27 | Pharmacokinetics of antiepileptic drugs. ( Neuvonen, PJ; Tokola, RA, 1983) |
| "Phenytoin continues to be a very popular drug for most types of seizures, but carbamazepine, used adjunctively until recently, is effective as monotherapy for the control of partial seizures, particularly those of the complex partial variety." | 1.27 | Treatment of the nonconvulsive epilepsies. ( Dreifuss, FE, 1983) |
| "Only when the epilepsy is uncontrolled despite high plasma concentrations which cannot be raised because of side effects, a second drug should be given." | 1.27 | [Pharmacotherapy of epilepsy--current problems and controversies]. ( Schmidt, D, 1983) |
| "Side effects of carbamazepine (CBZ), valproate (VPA) and clonazepam (CZP) are rare during long-term use but rather common and usually transient during the early phases of treatment." | 1.27 | Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. ( Keränen, T; Sivenius, J, 1983) |
| " However, whereas toxic reactions following phenytoin and carbamazepine are characterised by a rather short duration of exposure before symptoms occur with accompanying clinical features of hypersensitivity, valproate-induced hepatic toxicity exhibits no signs of hypersensitivity and often occurs following prolonged exposure, speaking in favor of a metabolic aberration as the underlying cause." | 1.27 | Hepatic toxicity of antiepileptic drugs: a review. ( Bentsen, KD; Gram, L, 1983) |
| " Significant positive correlations were found between the dosage of CBZ, DPH, PMD and PB and both indices of enzyme induction." | 1.27 | A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. ( Hedges, A; Makki, KA; Perucca, E; Richens, A; Ruprah, M; Wilson, JF, 1984) |
| " Fluctuations in carbamazepine concentrations were 79% +/- 29% higher than trough levels on a twice-daily dosage schedule and 40% +/- 13% higher during four-times-a-day administration." | 1.27 | Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects. ( Tomson, T, 1984) |
| " Fifty-one percent of the 53 patients receiving phenytoin were completely controlled at either below or above the 10 to 20 micrograms/ml range, suggesting that individual dosage adjustment is preferably based on clinical judgment rather than numerical limits of published therapeutic ranges." | 1.27 | Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type. ( Haenel, F; Schmidt, D, 1984) |
| " dosing schedule, total plasma levels of CBZ and CBZ-E fluctuated to a similar extent (average 34% and 29%, respectively)." | 1.27 | Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects. ( Albani, F; Ambrosetto, G; Baruzzi, A; Contin, M; Cortelli, P; Gobbi, G; Perucca, E; Procaccianti, G; Riva, R, 1984) |
| " Relatively large fluctuations were observed for both CBZ (mean, 57%; range, 32-100%) and EP (mean, 97%; range, 19-189%) during a dosage interval." | 1.27 | Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children. ( Aman, MG; Paxton, JW; Werry, JS, 1983) |
| "Most patients have quiescent seizure disorders and can manage well on monotherapy." | 1.27 | Reduction of polypharmacy for epilepsy in an institution for the retarded. ( Bennett, HS; Dunlop, T; Ziring, P, 1983) |
| " Serum carbamazepine levels were measured before, during, and, in most cases, after the toxic episodes." | 1.27 | Carbamazepine--erythromycin interaction leading to carbamazepine toxicity in four epileptic children. ( Cate, JC; Hedrick, R; Lamb, WA; Morin, R; Williams, F, 1983) |
| "Steady state carbamazepine (CBZ) plasma concentrations were similar in 15 epileptics receiving monotherapy and in 24 patients taking CBZ in combination with one other anticonvulsant." | 1.27 | Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. ( Brodie, MJ; Forrest, G; Rapeport, WG, 1983) |
| "The critical vomiting is always sudden, projectile, and lasts a short period." | 1.27 | [Vomiting: symptom of an epileptic seizure]. ( Aguglia, U; De Carvalho, GV; Farnarier, G; Tinuper, P, 1983) |
| "The effect of dosage frequency of carbamazepine (CBZ) (brand name Tegretol) on pseudo-steady state drug serum levels were studied in 14 male (16-18 years) epileptics." | 1.27 | Effect of dosage frequency of carbamazepine on drug serum levels in epileptic patients. ( Christfides, JA; Fry, DE; Ghose, K, 1983) |
| "Carbamazepine was the most effective to block SEA at concentrations of 1-15 microM." | 1.27 | Effects of anticonvulsants on spontaneous epileptiform activity which develops in the absence of chemical synaptic transmission in hippocampal slices. ( Franceschetti, S; Hamon, B; Heinemann, U; Konnerth, A; Yaari, Y, 1985) |
| "Phenytoin was associated with the most frequent and highest enzyme elevations in both adult and pediatric patients." | 1.27 | Serum 5'-nucleotidase in patients receiving anti-epileptic drugs. ( Fortman, CS; Witte, DL, 1985) |
| " Frequency and extent of increased activity of gamma-GT were highly related to daily dosage in both preparations." | 1.27 | The influence of long-term anticonvulsant therapy with diphenylhydantoin and carbamazepine on serum gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase. ( Aldenhövel, HG, 1988) |
| " Frequency and extent of increased activity of gamma-GT were highly related to daily dosage in both preparations." | 1.27 | [Altered gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase serum activities in long-term anticonvulsive therapy--comparison of diphenylhydantoin and carbamazepine]. ( Aldenhövel, HG, 1988) |
| "In 1983, she developed hyperimmunoglobulinemia E syndrome." | 1.27 | [Systemic lupus erythematosus and hyper-IgE syndrome in a 13-year-old child]. ( Leyh, F; Scherer, R; Wendt, V, 1986) |
| "Carbamazepine, in contrast, has rather a stimulatory action." | 1.27 | [Modification of psychophysical performance of the human by anticonvulsants]. ( Meyer, FP; Walther, H, 1987) |
| " These results show that barbiturates should not be first-choice drugs in patients who have a chronic disease such as epilepsy, and indicate a schedule for barbiturate withdrawal which is safe and independent of hospitalization or monitoring of antiepileptic drug serum concentrations." | 1.27 | Barbiturate-refractory epilepsy: safe schedule for therapeutic substitution. ( Bittencourt, PR; Gorz, AM; Silvado, CE, 1986) |
| "In particular, memory deficits, attentional problems, psychomotor slowing and reading and writing difficulties are highlighted, and the impact of the seizures, brain damage, and anticonvulsant drugs on cognitive function noted." | 1.27 | [Cognitive effects of antiepileptic drugs]. ( Trimble, R, 1987) |
| "Phenytoin levels were reduced to 37% of the original values, although the drug was given intravenously." | 1.27 | An interaction between cytostatic and anticonvulsant drugs. ( de Voogd-van der Straaten, I; Neef, C, 1988) |
| " In each patient, the average unbound fraction for a dosing interval increased with increase in sodium valproate dose." | 1.27 | Changes in clearance of sodium valproate with changes in dose. ( Bury, RW; Fullinfaw, RO; Kilpatrick, CJ; Moulds, RF, 1987) |
| "Major pharmacokinetic parameters of the Soviet anticonvulsive drug benzobarbital used with different regimens of administration (single and prolonged) are described." | 1.27 | [Pharmacokinetic aspects of anticonvulsant therapy with benzonal]. ( Antadze, ZI; Chanvetadze, BG; Chkhenkeli, SI; Okudzhava, VM; Rukhadze, MD, 1988) |
| "The aim of the present work was to analyse the predictive capacity of different optimization methods for carbamazepine dosage regimens according to population pharmacokinetic parameters and/or serum levels data." | 1.27 | Comparison of methods of carbamazepine dosage, individualization in epileptic patients. ( Alonso, AC; Dominguez-Gil, A; Garcia, MJ; Matesanz, C; Maza, A; Santos, D, 1988) |
| "Oxcarbazepine is a new anticonvulsant, currently undergoing clinical trials." | 1.27 | Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant. ( Dickinson, RG; Dunstan, PR; Eadie, MJ; Hooper, WD; Pendlebury, SC, 1987) |
| "Praziquantel was ineffective and hazardous, causing some known and some previously unreported responses and reactions." | 1.27 | Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel. ( Bhatt, M; Desai, S; Wadia, N, 1988) |
| " The pharmacokinetic parameters have been found to be important for specifying the causes of dissociation between the level of blood anticonvulsant and the therapeutic effect when the attacks cannot be controlled or there were signs of intoxication." | 1.27 | [Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment]. ( Antadze, ZI; Chankvetadze, BG; Okudzhava, VM; Vetrogon, FG, 1987) |
| "Zonisamide (CI-912) is an experimental antiepileptic drug." | 1.27 | Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy. ( Buchanan, RA; Friel, PN; Levy, RH; McLean, JR; Ojemann, LM; Shastri, RA; Wilensky, AJ, 1986) |
| " The most common of these causes include malpractice of the dosage build-up in the absence of the clinical effect, polytherapy--not infrequently with drugs of the same chemical group, and insufficient attention to the potentiating drug interaction." | 1.27 | [Phenomenon of "paradoxical poisoning" during antiepileptic therapy]. ( Geladze, TSh, 1986) |
| " Data were excluded for patients who required dosage adjustments because of toxicity or seizures." | 1.27 | Effect of influenza vaccine on serum anticonvulsant concentrations. ( Fidone, GS; Jann, MW, 1986) |
| " The mechanisms responsible for these effects have not been elucidated and possibly include decreased bioavailability or compliance, increased metabolic clearance, or decreased plasma protein binding." | 1.27 | Effects of pregnancy on antiepileptic drug utilization. ( Levy, RH; Yerby, MS, 1985) |
| "According to our convulsion intensity scoring system, these animals have an audiogenic response score (ARS) of 3 and the colony is designated the GEPR-3 colony." | 1.27 | Anticonvulsant drugs and the genetically epilepsy-prone rat. ( Dailey, JW; Jobe, PC, 1985) |
| "Fifty-nine patients with chronic generalized tonic-clonic or partial seizures refractory to the maximally tolerated daily dosage of single-drug therapy with carbamazepine, phenytoin, phenobarbital, or primidone subsequently received single-drug therapy with another one of these primary anticonvulsant drugs." | 1.27 | Alternative single anticonvulsant drug therapy for refractory epilepsy. ( Richter, K; Schmidt, D, 1986) |
| " Daily fluctuations in serum levels of carbamazepine and carbamazepine-10,11-epoxide did not appear to be related to the dosage schedule, but some patients tended to have lower fluctuations when the carbamazepine was given more frequently." | 1.26 | CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients. ( Bakke, J; Gerna, M; Johannessen, SI; Morselli, PL; Strandjord, RE, 1976) |
| "The Michaelis-Menten pharmacokinetics and bioavailability of phenytoin were evaluated in children." | 1.26 | Plasma levels and pharmacokinetics of antipileptic drugs in children. ( Miura, H, 1981) |
| "The diagnosis of functional seizures is difficult and emotional factors may be important in the cause and triggering of seizures." | 1.26 | Differentiating between organic and functional seizures: a common diagnostic problem. ( Chambers, BR; Vajda, FJ, 1981) |
| "Analysis of the recurrence of seizures suggested that the first year of treatment may be crucial in determining the long-term prognosis." | 1.26 | Early prognosis of epilepsy. ( Reynolds, EH; Shorvon, SD, 1982) |
| "Only 21% of those with myoclonic astatic epilepsy have become free from seizures." | 1.26 | Sodium valproate: monotherapy and polytherapy. ( Covanis, A; Gupta, AK; Jeavons, PM, 1982) |
| "Since epilepsy is a long-standing condition lasting for years to decades, short-spanned cross-sectional observations are often misleading." | 1.26 | Therapeutic concentration of antiepileptic drugs and the severity of epileptogenesis. ( Kakegawa, N; Seino, M, 1982) |
| "Among those who showed an IgA deficiency during phenytoin treatment, 14 had the antigen HLA-A2." | 1.26 | HLA antigens in epileptic patients with drug-induced immunodeficiency. ( Aarli, JA; Gilhus, NE; Thorsby, E, 1982) |
| "Carbamazepine treatment was effective in all patients." | 1.26 | Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome? ( Cirignotta, F; Lugaresi, E, 1981) |
| "Carbamazepine was given to 152 patients who were receiving multiple drug therapy for uncontrolled seizures." | 1.26 | Role of carbamazepine in reducing polypharmacy in epilepsy. ( Maheshwari, MC; Padmini, R, 1981) |
| "Epilepsy is a common disorder affecting approximately one in every two hundred people, from all walks of life, and presenting in addition to the seizure disorder itself, varying social, psychological and economic problems." | 1.26 | Epilepsy. ( Gilligan, B, 1976) |
| "phenytoin were evaluated." | 1.26 | Neuropsychological correlates of anticonvulsants and epileptiform discharges in adult epileptics. ( Dodrill, CB; Wilkus, RJ, 1978) |
| "Carbamazepine has recently been introduced for the treatment of generalized tonic-clonic and partial seizures." | 1.26 | Recent advances in drug therapy for epilepsy. ( Bruni, J, 1979) |
| " Pharmacokinetic of carbamazepine were made in 7 new-borns and in 5 children." | 1.26 | Pharmacokinetics of carbamazepine in the neonate and in the child. ( Aicardi, J; d'Athis, P; de Lauture, D; Dulac, O; Olive, G; Rey, E, 1979) |
| " Monitoring plasma concentrations may lead to adaptations of the choice of the drug and of the dosage regimen." | 1.26 | Kinetics of drug interactions in the treatment of epilepsy. ( Guelen, P; Knop, H; Schobten, F; van der Kleijn, E; Vree, T; Westenberg, H, 1978) |
| "Phenytoin produced a lower serum level than the same dose of its sodium salt." | 1.25 | Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy. ( Gamstorp, I; Lilienberg, G; Norell, E, 1975) |
| " Reduction in antiepileptic drug dosage should be carried out as a stepwise procedure over a period of about 2 years." | 1.25 | [A discussion of the curability of childhood epilepsies (author's transl)]. ( Groh, C, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 641 (27.02) | 18.7374 |
| 1990's | 546 (23.02) | 18.2507 |
| 2000's | 551 (23.23) | 29.6817 |
| 2010's | 481 (20.28) | 24.3611 |
| 2020's | 153 (6.45) | 2.80 |
| Authors | Studies |
|---|---|
| Anger, T | 1 |
| Madge, DJ | 1 |
| Mulla, M | 1 |
| Riddall, D | 1 |
| Owen, A | 1 |
| Pirmohamed, M | 10 |
| Tettey, JN | 1 |
| Morgan, P | 1 |
| Chadwick, D | 9 |
| Park, BK | 3 |
| Hoyt, SB | 1 |
| London, C | 1 |
| Wyvratt, MJ | 1 |
| Fisher, MH | 1 |
| Cashen, DE | 1 |
| Felix, JP | 1 |
| Garcia, ML | 1 |
| Li, X | 3 |
| Lyons, KA | 1 |
| Euan MacIntyre, D | 1 |
| Martin, WJ | 1 |
| Priest, BT | 1 |
| Smith, MM | 1 |
| Warren, VA | 1 |
| Williams, BS | 1 |
| Kaczorowski, GJ | 1 |
| Parsons, WH | 1 |
| Azam, F | 1 |
| El-Gnidi, BA | 1 |
| Alkskas, IA | 1 |
| Piao, FY | 1 |
| Han, RB | 1 |
| Zhang, W | 2 |
| Zhang, WB | 1 |
| Jiang, RS | 1 |
| McComsey, DF | 1 |
| Smith-Swintosky, VL | 1 |
| Parker, MH | 1 |
| Brenneman, DE | 1 |
| Malatynska, E | 1 |
| White, HS | 6 |
| Klein, BD | 1 |
| Wilcox, KS | 3 |
| Milewski, ME | 1 |
| Herb, M | 1 |
| Finley, MF | 1 |
| Liu, Y | 2 |
| Lubin, ML | 1 |
| Qin, N | 1 |
| Reitz, AB | 1 |
| Maryanoff, BE | 2 |
| Kumari, S | 1 |
| Mishra, CB | 1 |
| Tiwari, M | 1 |
| Tanaka, T | 3 |
| Yajima, N | 1 |
| Tanitame, A | 1 |
| Kiyoshi, T | 1 |
| Miura, Y | 1 |
| Karaźniewicz-Łada, M | 1 |
| Główka, AK | 1 |
| Mikulska, AA | 1 |
| Główka, FK | 1 |
| Fan, YX | 1 |
| Zhang, Z | 3 |
| Meng, JR | 1 |
| Yin, SJ | 1 |
| Wang, P | 6 |
| Zhou, T | 1 |
| Huang, YH | 1 |
| Meng, R | 1 |
| He, GH | 3 |
| Rochtus, AM | 1 |
| Herijgers, D | 1 |
| Jansen, K | 1 |
| Decallonne, B | 1 |
| Miceli, F | 1 |
| Guerrini, R | 3 |
| Nappi, M | 1 |
| Soldovieri, MV | 1 |
| Cellini, E | 1 |
| Gurnett, CA | 1 |
| Parmeggiani, L | 2 |
| Mei, D | 1 |
| Taglialatela, M | 1 |
| Jain, S | 2 |
| Nair, PP | 2 |
| Aghoram, R | 2 |
| Wadwekar, V | 2 |
| Wagh, S | 1 |
| Balachandran, M | 1 |
| Indira Priya, D | 1 |
| Meher, R | 1 |
| Nandwani, S | 1 |
| Sreekumaran Nair, N | 1 |
| Bisi-Onyemaechi, AI | 1 |
| Chikani, UN | 1 |
| Uwaezuoke, NA | 1 |
| Aronu, AE | 1 |
| Ojinnaka, NC | 1 |
| LoPinto-Khoury, C | 2 |
| Brennan, L | 1 |
| Mintzer, S | 7 |
| Pino, EJ | 1 |
| Pucheu, F | 1 |
| Alvarado, F | 1 |
| Gomez, B | 1 |
| De Diego, M | 1 |
| Mennickent, S | 2 |
| Aguayo, C | 1 |
| Pena, C | 1 |
| Rodriguez, A | 1 |
| Ilia, TS | 1 |
| Dragoumi, P | 1 |
| Papanikolopoulou, S | 1 |
| Goulis, DG | 1 |
| Pavlou, E | 1 |
| Zafeiriou, D | 1 |
| Larsson, D | 3 |
| Baftiu, A | 2 |
| Johannessen Landmark, C | 2 |
| von Euler, M | 2 |
| Kumlien, E | 3 |
| Åsberg, S | 2 |
| Zelano, J | 4 |
| Bernal Cobo, R | 1 |
| Giraldo Tapias, LM | 1 |
| Gómez Escobar, T | 1 |
| Rueda Cárdenas, LF | 1 |
| Zapata Berruecos, JF | 1 |
| Vásquez Trespalacios, EM | 1 |
| Giraldo Castrillón, YM | 1 |
| Rojas-Gualdrón, DF | 1 |
| Zhang, YJ | 2 |
| Lu, XM | 1 |
| Li, PW | 1 |
| Guo, CA | 1 |
| Wan, DJ | 1 |
| Bian, S | 1 |
| Tao, Y | 1 |
| Zhu, Z | 2 |
| Zhu, P | 1 |
| Wang, Q | 1 |
| Wu, H | 1 |
| Sawan, M | 1 |
| Bridwell, RE | 1 |
| Brown, S | 2 |
| Clerkin, S | 1 |
| Birdsong, S | 1 |
| Long, B | 1 |
| Midelfart-Hoff, J | 1 |
| Gradek, G | 1 |
| Wendelbo, Ø | 1 |
| Engelsen, BA | 2 |
| Pennell, PB | 11 |
| Karanam, A | 1 |
| Meador, KJ | 10 |
| Gerard, E | 1 |
| Kalayjian, L | 1 |
| Penovich, P | 1 |
| Matthews, A | 1 |
| McElrath, TM | 1 |
| Birnbaum, AK | 8 |
| Brigo, F | 6 |
| Igwe, SC | 2 |
| Bragazzi, NL | 2 |
| Lattanzi, S | 4 |
| Szulczyk, B | 1 |
| Spyrka, A | 1 |
| Boughrara, W | 1 |
| Chentouf, A | 1 |
| Fukuyama, K | 1 |
| Okada, M | 1 |
| Hochbaum, M | 1 |
| Kienitz, R | 1 |
| Rosenow, F | 4 |
| Schulz, J | 1 |
| Habermehl, L | 1 |
| Langenbruch, L | 1 |
| Kovac, S | 1 |
| Knake, S | 2 |
| von Podewils, F | 1 |
| von Brauchitsch, S | 1 |
| Hamacher, M | 1 |
| Strzelczyk, A | 2 |
| Willems, LM | 1 |
| Zhao, F | 1 |
| Xiao, K | 1 |
| Wu, C | 1 |
| Zhou, S | 2 |
| Li, R | 1 |
| Chen, Z | 1 |
| Ren, R | 1 |
| Wang, X | 9 |
| Dai, Q | 1 |
| Wen, D | 1 |
| Guan, Y | 1 |
| Zhang, X | 5 |
| Tang, S | 1 |
| Zhou, L | 1 |
| Huang, M | 2 |
| Čiauškaitė, J | 1 |
| Gelžinienė, G | 1 |
| Jurkevičienė, G | 1 |
| Santalucia, R | 1 |
| Vilain, C | 1 |
| Soblet, J | 1 |
| De Laet, C | 1 |
| Vuckovic, A | 1 |
| König, J | 1 |
| Aeby, A | 1 |
| Bjørk, MH | 6 |
| Zoega, H | 5 |
| Leinonen, MK | 5 |
| Cohen, JM | 5 |
| Dreier, JW | 3 |
| Furu, K | 5 |
| Gilhus, NE | 7 |
| Gissler, M | 5 |
| Hálfdánarson, Ó | 1 |
| Igland, J | 2 |
| Sun, Y | 4 |
| Tomson, T | 33 |
| Alvestad, S | 7 |
| Christensen, J | 6 |
| Han, Y | 2 |
| Yang, J | 1 |
| Zhong, R | 2 |
| Guo, X | 1 |
| Cai, M | 2 |
| Lin, W | 5 |
| Sayin, S | 1 |
| Bagci, M | 1 |
| Yang, Q | 1 |
| Hu, Y | 2 |
| Dai, H | 2 |
| Panda, SP | 1 |
| Dhurandhar, Y | 1 |
| Agrawal, M | 1 |
| Asadi-Pooya, AA | 3 |
| Patel, AA | 2 |
| Trinka, E | 9 |
| Mazurkiewicz-Beldzinska, M | 1 |
| Cross, JH | 1 |
| Welty, TE | 1 |
| Wentland, L | 1 |
| Downs, C | 1 |
| Fu, E | 1 |
| Schabert, VF | 1 |
| Stern, S | 1 |
| Ferrari, L | 1 |
| Wade, CT | 1 |
| Willke, RJ | 1 |
| Hauser, WA | 1 |
| Dell'Isola, GB | 1 |
| Mencaroni, E | 1 |
| Fattorusso, A | 1 |
| Tascini, G | 1 |
| Prontera, P | 2 |
| Imperatore, V | 1 |
| Di Cara, G | 1 |
| Striano, P | 6 |
| Verrotti, A | 17 |
| Olaciregui-Dague, K | 1 |
| Weinhold, L | 1 |
| Hoppe, C | 1 |
| Schmid, M | 1 |
| Surges, R | 1 |
| Zhang, YY | 1 |
| Xia, Y | 1 |
| Guo, HL | 1 |
| Hu, YH | 1 |
| Wen, XY | 1 |
| Chen, J | 1 |
| Lu, XP | 2 |
| Wang, SS | 1 |
| Qiu, JC | 1 |
| Chen, F | 2 |
| Yao, N | 1 |
| Huang, S | 1 |
| Huang, A | 1 |
| Song, H | 1 |
| Stelzle, D | 1 |
| Kaducu, J | 1 |
| Schmidt, V | 1 |
| Welte, TM | 1 |
| Ngowi, BJ | 1 |
| Matuja, W | 1 |
| Escheu, G | 1 |
| Hauke, P | 1 |
| Richter, V | 1 |
| Ovuga, E | 1 |
| Pfausler, B | 1 |
| Schmutzhard, E | 1 |
| Amos, A | 1 |
| Harrison, W | 1 |
| Keller, L | 1 |
| Winkler, AS | 1 |
| Wang, J | 7 |
| Fu, J | 2 |
| Sun, W | 2 |
| Yin, X | 1 |
| Lv, K | 1 |
| Zhang, J | 4 |
| Mensah, JA | 1 |
| Johnson, K | 1 |
| Reilly, CA | 1 |
| Rower, JE | 1 |
| Metcalf, CS | 1 |
| Ghazala, E | 1 |
| Shahin, DA | 1 |
| Wahba, Y | 1 |
| Gremke, N | 1 |
| Printz, M | 1 |
| Möller, L | 1 |
| Ehrenberg, C | 1 |
| Kostev, K | 3 |
| Kalder, M | 1 |
| Battino, D | 9 |
| Bromley, R | 3 |
| Kochen, S | 3 |
| Thomas, SV | 3 |
| Borowicz-Reutt, K | 2 |
| Banach, M | 3 |
| de Toledo, M | 1 |
| de la Fuente, E | 1 |
| Ramos, C | 1 |
| Ferreiros-Martinez, R | 1 |
| Muro, I | 1 |
| Vieira Campos, A | 1 |
| de Toledo, MP | 1 |
| Lagares, A | 1 |
| Sobrado, M | 1 |
| Ovejero-Benito, MC | 1 |
| Canitano, R | 1 |
| Palumbi, R | 1 |
| Scandurra, V | 1 |
| Omefe, PN | 1 |
| N Adeboye, MA | 1 |
| Biliaminu, SA | 1 |
| Ojuawo, A | 1 |
| Tateishi, Y | 1 |
| Ishikawa, N | 1 |
| Kobayashi, Y | 1 |
| Izumo, H | 1 |
| Eguchi, Y | 1 |
| Okada, S | 1 |
| Cesta, CE | 3 |
| Nørgaard, M | 3 |
| Einarsdóttir, K | 3 |
| Engeland, A | 3 |
| Karlstad, Ø | 3 |
| Klungsøyr, K | 3 |
| Odsbu, I | 3 |
| Reutfors, J | 3 |
| Selmer, RM | 3 |
| Ulrichsen, SP | 3 |
| Shewell, LK | 1 |
| Day, CJ | 1 |
| De Bisscop, X | 1 |
| Edwards, JL | 1 |
| Jennings, MP | 1 |
| Salahinejad, A | 1 |
| Meuthen, D | 1 |
| Attaran, A | 1 |
| Chivers, DP | 1 |
| Ferrari, MCO | 1 |
| Fairclough, S | 1 |
| Goodden, J | 1 |
| Chumas, P | 1 |
| Mathew, R | 1 |
| Maguire, M | 5 |
| Fujita, Y | 1 |
| Murai, M | 1 |
| Muraki, S | 1 |
| Suetsugu, K | 1 |
| Tsuchiya, Y | 1 |
| Hirota, T | 2 |
| Matsunaga, N | 1 |
| Ieiri, I | 1 |
| Wójcik, K | 1 |
| Franciszek Kołek, M | 1 |
| Dec-Ćwiek, M | 1 |
| Słowik, A | 2 |
| Bosak, M | 2 |
| Bui, TP | 1 |
| Nguyen, LTT | 1 |
| Le, PL | 1 |
| Le, NTT | 1 |
| Nguyen, TD | 1 |
| Van Nguyen, L | 1 |
| Van Nguyen, AT | 1 |
| Trinh, TH | 1 |
| Bonaccorso, A | 1 |
| Gigliobianco, MR | 1 |
| Lombardo, R | 1 |
| Pellitteri, R | 1 |
| Di Martino, P | 1 |
| Mancuso, A | 1 |
| Musumeci, T | 1 |
| Li, J | 5 |
| Sha, L | 1 |
| Xu, Q | 2 |
| Kośmider, K | 1 |
| Kamieniak, M | 1 |
| Czuczwar, SJ | 8 |
| Miziak, B | 1 |
| Hersi, H | 2 |
| Raitanen, J | 3 |
| Saarinen, JT | 2 |
| Peltola, J | 6 |
| Mesraoua, B | 1 |
| Perucca, E | 35 |
| Yuan, Y | 2 |
| Zhang, S | 1 |
| Yan, X | 2 |
| Zhang, L | 3 |
| Ran, YW | 1 |
| Sokolov, E | 1 |
| Dietrich, J | 1 |
| Cole, AJ | 2 |
| Lekhwani, S | 1 |
| Dhama, A | 1 |
| Kaushik, JS | 1 |
| Pekoz, MT | 1 |
| Aslan-Kara, K | 1 |
| Tekin, B | 1 |
| Gurses, C | 1 |
| Yeni, SN | 1 |
| Bozdemir, H | 1 |
| Keskin-Guler, S | 1 |
| Ataklı, D | 4 |
| Gul, G | 2 |
| Eren, F | 1 |
| Sarı, H | 1 |
| Gul, ZB | 1 |
| Ceyhan-Dirican, A | 1 |
| Genc, F | 1 |
| Bicer-Gomceli, Y | 1 |
| Ozkara, C | 2 |
| Delil, S | 1 |
| Atalar, AC | 1 |
| Bebek, N | 2 |
| Baykan, B | 1 |
| Bora, İ | 1 |
| Bican-Demir, A | 1 |
| Mısırlı, CH | 1 |
| Tutkavul, K | 1 |
| Velioglu, SK | 1 |
| Ilhan-Algin, D | 1 |
| Erdinc, O | 1 |
| Saygi, S | 1 |
| Tezer-Fılık, I | 1 |
| Apaydın-Dogan, E | 1 |
| Akyol, A | 1 |
| Kamisli, O | 1 |
| Yalcın, AD | 1 |
| Cakmak, G | 1 |
| Ersoy, A | 1 |
| Ustun-Ozek, S | 1 |
| Halac, G | 1 |
| Kutlu, G | 1 |
| Tantik-Pak, A | 1 |
| Yücel, SP | 1 |
| Ziganshina, LE | 1 |
| Abakumova, T | 1 |
| Hoyle, CHV | 1 |
| Perrott, S | 1 |
| Khan, QI | 1 |
| Counsell, CE | 1 |
| Macleod, AD | 1 |
| Du, Y | 1 |
| Lin, J | 1 |
| Gong, J | 1 |
| Xia, N | 1 |
| Zheng, R | 1 |
| Xu, H | 4 |
| Huang, P | 1 |
| Yu, Q | 1 |
| Lu, J | 1 |
| Liu, P | 1 |
| Yang, Y | 1 |
| Feng, Z | 1 |
| Cai, J | 1 |
| Yang, G | 1 |
| Yuan, H | 1 |
| Tang, H | 1 |
| Lu, Y | 2 |
| Demir, I | 1 |
| Adiguzel, A | 1 |
| Aricò, M | 1 |
| Mastrangelo, M | 1 |
| Di Noia, SP | 1 |
| Mabusi, MS | 1 |
| Kalolo, A | 1 |
| Pisani, F | 11 |
| Saleh Faisal, M | 1 |
| Jamil, A | 1 |
| Ali, N | 4 |
| Alshahrani, AM | 1 |
| Almarshad, F | 1 |
| Ma, Y | 1 |
| Deng, J | 1 |
| Fu, Z | 1 |
| Chen, C | 2 |
| Weng, J | 1 |
| Shen, Y | 1 |
| Fang, F | 3 |
| Qian, X | 1 |
| Deng, Y | 1 |
| Zhong, N | 1 |
| Li, Y | 3 |
| Yan, J | 2 |
| Liu, W | 1 |
| Ye, J | 2 |
| Liu, J | 3 |
| Xiao, G | 1 |
| Peng, L | 2 |
| Tao, T | 1 |
| Chen, Y | 3 |
| Mohammed, HS | 1 |
| Aboul Ezz, HS | 1 |
| Zedan, A | 1 |
| Ali, MA | 1 |
| Rawat, C | 1 |
| Kukal, S | 1 |
| Kushwaha, S | 1 |
| Agarwal, R | 1 |
| Sharma, S | 4 |
| Srivastava, AK | 3 |
| Kukreti, R | 3 |
| Revilla Orías, MD | 1 |
| Alonso, X | 1 |
| Campistol, J | 1 |
| Macaya, A | 1 |
| Escofet, C | 1 |
| Fons, C | 1 |
| Del Giovane, C | 1 |
| Nardone, R | 1 |
| Silvestrini, M | 1 |
| Zhao, GX | 2 |
| Shen, ML | 2 |
| Xie, CX | 1 |
| Pich, J | 1 |
| Qushawy, M | 1 |
| Prabahar, K | 1 |
| Abd-Alhaseeb, M | 1 |
| Swidan, S | 1 |
| Nasr, A | 1 |
| Yamamoto, Y | 3 |
| Takahashi, Y | 5 |
| Imai, K | 5 |
| Ohta, A | 1 |
| Kagawa, Y | 3 |
| Inoue, Y | 1 |
| Kardoost, M | 1 |
| Hajizadeh-Saffar, E | 1 |
| Ghorbanian, MT | 1 |
| Ghezelayagh, Z | 1 |
| Pooshang Bagheri, K | 1 |
| Behdani, M | 1 |
| Habibi-Anbouhi, M | 1 |
| Pejanovic-Skobic, N | 1 |
| Markovic, I | 1 |
| Bozina, N | 2 |
| Basic, S | 1 |
| Operto, FF | 2 |
| Pastorino, GMG | 2 |
| Mazza, R | 1 |
| Carotenuto, M | 1 |
| Roccella, M | 1 |
| Marotta, R | 1 |
| di Bonaventura, C | 3 |
| Ben-Menachem, E | 3 |
| Grebe, HP | 1 |
| Terada, K | 3 |
| Jensen, L | 1 |
| Li, T | 2 |
| De Backer, M | 4 |
| Steiniger-Brach, B | 3 |
| Gasalla, T | 2 |
| Brock, M | 2 |
| Biton, V | 3 |
| Schmitz, B | 1 |
| Dimova, S | 3 |
| Zhang, Y | 6 |
| Chellun, D | 2 |
| Husebye, ESN | 1 |
| Spigset, O | 1 |
| Daltveit, AK | 1 |
| Velghe, S | 1 |
| Delahaye, L | 1 |
| Ogwang, R | 1 |
| Hotterbeekx, A | 1 |
| Colebunders, R | 1 |
| Mandro, M | 1 |
| Idro, R | 1 |
| Stove, CP | 1 |
| Söderberg Löfdal, K | 1 |
| Asoğlu, R | 1 |
| Özdemir, M | 1 |
| Aladağ, N | 1 |
| Asoğlu, E | 1 |
| Brandt, C | 3 |
| Bozorg, A | 1 |
| Ferrò, B | 1 |
| Holmes, GL | 5 |
| Kälviäinen, R | 7 |
| Fox, J | 1 |
| Ajinkya, S | 1 |
| Lekoubou, A | 1 |
| Jha, S | 1 |
| Basnet, A | 1 |
| Ranjan Kumar, R | 1 |
| Dhooria, A | 1 |
| Krishnaraju, VS | 1 |
| Dhir, V | 1 |
| Diemar, SS | 1 |
| Sejling, AS | 1 |
| Eiken, P | 1 |
| Ellegaard, M | 1 |
| Ding, M | 2 |
| Andersen, NB | 1 |
| Jørgensen, NR | 1 |
| Nosal', LA | 1 |
| Simonova, NV | 1 |
| Dorovskikh, VA | 1 |
| Shtarberg, MA | 1 |
| Chen, Q | 1 |
| Li, M | 2 |
| Cui, L | 2 |
| Tayama, T | 1 |
| Mori, T | 1 |
| Goji, A | 1 |
| Toda, Y | 1 |
| Kagami, S | 1 |
| Watkins, L | 1 |
| O'Dwyer, M | 1 |
| Oak, K | 1 |
| Lawthom, C | 1 |
| Thomas, R | 1 |
| Shankar, R | 1 |
| Hagemann, A | 1 |
| Klimpel, D | 1 |
| Bien, CG | 1 |
| May, TW | 6 |
| Myers, KA | 1 |
| Tamon, U | 1 |
| Agnihotram, RV | 1 |
| Berrahmoune, S | 1 |
| Altun, Y | 1 |
| Yasar, E | 1 |
| Uribe-San-Martín, R | 1 |
| Ciampi, E | 1 |
| Santibañez, R | 1 |
| Irani, SR | 1 |
| Márquez, A | 1 |
| Cruz, JP | 1 |
| Soler, B | 1 |
| Miranda, MC | 1 |
| Henríquez, M | 1 |
| Cárcamo, C | 1 |
| Limotai, C | 2 |
| Phayaph, N | 1 |
| Pattanasilp, B | 1 |
| Mokklaew, J | 1 |
| Limotai, N | 1 |
| Yip, KL | 1 |
| Zhou, X | 1 |
| Chook, P | 1 |
| Leung, PC | 1 |
| Schachter, S | 1 |
| Mok, VCT | 1 |
| Leung, TWH | 1 |
| Koon, CM | 1 |
| Leung, H | 2 |
| Zhao, T | 1 |
| Li, HJ | 1 |
| Wang, TT | 1 |
| Bahatibieke, M | 1 |
| Jia, L | 1 |
| Wang, F | 1 |
| Liu, WL | 1 |
| Ji, Y | 1 |
| Sun, L | 2 |
| Yu, LH | 1 |
| Adney, SK | 1 |
| Millichap, JJ | 1 |
| DeKeyser, JM | 1 |
| Abramova, T | 1 |
| Thompson, CH | 1 |
| George, AL | 1 |
| Krarup, S | 1 |
| Mertz, C | 1 |
| Jakobsen, E | 1 |
| Lindholm, SEH | 1 |
| Pinborg, LH | 1 |
| Bak, LK | 1 |
| Noguchi, Y | 1 |
| Takaoka, M | 1 |
| Hayashi, T | 5 |
| Tachi, T | 1 |
| Teramachi, H | 1 |
| Söylemez, E | 1 |
| Öztürk, O | 1 |
| Baslo, SA | 1 |
| Balçık, ZE | 1 |
| Balabanova, S | 1 |
| Taylor, C | 1 |
| Sills, G | 1 |
| Burnside, G | 1 |
| Plumpton, C | 1 |
| Smith, PEM | 1 |
| Appleton, R | 2 |
| Leach, JP | 2 |
| Johnson, M | 1 |
| Baker, G | 3 |
| Hughes, DA | 3 |
| Williamson, PR | 11 |
| Tudur-Smith, C | 2 |
| Marson, AG | 32 |
| Ogunjimi, L | 2 |
| Yaria, J | 2 |
| Makanjuola, A | 2 |
| Alabi, A | 2 |
| Osalusi, B | 2 |
| Oboh, D | 2 |
| Olusola-Bello, M | 2 |
| Olawale, O | 1 |
| Ogunniyi, A | 2 |
| Yu, L | 2 |
| Feng, J | 1 |
| Yu, Z | 1 |
| Araki, Y | 1 |
| Fukushima, Y | 4 |
| Lee, JE | 1 |
| Min, KR | 1 |
| Kim, SH | 5 |
| Kim, AH | 1 |
| Kim, ST | 1 |
| Santhosh, AP | 1 |
| Kumar Goyal, M | 1 |
| Modi, M | 1 |
| Kharbanda, PS | 1 |
| Ahuja, CK | 1 |
| Tandyala, N | 1 |
| Prabhat, N | 1 |
| Singh, R | 1 |
| Mehta, S | 1 |
| Vinay Mahesh, K | 1 |
| Miyata-Nozaka, Y | 1 |
| Tan, HJ | 4 |
| Wong, SW | 3 |
| Raymond, AA | 4 |
| Omar, H | 1 |
| Zain, SM | 1 |
| Wiggs, KK | 1 |
| Rickert, ME | 1 |
| Sujan, AC | 1 |
| Quinn, PD | 1 |
| Larsson, H | 2 |
| Lichtenstein, P | 1 |
| Oberg, AS | 1 |
| D'Onofrio, BM | 1 |
| Åndell, E | 1 |
| Åmark, P | 1 |
| Pihlström, N | 1 |
| Tedroff, K | 1 |
| Carlsson, S | 1 |
| Daugaard, CA | 1 |
| Pedersen, L | 1 |
| Shiratani, Y | 1 |
| Asai, S | 1 |
| Usui, N | 1 |
| Nishida, T | 1 |
| Roebling, R | 1 |
| Yip, VLM | 1 |
| Pertinez, H | 1 |
| Meng, X | 1 |
| Maggs, JL | 2 |
| Carr, DF | 1 |
| Şimşek, F | 2 |
| Ceylan, M | 1 |
| Kızıltunç, A | 1 |
| İyigün, İ | 1 |
| Li, KY | 1 |
| Huang, LC | 1 |
| Chang, YP | 1 |
| Yang, YH | 2 |
| Blackmon, K | 1 |
| Waechter, R | 1 |
| Landon, B | 1 |
| Noël, T | 1 |
| Macpherson, C | 1 |
| Donald, T | 1 |
| Cudjoe, N | 1 |
| Evans, R | 1 |
| Burgen, KS | 1 |
| Jayatilake, P | 1 |
| Oyegunle, V | 1 |
| Pedraza, O | 1 |
| Abdel Baki, S | 1 |
| Thesen, T | 1 |
| Dlugos, D | 1 |
| Chari, G | 1 |
| Grossi-Soyster, EN | 1 |
| Krystosik, AR | 1 |
| LaBeaud, AD | 1 |
| Kong, FC | 1 |
| Ma, CL | 4 |
| Lang, LQ | 1 |
| Zhong, MK | 5 |
| Beydoun, A | 4 |
| DuPont, S | 2 |
| Zhou, D | 3 |
| Matta, M | 1 |
| Nagire, V | 1 |
| Lagae, L | 1 |
| Vajda, FJE | 3 |
| O'Brien, TJ | 7 |
| Graham, JE | 1 |
| Hitchcock, AA | 2 |
| Mitchell, J | 1 |
| Horgan, D | 1 |
| Lander, CM | 3 |
| Eadie, MJ | 15 |
| Borowicz-Reutt, KK | 1 |
| Stritzelberger, J | 1 |
| Lang, JD | 1 |
| Mueller, TM | 1 |
| Reindl, C | 1 |
| Westermayer, V | 1 |
| Hamer, HM | 2 |
| Kaplan, YC | 1 |
| Demir, O | 1 |
| Berghuis, B | 2 |
| Hulst, J | 1 |
| Sonsma, A | 1 |
| McCormack, M | 2 |
| de Haan, GJ | 3 |
| Sander, JW | 17 |
| Lindhout, D | 11 |
| Koeleman, BPC | 3 |
| Müller, RM | 1 |
| Herziger, B | 1 |
| Jeschke, S | 1 |
| Neininger, MP | 2 |
| Bertsche, T | 2 |
| Bertsche, A | 2 |
| Aderinola, A | 1 |
| Kissani, N | 1 |
| Cherkaoui Rhazouani, O | 1 |
| Souirti, Z | 1 |
| Khramaz, M | 1 |
| Meryem, C | 1 |
| Mebrouk, Y | 1 |
| Ouazzani, R | 2 |
| Jang, Y | 1 |
| Yoon, S | 1 |
| Kim, TJ | 3 |
| Lee, S | 1 |
| Yu, KS | 4 |
| Jang, IJ | 5 |
| Chu, K | 4 |
| Lee, SK | 5 |
| Cai, WK | 1 |
| Griepp, DW | 1 |
| Kim, DJ | 1 |
| Ganz, M | 1 |
| Dolphin, EJ | 1 |
| Sotudeh, N | 1 |
| Burekhovich, SA | 1 |
| Naziri, Q | 1 |
| Milligan, TA | 1 |
| Kakumoto, M | 1 |
| Shimokawa, K | 1 |
| Ueshima, S | 1 |
| Hira, D | 1 |
| Okano, T | 1 |
| Yuliwulandari, R | 1 |
| Shin, JG | 2 |
| Kristin, E | 1 |
| Suyatna, FD | 1 |
| Prahasto, ID | 1 |
| Prayuni, K | 1 |
| Mahasirimongkol, S | 2 |
| Cavallari, LH | 2 |
| Mitropoulou, C | 1 |
| Patrinos, GP | 1 |
| Hao, J | 2 |
| Williams, MS | 2 |
| Snyder, SR | 2 |
| Karlov, VA | 5 |
| Vlasov, PN | 4 |
| Kozhokaru, AB | 1 |
| Orlova, AS | 1 |
| Rohracher, A | 1 |
| Scuoppo, C | 1 |
| Padovano, C | 1 |
| Vivenzio, V | 1 |
| Donadio, S | 1 |
| Coppola, G | 2 |
| Tatum, S | 1 |
| Smith, ZZ | 1 |
| Taylor, JA | 1 |
| Poulsen, DJ | 1 |
| Dudek, FE | 4 |
| Barth, DS | 1 |
| Barzroodi Pour, M | 1 |
| Bayat, M | 1 |
| Navazesh, A | 1 |
| Soleimani, M | 1 |
| Karimzadeh, F | 1 |
| Loikas, D | 1 |
| Linnér, L | 1 |
| Sundström, A | 1 |
| Wettermark, B | 1 |
| Li, N | 1 |
| Zhao, D | 1 |
| Tensini, TS | 1 |
| Von Glehn, CQC | 1 |
| Bettinotti, MP | 1 |
| Iglehart, B | 1 |
| de Paola, L | 2 |
| Lohr, A | 1 |
| Rodrigues, M | 2 |
| Tensini, FS | 1 |
| Braatz, VL | 1 |
| Silvado, CES | 1 |
| Håkansson, S | 1 |
| Karlander, M | 1 |
| Mahamud, Z | 1 |
| Garcia-Ptacek, S | 1 |
| Zelezniak, A | 1 |
| Bertram, EH | 1 |
| Edelbroek, P | 1 |
| Uçan Tokuç, FE | 1 |
| Fatma, G | 1 |
| Abidin, E | 1 |
| Yasemin, GB | 1 |
| Hu, T | 1 |
| Zeng, X | 1 |
| Tian, T | 1 |
| Zhang, ML | 1 |
| Chen, XL | 1 |
| Bai, ZF | 1 |
| Zhao, X | 1 |
| Li, WX | 1 |
| Wang, XY | 1 |
| Zhang, H | 2 |
| Chen, XF | 1 |
| Zhang, SQ | 1 |
| Tang, JF | 1 |
| Xiao, XH | 1 |
| Zhao, YL | 1 |
| Pavone, C | 1 |
| Giacalone, N | 1 |
| Vella, M | 1 |
| Urso, L | 1 |
| Zummo, L | 1 |
| Fierro, B | 1 |
| Chong, HY | 1 |
| Mohamed, Z | 3 |
| Tan, LL | 1 |
| Wu, DBC | 1 |
| Shabaruddin, FH | 1 |
| Dahlui, M | 1 |
| Apalasamy, YD | 1 |
| Chaiyakunapruk, N | 1 |
| Das, S | 1 |
| Fleming, DH | 1 |
| Mathew, BS | 1 |
| Winston A, B | 1 |
| Prabhakar, AT | 1 |
| Alexander, M | 1 |
| Shih, FY | 1 |
| Chuang, YC | 2 |
| Chuang, MJ | 1 |
| Lu, YT | 1 |
| Tsai, WC | 1 |
| Fu, TY | 1 |
| Tsai, MH | 1 |
| Thomson, KE | 3 |
| Modi, AC | 1 |
| Glauser, TA | 3 |
| Rausch, JR | 1 |
| Steve White, H | 2 |
| Zuberi, NA | 1 |
| Baig, M | 1 |
| Bano, S | 1 |
| Batool, Z | 1 |
| Haider, S | 1 |
| Perveen, T | 1 |
| Pariente, G | 1 |
| Leibson, T | 1 |
| Shulman, T | 1 |
| Adams-Webber, T | 1 |
| Barzilay, E | 1 |
| Nulman, I | 3 |
| Lin, G | 1 |
| Zhang, K | 1 |
| Xie, J | 1 |
| Morris, G | 1 |
| Leite, M | 1 |
| Kullmann, DM | 1 |
| Pavlov, I | 1 |
| Schorge, S | 2 |
| Lignani, G | 1 |
| van der Palen, J | 1 |
| Patsalos, PN | 15 |
| Zugman, M | 1 |
| Lake, C | 1 |
| James, A | 1 |
| Ratnaraj, N | 5 |
| Bolin, K | 1 |
| Berggren, F | 1 |
| Berling, P | 1 |
| Morberg, S | 1 |
| Gauffin, H | 1 |
| Landtblom, AM | 1 |
| Valero, M | 1 |
| Averkin, RG | 2 |
| Fernandez-Lamo, I | 1 |
| Aguilar, J | 1 |
| Lopez-Pigozzi, D | 1 |
| Brotons-Mas, JR | 1 |
| Cid, E | 1 |
| Tamas, G | 1 |
| Menendez de la Prida, L | 2 |
| Rahman, MM | 1 |
| Alatawi, Y | 1 |
| Cheng, N | 1 |
| Qian, J | 1 |
| Plotkina, AV | 1 |
| Peissig, PL | 1 |
| Berg, RL | 1 |
| Page, D | 1 |
| Hansen, RA | 1 |
| Nevitt, SJ | 3 |
| Sudell, M | 2 |
| Weston, J | 3 |
| Tudur Smith, C | 6 |
| Veroniki, AA | 1 |
| Rios, P | 1 |
| Cogo, E | 1 |
| Straus, SE | 1 |
| Finkelstein, Y | 1 |
| Kealey, R | 1 |
| Reynen, E | 1 |
| Soobiah, C | 1 |
| Thavorn, K | 1 |
| Hutton, B | 1 |
| Hemmelgarn, BR | 1 |
| Yazdi, F | 1 |
| D'Souza, J | 6 |
| MacDonald, H | 1 |
| Tricco, AC | 1 |
| Rodrigues, C | 1 |
| Chiron, C | 3 |
| Rey, E | 5 |
| Dulac, O | 6 |
| Comets, E | 1 |
| Pons, G | 2 |
| Jullien, V | 1 |
| Sharma, TK | 2 |
| Vardey, SK | 2 |
| Sitaraman, S | 2 |
| Shen, C | 1 |
| Zhang, B | 1 |
| Liu, Z | 4 |
| Tang, Y | 1 |
| Wang, S | 4 |
| Guo, Y | 4 |
| Ding, Y | 1 |
| Graham, J | 3 |
| Chen, X | 2 |
| Durisic, N | 1 |
| Lynch, JW | 1 |
| Keramidas, A | 1 |
| Ay, H | 1 |
| Ethemoğlu, Ö | 1 |
| Wang, B | 1 |
| Hadzagic-Catibusic, F | 1 |
| Hasanbegovic, E | 1 |
| Melunovic, M | 1 |
| Zubcevic, S | 1 |
| Uzicanin, S | 1 |
| Shakir, S | 2 |
| Udin, Z | 1 |
| Nazish, H | 2 |
| Nabi, M | 1 |
| Häfele, CA | 1 |
| Freitas, MP | 1 |
| Gervini, BL | 1 |
| de Carvalho, RM | 1 |
| Rombaldi, AJ | 1 |
| Rosati, A | 1 |
| Ilvento, L | 1 |
| Lucenteforte, E | 1 |
| Pugi, A | 1 |
| Crescioli, G | 1 |
| McGreevy, KS | 1 |
| Virgili, G | 1 |
| Mugelli, A | 1 |
| De Masi, S | 1 |
| Gui, H | 1 |
| Ingason, A | 1 |
| Speed, D | 1 |
| Wright, GEB | 1 |
| Zhang, EJ | 1 |
| Secolin, R | 1 |
| Yasuda, C | 1 |
| Kwok, M | 2 |
| Wolking, S | 1 |
| Becker, F | 1 |
| Rau, S | 1 |
| Avbersek, A | 1 |
| Heggeli, K | 1 |
| Leu, C | 1 |
| Depondt, C | 2 |
| Sills, GJ | 5 |
| Auce, P | 1 |
| Brodie, MJ | 35 |
| Francis, B | 1 |
| Johnson, MR | 3 |
| Coppola, A | 1 |
| Zara, F | 2 |
| Kunz, WS | 1 |
| Lerche, H | 1 |
| Klein, KM | 1 |
| Weckhuysen, S | 1 |
| Krenn, M | 1 |
| Gudmundsson, LJ | 1 |
| Stefánsson, K | 1 |
| Krause, R | 1 |
| Shear, N | 1 |
| Ross, CJD | 1 |
| Delanty, N | 2 |
| Carleton, BC | 1 |
| Cendes, F | 2 |
| Lopes-Cendes, I | 1 |
| Liao, WP | 2 |
| Sisodiya, SM | 4 |
| Cherny, S | 1 |
| Kwan, P | 6 |
| Baum, L | 2 |
| Cavalleri, GL | 2 |
| Ocek, L | 1 |
| Tarhan, H | 1 |
| Uludağ, FI | 1 |
| Sarıteke, A | 1 |
| Köse, C | 1 |
| Colak, A | 1 |
| Zorlu, F | 1 |
| Zorlu, Y | 3 |
| Lee, BI | 2 |
| No, SK | 1 |
| Yi, SD | 1 |
| Lee, HW | 5 |
| Kim, OJ | 1 |
| Kim, MK | 3 |
| Kim, SE | 2 |
| Kim, YS | 1 |
| Kim, JM | 2 |
| Lee, SJ | 1 |
| Shin, DJ | 2 |
| Park, SP | 2 |
| Kim, YI | 1 |
| Heo, K | 3 |
| Cho, YW | 2 |
| Cho, YJ | 2 |
| Kim, YN | 1 |
| Egunsola, O | 2 |
| Choonara, I | 3 |
| Sammons, HM | 1 |
| Whitehouse, WP | 1 |
| Sreedharan, M | 1 |
| Devadathan, K | 1 |
| Mohammed Kunju, PA | 1 |
| Sasidharan, B | 1 |
| Pillai, JP | 1 |
| Vasumathy Amma, MA | 1 |
| Muthubeevi, S | 1 |
| Antonucci, R | 1 |
| Cuzzolin, L | 1 |
| Manconi, A | 1 |
| Cherchi, C | 1 |
| Oggiano, AM | 1 |
| Locci, C | 1 |
| Lovrić, M | 1 |
| Čajić, I | 1 |
| Petelin Gadže, Ž | 1 |
| Klarica Domjanović, I | 1 |
| Parveen, B | 1 |
| Tripathi, M | 3 |
| Vohora, D | 1 |
| McCauley, S | 1 |
| Thiraviaraj, A | 1 |
| Pranteda, G | 2 |
| D 'arino, A | 1 |
| Pigliacelli, F | 1 |
| Rampioni-Vinciguerra, GL | 1 |
| Bottoni, U | 1 |
| Rocha, JF | 1 |
| Soares-da-Silva, P | 5 |
| Higashida, K | 1 |
| Yamagami, H | 1 |
| Tomari, S | 1 |
| Fukuma, K | 1 |
| Okuno, Y | 1 |
| Abe, S | 2 |
| Nagatsuka, K | 1 |
| Toyoda, K | 1 |
| Ihara, M | 1 |
| Yu, Y | 3 |
| Nie, X | 2 |
| Zhao, L | 4 |
| Intravooth, T | 1 |
| Staack, AM | 1 |
| Juerges, K | 1 |
| Stockinger, J | 1 |
| Steinhoff, BJ | 4 |
| Leo, A | 1 |
| Russo, E | 2 |
| Belcastro, V | 3 |
| Dagiasi, I | 1 |
| Vall, V | 1 |
| Burman, J | 1 |
| Bonizzoni, E | 2 |
| Craig, J | 3 |
| Sabers, A | 6 |
| Vajda, F | 3 |
| Chouchi, M | 1 |
| Kaabachi, W | 1 |
| Tizaoui, K | 1 |
| Daghfous, R | 1 |
| Aidli, SE | 1 |
| Hila, L | 1 |
| Cyranka, K | 1 |
| Dudek, D | 1 |
| Kowalik, M | 1 |
| Mołek, P | 1 |
| Chemaly, N | 1 |
| Nehlig, A | 1 |
| Nabbout, R | 1 |
| Thangaratinam, S | 1 |
| Marlin, N | 1 |
| Newton, S | 1 |
| Weckesser, A | 1 |
| Bagary, M | 1 |
| Greenhill, L | 2 |
| Rikunenko, R | 1 |
| D'Amico, M | 1 |
| Rogozińska, E | 1 |
| Kelso, A | 1 |
| Hard, K | 1 |
| Coleman, J | 1 |
| Moss, N | 1 |
| Roberts, T | 1 |
| Middleton, L | 1 |
| Dodds, J | 1 |
| Pullen, A | 1 |
| Eldridge, S | 1 |
| Pirie, A | 1 |
| Denny, E | 1 |
| McCorry, D | 1 |
| Khan, KS | 1 |
| Hoyt, CT | 1 |
| Domingo-Fernández, D | 1 |
| Balzer, N | 1 |
| Güldenpfennig, A | 1 |
| Hofmann-Apitius, M | 1 |
| Fricke-Galindo, I | 1 |
| LLerena, A | 1 |
| Jung-Cook, H | 1 |
| López-López, M | 1 |
| Galappatthy, P | 1 |
| Liyanage, CK | 1 |
| Lucas, MN | 1 |
| Jayasekara, DTLM | 1 |
| Abhayaratna, SA | 1 |
| Weeraratne, C | 1 |
| De Abrew, K | 1 |
| Gunaratne, PS | 1 |
| Gamage, R | 1 |
| Wijeyaratne, CN | 1 |
| Fakhoury, T | 1 |
| McDonough, B | 1 |
| Colson, AO | 1 |
| Stockis, A | 4 |
| Elmoufti, S | 1 |
| Whitesides, J | 1 |
| Syu, FK | 1 |
| Pan, HY | 1 |
| Chuang, PC | 1 |
| Huang, YS | 1 |
| Cheng, CY | 1 |
| Cheng, FJ | 1 |
| Barton, S | 1 |
| Nadebaum, C | 1 |
| Anderson, VA | 1 |
| Reutens, DC | 1 |
| Wood, AG | 1 |
| Hamed, SA | 3 |
| Rageh, TA | 1 |
| Mohamad, AO | 1 |
| Abou Elnour, SM | 1 |
| Lu, Q | 1 |
| Huang, YT | 1 |
| Shu, Y | 1 |
| Xu, P | 1 |
| Xiang, DX | 1 |
| Qu, Q | 1 |
| Qu, J | 1 |
| Oseilly, AM | 1 |
| Kumkamthornkul, P | 1 |
| Udnaen, S | 1 |
| Tansit, T | 1 |
| Tuchinda, P | 1 |
| Srinoulprasert, Y | 1 |
| Zaccara, G | 1 |
| Gualdani, E | 1 |
| Policardo, L | 1 |
| Palumbo, P | 1 |
| Francesconi, P | 1 |
| Xiao, X | 2 |
| Ouyang, Y | 1 |
| Song, Z | 1 |
| Zheng, W | 1 |
| Kraemer, G | 1 |
| Chervoneva, I | 2 |
| Werhahn, KJ | 3 |
| Sahu, J | 1 |
| Ahn, JE | 1 |
| Bathena, SPR | 1 |
| Brundage, RC | 4 |
| Conway, JM | 3 |
| Leppik, IE | 18 |
| Martins, IL | 1 |
| Nunes, J | 1 |
| Charneira, C | 1 |
| Morello, J | 1 |
| Pereira, SA | 1 |
| Telo, JP | 1 |
| Marques, MM | 1 |
| Antunes, AMM | 1 |
| Kita, M | 1 |
| Kuwata, Y | 1 |
| Usui, T | 1 |
| Tutka, P | 1 |
| Mróz, K | 1 |
| Mróz, T | 1 |
| Buszewicz, G | 1 |
| Aebisher, D | 1 |
| Bartusik-Aebisher, D | 1 |
| Kołodziejczyk, P | 1 |
| Łuszczki, JJ | 1 |
| Ullah, S | 1 |
| Khan, A | 1 |
| Ali, S | 1 |
| Nazish, HR | 1 |
| Uddin, Z | 1 |
| Lin, WW | 1 |
| Li, XW | 1 |
| Jiao, Z | 6 |
| Rao, X | 1 |
| Zeng, DY | 1 |
| Lin, XH | 1 |
| Wang, CL | 1 |
| Lin, CW | 1 |
| Huang, WI | 1 |
| Chao, PH | 1 |
| Chen, WW | 1 |
| Hsiao, FY | 1 |
| Nishiyama, M | 1 |
| Takami, Y | 1 |
| Ishida, Y | 1 |
| Tomioka, K | 1 |
| Nagase, H | 1 |
| Nakagawa, T | 2 |
| Tokumoto, S | 1 |
| Yamaguchi, H | 2 |
| Toyoshima, D | 1 |
| Maruyama, A | 1 |
| Nozu, K | 1 |
| Nishimura, N | 2 |
| Iijima, K | 1 |
| Suljic, EM | 1 |
| Mehicevic, A | 1 |
| Mahmutbegovic, N | 1 |
| Manoharan, A | 1 |
| Kumar, AS | 1 |
| Sreedevi, A | 1 |
| Sathishkannan, AD | 1 |
| Gaddam, BK | 1 |
| Zhu, X | 2 |
| Zou, X | 1 |
| Chen, L | 1 |
| Arhan, E | 5 |
| Kurt, ANC | 1 |
| Neselioglu, S | 1 |
| Yerel, O | 1 |
| Uçar, HK | 1 |
| Aydin, K | 1 |
| Serdaroglu, A | 11 |
| Han, X | 1 |
| Huang, J | 2 |
| Lv, J | 1 |
| Ma, L | 1 |
| Xia, L | 1 |
| Zan, X | 1 |
| Jiang, W | 1 |
| Xia, T | 1 |
| Yun, Y | 1 |
| Zhang, F | 2 |
| Gao, S | 1 |
| Chen, W | 1 |
| Cohen, MJ | 2 |
| May, R | 1 |
| Loblein, H | 1 |
| Conrad, T | 1 |
| Baker, GA | 8 |
| Bromley, RL | 2 |
| Clayton-Smith, J | 6 |
| Kalayjian, LA | 4 |
| Kanner, A | 4 |
| Liporace, JD | 3 |
| Privitera, M | 5 |
| Loring, DW | 6 |
| Hill, AC | 1 |
| Newell, TG | 1 |
| Koristkova, B | 1 |
| Grundmann, M | 2 |
| Brozmanova, H | 2 |
| Kacirova, I | 2 |
| Yang, H | 2 |
| Zhang, R | 1 |
| Jia, C | 1 |
| Chen, M | 1 |
| Yin, W | 1 |
| Wei, L | 2 |
| Jiao, H | 1 |
| Grabenstatter, HL | 2 |
| Qian, Z | 1 |
| Chen, H | 1 |
| Huang, Q | 1 |
| Huang, L | 1 |
| Liu, G | 1 |
| Tang, X | 1 |
| Richards, N | 1 |
| Reith, D | 1 |
| Stitely, M | 1 |
| Smith, A | 1 |
| Yang, F | 1 |
| Yuan, W | 2 |
| Liang, H | 1 |
| Song, X | 1 |
| Gelaye, B | 1 |
| Miao, M | 1 |
| Yang, X | 1 |
| Yan, Y | 2 |
| Fang, S | 1 |
| Zeng, S | 1 |
| Ma, H | 1 |
| Qian, L | 1 |
| Wei, J | 1 |
| Gong, Z | 1 |
| Xu, Z | 2 |
| Seliger, J | 1 |
| Boyd, A | 1 |
| Razavi, B | 1 |
| Falco-Walter, J | 1 |
| Le, S | 1 |
| Mir, A | 1 |
| Chaudhary, M | 1 |
| Alkhaldi, H | 1 |
| Alhazmi, R | 1 |
| Albaradie, R | 1 |
| Housawi, Y | 1 |
| Baudou, E | 1 |
| Cances, C | 1 |
| Dimeglio, C | 1 |
| Hachon Lecamus, C | 1 |
| Kristensen, KB | 1 |
| Pedersen, SA | 1 |
| Schmidt, SAJ | 1 |
| Pottegård, A | 1 |
| Choi, H | 1 |
| Mohit, B | 1 |
| Lv, Y | 1 |
| Zheng, X | 1 |
| Shi, M | 1 |
| Wang, Z | 1 |
| Huber-Mollema, Y | 1 |
| Oort, FJ | 1 |
| Rodenburg, R | 1 |
| Mbizvo, GK | 1 |
| Derry, C | 1 |
| Davenport, R | 1 |
| Sharobeam, A | 1 |
| Mamun, A | 1 |
| Kwok, A | 1 |
| Zandiehvakili, M | 1 |
| Beran, RG | 4 |
| Jing, X | 1 |
| Li, G | 1 |
| Sun, J | 1 |
| Guo, H | 1 |
| Sun, F | 1 |
| Wen, X | 1 |
| Wang, T | 2 |
| Mroueh, L | 1 |
| Boumediene, F | 1 |
| Jost, J | 1 |
| Ratsimbazafy, V | 1 |
| Preux, PM | 1 |
| Salameh, P | 1 |
| Al-Hajje, A | 1 |
| Ren, T | 1 |
| Xiao, M | 1 |
| Yang, M | 1 |
| Zhao, J | 1 |
| Hu, M | 2 |
| Cheng, Y | 1 |
| Zhang, C | 1 |
| Zuo, Z | 1 |
| Kato, R | 1 |
| Ijiri, Y | 1 |
| Uetrecht, J | 1 |
| Wang, Y | 9 |
| Zhang, T | 1 |
| Pei, Y | 1 |
| Liu, L | 1 |
| Wang, H | 1 |
| Bain, BJ | 1 |
| Ahmed, GF | 1 |
| Marino, SE | 4 |
| Cloyd, JC | 7 |
| Ramsay, RE | 6 |
| Wilson, KL | 1 |
| Alexander, JM | 1 |
| Chen, YH | 1 |
| Wang, CC | 3 |
| Xu, G | 1 |
| Awa, HD | 1 |
| Chelo, D | 1 |
| Kinkela, MN | 1 |
| Ndombo, PO | 1 |
| Gaeti, WP | 1 |
| Obreli-Neto, PR | 1 |
| Moliterno, RA | 1 |
| Schiavon, GB | 1 |
| Cuman, RK | 1 |
| Tiamkao, S | 1 |
| Jitpimolmard, J | 1 |
| Sawanyawisuth, K | 1 |
| Jitpimolmard, S | 1 |
| Rolnitsky, A | 1 |
| Merlob, P | 2 |
| Klinger, G | 1 |
| Nolan, SJ | 1 |
| Muller, M | 2 |
| Alex, AB | 1 |
| Assenza, G | 1 |
| Campana, C | 1 |
| Tombini, M | 1 |
| Cosimo Quattrocchi, C | 1 |
| Giambattistelli, F | 1 |
| Benvenga, A | 1 |
| Pellegrino, G | 1 |
| Assenza, F | 1 |
| Vernieri, F | 1 |
| Di Lazzaro, V | 1 |
| Tica, OS | 1 |
| Tica, AA | 1 |
| Brailoiu, CG | 1 |
| Cernea, N | 1 |
| Tica, VI | 1 |
| Lang, N | 1 |
| Rothkegel, H | 1 |
| Peckolt, H | 1 |
| Deuschl, G | 1 |
| Rapinesi, C | 1 |
| Del Casale, A | 1 |
| Serata, D | 1 |
| Kotzalidis, GD | 1 |
| Scatena, P | 1 |
| Muzi, A | 1 |
| Lazanio, S | 1 |
| Savoja, V | 1 |
| Carbonetti, P | 1 |
| Fensore, C | 1 |
| Ferracuti, S | 1 |
| Angeletti, G | 1 |
| Tatarelli, R | 1 |
| Girardi, P | 1 |
| Lv, YD | 1 |
| Min, FL | 1 |
| He, N | 1 |
| Zeng, T | 1 |
| Ma, DH | 1 |
| Shi, YW | 1 |
| Kim, DW | 3 |
| Gu, N | 2 |
| Lee, H | 1 |
| Cho, JY | 2 |
| Yoon, SH | 2 |
| Na, HJ | 1 |
| Rattanavipapong, W | 1 |
| Koopitakkajorn, T | 1 |
| Praditsitthikorn, N | 1 |
| Teerawattananon, Y | 1 |
| Dahse, AJ | 1 |
| Syrbe, S | 1 |
| Bernhard, MK | 1 |
| Frontini, R | 1 |
| Kiess, W | 1 |
| Merkenschlager, A | 1 |
| Mishra, D | 1 |
| Juneja, M | 1 |
| Lee, SY | 1 |
| Shon, YM | 1 |
| Kim, JH | 1 |
| Wegner, I | 2 |
| Wilhelm, AJ | 2 |
| Kong, ST | 2 |
| Lim, SH | 2 |
| Chan, E | 3 |
| Ho, PC | 2 |
| Sankhyan, N | 2 |
| Gulati, S | 1 |
| Hari, S | 1 |
| Kabra, M | 1 |
| Ramakrishnan, L | 1 |
| Kalra, V | 1 |
| Wei, SH | 1 |
| Liu, CC | 1 |
| Fan, PC | 1 |
| Garoufi, A | 8 |
| Koemtzidou, E | 2 |
| Katsarou, E | 7 |
| Dinopoulos, A | 1 |
| Kalimeraki, I | 1 |
| Fotinou, A | 2 |
| Drakatos, A | 2 |
| Attilakos, A | 7 |
| Moghimi, N | 1 |
| Lhatoo, SD | 2 |
| Yun, W | 2 |
| Hu, C | 1 |
| Luo, X | 1 |
| Xue, P | 1 |
| Ge, Y | 2 |
| Meng, H | 2 |
| Begum, S | 1 |
| Sarma, SP | 1 |
| Brzaković, B | 1 |
| Vučićević, K | 3 |
| Kovačević, SV | 2 |
| Miljković, B | 3 |
| Prostran, M | 3 |
| Martinović, Ž | 3 |
| Pokrajac, M | 1 |
| Kellinghaus, C | 1 |
| Berning, S | 1 |
| Stögbauer, F | 1 |
| Dambach, H | 1 |
| Hinkerohe, D | 1 |
| Prochnow, N | 1 |
| Stienen, MN | 1 |
| Moinfar, Z | 1 |
| Haase, CG | 1 |
| Hufnagel, A | 1 |
| Faustmann, PM | 1 |
| Yeap, LL | 1 |
| Lim, KS | 3 |
| Ng, CC | 1 |
| Hui-Ping Khor, A | 1 |
| Lo, YL | 1 |
| Ma, A | 1 |
| Wang, C | 3 |
| Lee, HS | 2 |
| Wang, SY | 1 |
| Salter, DM | 1 |
| Chen, SJ | 2 |
| Fan, HC | 2 |
| Risselada, AJ | 1 |
| Visser, MJ | 1 |
| van Roon, E | 1 |
| Saruwatari, J | 2 |
| Yoshida, S | 1 |
| Tsuda, Y | 1 |
| Okada, Y | 1 |
| Ogusu, N | 1 |
| Yoshida, K | 1 |
| Oniki, K | 2 |
| Yasui-Furukori, N | 1 |
| Kaneko, S | 7 |
| Ishitsu, T | 6 |
| Nakagawa, K | 6 |
| Kim, JY | 3 |
| Lee, J | 3 |
| Ko, YJ | 1 |
| Shin, JY | 1 |
| Jung, SY | 1 |
| Choi, NK | 1 |
| Park, BJ | 1 |
| Yerdelen, D | 1 |
| Koc, F | 1 |
| Avakian, GN | 1 |
| Oleĭnikova, OM | 1 |
| Lagutin, IuV | 1 |
| Khromykh, EA | 1 |
| Bogomazova, MA | 1 |
| Delger, AB | 1 |
| Avakian, GG | 1 |
| Campbell, E | 1 |
| Kennedy, F | 1 |
| Russell, A | 1 |
| Smithson, WH | 1 |
| Parsons, L | 1 |
| Morrison, PJ | 1 |
| Liggan, B | 1 |
| Irwin, B | 1 |
| Hunt, SJ | 1 |
| Morrow, J | 3 |
| Powell, G | 5 |
| Saunders, M | 5 |
| Koo, DL | 1 |
| Hwang, KJ | 1 |
| Han, SW | 1 |
| Joo, EY | 1 |
| Shin, WC | 1 |
| Seo, DW | 1 |
| Hong, SB | 1 |
| Baek, JH | 1 |
| Seo, YH | 2 |
| Kim, GH | 1 |
| Eun, BL | 1 |
| Markoula, S | 1 |
| Teotonio, R | 1 |
| Duncan, JS | 3 |
| Rädisch, S | 1 |
| Dickens, D | 1 |
| Lang, T | 1 |
| Bonnett, L | 1 |
| Arlanov, R | 1 |
| Schwab, M | 1 |
| Lambrechts, DA | 1 |
| Cheung, YK | 1 |
| Hatch, RJ | 1 |
| Reid, CA | 1 |
| Petrou, S | 1 |
| Bhat, RY | 1 |
| Kakkar, S | 1 |
| Prakashini, K | 1 |
| Johnson, EL | 1 |
| Stowe, ZN | 1 |
| Ritchie, JC | 1 |
| Newport, DJ | 1 |
| Newman, ML | 1 |
| Knight, B | 1 |
| Stuhec, M | 1 |
| Singh, E | 1 |
| Pillai, KK | 1 |
| Mehndiratta, M | 1 |
| Kafadar, İ | 1 |
| Kılıç, BA | 1 |
| Arapoglu, M | 1 |
| Yalçın, K | 1 |
| Dalgıç, N | 1 |
| Vydrova, R | 1 |
| Kršek, P | 1 |
| Kyncl, M | 1 |
| Jahodova, A | 1 |
| Dvorak, J | 1 |
| Komarek, V | 2 |
| Delalande, O | 1 |
| Tichy, M | 1 |
| He, XJ | 1 |
| Jian, LY | 1 |
| He, XL | 1 |
| Tang, M | 1 |
| Wu, Y | 3 |
| Xu, YY | 1 |
| Sun, XJ | 1 |
| Zhao, LM | 1 |
| Peng, J | 2 |
| Zhang, HN | 2 |
| Liu, ZS | 1 |
| Burger, DM | 2 |
| Arends, JE | 1 |
| Jacobs, BS | 1 |
| van Elst-Laurijsen, DH | 1 |
| de Kanter, CT | 2 |
| van Maarseveen, EM | 1 |
| Verwey-van Wissen, CP | 1 |
| Hoepelman, AI | 1 |
| Keenan, N | 2 |
| Sadlier, LG | 1 |
| Wiltshire, E | 2 |
| Borowicz, KK | 5 |
| Zarczuk, R | 1 |
| Latalski, M | 1 |
| Borowicz, KM | 1 |
| Tsuji, S | 1 |
| Ito, S | 2 |
| Oguni, H | 1 |
| Inoue, T | 2 |
| Matsumoto, R | 1 |
| Ikeda, A | 3 |
| Zhou, Q | 1 |
| Sheng, Y | 1 |
| Tang, B | 1 |
| Zhou, B | 1 |
| Tekin, F | 1 |
| Celik, F | 1 |
| Nart, D | 1 |
| Akarca, U | 1 |
| Havali, C | 1 |
| Gücüyener, K | 4 |
| Buyan, N | 1 |
| Yılmaz, Ü | 1 |
| Gürkaş, E | 1 |
| Gülbahar, Ö | 3 |
| Demir, E | 2 |
| Chen, ZJ | 1 |
| Wang, XD | 1 |
| Zhou, LM | 1 |
| Fang, ZY | 1 |
| Wang, HS | 1 |
| Li, JL | 1 |
| Zhou, JQ | 1 |
| Huang, HB | 1 |
| Pothmann, L | 1 |
| Müller, C | 1 |
| Bellistri, E | 1 |
| Miklitz, C | 1 |
| Uebachs, M | 2 |
| Remy, S | 1 |
| Beck, H | 3 |
| Lee, B | 1 |
| Yu, HJ | 1 |
| Kang, ES | 1 |
| Lee, M | 1 |
| Wu, XY | 3 |
| Zheng, J | 1 |
| Wu, ZY | 3 |
| Hong, Z | 4 |
| Öz, O | 3 |
| Korkmaz, M | 1 |
| Alay, S | 1 |
| Tasdemir, S | 1 |
| Cetiz, A | 1 |
| Demirkaya, S | 1 |
| Singh, J | 1 |
| Gupta, R | 1 |
| de Goede, C | 1 |
| Vereczkey, A | 1 |
| Gerencsér, B | 1 |
| Czeizel, AE | 1 |
| Szabó, I | 1 |
| Niu, CH | 1 |
| Gao, P | 1 |
| Chen, YJ | 3 |
| Liu, MC | 1 |
| Taguchi, K | 1 |
| Kouroki, M | 1 |
| Ohmura, T | 1 |
| Jono, H | 1 |
| Endo, F | 1 |
| Saito, H | 1 |
| Lee, WB | 1 |
| Kumar, PK | 1 |
| Wang, HY | 1 |
| Ng, YL | 1 |
| Wong, PS | 1 |
| Shazadi, K | 1 |
| Petrovski, S | 1 |
| Roten, A | 1 |
| Miller, H | 1 |
| Huggins, RM | 1 |
| Hanrath, MA | 1 |
| Swart, EL | 1 |
| Adab, N | 2 |
| Greenhalgh, J | 1 |
| Sanniti, A | 1 |
| McKay, AJ | 1 |
| E L omairi, N | 1 |
| Abourazzak, S | 1 |
| Chaouki, S | 1 |
| Atmani, S | 1 |
| Hida, M | 1 |
| Jovanović, M | 2 |
| Golubović, B | 1 |
| Ding, J | 1 |
| Zhao, Z | 1 |
| Miao, L | 1 |
| Sadleir, L | 1 |
| Rigby, A | 2 |
| Sun, X | 1 |
| Qiu, F | 1 |
| Sirisamut, T | 1 |
| Chinvarun, Y | 2 |
| Tantisira, MH | 2 |
| Briggs, M | 1 |
| Cheyne, CP | 1 |
| García-Fiñana, M | 1 |
| Gummery, A | 1 |
| Kneen, R | 1 |
| Mawer, G | 2 |
| Shallcross, R | 1 |
| Klein, P | 2 |
| Ezura, M | 1 |
| Kakisaka, Y | 1 |
| Jin, K | 1 |
| Kato, K | 1 |
| Iwasaki, M | 1 |
| Fujikawa, M | 1 |
| Aoki, M | 1 |
| Nakasato, N | 1 |
| Chiesa, V | 1 |
| Vignoli, A | 4 |
| Canevini, MP | 4 |
| Malas, NM | 1 |
| Ortiz-Aguayo, R | 1 |
| Meyer, V | 1 |
| Rokan, Z | 1 |
| Kealey, WD | 1 |
| Zhang, Q | 1 |
| Xu, W | 2 |
| Lv, C | 1 |
| Hao, G | 1 |
| Sen, A | 2 |
| Guresci, B | 1 |
| Arpaci, B | 2 |
| Andrea, ŠK | 1 |
| Jakov, M | 1 |
| Nikola, G | 1 |
| Goldberg-Stern, H | 1 |
| Itzhaki, T | 1 |
| Landau, Z | 1 |
| de Vries, L | 1 |
| Kanemura, H | 1 |
| Sano, F | 1 |
| Tando, T | 1 |
| Sugita, K | 1 |
| Aihara, M | 2 |
| Pintaudi, M | 1 |
| Calevo, MG | 1 |
| Baglietto, MG | 1 |
| Hayek, Y | 1 |
| Traverso, M | 1 |
| Giacomini, T | 1 |
| Giordano, L | 1 |
| Renieri, A | 1 |
| Russo, S | 1 |
| Canevini, M | 1 |
| Veneselli, E | 1 |
| Lee, D | 2 |
| Kalu, U | 1 |
| Halford, JJ | 1 |
| Cloyd, J | 2 |
| Bekersky, I | 2 |
| Peng, G | 1 |
| Dheerendra, S | 1 |
| Tolbert, D | 2 |
| Weaver, D | 1 |
| Chorny, V | 1 |
| Tewari, S | 1 |
| Brotherton, BJ | 1 |
| Steinberg, I | 1 |
| Johnson, JL | 1 |
| Walzer, M | 1 |
| Wesche, D | 1 |
| Drummond, R | 1 |
| Sugiyama, I | 1 |
| Bouillon, T | 1 |
| Yamaguchi, M | 1 |
| Suzuki, H | 2 |
| Fink, M | 1 |
| Anderson, M | 1 |
| Cherrill, J | 1 |
| Millward, C | 1 |
| Fakis, A | 1 |
| Plumpton, CO | 2 |
| Yip, VL | 1 |
| Alfirevic, A | 1 |
| Harit, D | 1 |
| Aggarwal, A | 3 |
| Kalra, S | 1 |
| Chhillar, N | 1 |
| Holtkamp, M | 2 |
| Rocamora, R | 2 |
| Ryvlin, P | 2 |
| Sieradzan, K | 1 |
| Villanueva, V | 2 |
| Işık, M | 1 |
| Demir, Y | 1 |
| Kırıcı, M | 1 |
| Demir, R | 1 |
| Beydemir, Ş | 1 |
| Holmes, EA | 1 |
| Ring, A | 1 |
| Jacoby, A | 2 |
| Moses, L | 1 |
| Katz, N | 1 |
| Weizman, A | 2 |
| Ley, M | 1 |
| Principe, A | 1 |
| Jiménez-Conde, J | 1 |
| Noai, M | 1 |
| Soraoka, H | 1 |
| Kajiwara, A | 1 |
| Tanamachi, Y | 1 |
| Thompson, K | 1 |
| Pohlmann-Eden, B | 2 |
| Campbell, LA | 1 |
| Abel, H | 1 |
| Higuchi, H | 1 |
| Tomoyasu, Y | 1 |
| Ishii-Maruhama, M | 1 |
| Maeda, S | 1 |
| Miyawaki, T | 1 |
| Linder, C | 1 |
| Andersson, M | 1 |
| Wide, K | 5 |
| Beck, O | 1 |
| Pohanka, A | 1 |
| Homberg, V | 2 |
| Sattler, A | 1 |
| Schaefer, M | 1 |
| Cho, YS | 1 |
| Ah, YM | 1 |
| Jung, AH | 1 |
| Kim, KJ | 2 |
| Lee, JY | 1 |
| Kurata, M | 1 |
| Horie, C | 1 |
| Kano, Y | 1 |
| Shiohara, T | 1 |
| Yin, T | 2 |
| Ma, HY | 2 |
| Liu, DQ | 2 |
| Sheng, YH | 1 |
| Zhou, BT | 2 |
| Molina-Ruiz, AM | 1 |
| Lasanta, B | 1 |
| Barcia, A | 1 |
| Pérez-Vega, E | 1 |
| Requena, L | 1 |
| Rudakova, IG | 2 |
| Belova, YA | 1 |
| Dwivedi, R | 1 |
| Singh, M | 2 |
| Kaleekal, T | 1 |
| Gupta, YK | 5 |
| Sharma, M | 2 |
| Singh, T | 1 |
| Mathew, A | 1 |
| Lapadula, G | 1 |
| Caporlingua, F | 1 |
| Caporlingua, A | 1 |
| Currà, A | 1 |
| Fattapposta, F | 1 |
| Missori, P | 1 |
| Caccavale, S | 1 |
| La Montagna, M | 1 |
| Gambardella, A | 1 |
| Sheng, YA | 1 |
| Daci, A | 1 |
| Beretta, G | 1 |
| Vllasaliu, D | 1 |
| Shala, A | 1 |
| Govori, V | 1 |
| Norata, GD | 1 |
| Krasniqi, S | 2 |
| Shirzadi, M | 2 |
| Thorstensen, K | 1 |
| Helde, G | 1 |
| Moen, T | 1 |
| Brodtkorb, E | 4 |
| Xiao, Y | 2 |
| Gan, L | 2 |
| Luo, M | 2 |
| Luo, H | 2 |
| Lossius, MI | 4 |
| Nakken, KO | 2 |
| Mowinckel, P | 3 |
| Taubøll, E | 13 |
| Gjerstad, L | 14 |
| Sigaroudi, A | 1 |
| Kullak-Ublick, GA | 2 |
| Weiler, S | 1 |
| Sokić, D | 1 |
| Grabnar, I | 1 |
| Vovk, T | 1 |
| Erić, S | 1 |
| Kuzmanovski, I | 1 |
| Kowski, AB | 1 |
| Weissinger, F | 1 |
| Gaus, V | 1 |
| Fidzinski, P | 1 |
| Losch, F | 1 |
| Djordjevic, N | 2 |
| Milovanovic, DD | 4 |
| Radovanovic, M | 1 |
| Radosavljevic, I | 1 |
| Obradovic, S | 1 |
| Jakovljevic, M | 1 |
| Milovanovic, D | 2 |
| Milovanovic, JR | 6 |
| Jankovic, S | 2 |
| Lavi-Blau, T | 1 |
| Ekstein, D | 1 |
| Neufeld, MY | 2 |
| Eyal, S | 1 |
| Li, RR | 1 |
| Sheng, XY | 1 |
| Ma, LY | 1 |
| Yao, HX | 1 |
| Cai, LX | 1 |
| Chen, CY | 1 |
| Zhu, SN | 1 |
| Zhou, Y | 2 |
| Cui, YM | 1 |
| Hakami, T | 1 |
| Petty, SJ | 1 |
| Sakellarides, M | 1 |
| Christie, J | 1 |
| Kantor, S | 1 |
| Todaro, M | 1 |
| Gorelik, A | 1 |
| Seibel, MJ | 1 |
| Yerra, R | 1 |
| Wark, JD | 1 |
| Abou-Khalil, BW | 4 |
| Kaczmarska-Turek, D | 1 |
| Bartnik, P | 1 |
| Kacperczyk, J | 1 |
| Orlewski, J | 1 |
| Olszewska, M | 1 |
| Krasnodębska-Kiljańska, M | 1 |
| Bae, EK | 1 |
| Shin, JW | 1 |
| Moon, J | 2 |
| Lee, KJ | 1 |
| Shin, YW | 1 |
| Shin, D | 1 |
| Gierbolini, J | 1 |
| Giarratano, M | 1 |
| Benbadis, SR | 1 |
| Vartzelis, G | 1 |
| Tsentidis, C | 1 |
| Kossiva, L | 1 |
| Soldatou, A | 1 |
| Takeuchi, T | 1 |
| Natsume, J | 1 |
| Kidokoro, H | 1 |
| Ishihara, N | 1 |
| Yamamoto, H | 1 |
| Azuma, Y | 1 |
| Ito, Y | 1 |
| Kurahashi, N | 1 |
| Tsuji, T | 1 |
| Suzuki, M | 2 |
| Itomi, K | 1 |
| Yamada, K | 1 |
| Kurahashi, H | 1 |
| Okumura, A | 2 |
| Maruyama, K | 1 |
| Negoro, T | 2 |
| Watanabe, K | 2 |
| Kojima, S | 1 |
| Vanya, M | 1 |
| Devosa, I | 1 |
| Szok, D | 1 |
| Bártfai, G | 1 |
| Rakitin, A | 1 |
| Kõks, S | 1 |
| Haldre, S | 1 |
| Pulido Fontes, L | 1 |
| Pulido Fontes, M | 1 |
| Quesada Jiménez, P | 1 |
| Muruzabal Pérez, J | 1 |
| Mendioroz Iriarte, M | 1 |
| McKenzie, ED | 1 |
| Nirola, DK | 1 |
| Deki, S | 1 |
| Tshering, L | 1 |
| Patenaude, B | 1 |
| Clark, SJ | 1 |
| Cash, SS | 1 |
| Thibert, R | 1 |
| Zepeda, R | 1 |
| Leung, EC | 1 |
| Lam, AD | 1 |
| Lim, AS | 1 |
| Mantia, J | 1 |
| Cohen, J | 1 |
| Mateen, FJ | 1 |
| Lin, CM | 1 |
| Chao, TY | 1 |
| Chu, DM | 1 |
| Lai, CC | 1 |
| Sarangi, SC | 1 |
| Kakkar, AK | 1 |
| Chbili, C | 1 |
| Fathallah, N | 1 |
| Laouani, A | 1 |
| Nouira, M | 1 |
| Hassine, A | 1 |
| Ben Amor, S | 1 |
| Ben Ammou, S | 1 |
| Ben Salem, C | 1 |
| Saguem, S | 1 |
| French, JA | 5 |
| Blum, DE | 1 |
| Cramer, JA | 7 |
| Messenheimer, JA | 3 |
| Baulac, M | 2 |
| Qu, L | 1 |
| Fan, Y | 1 |
| Wang, W | 2 |
| Ma, K | 1 |
| Yin, Z | 1 |
| Ojeda, J | 1 |
| Rocamora, RA | 1 |
| Serrano-Castro, PJ | 1 |
| Parra, J | 1 |
| Rodríguez-Uranga, JJ | 1 |
| Bathal, H | 1 |
| Viteri, C | 1 |
| Albsoul-Younes, A | 1 |
| Gharaibeh, L | 1 |
| Murtaja, AA | 1 |
| Masri, A | 1 |
| Alabbadi, I | 1 |
| Al-Qudah, AA | 1 |
| Pontes, JC | 1 |
| Lima, TZ | 1 |
| Queiroz, CM | 1 |
| Cinini, SM | 1 |
| Blanco, MM | 1 |
| Mello, LE | 1 |
| Martinez Ferri, M | 1 |
| Peña Mayor, P | 1 |
| Perez López-Fraile, I | 1 |
| Escartin Siquier, A | 1 |
| Martin Moro, M | 1 |
| Forcadas Berdusan, M | 1 |
| Smolders, EJ | 1 |
| van 't Veer, N | 1 |
| D'avolio, A | 1 |
| Di Perri, G | 1 |
| van Wijngaarden, P | 1 |
| Noack-Rink, M | 1 |
| Ramirez, F | 1 |
| Tofighy, A | 1 |
| Wild, I | 1 |
| Thomas, RH | 1 |
| Robertson, NP | 1 |
| Lai, EC | 2 |
| Hsieh, CY | 2 |
| Su, CC | 1 |
| Yang, YK | 1 |
| Huang, CW | 1 |
| Lin, SJ | 2 |
| Setoguchi, S | 1 |
| Lim, JA | 1 |
| Sunwoo, JS | 1 |
| Byun, JI | 1 |
| Lee, ST | 1 |
| Jung, KH | 1 |
| Park, KI | 1 |
| Jung, KY | 1 |
| Jeon, D | 1 |
| Khishfe, BF | 1 |
| Lu, X | 1 |
| Wieshmann, UC | 1 |
| Chandrasekaran, S | 1 |
| Patil, S | 1 |
| Suthar, R | 1 |
| Attri, SV | 1 |
| Sahu, JK | 1 |
| Tageja, M | 1 |
| Singhi, P | 2 |
| Sargentini-Maier, ML | 1 |
| Toledo, M | 1 |
| Gandhi, S | 1 |
| McArthur, E | 1 |
| Mamdani, MM | 1 |
| Hackam, DG | 1 |
| McLachlan, RS | 1 |
| Weir, MA | 1 |
| Burneo, JG | 2 |
| Garg, AX | 1 |
| Fang, Y | 1 |
| Wu, X | 3 |
| Ma, C | 1 |
| Xu, L | 1 |
| Chen, CB | 1 |
| Hsiao, YH | 1 |
| Wu, T | 1 |
| Hsih, MS | 1 |
| Tassaneeyakul, W | 1 |
| Jorns, TP | 1 |
| Sukasem, C | 1 |
| Hsu, CN | 1 |
| Su, SC | 1 |
| Chang, WC | 1 |
| Hui, RC | 1 |
| Chu, CY | 1 |
| Wu, CY | 1 |
| Hsu, CK | 1 |
| Chiu, TM | 1 |
| Sun, PL | 1 |
| Lee, HE | 1 |
| Yang, CY | 1 |
| Kao, PH | 1 |
| Yang, CH | 1 |
| Ho, HC | 1 |
| Lin, JY | 1 |
| Chang, YC | 1 |
| Chen, MJ | 1 |
| Lu, CW | 1 |
| Ng, CY | 1 |
| Kuo, KL | 1 |
| Lin, CY | 1 |
| Yang, CS | 1 |
| Chen, DP | 1 |
| Chang, PY | 1 |
| Wu, TL | 1 |
| Lin, YJ | 1 |
| Weng, YC | 1 |
| Kuo, TT | 1 |
| Hung, SI | 1 |
| Chung, WH | 1 |
| Olusanya, A | 1 |
| Ogunleye, O | 1 |
| Godman, B | 1 |
| Fadare, J | 1 |
| Danesi, M | 1 |
| Iori, V | 1 |
| Iyer, AM | 1 |
| Ravizza, T | 1 |
| Beltrame, L | 1 |
| Paracchini, L | 1 |
| Marchini, S | 1 |
| Cerovic, M | 1 |
| Hill, C | 1 |
| Ferrari, M | 1 |
| Zucchetti, M | 1 |
| Molteni, M | 1 |
| Rossetti, C | 1 |
| Brambilla, R | 1 |
| D'Incalci, M | 1 |
| Aronica, E | 1 |
| Vezzani, A | 2 |
| Rezaei, S | 1 |
| Shab-Bidar, S | 1 |
| Abdulahi Abdurahman, A | 1 |
| Djafarian, K | 1 |
| Savini, MN | 1 |
| Nowbut, MS | 1 |
| Peron, A | 1 |
| Turner, K | 1 |
| La Briola, F | 1 |
| Jankovic, SM | 6 |
| Würtz, AM | 1 |
| Rytter, D | 1 |
| Vestergaard, CH | 1 |
| Vestergaard, M | 1 |
| Bech, BH | 1 |
| Serragui, S | 1 |
| Zalagh, F | 1 |
| Tanani, DS | 1 |
| Ouammi, L | 1 |
| Moussa, LA | 1 |
| Badrane, N | 1 |
| Bencheikh, RS | 1 |
| Fong, JK | 1 |
| Chan, EL | 1 |
| Chan, I | 1 |
| Chang, RS | 1 |
| Fong, GC | 1 |
| Fung, EL | 1 |
| Lui, CH | 1 |
| Fung, BB | 1 |
| Poon, TL | 1 |
| Siu, D | 1 |
| Wong, HT | 1 |
| Yeung, E | 1 |
| Yung, AW | 1 |
| Zhu, CX | 1 |
| Takeuchi, M | 1 |
| Yano, I | 1 |
| Sugimoto, M | 1 |
| Yamamoto, S | 1 |
| Yonezawa, A | 1 |
| Matsubara, K | 1 |
| Shih, JJ | 1 |
| Whitlock, JB | 1 |
| Chimato, N | 1 |
| Vargas, E | 1 |
| Karceski, SC | 1 |
| Frank, RD | 1 |
| Yu, P | 1 |
| Liao, W | 1 |
| Lang, S | 1 |
| Song, Y | 4 |
| Zhao, H | 1 |
| Schoemaker, R | 1 |
| Wade, JR | 1 |
| Mäkinen, J | 2 |
| Rainesalo, S | 3 |
| Zimprich, F | 1 |
| Stogmann, E | 1 |
| Bonelli, S | 1 |
| Baumgartner, C | 2 |
| Mueller, JC | 1 |
| Meitinger, T | 1 |
| Zimprich, A | 1 |
| Strom, TM | 1 |
| Gromov, SA | 3 |
| Eroshina, ES | 1 |
| Lipatova, LV | 1 |
| Fida, NM | 1 |
| Hamed, EA | 1 |
| Maschio, M | 5 |
| Albani, F | 15 |
| Jandolo, B | 2 |
| Zarabla, A | 1 |
| Contin, M | 9 |
| Dinapoli, L | 5 |
| Fabi, A | 4 |
| Pace, A | 4 |
| Baruzzi, A | 16 |
| van de Vrie-Hoekstra, NW | 1 |
| de Vries, TW | 1 |
| van den Berg, PB | 1 |
| Brouwer, OF | 2 |
| de Jong-van den Berg, LT | 2 |
| Locharernkul, C | 2 |
| Loplumlert, J | 1 |
| Korkij, W | 1 |
| Desudchit, T | 1 |
| Tongkobpetch, S | 1 |
| Kangwanshiratada, O | 1 |
| Hirankarn, N | 2 |
| Suphapeetiporn, K | 1 |
| Shotelersuk, V | 2 |
| Apeland, T | 2 |
| Frøyland, ES | 1 |
| Kristensen, O | 5 |
| Strandjord, RE | 12 |
| Mansoor, MA | 2 |
| Go, T | 1 |
| Espinosa, PS | 1 |
| Salazar, JC | 1 |
| Mendiondo, MS | 1 |
| Robertson, WC | 1 |
| Baumann, RJ | 3 |
| Midorikawa, A | 1 |
| Kawamura, M | 1 |
| Suzuki, Y | 1 |
| Fukuda, M | 1 |
| Tohyama, M | 1 |
| Ishikawa, M | 1 |
| Yasukawa, M | 1 |
| Ishii, E | 1 |
| Cansu, A | 7 |
| Yesilkaya, E | 2 |
| Hirfanoğlu, TL | 3 |
| Camurdan, O | 4 |
| Cinaz, P | 4 |
| Vaisleib, II | 1 |
| Neft, RA | 1 |
| Kolamunnage-Dona, R | 1 |
| Philipson, P | 1 |
| Johannessen, SI | 11 |
| Auriel, E | 1 |
| Landov, H | 1 |
| Blatt, I | 1 |
| Theitler, J | 1 |
| Gandelman-Marton, R | 1 |
| Chistik, V | 1 |
| Margolin, N | 1 |
| Gross, B | 1 |
| Parmet, Y | 1 |
| Andelman, F | 1 |
| Kanemoto, K | 1 |
| Tadokoro, Y | 1 |
| Oshima, T | 1 |
| AlAzwary, NH | 1 |
| Muayqil, T | 1 |
| Siddiqi, ZA | 2 |
| Ahmed, SN | 2 |
| Laus, M | 1 |
| Scardapane, A | 1 |
| Franzoni, E | 2 |
| Chiarelli, F | 15 |
| Tomoum, HY | 3 |
| Awadallah, MM | 1 |
| Fouad, DA | 1 |
| Ali, AH | 1 |
| Harden, CL | 3 |
| Sethi, NK | 2 |
| Wesnes, KA | 1 |
| Edgar, C | 1 |
| Dean, AD | 1 |
| Wroe, SJ | 1 |
| Dudley, RW | 1 |
| Penney, SJ | 1 |
| Buckley, DJ | 1 |
| Terzaghi, M | 1 |
| Sartori, I | 1 |
| Rustioni, V | 1 |
| Manni, R | 3 |
| Marrosu, F | 1 |
| Barberini, L | 1 |
| Puligheddu, M | 1 |
| Bortolato, M | 1 |
| Mascia, M | 1 |
| Tuveri, A | 1 |
| Muroni, A | 1 |
| Mallarini, G | 1 |
| Avanzini, G | 4 |
| Rouvel-Tallec, A | 1 |
| Krishnamoorthy, G | 1 |
| Karande, S | 1 |
| Ahire, N | 1 |
| Mathew, L | 1 |
| Kulkarni, M | 1 |
| Aksamija, A | 1 |
| Habek, D | 1 |
| Stanojević, M | 1 |
| Ujević, B | 1 |
| Jovanovic, D | 1 |
| Doğan, M | 2 |
| Yılmaz, C | 1 |
| Temel, H | 1 |
| Çaksen, H | 3 |
| Taşkın, G | 1 |
| Valencia, I | 3 |
| Legido, A | 4 |
| Franciotta, D | 1 |
| Pattanaik, S | 1 |
| Hota, D | 1 |
| Prabhakar, S | 2 |
| Kharbanda, P | 1 |
| Pandhi, P | 2 |
| White, JR | 3 |
| Eugene Ramsay, R | 1 |
| Rarick, JO | 2 |
| Musib, L | 1 |
| Ackers, R | 1 |
| Besag, FM | 3 |
| Wade, A | 1 |
| Murray, ML | 1 |
| Wong, IC | 1 |
| Sadzot, B | 1 |
| Moonen, G | 1 |
| Samaei, A | 1 |
| Nobahar, M | 1 |
| Vafaei, AA | 1 |
| Browning, N | 2 |
| Combs-Cantrell, DT | 2 |
| Cohen, M | 2 |
| Saetre, E | 3 |
| Abdelnoor, M | 2 |
| Amlie, JP | 2 |
| Tossebro, M | 1 |
| Anfinsen, OG | 1 |
| Isojärvi, J | 3 |
| Vidiri, A | 4 |
| Pompili, A | 2 |
| Carapella, MC | 1 |
| Höcht, C | 1 |
| Lazarowski, A | 1 |
| Gonzalez, NN | 1 |
| Mayer, MA | 1 |
| Opezzo, JA | 1 |
| Taira, CA | 1 |
| Girardi, E | 1 |
| Krishnakumar, A | 2 |
| Abraham, PM | 1 |
| Paul, J | 2 |
| Paulose, CS | 5 |
| Pellock, JM | 8 |
| Onwuekwe, IO | 1 |
| Onodugo, OD | 1 |
| Ezeala-Adikaibe, B | 1 |
| Aguwa, EN | 1 |
| Ejim, EC | 1 |
| Ndukuba, K | 1 |
| Abadom, TR | 1 |
| Illo, CK | 1 |
| Onyejizu, C | 1 |
| Uludag, IF | 1 |
| Kulu, U | 1 |
| Sener, U | 2 |
| Kose, S | 1 |
| Yiannopoulou, KG | 1 |
| Kounenou, D | 1 |
| Papageorgiou, CC | 1 |
| Bozhinov, P | 1 |
| Bozhinova, C | 1 |
| Markova, C | 1 |
| Ma, MS | 2 |
| Ding, YX | 2 |
| Ying, W | 1 |
| Ding, CH | 2 |
| Zou, LP | 2 |
| Feily, A | 1 |
| Namazi, MR | 1 |
| Punyawudho, B | 2 |
| Molochkova, VV | 1 |
| Ikeda, H | 1 |
| Yamazaki, E | 2 |
| Fujiwara, T | 2 |
| Kaniwa, N | 2 |
| Saito, Y | 2 |
| Kashiwagi, M | 1 |
| Muramatsu, M | 1 |
| Nandhu, MS | 2 |
| Rauchenzauner, M | 5 |
| Griesmacher, A | 1 |
| Tatarczyk, T | 1 |
| Haberlandt, E | 1 |
| Strasak, A | 1 |
| Zimmerhackl, LB | 3 |
| Falkensammer, G | 1 |
| Luef, G | 6 |
| Högler, W | 1 |
| Gökçil, Z | 2 |
| Bek, S | 1 |
| Cakir, E | 1 |
| Odabaşi, Z | 2 |
| Svalheim, S | 5 |
| Lossius, A | 1 |
| Sandvand, F | 1 |
| Bertelsen, M | 1 |
| Mørkrid, L | 4 |
| Anjos, AM | 1 |
| Nunes, ML | 1 |
| Ayçiçek, S | 1 |
| Akaln, N | 1 |
| Güven, A | 1 |
| Köse, G | 1 |
| Park, PW | 1 |
| Ahn, JY | 1 |
| Kim, KA | 1 |
| Park, JY | 1 |
| Prodam, F | 1 |
| Bellone, S | 1 |
| Casara, G | 1 |
| De Rienzo, F | 1 |
| Grassino, EC | 1 |
| Bonsignori, I | 1 |
| Demarchi, I | 1 |
| Rapa, A | 1 |
| Radetti, G | 1 |
| Bona, G | 1 |
| Gorgone, G | 1 |
| Costa, C | 1 |
| Ciampa, C | 1 |
| Caccamo, D | 1 |
| Pisani, LR | 1 |
| Oteri, G | 6 |
| Marciani, MG | 3 |
| Aguglia, U | 2 |
| Striano, S | 2 |
| Ientile, R | 1 |
| Calabresi, P | 1 |
| Saconato, H | 1 |
| Prado, GF | 1 |
| Puga, ME | 1 |
| Atallah, AN | 1 |
| McVearry, KM | 1 |
| Gaillard, WD | 2 |
| VanMeter, J | 1 |
| Ratanajamit, C | 1 |
| Kaewpibal, P | 1 |
| Setthawacharavanich, S | 1 |
| Faroongsarng, D | 1 |
| Kwon, S | 1 |
| Seo, HE | 1 |
| Choe, BH | 1 |
| Cho, MH | 1 |
| Song, D | 1 |
| Chiu, W | 1 |
| Mohamed, S | 1 |
| Candela, C | 2 |
| Riva, R | 12 |
| Mula, M | 1 |
| Dorszewska, J | 1 |
| Winczewska-Wiktor, A | 1 |
| Sniezawska, A | 1 |
| Kaczmarek, I | 1 |
| Steinborn, B | 6 |
| Azar, NJ | 3 |
| Lagrange, AH | 1 |
| Wang, L | 3 |
| Zeng, K | 1 |
| Xi, Z | 1 |
| Ghosh, C | 2 |
| Gonzalez-Martinez, J | 2 |
| Hossain, M | 2 |
| Cucullo, L | 1 |
| Fazio, V | 1 |
| Janigro, D | 3 |
| Marchi, N | 3 |
| Boylu, E | 1 |
| Domaç, FM | 1 |
| Misirli, H | 1 |
| Senol, MG | 1 |
| Saraçoğlu, M | 1 |
| Calabrò, RS | 2 |
| Ferlazzo, E | 1 |
| Italiano, D | 3 |
| Bramanti, P | 2 |
| Mathew, J | 3 |
| Buggy, Y | 1 |
| Layton, D | 1 |
| Fogg, C | 1 |
| Shakir, SA | 1 |
| Peeyush Kumar, T | 1 |
| Khan, RS | 1 |
| Wang, KX | 1 |
| Wei, Y | 2 |
| Xu, MH | 1 |
| Su, JM | 1 |
| Bao, YG | 1 |
| Zhao, SY | 1 |
| Kim, WJ | 2 |
| Lee, JH | 1 |
| Yi, J | 1 |
| Lee, SH | 1 |
| Kim, SW | 1 |
| Kim, KH | 1 |
| In Lee, B | 1 |
| Lee, MG | 1 |
| El-Khayat, HA | 2 |
| Aly, GS | 1 |
| Mamdouh, RM | 1 |
| Al-Badani, AK | 1 |
| Mohamed, EI | 1 |
| Santucci, R | 1 |
| Fothergill, H | 1 |
| Laugel, V | 1 |
| Perville, A | 1 |
| De Saint Martin, A | 1 |
| Gerout, AC | 1 |
| Fischbach, M | 1 |
| Arif, H | 1 |
| Buchsbaum, R | 1 |
| Pierro, J | 1 |
| Whalen, M | 1 |
| Sims, J | 1 |
| Resor, SR | 1 |
| Bazil, CW | 2 |
| Hirsch, LJ | 1 |
| Gube, M | 1 |
| Ell, W | 1 |
| Schiefer, J | 1 |
| Kraus, T | 1 |
| Arzy, S | 1 |
| Allali, G | 1 |
| Brunet, D | 1 |
| Michel, CM | 1 |
| Kaplan, PW | 1 |
| Seeck, M | 1 |
| Berger, I | 1 |
| Segal, I | 1 |
| Shmueli, D | 1 |
| Saada, A | 1 |
| Grover, S | 2 |
| Bala, K | 2 |
| Gourie-Devi, M | 2 |
| Baghel, R | 2 |
| Kaur, H | 2 |
| Gupta, M | 5 |
| Talwar, P | 2 |
| Helmstaedter, C | 1 |
| Witt, JA | 1 |
| Gaspari, CN | 1 |
| Guerreiro, CA | 4 |
| Hanhart, J | 1 |
| Vinker, S | 1 |
| Nemet, A | 1 |
| Levartovsky, S | 1 |
| Kaiserman, I | 1 |
| Lambrinoudaki, I | 1 |
| Kaparos, G | 1 |
| Armeni, E | 1 |
| Alexandrou, A | 1 |
| Damaskos, C | 1 |
| Logothetis, E | 1 |
| Creatsa, M | 1 |
| Antoniou, A | 1 |
| Kouskouni, E | 1 |
| Triantafyllou, N | 1 |
| Varoglu, AO | 1 |
| Yildirim, A | 1 |
| Aygul, R | 1 |
| Gundogdu, OL | 1 |
| Sahin, YN | 1 |
| Sharma, V | 1 |
| Nehru, B | 1 |
| Munshi, A | 1 |
| Jyothy, A | 1 |
| Hagemann, G | 1 |
| Zinke, J | 1 |
| Fuchs, M | 1 |
| Witte, OW | 1 |
| Sendrowski, K | 1 |
| Sobaniec, W | 1 |
| Boćkowski, L | 1 |
| Kułak, W | 1 |
| Smigielska-Kuzia, J | 1 |
| Neziri, B | 1 |
| Islami, H | 1 |
| Bauer, S | 1 |
| Hill, M | 1 |
| Zárubová, J | 1 |
| Marusič, P | 1 |
| Vrbíková, J | 1 |
| Velíková, M | 1 |
| Kancheva, R | 1 |
| Kancheva, L | 1 |
| Kubátová, J | 1 |
| Dušková, M | 1 |
| Zamrazilová, L | 1 |
| Kazihnitková, H | 1 |
| Simůnková, K | 1 |
| Stárka, L | 1 |
| Barbakadze, M | 1 |
| Bilanishvili, I | 1 |
| Chkhetiani, M | 1 |
| Khizanishvili, N | 1 |
| Koreli, A | 1 |
| Narayanasamy, K | 1 |
| Varma, B | 1 |
| Kaur, K | 1 |
| Giddaluru, S | 1 |
| Sharma, A | 1 |
| Brahmachari, SK | 1 |
| Muti, P | 2 |
| Meng, LL | 1 |
| Colugnati, DB | 1 |
| Arida, RM | 1 |
| Cysneiros, RM | 1 |
| Terra, VC | 1 |
| Sonoda, EY | 1 |
| Pansani, AP | 1 |
| Scorza, CA | 1 |
| Cavalheiro, EA | 2 |
| Scorza, FA | 1 |
| Kurt, AN | 1 |
| Aslanyavrusu, M | 1 |
| Lüders, HO | 1 |
| Gangadharan, G | 1 |
| Kuruvilla, KP | 1 |
| Shankarkumar, U | 1 |
| Shah, KN | 1 |
| Ghosh, K | 1 |
| Wu, XT | 1 |
| Hu, FY | 1 |
| An, DM | 1 |
| Yan, B | 1 |
| Jiang, X | 1 |
| Stefan, H | 6 |
| Dahlin, MG | 1 |
| Ohman, I | 2 |
| Liu, HJ | 1 |
| Li, P | 1 |
| Wei, Q | 1 |
| Zhao, M | 1 |
| Yang, L | 1 |
| Xiong, X | 1 |
| Zhai, SD | 1 |
| Wendling, AS | 1 |
| Bondareva, IB | 3 |
| Jelliffe, RW | 3 |
| Andreeva, OV | 1 |
| Bondareva, KI | 1 |
| Specht, U | 1 |
| Thorbecke, R | 1 |
| Coban, I | 1 |
| Aricò, I | 1 |
| Condurso, R | 1 |
| Granata, F | 1 |
| Nobili, L | 1 |
| Bruni, O | 1 |
| Silvestri, R | 1 |
| Ozturk, B | 1 |
| Ozturk, HS | 1 |
| Ozcelik, A | 1 |
| Kurt, N | 1 |
| Kutsal, E | 1 |
| Sevinc, N | 1 |
| Jentink, J | 2 |
| Dolk, H | 1 |
| Loane, MA | 1 |
| Morris, JK | 1 |
| Wellesley, D | 1 |
| Garne, E | 1 |
| de Jong-van den Berg, L | 1 |
| Gifford, RM | 1 |
| Ganesan, S | 1 |
| Hussain, N | 1 |
| Iniesta, I | 1 |
| Gros-Otero, J | 1 |
| Gorroño-Echebarría, M | 1 |
| Benítez-Herreros, J | 1 |
| Haerian, BS | 2 |
| Mohamed, EH | 2 |
| Tan, CT | 2 |
| Wong, CP | 2 |
| Kim, DH | 2 |
| Motamedi, GK | 1 |
| Arnaboldi, M | 1 |
| Taborelli, A | 1 |
| Gajda, Z | 1 |
| Török, R | 1 |
| Horváth, Z | 1 |
| Szántai-Kis, C | 1 |
| Orfi, L | 1 |
| Kéri, G | 1 |
| Szente, M | 1 |
| Cummings, C | 1 |
| Stewart, M | 1 |
| Stevenson, M | 1 |
| Nelson, J | 1 |
| Ramaratnam, S | 2 |
| Mathieu, O | 1 |
| Picot, MC | 1 |
| Gelisse, P | 3 |
| Breton, H | 2 |
| Demoly, P | 1 |
| Hillaire-Buys, D | 3 |
| Citraro, R | 1 |
| Scicchitano, F | 1 |
| De Fazio, S | 1 |
| Raggio, R | 1 |
| Mainardi, P | 1 |
| De Sarro, G | 2 |
| Quispe Gonzales, JO | 1 |
| Gómez Giralda, B | 1 |
| Ruiz-Zorrilla López, C | 1 |
| Acosta Ochoa, MI | 1 |
| Ampuero Anachuri, K | 1 |
| Molina Miguel, A | 1 |
| Guo, G | 1 |
| Ren, J | 1 |
| Zhou, H | 1 |
| Chauhan, A | 1 |
| Anand, S | 1 |
| Thomas, S | 1 |
| Subramanya, HC | 1 |
| Pradhan, G | 1 |
| Fortuna, A | 1 |
| Bicker, J | 1 |
| Alves, G | 1 |
| Falcão, A | 1 |
| Yoshino, A | 1 |
| Reeta, KH | 1 |
| Mehla, J | 1 |
| Pahuja, M | 1 |
| Bittner, S | 1 |
| Höhn, K | 1 |
| Göbel, K | 1 |
| Kleinschnitz, C | 1 |
| Wiendl, H | 1 |
| Meuth, SG | 1 |
| Hovdal, H | 1 |
| Espeset, K | 1 |
| Lydersen, S | 2 |
| Holmes, LB | 3 |
| Mittendorf, R | 1 |
| Shen, A | 1 |
| Smith, CR | 1 |
| Hernandez-Diaz, S | 1 |
| Yiş, U | 2 |
| Mania, M | 2 |
| Kasradze, S | 2 |
| Okujava, N | 2 |
| Rhee, Y | 1 |
| Lee, SA | 1 |
| Song, HK | 1 |
| Song, K | 1 |
| Pack, AM | 3 |
| Morrell, MJ | 4 |
| McMahon, DJ | 2 |
| Shane, E | 3 |
| Bachmann, T | 1 |
| Bertheussen, KH | 1 |
| Sitges, M | 1 |
| Sanchez-Tafolla, BM | 1 |
| Chiu, LM | 1 |
| Aldana, BI | 1 |
| Guarneros, A | 1 |
| Kulaga, S | 1 |
| Sheehy, O | 1 |
| Zargarzadeh, AH | 1 |
| Moussally, K | 1 |
| Bérard, A | 1 |
| Hewetson, K | 1 |
| Lohoff, FW | 1 |
| Kim, KB | 1 |
| Seo, KA | 1 |
| Bae, SK | 1 |
| Sperati, F | 2 |
| El Desoky, ES | 2 |
| Sabarinath, SN | 1 |
| Hamdi, MM | 1 |
| Bewernitz, M | 1 |
| Derendorf, H | 1 |
| Lee, KW | 1 |
| Song, WJ | 1 |
| Jee, YK | 1 |
| Lee, SM | 1 |
| Kang, HR | 1 |
| Park, HW | 1 |
| Cho, SH | 1 |
| Park, SH | 1 |
| Min, KU | 1 |
| Chang, YS | 1 |
| Jain, AS | 1 |
| Date, AA | 1 |
| Pissurlenkar, RR | 1 |
| Coutinho, EC | 1 |
| Nagarsenker, MS | 1 |
| Akamatsu, N | 1 |
| Zhang, LL | 1 |
| Zeng, LN | 1 |
| Li, YP | 1 |
| Lyseng-Williamson, KA | 1 |
| Kotov, AS | 1 |
| Werler, MM | 1 |
| Ahrens, KA | 1 |
| Bosco, JL | 1 |
| Mitchell, AA | 1 |
| Anderka, MT | 1 |
| Gilboa, SM | 1 |
| Tesfaye, H | 1 |
| Klapková, E | 1 |
| Tesfayeová, A | 1 |
| Then, SM | 1 |
| Rani, ZZ | 1 |
| Ratnaningrum, S | 1 |
| Jamal, R | 1 |
| Chuang, HY | 1 |
| Lin, TK | 1 |
| Chang, CC | 1 |
| Lu, CH | 1 |
| Chang, WN | 1 |
| Chen, SD | 1 |
| Tan, TY | 1 |
| Huang, CR | 1 |
| Chan, SH | 1 |
| Kim, HS | 1 |
| Oh, J | 1 |
| Ali, A | 1 |
| Dua, Y | 1 |
| Constance, JE | 1 |
| Franklin, MR | 1 |
| Skidmore, CT | 2 |
| Rankin, SJ | 1 |
| Pequinot, E | 1 |
| Capuzzi, DM | 1 |
| Sperling, MR | 3 |
| Aksoy, A | 1 |
| Sönmez, FM | 2 |
| Deger, O | 1 |
| Hosver, I | 1 |
| Karagüzel, G | 1 |
| Javashvili, L | 1 |
| Dostic, M | 1 |
| Hung, CC | 1 |
| Chang, WL | 1 |
| Ho, JL | 1 |
| Tai, JJ | 1 |
| Hsieh, TJ | 1 |
| Huang, HC | 1 |
| Hsieh, YW | 1 |
| Liou, HH | 1 |
| Samia, O | 1 |
| Hanan, R | 1 |
| Kamal, el T | 1 |
| Ishida, S | 2 |
| Sakamoto, Y | 1 |
| Nishio, T | 1 |
| Baulac, S | 2 |
| Kuwamura, M | 2 |
| Ohno, Y | 2 |
| Takizawa, A | 2 |
| Serikawa, T | 2 |
| Mashimo, T | 2 |
| Gerna, M | 3 |
| Bakke, J | 1 |
| Morselli, PL | 6 |
| Biberoglu, G | 2 |
| Tumer, L | 1 |
| Ezgu, FS | 1 |
| Hasanoglu, A | 2 |
| Cornacchio, AL | 1 |
| Aragon, CE | 1 |
| Musib, LC | 1 |
| Gross, CR | 1 |
| Mishra, U | 1 |
| Matlow, J | 1 |
| Koren, G | 3 |
| Bochyńska, A | 1 |
| Lipczyńska-Łojkowska, W | 1 |
| Gugała-Iwaniuk, M | 1 |
| Lechowicz, W | 1 |
| Restel, M | 1 |
| Graban, A | 1 |
| Lipska, B | 1 |
| Ryglewicz, D | 1 |
| Madruga Dias, J | 1 |
| Costa, MM | 1 |
| Pereira da Silva, JA | 1 |
| Viana de Queiroz, M | 1 |
| Ramsay, ER | 1 |
| Macias, FM | 1 |
| Collins, JF | 7 |
| Rasmussen, P | 1 |
| Alexopoulos, AV | 1 |
| Talati, R | 1 |
| Scholle, JM | 1 |
| Phung, OP | 1 |
| Baker, EL | 1 |
| Baker, WL | 1 |
| Ashaye, A | 1 |
| Kluger, J | 1 |
| Coleman, CI | 1 |
| White, CM | 1 |
| Yildiz, M | 1 |
| Chu, XM | 1 |
| Zhang, LF | 1 |
| Wang, GJ | 1 |
| Zhang, SN | 1 |
| Zhou, JH | 1 |
| Hao, HP | 1 |
| Boersma, C | 1 |
| Postma, MJ | 1 |
| Goodman, MJ | 1 |
| Durkin, M | 1 |
| Forlenza, J | 1 |
| Ye, X | 1 |
| Brixner, DI | 1 |
| Rosemergy, I | 1 |
| Bergin, P | 1 |
| Jones, P | 1 |
| Walker, E | 1 |
| Krysiak, R | 1 |
| Kedzia, A | 1 |
| Okopień, B | 1 |
| Dodel, R | 1 |
| Balzer-Geldsetzer, M | 1 |
| Reese, JP | 1 |
| Schöffski, O | 1 |
| Graf, W | 1 |
| Schwab, S | 1 |
| Oertel, WH | 1 |
| Brzaković, BB | 1 |
| Vezmar Kovačević, SD | 1 |
| Vučićević, KM | 1 |
| Miljković, BR | 1 |
| Martinović, ZJ | 1 |
| Pokrajac, MV | 1 |
| Prostran, MŠ | 1 |
| Sirmagul, B | 1 |
| Atli, O | 1 |
| Ilgin, S | 1 |
| Boillot, M | 1 |
| Fumoto, N | 1 |
| Aoto, T | 1 |
| Ueda, M | 1 |
| LeGuern, E | 1 |
| Takahashi, R | 1 |
| Akar, M | 1 |
| Dilli, D | 1 |
| Yilmaz, Y | 1 |
| Erdeve, O | 1 |
| Oguz, S | 1 |
| Uras, N | 1 |
| Dilmen, U | 1 |
| Karaoglu, A | 1 |
| Bideci, A | 3 |
| Bravo, A | 1 |
| Hernandez, D | 1 |
| Martinez-Villarreal, L | 1 |
| Elizondo, G | 1 |
| Esmer, C | 1 |
| Kang, SY | 1 |
| Han, YM | 1 |
| Choi, K | 1 |
| Hwang, SH | 1 |
| Tysse, I | 1 |
| Valsø, B | 1 |
| Larsson, PG | 2 |
| Rytter, E | 1 |
| Nishikura, N | 1 |
| Yoshioka, S | 1 |
| Takano, T | 1 |
| Beghi, E | 2 |
| Dong, D | 1 |
| Sung, C | 1 |
| Finkelstein, EA | 1 |
| Rani, S | 1 |
| Malik, AK | 1 |
| Akgün, H | 1 |
| Yücel, M | 1 |
| Pollicino, P | 1 |
| Corradini, I | 1 |
| Donzelli, A | 1 |
| Antonucci, F | 1 |
| Welzl, H | 1 |
| Loos, M | 1 |
| Martucci, R | 1 |
| De Astis, S | 1 |
| Pattini, L | 1 |
| Inverardi, F | 1 |
| Wolfer, D | 1 |
| Caleo, M | 1 |
| Bozzi, Y | 1 |
| Verderio, C | 1 |
| Frassoni, C | 1 |
| Braida, D | 1 |
| Clerici, M | 1 |
| Lipp, HP | 1 |
| Sala, M | 1 |
| Matteoli, M | 1 |
| Ding, JJ | 1 |
| Aurlien, D | 1 |
| Wu, S | 1 |
| Subhani, Q | 1 |
| Yang, B | 1 |
| Chen, D | 1 |
| Zhu, Y | 1 |
| Li, L | 1 |
| Hovinga, CA | 1 |
| Mushtaq, U | 1 |
| Mochol, M | 1 |
| Frøland, SS | 1 |
| Bialer, M | 7 |
| Carapella, CM | 1 |
| Puranik, YG | 1 |
| Ahmed, G | 1 |
| Remmel, RP | 2 |
| Lamba, JK | 1 |
| Kumar, V | 1 |
| Chillar, N | 1 |
| Mittal, H | 1 |
| Faridi, MM | 1 |
| Emeksiz, HC | 1 |
| Arga, M | 1 |
| Maren Staack, A | 1 |
| Wisniewski, I | 1 |
| Adamec, I | 1 |
| Nanković, S | 1 |
| Zadro, I | 1 |
| Hajnšek, S | 1 |
| Habek, M | 1 |
| Sachdeo, RC | 2 |
| Wasserstein, A | 1 |
| Mesenbrink, PJ | 1 |
| Capella, HM | 1 |
| Lemos, T | 1 |
| Abraham, I | 1 |
| Haslinger, M | 1 |
| Seppi, K | 1 |
| Unterberger, I | 2 |
| Alge, A | 1 |
| Windisch, J | 1 |
| Lechleitner, M | 2 |
| Bauer, G | 3 |
| Hermida, J | 4 |
| Fernández, MP | 1 |
| Tutor, JC | 3 |
| Poblano, A | 1 |
| Belmont, A | 1 |
| Sosa, J | 1 |
| Ibarra, J | 1 |
| Rosas, Y | 1 |
| López, V | 1 |
| Garza, S | 1 |
| Voudris, K | 3 |
| Moustaki, M | 1 |
| Zeis, PM | 1 |
| Dimou, S | 4 |
| Vagiakou, E | 1 |
| Tsagris, B | 1 |
| Skardoutsou, A | 4 |
| von Einsiedel, RW | 1 |
| Roesch-Ely, D | 1 |
| Diebold, K | 1 |
| Sartor, K | 1 |
| Mundt, C | 1 |
| Bergemann, N | 1 |
| Kroes, HY | 1 |
| Reefhuis, J | 1 |
| Cornel, MC | 2 |
| Zhang, ZJ | 1 |
| Postma, T | 1 |
| Obeng, K | 1 |
| Russell, S | 1 |
| Weiss, SR | 2 |
| Post, RM | 4 |
| Smyth, MD | 1 |
| Barbaro, NM | 1 |
| Baraban, SC | 1 |
| Wester, U | 1 |
| Brandberg, G | 1 |
| Larsson, M | 1 |
| Lönnerholm, T | 1 |
| Annerén, G | 1 |
| Galas-Zgorzalewicz, B | 3 |
| Sa'adah, MA | 1 |
| Shawabkeh, A | 1 |
| Sa'adah, LM | 1 |
| Inshasi, J | 1 |
| Mack, CJ | 1 |
| Kuc, S | 1 |
| Mulcrone, SA | 1 |
| Pilley, A | 1 |
| Grünewald, RA | 2 |
| Herranz, JL | 1 |
| Argumosa, A | 1 |
| Riss, JR | 1 |
| Kriel, RL | 1 |
| Kammer, NM | 1 |
| Judge, MK | 1 |
| Montgomery, MJ | 1 |
| Smith, CT | 2 |
| Hutton, JL | 4 |
| Moreno-Ramírez, D | 1 |
| García-Bravo, B | 1 |
| Rodríguez-Pichardo, A | 1 |
| Camacho, CR | 1 |
| Martínez, FC | 1 |
| Alfaro-Rodríguez, A | 1 |
| Labra-Ruíz, N | 1 |
| Carrasco-Portugal, M | 1 |
| González-Maciel, A | 2 |
| Pérez-Guille, B | 1 |
| Soriano-Rosales, R | 1 |
| Villegas, F | 1 |
| González-Piña, R | 1 |
| Espinoza-Villanueva, G | 1 |
| Ayala-Guerrero, F | 2 |
| Mandrioli, R | 2 |
| Ghedini, N | 1 |
| Kenndler, E | 1 |
| Raggi, MA | 1 |
| Sheth, RD | 2 |
| Greco, R | 3 |
| Latini, G | 1 |
| Morgese, G | 11 |
| Sánchez-Alcaraz, A | 1 |
| Quintana, MB | 1 |
| López, E | 1 |
| Rodríguez, I | 1 |
| Llopis, P | 1 |
| Sirven, JI | 1 |
| Chetty, M | 1 |
| Sarkar, P | 1 |
| Sakhuja, V | 1 |
| Lindberger, M | 1 |
| Lars, S | 1 |
| Patterson, CR | 1 |
| Davies, MG | 1 |
| Holtmann, M | 1 |
| Krause, M | 1 |
| Opp, J | 1 |
| Tokarzewski, M | 1 |
| Korn-Merker, E | 2 |
| Boenigk, HE | 3 |
| Oto, M | 1 |
| Russell, AJ | 1 |
| McGonigal, A | 1 |
| Duncan, R | 1 |
| Karabiber, H | 2 |
| Sonmezgoz, E | 1 |
| Ozerol, E | 1 |
| Yakinci, C | 2 |
| Otlu, B | 1 |
| Yologlu, S | 1 |
| Yoshikawa, H | 1 |
| Abe, T | 3 |
| Vergely, N | 1 |
| Mounier, C | 1 |
| Guy, C | 1 |
| Millot, L | 1 |
| Estour, B | 1 |
| Pylvänen, V | 1 |
| Knip, M | 6 |
| Pakarinen, AJ | 17 |
| Turkka, J | 2 |
| Kotila, M | 3 |
| Rättyä, J | 6 |
| Myllylä, VV | 15 |
| Isojärvi, JI | 20 |
| Kaaja, E | 2 |
| Kaaja, R | 1 |
| Hiilesmaa, V | 2 |
| Privitera, MD | 3 |
| Mattson, RH | 8 |
| Chadwick, DW | 10 |
| Neto, W | 2 |
| Bergin, AM | 1 |
| Connolly, M | 2 |
| Koch, HJ | 1 |
| Szecsey, A | 1 |
| Vogel, M | 1 |
| Callenbach, PM | 1 |
| Jol-Van Der Zijde, CM | 1 |
| Geerts, AT | 1 |
| Arts, WF | 1 |
| Van Donselaar, CA | 1 |
| Peters, AC | 1 |
| Stroink, H | 1 |
| Van Tol, MJ | 1 |
| Shahar, E | 2 |
| Barak, S | 1 |
| Irshaid, YM | 1 |
| Hamdi, AA | 1 |
| Al Homrany, M | 1 |
| Luszczki, JJ | 4 |
| Swiader, M | 1 |
| de Chadarévian, JP | 1 |
| Miles, DK | 1 |
| Katsetos, CD | 1 |
| Kutluay, E | 2 |
| McCague, K | 1 |
| Deda, G | 1 |
| Içağasioğlu, D | 1 |
| Jain, RS | 2 |
| Pamuk, ON | 1 |
| Cakir, N | 1 |
| Soy, M | 1 |
| Aktoz, M | 1 |
| Celik, Y | 1 |
| Akdemir, O | 1 |
| König, SA | 1 |
| Knolle, J | 1 |
| Friedewald, S | 1 |
| Koelfen, W | 1 |
| Longin, E | 3 |
| Lenz, T | 1 |
| Hannak, D | 1 |
| Shi, XJ | 1 |
| Zhang, JH | 1 |
| Finnell, RH | 1 |
| Gould, A | 1 |
| Spiegelstein, O | 1 |
| Croci, D | 5 |
| Rossini, A | 1 |
| Messina, S | 2 |
| Mamoli, D | 3 |
| Walczak, T | 1 |
| Okazaki, T | 1 |
| Nagai, T | 3 |
| Bang, L | 1 |
| Goa, K | 1 |
| Sofue, A | 1 |
| Hayakawa, F | 1 |
| Nakai, Y | 1 |
| Toyota, N | 1 |
| Betts, T | 1 |
| Yarrow, H | 1 |
| Dutton, N | 1 |
| Rolfe, T | 1 |
| Røste, LS | 2 |
| Haugen, TB | 1 |
| Bjørnenak, T | 2 |
| Saetre, ER | 2 |
| Szwed-Białozyt, B | 1 |
| Marszał, E | 2 |
| Vajda, FJ | 6 |
| Hitchcock, A | 1 |
| Lander, C | 1 |
| Narita, H | 1 |
| Odawara, T | 1 |
| Kawanishi, C | 1 |
| Kishida, I | 1 |
| Iseki, E | 1 |
| Kosaka, K | 1 |
| Almeida, L | 1 |
| Tartara, A | 3 |
| Galimberti, CA | 2 |
| Morini, R | 2 |
| Limido, G | 1 |
| Gatti, G | 7 |
| Bartoli, A | 3 |
| Strada, G | 1 |
| Dulger, H | 1 |
| Cesur, Y | 1 |
| Atas, B | 1 |
| Tuncer, O | 1 |
| Odabas, D | 1 |
| Mendez, M | 1 |
| Lim, G | 1 |
| Kurul, S | 2 |
| Dirik, E | 3 |
| Iscan, A | 2 |
| TCHICALOFF, M | 1 |
| PENNETTI, F | 1 |
| JONGMANS, JW | 1 |
| KOKKORES, P | 1 |
| GREGORIADES, A | 1 |
| HAJNSEK, F | 1 |
| SARTORIUS, N | 1 |
| KANEKO, Z | 1 |
| IDA, H | 1 |
| SHIMIZU, A | 1 |
| NAKAI, K | 1 |
| Yerby, MS | 6 |
| Guilloton, L | 1 |
| Drouet, A | 1 |
| Renoult, PA | 1 |
| Bedubourg, G | 1 |
| Vial, T | 1 |
| Felten, D | 1 |
| Pieters, MS | 1 |
| van Steveninck, AF | 1 |
| Schoemaker, RC | 1 |
| Kroon, JM | 1 |
| van Gerven, JM | 1 |
| Cohen, AF | 1 |
| Konno, S | 1 |
| Kudoh, M | 1 |
| Tohgi, H | 1 |
| Holanda, MM | 1 |
| Quinino, SC | 1 |
| da Silva, JA | 1 |
| Rabinovitz, S | 1 |
| Mostofsky, DI | 1 |
| Yehuda, S | 1 |
| Potschka, H | 1 |
| Fedrowitz, M | 1 |
| Löscher, W | 4 |
| Kumar, S | 1 |
| Miller, M | 1 |
| Zaninelli, R | 1 |
| Fuseau, E | 1 |
| EL Din Amry, S | 1 |
| Cosson, V | 1 |
| Kishore, P | 1 |
| Rajnarayana, K | 1 |
| Reddy, MS | 1 |
| Sagar, JV | 1 |
| Krishna, DR | 1 |
| Paulus, W | 5 |
| Kaminow, L | 1 |
| Schimschock, JR | 1 |
| Hammer, AE | 2 |
| Vuong, A | 2 |
| Persson, H | 1 |
| Ericson, M | 2 |
| Gaily, E | 4 |
| Kantola-Sorsa, E | 1 |
| Isoaho, M | 1 |
| Matila, R | 1 |
| Nylund, T | 1 |
| Bardy, A | 2 |
| Granström, ML | 5 |
| Durmaz, Y | 1 |
| Temel, I | 1 |
| Mehmet, N | 1 |
| Bang, LM | 1 |
| Goa, KL | 1 |
| Meischenguiser, R | 2 |
| D'Giano, CH | 2 |
| Ferraro, SM | 2 |
| Bauer, J | 4 |
| Blumenthal, S | 1 |
| Reuber, M | 2 |
| Stoffel-Wagner, B | 1 |
| Löfgren, E | 2 |
| Juntunen, KS | 1 |
| Päivänsalo, M | 2 |
| Rautakorpi, I | 1 |
| Tuomivaara, L | 1 |
| Ravid, S | 1 |
| Andraus, J | 1 |
| Siniscalchi, A | 1 |
| Mancuso, F | 1 |
| Scornaienghi, D | 1 |
| Ferreri, G | 1 |
| Tomka-Hoffmeister, M | 1 |
| Huber, B | 1 |
| Seidel, M | 1 |
| Vainionpää, LK | 2 |
| Mikkonen, K | 2 |
| Krishnan, A | 1 |
| Sahariah, SU | 1 |
| Kapoor, SK | 1 |
| Sato, A | 2 |
| Katada, S | 1 |
| Sato, M | 3 |
| Kobayashi, H | 1 |
| Iinuma, K | 1 |
| Nikolaos, T | 1 |
| Stylianos, G | 1 |
| Chryssoula, N | 1 |
| Irini, P | 1 |
| Christos, M | 1 |
| Dimitrios, T | 1 |
| Konstantinos, P | 1 |
| Antonis, T | 1 |
| Winbladh, B | 2 |
| Källén, B | 3 |
| Chaudhary, G | 1 |
| Kohli, K | 2 |
| Wheless, JW | 2 |
| Baldauf, CM | 1 |
| Kanner, AM | 2 |
| Bautista, J | 1 |
| Abou-Khalil, B | 1 |
| Browne, T | 1 |
| Theodore, WH | 5 |
| Bazil, C | 1 |
| Stern, J | 1 |
| Schachter, SC | 1 |
| Bergen, D | 2 |
| Hirtz, D | 1 |
| Montouris, GD | 1 |
| Nespeca, M | 1 |
| Gidal, B | 1 |
| Marks, WJ | 1 |
| Turk, WR | 1 |
| Fischer, JH | 1 |
| Bourgeois, B | 1 |
| Wilner, A | 1 |
| Faught, RE | 2 |
| Easterford, K | 1 |
| Clough, P | 1 |
| Kellett, M | 1 |
| Fallon, K | 1 |
| Duncan, S | 2 |
| Luef, GJ | 1 |
| Waldmann, M | 1 |
| Sturm, W | 1 |
| Naser, A | 1 |
| Miller, AD | 1 |
| Krauss, GL | 1 |
| Hamzeh, FM | 1 |
| Miles, MV | 2 |
| Tang, PH | 1 |
| Ryan, MA | 1 |
| Grim, SA | 1 |
| Fakhoury, TA | 2 |
| Strawsburg, RH | 1 |
| DeGrauw, TJ | 1 |
| Tapanainen, P | 1 |
| Mantzouranis, EC | 1 |
| Bertsias, GK | 1 |
| Pallis, EG | 1 |
| Tsatsakis, AM | 2 |
| Goyal, V | 1 |
| Bhatia, M | 1 |
| Behari, M | 2 |
| Lobefalo, L | 3 |
| Priolo, T | 1 |
| Rapinese, M | 2 |
| Trotta, D | 5 |
| Gallenga, PE | 3 |
| Konishi, H | 2 |
| Tanaka, K | 3 |
| Minouchi, T | 1 |
| Yamaji, A | 1 |
| Tutor-Crespo, MJ | 2 |
| Bolayir, E | 1 |
| Celik, K | 1 |
| Tas, A | 1 |
| Topaktas, S | 1 |
| Bakir, S | 1 |
| McKee, P | 1 |
| van Opstal, JM | 1 |
| Janknegt, R | 1 |
| Cilissen, J | 1 |
| L'Ortije, WH | 1 |
| Nel, JE | 1 |
| De Heer, F | 1 |
| Abd El-Basset, FZ | 1 |
| Tohamy, SM | 1 |
| Zaky, AA | 1 |
| Mohamed, MS | 1 |
| Hakky, SM | 1 |
| El Barbary, NS | 1 |
| Nassef, NM | 1 |
| Vazquez, B | 1 |
| Schmidt, D | 12 |
| Elger, CE | 4 |
| Hansen, CP | 1 |
| Wolf, P | 4 |
| Ecevit, C | 1 |
| Aydoğan, A | 1 |
| Kavakli, T | 1 |
| Altinöz, S | 1 |
| Morgan, CL | 1 |
| Buchan, S | 1 |
| Kerr, MP | 1 |
| Noronha, AL | 1 |
| Marques, LH | 1 |
| Borges, MA | 1 |
| Min, LL | 1 |
| Shorvon, SD | 12 |
| Bulteau, C | 1 |
| Motte, J | 1 |
| Tran, A | 2 |
| Sturm, Y | 1 |
| Markabi, S | 1 |
| Vestergaard, P | 1 |
| Rejnmark, L | 1 |
| Mosekilde, L | 1 |
| Miura, H | 7 |
| Akiyama, T | 2 |
| Ohtsuka, Y | 1 |
| Kobayashi, K | 2 |
| Oka, E | 4 |
| Ragueneau-Majlessi, I | 1 |
| Levy, RH | 14 |
| Garnett, W | 1 |
| Rosenfeld, W | 1 |
| Mather, G | 1 |
| Shah, J | 1 |
| Grundy, JS | 1 |
| Kłys, M | 1 |
| Rojek, S | 1 |
| Klementowicz, W | 1 |
| Bolechała, F | 1 |
| Voudris, KA | 3 |
| Mastroyianni, S | 5 |
| Araújo, IM | 1 |
| Ambrósio, AF | 2 |
| Leal, EC | 1 |
| Verdasca, MJ | 1 |
| Malva, JO | 1 |
| Carvalho, AP | 2 |
| Carvalho, CM | 2 |
| Agarwal, S | 1 |
| Aneja, S | 1 |
| Kalaivani, M | 1 |
| Singh, G | 1 |
| Driever, PH | 1 |
| Tutor-Crespo, M | 1 |
| Tutor, C | 1 |
| Fukuoka, N | 1 |
| Tsukamoto, T | 1 |
| Uno, J | 1 |
| Kimura, M | 3 |
| Morita, S | 1 |
| Morozov, GV | 1 |
| Semenova, NV | 1 |
| Slastenko, OA | 1 |
| Mishchenko, AL | 1 |
| Ficker, DM | 2 |
| Atkinson, RJ | 1 |
| Dennis, G | 1 |
| Cross, SS | 1 |
| McAlindon, ME | 1 |
| Sharrack, B | 1 |
| Sanders, DS | 1 |
| Murakami, N | 1 |
| Ogino, T | 1 |
| Ohmori, I | 1 |
| Ito, M | 1 |
| Auvinen, A | 2 |
| Keränen, T | 5 |
| Capponi, A | 1 |
| De Simone, C | 1 |
| Guerriero, C | 1 |
| Rotoli, M | 1 |
| Bartoloni, C | 1 |
| Yoshinaga, A | 1 |
| Ohno, R | 1 |
| Ishii, N | 1 |
| Kamata, S | 1 |
| Watanabe, T | 1 |
| Yamada, T | 2 |
| Marcus, R | 1 |
| Holloway, L | 1 |
| Flaster, E | 1 |
| Doñe, S | 1 |
| Randall, A | 2 |
| Seale, C | 1 |
| Mørland, T | 1 |
| Franceschi, L | 1 |
| Furlanut, M | 2 |
| Kimiskidis, VK | 1 |
| Papagiannopoulos, S | 1 |
| Sotirakoglou, K | 1 |
| Kazis, DA | 1 |
| Kazis, A | 1 |
| Mills, KR | 1 |
| Nakajima, Y | 1 |
| Shiseki, K | 1 |
| Fukushima-Uesaka, H | 1 |
| Hasegawa, R | 1 |
| Ozawa, S | 1 |
| Sugai, K | 1 |
| Katoh, M | 1 |
| Saitoh, O | 1 |
| Ohnuma, T | 1 |
| Kawai, M | 1 |
| Ohtsuki, T | 1 |
| Suzuki, C | 1 |
| Minami, N | 1 |
| Kimura, H | 1 |
| Goto, Y | 1 |
| Kamatani, N | 1 |
| Sawada, J | 1 |
| Tan, H | 1 |
| Gürbüz, T | 1 |
| Dağsuyu, IM | 1 |
| Mahmoudian, T | 1 |
| Iranpour, R | 1 |
| Messri, N | 1 |
| Ratti, S | 1 |
| Makis, AC | 1 |
| Tzoufi, M | 1 |
| Kateri, MD | 1 |
| Bourantas, KL | 1 |
| Papadopoulou, ZL | 1 |
| Tate, SK | 1 |
| Soranzo, N | 2 |
| Thom, M | 2 |
| Wood, NW | 1 |
| Goldstein, DB | 2 |
| Kasturi, L | 1 |
| Sawant, SP | 1 |
| Mohanraj, R | 1 |
| Mockenhaupt, M | 1 |
| Messenheimer, J | 1 |
| Tennis, P | 1 |
| Schlingmann, J | 1 |
| Rosaria Muscatello, M | 1 |
| Pacetti, M | 1 |
| Cacciola, M | 1 |
| La Torre, D | 1 |
| Zoccali, R | 1 |
| D'Arrigo, C | 1 |
| Migliardi, G | 1 |
| Spina, E | 6 |
| Senior, K | 1 |
| Tunca, A | 1 |
| Sayli, U | 1 |
| Atalar, H | 1 |
| Doğruel, H | 1 |
| Hiremath, GK | 1 |
| Kotagal, P | 1 |
| Bingaman, W | 1 |
| Hovinga, C | 1 |
| Wyllie, E | 2 |
| Morris, H | 1 |
| Nelson, D | 1 |
| Prats Viñas, JM | 1 |
| Martínez González, MJ | 1 |
| García Ribes, A | 1 |
| Martínez González, S | 1 |
| Alvarez Pitti, J | 1 |
| Nasrallah, K | 1 |
| Silver, B | 1 |
| Rowan, AJ | 3 |
| Pryor, F | 1 |
| Boardman, KD | 1 |
| Uthman, BM | 1 |
| Spitz, M | 1 |
| Frederick, T | 1 |
| Towne, A | 1 |
| Carter, GS | 1 |
| Marks, W | 1 |
| Felicetta, J | 1 |
| Tomyanovich, ML | 1 |
| Selai, C | 1 |
| Bannister, D | 1 |
| Trimble, M | 5 |
| Carlsson, KC | 1 |
| Hoem, NO | 1 |
| Glauser, T | 2 |
| Vinks, AA | 1 |
| Sachdeo, R | 1 |
| Sathyan, RR | 1 |
| Mimrod, D | 1 |
| Specchio, LM | 2 |
| Britzi, M | 1 |
| Specchio, N | 1 |
| La Neve, A | 1 |
| Soback, S | 1 |
| Doose, DR | 1 |
| Syn, WK | 1 |
| Naisbitt, DJ | 1 |
| Holt, AP | 1 |
| Mutimer, DJ | 1 |
| Berry, D | 1 |
| Millington, C | 1 |
| Parant, F | 1 |
| Moulsma, M | 1 |
| Gagnieu, MC | 1 |
| Lardet, G | 1 |
| Harrison, PK | 1 |
| Sheridan, RD | 1 |
| Green, AC | 1 |
| Tattersall, JE | 1 |
| Galeotti, F | 1 |
| Truini, A | 1 |
| Iannetti, GD | 1 |
| Romaniello, A | 1 |
| Biasiotta, A | 1 |
| Mascia, A | 1 |
| Virtuoso, M | 1 |
| Cruccu, G | 1 |
| Hara, H | 2 |
| Kobayashi, M | 1 |
| Yokoyama, A | 1 |
| Tochigi, M | 1 |
| Matsunaga, A | 1 |
| Shimizu, H | 1 |
| Goshima, J | 1 |
| Krauss, G | 1 |
| Moore, JL | 2 |
| Clinckers, R | 1 |
| Smolders, I | 1 |
| Meurs, A | 1 |
| Ebinger, G | 1 |
| Michotte, Y | 1 |
| Bourgeois, BF | 7 |
| Balboni, M | 1 |
| Callegati, E | 1 |
| Guiso, G | 1 |
| Rizzi, M | 1 |
| Pirker, S | 1 |
| Novak, K | 1 |
| Czech, T | 1 |
| Caccia, S | 1 |
| Schindlbeck, C | 1 |
| Janni, W | 1 |
| Friese, K | 1 |
| Herzog, AG | 1 |
| Drislane, FW | 1 |
| Schomer, DL | 1 |
| Bromfield, EB | 2 |
| Dworetzky, BA | 1 |
| Farina, EL | 1 |
| Frye, CA | 1 |
| Kostov, H | 1 |
| Marini, C | 1 |
| Masi, G | 1 |
| D'Arcangelo, G | 1 |
| Lees, G | 1 |
| Stöhr, T | 1 |
| Errington, AC | 1 |
| Kini, U | 1 |
| Vinten, J | 1 |
| Fryer, A | 1 |
| Geller, AM | 1 |
| Hudnell, HK | 1 |
| Vaughn, BV | 1 |
| Boyes, WK | 1 |
| Song, XQ | 1 |
| Wang, ZP | 1 |
| Bao, KR | 1 |
| Zhang, JM | 1 |
| Wu, J | 1 |
| Yan, CH | 1 |
| Shen, XM | 1 |
| Shinnar, S | 2 |
| Zenkov, LR | 1 |
| Holt, A | 1 |
| Dorofeeva, MIu | 1 |
| Ermakov, AIu | 1 |
| Belousova, ED | 1 |
| Ab Rahman, AF | 1 |
| Ibrahim, MI | 1 |
| Ismail, HI | 1 |
| Seng, TB | 1 |
| Kaddurah, AK | 1 |
| Epifanio, G | 1 |
| Auricchio, G | 1 |
| Federico, RR | 1 |
| Resicato, G | 1 |
| Pascotto, A | 1 |
| Auvin, S | 1 |
| Lamblin, MD | 1 |
| Pandit, F | 1 |
| Bastos, M | 1 |
| Derambure, P | 1 |
| Vallée, L | 1 |
| Dong, X | 1 |
| White, J | 1 |
| Rarick, J | 1 |
| Moreno, MC | 1 |
| Giagante, B | 1 |
| Saidon, P | 2 |
| Benozzi, J | 1 |
| Rosenstein, RE | 1 |
| Karaguzel, O | 1 |
| Ozdamar, O | 1 |
| Coker, I | 1 |
| Topbas, M | 2 |
| Andres, MM | 1 |
| Czuczwar, P | 1 |
| Cioczek-Czuczwar, A | 1 |
| Gamble, CL | 1 |
| Wild, JM | 2 |
| Robson, CR | 1 |
| Jones, AL | 2 |
| Cunliffe, IA | 1 |
| Smith, PE | 1 |
| Thomas, P | 1 |
| Valton, L | 1 |
| Genton, P | 6 |
| Di Nocera, P | 1 |
| Fasiello, C | 1 |
| Ruosi, P | 1 |
| Bilo, L | 1 |
| Mazzucchelli, I | 2 |
| Onat, FY | 1 |
| Neve, AL | 1 |
| Boppana, P | 1 |
| Toguri, J | 1 |
| DeSantis, A | 1 |
| Castro-Gago, M | 5 |
| Novo-Rodríguez, MI | 3 |
| Blanco-Barca, MO | 1 |
| Urisarri-Ruíz de Cortázar, A | 1 |
| Rodríguez-García, J | 1 |
| Rodríguez-Segade, S | 2 |
| Eirís-Puñal, J | 3 |
| Orem, A | 2 |
| Yildirmis, S | 2 |
| Orhan, F | 2 |
| Aslan, A | 1 |
| Kazek, B | 1 |
| Jamroz, E | 1 |
| Mandera, M | 1 |
| Bierzyńska-Macyszyn, G | 1 |
| Kluczewska, E | 1 |
| Protass, LM | 1 |
| Yoshida, T | 1 |
| Motohashi, S | 1 |
| Hamano, S | 1 |
| Altobelli, E | 1 |
| Di Mascio, R | 1 |
| Lattanzi, D | 1 |
| Fife, TD | 1 |
| Blum, D | 2 |
| Fisher, RS | 1 |
| Guven, MA | 1 |
| Batukan, C | 1 |
| Ceylaner, S | 1 |
| Ceylaner, G | 1 |
| Uzel, M | 1 |
| Seo, T | 4 |
| Nakada, N | 2 |
| Ueda, N | 3 |
| Hagiwara, T | 1 |
| Hashimoto, N | 1 |
| Kryscio, RJ | 1 |
| Barqawi, R | 1 |
| Artama, M | 1 |
| Yurube, K | 1 |
| Ueda, K | 3 |
| Zhao, Y | 1 |
| Rui, JZ | 1 |
| Li, JH | 1 |
| Xiang, BR | 1 |
| Clemens, B | 1 |
| Ménes, A | 1 |
| Piros, P | 1 |
| Bessenyei, M | 1 |
| Altmann, A | 1 |
| Jerney, J | 1 |
| Kollár, K | 1 |
| Rosdy, B | 1 |
| Rózsavölgyi, M | 1 |
| Steinecker, K | 1 |
| Hollódy, K | 1 |
| Prassouli, A | 2 |
| Bóné, B | 1 |
| Janszky, J | 2 |
| Gusev, EI | 1 |
| Guekht, AB | 1 |
| Melikyan, EG | 1 |
| Belousov, YB | 1 |
| Tocco, AM | 1 |
| Spalice, A | 1 |
| Iannetti, P | 1 |
| Kraiprab, P | 1 |
| Papakonstantinou, E | 1 |
| Schulpis, K | 1 |
| Mendiratta, V | 1 |
| Bhushan, P | 1 |
| Nicolaidou, P | 1 |
| Georgouli, H | 1 |
| Kotsalis, H | 1 |
| Matsinos, Y | 1 |
| Papadopoulou, A | 1 |
| Fretzayas, A | 1 |
| Syriopoulou, V | 1 |
| Krikos, X | 1 |
| Karantana, A | 1 |
| Karpathios, T | 2 |
| Kothare, SV | 2 |
| Mostofi, N | 1 |
| Khurana, DS | 2 |
| Mohsem, B | 1 |
| Melvin, JJ | 1 |
| Hardison, HH | 1 |
| Babayigit, A | 1 |
| Bober, E | 1 |
| Cakmakci, H | 1 |
| Rufo-Campos, M | 1 |
| Casas-Fernández, C | 1 |
| Martínez-Bermejo, A | 1 |
| Kimiskidis, V | 1 |
| Spanakis, M | 1 |
| Niopas, I | 1 |
| Kazis, D | 1 |
| Gabrieli, C | 1 |
| Kanaze, FI | 1 |
| Divanoglou, D | 1 |
| Gumbrevicius, G | 1 |
| Sveikata, A | 1 |
| Tapanainen, JS | 2 |
| Koivunen, R | 2 |
| Pakarinen, A | 1 |
| Matricardi, S | 1 |
| Manco, R | 1 |
| Lavebratt, C | 2 |
| Trifunovski, A | 1 |
| Persson, AS | 1 |
| Wang, FH | 1 |
| Klason, T | 1 |
| Josephsson, A | 1 |
| Olson, L | 2 |
| Spenger, C | 1 |
| Schalling, M | 2 |
| Gerstner, T | 2 |
| Woelfing, C | 1 |
| Witsch, M | 1 |
| Bell, N | 1 |
| König, S | 1 |
| Jose, VM | 1 |
| Medhi, B | 1 |
| Feuerstein, TJ | 1 |
| Beltrán-Marín, I | 1 |
| Mauri-Lledrá, JA | 1 |
| Letona-Carbajo, S | 1 |
| Flamarique-Pascual, A | 1 |
| Viinikainen, K | 1 |
| Eriksson, K | 1 |
| Mönkkönen, A | 1 |
| Aikiä, M | 4 |
| Nieminen, P | 1 |
| Heinonen, S | 1 |
| Yegnanarayan, R | 1 |
| Mahesh, SD | 1 |
| Sangle, S | 1 |
| Sidenius, P | 1 |
| Michoulas, A | 1 |
| Tong, V | 1 |
| Teng, XW | 1 |
| Chang, TK | 1 |
| Abbott, FS | 1 |
| Farrell, K | 2 |
| Sun, GC | 1 |
| Werkman, TR | 1 |
| Wadman, WJ | 2 |
| Oscarson, M | 1 |
| Zanger, UM | 1 |
| Rifki, OF | 1 |
| Klein, K | 1 |
| Eichelbaum, M | 5 |
| Meyer, UA | 1 |
| Chakir, A | 1 |
| Fabene, PF | 1 |
| Bentivoglio, M | 1 |
| Hirfanoğlu, T | 2 |
| Marchiani, V | 1 |
| Cecconi, I | 1 |
| Moscano, FC | 1 |
| Gualandi, S | 1 |
| Garone, C | 1 |
| Sarajlija, J | 1 |
| Malaspina, E | 1 |
| Tekgul, H | 1 |
| Demir, N | 1 |
| Gokben, S | 1 |
| Taylor, S | 1 |
| Gonzalez-Heydrich, J | 1 |
| Weiss, M | 1 |
| Wambera, K | 1 |
| Jan, JE | 1 |
| Plioplys, S | 1 |
| Dunn, DW | 1 |
| Kratochvil, CJ | 1 |
| Banu, SH | 1 |
| Jahan, M | 1 |
| Koli, UK | 1 |
| Ferdousi, S | 1 |
| Khan, NZ | 1 |
| Neville, B | 1 |
| Martínez, HR | 1 |
| Cantú-Martínez, L | 1 |
| González, HC | 1 |
| Flores, Lde L | 1 |
| Villarreal, HJ | 1 |
| Onofre-Castillo, J | 1 |
| Aycicek, A | 1 |
| Freidel, M | 1 |
| Krause, E | 1 |
| Kuhn, K | 1 |
| Peper, R | 1 |
| Vogel, H | 1 |
| Hessen, E | 1 |
| Reinvang, I | 1 |
| Bidzan, L | 1 |
| Lee, JW | 1 |
| Choi, KG | 1 |
| Chung, HW | 1 |
| Werner, T | 1 |
| Treiss, I | 1 |
| Kohlmueller, D | 1 |
| Mehlem, P | 1 |
| Teich, M | 1 |
| Koenig, SA | 1 |
| Schulze, A | 1 |
| Dahl, ML | 1 |
| Kimland, E | 1 |
| Tint, NL | 1 |
| Pherwani, A | 1 |
| Robson, K | 1 |
| Dua, HS | 1 |
| Meencke, HJ | 1 |
| Mazza, M | 1 |
| Della Marca, G | 1 |
| Di Nicola, M | 1 |
| Martinotti, G | 1 |
| Pozzi, G | 1 |
| Janiri, L | 1 |
| Bria, P | 1 |
| Mazza, S | 1 |
| Carta, M | 1 |
| Cimador, M | 1 |
| Giuffrè, M | 1 |
| Sergio, M | 1 |
| Di Pace, MR | 1 |
| De Grazia, E | 1 |
| Corsello, G | 1 |
| Matsuura, M | 1 |
| Babaei, A | 1 |
| Eslamai, MH | 1 |
| Sajatovic, M | 1 |
| Ramsay, E | 1 |
| Nanry, K | 1 |
| Thompson, T | 1 |
| Kanbay, M | 1 |
| Alkis, M | 1 |
| Turgut, F | 1 |
| Uz, E | 1 |
| Bavbek, N | 1 |
| Akcay, A | 1 |
| Simon, C | 1 |
| Stieger, B | 1 |
| Fried, M | 1 |
| Mueller, S | 1 |
| Fritschy, JM | 1 |
| Wieser, HG | 1 |
| Pauli-Magnus, C | 1 |
| Wieck, A | 1 |
| Rao, S | 1 |
| Sein, K | 1 |
| Haddad, PM | 1 |
| Cognato, Gde P | 1 |
| Bruno, AN | 1 |
| da Silva, RS | 1 |
| Bogo, MR | 1 |
| Sarkis, JJ | 1 |
| Bonan, CD | 1 |
| Balabanov, PP | 1 |
| Zahariev, ZI | 1 |
| Kocak, S | 1 |
| Girisgin, SA | 1 |
| Gul, M | 1 |
| Cander, B | 1 |
| Kaya, H | 1 |
| Kaya, E | 1 |
| Papadimitriou, DT | 1 |
| Gavalakis, N | 1 |
| Kelly, L | 1 |
| Martinian, L | 1 |
| Burley, MW | 1 |
| Sali, A | 1 |
| Kroetz, DL | 1 |
| Schaub, C | 1 |
| Marson, T | 1 |
| Murata, T | 1 |
| Hori, M | 2 |
| Zgorzalewicz, M | 2 |
| Devereux, JA | 1 |
| Vega, M | 1 |
| Godoy, CG | 1 |
| León, MD | 1 |
| Man, CB | 1 |
| Yu, E | 1 |
| Lau, KM | 1 |
| Cheng, AS | 1 |
| Ng, MH | 1 |
| Mechulan, A | 1 |
| Rossi, P | 1 |
| Somma-Mauvais, H | 1 |
| Sbragia, P | 1 |
| Aissi, K | 1 |
| Granel, B | 1 |
| Bagnères, D | 1 |
| Demoux, AL | 1 |
| Francès, Y | 1 |
| Cowling, BJ | 1 |
| Shaw, JE | 1 |
| Malek, R | 1 |
| Dannhardt, G | 1 |
| Kiefer, W | 1 |
| Nabatame, S | 1 |
| Okinaga, T | 1 |
| Kamio, N | 1 |
| Kagitani-Shimono, K | 1 |
| Kurosawa, K | 1 |
| Ozono, K | 1 |
| Vendrame, M | 1 |
| Cruz, M | 1 |
| Melvin, J | 1 |
| Otoul, C | 1 |
| De Smedt, H | 1 |
| Panayiotopoulos, CP | 4 |
| Alexandre, V | 1 |
| Cross, H | 1 |
| Ferrie, C | 1 |
| Lascelles, K | 1 |
| Livingston, J | 1 |
| Mewasingh, L | 1 |
| Mexicano, G | 1 |
| Campos-Sepúlveda, E | 1 |
| Romero, RM | 1 |
| Reynoso-Robles, R | 1 |
| López Pisón, J | 1 |
| Fernández Espuelas, C | 1 |
| Sáenz Moreno, I | 1 |
| García Oguiza, A | 1 |
| Cabrerizo de Diago, R | 1 |
| Peña Segura, JL | 1 |
| Knudsen, JF | 1 |
| Flowers, CM | 1 |
| Kortepeter, C | 1 |
| Awaad, Y | 1 |
| Clark, S | 1 |
| Torgovnick, J | 1 |
| Arsura, E | 1 |
| Gawlikowski, T | 1 |
| Hydzik, P | 1 |
| Simko, J | 1 |
| Horacek, J | 1 |
| Livingston, S | 4 |
| Pauli, LL | 3 |
| Berman, W | 1 |
| Savica, R | 1 |
| Mazzaglia, G | 1 |
| Innocenti, F | 1 |
| Brignoli, O | 1 |
| Cricelli, C | 1 |
| Caputi, AP | 1 |
| Musolino, R | 2 |
| Trifirò, G | 1 |
| Doughty, J | 1 |
| Eaton, B | 1 |
| Gamble, C | 1 |
| Shackley, P | 1 |
| Smith, DF | 1 |
| Vanoli, A | 1 |
| Ozgon, GO | 1 |
| Cine, N | 1 |
| Azuma, H | 1 |
| Negi, A | 1 |
| Hattori, M | 1 |
| Masayasu, T | 1 |
| Akechi, T | 1 |
| Furukawa, TA | 1 |
| Thussu, A | 1 |
| Chattopadhyay, A | 1 |
| Sawhney, IM | 1 |
| Khandelwal, N | 1 |
| Piovesan, EJ | 1 |
| Teive, HG | 1 |
| Silvado, CE | 2 |
| Crippa, A | 1 |
| Amaral, VC | 1 |
| Della Colleta, MV | 1 |
| Di Stani, F | 1 |
| Werneck, LC | 1 |
| Buchmüller, L | 1 |
| Burr, W | 1 |
| Badiou, S | 1 |
| Peyriere, H | 1 |
| Charasson, V | 1 |
| Crespel, A | 2 |
| Cristol, JP | 1 |
| Rajna, P | 1 |
| Weisler, RH | 1 |
| Calabrese, JR | 2 |
| Bowden, CL | 1 |
| Ascher, JA | 1 |
| DeVeaugh-Geiss, J | 1 |
| Evoniuk, G | 1 |
| Ruiz Ginés, MA | 1 |
| García García, S | 1 |
| Ruiz Ginés, JA | 1 |
| Tze Kiong, E | 1 |
| Fernández Rodríguez, E | 1 |
| Seneviratne, U | 1 |
| D'Souza, W | 1 |
| Cook, M | 1 |
| Macleod, S | 1 |
| Appleton, RE | 1 |
| Halaili, E | 1 |
| Jean-Pastor, MJ | 1 |
| Vespignan, H | 1 |
| Coubes, P | 1 |
| Linnet, K | 1 |
| Steentoft, A | 1 |
| Simonsen, KW | 1 |
| Hansen, SH | 1 |
| Fattouch, J | 1 |
| Fabbrini, G | 1 |
| Manfredi, M | 1 |
| Prencipe, M | 1 |
| Giallonardo, TA | 1 |
| Yuen, AW | 3 |
| Flugel, D | 1 |
| Browning, L | 1 |
| Bell, GS | 1 |
| Koepp, MM | 1 |
| Unalp, A | 1 |
| Kowalik, A | 1 |
| Rimpau, W | 1 |
| Adam, H | 1 |
| Kühn, F | 1 |
| van Oene, J | 1 |
| Schreiner, A | 1 |
| Bogdanow, M | 1 |
| Schauble, B | 1 |
| Kovacs, N | 1 |
| Nagy, F | 1 |
| Balas, I | 1 |
| Komoly, S | 1 |
| Vurucu, S | 1 |
| Demirkaya, E | 1 |
| Kul, M | 1 |
| Unay, B | 1 |
| Gul, D | 1 |
| Akin, R | 3 |
| Gokçay, E | 3 |
| Almgren, M | 1 |
| Bertilsson, L | 7 |
| Diczfalusy, U | 1 |
| Baillieux, H | 1 |
| Verslegers, W | 1 |
| Paquier, P | 1 |
| De Deyn, PP | 1 |
| Mariën, P | 1 |
| Hwang, H | 1 |
| Dogan, EA | 1 |
| Usta, BE | 1 |
| Bilgen, R | 1 |
| Senol, Y | 1 |
| Aktekin, B | 1 |
| Ferrie, CD | 1 |
| Livingston, JH | 1 |
| Le Louët, H | 1 |
| Thomas, L | 1 |
| Babai, S | 1 |
| Asadi-Pooya, K | 1 |
| Berg, AT | 1 |
| Aouam, K | 1 |
| Bel Hadj Ali, H | 1 |
| Youssef, M | 1 |
| Chaabane, A | 1 |
| Amri, M | 1 |
| Boughattas, NA | 1 |
| Zili, JE | 1 |
| Wright, AT | 1 |
| Geraldini, C | 1 |
| Faedda, MT | 1 |
| Sideri, G | 2 |
| Markestad, T | 1 |
| Ulstein, M | 1 |
| Aksnes, L | 1 |
| Aarskog, D | 1 |
| Tollefson, G | 1 |
| Fichsel, H | 5 |
| Parnas, J | 3 |
| Gram, L | 13 |
| Flachs, H | 3 |
| Maheshwari, MC | 5 |
| Rump, S | 1 |
| Pei, YQ | 1 |
| Yeung Laiwah, AA | 1 |
| Rapeport, WG | 4 |
| Thompson, GG | 1 |
| Macphee, GJ | 3 |
| Philip, MF | 1 |
| Moore, MR | 1 |
| Goldberg, A | 1 |
| Deisenhammer, E | 3 |
| Schwarzbach, H | 1 |
| Sommer, R | 2 |
| Shanley, BC | 1 |
| Meijer, JW | 8 |
| Binnie, CD | 2 |
| Debets, RM | 1 |
| van Parys, JA | 3 |
| de Beer-Pawlikowski, NK | 1 |
| Tokola, RA | 1 |
| Neuvonen, PJ | 4 |
| Doss, M | 1 |
| Schäfer, HJ | 1 |
| Kugoh, T | 1 |
| Hosokawa, K | 1 |
| Sheard, MH | 1 |
| Nautsch, JP | 1 |
| Rolf, LH | 1 |
| Brune, GG | 1 |
| Lundberg, B | 1 |
| Nergårdh, A | 2 |
| Boréus, LO | 1 |
| Krause, KH | 2 |
| Rascher, W | 1 |
| Berlit, P | 2 |
| Dodson, WE | 4 |
| Ferrendelli, JA | 2 |
| Shaw, MD | 3 |
| Foy, P | 1 |
| Rawlins, MD | 1 |
| Turnbull, DM | 1 |
| Monroe, RR | 1 |
| Danner, R | 3 |
| Tjellesen, L | 5 |
| Gotfredsen, A | 1 |
| Christiansen, C | 4 |
| Kalff, R | 1 |
| Houtkooper, MA | 1 |
| Meyer, JW | 1 |
| Goedhart, DM | 1 |
| Augusteijn, R | 1 |
| Meinardi, H | 10 |
| Smith, DB | 5 |
| Delgado Escueta, AV | 2 |
| Froescher, W | 1 |
| Niesen, M | 2 |
| Dietrich, K | 1 |
| Rausch, P | 1 |
| Heldenberg, D | 1 |
| Harel, S | 1 |
| Holtzman, M | 1 |
| Levtow, O | 1 |
| Tamir, I | 1 |
| Bentsen, KD | 4 |
| Veje, A | 1 |
| Hertrich, O | 1 |
| Goedhart, D | 1 |
| Andersen, EB | 2 |
| Philbert, A | 2 |
| Klee, JG | 1 |
| Friis, ML | 3 |
| Hvidberg, EF | 3 |
| Bouguerra, L | 1 |
| de Lauture, D | 2 |
| Arthuis, M | 1 |
| Hiilesmaa, VK | 2 |
| Teramo, K | 1 |
| Bardy, AH | 2 |
| Dreifuss, FE | 1 |
| Reynolds, EH | 16 |
| Callaghan, N | 11 |
| O'Dwyer, R | 1 |
| Keating, J | 1 |
| Moreland, TA | 2 |
| Sivenius, J | 4 |
| Dana-Haeri, J | 1 |
| Oxley, J | 2 |
| Richens, A | 12 |
| Loiseau, P | 6 |
| Ghose, K | 3 |
| Guyot, M | 2 |
| Brachet-Liermain, A | 2 |
| Mares, P | 3 |
| Maresová, D | 2 |
| Pohl, M | 1 |
| Koryntová, H | 1 |
| Seidl, J | 1 |
| Velísek, L | 1 |
| Hendel, J | 1 |
| Dam, M | 19 |
| Winkel, P | 1 |
| Mondadori, C | 2 |
| Schmutz, M | 3 |
| Baltzer, V | 1 |
| Peterson, GM | 1 |
| McLean, S | 1 |
| Millingen, KS | 1 |
| Notani, M | 1 |
| Kawamura, H | 1 |
| Amano, K | 1 |
| Tanikawa, T | 1 |
| Kawabatake, H | 1 |
| Iseki, H | 1 |
| Shiwaku, T | 1 |
| Nagao, T | 1 |
| Kakinoki, Y | 1 |
| Kitamura, K | 1 |
| Biniaurishvili, RG | 1 |
| Veĭn, AM | 1 |
| Chalkov, VG | 1 |
| Porter, RJ | 2 |
| Hedges, A | 1 |
| Makki, KA | 1 |
| Ruprah, M | 1 |
| Wilson, JF | 3 |
| De Paiva, VJ | 1 |
| Subirana, A | 2 |
| Subirana, M | 1 |
| Fröscher, W | 4 |
| Stoll, KD | 2 |
| Hoffmann, F | 1 |
| Ashok, PP | 1 |
| Butlin, AT | 3 |
| Danta, G | 3 |
| Cook, ML | 2 |
| Schoeman, JF | 2 |
| Elyas, AA | 6 |
| Brett, EM | 4 |
| Lascelles, PT | 6 |
| Davies, SM | 1 |
| Luchins, DJ | 1 |
| Rubinow, DR | 1 |
| Uhde, TW | 2 |
| Hoikka, V | 1 |
| Alhava, EM | 1 |
| Karjalainen, P | 1 |
| Savolainen, KE | 1 |
| Riekkinen, P | 2 |
| Korhonen, R | 1 |
| Kochen, W | 1 |
| Bonjour, JP | 1 |
| Wad, N | 1 |
| Sereno Colo, JA | 1 |
| Domínguez Chavez, FJ | 1 |
| Núñez Gutiérrez, J | 1 |
| Fromm, GH | 2 |
| Terrence, CF | 1 |
| Chattha, AS | 1 |
| Jawad, S | 1 |
| Lesser, RP | 1 |
| Pippenger, CE | 4 |
| Lüders, H | 1 |
| Dinner, DS | 1 |
| Haenel, F | 2 |
| Ambrosetto, G | 2 |
| Gobbi, G | 1 |
| Cortelli, P | 1 |
| Procaccianti, G | 3 |
| Murasaki, M | 1 |
| Okamoto, K | 1 |
| Takahashi, A | 1 |
| Mellanby, J | 2 |
| Hawkins, C | 1 |
| Wilks, L | 1 |
| Andrewes, DG | 1 |
| Tomlinson, L | 2 |
| Elwes, RD | 1 |
| Rousso, I | 1 |
| Pharmakiotis, A | 1 |
| Gatzola, M | 1 |
| Karatza, E | 1 |
| Tourkantonis, A | 1 |
| Sklavounou-Tsouroutsoglou, S | 1 |
| Garcia Rodriguez, MC | 1 |
| de la Concha, EG | 1 |
| Fontán, G | 1 |
| Pascual-Salcedo, D | 1 |
| Fernandez, J | 1 |
| Ojeda, JA | 1 |
| Garcia Diaz, A | 1 |
| Nilas, L | 1 |
| Boesen, F | 1 |
| Jensen, EK | 1 |
| Ladefoged, SD | 1 |
| Majkowski, J | 6 |
| Paxton, JW | 3 |
| Aman, MG | 3 |
| Werry, JS | 1 |
| Butler, CD | 1 |
| Wolschendorf, K | 1 |
| Vanselow, K | 1 |
| Möller, WD | 1 |
| Schulz, H | 1 |
| Bennett, HS | 1 |
| Dunlop, T | 1 |
| Ziring, P | 1 |
| Hedrick, R | 1 |
| Williams, F | 1 |
| Morin, R | 1 |
| Lamb, WA | 1 |
| Cate, JC | 1 |
| Hundt, HK | 1 |
| Aucamp, AK | 3 |
| Müller, FO | 1 |
| Potgieter, MA | 1 |
| Forrest, G | 2 |
| Traccis, S | 1 |
| Monaco, F | 8 |
| Sechi, GP | 1 |
| Moglia, A | 1 |
| Mutani, R | 4 |
| Tinuper, P | 1 |
| Farnarier, G | 2 |
| De Carvalho, GV | 1 |
| Kuhnz, W | 2 |
| Jäger-Roman, E | 1 |
| Rating, D | 1 |
| Deichl, A | 1 |
| Kunze, J | 1 |
| Helge, H | 1 |
| Nau, H | 3 |
| Bruguerolle, B | 2 |
| Bussière, H | 2 |
| Jadot, G | 2 |
| Höppener, RJ | 2 |
| Bladin, PF | 1 |
| Steldinger, R | 1 |
| Kouchupillai, N | 1 |
| Jailkhani, BL | 1 |
| Gupta, SK | 1 |
| Lang, H | 1 |
| Yale, C | 1 |
| Narbone, MC | 1 |
| Fazio, A | 6 |
| Crisafulli, P | 1 |
| Primerano, G | 1 |
| D'Agostino, AA | 1 |
| Di Perri, R | 4 |
| Nitsche, V | 1 |
| Aanderud, S | 1 |
| Myking, OL | 1 |
| Aminoff, MJ | 1 |
| Gentile, A | 2 |
| Caruso, C | 2 |
| Puccini, A | 2 |
| Celentano, I | 2 |
| Scollo-Lavizzari, G | 1 |
| Pejrone, F | 1 |
| Piccinini, GP | 1 |
| De Maria, F | 1 |
| Buccheri, G | 1 |
| Pisarski, W | 1 |
| Woźniak, J | 1 |
| Tokarz, A | 1 |
| Chambers, BR | 1 |
| Valsalan, VC | 1 |
| Cooper, GL | 1 |
| Wolfendale, L | 1 |
| Boldyrev, AI | 1 |
| Engel, J | 2 |
| Troupin, AS | 6 |
| Crandall, PH | 1 |
| Sterman, MB | 2 |
| Wasterlain, CG | 1 |
| Asconapé, JJ | 1 |
| Penry, JK | 8 |
| Covanis, A | 1 |
| Gupta, AK | 1 |
| Jeavons, PM | 2 |
| Seino, M | 1 |
| Kakegawa, N | 1 |
| Hildenbrand, G | 1 |
| Hildenbrand, K | 1 |
| Penin, H | 2 |
| Herzer, H | 1 |
| Perlwitz, R | 1 |
| Herzer, R | 1 |
| Rosenberry, KR | 1 |
| Defusco, CJ | 1 |
| Mansmann, HC | 1 |
| McGeady, SJ | 1 |
| Lühdorf, K | 2 |
| Nielsen, CJ | 1 |
| Orbaek, K | 1 |
| Hammerberg, PE | 1 |
| Fry, DE | 2 |
| Christfides, JA | 1 |
| Kumps, A | 1 |
| Mardens, Y | 1 |
| de Campos, CJ | 1 |
| Izquierdo, I | 1 |
| Thompson, P | 2 |
| Huppert, F | 1 |
| Thompson, PJ | 2 |
| Trimble, MR | 7 |
| Sillanpää, M | 3 |
| Mesdjian, E | 9 |
| Dravet, C | 4 |
| Cenraud, B | 2 |
| Roger, J | 3 |
| Visintini, D | 1 |
| Savi, M | 1 |
| Mori, P | 1 |
| Christiansen, J | 7 |
| Kristensen, CB | 3 |
| Helles, A | 1 |
| Jaegerskou, A | 1 |
| Schmiegelow, M | 1 |
| Larsen, HF | 1 |
| Hansen, BS | 4 |
| Brandt, J | 1 |
| Angelo, H | 2 |
| Christensen, JM | 2 |
| Lous, P | 1 |
| Tatzer, E | 1 |
| Groh, C | 2 |
| Sonis, WA | 1 |
| Petti, TA | 1 |
| Richey, ET | 1 |
| Sowińska, T | 1 |
| Szubert, MM | 1 |
| Dawson, M | 1 |
| Christofides, JA | 1 |
| Carl, GF | 1 |
| O'Neill, B | 1 |
| Stapleton, M | 1 |
| Molloy, W | 1 |
| Aarli, JA | 5 |
| Sironi, VA | 2 |
| Ravagnati, L | 2 |
| Ettorre, G | 1 |
| Cabrini, GP | 1 |
| Marossero, F | 2 |
| Grasso, E | 1 |
| Gerbino Promis, PC | 1 |
| Cognazzo, A | 1 |
| Seliak, D | 1 |
| Zagnoni, P | 1 |
| Sawchuk, RJ | 1 |
| Cartier, LL | 1 |
| DeMarco, P | 1 |
| Wilensky, AJ | 2 |
| Friel, PN | 4 |
| Comfort, CP | 1 |
| Kaluzny, SP | 1 |
| Wright, JM | 1 |
| Stokes, EF | 1 |
| Sweeney, VP | 1 |
| Thorsby, E | 1 |
| Padmini, R | 2 |
| Lawless, LM | 1 |
| DeMonaco, HJ | 1 |
| Muido, LR | 1 |
| Reid, AH | 1 |
| Naylor, GJ | 1 |
| Kay, DS | 1 |
| Nikkuni, S | 1 |
| Honda, K | 1 |
| Ono, T | 1 |
| Kumashiro, H | 1 |
| Bittencourt, PR | 8 |
| Gresty, MA | 1 |
| Bossi, L | 1 |
| Franceschetti, S | 3 |
| Gomeni, C | 1 |
| Moise, A | 1 |
| Vitali, A | 1 |
| Morgante, L | 1 |
| Serra, S | 1 |
| Gallitto, G | 1 |
| Spencer, SS | 1 |
| Spencer, DD | 1 |
| Williamson, PD | 2 |
| MacKichan, JJ | 2 |
| Duffner, PK | 1 |
| Cohen, ME | 1 |
| Lugaresi, E | 3 |
| Cirignotta, F | 1 |
| Day, RE | 1 |
| Chambers, RE | 1 |
| Hopen, G | 1 |
| Nesthus, I | 1 |
| Laerum, OD | 1 |
| Kumps, AH | 1 |
| Krag, B | 1 |
| Martínez-Lage, JM | 1 |
| Baars, A | 1 |
| Baars, M | 1 |
| Beier, R | 1 |
| Bretschneider, T | 1 |
| Höjer, B | 2 |
| Tybring, G | 2 |
| Osterloh, J | 1 |
| Rane, A | 4 |
| Dardick, KR | 1 |
| Russman, BS | 1 |
| Wannamaker, BB | 1 |
| Morton, WA | 1 |
| Gross, AJ | 1 |
| Saunders, S | 1 |
| Luoma, PV | 1 |
| Sotaniemi, EA | 2 |
| Lehtinen, IA | 1 |
| Hokkanen, EJ | 1 |
| Cabrini, G | 1 |
| Porro, MG | 1 |
| O'Hare, J | 1 |
| O'Driscoll, D | 2 |
| Duggan, B | 3 |
| Kuyer, A | 1 |
| Hulsman, J | 2 |
| Huf, R | 1 |
| Schain, RJ | 2 |
| Haidukewych, D | 4 |
| Rodin, EA | 3 |
| Pritchett, EL | 1 |
| McNamara, JO | 3 |
| Gallagher, JJ | 1 |
| Pynnönen, S | 3 |
| Frey, H | 2 |
| O'Hare, JA | 1 |
| Martinón, JM | 1 |
| Docampo, G | 1 |
| Martinón, F | 1 |
| Viso, JA | 1 |
| Peña, J | 1 |
| Despland, PA | 3 |
| Pulliainen, V | 2 |
| Jokelainen, M | 3 |
| Eto, S | 2 |
| Tanaka, N | 2 |
| Noda, H | 2 |
| Noda, A | 2 |
| Kürekçi, AE | 1 |
| Alpay, F | 1 |
| Tanindi, S | 1 |
| Ozcan, O | 1 |
| Işimer, A | 1 |
| Sayal, A | 1 |
| Laatikainen, TJ | 2 |
| Juntunen, KT | 2 |
| Kodama, Y | 5 |
| Kuranari, M | 5 |
| Kodama, H | 4 |
| Fujii, I | 4 |
| Takeyama, M | 5 |
| Kholodov, LE | 1 |
| Prityko, AG | 1 |
| Ivanova, ES | 1 |
| Sokolov, AV | 3 |
| Tishchenkova, IF | 2 |
| Dubrovina, LIu | 1 |
| Postnikov, SS | 1 |
| Tatarinov, PA | 1 |
| Kopanev, IuA | 1 |
| Veselov, NK | 2 |
| Saukkonen, AM | 1 |
| Mervaala, E | 2 |
| Riekkinen, PJ | 5 |
| Johansen, K | 1 |
| Krogh, M | 1 |
| Andresen, AT | 1 |
| Christophersen, AS | 1 |
| Lehne, G | 1 |
| Rasmussen, KE | 1 |
| Yuksel, A | 5 |
| Senocak, D | 1 |
| Sozuer, D | 1 |
| Keskin, G | 1 |
| Dirican, A | 2 |
| Cenani, A | 3 |
| Yalcin, E | 4 |
| Tiihonen, M | 2 |
| Liewendahl, K | 1 |
| Waltimo, O | 2 |
| Ojala, M | 2 |
| Välimäki, M | 1 |
| Lindbom, U | 1 |
| Sundqvist, A | 1 |
| Berg, A | 1 |
| O'Donoghue, MF | 1 |
| Repo, M | 2 |
| Lukkarinen, O | 1 |
| Pacifici, R | 2 |
| Paris, L | 2 |
| Di Carlo, S | 1 |
| Bacosi, A | 1 |
| Pichini, S | 2 |
| Zuccaro, P | 2 |
| Liu, H | 6 |
| Delgado, MR | 6 |
| Svinarov, DA | 2 |
| Airaksinen, KE | 2 |
| Mustonen, JN | 1 |
| Rautio, A | 1 |
| Pelkonen, O | 1 |
| Wesolowski, CA | 1 |
| Jacob, JC | 1 |
| Penney, S | 1 |
| Hobbs, GR | 1 |
| Riggs, JE | 1 |
| Bodensteiner, JB | 1 |
| Bernus, I | 3 |
| Hooper, WD | 5 |
| Dickinson, RG | 5 |
| Sarslan, O | 1 |
| Devranoğlu, K | 1 |
| Hattat, N | 1 |
| Aldenkamp, AP | 6 |
| Vermeulen, J | 2 |
| Dantendorfer, K | 1 |
| Amering, M | 1 |
| Baischer, W | 1 |
| Berger, P | 1 |
| Steinberger, K | 1 |
| Windhaber, J | 1 |
| Katschnig, H | 1 |
| Başaran, N | 1 |
| Hincal, F | 1 |
| Kansu, E | 1 |
| Ciğer, A | 1 |
| Bayer, A | 2 |
| Thiel, HJ | 3 |
| Zrenner, E | 3 |
| Ried, S | 3 |
| Hoare, P | 1 |
| Mann, H | 1 |
| Lanchote, VL | 1 |
| Bonato, PS | 1 |
| Campos, GM | 1 |
| Rodrigues, I | 1 |
| Zelnik, N | 1 |
| Fridkis, I | 1 |
| Gruener, N | 1 |
| Smith, SE | 1 |
| Parvez, NS | 1 |
| Chapman, AG | 1 |
| Meldrum, BS | 2 |
| Badalian, LO | 1 |
| Temin, PA | 2 |
| Medvedev, MI | 1 |
| Mukhin, KIu | 1 |
| Iskander, MB | 1 |
| Kharlamov, DA | 1 |
| Eeg-Olofsson, O | 1 |
| Pimentel, J | 1 |
| Pinto, F | 1 |
| Schmidt, S | 1 |
| Schmitz-Buhl, M | 1 |
| De Vriese, AS | 1 |
| Philippe, J | 1 |
| Van Renterghem, DM | 1 |
| De Cuyper, CA | 1 |
| Hindryckx, PH | 1 |
| Matthys, EG | 1 |
| Louagie, A | 1 |
| Konishi, T | 3 |
| Naganuma, Y | 3 |
| Hongou, K | 3 |
| Murakami, M | 3 |
| Yamatani, M | 3 |
| Okada, T | 3 |
| Arvidsson, J | 1 |
| Nilsson, HL | 2 |
| Sandstedt, P | 3 |
| Steinwall, G | 1 |
| Tonnby, B | 3 |
| Flesch, G | 2 |
| Eirís, JM | 1 |
| Lojo, S | 1 |
| Del Río, MC | 2 |
| Novo, I | 1 |
| Bravo, M | 1 |
| Pavón, P | 1 |
| de Romanis, F | 1 |
| Sopranzi, N | 1 |
| Wohlhüter, M | 1 |
| May, T | 9 |
| Artesi, C | 1 |
| Xiao, B | 1 |
| Schnabel, R | 6 |
| Rambeck, B | 11 |
| Jürgens, U | 7 |
| Lahl, R | 3 |
| Ma, S | 1 |
| Alpherts, WC | 2 |
| Diepman, L | 2 |
| van 't Slot, B | 1 |
| Overweg, J | 1 |
| Stafstrom, CE | 1 |
| Nohria, V | 1 |
| Loganbill, H | 1 |
| Nahouraii, R | 1 |
| Boustany, RM | 1 |
| DeLong, GR | 1 |
| Jauhari, J | 1 |
| Jauhari, S | 1 |
| Korinthenberg, R | 2 |
| Wehrle, L | 1 |
| Bridge, TA | 1 |
| Norton, RL | 1 |
| Robertson, WO | 1 |
| Tsutsumi, K | 3 |
| Okamoto, T | 1 |
| Yasunaga, F | 1 |
| Sinués, B | 1 |
| Gazulla, J | 1 |
| Bernal, ML | 1 |
| Lanuza, J | 1 |
| Fanlo, A | 1 |
| Saenz, MA | 1 |
| Barolome, M | 1 |
| Norman, J | 1 |
| Prettyman, R | 1 |
| Sand, T | 1 |
| Majeed, T | 1 |
| O'Connell, A | 1 |
| Oliveira, DB | 1 |
| Lackner, TE | 3 |
| Riela, AR | 2 |
| Mills, J | 1 |
| Browne, R | 1 |
| Roach, ES | 1 |
| Pledger, GW | 2 |
| Sackellares, JC | 2 |
| Treiman, DM | 2 |
| Wright, FS | 1 |
| Mikati, M | 2 |
| Sahlroot, JT | 2 |
| Tsay, JY | 1 |
| Drake, ME | 4 |
| Liu, YX | 1 |
| Wang, MZ | 1 |
| Sun, XF | 1 |
| Zhu, SQ | 1 |
| Liu, XM | 1 |
| Ruan, XZ | 1 |
| Cai, Z | 1 |
| Dekker-de Kiefte, PA | 1 |
| Lammers, MW | 3 |
| Wijsman, DJ | 1 |
| Hekster, YA | 5 |
| Keyser, A | 5 |
| Renier, WO | 4 |
| van Lier, H | 2 |
| Rosenthal, E | 1 |
| Hoffer, E | 1 |
| Ben-Aryeh, H | 1 |
| Badarni, S | 1 |
| Benderly, A | 1 |
| Hemli, Y | 1 |
| Alldredge, BK | 1 |
| Knutsen, AP | 1 |
| Ferriero, D | 1 |
| Schwabe, S | 2 |
| Nikanorova, MIu | 1 |
| Plotnikova, IV | 1 |
| Välimäki, MJ | 1 |
| Laitinen, K | 1 |
| Tähtelä, R | 1 |
| Kärkkäinen, M | 1 |
| Lamberg-Allardt, C | 1 |
| Mäkelä, P | 1 |
| Tunninen, R | 1 |
| Matteoli, S | 1 |
| Trappolini, M | 1 |
| Curione, M | 1 |
| Fanari, F | 1 |
| Borgia, MC | 1 |
| Puletti, M | 1 |
| Schüler, P | 1 |
| Kalb, R | 1 |
| Halonen, T | 3 |
| Pitkänen, A | 1 |
| Parha, S | 1 |
| Yiallouros, P | 1 |
| Theodoridis, C | 1 |
| McKee, PJ | 7 |
| Blacklaw, J | 6 |
| Gillham, RA | 6 |
| Walker, SM | 1 |
| Connelly, D | 1 |
| Verma, NP | 1 |
| Yusko, MJ | 1 |
| Greiffenstein, MF | 1 |
| Martin, PJ | 1 |
| Millac, PA | 1 |
| Yagi, S | 1 |
| Brenner, S | 1 |
| Wolf, R | 1 |
| Landau, M | 1 |
| Politi, Y | 1 |
| Freeman, JM | 5 |
| Vining, EP | 4 |
| Cost, S | 1 |
| Young, JL | 1 |
| Hillbrand, M | 1 |
| Bareggi, SR | 1 |
| Tata, MR | 1 |
| Guizzaro, A | 1 |
| Pirola, R | 1 |
| Parisi, A | 1 |
| Monza, CG | 1 |
| Hashimoto, Y | 1 |
| Odani, A | 1 |
| Tanigawara, Y | 1 |
| Yasuhara, M | 1 |
| Okuno, T | 1 |
| Hori, R | 1 |
| Ramos, MC | 1 |
| Annes, M | 1 |
| Dooley, JM | 3 |
| Camfield, PR | 4 |
| Camfield, CS | 4 |
| Gordon, KE | 1 |
| Fraser, AD | 1 |
| Graves, NM | 3 |
| Walden, J | 3 |
| Grunze, H | 3 |
| Mayer, A | 1 |
| Düsing, R | 2 |
| Schirrmacher, K | 1 |
| Bingmann, D | 2 |
| Malow, BA | 1 |
| Blaxton, TA | 1 |
| Stertz, B | 1 |
| Delgado, M | 1 |
| Iannaccone, ST | 1 |
| Forman, LJ | 1 |
| Eggers, CM | 1 |
| Shechter-Amir, D | 1 |
| Yavetz, H | 1 |
| Homonnai, TZ | 1 |
| Huberman, M | 1 |
| Cohn, DF | 1 |
| Kurowski, HL | 1 |
| Gospe, SM | 1 |
| Zeman, FJ | 1 |
| Grivetti, LE | 1 |
| Oles, KS | 2 |
| Gal, P | 1 |
| Antoniuk, SA | 2 |
| Bigarella, MM | 2 |
| da Costa, JC | 1 |
| Doro, MP | 2 |
| Ferreira, AS | 1 |
| Fonseca, LC | 1 |
| Gorz, AM | 3 |
| Gonçalves e Silva, GE | 1 |
| Marcourakis, T | 1 |
| Hosoda, N | 2 |
| Takanashi, S | 2 |
| Shirai, H | 3 |
| Sunaoshi, W | 3 |
| Abo, K | 1 |
| Abo, J | 1 |
| Otani, K | 2 |
| Kondo, T | 3 |
| Kan, R | 1 |
| Takeda, A | 2 |
| Nakane, Y | 1 |
| Atalay, S | 1 |
| Oner, A | 1 |
| Gürer, YK | 1 |
| Karademir, S | 1 |
| Chapron, DJ | 1 |
| LaPierre, BA | 1 |
| Abou-Elkair, M | 1 |
| Raitasuo, V | 1 |
| Lehtovaara, R | 3 |
| Huttunen, MO | 1 |
| Blennow, G | 2 |
| Elmqvist, D | 1 |
| Heijbel, J | 2 |
| Wåhlander, L | 1 |
| Wosse, E | 1 |
| Berg, I | 2 |
| Butler, A | 1 |
| Ellis, M | 1 |
| Foster, J | 1 |
| Ratti, MT | 1 |
| Morrison, C | 1 |
| Rieder, MJ | 1 |
| Omtzigt, JG | 2 |
| Los, FJ | 1 |
| Jain, KK | 1 |
| Watts, AE | 1 |
| Jefferys, JG | 1 |
| Boas, J | 2 |
| Dalby, M | 1 |
| Deth, SH | 1 |
| Mikkelsen, M | 2 |
| Pedersen, B | 2 |
| Worm-Petersen, J | 1 |
| Wagner, ML | 1 |
| Server Climent, M | 1 |
| Larkin, JG | 5 |
| Brodie, AF | 1 |
| Percy-Robb, IW | 1 |
| Villagran, R | 2 |
| Bonneton, J | 4 |
| Iliadis, A | 2 |
| Viallat, D | 1 |
| Salmela, P | 1 |
| Nagai, H | 1 |
| Ikeno, T | 1 |
| Sharpe, PC | 1 |
| Trimble, ER | 1 |
| Checchini, M | 1 |
| Magni, M | 1 |
| Scaglione, M | 1 |
| Vaccarella, A | 1 |
| Kintz, P | 1 |
| Marescaux, C | 1 |
| Mangin, P | 1 |
| Botha, JH | 1 |
| Gray, AL | 1 |
| Miller, R | 1 |
| O'Connell, MT | 1 |
| Doheny, MH | 1 |
| Darsot, S | 1 |
| Niketić, V | 2 |
| Ristić, S | 1 |
| Saicić, ZS | 1 |
| Spasić, M | 1 |
| Buzadzić, B | 1 |
| Stojković, M | 2 |
| Majamaa, K | 1 |
| Rusanen, H | 1 |
| Remes, AM | 1 |
| Pyhtinen, J | 1 |
| Hassinen, IE | 1 |
| Backman, JT | 1 |
| Olkkola, KT | 1 |
| Laaksovirta, H | 1 |
| de Silva, M | 1 |
| MacArdle, B | 1 |
| McGowan, M | 1 |
| Hughes, E | 1 |
| Stewart, J | 2 |
| Neville, BG | 1 |
| Johnson, AL | 3 |
| Alloul, K | 1 |
| Whalley, DG | 1 |
| Shutway, F | 1 |
| Ebrahim, Z | 1 |
| Varin, F | 1 |
| Kang, WM | 1 |
| So, WC | 1 |
| Kubova, H | 1 |
| Lanstiakova, M | 1 |
| Mockova, M | 1 |
| Vorlicek, J | 1 |
| Yoshino, K | 2 |
| Suzuki, N | 2 |
| Maeoka, Y | 1 |
| Salinsky, MC | 2 |
| Oken, BS | 2 |
| Binder, LM | 2 |
| Zeffiro, T | 1 |
| Fazilat, S | 1 |
| DeCarli, C | 1 |
| Browne, RH | 1 |
| Hasegawa, H | 1 |
| Gonzalez, IG | 1 |
| Martin Luquero, M | 1 |
| Marcos Martinez, L | 1 |
| Gargallo Fernandez, MA | 1 |
| Iivanainen, M | 2 |
| Wlaź, P | 1 |
| Roliński, Z | 1 |
| Hermanns, G | 1 |
| Noachtar, S | 1 |
| Tuxhorn, I | 1 |
| Holthausen, H | 1 |
| Ebner, A | 1 |
| Rodriguez Macias, KA | 1 |
| Corazza, M | 1 |
| Mantovani, L | 1 |
| Casetta, I | 1 |
| Virgili, A | 1 |
| Vivancos Mora, J | 1 |
| Xiao, CH | 1 |
| Haeusler, MC | 1 |
| Hoellwarth, ME | 1 |
| Holzer, P | 1 |
| Eriksson, AS | 1 |
| Hoppu, K | 1 |
| Boreus, L | 1 |
| Lekhra, OP | 1 |
| Bansal, SK | 1 |
| Mota, CR | 1 |
| Carvalho, C | 1 |
| Mota, C | 3 |
| Ferreira, P | 1 |
| Vilarinho, A | 1 |
| Pereira, E | 1 |
| Macdonald, RL | 2 |
| Kelly, KM | 1 |
| Fisher, R | 1 |
| Rogvi-Hansen, B | 1 |
| Ferrarese, C | 1 |
| Perego, M | 1 |
| Marzorati, C | 1 |
| Bianchi, G | 1 |
| Frigo, M | 1 |
| Pecora, N | 1 |
| Moretti, G | 1 |
| Frattola, L | 1 |
| Giaccone, M | 1 |
| Marchiselli, R | 1 |
| Latella, MA | 1 |
| Gillham, R | 2 |
| Birbeck, K | 1 |
| McGuire, A | 1 |
| Eckersley, L | 1 |
| Silveira, C | 1 |
| Chiba, S | 1 |
| Ashikari, Y | 1 |
| Sakata, T | 1 |
| de Juan Frigola, J | 1 |
| Crespo Hernández, M | 1 |
| Braga Hernández, S | 1 |
| Sälke-Kellermann, A | 1 |
| Sözüer, DT | 2 |
| Barutçu, UB | 1 |
| Karakoç, Y | 1 |
| Onen, S | 1 |
| Yukawa, E | 6 |
| Wein, T | 1 |
| Andermann, F | 1 |
| Silver, K | 1 |
| Dubeau, F | 1 |
| Andermann, E | 1 |
| Rourke-Frew, F | 1 |
| Keene, D | 1 |
| Vauzelle-Kervroedan, F | 1 |
| Pous, G | 1 |
| d'Athis, P | 2 |
| Renard, F | 1 |
| Olive, G | 2 |
| Leinonen, E | 1 |
| Lepola, U | 1 |
| Koponen, H | 1 |
| Prevey, ML | 1 |
| Delaney, RC | 1 |
| Cattanach, L | 1 |
| Panjwani, U | 1 |
| Singh, SH | 1 |
| sel Vamurthy, W | 1 |
| Gupta, HL | 1 |
| Mukhopadhyay, S | 1 |
| Thakur, L | 1 |
| Shinoda, M | 1 |
| Akita, M | 1 |
| Hasegawa, M | 1 |
| Hasegawa, T | 1 |
| Nabeshima, T | 1 |
| Aoyama, T | 5 |
| Fritsch, W | 1 |
| Enoki, H | 1 |
| Sanada, S | 1 |
| Ohtahara, S | 1 |
| Henskens, YM | 1 |
| Strooker, H | 1 |
| van den Keijbus, PA | 1 |
| Veerman, EC | 1 |
| Nieuw Amerongen, AV | 1 |
| Ceci, O | 1 |
| Loizzi, P | 1 |
| Caruso, G | 1 |
| Caradonna, F | 1 |
| Clemente, R | 1 |
| Ferreri, R | 1 |
| Stevanovic, HL | 1 |
| Jovic, N | 1 |
| Sennoune, S | 2 |
| Barra, Y | 2 |
| Jamieson, V | 2 |
| Jones, T | 1 |
| Wilder, BJ | 2 |
| Reunanen, M | 3 |
| Yelín, B | 1 |
| Grippo, J | 1 |
| Garza-Morales, S | 2 |
| Ibarra-Puig, JM | 1 |
| Poblano-Luna, A | 1 |
| Gilda Mayén-Molina, D | 1 |
| Córdova-López, S | 1 |
| Scolnik, D | 1 |
| Chitayat, D | 2 |
| Farkas, LD | 1 |
| Baraka, A | 1 |
| Idriss, N | 1 |
| Schicht, S | 1 |
| Wigger, D | 1 |
| Frey, HH | 2 |
| Ornoy, A | 2 |
| Cohen, E | 1 |
| Suzuki, K | 4 |
| Iwasa, H | 1 |
| Kikuchi, S | 1 |
| Sato, T | 4 |
| Miyake, M | 1 |
| Morinaga, N | 1 |
| Noda, M | 1 |
| Eijgenraam, JW | 1 |
| Buurke, EJ | 1 |
| van der Laan, JS | 1 |
| Williams, J | 2 |
| Mercadé Cerdá, JM | 1 |
| Wilson, EA | 1 |
| Pienimäki, P | 2 |
| Lampela, E | 1 |
| Hakkola, J | 1 |
| Arvela, P | 1 |
| Raunio, H | 1 |
| Vähäkangas, K | 2 |
| Kishi, T | 1 |
| Fujita, N | 1 |
| Eguchi, T | 1 |
| Kluczyński, A | 2 |
| Gasior, M | 1 |
| Kleinrok, Z | 2 |
| Delgado Iribarnegaray, MF | 1 |
| Santo Bueldga, D | 1 |
| García Sánchez, MJ | 2 |
| Otero, MJ | 1 |
| Falcão, AC | 2 |
| Domínguez-Gil, A | 2 |
| Carswell, A | 1 |
| Bonanni, E | 1 |
| Massetani, R | 1 |
| Galli, R | 1 |
| Gneri, C | 1 |
| Petri, M | 1 |
| Iudice, A | 1 |
| Murri, L | 1 |
| Deckers, CL | 2 |
| Bayer, AU | 1 |
| Dichgans, J | 1 |
| Kuehn, M | 1 |
| Easter, D | 1 |
| O'Bryan-Tear, CG | 1 |
| Verity, C | 1 |
| Miranda Mallea, J | 1 |
| Güemes Heras, I | 1 |
| Barbero Aguirre, P | 1 |
| Menor Serrano, F | 1 |
| García Tena, J | 1 |
| Moreno Rubio, JA | 1 |
| Mulas Delgado, F | 1 |
| Chapman, DP | 1 |
| Giles, WH | 1 |
| Johnson, CD | 1 |
| Rivera, H | 1 |
| Jiménez, JE | 1 |
| Silpakit, O | 1 |
| Amornpichetkoon, M | 1 |
| Kaojarern, S | 1 |
| Geisler, J | 1 |
| Berntsen, H | 1 |
| Geisler, S | 1 |
| Lønning, PE | 1 |
| Kitteringham, NR | 1 |
| Braathen, G | 1 |
| von Bahr, L | 1 |
| Theorell, K | 1 |
| Dailey, JW | 4 |
| Reith, ME | 1 |
| Yan, QS | 2 |
| Li, MY | 1 |
| Jobe, PC | 4 |
| Mitsudome, A | 1 |
| Ohfu, M | 1 |
| Yasumoto, S | 1 |
| Ogawa, A | 1 |
| Hirose, S | 2 |
| Ogata, H | 1 |
| Tagawa, T | 1 |
| Sumi, K | 1 |
| Uno, R | 1 |
| Itagaki, Y | 1 |
| Fujii, F | 1 |
| Aykut-Bingol, C | 1 |
| Tekin, S | 1 |
| Ince, D | 1 |
| Aktan, S | 1 |
| Davanzo, PA | 1 |
| King, BH | 1 |
| Pluskiewicz, W | 1 |
| Nowakowska, J | 1 |
| Hassanzadeh, A | 1 |
| Mawlud, K | 1 |
| Atakil, D | 1 |
| Dogu, O | 1 |
| Baybas, S | 1 |
| Psillakis, TK | 1 |
| Tzatzarakis, M | 1 |
| Kourtopoulos, H | 1 |
| Paritsis, N | 1 |
| Caldiroli, E | 2 |
| De Ponti, F | 4 |
| Cosentino, M | 2 |
| Marino, F | 2 |
| Fietta, AM | 2 |
| Taddei, M | 1 |
| Zibetti, A | 2 |
| Mazzone, A | 3 |
| Lecchini, S | 4 |
| Frigo, GM | 4 |
| Rostock, A | 1 |
| Tober, C | 1 |
| Rundfeldt, C | 2 |
| Bartsch, R | 1 |
| Unverferth, K | 1 |
| Wolf, HH | 1 |
| Gaulier, JM | 1 |
| Boulieu, R | 1 |
| Fischer, C | 1 |
| Mauguiere, F | 1 |
| Domizio, S | 2 |
| Angelozzi, B | 1 |
| Sabatino, G | 2 |
| Panagopoulos, GR | 1 |
| Thomaides, T | 1 |
| Tagaris, G | 1 |
| Karageorgiou, CL | 1 |
| Simko, M | 1 |
| Mokrán, V | 1 |
| Nyulassy, S | 1 |
| Belmont-Gomez, A | 1 |
| Ibarra-Puig, J | 1 |
| López-Ugalde, V | 1 |
| Morales-Garcia, A | 1 |
| Kunhardt-Rasch, J | 1 |
| Corman, CL | 1 |
| Leung, NM | 1 |
| Guberman, AH | 1 |
| Widén, J | 1 |
| Chang, M | 1 |
| Böttcher, T | 1 |
| Buchmann, J | 1 |
| Zettl, UK | 1 |
| Benecke, R | 1 |
| Kouno, Y | 1 |
| Ishikura, C | 1 |
| Homma, M | 1 |
| Oka, K | 1 |
| Glue, P | 1 |
| Banfield, CR | 1 |
| Perhach, JL | 1 |
| Mather, GG | 1 |
| Racha, JK | 1 |
| Gidal, BE | 1 |
| Rutecki, P | 1 |
| Shaw, R | 1 |
| Maly, MM | 1 |
| Collins, DM | 1 |
| Pitterle, ME | 1 |
| Koopowitz, LF | 1 |
| Berk, M | 1 |
| Brown, RI | 1 |
| Cooper, TG | 1 |
| Arena, D | 1 |
| Scordo, MG | 1 |
| Mahajan, L | 1 |
| Wyllie, R | 2 |
| Goldblum, J | 1 |
| Honda, T | 1 |
| Ohdo, S | 4 |
| Higuchi, S | 4 |
| Reiffers-Mettelock, J | 1 |
| Hentges, F | 1 |
| Humbel, RL | 1 |
| Gordon, K | 2 |
| Liukkonen, E | 2 |
| Phillips, I | 1 |
| Martin, KF | 1 |
| Thompson, KS | 1 |
| Heal, DJ | 1 |
| Kayemba Kay'S, S | 1 |
| Beust, M | 1 |
| Aboulghit, H | 1 |
| Voisin, M | 1 |
| Mourtada, A | 1 |
| Morimoto, K | 1 |
| Sato, H | 1 |
| Sato, K | 1 |
| Sato, S | 1 |
| Yamada, N | 1 |
| Van Paesschen, W | 1 |
| Connelly, A | 1 |
| Parker, AC | 1 |
| Pritchard, P | 1 |
| Preston, T | 1 |
| To, H | 2 |
| Pedley, TA | 1 |
| Khorshev, SK | 2 |
| Vaz, J | 1 |
| Kulkarni, C | 1 |
| David, J | 1 |
| Joseph, T | 1 |
| De la Fuente, JM | 1 |
| Tugendhaft, P | 1 |
| Mavroudakis, N | 1 |
| Kennedy, BT | 1 |
| Haller, JS | 1 |
| Akobeng, AK | 1 |
| Miller, V | 1 |
| Thomas, AG | 1 |
| Nieto Barrera, M | 1 |
| López Alcaide, MI | 1 |
| Candau Fernández-Mensaque, R | 1 |
| Ruiz del Portal Bermudo, L | 1 |
| Rufo Campos, M | 1 |
| Correa Charro, A | 1 |
| Berry, DJ | 2 |
| Pool, F | 1 |
| Newbery, JE | 2 |
| Subel, B | 1 |
| Garnett, WR | 2 |
| Levy, B | 1 |
| McLean, AM | 1 |
| Couch, RA | 1 |
| Rudnic, EM | 1 |
| Belendiuk, GW | 1 |
| Stefani, A | 1 |
| Spadoni, F | 1 |
| Bernardi, G | 3 |
| Naqvi, SZ | 1 |
| Greenwood, RS | 2 |
| D'Cruz, OF | 1 |
| De Sarro, GB | 1 |
| Berlinghieri, MC | 1 |
| Elia, M | 1 |
| Musumeci, SA | 1 |
| David, E | 1 |
| Dominijanni, A | 1 |
| Gulletta, E | 1 |
| Cohen, H | 1 |
| Howland, MA | 1 |
| Luciano, DJ | 1 |
| Rubin, RN | 1 |
| Kutt, H | 4 |
| Hoffman, RS | 1 |
| Leung, LK | 1 |
| Devinsky, O | 2 |
| Goldfrank, LR | 1 |
| Rentmeester, T | 1 |
| Majoie, M | 1 |
| Doelman, J | 1 |
| Schellekens, A | 1 |
| Franken, M | 1 |
| Olling, M | 1 |
| Shakespeare, A | 1 |
| Simeon, G | 1 |
| Read, CL | 1 |
| Stephen, LJ | 2 |
| Stolarek, IH | 1 |
| Paul, A | 1 |
| Sköld, AC | 1 |
| Holmgen, P | 1 |
| Nilsson, L | 2 |
| Danielsson, B | 1 |
| Borusiak, P | 1 |
| Holert, N | 1 |
| Suemaru, K | 1 |
| Kawasaki, H | 1 |
| Yasuhara, K | 1 |
| Yao, K | 1 |
| Furuno, K | 1 |
| Kawakami, Y | 1 |
| Araki, H | 1 |
| Gomita, Y | 1 |
| Kennebäck, G | 3 |
| Bergfeldt, L | 3 |
| Proudfoot, AT | 1 |
| Timmings, PL | 1 |
| Brusentsov, AI | 1 |
| Moroz, VV | 1 |
| Suprun, SA | 1 |
| Pomazanova, TN | 1 |
| Shandra, AA | 1 |
| Godlevskiĭ, LS | 1 |
| Okutan, V | 1 |
| Sarici, U | 1 |
| Altunbas, A | 1 |
| Garg, SK | 1 |
| Kumar, N | 1 |
| Bhargava, VK | 1 |
| Prabhakar, SK | 1 |
| Mendler, MH | 1 |
| Sautereau, D | 1 |
| Pillegand, B | 1 |
| Ravon, R | 1 |
| Cepelak, I | 1 |
| Zanić Grubisić, T | 1 |
| Mandusić, A | 1 |
| Rekić, B | 1 |
| Lenicek, J | 1 |
| Garaizar, C | 1 |
| Pérez-García, J | 1 |
| Gil-Antón, J | 1 |
| Prats, JM | 1 |
| Thomas, LW | 1 |
| Nguyen, VH | 1 |
| Spanedda, F | 1 |
| Placidi, F | 2 |
| Bassetti, MA | 1 |
| Romigi, A | 2 |
| Mattia, D | 1 |
| Leeder, JS | 1 |
| Schlienger, RG | 1 |
| Shear, NH | 1 |
| Kloster, R | 1 |
| Børresen, HC | 1 |
| Hoff-Olsen, P | 1 |
| Takayanagi, K | 1 |
| Hisauchi, I | 1 |
| Watanabe, J | 1 |
| Maekawa, Y | 1 |
| Fujito, T | 1 |
| Sakai, Y | 1 |
| Hoshi, K | 1 |
| Kase, M | 1 |
| Morooka, S | 1 |
| Tan, LC | 1 |
| Tan, AK | 1 |
| Tjia, H | 1 |
| Prasad, AN | 1 |
| Stefanelli, M | 1 |
| Nagarajan, L | 1 |
| Couceiro, J | 1 |
| Camiña, F | 1 |
| Pita-Calandre, E | 1 |
| Rodríguez-López, CM | 1 |
| Cano, MD | 1 |
| Peña-Bernal, M | 1 |
| Gritti, D | 1 |
| Canale, C | 1 |
| Fossati, G | 1 |
| Almeida, AM | 1 |
| Sales, F | 1 |
| Leitão, F | 1 |
| Santos, J | 1 |
| Costa, IM | 1 |
| Caramona, MM | 1 |
| Basciani, F | 5 |
| Parmeggiani, A | 1 |
| Fraticelli, E | 1 |
| Rossi, PG | 1 |
| Mawer, GE | 1 |
| Lucas, SB | 1 |
| Beastall, GH | 2 |
| Cengiz, M | 3 |
| Seven, M | 3 |
| Cengiz, S | 1 |
| Gomes, Mda M | 1 |
| Maia Filho, Hde S | 1 |
| Noé, RA | 1 |
| Waisburg, H | 1 |
| Alvarez, N | 1 |
| Kafali, G | 1 |
| Erselcan, T | 1 |
| Tanzer, F | 1 |
| Vainionpää, L | 1 |
| Lanning, P | 1 |
| Mesec, A | 1 |
| Rot, U | 1 |
| Perkovic, T | 1 |
| Lunder, T | 1 |
| Sibanc, B | 1 |
| Schwaninger, M | 1 |
| Ringleb, P | 1 |
| Winter, R | 1 |
| Kohl, B | 1 |
| Fiehn, W | 1 |
| Rieser, PA | 1 |
| Walter-Sack, I | 1 |
| Al Bunyan, M | 1 |
| Abo-Talib, Z | 1 |
| Bawden, HN | 1 |
| Cunningham, C | 1 |
| Darwish, H | 1 |
| Ronen, G | 1 |
| van Mastrigt, R | 1 |
| Barcia, JA | 1 |
| Rubio, P | 1 |
| Alós, M | 1 |
| Serralta, A | 1 |
| Belda, V | 1 |
| Sérée, E | 1 |
| Charvet, B | 1 |
| Mirrione, A | 1 |
| Bourgarel-Rey, V | 1 |
| Desobry, A | 1 |
| Grasela, TH | 1 |
| Fiedler-Kelly, J | 1 |
| Cox, E | 1 |
| Womble, GP | 1 |
| Risner, ME | 1 |
| El Desoky, E | 1 |
| Kandil, MR | 1 |
| Afifi, AH | 1 |
| Mostafa, OA | 1 |
| Sudhop, T | 1 |
| von Bergmann, K | 1 |
| Graumlich, JF | 1 |
| McLaughlin, RG | 1 |
| Birkhahn, D | 1 |
| Shah, N | 1 |
| Burk, A | 1 |
| Champel, V | 1 |
| Radal, M | 1 |
| Moulin-Vallez, M | 1 |
| Jonville-Béra, AP | 1 |
| Autret-Leca, E | 1 |
| Ozkaya-Bayazit, E | 1 |
| Güngör, H | 1 |
| Carvill, S | 1 |
| Clarke, D | 1 |
| Cassidy, G | 1 |
| Gatzonis, SD | 1 |
| Georgaculias, N | 1 |
| Singounas, E | 1 |
| Jenkins, A | 1 |
| Stamboulis, E | 1 |
| Siafakas, A | 1 |
| Peytchev, L | 1 |
| Chakova, L | 1 |
| McLean, MJ | 2 |
| Willmore, LJ | 2 |
| Magnus-Miller, L | 1 |
| Bernstein, P | 1 |
| Rose-Legatt, A | 1 |
| Bernatik, J | 1 |
| Knorr, J | 1 |
| Canger, R | 2 |
| Fumarola, C | 1 |
| Guidolin, L | 1 |
| Palmieri, C | 1 |
| Molteni, F | 1 |
| Granata, T | 2 |
| Hassibi, P | 1 |
| Zamperini, P | 1 |
| Pardi, G | 1 |
| Overstall, PW | 1 |
| Giorgi, L | 1 |
| Haruda, FD | 1 |
| Kuruvilla, A | 1 |
| Loiseau, PJ | 1 |
| Fernández, G | 1 |
| Tecoma, ES | 1 |
| Dhar, S | 1 |
| Todi, SK | 1 |
| Vreugdenhil, M | 1 |
| Duggal, HS | 1 |
| Jain, R | 1 |
| Nizamie, SH | 1 |
| Hemingway, C | 1 |
| Leary, M | 1 |
| Riordan, G | 1 |
| Schlegal, B | 1 |
| Walker, K | 1 |
| Rashid, S | 1 |
| Lee, I | 2 |
| Anderson, AE | 1 |
| Hrachovy, RA | 1 |
| Swann, JW | 2 |
| Del Río-Garma, M | 1 |
| Del Río-Garma, MC | 1 |
| Lojo-Rocamonde, S | 1 |
| Novo-Rodríguez, I | 1 |
| Sarioğlu, AC | 1 |
| Kaynar, MY | 1 |
| Hanci, M | 1 |
| Uzan, M | 1 |
| Goldman, WJ | 1 |
| Jannuzzi, G | 1 |
| Cian, P | 1 |
| Fattore, C | 1 |
| Lin, SS | 1 |
| Diomedi, M | 1 |
| Scalise, A | 1 |
| Gigli, GL | 3 |
| Jović, NJ | 1 |
| Mirković, D | 1 |
| Majkić-Singh, N | 1 |
| Soriano, SG | 1 |
| Kaus, SJ | 1 |
| Sullivan, LJ | 1 |
| Martyn, JA | 1 |
| Goraya, JS | 1 |
| Gupta, PN | 1 |
| Gupta, RK | 1 |
| Bahadur, R | 1 |
| Parmar, VR | 1 |
| Jedrzejczak, J | 1 |
| Dławichowska, E | 1 |
| Owczarek, K | 1 |
| Szymańska-Shawkat, E | 1 |
| Dyderski, S | 1 |
| Dobrowolska, E | 1 |
| Persinger, MA | 1 |
| Telci, A | 1 |
| Cakatay, U | 1 |
| Kurt, BB | 1 |
| Kayali, R | 1 |
| Sivas, A | 1 |
| Akçay, T | 1 |
| Gökyiğit, A | 1 |
| Gueye, L | 1 |
| Sene, MC | 1 |
| Sene, F | 1 |
| Diagne, M | 1 |
| Ndiaye, IP | 1 |
| Fiedler, M | 1 |
| Nousiainen, I | 1 |
| Mäntyjärvi, M | 1 |
| Shorvon, S | 1 |
| Ulutin, T | 1 |
| Ono, H | 1 |
| Sakamoto, A | 1 |
| Sakura, N | 1 |
| Moore, SJ | 2 |
| Turnpenny, P | 1 |
| Quinn, A | 1 |
| Glover, S | 1 |
| Lloyd, DJ | 1 |
| Montgomery, T | 1 |
| Dean, JC | 3 |
| Aitio, ML | 1 |
| Toivonen, M | 1 |
| Queen, JR | 1 |
| Clough, HE | 2 |
| Eirís, J | 1 |
| Del Río, M | 1 |
| Meseguer, P | 1 |
| Hogan, RE | 1 |
| Bertrand, ME | 1 |
| Deaton, RL | 1 |
| Sommerville, KW | 1 |
| Dasheiff, R | 1 |
| Jarre, A | 1 |
| Klingmüller, D | 1 |
| Ebbesen, F | 1 |
| Joergensen, A | 1 |
| Hoseth, E | 1 |
| Kaad, PH | 1 |
| Moeller, M | 1 |
| Holsteen, V | 1 |
| Rix, M | 1 |
| Pascarella, R | 3 |
| Giuva, T | 1 |
| Kane, K | 1 |
| Bryant-Comstock, L | 1 |
| Fairgrieve, SD | 1 |
| Jackson, M | 1 |
| Jonas, P | 1 |
| Walshaw, D | 1 |
| White, K | 1 |
| Montgomery, TL | 1 |
| Burn, J | 1 |
| Lynch, SA | 1 |
| Margineanu, DG | 1 |
| Klitgaard, H | 1 |
| Volosov, A | 1 |
| Yagen, B | 1 |
| Demircioğlu, S | 1 |
| Soylu, A | 1 |
| Mikhaĭlov, VA | 1 |
| Pedrera, JD | 1 |
| Canal, ML | 1 |
| Carvajal, J | 1 |
| Postigo, S | 1 |
| Villa, LF | 1 |
| Hernández, ER | 1 |
| Rico, H | 1 |
| Jozwiak, S | 1 |
| Terczynski, A | 1 |
| Ingwersen, SH | 1 |
| Pedersen, PC | 1 |
| Groes, L | 1 |
| Nielsen, KK | 1 |
| Aarons, L | 2 |
| Matera, V | 1 |
| Morresi, S | 2 |
| Cutarella, R | 2 |
| Foletti, GB | 1 |
| Kaul, S | 1 |
| Meena, AK | 1 |
| Murthy, JM | 1 |
| Mei, Z | 1 |
| Schapel, G | 1 |
| Sokic, DV | 1 |
| Stojsavljevic, N | 1 |
| Drulovic, J | 1 |
| Dujmovic, I | 1 |
| Mesaros, S | 1 |
| Ercegovac, M | 1 |
| Peric, V | 1 |
| Dragutinovic, G | 1 |
| Levic, Z | 1 |
| Klostermann, F | 1 |
| Nolte, G | 1 |
| Curio, G | 1 |
| Chi Chow, J | 1 |
| Nag, D | 1 |
| Garg, RK | 1 |
| Agarwal, A | 1 |
| Säger, J | 1 |
| Harvey, EA | 1 |
| Coull, BA | 1 |
| Huntington, KB | 1 |
| Khoshbin, S | 1 |
| Hayes, AM | 1 |
| Ryan, LM | 1 |
| Hokazono, T | 1 |
| Satou, M | 1 |
| Minkova, GD | 1 |
| Getova, DP | 1 |
| Bergman, U | 1 |
| Diwan, V | 1 |
| Farahmand, BY | 1 |
| Persson, PG | 1 |
| Koutroumanidis, M | 1 |
| Pearce, R | 1 |
| Sadoh, DR | 1 |
| Aynaci, FM | 1 |
| Gedik, Y | 1 |
| Kalis, MM | 1 |
| Huff, NA | 1 |
| Hue, SS | 1 |
| Huuskonen, UE | 1 |
| Vuolteenaho, O | 1 |
| Tischenkova, IF | 1 |
| Viola, MS | 1 |
| Bercellini, MA | 1 |
| Rubio, MC | 1 |
| Temkin, NR | 1 |
| Klassen, BD | 1 |
| Sadler, RM | 1 |
| Finsterer, J | 1 |
| Pelzl, G | 1 |
| Hess, B | 1 |
| Bruck, I | 1 |
| Halick, SM | 1 |
| Spessatto, A | 1 |
| Bruyn, LR | 1 |
| Koneski, J | 1 |
| Facchim, D | 1 |
| Diav-Citrin, O | 1 |
| Shechtman, S | 1 |
| Arnon, J | 1 |
| Goldberg, JF | 1 |
| Burdick, KE | 1 |
| Wolańczyk, T | 1 |
| Grabowska-Grzyb, A | 1 |
| Deleu, D | 1 |
| Ahmed, IA | 1 |
| Repo-Outakoski, M | 1 |
| Grieco, A | 1 |
| Alfei, B | 1 |
| Di Rocco, P | 1 |
| Miele, L | 1 |
| Biolcati, G | 1 |
| Griso, D | 1 |
| Vecchio, FM | 1 |
| Bianco, A | 1 |
| Gasbarrini, G | 1 |
| van Parys, J | 1 |
| Harbo, HF | 1 |
| Dale, PO | 1 |
| Fauser, BC | 1 |
| Højskov, CS | 1 |
| Poulsen, JH | 1 |
| Quaid, KA | 1 |
| Faden, RR | 1 |
| Casamenti, G | 1 |
| Sabbioni, C | 1 |
| Raggia, MA | 1 |
| Edelbroek, PM | 1 |
| Augustijn, PB | 1 |
| Rademaker, MV | 1 |
| Geesink, HH | 1 |
| Crawford, P | 1 |
| Hall, W | 1 |
| Chappell, V | 1 |
| Collings, J | 1 |
| Stewart, A | 1 |
| Rieger-Wettengl, G | 1 |
| Tutlewski, B | 1 |
| Stabrey, A | 1 |
| Rauch, F | 1 |
| Herkenrath, P | 1 |
| Schauseil-Zipf, U | 1 |
| Schoenau, E | 1 |
| Arroyo, S | 1 |
| Ohno, K | 1 |
| Higashima, M | 1 |
| Kushlinskiĭ, NE | 1 |
| Gupta, G | 1 |
| Bansal, A | 1 |
| Vorob'eva, OV | 1 |
| Kudriavtseva, EP | 1 |
| McAuley, JW | 1 |
| Biederman, TS | 1 |
| Smith, JC | 1 |
| Pomilio, MP | 1 |
| Yilmaz, E | 1 |
| Doşan, Y | 1 |
| Gürgöze, MK | 1 |
| Güngör, S | 1 |
| Ma, J | 1 |
| Zhu, PL | 1 |
| Xie, JW | 1 |
| Jia, ZP | 1 |
| Yang, JS | 1 |
| Santangeli, S | 1 |
| Stone, TW | 1 |
| van Lier, HJ | 1 |
| Myllynen, P | 1 |
| Jouppila, P | 1 |
| Schulze-Bonhage, A | 1 |
| Hurkacz, M | 1 |
| Wiela-Hojeńska, A | 1 |
| Orzechowska-Juzwenko, K | 1 |
| Kozik, A | 1 |
| Unolt, J | 1 |
| Frey, B | 2 |
| Braegger, CP | 1 |
| Ghelfi, D | 1 |
| Jones, MW | 2 |
| Blume, WT | 1 |
| Guberman, A | 1 |
| Lee, MA | 1 |
| Pillay, N | 1 |
| Weaver, DF | 1 |
| Veloso, F | 1 |
| Holdich, TA | 2 |
| Betts, TA | 1 |
| Boddie, HG | 1 |
| Crawford, PM | 1 |
| Lindstrom, P | 1 |
| Newman, PK | 1 |
| Soryal, I | 1 |
| Wroe, S | 1 |
| Vasudev, A | 1 |
| Tripathi, KD | 1 |
| Puri, V | 1 |
| Tsukahara, H | 1 |
| Kimura, K | 1 |
| Todoroki, Y | 1 |
| Ohshima, Y | 1 |
| Hiraoka, M | 1 |
| Shigematsu, Y | 1 |
| Tsukahara, Y | 1 |
| Miura, M | 1 |
| Mayumi, M | 1 |
| Jung, P | 1 |
| Doussard-Lefaucheux, S | 1 |
| Glover, SJ | 1 |
| Quinn, AG | 1 |
| Barter, P | 1 |
| Hart, J | 1 |
| Turnpenny, PD | 1 |
| Avoni, P | 1 |
| van Meel, HF | 1 |
| Brooks, J | 1 |
| Hendriks, MP | 1 |
| Storzbach, D | 1 |
| Aron, CR | 1 |
| Dodrill, CB | 4 |
| Clough, H | 1 |
| Birbeck, GL | 1 |
| Hays, RD | 1 |
| Cui, X | 1 |
| Vickrey, BG | 1 |
| Camfield, P | 2 |
| Camfield, C | 2 |
| Smith, S | 1 |
| Dooley, J | 1 |
| Smith, E | 1 |
| Bohlen, N | 1 |
| Hertl, M | 1 |
| Brandt, S | 1 |
| Kaspar, U | 1 |
| Gilligan, B | 1 |
| Buchthal, A | 1 |
| Heipertz, R | 1 |
| Eickhoff, K | 1 |
| Poser, W | 2 |
| Wilkus, RJ | 2 |
| Breyer-Pfaff, U | 1 |
| Jerg, H | 1 |
| Petruch, F | 2 |
| Cameron, JD | 1 |
| Hedley, DW | 1 |
| Knöpfle, G | 3 |
| Rootwelt, K | 1 |
| Ganes, T | 1 |
| Kosteljanetz, M | 1 |
| Dam, AM | 1 |
| Lyon, BB | 1 |
| Pedersen, H | 1 |
| Lidgren, L | 2 |
| Nilsson, BE | 1 |
| Wallöe, A | 2 |
| Salomez, JL | 1 |
| Wada, JA | 2 |
| Wake, A | 1 |
| Green, JR | 3 |
| Lai, CW | 1 |
| Hung, TP | 1 |
| Lin, WS | 1 |
| Pruce, I | 2 |
| Vol'f, MSh | 1 |
| Janz, D | 1 |
| Lechner, H | 1 |
| Hebenstreit, G | 1 |
| Müller-Oerlinghausen, B | 2 |
| Stores, G | 2 |
| Elomaa, E | 1 |
| Poser, S | 1 |
| Ritter, G | 2 |
| Windorfer, A | 1 |
| Sauer, W | 1 |
| Trompetter-van Woerden, ML | 1 |
| van der Zwan, A | 1 |
| Permin, H | 1 |
| Sestoft, L | 1 |
| Mihaly, GW | 1 |
| Phillips, JA | 1 |
| Louis, WJ | 1 |
| Joubert, PH | 1 |
| Potgieter, GM | 1 |
| Verster, F | 1 |
| Oettinger, L | 1 |
| Klotz, U | 1 |
| Watanabe, S | 1 |
| Kuyama, C | 1 |
| Yokoyama, S | 2 |
| Kubo, S | 1 |
| Iwai, H | 1 |
| Conomy, JP | 1 |
| Lhermitte, F | 1 |
| Marteau, R | 1 |
| Serdaru, M | 1 |
| Bruni, J | 3 |
| Newmark, ME | 1 |
| Würtz-Jørgensen, A | 1 |
| Andersen, B | 1 |
| Aicardi, J | 2 |
| Swanson, PD | 1 |
| Vaĭntrub, MIa | 2 |
| Shapiro, IuL | 1 |
| Dymling, JF | 1 |
| Galbraith, AW | 3 |
| Bäckström, T | 1 |
| Jorpes, P | 1 |
| Franks, RD | 1 |
| Richter, AJ | 1 |
| Mehta, PS | 1 |
| Köthe, KW | 1 |
| Hoffman, F | 1 |
| von Unruh, GE | 2 |
| Riccio, A | 4 |
| Fantini, M | 2 |
| Helmchen, H | 1 |
| Mastropaolo, C | 1 |
| Tondi, M | 1 |
| Kurata, K | 1 |
| Johnston, CK | 1 |
| Lester, GH | 1 |
| Perchalski, RJ | 1 |
| Hicks, EP | 1 |
| McKauge, L | 1 |
| Tyrer, JH | 2 |
| Ward, JW | 1 |
| Guthrie, D | 1 |
| Rylance, GW | 1 |
| Butcher, GM | 1 |
| Moreland, T | 1 |
| Jenner, P | 1 |
| Driver, MV | 1 |
| Metz, SA | 1 |
| Halter, JB | 1 |
| Porte, D | 1 |
| Robertson, RP | 1 |
| Wallace, SJ | 2 |
| Walther, H | 2 |
| Meyer, FP | 2 |
| Leuschner, U | 1 |
| Quednow, B | 1 |
| Köhler, E | 1 |
| Garratt, A | 1 |
| Hebdige, S | 1 |
| van der Kleijn, E | 1 |
| Vree, T | 1 |
| Guelen, P | 1 |
| Schobten, F | 1 |
| Westenberg, H | 1 |
| Knop, H | 1 |
| Vesterhus, P | 1 |
| Zavalishin, IA | 1 |
| Nevskaia, OM | 1 |
| Niiazbekova, AS | 1 |
| O'Callaghan, M | 2 |
| Feely, M | 3 |
| Brachet, A | 1 |
| Henry, P | 1 |
| Takigawa, M | 1 |
| Kanoh, T | 1 |
| Imamura, S | 1 |
| Takahashi, C | 1 |
| Gastaut, H | 1 |
| Osuntokun, BO | 1 |
| Norell, E | 1 |
| Lilienberg, G | 1 |
| Gamstorp, I | 2 |
| Singer, HS | 1 |
| Karbowski, K | 1 |
| Meienberg, O | 1 |
| Iisalo, E | 1 |
| Stephens, WP | 1 |
| Espir, ML | 1 |
| Tattersall, RB | 1 |
| Quinn, NP | 1 |
| Gladwell, SR | 1 |
| Yrjänä, T | 1 |
| Munthe-Kaas, AW | 1 |
| Duggan, F | 1 |
| Seldrup, J | 1 |
| Centraud, B | 1 |
| Helin, I | 1 |
| Nilsson, KO | 1 |
| Bjerre, I | 1 |
| Vegfors, P | 1 |
| Bartels, H | 1 |
| Oldigs, HD | 1 |
| Günther, E | 1 |
| Zucker, P | 1 |
| Daum, F | 1 |
| Cohen, MI | 1 |
| Abraham, CV | 1 |
| Kanto, J | 1 |
| Berman, PH | 1 |
| Glötzner, FL | 2 |
| Samland, O | 1 |
| Dommasch, D | 1 |
| Lund, L | 2 |
| Palmér, L | 2 |
| Sjöqvist, F | 1 |
| Benna, P | 1 |
| Covacich, A | 1 |
| Durelli, L | 1 |
| Furlan, PM | 2 |
| Gilli, M | 1 |
| Troni, W | 1 |
| Visnevskaia, LIa | 1 |
| Herha, J | 1 |
| Obe, G | 1 |
| Halpern, LM | 1 |
| Cereghino, JJ | 4 |
| Brock, JT | 3 |
| Van Meter, JC | 2 |
| Smith, LD | 4 |
| White, BG | 3 |
| Johnson, J | 1 |
| Ames, FR | 1 |
| Enderstein, O | 1 |
| Leviatov, VM | 1 |
| Veselovskaia, TD | 1 |
| Mar'enko, GF | 1 |
| Shchegoleva, AP | 1 |
| Gauchel, FD | 1 |
| Holzbach, E | 1 |
| Rabe, F | 2 |
| Spancken, E | 1 |
| Schneider, H | 1 |
| Stenzel, E | 1 |
| Schüppel, RV | 1 |
| Anlezark, G | 1 |
| Balzamo, E | 1 |
| Horton, RW | 1 |
| Kiørboe, E | 1 |
| Parsonage, M | 2 |
| Dalby, MA | 1 |
| Pisciotta, AV | 1 |
| Recchia, M | 1 |
| Wilson, JT | 1 |
| Farmer, PJ | 1 |
| Placencia, M | 2 |
| Jumbo, L | 1 |
| Manford, M | 1 |
| Kanno, T | 1 |
| Miyata, M | 1 |
| Kazuta, Y | 1 |
| Sato, Y | 1 |
| Nishimaki, T | 1 |
| Kasukawa, R | 1 |
| Sugarman, P | 1 |
| Mader, MJ | 1 |
| Marcourakis, TM | 1 |
| Ferreira, ZS | 1 |
| Kostadinova, I | 1 |
| Millusheva, M | 1 |
| Krustev, A | 1 |
| Toreva, D | 1 |
| Wunderlich, HP | 1 |
| Herkes, GK | 3 |
| Percy-Robb, I | 1 |
| Kaciński, M | 2 |
| Mor, N | 1 |
| Litwin, A | 1 |
| Mishra, PK | 1 |
| Burger, RL | 1 |
| Bettendorf, AF | 1 |
| Besser, R | 1 |
| Hornung, K | 1 |
| Theisohn, M | 1 |
| Rothacher, G | 1 |
| Krämer, G | 1 |
| Grant, SM | 1 |
| Faulds, D | 1 |
| Butler, E | 5 |
| Foy, PM | 2 |
| Rajgopalan, N | 1 |
| Boon, DM | 1 |
| Swaak, AJ | 1 |
| Thakker, KM | 1 |
| Mangat, S | 1 |
| Kochak, GM | 1 |
| Monza, G | 1 |
| Grazia Marciani, M | 1 |
| Stefanini, F | 1 |
| Stefani, N | 1 |
| Sabbadini, M | 1 |
| Maoz, E | 1 |
| Grossman, E | 1 |
| Thaler, M | 1 |
| Rosenthal, T | 1 |
| Churchyard, A | 1 |
| Khangure, M | 1 |
| Grainger, K | 1 |
| Williams, PL | 1 |
| Styles, E | 1 |
| Zaiwalla, Z | 1 |
| Karande, SC | 1 |
| Joshi, MV | 1 |
| Kshirsagar, NA | 1 |
| Shah, PU | 1 |
| Fenwick, PB | 1 |
| Gallassi, R | 2 |
| Morreale, A | 2 |
| Di Sarro, R | 1 |
| Marra, M | 1 |
| Suarez, J | 1 |
| Crespo, F | 1 |
| Ellison, RH | 1 |
| Cascante, SM | 1 |
| Lancaster, JM | 1 |
| Davies, JA | 1 |
| Tyrer, S | 1 |
| Moore, PB | 1 |
| Mogensen, PH | 1 |
| Jórgensen, L | 1 |
| Vesterager, A | 1 |
| Jensen, PK | 2 |
| Gracia, CM | 1 |
| Martins, R | 1 |
| Fernandes, AG | 1 |
| Diekmann, HW | 1 |
| Jung, W | 1 |
| Beslo, D | 1 |
| Raicević, S | 1 |
| Sredić, S | 1 |
| Friedman, DL | 1 |
| Kastner, T | 1 |
| Plummer, AT | 1 |
| Ruiz, MQ | 1 |
| Henning, D | 1 |
| Heinonen, EH | 1 |
| Nyman, L | 1 |
| Anttila, M | 3 |
| Stodieck, SR | 1 |
| Chan, KM | 1 |
| Leavitt, A | 1 |
| Erickson, DM | 1 |
| McCormick, KB | 1 |
| Loewenson, RB | 1 |
| Sells, CJ | 2 |
| Benedetti, TJ | 1 |
| Lenn, NJ | 1 |
| Robertson, M | 1 |
| Gladstone, DJ | 1 |
| Bologa, M | 1 |
| Maguire, C | 1 |
| Pastuszak, A | 1 |
| Craig, CR | 1 |
| Colasanti, BK | 1 |
| Anderson, RL | 1 |
| Pezzilli, R | 1 |
| Billi, P | 1 |
| Melandri, R | 1 |
| Broccoli, PL | 1 |
| Fontana, G | 1 |
| Hwang, P | 1 |
| Fraser, A | 1 |
| Soldin, S | 1 |
| al-Quadah, AK | 1 |
| Rock, DM | 1 |
| Catterall, WA | 1 |
| Taylor, CP | 1 |
| Feksi, AT | 1 |
| Kaamugisha, J | 1 |
| Gatiti, S | 1 |
| Hartley, R | 6 |
| Aleksandrowicz, J | 2 |
| Bowmer, CJ | 4 |
| Cawood, A | 1 |
| Forsythe, WI | 5 |
| Okesina, AB | 2 |
| Donaldson, D | 2 |
| Declerck, AC | 2 |
| Wauquier, A | 2 |
| So, N | 1 |
| Gotman, J | 2 |
| Brignolio, F | 1 |
| Verzè, L | 2 |
| Baruchello, M | 2 |
| de Feo, MR | 1 |
| Mecarelli, O | 1 |
| Ricci, G | 1 |
| Rina, MF | 1 |
| Ryback, RS | 1 |
| Gardner, EA | 1 |
| Rijlaarsdam, U | 1 |
| Scheffer, E | 1 |
| Meijer, CJ | 1 |
| Kruyswijk, MR | 1 |
| Willemze, R | 1 |
| Kiker, M | 1 |
| Papazian, O | 1 |
| Forsythe, I | 2 |
| Butler, R | 1 |
| McGuire, R | 1 |
| Schmidt, B | 1 |
| Ring, HA | 1 |
| Heller, AJ | 1 |
| Marshall, WJ | 1 |
| Pakalnis, A | 2 |
| Padamadan, H | 1 |
| Weate, SM | 1 |
| Cannon, PA | 1 |
| Tanaka, H | 1 |
| Izumi, M | 1 |
| Okada, H | 1 |
| Ishikawa, S | 1 |
| Kaski, M | 1 |
| Heinonen, E | 3 |
| Tuominen, J | 1 |
| Silver, JM | 1 |
| Shin, C | 1 |
| Safe, AF | 1 |
| Maxwell, RT | 1 |
| Partanen, J | 1 |
| Mumford, J | 1 |
| Saksa, M | 1 |
| Dupuis, RE | 1 |
| Miranda-Massari, J | 1 |
| Giardina, M | 1 |
| Schramm, W | 1 |
| Annesley, TM | 1 |
| Siegel, GJ | 1 |
| Smith, RH | 1 |
| van der Pol, MC | 1 |
| Hadders-Algra, M | 1 |
| Huisjes, HJ | 1 |
| Touwen, BC | 1 |
| Tennison, MB | 1 |
| Rosa, FW | 1 |
| Altshuler, LL | 1 |
| Ketter, TA | 1 |
| Denicoff, K | 1 |
| Olpe, H | 1 |
| Kolb, CN | 1 |
| Hausdorf, A | 1 |
| Haas, HL | 1 |
| Lenti, C | 1 |
| Masserini, C | 1 |
| Peruzzi, C | 1 |
| Guareschi Cazzullo, A | 1 |
| Vallin, H | 1 |
| Edhag, O | 1 |
| McLain, B | 3 |
| Ng, PC | 3 |
| Lucock, MD | 2 |
| Loonen, AJ | 1 |
| Doorschot, CH | 1 |
| Van Bavel, LP | 1 |
| Groot, B | 1 |
| De Blok, HJ | 1 |
| Krijgsman, LJ | 1 |
| Van Dongen, PH | 1 |
| Jaspers, AA | 1 |
| Vanbrabant, LC | 1 |
| Dhalla, Z | 1 |
| Sutton, J | 1 |
| Vestermark, V | 1 |
| Vestermark, S | 1 |
| Betticher, DC | 1 |
| Wolfisberg, HP | 1 |
| Krapf, R | 1 |
| Calandre, EP | 1 |
| Rodriquez-Lopez, C | 1 |
| Blazquez, A | 1 |
| Cano, D | 1 |
| Martines, C | 1 |
| Trio, R | 2 |
| Lampl, Y | 1 |
| Eshel, Y | 1 |
| Rapaport, A | 1 |
| Sarova-Pinhas, I | 1 |
| Hirano, T | 1 |
| Tempelhoff, R | 1 |
| Modica, PA | 1 |
| Spitznagel, EL | 1 |
| van Wieringen, A | 1 |
| van Emde Boas, W | 1 |
| Vermeij, TA | 1 |
| Sälke-Treumann, A | 1 |
| McManus, DQ | 1 |
| Guterman, A | 1 |
| Briggle, TV | 1 |
| Vazquez, D | 1 |
| Perchalski, R | 1 |
| Yost, RA | 1 |
| Wong, P | 1 |
| Robbins, DK | 1 |
| Wedlund, PJ | 1 |
| Kuhn, R | 1 |
| Chang, SL | 1 |
| Peng, SM | 1 |
| Wu, JZ | 1 |
| Tokola, O | 1 |
| Parantainen, J | 1 |
| Tamminen, M | 1 |
| Allonen, H | 1 |
| Remy, C | 1 |
| Foley, H | 1 |
| Wang, RB | 1 |
| Liu, LT | 1 |
| Yiu, CH | 1 |
| Chang, TY | 1 |
| Gerasimiuk, DL | 1 |
| Gusel', VA | 1 |
| Klimenko, VA | 1 |
| Korovin, AM | 1 |
| Persson, LI | 1 |
| Bengtsson, E | 1 |
| Rainbow, SJ | 1 |
| Dawson, CM | 1 |
| Tickner, TR | 1 |
| Ryan, SW | 2 |
| Haworth, M | 1 |
| Ristanović, D | 1 |
| Dokić-Ristanović, D | 1 |
| Jovanović, V | 1 |
| Cosgrove, M | 1 |
| Pople, S | 1 |
| Kothari, SS | 1 |
| Grunwald, MH | 1 |
| Ben-Dor, D | 1 |
| Livni, E | 1 |
| Halevy, S | 1 |
| Miyauchi, T | 1 |
| Yamaguchi, T | 1 |
| Endo, K | 1 |
| Hagimoto, H | 1 |
| Ishii, M | 1 |
| Bun, H | 1 |
| Monjanel-Mouterde, S | 1 |
| Noel, F | 1 |
| Durand, A | 1 |
| Cano, JP | 1 |
| Termond, E | 1 |
| Theeuwes, A | 1 |
| Schaap, M | 1 |
| Rwiza, HT | 1 |
| Schubiger, G | 1 |
| Musy, JP | 1 |
| Ruser, I | 1 |
| Kubota, T | 1 |
| Jibiki, I | 1 |
| Yamaguchi, N | 1 |
| Williams, N | 2 |
| Wiedmann, KD | 1 |
| Amendola D'Agostino, AM | 1 |
| Ioculano, MP | 1 |
| Huh, K | 1 |
| Gallagher, BB | 1 |
| King, DW | 1 |
| Laminack, L | 1 |
| Niediek, T | 1 |
| Franke, HG | 1 |
| Degen, R | 1 |
| Ettlinger, G | 1 |
| Askmark, H | 1 |
| Wiholm, BE | 1 |
| von Albert, HH | 1 |
| Brent, DA | 2 |
| Crumrine, PK | 2 |
| Varma, R | 1 |
| Brown, RV | 1 |
| Allan, MJ | 1 |
| Stracciari, A | 1 |
| Ciucci, G | 1 |
| Bianchedi, G | 1 |
| Rebucci, GG | 1 |
| Binelli, S | 1 |
| Casazza, M | 1 |
| Lodrini, S | 1 |
| Panzica, F | 1 |
| Pluchino, F | 1 |
| Solero, CL | 1 |
| Karunanayake, EH | 1 |
| Joice, PD | 1 |
| Peiris, JB | 1 |
| Almkvist, O | 1 |
| Nilsson, BY | 2 |
| Svensson, JO | 2 |
| Muñoz, JJ | 1 |
| De Salamanca, RE | 1 |
| Diaz-Obregón, C | 1 |
| Timoneda, FL | 1 |
| Gaily, EK | 1 |
| McCormick, K | 1 |
| Koerner, M | 1 |
| Van Allen, M | 1 |
| Leavitt, AM | 1 |
| Yerby, JA | 1 |
| Russell-Jones, D | 1 |
| Finnerty, G | 1 |
| Goldberg, VD | 1 |
| Järvensivu, P | 1 |
| Lehto, H | 1 |
| Hokkanen, E | 1 |
| West, J | 1 |
| Burke, JP | 1 |
| Strachan, I | 1 |
| Tiihonen, P | 1 |
| Puche, E | 2 |
| Garcia de la Serrana, H | 2 |
| Saucedo, R | 1 |
| Leary, PM | 1 |
| Luss, K | 1 |
| Haust, HL | 1 |
| Poon, HC | 1 |
| Carson, R | 1 |
| VanDeWetering, C | 1 |
| Peter, F | 1 |
| Wietholtz, H | 1 |
| Zysset, T | 1 |
| Kreiten, K | 1 |
| Kohl, D | 1 |
| Büchsel, R | 1 |
| Matern, S | 1 |
| Lorz, U | 1 |
| Garcia Morillas, M | 1 |
| Fukuyama, Y | 1 |
| Vaillant, L | 1 |
| Camenen, I | 1 |
| Lorette, G | 1 |
| Heinemann, U | 1 |
| Hamon, B | 1 |
| Konnerth, A | 1 |
| Yaari, Y | 1 |
| Racine-Poon, A | 1 |
| Dubois, JP | 1 |
| Varghese, A | 1 |
| Murphy, B | 1 |
| McCluskey, DR | 1 |
| Irvine, AE | 1 |
| Teehan, CJ | 1 |
| White, AJ | 1 |
| Turbott, SH | 1 |
| Vaithianathan, C | 1 |
| Pendlebury, SC | 3 |
| Moses, DK | 1 |
| Vani, SN | 1 |
| Martynova, LA | 1 |
| Puzin, MN | 1 |
| Seleznev, AN | 1 |
| Dambrosia, J | 1 |
| Nice, FJ | 1 |
| Bag, S | 1 |
| Ahuja, GK | 2 |
| Karmarkar, MG | 1 |
| Keitner, GI | 1 |
| Fruzzetti, AE | 1 |
| Miller, IW | 1 |
| Norman, WH | 1 |
| Brown, WA | 1 |
| Evans, OB | 1 |
| Gay, H | 1 |
| Swisher, A | 1 |
| Parks, B | 1 |
| Summers, B | 1 |
| Summers, RS | 1 |
| Hilton-Brown, P | 1 |
| Pacifici, GM | 1 |
| Fortman, CS | 1 |
| Witte, DL | 1 |
| Sturzenegger, M | 1 |
| von Gumppenberg, S | 1 |
| Elton, M | 1 |
| Aldenhövel, HG | 2 |
| Vönöczky, K | 1 |
| Radó, J | 1 |
| Leyh, F | 1 |
| Wendt, V | 1 |
| Scherer, R | 1 |
| Paar, WD | 1 |
| Komatsu, M | 1 |
| Kodama, S | 1 |
| Momota, K | 1 |
| Wada, H | 1 |
| Matsuo, T | 2 |
| Marsden, JR | 1 |
| Rødbro, P | 1 |
| Hummer, L | 1 |
| Evans, RW | 1 |
| Gualtieri, CT | 1 |
| Ogata, N | 1 |
| Inoue, M | 1 |
| Ioannides-Demos, LL | 2 |
| Horne, MK | 1 |
| Tong, N | 2 |
| Wodak, J | 2 |
| Harrison, PM | 2 |
| McNeil, JJ | 1 |
| Gilligan, BS | 2 |
| McLean, AJ | 2 |
| Holmes, GB | 1 |
| Moses, D | 1 |
| Duncan, J | 1 |
| Brown, SW | 1 |
| McGowan, ME | 1 |
| Streete, JM | 1 |
| Pettit, LI | 1 |
| Goggin, T | 4 |
| Casey, C | 1 |
| Schäfer, H | 1 |
| Kuhnen, C | 1 |
| Gough, H | 2 |
| Bissessar, A | 2 |
| Baker, M | 2 |
| Crowley, M | 2 |
| Larrieu, JL | 1 |
| Lagueny, A | 1 |
| Ferrer, X | 1 |
| Julien, J | 1 |
| John, K | 1 |
| Kellum, JB | 1 |
| Clancy, RR | 1 |
| Zielinski, JJ | 3 |
| Lichten, EM | 1 |
| Faingold, CL | 1 |
| Browning, RA | 1 |
| Bertollini, R | 1 |
| Mastroiacovo, P | 1 |
| Robert, E | 1 |
| Trimble, R | 1 |
| Garrett, A | 1 |
| Neef, C | 1 |
| de Voogd-van der Straaten, I | 1 |
| Connacher, AA | 1 |
| Borsey, DQ | 1 |
| Browning, MC | 1 |
| Davidson, DL | 1 |
| Jung, RT | 1 |
| Feucht, M | 1 |
| Spiel, G | 1 |
| Ilyés, I | 1 |
| Princzinger, A | 1 |
| Sári, B | 1 |
| György, I | 1 |
| Yuen, WC | 1 |
| Whiteoak, R | 1 |
| Thompson, RP | 1 |
| Hicks, RA | 1 |
| Murphy, JV | 1 |
| Jackson, MA | 1 |
| Krall, RL | 1 |
| Resor, SJ | 1 |
| Anderson, L | 1 |
| Hall, JG | 1 |
| Damasceno, BP | 1 |
| Campos Junior, Sda S | 1 |
| Martins, LF | 1 |
| de Melo-Souza, SE | 1 |
| Kilpatrick, CJ | 1 |
| Bury, RW | 1 |
| Fullinfaw, RO | 1 |
| Moulds, RF | 1 |
| Okudzhava, VM | 2 |
| Chanvetadze, BG | 1 |
| Antadze, ZI | 2 |
| Chkhenkeli, SI | 1 |
| Rukhadze, MD | 1 |
| Aita, JF | 1 |
| Alonso Gonzalez, AC | 1 |
| Dominguez-Gil Hurle, A | 1 |
| Wiedmann, K | 1 |
| Gianelli, M | 1 |
| Gentile, S | 1 |
| Dimanico, U | 1 |
| Smísek, M | 1 |
| Kuchar, M | 1 |
| Volmut, J | 1 |
| Garcia, MJ | 1 |
| Alonso, AC | 1 |
| Maza, A | 1 |
| Santos, D | 1 |
| Matesanz, C | 1 |
| Sztefko, K | 1 |
| Szafran, Z | 1 |
| Stopyrowa, J | 1 |
| Reininghaus, R | 1 |
| Winkel, R | 1 |
| Dunstan, PR | 1 |
| Neppe, VM | 1 |
| Tucker, GJ | 1 |
| Novelly, RA | 1 |
| Craft, B | 1 |
| Borromei, A | 1 |
| Caramelli, R | 1 |
| Cipriani, G | 1 |
| Giancola, LC | 1 |
| Guerra, L | 1 |
| Lozito, A | 1 |
| Nespolo, A | 1 |
| Tarenghi, G | 1 |
| Wadia, N | 1 |
| Desai, S | 1 |
| Bhatt, M | 1 |
| Browne, TR | 2 |
| Szabo, GK | 1 |
| Evans, JE | 1 |
| Evans, BA | 1 |
| Greenblatt, DJ | 1 |
| Mikati, MA | 1 |
| Lorusso, S | 1 |
| Levi, R | 1 |
| Gilman, JT | 1 |
| Duchowny, MS | 1 |
| Resnick, TJ | 1 |
| Hershorin, ER | 1 |
| Chankvetadze, BG | 1 |
| Vetrogon, FG | 1 |
| Leite, PJ | 1 |
| Tsanaclis, LM | 1 |
| Markourakis, T | 1 |
| Silveira, DC | 1 |
| Guerreiro, MM | 1 |
| Hawkins, CA | 2 |
| Mellanby, JH | 1 |
| Matre, R | 1 |
| Reinikainen, KJ | 1 |
| Komulainen, H | 1 |
| Utech, K | 1 |
| Wedlund, JE | 1 |
| Arranz Peña, MI | 1 |
| Saenz Lope, E | 1 |
| Vinçon, G | 1 |
| Albin, H | 1 |
| Demotes-Mainard, F | 1 |
| Bistue, C | 1 |
| Morris, JC | 1 |
| Hatlelid, JM | 1 |
| Ward, DJ | 1 |
| Tanne, Z | 1 |
| Karp, L | 1 |
| Martfeld, Y | 1 |
| Tyano, S | 1 |
| Gavish, M | 1 |
| Juergens, U | 1 |
| Varma, RR | 1 |
| Allan, M | 1 |
| Allman, C | 1 |
| Field, CJ | 1 |
| Foote, SE | 1 |
| van Belle, G | 1 |
| McGlone, R | 1 |
| Pritty, P | 1 |
| Gulledge, AD | 1 |
| Thweatt, RE | 1 |
| Ward, CD | 1 |
| Agbato, OA | 2 |
| Ojemann, LM | 1 |
| Shastri, RA | 1 |
| McLean, JR | 1 |
| Buchanan, RA | 1 |
| Geladze, TSh | 1 |
| Hidano, F | 1 |
| Danneberg, P | 1 |
| Knappen, F | 1 |
| Sersen, EA | 1 |
| Jann, MW | 1 |
| Fidone, GS | 1 |
| Klitgaard, NA | 1 |
| Russo, M | 1 |
| Pisani, B | 1 |
| Panagariya, A | 1 |
| McPhail, EM | 1 |
| Li, BY | 1 |
| Olivesi, A | 1 |
| Smith, KL | 1 |
| Heinzow, U | 1 |
| Horne, M | 1 |
| Kuoppala, T | 1 |
| Tuimala, R | 1 |
| Koskinen, T | 1 |
| Marcoli, M | 1 |
| Ippoliti, G | 1 |
| Lombardi, M | 1 |
| Crema, A | 1 |
| Zocchi, MT | 1 |
| Dalessio, DJ | 1 |
| Subakov, M | 1 |
| Sinanović, O | 1 |
| Delgado-Escueta, AV | 1 |
| McCutchen, CB | 1 |
| Lisk, DR | 1 |
| Greene, SH | 1 |
| Cornaggia, C | 1 |
| Giuccioli, D | 1 |
| Pinelli, P | 1 |
| Pruneri, C | 1 |
| Cathro, DM | 1 |
| Hardman, RP | 1 |
| Burgess, RJ | 1 |
| Paulson, GW | 1 |
| Martens, WL | 1 |
| John, G | 1 |
| Muuronen, A | 1 |
| Kaste, M | 1 |
| Nikkilä, EA | 1 |
| Tolppanen, EM | 1 |
| Lewis, JH | 1 |
| Nolte, JL | 1 |
| Westwood, AP | 1 |
| Bell, AD | 1 |
| Gerlis, LM | 1 |
| Variend, S | 1 |
| Richter, K | 1 |
| Einicke, I | 1 |
| Lamontanara, G | 3 |
| Montanari, G | 1 |
| Bonin, P | 1 |
| Casara, GL | 1 |
| Levine, M | 1 |
| Sheppard, I | 1 |
| Leheta, BJ | 1 |
| Smith, JL | 1 |
| Sacks, E | 1 |
| Borah, NC | 1 |
| Matheshwari, MC | 1 |
| Lahr, MB | 1 |
| Shimada, K | 1 |
| Wakabayashi, H | 1 |
| Pritchard, PB | 1 |
| Holmstrom, VL | 1 |
| Roitzsch, JC | 1 |
| Giacinto, J | 1 |
| McKenna, PJ | 1 |
| Kane, JM | 1 |
| Parrish, K | 1 |
| Hampton, KK | 1 |
| Bramley, PN | 1 |
| Brown, J | 1 |
| Godbout, R | 1 |
| Montplaisir, J | 1 |
| Rouleau, I | 1 |
| Santucci, M | 1 |
| Galeone, D | 1 |
| Torelli, D | 1 |
| Hegedüs, L | 1 |
| Hansen, JM | 1 |
| Perrild, H | 1 |
| Feldt-Rasmussen, U | 1 |
| Kampmann, JP | 1 |
| Lund, A | 1 |
| Gormsen, H | 1 |
| Shuper, A | 1 |
| Stahl, B | 1 |
| Weitz, R | 1 |
| Guron, CS | 1 |
| Grewal, MS | 1 |
| Falconer, MA | 1 |
| Davidson, S | 1 |
| McLellan, DL | 1 |
| Swash, M | 1 |
| Radó, JP | 1 |
| Lockard, JS | 1 |
| Uhlir, V | 1 |
| Farquhar, JA | 1 |
| Hakkarainen, HK | 1 |
| Puranen, JA | 1 |
| Lahti, RO | 1 |
| Almeyda, J | 1 |
| Levantine, A | 1 |
| Krupp, P | 1 |
| Pachioli, R | 1 |
| Battista Cavazzuti, G | 1 |
| Eisen, AA | 1 |
| Woods, JF | 1 |
| Sherwin, AL | 1 |
| Hooshmand, H | 1 |
| Landy, PJ | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Wilson, J | 1 |
| Scott, D | 1 |
| Jannasch, R | 1 |
| Gardner-Thorpe, C | 2 |
| Parsonage, MJ | 2 |
| Toothill, C | 2 |
| Leibovitz, U | 1 |
| Louis, S | 1 |
| Friedlander, WJ | 1 |
| Weinmann, HM | 1 |
| Willms, E | 1 |
| Gascon, GG | 1 |
| Vogt, HJ | 1 |
| Schlack, HG | 1 |
| Strandjord, R | 1 |
| Johannessen, S | 1 |
| van Duijn, H | 1 |
| Visser, SL | 1 |
| Mourot, H | 1 |
| Hishikawa, Y | 1 |
| Furuya, E | 1 |
| Yamamoto, J | 1 |
| Nan'no, H | 1 |
| Kyösola, K | 1 |
| Meter, JC | 1 |
| Cremers, HM | 1 |
| Verheesen, PE | 1 |
| Meyer, JG | 1 |
| Kristof, M | 1 |
| Kolínová, M | 1 |
| Reizenstein, P | 1 |
| Nicholson, WJ | 1 |
| Henry, TP | 1 |
| Kauko, K | 1 |
| Tammisto, P | 1 |
| Myrstener, A | 1 |
| Dehing, J | 1 |
| Bonetti, U | 1 |
| Taraschi, G | 1 |
| Brotto, M | 1 |
| Greppi, G | 1 |
| Blomberg, LH | 1 |
| Burén, A | 1 |
| Dahlqvist, L | 1 |
| Heyer, R | 1 |
| Auert, G | 1 |
| Bittner-Manicka, M | 1 |
| Wasilewski, R | 1 |
| Lewicka, E | 1 |
| Kurz, JF | 1 |
| Finavera, L | 1 |
| Mascetti, A | 1 |
| Zamberletti, P | 1 |
| Smethurst, PF | 1 |
| Krüger, HJ | 1 |
| Harms, D | 1 |
| Cendrowski, W | 1 |
| Linde, J | 1 |
| Molholm Hansen, J | 1 |
| Siersbaek-Nielsen, K | 1 |
| Fuglsang-Fredriksen, V | 1 |
| Fröbärj, G | 1 |
| Durdević, M | 1 |
| Nikolić, M | 1 |
| Antonović, OH | 1 |
| Pejović, M | 1 |
| Ekstedt, J | 1 |
| Houben, PF | 1 |
| Hommes, OR | 1 |
| Knaven, PJ | 1 |
| Barbosa, JC | 1 |
| Poch, GF | 1 |
| Maxion, H | 1 |
| Leder, A | 1 |
| Sampson, D | 1 |
| Harasymiv, I | 1 |
| Hensley, WJ | 1 |
| Oller-Daurella, L | 1 |
| Chillón, D | 1 |
| Rajotte, P | 1 |
| Jilek, W | 1 |
| Jilek, L | 1 |
| Perales, A | 1 |
| Giard, N | 1 |
| Bordeleau, JM | 1 |
| Tétreault, L | 1 |
| García-Pardo, M | 1 |
| Mariategui, J | 1 |
| Chavez, H | 1 |
| Oballe, J | 1 |
| Ortiz de Zárate, JC | 1 |
| Sica, R | 1 |
| Sánchez Ordóñez, M | 1 |
| Moëne, Y | 1 |
| Courjon, J | 1 |
| Dolce, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Physiological-based Pharmacokinetics Approach to Determine the Extent of Drug Exposure of Antiseizure Medications During Pregnancy and Breastfeeding[NCT05450978] | 60 participants (Anticipated) | Observational [Patient Registry] | 2022-07-20 | Recruiting | |||
| The BrainDrugs-Epilepsy Study: A Prospective Open-label Cohort Precision Medicine Study in Epilepsy[NCT05450822] | 550 participants (Anticipated) | Observational | 2022-02-18 | Recruiting | |||
| A Multicenter, Double-blind, Double-dummy, Randomized, Positive- Controlled Study Comparing the Efficacy and Safety of Lacosamide (200 to 600 mg/Day) to Controlled Release Carbamazepine (400 to 1200 mg/Day), Used as Monotherapy in Subjects (≥ 16 Years) Ne[NCT01243177] | Phase 3 | 888 participants (Actual) | Interventional | 2011-04-30 | Completed | ||
| An International, Double-blind, Parallel-group, Placebo-controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures[NCT00464269] | Phase 3 | 400 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥16 to 80 Years Old) With Partial Onset Seizures[NCT01261325] | Phase 3 | 768 participants (Actual) | Interventional | 2010-12-31 | Completed | ||
| A Multi-center, Double-blind, Parallel-group, Placebo Controlled, Randomized Study: Evaluation of the Efficacy and Safety of Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures.[NCT00490035] | Phase 3 | 399 participants (Actual) | Interventional | 2007-09-30 | Completed | ||
| HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions: a Multicenter Clinical Study[NCT03184597] | 4,000 participants (Anticipated) | Interventional | 2017-08-01 | Recruiting | |||
| A Sequential, Open-Label Study of the Pharmacokinetics and Safety of Intravenous Carbamazepine Relative to Oral Carbamazepine in Adult Patients With Epilepsy[NCT01079351] | Phase 1 | 98 participants (Actual) | Interventional | 2007-04-30 | Completed | ||
| Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy[NCT01128959] | Phase 3 | 108 participants (Actual) | Interventional | 2010-06-30 | Completed | ||
| A Therapeutic Confirmatory, Open-label, Multi-center, Randomized 2 Parallel Groups, Community-based Trial Studying the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral Tablets 250-500 mg b.i.d.) Compared to Sodium Valproate (1000 to 2000 mg/[NCT00175903] | Phase 3 | 1,701 participants (Actual) | Interventional | 2005-02-28 | Completed | ||
| Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children Attending Assiut Pediatric University Hospital[NCT04542629] | Phase 4 | 140 participants (Anticipated) | Interventional | 2020-10-01 | Not yet recruiting | ||
| Levetiracetam, Carbamazepine and Lamotrigine and Hormonal Side Effects in Adult Males and Females.[NCT00460070] | 240 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| EEG Objectification in Neuropsychiatry[NCT01476228] | 100 participants (Anticipated) | Interventional | 2011-11-30 | Not yet recruiting | |||
| Phase 1 Study for Measuring the Effect of Antiepileptic Drugs on Mitochondrial Activity[NCT01218321] | 60 participants (Actual) | Observational | 2011-01-31 | Completed | |||
| Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) - A Phase II Exploratory Study[NCT04004702] | Phase 2 | 65 participants (Anticipated) | Interventional | 2020-01-31 | Not yet recruiting | ||
| Evaluation of Repetitive Magnetic Stimulation Versus Direct Current Stimulation, in Chronic Neuropathic and Drug-resistant Pain Treatment[NCT02854332] | 40 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | |||
| A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia[NCT06010030] | 200 participants (Anticipated) | Interventional | 2023-08-25 | Recruiting | |||
| Effects of tDCS in Language Recovery and Reorganization in Chronic Aphasia[NCT04166513] | 4 participants (Anticipated) | Interventional | 2019-12-01 | Recruiting | |||
| The Impact of Concurrent Brain Stimulation and Working Memory Training on Cognitive Performance in Acquired Brain Injury[NCT04010149] | 40 participants (Anticipated) | Interventional | 2019-11-30 | Not yet recruiting | |||
| Augmentation of Locomotor Adaptation Post-Stroke[NCT02892084] | Phase 1 | 29 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Effects and Consequences for Mother and Child From Treatment for Depression, A Prospective Randomized, Placebo- Controlled, Trial With Internet-based Cognitive Behavior Therapy and Sertraline or Placebo for Moderate Depression in Pregnancy[NCT02185547] | Phase 4 | 17 participants (Actual) | Interventional | 2016-02-21 | Terminated (stopped due to Difficulties in recruiting participants.) | ||
| TOPAMAX (Topiramate) Monotherapy Comparison Trial to Standard Monotherapy in the Treatment of Newly Diagnosed Epilepsy (RWJ-17021-000); Phase IIIB[NCT00236717] | Phase 3 | 865 participants (Actual) | Interventional | 1997-09-30 | Completed | ||
| Efficacy and Safety of an ER-formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients Under Consideration of Quality of Life Parameters[NCT01086501] | 225 participants (Actual) | Observational | 2010-02-28 | Completed | |||
| A Preliminary Study of the Efficacy and Safety of Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency[NCT01379469] | Phase 2 | 20 participants (Actual) | Interventional | 2012-01-31 | Terminated | ||
| Effect of the Treatment of Vitamin D Deficiency in Drug-resistant Epilepsy[NCT03475225] | Phase 3 | 400 participants (Anticipated) | Interventional | 2018-04-30 | Not yet recruiting | ||
| A Multicentre, Double-blind, Randomized, Phase IV Clinical Trial Comparing the Safety, Tolerability and Efficacy of Levetiracetam Versus Lamotrigine and Carbamazepine in the Oral Antiepileptic Therapy of Newly Diagnosed Elderly Patients With Focal Epileps[NCT00438451] | Phase 4 | 361 participants (Actual) | Interventional | 2007-01-31 | Completed | ||
| A Study of Divalproex Sodium in Children With Autism Spectrum Disorder and Epileptiform EEG[NCT01170325] | Phase 2 | 0 participants (Actual) | Interventional | 2010-06-30 | Withdrawn | ||
| [NCT00381537] | 92 participants | Interventional | Completed | ||||
| A Multicenter, Double-blind, Randomized, Parallel Group, Positive-controlled Trial Comparing the Efficacy and Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) to Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy for up to a Maxi[NCT00150735] | Phase 3 | 580 participants | Interventional | 2002-06-30 | Completed | ||
| A Multicenter, Double-blind, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam (1000 to 3000 mg/Day Oral b.i.d.) and Carbamazepine (400 to 1200 mg/Day Oral b.i.d.), Used as Monotherapy in Subjects (≥ 16 Years) Coming From the N01061 Trial.[NCT00150787] | Phase 3 | 250 participants | Interventional | 2003-07-31 | Completed | ||
| Bioequivalence Study of Sodium Valproate and Valproic Acid Extended Release Tablets in Healthy Human Volunteers[NCT05641649] | Phase 4 | 16 participants (Anticipated) | Interventional | 2023-08-06 | Active, not recruiting | ||
| Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy in Adults Patients[NCT03183076] | 14 participants (Actual) | Interventional | 2015-09-01 | Completed | |||
| Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome[NCT01607073] | Phase 2 | 2 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
| Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva[NCT00395499] | 19 participants | Observational | 2001-05-31 | Completed | |||
| A Prospective Study on Long-term Outcome and Potential Usefulness fo an Intervention Aimed at Reducing Adverse Effects in Patients With Refractory Epilepsy[NCT03939507] | 1,000 participants (Actual) | Interventional | 2006-11-06 | Completed | |||
| Therapeutic Drug Monitoring of Corticosteroids/β2-agonists in Hair in Asthmatic Patients: an Open-label Feasibility Study[NCT03691961] | 24 participants (Actual) | Interventional | 2018-09-20 | Active, not recruiting | |||
| An MRI Ancillary Study of a Malaria Fever Randomized Controlled Trial (RCT)[NCT05746819] | 256 participants (Anticipated) | Observational | 2021-01-02 | Enrolling by invitation | |||
| The Diagnosis and Management of Patients With Epilepsy: Nationwide, Multicenter Study of Recordings for the Diagnosis and Management of Patients With Epilepsy and Treatment With Levetiracetam in Daily Clinical Practice in Greece[NCT02356731] | 450 participants (Actual) | Observational | 2015-03-31 | Completed | |||
| An Open Prospective Randomised Long-Term Effectiveness Study, Comparing Best Medical Practice With or Without Adjunctive VNS Therapy in Patients 16 Years and Older With Pharmaco-resistant Partial Epilepsy[NCT00522418] | Phase 4 | 122 participants (Actual) | Interventional | 2006-02-28 | Terminated (stopped due to Insufficient enrollment) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
An Adverse Event is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. Treatment-emergent AEs were defined as AEs that started on or after the date of first dose of study medication and within 30 days following the date of final study medication administration, or AEs whose intensity worsened on or after the date of first dose of study medication and within 30 days following the date of last dose. (NCT01243177)
Timeframe: Duration of the Treatment Phase (up to 113 weeks)
| Intervention | Participants (Number) |
|---|---|
| Lacosamide | 47 |
| Carbamazepine-Controlled Release (CBZ-CR) | 69 |
An Adverse Event is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. Treatment-emergent AEs were defined as AEs that started on or after the date of first dose of study medication and within 30 days following the date of final study medication administration, or AEs whose intensity worsened on or after the date of first dose of study medication and within 30 days following the date of last dose. (NCT01243177)
Timeframe: Duration of the Treatment Phase (up to 113 weeks)
| Intervention | Participants (Number) |
|---|---|
| Lacosamide | 328 |
| Carbamazepine-Controlled Release (CBZ-CR) | 332 |
"An Adverse Event is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign, symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product.~A Serious Adverse Event must meet 1 or more predefined criteria like death, life-threatening, etc. Treatment-emergent AEs were defined as AEs that started on or after the date of first dose of study medication and within 30 days following the date of final study medication administration, or AEs whose intensity worsened on or after the date of first dose of study medication and within 30 days following the date of last dose." (NCT01243177)
Timeframe: Duration of the Treatment Phase (up to 113 weeks)
| Intervention | Participants (Number) |
|---|---|
| Lacosamide | 32 |
| Carbamazepine-Controlled Release (CBZ-CR) | 43 |
The proportion of subjects remaining seizure free for 6 months (26 weeks) was estimated using Kaplan-Meier methods. (NCT01243177)
Timeframe: 6 consecutive months (26 consecutive weeks) of treatment following stabilization at the last evaluated dose for each subject
| Intervention | percentage of subjects (Number) |
|---|---|
| Lacosamide | 89.8 |
| Carbamazepine-Controlled Release (CBZ-CR) | 91.1 |
The proportion of subjects remaining seizure free for 6 months (26 weeks) was estimated using Kaplan-Meier methods. (NCT01243177)
Timeframe: 6 consecutive months (26 consecutive weeks) of treatment
| Intervention | percentage of subjects (Number) |
|---|---|
| Lacosamide | 91.4 |
| Carbamazepine-Controlled Release (CBZ-CR) | 92.8 |
The proportion of subjects remaining seizure free for 12 months (52 weeks) was estimated using Kaplan-Meier methods. (NCT01243177)
Timeframe: 12 consecutive months of treatment following stabilization at the last evaluated dose for each subject
| Intervention | percentage of subjects (Number) |
|---|---|
| Lacosamide | 77.8 |
| Carbamazepine-Controlled Release (CBZ-CR) | 82.7 |
"There are three different types of seizures:~Type I: Partial seizures~Type II: Generalized seizures~Type III: Unclassified epileptic seizures.~All seizure frequency per week over Treatment Period (TP) was calculated as: (Total number of seizures over the TP)*7/(Total number of days with no missing seizure count in the TP)" (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | seizures per week (Median) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 2.15 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 1.80 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 1.96 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 1.77 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00464269)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 2.79 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 4.26 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 6.36 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 3.37 |
"The Quality of Life in Epilepsy Inventory-Form 31 (QOLIE-31-P) is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-items subscales - seizure worry (5 items), overall quality of life (2 items), emotional well-being (5 items), energy / fatigue (4 items), cognitive functioning (6 items), medication effects (3 items), and social function (5 items) - and a health status item.~The subscale scores, the total score and the health status item score range from 0 to 100 and higher scores indicating better function." (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 1.97 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 7.03 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 7.73 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 2.06 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00464269)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 2.14 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 1.69 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 2.07 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 1.97 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00464269)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 6.41 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 2.24 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 3.94 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 0.45 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00464269)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 8.1 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 6.9 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 7.3 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 5.5 |
The Hospital Anxiety and Depression Scale (HADS) was used to evaluate anxiety and depression. The HADS was developed as a self administered scale to assess the presence and severity of both anxiety and depression simultaneously. It consists of 14 items that are scored on a 4-point severity scale ranging from 0 to 3. A score per dimension was calculated with each score ranging from 0 to 21 and higher scores indicating higher depression / anxiety. A negative value in change from Baseline shows an improvement in HADS from Baseline. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 7.44 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 7.32 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 6.55 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 7.99 |
The Hospital Anxiety and Depression Scale (HADS) was used to evaluate anxiety and depression. The HADS was developed as a self administered scale to assess the presence and severity of both anxiety and depression simultaneously. It consists of 14 items that are scored on a 4-point severity scale ranging from 0 to 3. A score per dimension was calculated with each score ranging from 0 to 21 and higher scores indicating higher depression / anxiety. A negative value in change from Baseline shows an improvement in HADS from Baseline. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 5.36 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 4.97 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 4.82 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 5.81 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00464269)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 1.02 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | -2.61 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 0.73 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 6.07 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00464269)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 5.49 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 3.39 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 3.66 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 2.33 |
"The Quality of Life in Epilepsy Inventory-Form 31 (QOLIE-31-P) is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-items subscales - seizure worry (5 items), overall quality of life (2 items), emotional well-being (5 items), energy / fatigue (4 items), cognitive functioning (6 items), medication effects (3 items), and social function (5 items) - and a health status item.~The subscale scores, the total score and the health status item score range from 0 to 100 and higher scores indicating better function." (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 9.36 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 3.34 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 3.69 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 5.97 |
"The Quality of Life in Epilepsy Inventory-Form 31 (QOLIE-31-P) is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-items subscales - seizure worry (5 items), overall quality of life (2 items), emotional well-being (5 items), energy / fatigue (4 items), cognitive functioning (6 items), medication effects (3 items), and social function (5 items) - and a health status item.~The subscale scores, the total score and the health status item score range from 0 to 100 and higher scores indicating better function." (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 3.88 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 4.07 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 5.19 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 2.88 |
"Partial (Type I) seizures can be classified into one of the following three groups:~Simple partial seizures~Complex partial seizures~Partial seizures evolving to generalized tonic-clonic convulsions.~Partial Onset Seizure (POS) Frequency per week over the Treatment Period (TP) was calculated as:~(Total Type I seizures over the TP)*7/(Total number of days with no missing seizure count in the TP)" (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | seizures per week (Median) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 2.15 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 1.80 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 1.96 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 1.70 |
"Percent change from Baseline was calculated as percent reduction by:~(weekly seizure frequency Baseline - weekly seizure frequency Treatment)*100/(weekly seizure frequency Baseline).~The higher the values for percent change in Partial Onset Seizure (POS) frequency, the higher the improvement from Baseline." (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | Percent change in POS frequency (Median) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 17.75 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 19.95 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 22.52 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 30.47 |
The type IC/Type I seizure frequency ratio is represented by the percentage of subjects having a reduction in the ratio of Type IC seizure frequency over Type IA, IB, and IC seizure frequency from Baseline to Treatment Period. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | percentage of participants (Number) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 56.3 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 50.0 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 77.8 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 63.6 |
The time to fifth Partial Onset Seizure (POS) in the Treatment Period is defined as the time between beginning of the Treatment Period and the date of occurrence of fifth Type I seizure. Subjects withdrawing during the Treatment Period before having a fifth Type I seizure were considered as having a fifth Type I seizure on the last day of their Treatment Period. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | days (Median) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 15 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 14 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 17 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 19 |
The time to first Partial Onset Seizure (POS) in the Treatment Period is defined as the time between beginning of the Treatment Period and the date of occurrence of first Type I seizure. Subjects withdrawing during the Treatment Period before having a first Type I seizure were considered as having a first Type I seizure on the last day of their Treatment Period. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | days (Median) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 3 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 4 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 5 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 4 |
The time to tenth Partial Onset Seizure (POS) in the Treatment Period is defined as the time between beginning of the Treatment Period and the date of occurrence of tenth Type I seizure. Subjects withdrawing during the Treatment Period before having a tenth Type I seizure were considered as having a tenth Type I seizure on the last day of their Treatment Period. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | days (Median) |
|---|---|
| Modified Intention-to-Treat (Placebo Treated Subjects) | 28 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 30 |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 34 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 37 |
"Subjects were classified in 1 of the following categories based on their percent reduction from Baseline to Treatment Period in Partial Onset Seizure (POS) frequency per week: <-25 %, -25 % to <25 %, 25 % to <50 %, 50 % to <75 %, 75 % to <100 %, and 100 %.~Subjects having zero for Baseline seizure frequency per week were classified in the <-25 % category." (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | percentage of participants (Number) | |||||
|---|---|---|---|---|---|---|
| <-25 % | -25 % to < 25 % | 25 % to < 50 % | 50 % to < 75 % | 75 % to < 100 % | 100 % | |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 14.1 | 38.4 | 24.2 | 15.2 | 6.1 | 2.0 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 21.9 | 31.3 | 25.0 | 12.5 | 8.3 | 1.0 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 9.9 | 31.7 | 25.7 | 19.8 | 8.9 | 4.0 |
| Modified Intention-to-Treat (Placebo Treated Subjects) | 14.6 | 44.8 | 24.0 | 12.5 | 4.2 | 0 |
The Investigator's Global Evaluation Scale (I-GES) is a global assessment of the disease evolution which was performed using a seven-point scale (1 = Marked worsening to 7 = Marked improvement) with the start of the study medication as the reference time point. The investigator completed it by answering to the following: 'Assess the overall change in the severity of patient's illness, compared to start of study medication.' (NCT00464269)
Timeframe: Baseline to Last Visit or Early Discontinuation Visit in the 12-week Treatment Period
| Intervention | percentage of participants (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Marked improvement | Moderate improvement | Slight improvement | No change | Slight worsening | Moderate worsening | Marked worsening | |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 17.2 | 18.2 | 31.3 | 32.3 | 1.0 | 0 | 0 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 12.2 | 18.9 | 24.4 | 34.4 | 2.2 | 7.8 | 0 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 16.3 | 27.6 | 24.5 | 25.5 | 2.0 | 3.1 | 1.0 |
| Modified Intention-to-Treat (Placebo Treated Subjects) | 12.6 | 20.0 | 21.1 | 41.1 | 3.2 | 1.1 | 1.1 |
Patient's Global Evaluation Scale (P-GES) is a global assessment of the disease evolution which was performed using a seven-point scale (1= Marked worsening to 7 = Marked improvement) with the start of the study medication as the reference time point. The subject completed it by answering to the following: 'Overall, has there been a change in your seizures since the start of the study medication?' (NCT00464269)
Timeframe: Baseline to Last Visit or Early Discontinuation Visit in the 12-week Treatment Period
| Intervention | percentage of participants (Number) | ||||||
|---|---|---|---|---|---|---|---|
| Marked improvement | Moderate improvement | Slight improvement | No change | Slight worsening | Moderate worsening | Marked worsening | |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 18.8 | 26.3 | 21.3 | 27.5 | 1.3 | 3.8 | 1.3 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 19.8 | 24.7 | 18.5 | 23.5 | 6.2 | 7.4 | 0 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 26.7 | 19.8 | 22.1 | 23.3 | 4.7 | 1.2 | 2.3 |
| Modified Intention-to-Treat (Placebo Treated Subjects) | 15.5 | 25.0 | 23.8 | 28.6 | 4.8 | 1.2 | 1.2 |
The responder rate was presented as the number of responders and non-responders. A subject is a responder, if the subject has at least 50 % reduction in partial onset seizure frequency per week from Baseline to Treatment Period. Subjects with zero seizure frequency per week at Baseline were considered as non-responders. (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | participants (Number) | |
|---|---|---|
| Responders | Non-responders | |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 23 | 76 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 21 | 75 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 33 | 68 |
| Modified Intention-to-Treat (Placebo Treated Subjects) | 16 | 80 |
"Subjects were considered seizure free if their seizure counts for every day over the Treatment Period (TP) was zero and if they did not discontinue before the end of the TP. Seizure freedom rate was calculated as:~(total number of seizure - free subjects in treatment group during TP)/(total number of evaluable Intent-To-Treat (ITT) subjects in treatment group)" (NCT00464269)
Timeframe: Baseline to 12-week Treatment Period
| Intervention | percentage of participants (Number) | ||
|---|---|---|---|
| Seizure-free | No seizures but non-completer | Not seizure-free | |
| Modified Intention-to-Treat (BRV 20 mg/Day Treated Subjects) | 1.0 | 1.0 | 98.0 |
| Modified Intention-to-Treat (BRV 5 mg/Day Treated Subjects) | 1.0 | 0 | 99.0 |
| Modified Intention-to-Treat (BRV 50 mg/Day Treated Subjects) | 4.0 | 0 | 96.0 |
| Modified Intention-to-Treat (Placebo Treated Subjects) | 0 | 0 | 100.0 |
(NCT01261325)
Timeframe: 12 week Treatment Period
| Intervention | number of seizures/ 28-day (Median) |
|---|---|
| Placebo | 8.7 |
| Brivaracetam 100 mg/Day | 6.3 |
| Brivaracetam 200 mg/Day | 5.8 |
(NCT01261325)
Timeframe: Baseline to 12 week Treatment Period
| Intervention | percentage of change (Median) |
|---|---|
| Placebo | 17.6 |
| Brivaracetam 100 mg/Day | 37.2 |
| Brivaracetam 200 mg/Day | 35.6 |
Primary endpoint: United States of America (FDA) (NCT01261325)
Timeframe: 12 week Treatment Period
| Intervention | Percentage of reduction (Number) |
|---|---|
| Brivaracetam 100 mg/Day | 22.8 |
| Brivaracetam 200 mg/Day | 23.2 |
| Placebo | 0 |
(NCT01261325)
Timeframe: 12 week Treatment Period
| Intervention | days (Median) |
|---|---|
| Placebo | 16 |
| Brivaracetam 100 mg/Day | 21 |
| Brivaracetam 200 mg/Day | 23 |
(NCT01261325)
Timeframe: 12 week Treatment Period
| Intervention | days (Median) |
|---|---|
| Placebo | 3 |
| Brivaracetam 100 mg/Day | 5 |
| Brivaracetam 200 mg/Day | 6 |
(NCT01261325)
Timeframe: 12 week Treatment Period
| Intervention | days (Median) |
|---|---|
| Placebo | 32 |
| Brivaracetam 100 mg/Day | 37 |
| Brivaracetam 200 mg/Day | 43 |
Primary Endpoint: European Regulatory Authorities A responder is a participant who experienced a 50% or greater reduction in partial onset seizure (Type I) frequency over the Treatment Period standardized to a 28-day duration. (NCT01261325)
Timeframe: Baseline to 12 week Treatment Period
| Intervention | Percentage of subjects (Number) | |
|---|---|---|
| Responders | Non-Responders | |
| Brivaracetam 100 mg/Day | 38.9 | 61.1 |
| Brivaracetam 200 mg/Day | 37.8 | 62.2 |
| Placebo | 21.6 | 78.4 |
(NCT01261325)
Timeframe: Baseline to 12 week Treatment Period
| Intervention | percentage of subjects (Number) | |||||
|---|---|---|---|---|---|---|
| <-25 % | -25 % to <25 % | 25 % to <50 % | 50 % to <75 % | 75 % to <100 % | 100 % | |
| Brivaracetam 100 mg/Day | 14.3 | 28.6 | 18.3 | 19.0 | 13.9 | 6.0 |
| Brivaracetam 200 mg/Day | 10.8 | 29.3 | 22.1 | 18.1 | 13.7 | 6.0 |
| Placebo | 16.6 | 40.5 | 21.2 | 13.9 | 6.9 | 0.8 |
(NCT01261325)
Timeframe: 12 week Treatment Period
| Intervention | percentage of subjects (Number) | ||
|---|---|---|---|
| Seizure free | No seizures but discontinued | Not seizure free | |
| Brivaracetam 100 mg/Day | 5.2 | 1.2 | 93.7 |
| Brivaracetam 200 mg/Day | 4.0 | 1.2 | 94.8 |
| Placebo | 0.8 | 0.4 | 98.8 |
There are three types of Epilepsy: Partial Epilepsies (Type I), Generalized Epilepsies (Type II) and uncertain classification of Epilepsies (Type III). (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Times per week (Median) |
|---|---|
| Placebo | 1.75 |
| Brivaracetam 20 mg/Day | 1.34 |
| Brivaracetam 50 mg/Day | 1.49 |
| Brivaracetam 100 mg/Day | 1.26 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 1.80 |
| Brivaracetam 20 mg/Day | 5.36 |
| Brivaracetam 50 mg/Day | 1.02 |
| Brivaracetam 100 mg/Day | 0.69 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | -2.09 |
| Brivaracetam 20 mg/Day | 3.35 |
| Brivaracetam 50 mg/Day | 3.09 |
| Brivaracetam 100 mg/Day | 3.50 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 3.80 |
| Brivaracetam 20 mg/Day | 3.75 |
| Brivaracetam 50 mg/Day | 3.13 |
| Brivaracetam 100 mg/Day | -2.45 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 3.49 |
| Brivaracetam 20 mg/Day | 3.53 |
| Brivaracetam 50 mg/Day | 1.95 |
| Brivaracetam 100 mg/Day | 1.99 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 6.6 |
| Brivaracetam 20 mg/Day | 6.9 |
| Brivaracetam 50 mg/Day | 9.7 |
| Brivaracetam 100 mg/Day | 4.9 |
The Hospital Anxiety and Depression Scale (HADS) was used to evaluate anxiety and depression simultaneously. The HADS was developed as a self-administered scale that has been designed to assess the presence and severity of both anxiety and depression. It consists of 14 items that are scored on a 4-point severity scale ranging from 0 to 3. A score per dimension was calculated with each score ranging from 0 to 21 and higher scores indicating higher depression / anxiety. Negative values in Change from Baseline indicate a decrease of HADS from Baseline to Treatment Period. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | -1.54 |
| Brivaracetam 20 mg/Day | -0.59 |
| Brivaracetam 50 mg/Day | -0.41 |
| Brivaracetam 100 mg/Day | 0.08 |
The Hospital Anxiety and Depression Scale (HADS) was used to evaluate anxiety and depression simultaneously. The HADS was developed as a self-administered scale that has been designed to assess the presence and severity of both anxiety and depression. It consists of 14 items that are scored on a 4-point severity scale ranging from 0 to 3. A score per dimension was calculated with each score ranging from 0 to 21 and higher scores indicating higher depression / anxiety. Negative values in Change from Baseline indicate a decrease of HADS from Baseline to Treatment Period. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | -0.65 |
| Brivaracetam 20 mg/Day | -0.10 |
| Brivaracetam 50 mg/Day | 0.26 |
| Brivaracetam 100 mg/Day | -0.24 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 0.92 |
| Brivaracetam 20 mg/Day | 3.64 |
| Brivaracetam 50 mg/Day | -0.85 |
| Brivaracetam 100 mg/Day | 3.00 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 5.11 |
| Brivaracetam 20 mg/Day | 4.52 |
| Brivaracetam 50 mg/Day | 4.55 |
| Brivaracetam 100 mg/Day | 2.24 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 8.25 |
| Brivaracetam 20 mg/Day | 6.23 |
| Brivaracetam 50 mg/Day | 5.34 |
| Brivaracetam 100 mg/Day | 8.04 |
The QOLIE-31-P is an adaptation of the original QOLIE-31 instrument that includes 30 items grouped into seven multi-item subscales - Seizure Worry (5 items), Overall Quality of Life (2 items), Emotional Well-Being (5 items), Energy/Fatigue (4 items), Cognitive Functioning (6 items), Medication Effects (3 items) and Daily Activities/Social Functioning (5 items) - and a Health Status item. The subscale scores, the Total score and the Health Status item score are calculated according to the scoring algorithm defined by the author with scores ranging from 0 to 100 and higher scores indicating better function. A positive value in Change from Baseline indicates an improvement from Baseline. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 2.29 |
| Brivaracetam 20 mg/Day | 4.50 |
| Brivaracetam 50 mg/Day | 3.09 |
| Brivaracetam 100 mg/Day | 1.78 |
"The Investigator's Global Evaluation Scale (I-GES) is a global assessment of the disease evolution which was performed using a seven-point scale (1 = Marked worsening to 7 = Marked improvement), with the start of the study medication as reference time point. The Investigator was to complete it by answering the following question: Assess the Overall change in the severity of patient's illness, compared to start of study medication." (NCT00490035)
Timeframe: Last Visit or Early Discontinuation Visit in the 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 4.78 |
| Brivaracetam 20 mg/Day | 4.99 |
| Brivaracetam 50 mg/Day | 4.99 |
| Brivaracetam 100 mg/Day | 5.34 |
Partial (Type I) Seizures can be classified into one of the following three groups: Simple Partial Seizures, Complex Partial Seizures, Partial Seizures evolving to Secondarily Generalized Seizures. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Seizure Frequency per Week (Median) |
|---|---|
| Placebo | 1.75 |
| Brivaracetam 20 mg/Day | 1.34 |
| Brivaracetam 50 mg/Day | 1.49 |
| Brivaracetam 100 mg/Day | 1.26 |
"The Patient's Global Evaluation Scale (P-GES) is a global assessment of the disease evolution which was performed using a seven-point scale (1 = Marked worsening to 7 = Marked improvement) with the start of the study medication as the reference time point. The subject not mentally impaired had to complete it by answering the following question: Overall, has there been a change in your seizures since the start of the study medication?" (NCT00490035)
Timeframe: Last Visit or Early Discontinuation Visit in the 12-week Treatment Period
| Intervention | units on a scale (Mean) |
|---|---|
| Placebo | 4.93 |
| Brivaracetam 20 mg/Day | 5.17 |
| Brivaracetam 50 mg/Day | 5.04 |
| Brivaracetam 100 mg/Day | 5.47 |
The percent change from Baseline was computed as: Weekly Seizure Frequency (Treatment) - Weekly Seizure Frequency (Baseline) / Weekly Seizure Frequency (Baseline) * 100. Negative values indicate a reduction from Baseline with higher negative values showing higher reduction. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Percent change in seizures per week (Median) |
|---|---|
| Placebo | -17.03 |
| Brivaracetam 20 mg/Day | -30.03 |
| Brivaracetam 50 mg/Day | -26.83 |
| Brivaracetam 100 mg/Day | -32.45 |
The type IC/Type I seizure frequency ratio is represented by the percentage of subjects having a reduction in the ratio of Type IC seizure frequency over Type IA, IB, and IC seizure frequency from Baseline to Treatment Period. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | percentage of participants (Number) |
|---|---|
| Placebo | 45.9 |
| Brivaracetam 20 mg/Day | 47.2 |
| Brivaracetam 50 mg/Day | 62.5 |
| Brivaracetam 100 mg/Day | 41.0 |
The time to Fifth Type I Seizure during the 12-week Treatment Period was measured in days. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Days (Median) |
|---|---|
| Placebo | 19 |
| Brivaracetam 20 mg/Day | 25 |
| Brivaracetam 50 mg/Day | 24 |
| Brivaracetam 100 mg/Day | 24 |
The time to first Type I Seizure during the 12-week Treatment Period was measured in days. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Days (Median) |
|---|---|
| Placebo | 4 |
| Brivaracetam 20 mg/Day | 6 |
| Brivaracetam 50 mg/Day | 6 |
| Brivaracetam 100 mg/Day | 4 |
The time to tenth Type I Seizure during the 12-week Treatment Period was measured in days. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Days (Median) |
|---|---|
| Placebo | 39 |
| Brivaracetam 20 mg/Day | 49 |
| Brivaracetam 50 mg/Day | 40 |
| Brivaracetam 100 mg/Day | 46 |
"The categories are:~<= 25 %~- 25 % to < 25 %~25 % to < 50 %~50 % to < 75 %~75 % to < 100 %~100 %" (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Percentage of Participants (Number) | |||||
|---|---|---|---|---|---|---|
| <= 25 % | - 25 % to < 25 % | 25 % to < 50 % | 50 % to < 75 % | 75 % to < 100 % | 100 % | |
| Brivaracetam 100 mg/Day | 10.0 | 33.0 | 21.0 | 14.0 | 18.0 | 4.0 |
| Brivaracetam 20 mg/Day | 10.1 | 35.4 | 27.3 | 18.2 | 7.1 | 2.0 |
| Brivaracetam 50 mg/Day | 15.2 | 33.3 | 24.2 | 17.2 | 9.1 | 1.0 |
| Placebo | 19.0 | 41.0 | 20.0 | 12.0 | 8.0 | 0 |
"Responders are those subjects with at least 50 % reduction from Baseline to Treatment Period in Partial Onset Seizure frequency per week.~The Responder Rate for Partial Onset Seizures (Type I) is the proportion of subjects who have a >= 50 % reduction in seizure frequency per week from Baseline." (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Percentage of Participants (Number) | |
|---|---|---|
| Non-responders | Responders | |
| Brivaracetam 100 mg/Day | 64.0 | 36.0 |
| Brivaracetam 20 mg/Day | 72.7 | 27.3 |
| Brivaracetam 50 mg/Day | 72.7 | 27.3 |
| Placebo | 80.0 | 20.0 |
Subjects were considered seizure free if their seizure counts for every day over the entire Treatment Period was zero and if they completed the Treatment Period. (NCT00490035)
Timeframe: From Baseline to 12-week Treatment Period
| Intervention | Percentage of Participants (Number) | ||
|---|---|---|---|
| Seizure free | No Seizures but non-completer | Not Seizure-free | |
| Brivaracetam 100 mg/Day | 4.0 | 0 | 96.0 |
| Brivaracetam 20 mg/Day | 2.0 | 0 | 98.0 |
| Brivaracetam 50 mg/Day | 0 | 1.0 | 99.0 |
| Placebo | 0 | 0 | 100.0 |
(NCT01128959)
Timeframe: Baseline to after last iv dose on day 4
| Intervention | Number of adverse events (Number) |
|---|---|
| Intravenous Carbamazepine (IV CBZ) 15 Minutes Infusion | 126 |
| Intravenous Carbamazepine (IV CBZ) 5 Minutes Infusion | 26 |
(NCT00438451)
Timeframe: 58 weeks
| Intervention | proportion of participants (Mean) |
|---|---|
| Levetiracetam | 0.61 |
| Carbamazepine | 0.46 |
| Lamotrigine | 0.56 |
Percentage of patients experiencing no seizures until week 58 (Visit 6) and did not discontinue the study until week 58. (NCT00438451)
Timeframe: week 58
| Intervention | percentage of participants (Number) |
|---|---|
| Levetiracetam | 43 |
| Carbamazepine | 33 |
| Lamotrigine | 38 |
Percentage of patients experiencing no seizures until week 30 (Visit 4) and did not discontinue the study until week 30. (NCT00438451)
Timeframe: Week 30
| Intervention | percentage of participants (Number) |
|---|---|
| Levetiracetam | 48 |
| Carbamazepine | 39 |
| Lamotrigine | 49 |
(NCT00438451)
Timeframe: 52 weeks
| Intervention | proportion of seizure-free days (Number) |
|---|---|
| Levetiracetam | 0.99 |
| Carbamazepine | 0.99 |
| Lamotrigine | 0.99 |
EPITrack-Score shows the performance of attention and executive functions. Higher values indicate a better performance. The results of EPITrack Score ranges between 7 and 45. (NCT00438451)
Timeframe: week 58
| Intervention | units on a scale (Mean) |
|---|---|
| Levetiracetam | 26.0 |
| Carbamazepine | 26.0 |
| Lamotrigine | 25.4 |
"Seizure frequency was assessed by investigators in the CRF at the Visits V3, V4, V5 and V6.~The absolute seizure frequency during the maintenance phase was defined as the sum of those entries." (NCT00438451)
Timeframe: over 52 weeks
| Intervention | number of seizures (Number) |
|---|---|
| Levetiracetam | 168 |
| Carbamazepine | 131 |
| Lamotrigine | 130 |
(NCT00438451)
Timeframe: over the whole duration of 58 weeks
| Intervention | days (Median) |
|---|---|
| Levetiracetam | NA |
| Carbamazepine | NA |
| Lamotrigine | NA |
number of days between randomization and premature discontinuation of the study (NCT00438451)
Timeframe: 58 weeks
| Intervention | days (Median) |
|---|---|
| Levetiracetam | NA |
| Carbamazepine | 265 |
| Lamotrigine | NA |
"The PNS is a 15-item scale. Each item can be scored from 1 to 9. There are a total score (includes all items, range:15 to 135) and two subscores: The cognitive toxicity subscore (10 items: Energy Level, Memory, Interest, Concentration, Forgetfulness, Sleepliness, Moodiness, Alertness, Attention Span, Motivation, range:10 to 90) and the somatomoto subscore (5 items: Vision, Walking, Coordination, Tremor, Speech, range:5-45). The score is calculated by taking the mean of all non-missing values times the number of items.~Lower values indicate better quality of life." (NCT00438451)
Timeframe: at week 58
| Intervention | units on a scale (Mean) | ||
|---|---|---|---|
| Cognitive toxicity subscore | Somatomotor subscore | Total Score | |
| Carbamazepine | 27.3 | 11.4 | 38.7 |
| Lamotrigine | 23.7 | 10.8 | 34.5 |
| Levetiracetam | 22.2 | 10.5 | 32.7 |
The QOLIE-31 is a 31 item score that measures the quality of life in epilepsy (each item with a range of 0 to 100). There are 7 sub-scores seizure worry (items 11,21,22,23,25), overall quality of life (items 1,14), emotional well-being (items 3,4,5,7,9), energy/fatigue (items 2,6,8,10), cognitive functioning (items 12,15,16,17,18,26), medication effects (items 24,29,30) and social functioning (13,19,20,27,28). These scores were combined to a total score by Total score = seizure worry*0.08 + overall quality of life*0.14 + emotional well-being*0.15 + energy/fatigue*0.12 + cognitive functioning*0.27 + medication effects*0.03 + social functioning*0.21 For all scores, higher values indicate better quality of life. Each score has a possible range from 0 to 100. (NCT00438451)
Timeframe: 58 weeks, final visit
| Intervention | units on a scale (Mean) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Seizure worry | Overall quality of life | Emotional well-being | Energy/fatigue | Cognitive functioning | Medication effects | Social functioning | Total Score | Health Scale | |
| Carbamazepine | 75.4 | 65.0 | 69.8 | 54.5 | 68.9 | 70.6 | 76.3 | 68.9 | 65.7 |
| Lamotrigine | 75.0 | 67.1 | 67.4 | 59.8 | 68.0 | 72.6 | 76.7 | 69.1 | 67.5 |
| Levetiracetam | 85.1 | 67.2 | 72.0 | 60.8 | 75.1 | 77.6 | 81.1 | 73.9 | 69.5 |
"Evaluation of current testing at V6:~≥29 score points: Inconspicuous; 26 to 28 score points: Borderline;~≤25 score points: Impaired" (NCT00438451)
Timeframe: 58 weeks
| Intervention | participants (Number) | ||
|---|---|---|---|
| Without pathological findings | Borderline | Impaired | |
| Carbamazepine | 34 | 17 | 33 |
| Lamotrigine | 31 | 15 | 39 |
| Levetiracetam | 38 | 10 | 36 |
"Evaluation of Changes~Changes in the EpiTrack® Score were categorized as follows:~≥5 score points: Improved;~-3 to 4 score points: Unchanged;~≤-4 score points: Worsened" (NCT00438451)
Timeframe: week 58
| Intervention | participants (Number) | ||
|---|---|---|---|
| Improved | Unchanged | Worsened | |
| Carbamazepine | 16 | 56 | 8 |
| Lamotrigine | 15 | 53 | 13 |
| Levetiracetam | 15 | 61 | 6 |
The secondary outcome measure is the change in number of absence seizures from Week 8 (Baseline) to Week 12 (NCT01607073)
Timeframe: Week 8 to Week 12
| Intervention | Abscence seizures (Number) |
|---|---|
| Week 8 Baseline | 165 |
| Week 12 Verapamil 4mg/kg/Day | 101 |
The primary study endpoint is the change in number of seizures from baseline. Since we only had one participant finish the study, the endpoint was changed to Week 12 visit. Participants were on verapamil for 4 weeks at Week 12. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
| Intervention | General tonic-clonic seizures (Number) |
|---|---|
| Week 8 Baseline | 39 |
| Week 12 Verapamil 4mg/kg/Day | 14 |
The secondary outcome is the change in number of myoclonic seizures between baseline Week 8 visit and Week 12 visit. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
| Intervention | Myoclonic seizures (Number) |
|---|---|
| Week 8 Baseline | 116 |
| Week 12 Verapamil 4mg/kg/Day | 175 |
Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Mean change from baseline AEP Score at 12 months
| Intervention | Units on a scale (Mean) |
|---|---|
| VNS Therapy | -6.0 |
| Best Medical Practice | -3.2 |
The Center for Epidemiologic Studies Depression Scale (CES-D) includes 20 items comprising six scales reflecting major dimensions of depression: depressed mood, feelings of guilt and worthlessness, feelings of helplessness and hopelessness, psychomotor retardation, loss of appetite, and sleep disturbance. Possible range of scores is 0 to 60, higher scores indicate more depressive symptoms. (NCT00522418)
Timeframe: Mean change from baseline CES-D Score at 12 months
| Intervention | Units on a Scale (Mean) |
|---|---|
| VNS Therapy | -2.2 |
| Best Medical Practice | 0.5 |
The Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) is a 6-item questionnaire validated to screen for depression in people with epilepsy. Scores range from 6 to 24, with higher scores indicating more depressive symptoms. (NCT00522418)
Timeframe: Mean change from baseline NDDI-E Score at 12 months
| Intervention | Units on a Scale (Mean) |
|---|---|
| VNS Therapy | -1.0 |
| Best Medical Practice | -0.2 |
Change from baseline in number of AED medications by visit (NCT00522418)
Timeframe: Change from baseline in number of AEDs at 12 months
| Intervention | Number of AEDs Taken (Median) |
|---|---|
| VNS Therapy | 0 |
| Best Medical Practice | 0 |
The Clinical Global Impression scale (CGI-I) is a 7 point scale that requires the clinician to assess how much the patient's illness has improved or worsened relative to a baseline state at the beginning of the intervention Scores range from 1-7: 1, very much improved; 2, much improved; 3, minimally improved; 4, no change; 5, minimally worse; 6, much worse; or 7, very much worse. (NCT00522418)
Timeframe: Mean change from baseline CGI-I Score at 12 months
| Intervention | Units on a Scale (Mean) |
|---|---|
| VNS Therapy | -0.8 |
| Best Medical Practice | -0.3 |
Percent change in total seizuires per week from baseline at 12 months (NCT00522418)
Timeframe: Mean percent change from baseline in seizure frequency at 12 months
| Intervention | Percent Change (Mean) |
|---|---|
| VNS Therapy | -19.1 |
| Best Medical Practice | -1.0 |
QOLIE-89 contains 17 multi-item measures of overall quality of life, emotional well-being, role limitations due to emotional problems, social support, social isolation, energy/fatigue, worry about seizure, medication effects, health discouragement, work/driving/social function, attention/concentration, language, memory, physical function, pain, role limitations due to physical problems, and health perceptions. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. (NCT00522418)
Timeframe: Mean change from baseline QOLIE-89 Overall Score at 12 months
| Intervention | units on a scale (Mean) |
|---|---|
| VNS Therapy | 5.5 |
| Best Medical Practice | 1.2 |
Response Rate is defined as the percent of participants who are responders. A Responder is defined as participants with a reduction of at least 50% or 75% in seizure frequency from baseline to the seizure count evaluation period. (NCT00522418)
Timeframe: Number of Responders at 12 Months
| Intervention | participants (Number) |
|---|---|
| VNS Therapy | 10 |
| Best Medical Practice | 7 |
QOLIE-89 contains 17 multi-item measures of overall quality of life. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Change from baseline up to 12 months
| Intervention | units on a scale (Least Squares Mean) | |
|---|---|---|
| VNS Therapy | Best Medical Practice | |
| Baseline Adverse Event Profile Score < 40 | 3.3 | 0.5 |
QOLIE-89 contains 17 multi-item measures of overall quality of life. Range of values 0-100. Higher scores reflect better quality of life; lower ones, worse quality of life. Adverse Events Profile (AEP) is a 19-item scale used as a systematic measure of adverse effects from antiepileptic drugs (AEDs). Scores range from 19-76; higher scores indicate high prevelance and severity of adverse events. (NCT00522418)
Timeframe: Change from baseline up to 12 months
| Intervention | Units on a Scale (Least Squares Mean) | |
|---|---|---|
| VNS Therapy | Best Medical Practice | |
| Baseline Adverse Event Profile Score >= 40 | 3.3 | 0.7 |
291 reviews available for carbamazepine and Aura
| Article | Year |
|---|---|
Medicinal chemistry of neuronal voltage-gated sodium channel blockers.
Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Mo | 2001 |
Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients.
Topics: Anticonvulsants; Cannabidiol; Carbamazepine; Clobazam; COVID-19; COVID-19 Drug Treatment; Drug Inter | 2021 |
Association of ABCB1 polymorphisms with carbamazepine metabolism and resistance in epilepsy: A meta-analysis.
Topics: Asian People; ATP Binding Cassette Transporter, Subfamily B; Carbamazepine; Epilepsy; Genetic Predis | 2021 |
Antiseizure medications and thyroid hormone homeostasis: Literature review and practical recommendations.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Homeosta | 2022 |
Impact of carbamazepine on vitamin D levels: A meta-analysis.
Topics: Carbamazepine; Epilepsy; Humans; Vitamin D; Vitamin D Deficiency; Vitamins | 2021 |
Is the prevalence of thyroid disease higher in children receiving antiepileptic medication? A systematic review and meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Levetiracetam; Prevalence; Thyroid Diseases | 2022 |
Oxcarbazepine versus Carbamazepine for the Treatment of Post-Stroke Epilepsy: A Systematic Review and Meta-Analysis.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine | 2022 |
Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Clonazepam; Epilepsy; Humans; Seizures | 2022 |
The ABCB1, ABCC2 and RALBP1 polymorphisms are associated with carbamazepine response in epileptic patient: a systematic review.
Topics: Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; C | 2022 |
Side effects of long-term oral anti-seizure drugs on thyroid hormones in patients with epilepsy: a systematic review and network meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lamotrigine; Levetiracetam; Network Meta-Analysis; | 2022 |
The interplay of epilepsy with impaired mitophagy and autophagy linked dementia (MAD): A review of therapeutic approaches.
Topics: Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Felbamate; Gabapentin; Humans; Inflammasomes; La | 2022 |
Anti-seizure efficacy and retention rate of carbamazepine is highly variable in randomized controlled trials: A meta-analysis.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Humans; Randomized Controlled Trials as T | 2022 |
Characteristics of people with epilepsy in three Eastern African countries - a pooled analysis.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Humans; Male; Neur | 2022 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Eve | 2022 |
Effects of common antiepileptic drugs on teleost fishes.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Ecosystem; Epilepsy; Fishes; Humans | 2023 |
Second Generation of Antiepileptic Drugs and Oxidative Stress.
Topics: Anticonvulsants; Carbamazepine; Diazepam; Epilepsy; Epilepsy, Generalized; Fructose; Gabapentin; Hum | 2023 |
Should antiseizure medications be withdrawn after an extended period of seizure freedom in individuals with adult-onset epilepsy?
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; | 2023 |
Pharmacogenomics of oxcarbazepine in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine; Pharmacogenetics | 2023 |
The complexities underlying epilepsy in people with glioblastoma.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Glioblastoma; | 2023 |
Gabapentin monotherapy for epilepsy: A review.
Topics: Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Gabapentin; | 2023 |
Antiepileptic drugs: evolution of our knowledge and changes in drug trials.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Epilepsy, Generalized; Epileptic Syndrome | 2019 |
Effects of Second-Generation Antiepileptic Drugs Compared to First-Generation Antiepileptic Drugs on Bone Metabolism in Patients with Epilepsy: A Meta-Analysis.
Topics: Anticonvulsants; Bone and Bones; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Lamotrig | 2019 |
Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
Topics: Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Gabapentin; Humans; Levetiracetam; Male; Net | 2019 |
Association between EPHX1 polymorphisms and carbamazepine metabolism in epilepsy: a meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Epoxide Hydrolases; Humans; Polymorphism, | 2019 |
Clonazepam monotherapy for treating people with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Clonazepam; Epilepsy; Humans; Quality of Life; Randomi | 2019 |
Phenobarbital rheumatism-A fresh look at an old malady: Case report and systematic review of literature.
Topics: Adult; Anticonvulsants; Antirheumatic Agents; Arthritis, Rheumatoid; Carbamazepine; Complex Regional | 2020 |
Effect of carbamazepine on the bone health of people with epilepsy: a systematic review and meta-analysis.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Calcium; Carbamazepine; Child, Preschool; | 2020 |
The evidence for switching dibenzazepines in people with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Substitution; Epilepsy; Evidence-Based Medicine | 2020 |
The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy.
Topics: Adult; Affect; Anticonvulsants; Carbamazepine; Cognition; Epilepsy; Humans; Lacosamide; Lamotrigine; | 2020 |
Current role of carbamazepine and oxcarbazepine in the management of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Oxcarbazepine; Topiramate | 2020 |
Use of Phenytoin, Phenobarbital Carbamazepine, Levetiracetam Lamotrigine and Valproate in Pregnancy and Breastfeeding: Risk of Major Malformations, Dose-dependency, Monotherapy vs Polytherapy, Pharmacokinetics and Clinical Implications.
Topics: Anticonvulsants; Breast Feeding; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam | 2021 |
Epilepsy in Morocco: Realities, pitfalls and prospects.
Topics: Academic Medical Centers; Anticonvulsants; Carbamazepine; Epilepsy; Health Services Accessibility; H | 2021 |
Associations between CYP3A4, CYP3A5 and SCN1A polymorphisms and carbamazepine metabolism in epilepsy: A meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Epilepsy; Genotype; Humans; NAV1.1 Voltage-G | 2021 |
The effects of antiepileptic drugs on bone health: A systematic review.
Topics: Anticonvulsants; Bone Density; Carbamazepine; Epilepsy; Humans; Lamotrigine | 2021 |
Epilepsy: A Clinical Overview.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans | 2021 |
Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; NAV1.1 Voltage-Gated Sodium Channel; Polymorphism, | 2021 |
Association of EPHX1 polymorphisms with plasma concentration of carbamazepine in epileptic patients: Systematic review and meta-analysis.
Topics: Carbamazepine; Epilepsy; Epoxide Hydrolases; Epoxy Compounds; Genetic Predisposition to Disease; Hum | 2021 |
ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
Topics: Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transpor | 2021 |
Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant, Newbo | 2017 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti | 2017 |
Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis.
Topics: Anticonvulsants; Autistic Disorder; Bayes Theorem; Breast Feeding; Carbamazepine; Child; Epilepsy; F | 2017 |
Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Epilepsies, Parti | 2017 |
Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Carbamazepine; Ch | 2018 |
Genetic variation in
Topics: Anticonvulsants; Apolipoproteins; Asian People; Carbamazepine; Case-Control Studies; Complement Fact | 2018 |
Association between HLA-B*15:02 and oxcarbazepine-induced cutaneous adverse reaction: a meta-analysis.
Topics: Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; HLA-B15 Antigen; H | 2018 |
Extended-release drug formulations for the treatment of epilepsy.
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Delayed-Action Preparations; Dr | 2018 |
The HLA-B*15:02 polymorphism and Tegretol
Topics: Anticonvulsants; Carbamazepine; Drug Eruptions; Epilepsy; HLA-B Antigens; Humans; Polymorphism, Gene | 2018 |
Carbamazepine adverse drug reactions.
Topics: Anticonvulsants; Biomarkers; Carbamazepine; Dose-Response Relationship, Drug; Drug Monitoring; Epile | 2018 |
Epilepsy in patients with EAST syndrome caused by mutation in the KCNJ10.
Topics: Anticonvulsants; Brain; Carbamazepine; Cerebellar Ataxia; Child; Child, Preschool; Epilepsy; Female; | 2019 |
Valproate decreases vitamin D levels in pediatric patients with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Valproic Acid | 2019 |
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Phenytoin; Randomized Controlled Trials as | 2019 |
Seizures and intracranial hemorrhage.
Topics: Anticonvulsants; Carbamazepine; Congenital Abnormalities; Eclampsia; Epilepsy; Female; Folic Acid; H | 2013 |
Oxcarbazepine versus phenytoin monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Induction Chemotherapy; Oxcar | 2013 |
Sudden unexpected death in epilepsy or voodoo heart: analysis of heart/brain connections.
Topics: Anticonvulsants; Arrhythmias, Cardiac; Autonomic Nervous System; Brugada Syndrome; Carbamazepine; Ca | 2013 |
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans; Randomized Controlled | 2014 |
[Clinical guidelines for epilepsy].
Topics: Anticonvulsants; Asia; Carbamazepine; Epilepsy; Europe; Evidence-Based Medicine; Humans; Internation | 2014 |
[Treatment of pediatric epilepsy].
Topics: Adolescent; Amines; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic A | 2014 |
[Treatment of epilepsy in patients of adolescence and adulthood].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Combined Modality Therapy; Drug Substitution; Epi | 2014 |
Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Clobazam; Epilepsy; Fructose; Humans; Induct | 2014 |
Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.
Topics: Age Factors; Anticonvulsants; Carbamazepine; Child; Developmental Disabilities; Epilepsy; Female; Hu | 2014 |
Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) induced by carbamazepine: a case report and literature review.
Topics: Anticonvulsants; Carbamazepine; Child; Drug Hypersensitivity Syndrome; Epilepsy; Humans; Male | 2014 |
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans; Randomized Controlled | 2014 |
Pharmacological treatments for preventing epilepsy following traumatic head injury.
Topics: Adult; Anticonvulsants; Carbamazepine; Cause of Death; Child; Craniocerebral Trauma; Epilepsy; Human | 2015 |
[New possibilities of monotherapy of symptomatic and cryptogenic partial epilepsy].
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Isoxazoles; Zonisamide | 2015 |
Antiepileptic drugs for seizure control in people with neurocysticercosis.
Topics: Adolescent; Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Child; Child, Preschool; Epilepsy | 2015 |
Is carbamazepine a human teratogen?
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Australia; Carbamazepine; Epilepsy; Female; Fet | 2016 |
Vigabatrin versus carbamazepine monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Randomized Controlled Trials as Topic; Risk Assess | 2015 |
Antiepileptic Drugs.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; O | 2016 |
Carbamazepine-related antiepileptic drugs for the treatment of epilepsy - a comparative review.
Topics: Anticonvulsants; Carbamazepine; Dibenzazepines; Drugs, Generic; Epilepsy; Humans; Oxcarbazepine | 2016 |
[Preconceptional and perinatal challenges of pregnancy in women with epilepsy].
Topics: Adult; Amines; Anticonvulsants; Benzodiazepines; Carbamazepine; Cyclohexanecarboxylic Acids; Epileps | 2016 |
Hyponatremia induced by antiepileptic drugs in patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Hyponatremia; Incidence; Oxcarbazepine; Risk Facto | 2017 |
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans; Randomized Controlled | 2016 |
Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Folic Acid; Homocysteine; Humans; Oxcarbazepine; Vitamin B | 2017 |
Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Multidrug Resistance-Associated Protein 2; | 2017 |
An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Consensus; Drugs, Generic; Epilepsy; Hong Kong; Humans; | 2017 |
Epilepsy treatment in adults and adolescents: Expert opinion, 2016.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Depression; Double-Blind Method; Dru | 2017 |
[The use of the antiepileptic drug trileptal in the clinical practice].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine; Treatment Outcome | 2008 |
[Seizure exacerbation caused by antiepileptic drugs].
Topics: Anticonvulsants; Carbamazepine; Disease Progression; Epilepsies, Myoclonic; Epilepsy; Epilepsy, Abse | 2008 |
[Diagnosis and treatment of epilepsy in the field of psychiatry].
Topics: Adult; Anticonvulsants; Carbamazepine; Diazepam; Electroencephalography; Epilepsy; Female; Humans; M | 2008 |
Epileptic disorders in pregnancy: an overview.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Folic Acid; Hemorrhag | 2008 |
Fetal malformations associated with the use of methylphenobarbital and carbamazepine during pregnancy. Two case reports and review of the literature.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; | 2009 |
[Role of monotherapy with new antiepileptic drugs in the treatment of childhood epilepsy].
Topics: Anticonvulsants; Carbamazepine; Child; Drug Administration Schedule; Epilepsy; Fructose; Humans; Iso | 2009 |
Genetic basis for idiosyncratic reactions to antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Epile | 2009 |
New pharmacotherapies for pediatric seizures.
Topics: Adolescent; Amines; Animals; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecar | 2004 |
Managing antiepileptic drugs during pregnancy and lactation.
Topics: Anticonvulsants; Breast Feeding; Carbamazepine; Epilepsy; Female; Humans; Infant; Lactation; Lamotri | 2009 |
[The use of oxcarbazepine (trileptal) in young epileptic women].
Topics: Age Factors; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fertility; Humans; Oxcarbazepine; Tre | 2009 |
Oxcarbazepine for refractory epilepsy: systematic review of the literature.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Oxcarbazepine; Randomized Controlled | 2009 |
New antiepileptic drugs: molecular targets.
Topics: Action Potentials; Animals; Anticonvulsants; Barbiturates; Carbamazepine; Clinical Trials as Topic; | 2009 |
[Homocysteine and asymmetric dimethylarginine (ADMA) in epilepsy].
Topics: Anticonvulsants; Arginine; Carbamazepine; Epilepsy; Homocysteine; Humans; Nitric Oxide; Nitric Oxide | 2009 |
Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans; Randomized Controlled | 2010 |
Medicolegal assessment of the ability to drive a motor vehicle in persons with epilepsy.
Topics: Accidents, Occupational; Accidents, Traffic; Anticonvulsants; Automobile Driving; Carbamazepine; Dec | 2010 |
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Case-Control Studies; Epilepsy; Europe; | 2010 |
Question 2 Should phenytoin and carbamazepine be avoided in Asian populations with the HLA-B*1502 positive genetic variant?
Topics: Anticonvulsants; Asian People; Carbamazepine; Child; Contraindications; Drug Eruptions; Epilepsy; Ev | 2011 |
Epilepsy (generalised).
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Incidence; Phenytoin; Remis | 2010 |
[Rational combinations of antiepileptic drugs for refractory epilepsy].
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbamazepine; Cl | 2011 |
[Pregabalin and gabapentin in multiple sclerosis: clinical experiences and therapeutic implications].
Topics: Adult; Aged; Aged, 80 and over; Amines; Anticonvulsants; Antineoplastic Agents; Carbamazepine; Cohor | 2011 |
Side effects of phenobarbital in epilepsy: a systematic review.
Topics: Anticonvulsants; Carbamazepine; Child; Cognition Disorders; Cohort Studies; Cross-Over Studies; Data | 2011 |
Spotlight on levetiracetam in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chemotherapy, Adjuvant; Epilepsy; Humans; Levetiracetam; Piracetam; | 2011 |
Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects.
Topics: Aged; Animals; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Choice Behavior; Drug Intera | 2012 |
Vigabatrin versus carbamazepine monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Randomized Controlled Trials as Topic; Risk Assess | 2012 |
The effects of antiepileptic drugs on oral health.
Topics: Alveolar Bone Loss; Anticonvulsants; Carbamazepine; Epilepsy; Gingival Hyperplasia; Humans; Oral Hea | 2011 |
Epilepsy (generalised).
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Incidence; Phenytoin; Remis | 2012 |
Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review.
Topics: Anticonvulsants; Carbamazepine; Data Interpretation, Statistical; Dose-Response Relationship, Drug; | 2012 |
Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Drug Tolerance; Epilepsy; Humans; Valpr | 2013 |
Is there an association between maternal carbamazepine use during pregnancy and eye malformations in the child?
Topics: Carbamazepine; Databases as Topic; Epilepsy; Eye Abnormalities; Female; Humans; Incidence; Netherlan | 2002 |
Pilomotor seizures: symptomatic vs. idiopathic report of two cases and literature review.
Topics: Adult; Carbamazepine; Electroencephalography; Epilepsy; Female; Frontal Lobe; Humans; Male; Severity | 2002 |
[Characteristics and indications of oxcarbazepine].
Topics: Animals; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Disease Models, Animal; Dose-Resp | 2002 |
Antiepileptic drug therapy for adults: when to initiate and how to choose.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Felb | 2002 |
New antiepileptic drug therapies.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Dioxolanes; Ep | 2002 |
Mitral valve vegetation and cerebral emboli in a primary antiphospholipid syndrome patient who had hepatitis C virus infection: report of a case and review of the literature.
Topics: Adult; Antibodies, Anticardiolipin; Anticoagulants; Anticonvulsants; Antiphospholipid Syndrome; Carb | 2003 |
Pathobiology and genetics of neural tube defects.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Female; Folic Acid; Genetic Predisposition to Dis | 2003 |
Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?
Topics: Anticonvulsants; Carbamazepine; Death, Sudden; Epilepsy; Humans; Incidence; Severity of Illness Inde | 2003 |
Oxcarbazepine: a review of its use in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Brain; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic | 2003 |
The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Interac | 2003 |
Seizures in elderly patients with dementia: epidemiology and management.
Topics: Aged; Anticonvulsants; Carbamazepine; Case Management; Dementia; Epilepsy; Humans | 2003 |
Management issues for women with epilepsy: neural tube defects and folic acid supplementation.
Topics: Adult; Animals; Anticonvulsants; Carbamazepine; Cleft Lip; Cleft Palate; Epilepsy; Female; Folic Aci | 2003 |
Half pitch lower sound perception caused by carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Epilepsy; Female; Hearing Disorders; Humans; Music; Pitc | 2003 |
[Clinical guidelines for treatment of epilepsy in children].
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Cosyntropin; Electroencephalography; Epileps | 2004 |
Oxcarbazepine in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Humans; Oxcarbazepine; Treatment Outcom | 2003 |
Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epileps
Topics: Acetates; Acute Disease; Adolescent; Adult; Amines; Anticonvulsants; Carbamazepine; Child; Controlle | 2004 |
Monotherapy in epilepsy: role of the newer antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Lamotrigine; Oxcarbazepi | 2004 |
What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
Topics: Animals; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Hum | 2004 |
[Therapy of epilepsy: current strategy and tactics].
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; | 2004 |
Cancer risk in people with epilepsy: the role of antiepileptic drugs.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Neoplasms; Phenobarbital; Phenytoin; Rats | 2005 |
Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Delivery of Health Care; Drug Administrati | 2004 |
Carbamazepine-induced acute liver failure as part of the DRESS syndrome.
Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury, Chronic; Drug Eruptio | 2005 |
Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Databases, Factual; Dou | 2005 |
Lamotrigine versus carbamazepine monotherapy for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; | 2006 |
Oxcarbazepine versus phenytoin monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Oxcarbazepine; Phenytoin; Ran | 2006 |
New antiepileptic drugs that are second generation to existing antiepileptic drugs.
Topics: Amines; Animals; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Drug | 2006 |
[Epilepsy and male sexual dysfunction: etiology, diagnosis and therapy].
Topics: Androgens; Anticonvulsants; Bromocriptine; Carbamazepine; Cognition; Enzyme Induction; Epilepsy; Gon | 2006 |
Novel anticonvulsant drugs.
Topics: Amines; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Fructose; Ga | 2007 |
Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Interactions; Drug Monitor | 2006 |
[Anticonvulsants treatment of psychiatric disorder in elderly patients].
Topics: Aged; Anticonvulsants; Anxiety Disorders; Bipolar Disorder; Carbamazepine; Epilepsy; Humans; Mental | 2006 |
Therapeutic monitoring of antiepileptic drugs for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Humans; Phenobarbital; Phenytoin; Primido | 2007 |
[Newer antiepileptic drugs].
Topics: Amines; Animals; Anti-Anxiety Agents; Anticonvulsants; Calcium Channel Blockers; Carbamazepine; Cycl | 2007 |
Plasticity of antiepileptic drug targets.
Topics: Animals; Anticonvulsants; Blood-Brain Barrier; Brain; Carbamazepine; Disease Models, Animal; Drug De | 2007 |
Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
Topics: Aged; Aged, 80 and over; Amines; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; | 2007 |
[The ictal bradycardia syndrome: a case report and review of the literature].
Topics: Anticonvulsants; Arrhythmia, Sinus; Bradycardia; Carbamazepine; Echocardiography; Echocardiography, | 2007 |
New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
Topics: Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Data Interpretation, Statistical; Epileps | 2007 |
[New antiepileptics in development].
Topics: Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Felbamate; Humans; Levetiracetam | 2007 |
Clinical profile of oxcarbazepine-related angioneurotic edema: case report and review.
Topics: Angioedema; Anticonvulsants; Carbamazepine; Child, Preschool; Epilepsy; Humans; Male; Oxcarbazepine; | 2007 |
Extended-release formulations for the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Delayed-Action Prep | 2007 |
[Effects of antiepileptic drugs on mood of people with epilepsy].
Topics: Affect; Anticonvulsants; Antidepressive Agents; Carbamazepine; Depressive Disorder; Epilepsy; Fructo | 2007 |
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
Topics: Adult; Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Clinical Trials as | 2008 |
The new antiepileptic drugs.
Topics: Amines; Anticonvulsants; Carbamazepine; Child; Cyclohexanecarboxylic Acids; Dioxolanes; Epilepsies, | 2007 |
The treatment of the first seizure: the benefits.
Topics: Actuarial Analysis; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenobarbital; Prognosis; Rand | 2008 |
Idiopathic megalencephaly-possible cause and treatment opportunities: from patient to lab.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; Epilepsy; Humans; Kv1.1 Pota | 2008 |
Antiepileptic drugs as human teratogens.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Phenobarbital | 2008 |
Psychopharmacological aspects of antiepileptic treatment.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Electroencephalography; Epilepsy; Ethosux | 1980 |
[Advance and clinic of antiepileptic drugs (author's transl)].
Topics: Animals; Anticonvulsants; Benzodiazepines; Brain; Carbamazepine; Epilepsy; Humans; Ion Channels; Mic | 1981 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adult; Aged; Aggression; Anger; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; C | 1984 |
Diagnosis and treatment of epilepsy.
Topics: Automatism; Benzodiazepines; Carbamazepine; Electroencephalography; Epilepsies, Partial; Epilepsy; E | 1983 |
Mental effects of antiepileptic medication: a review.
Topics: Adolescent; Adult; Anticonvulsants; Attention; Barbiturates; Brain Chemistry; Carbamazepine; Child; | 1983 |
Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
Topics: Carbamazepine; Drug Interactions; Epilepsy; Humans; Intestinal Absorption; Kinetics; Phenytoin; Valp | 1984 |
Pharmacological principles in the long-term treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Diazepam; Epilepsy; Ethosuximide; Humans; Kinetics; Long | 1981 |
The epileptic mother and her child.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Breast Feeding; Carbamazepine; Epilepsy; Female; Fetal | 1982 |
Recent developments in the diagnosis and therapy of epilepsy.
Topics: Anticonvulsants; Biofeedback, Psychology; Carbamazepine; Clonazepam; Clorazepate Dipotassium; Condit | 1982 |
Controlled trials in epilepsy: a review.
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Clinical Trials as Topic; Double-Blin | 1982 |
Use of antiepileptic drugs in the presence of liver and kidney diseases: a review.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Half-Life; Humans; Kidney Diseases; Kinetics; Liver Diseas | 1982 |
[Current viewpoints in the treatment of epilepsies: role of new antiepileptics?].
Topics: 4-Aminobutyrate Transaminase; Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxyli | 1995 |
Behavioural abnormalities and retention rates of anti-epilepsy drugs during long-term treatment of epilepsy: a clinical perspective.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Epilepsy | 1995 |
Phenytoin and carbamazepine: differential effects on cognitive function.
Topics: Carbamazepine; Clinical Trials as Topic; Cognition; Drug Therapy, Combination; Epilepsy; Humans; Neu | 1995 |
[New antiepileptic medications].
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Gabapentin; | 1995 |
Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature.
Topics: Adult; Aged; Carbamazepine; Drug Hypersensitivity; Epilepsy; Female; Humans; Lymphocyte Activation; | 1995 |
Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Topics: Acetamides; Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dioxolane | 1994 |
Metabolism and action of vitamin D in epileptic patients on anticonvulsive treatment and healthy adults.
Topics: Anticonvulsants; Calcium; Carbamazepine; Cholecalciferol; Epilepsy; Ergocalciferols; Female; Humans; | 1994 |
[The effect of carbamazepine on the thyroid status of epilepsy patients (a review)].
Topics: Aging; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Thyroid Gland; Thyroid Hor | 1993 |
Oxcarbazepine: pharmacokinetic interactions and their clinical relevance.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Interactions; Epilepsy; Humans; Kinet | 1994 |
Clinical experience with oxcarbazepine.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Oxcarbazepine | 1994 |
Standard approach to antiepileptic drug treatment in the United States.
Topics: Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Drug Administration Schedule; Drug Th | 1994 |
Standard approach to antiepileptic drug treatment in the United Kingdom.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Administration Schedule; Drug Monitor | 1994 |
Carbamazepine lowers aggression: a review.
Topics: Aggression; Carbamazepine; Epilepsy; Humans; Male; Mental Disorders | 1994 |
Advances in pharmacotherapy: recent developments in the treatment of epilepsy.
Topics: Acetates; Amines; Aminocaproates; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Aci | 1993 |
Pharmacologic intervention and treatment of childhood seizure disorders: relative efficacy and safety of antiepileptic drugs.
Topics: Animals; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Drug Administration Schedu | 1994 |
Drug interaction profile of topiramate.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Epile | 1996 |
Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Biological Availability; Carbamazepine; Clinical Trials as Topic; | 1996 |
Utilization of new antiepileptic drugs in children.
Topics: Acetates; Adolescent; Adult; Age Factors; Amines; Anticonvulsants; Carbamazepine; Child; Child, Pres | 1996 |
Interactions of valproic acid with carbamazepine and its metabolites' concentrations, concentrations ratios, and level/dose ratios in epileptic children.
Topics: Carbamazepine; Child; Drug Interactions; Epilepsy; Female; Humans; Linear Models; Male; Valproic Aci | 1995 |
[Current anti-epilepsy drugs].
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Therapy, Combina | 1995 |
[Treatment of neurological complications: cerebral edema and epileptic seizures].
Topics: Adrenal Cortex Hormones; Anticonvulsants; Brain Edema; Brain Ischemia; Carbamazepine; Diuretics, Osm | 1995 |
Carbamazepine clinical pharmacology: a review.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Mental Disorders; Pregnancy | 1995 |
Antiepileptic drug mechanisms of action.
Topics: Acetates; Action Potentials; Amines; Animals; Anticonvulsants; Barbiturates; Benzodiazepines; Calciu | 1995 |
Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Cl | 1995 |
Adverse effects of established and new antiepileptic drugs: an attempted comparison.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; gamma-Aminobutyric Acid; Gastrointestinal Disease | 1995 |
Important pharmacokinetic properties of antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Biological Availability; Biopharmaceutics; Carbamazepine; Cyclohe | 1995 |
Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Humans; Phenobarbital; Phenytoin | 1996 |
Pharmacokinetics of new antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Biological Availability; Carbamazepine; Cyclohexanecarboxylic Aci | 1996 |
Antiepileptic drugs--current use.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenytoin; Valproic Acid | 1996 |
[Cognitive rehabilitation in closed head injuries in childhood and adolescence].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Cognition Disorders; Cognitive Behavioral Therapy; Epile | 1996 |
[Treatment of the epilepsy: new drugs].
Topics: Acetates; Amines; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamaz | 1996 |
[Antiepileptic drugs: mechanism of action].
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Epilepsy; GABA Antagonists; gamma-Aminobutyric Acid; H | 1996 |
Established antiepileptic drugs.
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Epilepsy; Humans; Phenytoin; Succinim | 1996 |
New antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Felbamate; | 1996 |
Adverse effects in epilepsy therapy. Wait and see or go for it?
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; MEDLINE; Valproic Acid | 1997 |
Pharmacologic and dietary therapies in epilepsy: conventional treatments and recent advances.
Topics: Acetates; Amines; Anticonvulsants; Benzodiazepines; Carbamazepine; Cyclohexanecarboxylic Acids; Epil | 1997 |
Carbamazepine-induced sinus node dysfunction.
Topics: Adult; Anticonvulsants; Carbamazepine; Electrocardiography, Ambulatory; Epilepsy; Humans; Male; Sick | 1997 |
Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation.
Topics: Anticonvulsants; Area Under Curve; Carbamazepine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-4 | 1997 |
Lymphocytic colitis in a pediatric patient: a possible adverse reaction to carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Chronic Disease; Colitis; Diarrhea; Epilepsy; Humans; Lymphoc | 1997 |
Does carbamazepine have a narrow therapeutic plasma concentration range?
Topics: Anticonvulsants; Canada; Carbamazepine; Chemistry, Pharmaceutical; Epilepsy; Humans; Seizures; Unite | 1998 |
Advances in the medical treatment of epilepsy.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Diazepam; Drug Approv | 1998 |
Antiepileptic drugs as a cause of worsening seizures.
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; | 1998 |
Voltage-activated calcium channels: targets of antiepileptic drug therapy?
Topics: Animals; Anticonvulsants; Calcium Channels; Carbamazepine; Drug Design; Epilepsy; Felbamate; Humans; | 1997 |
Features and management of poisoning with modern drugs used to treat epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenytoin; Valproic Acid | 1998 |
New antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Approval; Epilep | 1998 |
Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs.
Topics: Anticonvulsants; Biotransformation; Carbamazepine; Cytochrome P-450 Enzyme System; Drug Hypersensiti | 1998 |
Antiepileptic drug hypersensitivity syndrome.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross Reactions; Diagnosis, Differential; D | 1998 |
Carbamazepine in the treatment of epilepsy in people with intellectual disability.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Intellectual Disability | 1998 |
Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Clinical Trials, Phase II as Topic; Clinical Tria | 1999 |
Options after the first antiepileptic drug has failed.
Topics: Acetates; Amines; Anticonvulsants; Attitude to Health; Carbamazepine; Clinical Trials as Topic; Cycl | 1999 |
Monostars: an aid to choosing an antiepileptic drug as monotherapy.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Administration S | 1999 |
Oxcarbazepine.
Topics: Adult; Animals; Anticonvulsants; Biological Availability; Biotransformation; Carbamazepine; Controll | 1999 |
Sylvian fissure lipomas: case reports and review of the literature.
Topics: Adult; Anticonvulsants; Carbamazepine; Cerebral Veins; Epilepsy; Female; Humans; Lipoma; Magnetic Re | 1999 |
New antiepileptic drugs.
Topics: Acetates; Amines; Animals; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Interac | 2000 |
Oxcarbazepine: a review.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine | 2000 |
Carbamazepine versus valproate monotherapy for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Confidence Intervals; Epilepsy; Humans; Outcome Assess | 2000 |
Is generic prescribing acceptable in epilepsy?
Topics: Anticonvulsants; Area Under Curve; Biological Availability; Carbamazepine; Chemistry, Pharmaceutical | 2000 |
Therapeutic safety monitoring: what to look for and when to look for it.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Monitoring; Epil | 2000 |
Oxcarbazepine, an antiepileptic agent.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; | 2001 |
Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials.
Topics: Anticonvulsants; Brain Diseases; Brain Injuries; Carbamazepine; Controlled Clinical Trials as Topic; | 2001 |
Cognitive side effects of anticonvulsants.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cognition Disorders; Cyclohexane | 2001 |
The role of new antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsies, Partial; Epilepsy; Epi | 2001 |
Treatment of epilepsy in 3 specialized populations.
Topics: Age Factors; Aged; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Female; Human | 2001 |
Oxcarbazepine.
Topics: Adult; Animals; Anticonvulsants; Carbamazepine; Child; Cognition; Epilepsy; Humans; Oxcarbazepine; R | 2002 |
Newer therapies in the drug treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Interactions; Epilepsy; Humans; Isoxa | 2002 |
Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Levetiraceta | 2002 |
Using the new antiepilepsy drugs in children.
Topics: Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Epilepsy; Humans; Isoxazoles; Levet | 2002 |
Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.
Topics: Animals; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy; Humans; Oxcarbazepine; Sodium Cha | 2002 |
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; | 2002 |
Carbamazepine versus phenytoin monotherapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenytoin; Randomized Controlled Trials as Topic | 2002 |
[Diphenylhydantoin. Metabolism, pharmacokinetics, interactions and side effects].
Topics: Anti-Anxiety Agents; Benzodiazepines; Bone and Bones; Bone Marrow; Carbamazepine; Cerebellar Disease | 1976 |
[Pharmacotherapy of epilepsy. II].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Benzodiazepines; Carbamazepin | 1978 |
[Long-term anticonvulsant therapy (author's transl)].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Clonazepam; Epilepsy; Ethosuximide; Humans; Long-Te | 1978 |
The pharmacological treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Clonazepam; Drug Therapy, Combination; Epilepsies, | 1979 |
The medical treatment of epilepsy: initiation of drug therapy.
Topics: Adolescent; Adrenocorticotropic Hormone; Anticonvulsants; Bromides; Carbamazepine; Child; Child, Pre | 1979 |
The teratogenic risk of antiepileptic drugs.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Anencephaly; Anti-Anxiety Agents; Anticonvulsa | 1975 |
Behavioural effects of anti-epileptic drugs.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Confusion; Disorders of Excess | 1975 |
Pediatric psychopharmacology. A review with special reference to deanol.
Topics: Adolescent; Adult; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Attention Deficit Disord | 1977 |
The medical treatment of epilepsy: maintenance of drug therapy.
Topics: Adolescent; Adult; Anticonvulsants; Biological Availability; Bromides; Carbamazepine; Child; Dextroa | 1979 |
The effect of anti-convulsant drugs on cognitive abilities.
Topics: Anticonvulsants; Carbamazepine; Cognition; Epilepsy; Ethosuximide; Humans; Phenobarbital; Phenytoin; | 1979 |
Pharmacological prophylaxis in the kindling model of epilepsy.
Topics: Amygdala; Anesthetics, Local; Animals; Antidepressive Agents, Tricyclic; Atropine; Aziridines; Carba | 1977 |
Carbamazepine-induced systemic lupus erythematosus-like disease.
Topics: Adolescent; Carbamazepine; Epilepsy; Female; Humans; Lupus Erythematosus, Systemic; Prednisolone | 1992 |
[Carbamazepine in affective psychoses].
Topics: Affective Disorders, Psychotic; Brain; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Sy | 1992 |
[The effect of monotherapy on concentration of selected blood serum hormones and upon cognitive function of children with epilepsy].
Topics: Adolescent; Carbamazepine; Child; Cognition; Epilepsy; Female; Follow-Up Studies; Humans; Male; Phen | 1992 |
Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.
Topics: Affective Disorders, Psychotic; Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Humans; | 1992 |
Metabolism of antiepileptic medication: newborn to elderly.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Child; Dose-Response Relations | 1992 |
Antiepileptic drugs and their psychotropic effects.
Topics: Affect; Anticonvulsants; Brain; Carbamazepine; Clonazepam; Epilepsy; Humans; Mental Disorders; Psych | 1992 |
Pharmacokinetic evaluation of sustained release formulations of antiepileptic drugs. Clinical implications.
Topics: Absorption; Biological Availability; Carbamazepine; Delayed-Action Preparations; Epilepsy; Half-Life | 1992 |
Routine laboratory monitoring for serious adverse effects of antiepileptic medications: the controversy.
Topics: Anemia, Aplastic; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Drug Monit | 1991 |
Oxcarbazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Drugs, Investigational; Electroencephalography; Epilepsy; E | 1991 |
Antiepileptic drugs for children: carbamazepine and valproic acid derivatives.
Topics: Carbamazepine; Child; Electroencephalography; Epilepsy; Humans; Valproic Acid | 1991 |
Anticonvulsants: pharmacotherapeutic issues in the critically ill patient.
Topics: Anticonvulsants; Benzodiazepines; Brain Injuries; Carbamazepine; Central Nervous System Diseases; Ep | 1991 |
Established anticonvulsants and treatment of refractory epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Quality of Life | 1990 |
Spina bifida in infants of women treated with carbamazepine during pregnancy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Cohort Studies; Epilepsy; Female; Human | 1991 |
The newer antiepileptic drugs: carbamazepine and valproic acid.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy; Humans; Infant | 1991 |
Antiepileptic drugs in affective illness. Clinical and theoretical implications.
Topics: Acute Disease; Anticonvulsants; Benzodiazepines; Bipolar Disorder; Carbamazepine; Depression; Drug T | 1991 |
Antiepileptic drugs, cognitive function, and behavior in children: evidence from recent studies.
Topics: Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Cognition; Cognition Disorders; Epilepsy; | 1990 |
Epilepsy in women of childbearing age.
Topics: Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pregnancy Complications | 1989 |
Medical treatment and pharmacology of antiepileptic drugs.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Half-Life; Humans; Phenytoin | 1989 |
Efficacy and adverse effects of antiepileptic drugs.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Phenobarbital | 1989 |
Drug therapy. Carbamazepine.
Topics: Adult; Carbamazepine; Child; Epilepsy; Humans | 1989 |
[Clinical pharmacokinetics of carbamazepine (review of the literature)].
Topics: Biological Availability; Carbamazepine; Epilepsy; Humans; Intestinal Absorption; Trigeminal Neuralgi | 1989 |
Use of phenytoin and carbamazepine in treatment of epilepsy.
Topics: Anemia, Aplastic; Carbamazepine; Cerebellar Ataxia; Chemical and Drug Induced Liver Injury; Cognitio | 1986 |
Carbamazepine side effects in children and adults.
Topics: Adult; Agranulocytosis; Anemia, Aplastic; Carbamazepine; Chemical and Drug Induced Liver Injury; Chi | 1987 |
Carbamazepine: a neuropsychological and psychiatric profile.
Topics: Adolescent; Adult; Attention; Blood Proteins; Carbamazepine; Child; Cognition; Epilepsy; Female; Hum | 1985 |
Antiepileptic drugs in adolescents.
Topics: Adaptation, Psychological; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Clonazepam; Dru | 1987 |
New anticonvulsants in pediatrics: carbamazepine and valproate.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epilepsy; Female; Humans | 1987 |
Mechanisms of anticonvulsant drug action. I. Drugs primarily used for generalized tonic-clonic and partial epilepsies.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Kinetics; Phenobarbital; Phen | 1987 |
[Thyroid function in children under prolonged anticonvulsant therapy].
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Ethosuximide; Humans; Secretory Rate; Thyroid Gland | 1988 |
Drug treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Ethosuximide; Humans; Ph | 1987 |
Carbamazepine and mood: evidence from patients with seizure disorders.
Topics: Affect; Carbamazepine; Cognition; Epilepsy; Humans; Psychotropic Drugs | 1988 |
Modern perspectives on epilepsy in relation to psychiatry: behavioral disturbances of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Kindling, Neurologic; Psychotic Disorders; Seizure | 1988 |
Problems and management of the pregnant woman with epilepsy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pr | 1987 |
Anticonvulsant drugs and cognitive function: a review of the literature.
Topics: Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Epilepsy; Humans; Phenobarbital; Phe | 1987 |
Clinically significant carbamazepine drug interactions: an overview.
Topics: Carbamazepine; Drug Interactions; Epilepsy; Humans; Liver | 1987 |
Polytherapy, monotherapy, and carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Epilepsy; Human | 1987 |
[Neurotraumatology and post-traumatic epilepsy. Prevention, treatment and long-term follow-up. Barbexaclone + phenobarbital (maliasin) versus diphenylhydantoin, phenobarbital, primidone, carbamazepine].
Topics: Adolescent; Adult; Anticonvulsants; Brain Injuries; Carbamazepine; Child; Child, Preschool; Drug The | 1987 |
Current concepts. Seizure disorders and pregnancy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Epilepsy; | 1985 |
Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy.
Topics: Brain Chemistry; Carbamazepine; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, | 1985 |
Pharmacokinetics of anti-epileptic drugs in the dog: a review.
Topics: Animals; Anticonvulsants; Blood Proteins; Carbamazepine; Clonazepam; Diazepam; Dog Diseases; Dogs; E | 1985 |
Usefulness of blood levels of antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Chloramphenicol; Chlordiazepoxide; Chlorpromazine; Chromatography, G | 1974 |
Plasma levels of anticonvulsants.
Topics: Administration, Oral; Adult; Animals; Anticonvulsants; Barbiturates; Blood Proteins; Carbamazepine; | 1973 |
Drug reactions. XX. Cutaneous reactions to anticonvulsants.
Topics: Adolescent; Adult; Alopecia; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dermatitis, Ex | 1972 |
[Course and prognosis of infantile epilepsy in relation to present-day treatment].
Topics: Adolescent; Adrenocorticotropic Hormone; Anticonvulsants; Brain Diseases; Carbamazepine; Central Ner | 1970 |
Toxic effects of anticonvulsants: general principles.
Topics: Adrenocorticotropic Hormone; Adult; Anticonvulsants; Benzodiazepinones; Body Surface Area; Body Weig | 1974 |
The management of children with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epilepsy; Ethosuxim | 1970 |
[Antiepileptics. 39].
Topics: Acetazolamide; Adrenocorticotropic Hormone; Aminoglutethimide; Anticonvulsants; Barbiturates; Carbam | 1969 |
Epilepsy.
Topics: Animals; Brain; Carbamazepine; Diet Therapy; Epilepsy; Humans; Phenobarbital; Phenytoin | 1972 |
Epilepsy in the adolescent.
Topics: Acetazolamide; Adolescent; Age Factors; Alcoholic Intoxication; Amphetamine; Anticonvulsants; Attitu | 1974 |
The use of blood levels of antiepileptic drugs in clinical practice.
Topics: Administration, Oral; Adult; Anticonvulsants; Biopharmaceutics; Carbamazepine; Child; Drug Tolerance | 1974 |
[The most important antiepileptic drugs--serum levels and clinical aspects].
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Half-Life; Humans; Tranquilizin | 1974 |
297 trials available for carbamazepine and Aura
| Article | Year |
|---|---|
Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dizziness; Double-Blind Method; | 2019 |
Tolerability and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy and concomitant psychiatric conditions: Post hoc analysis of a prospective, randomized, double-blind trial.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Delayed-Action Preparations; Depression; Doubl | 2020 |
Lacosamide in patients with epilepsy of cerebrovascular etiology.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cerebrovascular Disorders; Dose-Response Re | 2020 |
[The effect of reamberin on the antioxidant status in children with epilepsy].
Topics: Antioxidants; Carbamazepine; Catalase; Ceruloplasmin; Child; Epilepsy; Humans; Lipid Peroxides; Malo | 2019 |
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II).
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Cost-Benefit Anal | 2020 |
Carbamazepine versus levetiracetam in epilepsy due to neurocysticercosis.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Levetiracetam; M | 2021 |
Effects of lacosamide and carbamazepine on lipids in a randomized trial.
Topics: Anticonvulsants; Carbamazepine; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method | 2020 |
An investigation on the effects of carbamazepine and sodium valproate on neuromuscular transmission.
Topics: Adult; Anticonvulsants; Carbamazepine; Electromyography; Epilepsy; Female; Humans; Male; Synaptic Tr | 2020 |
Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Drug Therapy, Combination; Epile | 2018 |
AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies.
Topics: Anticonvulsants; Carbamazepine; Double-Blind Method; Drug Monitoring; Epilepsy; Female; Humans; Lamo | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relationshi | 2018 |
Impact of carbamazepine, lamotrigine, and levetiracetam on vascular risk markers and lipid-lowering agents in the elderly.
Topics: Aged; Aged, 80 and over; Anticonvulsants; C-Reactive Protein; Carbamazepine; Cholesterol, LDL; Doubl | 2018 |
Epilepsy control with carbamazepine monotherapy from a genetic perspective.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Genotype; Humans; Male; | 2018 |
Comparative neuropsychological effects of carbamazepine and eslicarbazepine acetate.
Topics: Adolescent; Adult; Affect; Anticonvulsants; Attention; Carbamazepine; Cross-Over Studies; Dibenzazep | 2019 |
Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Fema | 2013 |
Effects of lacosamide and carbamazepine on human motor cortex excitability: a double-blind, placebo-controlled transcranial magnetic stimulation study.
Topics: Acetamides; Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Dose-Response Relationship, | 2013 |
Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Epi | 2013 |
Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients--nonlinear mixed effects modelling approach.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug | 2014 |
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug-Rela | 2015 |
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug-Rela | 2015 |
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug-Rela | 2015 |
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug-Rela | 2015 |
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Drug-Related Si | 2015 |
Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities.
Topics: Administration, Oral; Adolescent; Age Factors; Anticonvulsants; Asian People; Biotransformation; Bod | 2015 |
Favorable change of lipid profile after carbamazepine withdrawal.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Apolipoproteins B; Carbamazepine; Cholesterol; Cholesterol | 2016 |
Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
Topics: Adolescent; Anticonvulsants; Asian People; Carbamazepine; Child; Child, Preschool; Chromatography, H | 2016 |
Monotherapy with Levetiracetam Versus Older AEDs: A Randomized Comparative Trial of Effects on Bone Health.
Topics: Absorptiometry, Photon; Adult; Aged; Anticonvulsants; Bone and Bones; Bone Density; Bone Remodeling; | 2016 |
Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Ma | 2016 |
Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
Topics: Adult; Anticonvulsants; Biomarkers; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactio | 2016 |
Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Dou | 2017 |
Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
Topics: Administration, Oral; Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Prescho | 2017 |
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
Topics: Adult; Anticonvulsants; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carbamazepine; Dacarbazi | 2008 |
Effect of antiepileptic drug polytherapy on urinary pH in children and young adults.
Topics: Acetazolamide; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Ther | 2009 |
Evaluation of bone turnover in epileptic children using oxcarbazepine.
Topics: Administration, Oral; Adolescent; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone Density; B | 2008 |
Lipid profile, apolipoproteins A and B in children with epilepsy.
Topics: Anticonvulsants; Apolipoproteins A; Apolipoproteins B; Carbamazepine; Case-Control Studies; Child; C | 2008 |
The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Do | 2009 |
Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients.
Topics: Adult; Alkaloids; Area Under Curve; Benzodioxoles; Biological Availability; Carbamazepine; Dose-Resp | 2009 |
Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cardiovascular System; Cohort Studies; Doub | 2009 |
The role side effects play in the choice of antiepileptic therapy in brain tumor-related epilepsy: a comparative study on traditional antiepileptic drugs versus oxcarbazepine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Brain Neoplasms; Carbamazepine; Epileps | 2009 |
The effect of carbamazepine treatment on serum leptin levels.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Body Mass Index; Carbamazepine; Epilepsy; Female; Humans; | 2009 |
Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study.
Topics: Adolescent; Adult; Age of Onset; Aged; Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsy | 2009 |
Differential effects of levetiracetam, carbamazepine, and lamotrigine on reproductive endocrine function in adults.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; F | 2009 |
Antiepileptic drugs and quality of life in the elderly: results from a randomized double-blind trial of carbamazepine and lamotrigine in patients with onset of epilepsy in old age.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cognition; Double-Blind Method; Epilepsy; F | 2010 |
Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Epilepsy; Exec | 2010 |
Effects of valproate, carbamazepine, and levetiracetam on the antioxidant and oxidant systems in epileptic patients and their clinical importance.
Topics: Adolescent; Adult; Anticonvulsants; Antioxidants; Aryldialkylphosphatase; Biomarkers; Carbamazepine; | 2010 |
Somatosensory evoked potentials in epileptic children treated with carbamazepine or valproate in monotherapy - a preliminary study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Evoked Potentials, Somatosensory; Femal | 2010 |
[Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; | 2010 |
[Comparative efficacy of carbamazepine, valproic acid and topiramate in symptomatic and cryptogenic occipital lobe epilepsy in children].
Topics: Adolescent; Anticonvulsants; Benzodiazepines; Brain Injuries; Carbamazepine; Child; Epilepsies, Part | 2010 |
Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Lipid Peroxidatio | 2011 |
The effect of levetiracetam monotherapy on subjective sleep quality and objective sleep parameters in patients with epilepsy: compared with the effect of carbamazepine-CR monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Ma | 2011 |
Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication.
Topics: Acridines; Adult; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Therapy, Combination; E | 2011 |
The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Topics: Adult; Alkaline Phosphatase; Anticonvulsants; Bicarbonates; Bone and Bones; Bone Density; Calcificat | 2011 |
Serum insulin, cortisol, leptin, neuropeptide Y, galanin and ghrelin levels in epileptic children receiving oxcarbazepine.
Topics: Adolescent; Anticonvulsants; Blood Glucose; Body Weight; Carbamazepine; Child; Child, Preschool; Epi | 2011 |
The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dietary Supplements; Epilepsy; Female; Foli | 2012 |
Population pharmacokinetics of carbamazepine in elderly patients.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Body Weight; Carbamazepine; Dose-Response Rel | 2012 |
Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Area Under Curve; Body Weight; Carbamazepine; Child | 2012 |
The effects of oxcarbazepine and valproate therapies on growth in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Body Height; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; | 2012 |
Reduced immunoglobulin levels in epilepsy patients treated with levetiracetam, lamotrigine, or carbamazepine.
Topics: Adolescent; Adult; Anticonvulsants; Body Mass Index; Carbamazepine; Double-Blind Method; Epilepsy; F | 2013 |
Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
Topics: Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Su | 2013 |
Effects of oxcarbazepine on sodium concentration and water handling.
Topics: Adolescent; Adult; Anticonvulsants; Arginine Vasopressin; Body Water; Carbamazepine; Epilepsy; Femal | 2002 |
Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Extracellular Space; Female; Humans; Male; Microdia | 2002 |
Fasting serum insulin and lipid levels in men with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Body Mass Index; Carbamazepine; Epilepsy; Fasting; Humans; Hyper | 2003 |
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Double-Blind M | 2003 |
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Tolerance; Epilepsy | 2003 |
Effect of long-term carbamazepine therapy on serum lipids, vitamin B12 and folic acid levels in children.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol; Cholesterol | 2003 |
Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Dose-Respon | 2003 |
The pharmacokinetics of oxcarbazepine and its active metabolite 10-hydroxy-carbazepine in healthy subjects and in epileptic patients treated with phenobarbitone or valproic acid.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Female; Ha | 1993 |
Evaluation of thyroid and parathyroid functions in children receiving long-term carbamazepine therapy.
Topics: Alkaline Phosphatase; Anticonvulsants; Calcium; Carbamazepine; Child; Epilepsy; Humans; Matched-Pair | 2003 |
The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.
Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, High Pressure L | 2003 |
Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Evaluation | 2003 |
Major malformations in offspring of women with epilepsy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Logistic Mode | 2003 |
Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Cross-Sectional Studies; Drug Administration Sche | 2004 |
Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Dose-Response Relationship, Drug; Double-Blind Me | 2004 |
Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Incidence; Male; Middle Aged; | 2004 |
Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Fema | 2004 |
Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Fema | 2004 |
Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Fema | 2004 |
Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Fema | 2004 |
Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Drug Interactions; Drug Tolerance; E | 2004 |
Increased depressant effect of phenytoin sodium as compared to carbamazepine on cortical excitability: a transcranial magnetic evaluation.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Magnetoencephalography; Male; Pheny | 2004 |
Treating refractory epilepsy with tiagabine: clinical experience.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedul | 2004 |
Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
Topics: Anticonvulsants; Area Under Curve; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination | 2004 |
Zonisamide monotherapy with once-daily dosing in children with cryptogenic localization-related epilepsies: clinical effects and pharmacokinetic studies.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Rela | 2004 |
Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Area Under Curve; Biotransformation; Carbamazepine; Cytochrome P | 2004 |
Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
Topics: Anticonvulsants; Antioxidants; Carbamazepine; Child; Child, Preschool; Double-Blind Method; Drug Int | 2004 |
Silent period to transcranial magnetic stimulation: construction and properties of stimulus-response curves in healthy volunteers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Electric Stimulation; Ep | 2005 |
Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Epoxide Hydrolases; Female; Haplotypes; Hum | 2005 |
Serum lipid levels during carbamazepine therapy in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Lipid | 2005 |
Pharmacological outcomes in newly diagnosed epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, C | 2005 |
Risk factors for carbamazepine elevation and toxicity following epilepsy surgery.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Body Weight; Carbamazepine; Child; Child, Preschool | 2005 |
New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine.
Topics: Aged; Aging; Amines; Anticonvulsants; Carbamazepine; Cerebral Infarction; Cyclohexanecarboxylic Acid | 2005 |
Early alteration in bone metabolism in epileptic children receiving carbamazepine monotherapy owing to the induction of hepatic drug-metabolizing enzymes.
Topics: Alkaline Phosphatase; Anticonvulsants; Bone Resorption; Carbamazepine; Child; Child, Preschool; Epil | 2005 |
Analysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLC.
Topics: Anticonvulsants; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Dose-Response Rel | 2005 |
Laser evoked potentials and carbamazepine in epileptic patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Evoked Potentials; Female; Humans | 2005 |
Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child, Preschool; Confusion; Consciousness | 2005 |
Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy.
Topics: Adolescent; Adult; Age Factors; Aging; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Down | 2005 |
Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Carnitine; Child; Child, Preschool; Dietary Fats; | 2006 |
Evolution of serum lipids and lipoprotein (a) levels in epileptic children treated with carbamazepine, valproic acid, and phenobarbital.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Diet; Epilepsy; Female; Humans; Lipids; Lipoprote | 2006 |
Effect of antiepileptic drugs on plasma lipids, lipoprotein (a), and liver enzymes.
Topics: Adolescent; Alkaline Phosphatase; Anticonvulsants; Apolipoproteins; Carbamazepine; Child; Child, Pre | 2006 |
Evaluation of antiepileptic drugs in pregnancy in a Jordanian army hospital.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Clinical Protocols; Drug Monitor | 2005 |
Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings.
Topics: Adolescent; Adult; Alpha Rhythm; Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epil | 2006 |
Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Lipid | 2006 |
Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Color Perception; Epilepsy; Female | 2006 |
Oxcarbazepine as add-on therapy in Thai epileptic patients with refractory partial seizures.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Me | 2005 |
Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study.
Topics: Anticonvulsants; Calcium; Carbamazepine; Child; Epilepsy; Female; Follow-Up Studies; Humans; Male; P | 2006 |
Long-term use of oxcarbazepine oral suspension in childhood epilepsy: open-label study.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Admi | 2006 |
Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study.
Topics: Acetonitriles; Amines; Anticonvulsants; Biotransformation; Buffers; Calibration; Carbamazepine; Chro | 2007 |
Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Chronotherapy; Dose-Response Relationship, | 2006 |
Preliminary report on effects of oxcarbazepine-treatment on serum lipid levels in children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; | 2006 |
Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Administration | 2006 |
Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Doubl | 2007 |
Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Attention; Carbamazepine; Cognition; Cognition Disorders; | 2006 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug | 2007 |
Oxcarbazepine improves mood in patients with epilepsy.
Topics: Adult; Analysis of Variance; Anticonvulsants; Antidepressive Agents; Anxiety; Carbamazepine; Case-Co | 2007 |
Antiepileptic drugs and the significance of event-related potentials.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Case-Control Studies; Electroencephalog | 2007 |
Reversible effects of antiepileptic drugs on reproductive endocrine function in men and women with epilepsy--a prospective randomized double-blind withdrawal study.
Topics: Adolescent; Adult; Aged; Androgens; Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsy; E | 2007 |
An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cross-Cultural Comparison; Del | 2007 |
Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Therapy | 2007 |
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.
Topics: Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; Female; Fructo | 2007 |
Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey.
Topics: Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transpor | 2008 |
Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Carbamazepine; Cerebral Cortex; Child; Child, Prescho | 2008 |
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Cysteine; Dipeptides; Ep | 2008 |
Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Hypot | 2007 |
Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations?
Topics: Anticonvulsants; Carbamazepine; Cell Membrane; Dietary Supplements; Docosahexaenoic Acids; Double-Bl | 2008 |
Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fructose; Humans; Male; Middle | 2008 |
Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Evaluation; Epilep | 2008 |
Antinuclear antibodies in children with epilepsy treated by carbamazepine.
Topics: Adolescent; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antinuclear; Anticonvulsants; Carbam | 2008 |
Historical perspective on the choice of antiepileptic drugs for the treatment of seizures in adults.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; History, 20th Century; Hu | 1983 |
Developments in pharmacotherapy of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Research Design; Valproi | 1983 |
Controlled and comparative trials of valproate performed in Europe and Asia.
Topics: Adolescent; Adult; Asia; Carbamazepine; Child; Clinical Trials as Topic; Epilepsy; Europe; Humans; P | 1984 |
l-Tryptophan in hyperactive child syndrome associated with epilepsy: a controlled study.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Clinical Trials as | 1983 |
A randomised trial of strategies to improve patient compliance with anticonvulsant therapy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Counseling; Drug Packag | 1984 |
Role of combination of valproic acid with diphenylhydantoin and carbamazepine in the management of intractable seizures.
Topics: Adolescent; Adult; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Epilepsy; Fem | 1984 |
Controlled trials in epilepsy: a review.
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Clinical Trials as Topic; Double-Blin | 1982 |
[Prospective studies on epilepsy therapy with carbamazepine].
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Clinical Trials as Topic; Epilepsies, Myoclonic; Epil | 1982 |
[Carbamazepine. A controlled clinical trial].
Topics: Absorption; Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; E | 1980 |
Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man.
Topics: Adolescent; Adult; Aged; Carbamazepine; Chromatography, Gas; Chromatography, High Pressure Liquid; C | 1980 |
Is the therapy with carbamazepine more effective when measuring blood levels?
Topics: Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Epilepsy; Humans; Infant; Monitori | 1980 |
Epilepsy and psychopathology in childhood: a controlled study with carbamazepine.
Topics: Carbamazepine; Child; Child Behavior Disorders; Clinical Trials as Topic; Electroencephalography; Ep | 1981 |
Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
Topics: Adolescent; Behavior; Brain; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Electroen | 1981 |
Kinetics of phenobarbital in normal subjects and epileptic patients.
Topics: Administration, Oral; Adult; Biological Availability; Carbamazepine; Epilepsy; Female; Humans; Injec | 1982 |
Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up.
Topics: Adult; Affect; Carbamazepine; Cognition; Epilepsy; Female; Follow-Up Studies; Humans; Male; Neuropsy | 1995 |
Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; gamma-Aminobutyric Acid; Humans; Male; Midd | 1995 |
Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial.
Topics: Adult; Age Distribution; Anticonvulsants; Carbamazepine; Comorbidity; Cross-Over Studies; Double-Bli | 1995 |
Effect of valproate and carbamazepine on visual evoked potentials in epileptic children.
Topics: Carbamazepine; Child; Child, Preschool; Epilepsy; Evoked Potentials, Visual; Female; Humans; Male; N | 1995 |
Double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy. The Tegretol OROS Osmotic Release Delivery System Study Group.
Topics: Adolescent; Adult; Aged; Carbamazepine; Delayed-Action Preparations; Double-Blind Method; Drug Admin | 1995 |
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsy; Female; Huma | 1995 |
Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults.
Topics: Adolescent; Adult; Aging; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Chromatography, H | 1995 |
[The enkorat treatment of infantile spasms and the Lennox-Gastaut syndrome].
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Clonazepam; Drug Therapy, Combination; Epilepsy; E | 1994 |
Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Cholesterol, | 1995 |
[Lamotrigine: first experience in Italy].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female | 1995 |
Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Depressive Disorder; Double-Blind Method; | 1994 |
[Effects of phenytoin and cabamazepine on sex hormones in male patients with epilepsy: a controlled study].
Topics: Adolescent; Adult; Carbamazepine; Case-Control Studies; Epilepsy; Estradiol; Humans; Male; Phenytoin | 1994 |
Cognitive side-effects of phenytoin compared with carbamazepine in patients with localization-related epilepsy.
Topics: Adolescent; Adult; Attention; Carbamazepine; Cognition Disorders; Epilepsy; Female; Humans; Male; Me | 1994 |
Renal tubular dysfunction following treatment with anti-epileptic drugs.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Sectional Studies; Epilep | 1994 |
Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
Topics: Aging; Body Weight; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilep | 1994 |
Thrombocytopenia secondary to high valproate levels in children with epilepsy.
Topics: Carbamazepine; Child; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Male; Platelet Cou | 1994 |
Flunarizine for treatment of partial seizures: results of a concentration-controlled trial.
Topics: Adolescent; Adult; Aged; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Drug | 1994 |
[Clinical analysis of 72 epileptic patients treated with alkaline extract of Euphorbia fisheriana].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Drugs, Chinese | 1994 |
Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria?
Topics: Attitude of Health Personnel; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; | 1994 |
A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Double-Blind Method; Drug Interactions; Epilepsy; Female; Hal | 1994 |
Does carnitine administration improve the symptoms attributed to anticonvulsant medications?: a double-blinded, crossover study.
Topics: Carbamazepine; Carnitine; Child; Double-Blind Method; Epilepsy; Female; Health Status; Humans; Male; | 1994 |
Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients.
Topics: Adult; Carbamazepine; Cognition Disorders; Epilepsy; Female; Follow-Up Studies; Humans; Learning; Ma | 1994 |
Carbamazepine and phenytoin in epilepsies refractory to barbiturates: efficacy, toxicity and mental function.
Topics: Adolescent; Adult; Affect; Carbamazepine; Child; Cognition; Epilepsies, Partial; Epilepsy; Female; H | 1993 |
Developmental and therapeutic pharmacology of antiepileptic drugs.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Dru | 1993 |
Withdrawal of antiepileptic medication in children--effects on cognitive function: The Multicenter Holmfrid Study.
Topics: Adolescent; Carbamazepine; Child; Cognition; Cognition Disorders; Epilepsy; Female; Follow-Up Studie | 1993 |
Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Follow-Up Studies; Humans; Mal | 1993 |
Effect of felbamate on carbamazepine and its major metabolites.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Double-Blind Method; Drug Interactions; Epilepsy; | 1993 |
A comparison of the OPUS and TDx analysers for antiepileptic drug monitoring.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Female; Fluorescence Polarization Immunoa | 1995 |
Activities of antioxidant enzymes and formation of the glutathione adduct of hemoglobin (Hb ASSG) in epileptic patients with long-term antiepileptic therapy.
Topics: Anticonvulsants; Antioxidants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Erythrocytes; Fem | 1995 |
Neither dosage nor serum levels of antiepileptic drugs are predictive for efficacy and adverse effects.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; | 1995 |
Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; | 1996 |
Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients.
Topics: Adult; Anesthesia Recovery Period; Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Female | 1996 |
Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study.
Topics: Adolescent; Anticonvulsants; Bender-Gestalt Test; Carbamazepine; Child; Cognition; Epilepsy; Event-R | 1996 |
Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy.
Topics: Adult; Age Factors; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy; Humans; Middle | 1996 |
Systematic testing of medical intractability for carbamazepine, phenytoin, and phenobarbital or primidone in monotherapy for patients considered for epilepsy surgery.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clinical Protocols; Dose | 1996 |
Pharmacokinetic interactions between lamotrigine and other antiepileptic drugs in children with intractable epilepsy.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cl | 1996 |
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Enzyme Induction; Epilepsy; Ethosuximide; | 1996 |
Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments.
Topics: Adolescent; Adult; Affect; Aging; Anticonvulsants; Behavior; Carbamazepine; Cognition Disorders; Dou | 1996 |
Effect of stiripentol on carbamazepine plasma concentration and metabolism in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dioxolanes; Drug Interactions; | 1996 |
Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cognition; Double-Blind Method; Epilepsy; Female; Follo | 1996 |
Brainstem auditory evoked potentials in epileptics on different anti-epileptic drugs.
Topics: Acoustic Stimulation; Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Combinations; Epilepsy | 1996 |
Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
Topics: Adult; Age Factors; Anticonvulsants; Body Weight; Carbamazepine; Dose-Response Relationship, Drug; D | 1996 |
Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Double-Blind Method; Drug Int | 1996 |
Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug | 1996 |
A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Male | 1996 |
Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications.
Topics: Adult; Carbamazepine; Cohort Studies; Craniofacial Abnormalities; Epilepsy; Female; Fingers; Humans; | 1997 |
Carbamazepine population pharmacokinetics in children: mixed-effect models.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy; Fema | 1997 |
Double dummy comparison between once and twice daily dosing with modified-release carbamazepine in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Double-Blind Method; Drug Administration | 1993 |
A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; gamm | 1997 |
Weight gain with valproate or carbamazepine--a reappraisal.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Over Studies; Dose-Respon | 1997 |
Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Area Under Curve; Biological Availability; | 1997 |
The effectiveness of clonazepam on the Rolandic discharges.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Electroencephalography; Epileps | 1997 |
The mechanism of the carbamazepine-valproate interaction in humans.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Mi | 1997 |
[Immunomodulatory therapy of epilepsy with transfer factor].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cross-Over Studies; Double-Blind Method; Epilepsy | 1997 |
Weight gain in epileptic patients during treatment with valproic acid: a retrospective study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged | 1997 |
Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.
Topics: Adult; Aged; Anticonvulsants; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Cytoch | 1997 |
A comparison of the neuropathological effects of vigabatrin and carbamazepine in patients with newly diagnosed localization-related epilepsy using MR-based cerebral T2 relaxation time measurements.
Topics: Adolescent; Adult; Anticonvulsants; Brain; Brain Mapping; Carbamazepine; Cerebellum; Epilepsy; Femal | 1998 |
Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers.
Topics: Anticonvulsants; Caffeine; Carbamazepine; Cross-Over Studies; Drug Interactions; Epilepsy; Humans; M | 1998 |
Electroencephalographic abnormalities in borderline personality disorder.
Topics: Adult; Anticonvulsants; Borderline Personality Disorder; Brain; Carbamazepine; Double-Blind Method; | 1998 |
Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.
Topics: Adolescent; Adult; Carbamazepine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dou | 1998 |
Feasibility and pharmacokinetics of carbamazepine oral loading doses.
Topics: Adult; Anticonvulsants; Area Under Curve; Carbamazepine; Epilepsy; Female; Half-Life; Humans; Male; | 1998 |
Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.
Topics: Adult; Anticonvulsants; Biological Availability; Carbamazepine; Chemistry, Pharmaceutical; Cognition | 1998 |
Economic analysis of epilepsy treatment: a cost minimization analysis comparing carbamazepine and lamotrigine in the UK.
Topics: Anticonvulsants; Carbamazepine; Cost Control; Decision Support Techniques; Drug Costs; Epilepsies, P | 1998 |
Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cognition Disorders; Dose-Response Relation | 1998 |
Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Linear Models; Male; Va | 1998 |
Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy.
Topics: Adolescent; Age Factors; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; C | 1998 |
Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy.
Topics: Adult; Anticonvulsants; Area Under Curve; Beverages; Carbamazepine; Citrus; Cross-Over Studies; Drug | 1998 |
[Therapeutic failure, treatment and non-treatment of childhood epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epileps | 1998 |
Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital.
Topics: Adolescent; Animals; Anticonvulsants; Carbamazepine; Carnitine; Child; Child, Preschool; Epilepsy; H | 1998 |
Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Double-Blind Method; Drug Administration Schedule; Drug | 1999 |
Antiepileptic drug therapy and sexual function in men with epilepsy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Androgen-Binding Protein; Androstenedione; Anticonvul | 1999 |
Anti-epileptic drug intake adherence. The value of the blood drug level measurement and the clinical approach.
Topics: Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Drug Monitoring; Epilepsy; Female; Humans; | 1998 |
Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Follow-Up Studies; Hu | 1998 |
Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years.
Topics: Anticonvulsants; Bone Density; Carbamazepine; Child; Epilepsy; Female; Humans; Lumbar Vertebrae; Mal | 1999 |
Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Combinations; Epilepsy; Female; Human | 1999 |
The cognitive and behavioural effects of clobazam and standard monotherapy are comparable. Canadian Study Group for Childhood Epilepsy.
Topics: Adolescent; Adolescent Behavior; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepin | 1999 |
Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Monitoring; Drug Therapy, Combination; Epile | 1999 |
Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
Topics: Acetates; Adolescent; Adult; Ambulatory Care; Amines; Anticonvulsants; Asthenia; Carbamazepine; Cycl | 1999 |
[Visual field defects due to antiepileptic drugs].
Topics: Acetates; Adolescent; Adult; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dr | 1999 |
Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Bl | 1999 |
A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. The Italian TDM Study Group in Epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dizziness; Drug Administration Sched | 2000 |
The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Erythrocytes; Female; | 2000 |
Effect of anticonvulsants on nocturnal sleep in epilepsy.
Topics: Acetates; Adult; Amines; Anticonvulsants; Carbamazepine; Circadian Rhythm; Cyclohexanecarboxylic Aci | 2000 |
Plasma and urinary serotonin and 5-HIAA in children treated with lamotrigine for intractable epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epil | 1999 |
Effect of vigabatrin addition on carbamazepine blood serum levels in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; | 2000 |
Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Color Perception; Color Perception Tests; Color Vision | 2000 |
Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Erythrocytes; Female; | 2000 |
Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin.
Topics: Anticonvulsants; Body Weight; Carbamazepine; Double-Blind Method; Drug Therapy, Combination; Epileps | 2000 |
Topiramate in refractory epilepsy: a prospective observational study.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Anticonvulsants; Carbamazepine; Drug Administration Schedu | 2000 |
Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Epilepsy; Female; Homocysteine; Humans; Male; Valproic A | 2000 |
A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.
Topics: Animals; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Double-Blind Method; Epilepsy; Hea | 2000 |
[The optimization of epilepsy therapy with finlepsin].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Chronic Dis | 2000 |
Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy.
Topics: 25-Hydroxyvitamin D 2; Adult; Aged; Anticonvulsants; Bone and Bones; Calcifediol; Carbamazepine; Epi | 2000 |
Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Calcium Channel Blockers; Carbamazepine; Child; Drug Administrat | 2000 |
Population pharmacokinetics of tiagabine in epileptic patients on monotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; | 2000 |
Developmental and therapeutic pharmacology of antiepileptic drugs.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Admini | 2000 |
A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Chemistry, Pharmaceutical; Delayed-Action Prepara | 1998 |
Influence of carbamazepine-10,11-epoxide on the serum level of valproic acid in epileptic patients on combined treatment with carbamazepine and valproic acid.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Intera | 2000 |
Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
Topics: Adult; Aged; Anticonvulsants; Area Under Curve; Carbamazepine; Epilepsy; Female; Half-Life; Humans; | 2001 |
Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cognition Disorders; Double-Blind Method; Drug Ad | 2001 |
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 800 mg/day) in a B.I.D. regimen.
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Confid | 2002 |
Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen.
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Dose-R | 2002 |
Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Dr | 2002 |
Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers.
Topics: Acetates; Adolescent; Adult; Alpha Rhythm; Amines; Anticonvulsants; Brain; Carbamazepine; Cognition; | 2002 |
Seizure reduction and quality of life improvements in people with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Attitude to Health; Carbamazepine; Drug Therapy, Combinati | 2002 |
Long-term outcome is unchanged by antiepileptic drug treatment after a first seizure: a 15-year follow-up from a randomized trial in childhood.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Lon | 2002 |
Carbamazepine vs phenytoin. A controlled clinical trial in focal motor and generalized epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsies, P | 1979 |
[Experiences with sodium 2-propyl valerate (Depakine) in the treatment of epilepsy].
Topics: Adolescent; Adult; Aged; Carbamazepine; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Clinica | 1977 |
Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin.
Topics: Adult; Attention; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Emo | 1977 |
Carbamazepine and the electroencephalogram of epileptics: a double blind study in comparison to phenytoin.
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Electroencephalography; Epilepsy; Humans; Hyperventi | 1978 |
Sodium valproate, serum level and clinical effect in epilepsy: a controlled study.
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Dimethadione; Dose-Response Relati | 1979 |
Manipulation of cerebral monoamines in the treatment of human epilepsy: a pilot study.
Topics: Adult; Biogenic Amines; Brain Chemistry; Carbamazepine; Drug Evaluation; Epilepsy; Homovanillic Acid | 1978 |
One drug for epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Middle Aged; Phenytoi | 1978 |
Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin).
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Epile | 1975 |
The efficacy of carbamazepine combinations in epilepsy.
Topics: Adult; Biological Availability; Carbamazepine; Clinical Trials as Topic; Drug Administration Schedul | 1975 |
Bioavailability of two carbamazepine preparations during chronic administration to epileptic patients.
Topics: Administration, Oral; Adult; Biological Availability; Carbamazepine; Child; Epilepsy; Humans; Male; | 1975 |
Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Cognition; Double-Blind Method; Epilepsy; Female; | 1992 |
Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy?
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Brain Diseases; Carbamazepine; Craniotomy; Dose-Respons | 1992 |
Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients.
Topics: Adolescent; Adult; Biological Availability; Carbamazepine; Child; Delayed-Action Preparations; Drug | 1992 |
A large-scale study of epilepsy in Ecuador: methodological aspects.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Cross-Sectional Studies; Developing Count | 1992 |
Comparative bioavailability of carbamazepine from two slow-release preparations.
Topics: Adult; Biological Availability; Carbamazepine; Delayed-Action Preparations; Epilepsy; Female; Humans | 1992 |
Therapeutic bioequivalency study of brand name versus generic carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Double-Blind Method; Drugs, Generic; Epilepsy; Humans; Middl | 1992 |
Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Female; Follow-Up Studies; Humans; Kenya; M | 1991 |
Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy.
Topics: Adolescent; Biological Availability; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Random Al | 1991 |
Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cognition; Epilepsy; Humans; In | 1991 |
Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.
Topics: Adult; Carbamazepine; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule | 1991 |
Treatment of epilepsy in mentally retarded patients with a slow-release carbamazepine preparation.
Topics: Adolescent; Adult; Carbamazepine; Child; Delayed-Action Preparations; Double-Blind Method; Drug Admi | 1991 |
Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticonvulsants; Carbamazepine; Electroencephalography; Epi | 1991 |
A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Ataxia; Attitude of Health Personnel; Attitude to Health; | 1991 |
A controlled study with taltrimide and sodium valproate: valproate effective in partial epilepsy.
Topics: Adolescent; Adult; Ambulatory Care; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; F | 1990 |
[Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults].
Topics: Adolescent; Adult; Aged; Analysis of Variance; Carbamazepine; Clinical Trials as Topic; Delayed-Acti | 1990 |
Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine.
Topics: Adult; Aged; Carbamazepine; Delayed-Action Preparations; Double-Blind Method; Epilepsy; Female; Huma | 1990 |
Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability?
Topics: Adolescent; Biological Availability; Carbamazepine; Child; Double-Blind Method; Epilepsy; Female; Hu | 1990 |
Slow release carbamazepine in treatment of poorly controlled seizures.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Delayed-Action Preparations; Epilepsy; Female; H | 1990 |
Discontinuation of antiepileptic drugs in children who have outgrown epilepsy: effects on cognitive function.
Topics: Adolescent; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Epilepsy; Ethosuximide; Hum | 1990 |
[Clinical and experimental control of optimal therapy in epilepsy].
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Neurocognitive Disorder | 1990 |
Comparative cognitive effects of anticonvulsants.
Topics: Adult; Anticonvulsants; Carbamazepine; Cognition; Epilepsy; Female; Humans; Male; Middle Aged; Neuro | 1990 |
Multiple-dose pharmacokinetic study with a slow-release carbamazepine preparation.
Topics: Adult; Carbamazepine; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Epilepsy; F | 1990 |
Haloperidol treatment with chronically medicated residents: dose effects on clinical behavior and reinforcement contingencies.
Topics: Adolescent; Adult; Behavior Therapy; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind Me | 1989 |
Hyponatraemia during oxcarbazepine therapy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Male; Multicenter Stu | 1989 |
Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
Topics: Anticonvulsants; Biological Availability; Carbamazepine; Clinical Trials as Topic; Epilepsy; Gas Chr | 1986 |
Compliant populations: variability in serum concentrations.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combina | 1988 |
Oxcarbazepine and spasticity: further observations.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsy; Fema | 1988 |
Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationship, Drug; E | 1988 |
Serum levels of sodium valproate, phenytoin and carbamazepine and seizure control in epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; Fema | 1986 |
Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Par | 1988 |
Withdrawal symptoms from phenytoin, carbamazepine and sodium valproate.
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1988 |
Aspects of compliance: taking drugs and keeping clinic appointments.
Topics: Adolescent; Adult; Anticonvulsants; Appointments and Schedules; Carbamazepine; Clinical Trials as To | 1988 |
Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone.
Topics: Adult; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsy; Humans; Phenobarbital | 1987 |
Polytherapy, monotherapy, and carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Therapy, Combination; Epilepsy; Human | 1987 |
Comparison of oxcarbazepine and carbamazepine: a double-blind study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Double-Bl | 1987 |
Progabide for refractory partial epilepsy: a controlled add-on trial.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Double-Blind Meth | 1986 |
Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.
Topics: Adult; Aged; Carbamazepine; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsy; Female; | 1986 |
Are the psychotropic effects of carbamazepine in manic-depressive illness mediated through the limbic system?
Topics: Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Electroencephalograp | 1985 |
Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.
Topics: Adolescent; Adult; Aged; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsies, P | 1985 |
[Efficient serum concentrations after single doses of antiepileptic drugs: concept of loading-dose].
Topics: Absorption; Administration, Oral; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epil | 1985 |
Carbamazepine for epilepsy. A controlled prospective evaluation.
Topics: Adult; Blood Cell Count; Bone Marrow Diseases; Carbamazepine; Clinical Trials as Topic; Electroencep | 1974 |
Studies with new drugs in the treatment of convulsive disorders.
Topics: Adult; Aggression; Anticonvulsants; Anxiety; Carbamazepine; Clinical Trials as Topic; Diazepam; Dibe | 1968 |
[Short report on the effect of the anticonvulsant Ro 5-4023 (clonazepam) in different forms of epilepsy].
Topics: Adolescent; Anticonvulsants; Barbiturates; Benzodiazepinones; Carbamazepine; Child; Child, Preschool | 1973 |
[Preliminary report on the use of Tegretol sirup in epileptic patients].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic | 1974 |
[Carbamazepine treatment of epileptic psychosis].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Depression; Dibenzazepi | 1968 |
Studies on the psychotropic action of Tegretol.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; | 1968 |
1786 other studies available for carbamazepine and Aura
| Article | Year |
|---|---|
Carbamazepine is not a substrate for P-glycoprotein.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Caco-2 Cel | 2001 |
3-Amino-1,5-benzodiazepinones: potent, state-dependent sodium channel blockers with anti-epileptic activity.
Topics: Animals; Anticonvulsants; Benzodiazepinones; Electrophysiology; Electroshock; Epilepsy; Ether-A-Go-G | 2008 |
Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl)semicarbazides.
Topics: Animals; Anticonvulsants; Antioxidants; Benzylidene Compounds; Drug Design; Electrons; Epilepsy; Mal | 2010 |
Synthesis and anticonvulsant activity of 8-alkoxy-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1]benzazepin-1-one derivatives.
Topics: Animals; Anticonvulsants; Benzazepines; Electroshock; Epilepsy; Mice; Nervous System; Pentylenetetra | 2011 |
Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).
Topics: Absorption; Amides; Animals; Anticonvulsants; Dioxanes; Dogs; Drug Evaluation, Preclinical; Drug Res | 2013 |
Design, synthesis and pharmacological evaluation of N-[4-(4-(alkyl/aryl/heteroaryl)-piperazin-1-yl)-phenyl]-carbamic acid ethyl ester derivatives as novel anticonvulsant agents.
Topics: Animals; Anticonvulsants; Carbamates; Drug Design; Electroshock; Epilepsy; Mice; Pentylenetetrazole; | 2015 |
Discovery of benzothiazine derivatives as novel, orally-active anti-epileptic drug candidates with broad anticonvulsant effect.
Topics: Administration, Oral; Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, | 2015 |
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.
Topics: Carbamazepine; Epilepsy; Humans; Kv1.1 Potassium Channel; Mutation; Phenotype | 2022 |
Interictal autonomic changes in persons with epilepsy (PWE) on carbamazepine (CBZ) versus other anti-seizure drug monotherapy: A cross-sectional study.
Topics: Carbamazepine; Cross-Sectional Studies; Epilepsy; Hand Strength; Humans; Pharmaceutical Preparations | 2021 |
Serum folate levels in children on long-term anti-seizure medication in a Nigerian tertiary center-Implications for practice and public health.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Folic Acid; Humans; I | 2021 |
Carbamazepine Biosensor Development for Epilepsy Patient Screening.
Topics: Biosensing Techniques; Carbamazepine; Electrodes; Epilepsy; Humans; Saliva | 2021 |
Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Cohort Studies; Dr | 2022 |
Factors involved in time reduction between seizure relapses in patients with epilepsy attending emergency rooms in Medellín, Colombia.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Colombia; Emergency Service, Hospital; Epilepsies, Parti | 2022 |
On-Site Biolayer Interferometry-Based Biosensing of Carbamazepine in Whole Blood of Epileptic Patients.
Topics: Biosensing Techniques; Carbamazepine; Chromatography, Liquid; Epilepsy; Horseradish Peroxidase; Huma | 2021 |
Neurologic toxicity of carbamazepine in treatment of trigeminal neuralgia.
Topics: Adult; Bipolar Disorder; Carbamazepine; Epilepsy; Female; Humans; Neuralgia; Trigeminal Neuralgia | 2022 |
A woman in her sixties with epilepsy and syncope.
Topics: Benzodiazepines; Carbamazepine; Electrocardiography; Electroencephalography; Epilepsy; Female; Human | 2022 |
Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lacosamide; Lamotrigine; Levetirace | 2022 |
Menthol exerts TRPM8-independent antiepileptic effects in prefrontal cortex pyramidal neurons.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Magnesium; Menthol; Prefrontal Cortex; Pyramidal C | 2022 |
High frequency oscillations play important roles in development of epileptogenesis/ictogenesis via activation of astroglial signallings.
Topics: Animals; Astrocytes; Carbamazepine; Connexin 43; Epilepsy; Glutamic Acid; Proto-Oncogene Proteins c- | 2022 |
Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
Topics: Aged; Anticonvulsants; Benzodiazepines; Carbamazepine; Drug Prescriptions; Epilepsy; Epilepsy, Gener | 2022 |
Glucose-PEG2000-DSPE modified carbamazepine nano system alleviated cell apoptosis and oxidative stress in epilepsy.
Topics: Animals; Apoptosis; Carbamazepine; Epilepsy; Glucose; Glucose Transporter Type 1; Male; Oxidative St | 2022 |
LC-MS/MS quantification of levetiracetam, lamotrigine and 10-hydroxycarbazepine in TDM of epileptic patients.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Chromatography, Liquid; Drug M | 2022 |
Oxcarbazepine and Hyponatremia.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Oxcarbazepine; Retrospective | 2022 |
Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy.
Topics: Benzodiazepines; Carbamazepine; Epilepsy; Humans; Mutation; Phenotype; Symporters | 2022 |
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.
Topics: Anticonvulsants; Autism Spectrum Disorder; Autistic Disorder; Carbamazepine; Child; Cohort Studies; | 2022 |
Acute lymphocytic leukemia in a patient with long-term carbamazepine exposure: Acute lymphoblastic leukemia that develops in a patient who has been using carbamazepine for a long time.
Topics: Anemia, Aplastic; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Neutropenia; Precursor Cell Lymp | 2023 |
Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; East Asian People; Epilepsy; Humans; Oxcarbazepine; Polymorph | 2023 |
Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Generalized; Humans; Oxcarbazepine | 2022 |
Comparison of signal enhancement strategies for carbamazepine detection in undiluted human saliva using an electrochemical sensor with stencil-printed carbon electrodes.
Topics: Carbamazepine; Carbon; Electrodes; Epilepsy; Humans; Saliva | 2022 |
Incidence of mental health conditions by seizure control among adults with epilepsy in the United States.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Ge | 2022 |
Expanding the genetic and clinical characteristics of Protocadherin 19 gene mutations.
Topics: Cadherins; Carbamazepine; Child, Preschool; Clonazepam; Epilepsy; Female; Humans; Infant; Mutation; | 2022 |
An LC-ESI-MS/MS assay for the therapeutic drug monitoring of 15 antiseizure medications in plasma of children with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Drug Monitoring; Epilepsy; Humans; Tandem Mass Spectrometry | 2022 |
Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Oxcarbazepine; Seizures | 2022 |
Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy.
Topics: Animals; Brain; Carbamazepine; Drug Resistant Epilepsy; Epilepsy; Kainic Acid; Ketoconazole; Mice; M | 2022 |
Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach.
Topics: Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Clobazam; Epilepsy; Levetiracetam; Male; M | 2022 |
Polymorphisms of the sodium voltage-gated channel, alpha subunit 1 (SCN1A -A3184G) gene among children with non-lesional epilepsy: a case-control study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Epilepsy; Genotype; Humans; | 2022 |
[An epileptic elderly with carbamazepine-induced bradycardia].
Topics: Aged; Bradycardia; Carbamazepine; Epilepsy; Humans | 2022 |
Association between anti-seizure medication and the risk of lower urinary tract infection in patients with epilepsy.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Epilepsy; Female; Gabapentin; Humans; | 2022 |
Long-Term Effects of Antiseizure Medications.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenytoin; Seizures | 2022 |
Trimetazidine, an Anti-Ischemic Drug, Reduces the Antielectroshock Effects of Certain First-Generation Antiepileptic Drugs.
Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease Models, Animal; Dose-Res | 2022 |
Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Levetiracetam; Piracetam; Retrospective Studies | 2022 |
Autism with Epilepsy: A Neuropsychopharmacology Update.
Topics: Adolescent; Anticonvulsants; Autistic Disorder; Carbamazepine; Child; Epilepsy; Humans; Lamotrigine | 2022 |
Serum folate levels in children with epilepsy seen in a tertiary health care facility in north central Nigeria.
Topics: Anticonvulsants; Carbamazepine; Child; Cross-Sectional Studies; Delivery of Health Care; Epilepsy; F | 2022 |
Effect of Lacosamide therapy on blood cells and IgA levels in children and adolescents with epilepsy in a clinical setting.
Topics: Acetamides; Adolescent; Anticonvulsants; Blood Cells; Carbamazepine; Child; Dose-Response Relationsh | 2022 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Benzodiazepines; Carbamazepine; Cohort Studies; Epilep | 2023 |
Ranolazine Interacts Antagonistically with Some Classical Antiepileptic Drugs-An Isobolographic Analysis.
Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease Models, Animal; Dose-Res | 2022 |
Repurposing Carbamazepine To Treat Gonococcal Infection in Women: Oral Delivery for Control of Epilepsy Generates Therapeutically Effective Levels in Vaginal Secretions.
Topics: Carbamazepine; Drug Repositioning; Epilepsy; Female; Gonorrhea; Humans; Neisseria gonorrhoeae | 2023 |
Levetiracetam as a first-line antiseizure medication in WHO grade 2 glioma: Time to seizure freedom and rates of treatment failure.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Freedom; Glioma; Humans; Levetiraceta | 2023 |
Population Pharmacokinetic Analysis of Drug-Drug Interactions Between Perampanel and Carbamazepine Using Enzyme Induction Model in Epileptic Patients.
Topics: Benzodiazepines; Carbamazepine; Drug Interactions; Enzyme Induction; Epilepsy; Humans; Retrospective | 2023 |
Trends in antiseizure medications utilization among women of childbearing age with epilepsy in Poland between 2015 and 2019.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiraceta | 2023 |
Next-generation sequencing-based HLA typing reveals the association of HLA-B*46:01:01 and HLA-DRB1*09:01:02 alleles with carbamazepine-induced hypersensitivity reactions in Vietnamese patients with epilepsy.
Topics: Alleles; Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Epilepsy; High-Throughput Nucleotide | 2023 |
Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development.
Topics: Anticonvulsants; Brain; Carbamazepine; Drug Compounding; Epilepsy; Humans | 2023 |
Long-term outcomes of classic and novel anti-seizure medication in a kainate-induced model of chronic epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Temporal Lobe; Kainic Acid; Mice; Valpr | 2023 |
Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Freedom; Humans; Oxcarbazepine; Retrospec | 2023 |
Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders.
Topics: Adolescent; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Ch | 2023 |
Change in Apo B100/A1 Ratio in Children With Epilepsy on Monotherapy With Sodium Valproate, Oxcarbazepine or Levetiracetam.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Levetiracetam; Longitudinal Studies; Oxcarb | 2023 |
Birth outcomes in pregnant women with epilepsy: A Nationwide multicenter study from Türkiye.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant; Infant, Newborn; Lamotrigine; Preg | 2023 |
Progressive multifocal leukoencephalopathy associated with carbamazepine-induced immune dysfunction and recovery after carbamazepine cessation.
Topics: Anticonvulsants; Carbamazepine; Contrast Media; Epilepsy; Gadolinium; Humans; Immune System Diseases | 2023 |
External validation of the AntiEpileptic Drug Monitoring in PREgnancy (EMPiRE) model for predicting seizures in pregnant women with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Cohort Studies; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam | 2023 |
Epilepsy and long-term risk of arrhythmias.
Topics: Atrial Fibrillation; Carbamazepine; Epilepsy; Genetic Predisposition to Disease; Humans; Valproic Ac | 2023 |
Assessment of vestibulo-ocular reflex with video head impulse test in epilepsy patients undergoing carbamazepine monotherapy.
Topics: Carbamazepine; Dizziness; Epilepsy; Head Impulse Test; Humans; Reflex, Vestibulo-Ocular | 2023 |
The impact of a newly established specialized pediatric epilepsy center in Tanzania: An observational study.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Epilepsy; Humans; Phenobarbital; Tanzania; V | 2023 |
Distribution pattern of UGT1A6 and UGT2B7 gene polymorphism and its impact on the pharmacokinetics of valproic acid and carbamazepine: Prospective genetic association study conducted in Pakistani patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Glucuronosyltransferase; Humans; | 2024 |
Efficacy and tolerability of oxcarbazepine in the treatment of focal epilepsy in neonates and infants under 3 months of age: A single-center retrospective analysis.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Humans; Infant; Infant, Newbor | 2023 |
Study on the reversal of epileptic drug resistance by tetramethylpyrazine in combination with carbamazepine through modulation of P-Glycoprotein expression in rat brain microvessel endothelial cell.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2023 |
Electrophysiological and Neurochemical Assessment of Selenium Alone or Combined with Carbamazepine in an Animal Model of Epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Electrodes; Electroencephalography; | 2020 |
Elevated serum alkaline phosphatase in epilepsy: effect of age and treatment.
Topics: Adolescent; Adult; Age Factors; Alkaline Phosphatase; Anticonvulsants; Carbamazepine; Child; Child, | 2020 |
[Epilepsy in children with congenital hemiparesis secondary to perinatal ictus].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infan | 2019 |
Lamotrigine vs. Carbamazepine Monotherapy for Epilepsy Treatment.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lamotrigine; Systematic Reviews as Topic | 2019 |
Preparation and Evaluation of Carbamazepine Solid Lipid Nanoparticle for Alleviating Seizure Activity in Pentylenetetrazole-Kindled Mice.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Drug Compounding; Epilepsy; Humans; | 2019 |
Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; | 2019 |
Genotoxicity assessment of antiepileptic drugs (AEDs) in human embryonic stem cells.
Topics: Anticonvulsants; Carbamazepine; DNA Damage; Epilepsy; Female; Human Embryonic Stem Cells; Humans; La | 2019 |
Lack of association of SCN2A rs17183814 polymorphism with the efficacy of lamotrigine monotherapy in patients with focal epilepsy from Herzegovina area, Bosnia and Herzegovina.
Topics: Adult; Anticonvulsants; Bosnia and Herzegovina; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilep | 2019 |
Effects on executive functions of antiepileptic monotherapy in pediatric age.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Epilepsy; Executive Function; Female | 2020 |
Language impairment in children aged 5 and 8 years after antiepileptic drug exposure in utero - the Norwegian Mother and Child Cohort Study.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cohort Studies; Epilepsy; Female; Humans; L | 2020 |
Dried Blood Microsampling-Based Therapeutic Drug Monitoring of Antiepileptic Drugs in Children With Nodding Syndrome and Epilepsy in Uganda and the Democratic Republic of the Congo.
Topics: Anticonvulsants; Carbamazepine; Child; Chromatography, Liquid; Democratic Republic of the Congo; Dri | 2020 |
[New recommendations for antiepileptic drug therapy: the last piece in the review of epilepsy care].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Pregnancy; Pre | 2020 |
Evaluation of Cardiac Repolarization Indices in Epilepsy Patients Treated with Carbamazepine and Valproic Acid.
Topics: Adolescent; Adult; Carbamazepine; Cross-Sectional Studies; Electrocardiography; Epilepsy; Female; He | 2020 |
Patterns of antiepileptic drug use among elderly patients with epilepsy: 2004-2015.
Topics: Aged; Aged, 80 and over; Aging; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; F | 2020 |
Effects of carbamazepine, eslicarbazepine, valproic acid and levetiracetam on bone microarchitecture in rats.
Topics: Animals; Anticonvulsants; Bone and Bones; Carbamazepine; Dibenzazepines; Disease Models, Animal; Epi | 2020 |
Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome.
Topics: Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsy; Humans; Lacosamide; Lamotri | 2020 |
Influence of dose and antiepileptic comedication on brivaracetam serum concentrations in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Drug Interactions; D | 2020 |
Serum Levels of Valproic Acid and Carbamazepine Do Not Correlate Well with End-Organ Dysfunction.
Topics: Adolescent; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Child, Preschool; Drug Therapy, | 2020 |
Effects of valproate, carbamazepine and levetiracetam on Tp-e interval, Tp-e/QT and Tp-e/QTc ratio.
Topics: Adult; Anticonvulsants; Arrhythmias, Cardiac; Carbamazepine; Case-Control Studies; Electrocardiograp | 2020 |
LGI1-antibody associated epilepsy successfully treated in the outpatient setting.
Topics: Adult; Aged; Ambulatory Care; Anticonvulsants; Autoantibodies; Carbamazepine; Epilepsy; Female; Huma | 2020 |
Effects of antiepileptic drugs on electroencephalography (EEG): Insights and applicability.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepines; Carbamazepine; Electroencephalography; Epilepsy | 2020 |
Herb-drug interaction of gastrodiae rhizoma on carbamazepine: A pharmacokinetic study in rats.
Topics: Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Chromatography, High Pressure Liquid; Drug | 2020 |
Association between HLA genotype and antiseizure medications (ASMs)-induced maculopapular eruption among epilepsy patients in Xinjiang, China.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Carbamazepine; China; Drug Eruptions; Epilepsy; Fe | 2020 |
Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy.
Topics: Age of Onset; Anticonvulsants; Carbamazepine; Electrophysiological Phenomena; Epilepsy; Genetic Asso | 2020 |
Distinct effects on cAMP signaling of carbamazepine and its structural derivatives do not correlate with their clinical efficacy in epilepsy.
Topics: Adenylyl Cyclases; Anticonvulsants; Calcium Signaling; Carbamazepine; Cyclic AMP; Cyclic AMP Respons | 2020 |
Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Topics: Anticonvulsants; Carbamazepine; Clobazam; Clonazepam; Databases, Factual; Drug Therapy, Combination; | 2020 |
Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; | 2020 |
Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Nigeria; Polycystic | 2021 |
Trends of anti-seizure medication use in pediatric patients in six cities in China from 2013 to 2018.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; China; Epilepsy; Female; Humans | 2020 |
Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; Drug Interactions; Drug Monitoring; Drug Therap | 2020 |
Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bipolar Disorder; Carbamazepine; Drug-Related Side Effects | 2020 |
Topics: Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Epilepsy; Humans; Malaysia; Valproic Acid | 2021 |
Antiseizure medication use during pregnancy and risk of ASD and ADHD in children.
Topics: Adolescent; Adult; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Autism Spectrum D | 2020 |
Childhood-onset seizures: A long-term cohort study of use of antiepileptic drugs, and drugs for neuropsychiatric conditions.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Comorbidity; Drug-Related Side | 2020 |
Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Denmark; Developmen | 2020 |
Pharmacokinetics, tolerability, and clinical effectiveness of perampanel in Japanese patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Drug Monitoring; Drug T | 2020 |
Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epoxide Hydrolases; Humans; Phenytoin | 2021 |
The correlation between carbamazepine and valproic acid monotherapy with serum adiponectin and carnitine.
Topics: Adiponectin; Adult; Anticonvulsants; Biomarkers; Carbamazepine; Carnitine; Dose-Response Relationshi | 2021 |
Epilepsy surveillance in normocephalic children with and without prenatal Zika virus exposure.
Topics: Anticonvulsants; Carbamazepine; Cohort Studies; Electroencephalography; Epilepsy; Female; Grenada; H | 2020 |
Association of xenobiotic receptor polymorphisms with carbamazepine response in epilepsy patients.
Topics: Adolescent; Adult; Basic Helix-Loop-Helix Transcription Factors; Carbamazepine; Case-Control Studies | 2021 |
Antiepileptic drugs and depression during pregnancy in women with epilepsy.
Topics: Adult; Anticonvulsants; Australia; Carbamazepine; Depression; Epilepsy; Female; Humans; Levetiraceta | 2020 |
Acute and chronic treatment with moclobemide, a reversible MAO-inhibitor, potentiates the antielectroshock activity of conventional antiepileptic drugs in mice.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, | 2021 |
Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Germany; Humans; Middle Aged; Neo | 2021 |
Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Dizziness; Epilepsy; Fatigue; Female; Humans; Hyponatremia; M | 2021 |
Knowledge of epilepsy among German pharmacists.
Topics: Anticonvulsants; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Humans; L | 2021 |
Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cognitive Dysfunction; Epilepsy; Female; Humans; | 2021 |
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Diplopia; Dizziness; Dru | 2021 |
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; Humans | 2020 |
Effects of antiepileptic drugs' administration during pregnancy on the nerve cell proliferation and axonal outgrowth of human neuroblastoma SH-SY5Y nerve cells.
Topics: Anticonvulsants; Carbamazepine; Cell Line, Tumor; Cell Proliferation; Child; Epilepsy; Female; Human | 2021 |
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.
Topics: Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Cost-Benefit Analysis; Epilepsy; Femal | 2021 |
[The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generali | 2021 |
Response to first antiseizure medication in patients diagnosed with epilepsy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cohort Studies; Epilepsy; Female; Follow-Up Studies; Hu | 2021 |
[Epilepsy in the aged : Challenges in diagnostics and treatment].
Topics: Aged; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lamotrigine; Levetiracetam | 2021 |
Effects of antiseizure monotherapy on visuospatial memory in pediatric age.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Ethosuximide; Executive Function; Femal | 2021 |
Sensitivity of unilateral- versus bilateral-onset spike-wave discharges to ethosuximide and carbamazepine in the fluid percussion injury rat model of traumatic brain injury.
Topics: Animals; Anticonvulsants; Brain Injuries, Traumatic; Carbamazepine; Disease Models, Animal; Electroc | 2021 |
Exercise Improved the Anti-Epileptic Effect of Carbamazepine through GABA Enhancement in Epileptic Rats.
Topics: Animals; Anticonvulsants; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Carbamazepine; Epilepsy; | 2021 |
Post-stroke epilepsy and antiepileptic drug use in men and women.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigin | 2021 |
Efficacy of phenobarbital in treating elderly epilepsy patients in rural northeast China: A community-based intervention trial.
Topics: Aged; Anticonvulsants; Carbamazepine; China; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; H | 2021 |
Cutaneous adverse reactions associated with antiseizure medication: clinical characteristics and implications in epilepsy treatment.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Exanthema; Humans; Oxcarbazepine; Stevens-Johnson Syndrome | 2021 |
Potential for improved retention rate by personalized antiseizure medication selection: A register-based analysis.
Topics: Anticonvulsants; Brain Injuries, Traumatic; Carbamazepine; Dementia; Epilepsy; Humans; Levetiracetam | 2021 |
Chronic limbic epilepsy models for therapy discovery: Protocols to improve efficiency.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Epilepsy; Levetiracetam; Pharmaceut | 2021 |
Management of bone metabolism in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Retrospective Studies; Valproic Acid | 2021 |
Relation between sexual dysfunctions and epilepsy, type of epilepsy, type of antiepileptic drugs: a prospective study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Incidence; Male; Middle Aged; P | 2017 |
Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Carbamazepine; Cost-Benefit Analysis; Efficiency; | 2017 |
Determination of serum carbamazepine concentration using dried blood spot specimens for resource-limited settings.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Chromatography, High Pressure Liquid; Cros | 2017 |
Effects of antiepileptic drugs on thyroid hormone function in epilepsy patients.
Topics: Adult; Age Factors; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Drug Therapy, Combinati | 2017 |
The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Cross-Over Studies; Disease Models, Animal; Dose-Response R | 2017 |
Assessment of atherosclerotic risk among patients with epilepsy on valproic acid, lamotrigine, and carbamazepine treatment.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Cross-Sectional Studies; Epilepsy; Female; Human | 2017 |
External quality assessment for laboratory testing of HLA-B*15:02 allele in relation to carbamazepine therapy.
Topics: Carbamazepine; Contraindications, Drug; Epilepsy; Genetic Predisposition to Disease; HLA-B15 Antigen | 2018 |
Activity Clamp Provides Insights into Paradoxical Effects of the Anti-Seizure Drug Carbamazepine.
Topics: Action Potentials; Animals; Anticonvulsants; Biological Clocks; Carbamazepine; Cells, Cultured; Dose | 2017 |
Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Therapy, Combination; Epilepsy; Female; | 2017 |
Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations.
Topics: Adult; Anticonvulsants; Benzodiazepines; Biological Availability; Blood-Brain Barrier; Carbamazepine | 2017 |
Patterns of antiepileptic drug prescription in Sweden: A register-based approach.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Drug Prescriptions; Epilepsy; Female; Humans; Lamotrigi | 2017 |
Mechanisms for Selective Single-Cell Reactivation during Offline Sharp-Wave Ripples and Their Distortion by Fast Ripples.
Topics: Action Potentials; Animals; Anticonvulsants; Brain Waves; CA1 Region, Hippocampal; Carbamazepine; Di | 2017 |
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
Topics: Adverse Drug Reaction Reporting Systems; Anticonvulsants; Carbamazepine; Drugs, Generic; Epilepsy; H | 2017 |
Population pharmacokinetics of oxcarbazepine and its monohydroxy derivative in epileptic children.
Topics: Age Factors; Anticonvulsants; Area Under Curve; Biotransformation; Carbamazepine; Child; Child, Pres | 2017 |
Homocysteine Metabolism and Hematological Parameters in Early Stage of Phenytoin Treated Epileptic Children.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Folic Acid; Homocysteine; Humans; Male; Phe | 2017 |
Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
Topics: Adult; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfamily B; Carbamazepine; | 2017 |
Anti-epileptic drug exposure and risk of foetal death in utero.
Topics: Adult; Anticonvulsants; Australia; Carbamazepine; Epilepsy; Female; Fetal Death; Humans; Pregnancy; | 2018 |
Inhibitory synapse deficits caused by familial α1 GABA
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebral Cortex; Coculture Techniques; Epilepsy; HEK293 Cel | 2017 |
Correlations between UGT2B7∗2 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 2018 |
Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
Topics: Adolescent; Alanine Transaminase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Child | 2017 |
Vitamin B
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistant Epilepsy; | 2017 |
Who are the individuals diagnosed with epilepsy using the Public Health System in the city of Pelotas, southern Brazil?
Topics: Adolescent; Adult; Aged; Anticonvulsants; Anxiety; Brazil; Carbamazepine; Child; Cross-Sectional Stu | 2018 |
Evaluation of sex hormones and sperm parameters in male epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Gonadal Steroid Hormones; Gonadotropins | 2018 |
Safety of antiepileptic drugs in children and young people: A prospective cohort study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Child, Preschool; Cohort | 2018 |
Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Child, Preschool; Cross-Sec | 2018 |
Maternal Carbamazepine Therapy and Unusual Adverse Effects in a Breastfed Infant.
Topics: Adult; Anticonvulsants; Bottle Feeding; Breast Feeding; Carbamazepine; Child of Impaired Parents; Ep | 2018 |
Effect of antiepileptic drug comedication on lamotrigine concentrations.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Inte | 2018 |
A Cross-Sectional Study to Assess the Modulation of Wnt Inhibitors following Anti-Epileptic Drug Therapy and their Correlation with Vitamin D and Receptor Activator of Nuclear Factor κ B Ligand in Indian Women with Epilepsy.
Topics: Adaptor Proteins, Signal Transducing; Adult; Anticonvulsants; Bone Morphogenetic Proteins; Carbamaze | 2018 |
PRE-OPERATIVE CARBAMAZEPINE-INDUCED HYPONATRAEMIA: SHOULD WE ACCEPT A RESET HYPO-OSMOLAR BASELINE AND PROCEED WITH SURGERY?
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Myasthenia Gravis; Pr | 2017 |
Carbamazepine-induced necrotizing leukocytoclastic vasculitis with a 20-year latency.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Middle Aged; Time Factors; Vasculitis, Leu | 2018 |
Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair".
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; H | 2018 |
Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair"?
Topics: Acetamides; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Epilepsy; H | 2018 |
[A nationwide multi-center questionnaire survey on the management and treatment of post-stroke seizure and epilepsy in Japan].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Japan; Levetiracetam; Male; Piracetam; Sei | 2018 |
Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy; Female; Hospitalization; Huma | 2018 |
Intravenous carbamazepine for the treatment of epilepsy.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; | 2018 |
Treatment of epilepsy in multiple sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Disability Evaluation; Electronic He | 2018 |
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug | 2018 |
Carbamazepine Verses Valproic Acid as Monotherapy in Epileptic Patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Chromatography, Liquid; Epilepsy; Female; | 2018 |
Psychiatric comedication in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Interactions; Drug | 2018 |
Electrocorticographic telemetric recording in unrestrained mouse pups.
Topics: Animals; Behavior, Animal; Brain; Carbamazepine; Electrocorticography; Epilepsy; Female; Male; Mice, | 2018 |
A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities.
Topics: Alzheimer Disease; Carbamazepine; Comorbidity; Data Mining; Databases, Bibliographic; Databases, Gen | 2018 |
Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anticonvulsants; Body Height; Body Weight; Carbamazepine; | 2018 |
Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.
Topics: Adult; Aged; Allopurinol; Anticonvulsants; Carbamazepine; Case-Control Studies; Drug Combinations; E | 2018 |
Memory dysfunction in school-aged children exposed prenatally to antiepileptic drugs.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Dose-Response Relationship, Drug; Epilepsy; Female; Hu | 2018 |
Renal dysfunctions/injury in adult epilepsy patients treated with carbamazepine or valproate.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Creatinine; Cross-Sectional Studies; Epilepsy; Fe | 2018 |
Effects of CYP3A5 and UGT2B7 variants on steady-state carbamazepine concentrations in Chinese epileptic patients.
Topics: Adult; Anticonvulsants; Asian People; Body Weight; Carbamazepine; Cytochrome P-450 CYP3A; Epilepsy; | 2018 |
Cochlear Function in Adults with Epilepsy and Treated with Carbamazepine.
Topics: Adult; Anticonvulsants; Audiometry, Pure-Tone; Auditory Threshold; Carbamazepine; Cochlea; Epilepsy; | 2018 |
Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS/TEN in epilepsy patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Cytokines; Drug Hypersensitivity Syndrome; Epilepsy; Female; | 2018 |
Frequency of drug combinations between enzyme-inducing first-generation antiepileptic drugs and inducible drugs in patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Cytochrome P-450 Enzyme Inducers; Drug Interactions; Drug Therapy, C | 2018 |
[Progress in synaptic mechanism in epileptogenesis].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Isoxazoles; N-Ethylmaleimide-Sensitive Proteins; N | 2018 |
New-onset interictal headache in Persons with epilepsy (PWE): A case-control study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Epilepsy; Female; He | 2018 |
Iron supplements in nursing home patients associated with reduced carbamazepine absorption.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Dietary Supplements; Drug Monitoring; Epile | 2018 |
The first-line antiepileptic drug carbamazepine: Reaction with biologically relevant free radicals.
Topics: Acetylcysteine; Animals; Anticonvulsants; Biotransformation; Carbamazepine; Chromatography, Liquid; | 2018 |
Familial congenital choanal atresia with GATA3 associated hypoparathyroidism-deafness-renal dysplasia syndrome unidentified on auditory brainstem response.
Topics: Adult; Anticonvulsants; Audiometry, Pure-Tone; Carbamazepine; Child; Choanal Atresia; Epilepsy; Evok | 2019 |
Effects of androsterone on the protective action of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Androgens; Androsterone; Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease | 2019 |
Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
Topics: Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette T | 2019 |
Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: A nationwide study.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Asian People; Carbamazepin | 2018 |
Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, | 2019 |
Effect of Long-term Carbamazepine Therapy on Bone Health.
Topics: Adult; Anticonvulsants; Biomarkers; Bone and Bones; Bone Density; Carbamazepine; Epilepsy; Female; H | 2018 |
Retention rate of first antiepileptic drug in poststroke epilepsy: A nationwide study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Leve | 2019 |
HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions.
Topics: Acute Generalized Exanthematous Pustulosis; Alleles; Anticonvulsants; Carbamazepine; Epilepsy; Genet | 2019 |
Factors predicting uncontrolled seizures in epilepsy with auditory features.
Topics: Adult; Anticonvulsants; Auditory Pathways; Carbamazepine; Databases, Bibliographic; Dose-Response Re | 2019 |
Effects of antiepileptic drugs on dynamic thiol/disulphide homeostasis in children with idiopathic epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Disulfides; Epilepsy; Female; H | 2019 |
The influence of concomitant antiepileptic drugs on lamotrigine serum concentrations in Northwest Chinese Han population with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Carbamazepine; Child; Child, Preschool; China; Dru | 2019 |
UHPLC-MS/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients.
Topics: Acridines; Carbamazepine; Chromatography, High Pressure Liquid; Dibenzazepines; Drug Monitoring; Epi | 2019 |
Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Lamotrigine; Learning; Memor | 2019 |
Correction of medication nonadherence results in better seizure outcomes than dose escalation in a novel preclinical epilepsy model of adherence.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Electroencephalography; Epilepsy; M | 2019 |
Lamotrigine drug interactions in combination therapy and the influence of therapeutic drug monitoring on clinical outcomes in paediatric patients.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Czech Republic; Dose-Response R | 2019 |
Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats.
Topics: Animals; Anticonvulsants; Apoptosis; Carbamazepine; Caspase 9; Cognition; Drug Therapy, Combination; | 2019 |
Effect of carbamazepine on spontaneous recurrent seizures recorded from the dentate gyrus in rats with kainate-induced epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Convulsants; Dentate Gyrus; Disease Models, Animal; Epileps | 2019 |
[Association of single nucleotide polymorphisms of SCN1A gene with therapeutic effect of carbamazepine among ethnic Zhuang Chinese patients with epilepsy].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Genotype; Humans; NAV1.1 Voltage-Gated Sodium Channel; Pol | 2019 |
Developmental outcomes at age four following maternal antiepileptic drug use.
Topics: Adult; Anticonvulsants; Carbamazepine; Child Development; Child, Preschool; Cohort Studies; Epilepsy | 2019 |
Preconceptional paternal antiepileptic drugs use and risk of congenital anomalies in offspring: a nationwide cohort study.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cohort Studies; Denmark; Epilepsy; F | 2019 |
Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Sub | 2019 |
Etiology of neonatal seizures and maintenance therapy use: a 10-year retrospective study at Toulouse Children's hospital.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Cohort Studies; Databases, Factual; Dose-Response Relati | 2019 |
Use of antiepileptic drugs and risk of skin cancer: A nationwide case-control study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Carcinoma, Basal Cell; Carcinoma, Squamous | 2020 |
Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; Cost-Benefit Analysis; Epilepsy; Genetic Predis | 2019 |
Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; DNA Methylation; Drug Resistance; Drug Resistan | 2019 |
Behavioral problems in children of mothers with epilepsy prenatally exposed to valproate, carbamazepine, lamotrigine, or levetiracetam monotherapy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Child Behavior Disorders; Epilepsy; Female; Humans; La | 2019 |
Ictal asystole: a diagnostic and management conundrum.
Topics: Anticonvulsants; Bradycardia; Carbamazepine; Deja Vu; Epilepsy; Female; Heart Arrest; Humans; Lamotr | 2019 |
Management and attitudes toward patients with epilepsy in general practice: How far have we come in three decades?
Topics: Adult; Anticonvulsants; Attitude of Health Personnel; Australia; Carbamazepine; Clinical Competence; | 2019 |
Self-reported attitudes about medication in Lebanese people with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Attitude to Health; Carbamazepine; Cros | 2019 |
Reduced Systemic and Brain Exposure with Inhibited Liver Metabolism of Carbamazepine After Its Long-Term Combination Treatment with Piperine for Epilepsy Control in Rats.
Topics: Alkaloids; Animals; Anticonvulsants; Benzodioxoles; Brain; Carbamazepine; Cytochrome P-450 Enzyme In | 2019 |
The 2-Hydroxyiminostilbene Metabolite of Carbamazepine or the Supernatant from Incubation of Hepatocytes with Carbamazepine Activates Inflammasomes: Implications for Carbamazepine-Induced Hypersensitivity Reactions.
Topics: Alarmins; Anticonvulsants; Carbamazepine; Cell Line, Tumor; Dibenzazepines; Drug Hypersensitivity; E | 2019 |
Development of a rapid and reliable single-tube multiplex real-time PCR method for
Topics: Alleles; Anticonvulsants; Asian People; Carbamazepine; Epilepsy; Female; Genetic Predisposition to D | 2019 |
Reactive lymphocytes in an allergic drug reaction.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Eruptions; Drug Hypersensitivity; Epilepsy; Female; Huma | 2019 |
Multidrug resistance-associated protein 1 decreases the concentrations of antiepileptic drugs in cortical extracellular fluid in amygdale kindling rats.
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebral Cortex; Epilepsy; Extracellular Fluid; Hippocampus | 2013 |
[Patent rickets disclosed by loss of convulsion control in a boy with cerebral palsy].
Topics: Anticonvulsants; Calcium; Carbamazepine; Cerebral Palsy; Child, Preschool; Diazepam; Epilepsy; Human | 2013 |
HLA typing in Brazilian boys with aromatic antiepileptic drug-induced DRESS.
Topics: Alleles; Anticonvulsants; Brazil; Carbamazepine; Child; Drug Eruptions; Eosinophilia; Epilepsy; Hist | 2013 |
Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand.
Topics: Alleles; Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Epilepsy; Genetic Predisposition to | 2013 |
In utero oxcarbazepine and a withdrawal syndrome, anomalies, and hyponatremia.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Infant; Oxcarbazepine; Pregn | 2013 |
Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.
Topics: Action Potentials; Animals; Anticonvulsants; Biophysics; Carbamazepine; Disease Models, Animal; Dose | 2013 |
Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs.
Topics: Anticonvulsants; Bone Density Conservation Agents; Carbamazepine; Cholecalciferol; Epilepsy; Humans; | 2013 |
Sirenomelia after phenobarbital and carbamazepine therapy in pregnancy.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Ectromelia; Epilepsy; Fatal Outcome; Female; Humans; Phe | 2013 |
Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle.
Topics: Accidents, Traffic; Aggression; Amines; Anterior Temporal Lobectomy; Anticonvulsants; Brain Injuries | 2013 |
The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a northern Han Chinese population.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; China; Drug Eruptions; Epilepsy; Female; Gene F | 2013 |
Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug-Related Side Effects and Adverse Reactions; Epilepsy; HL | 2013 |
Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infan | 2014 |
Ventricular ectopic beats in a child receiving carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Electrocardiography; Epilepsy; Humans; Male; Syncope; Valproi | 2013 |
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Biomarkers; Carbamaz | 2013 |
The impact of age on lamotrigine and oxcarbazepine kinetics: a historical cohort study.
Topics: Adult; Aged; Aging; Anticonvulsants; Carbamazepine; Cohort Studies; Dose-Response Relationship, Drug | 2013 |
Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Dried Blood Spot Testing; Drug | 2014 |
Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study.
Topics: Anticonvulsants; Atherosclerosis; Carbamazepine; Carotid Arteries; Carotid Intima-Media Thickness; C | 2013 |
A comparison of the efficacy and tolerability of oxcarbazepine oral suspension between infants and children with epilepsy: a retrospective chart review at a single medical center in Taiwan.
Topics: Administration, Oral; Anticonvulsants; Carbamazepine; Child; Drug Evaluation; Epilepsy; Humans; Infa | 2014 |
Lipid profile and thyroid hormone concentrations in children with epilepsy treated with oxcarbazepine monotherapy: a prospective long-term study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Immun | 2014 |
Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
Topics: Adult; Asian People; Carbamazepine; Cytochrome P-450 CYP3A; Drug Resistance; Epilepsy; Epoxide Hydro | 2013 |
Malformation in index pregnancy in women with epilepsy is not followed by recurrence in subsequent pregnancy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; India; Pregna | 2013 |
Use of oxcarbazepine for treatment of refractory status epilepticus.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Hyponatremia; Mal | 2014 |
Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation.
Topics: Amines; Animals; Anticonvulsants; Astrocytes; Blotting, Western; Carbamazepine; Cells, Cultured; Coc | 2014 |
Slow carbamazepine clearance in a nonadherent Malay woman with epilepsy and thyrotoxicosis.
Topics: Adult; Anticonvulsants; Antithyroid Agents; Carbamazepine; Carbimazole; Dose-Response Relationship, | 2014 |
P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barri | 2013 |
The impact of the use of antiepileptic drugs on the growth of children.
Topics: Adolescent; Anticonvulsants; Body Height; Bone Diseases, Developmental; Calcium; Carbamazepine; Cell | 2013 |
[Pulmonary embolism due to interaction between rivaroxaban and carbamazepine].
Topics: Anticoagulants; Anticonvulsants; Arthroplasty, Replacement, Knee; Carbamazepine; Drug Interactions; | 2013 |
Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction.
Topics: Adolescent; Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Child; Cytochrome | 2014 |
Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Case-Control Studies; Databases, Factual; D | 2013 |
The effects of valproic acid and carbamazepine on strength-duration properties of peripheral nerve.
Topics: Adolescent; Adult; Anticonvulsants; Biophysics; Carbamazepine; Child; Electric Stimulation; Electroe | 2014 |
[Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged; Seasons; Valproi | 2013 |
Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug | 2014 |
Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Topics: Absorptiometry, Photon; Adolescent; Adult; Analysis of Variance; Anticonvulsants; Bone Density; Bone | 2014 |
Vitamin D levels in children and adolescents with antiepileptic drug treatment.
Topics: Adolescent; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Carbamazepine; Child; Child, Pr | 2014 |
Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.
Topics: Acetamides; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Inte | 2014 |
A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Multidrug Resistance-Associated Protein 2; Mul | 2014 |
Effect of oral contraceptives on lamotrigine levels depends on comedication.
Topics: Adult; Anticonvulsants; Blood Chemical Analysis; Carbamazepine; Contraceptives, Oral; Drug Interacti | 2014 |
Rapid detection of HLA-A*31:01 allele in DNA and blood samples using loop-mediated isothermal amplification.
Topics: Alleles; Anticonvulsants; Biomarkers; Carbamazepine; Cell Line; DNA; Drug Eruptions; Early Diagnosis | 2014 |
Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy.
Topics: Action Potentials; Animals; Anticonvulsants; CA1 Region, Hippocampal; Carbamates; Carbamazepine; Dis | 2014 |
Hemiconvulsion-hemiplegia-epilepsy syndrome: clinical course and neuroradiological features in a 20-month-old girl.
Topics: Anticonvulsants; Atrophy; Brain; Carbamazepine; Epilepsy; Female; Hemiplegia; Humans; Infant; Syndro | 2014 |
Carbamazepine clearance and seizure stability during pregnancy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pregnancy Complications; | 2014 |
Oxcarbamazepine associated with serious skin reaction: a case report.
Topics: Anticonvulsants; Carbamazepine; Drug Eruptions; Epilepsy; Humans; Male; Middle Aged; Severity of Ill | 2014 |
Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms.
Topics: Animals; Anticonvulsants; Calcium Channels; Carbamazepine; Disease Models, Animal; Drug Resistance; | 2014 |
Evaluation of thyroid hormones in children receiving carbamazepine or valproate: a prospective study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Prospective Studi | 2015 |
Peri-ictal headache due to epileptiform activity in a disconnected hemisphere.
Topics: Anticonvulsants; Brain; Carbamazepine; Child, Preschool; Electroencephalography; Epilepsy; Female; F | 2014 |
Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.
Topics: Adolescent; Adult; Alleles; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfami | 2014 |
Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
Topics: Adolescent; Anticonvulsants; Asian People; Carbamazepine; Child; Child, Preschool; Chromatography, H | 2014 |
Managing drug-drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: a 'tour de force' for clinical pharmacologists.
Topics: Anticonvulsants; Antiviral Agents; Atazanavir Sulfate; Carbamazepine; Cytochrome P-450 CYP3A; Drug D | 2014 |
Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine.
Topics: Adolescent; Anticonvulsants; Aorta; Blood Glucose; Brachial Artery; Carbamazepine; Carotid Arteries; | 2014 |
Reboxetine and its influence on the action of classical antiepileptic drugs in the mouse maximal electroshock model.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Disease Models, Animal; Drug Interactions; Electrosh | 2014 |
Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients.
Topics: Alleles; Asian People; Carbamazepine; Epilepsy; Genotype; Humans; NAV1.1 Voltage-Gated Sodium Channe | 2014 |
The first report of oxcarbazepine-induced vanishing bile duct syndrome.
Topics: Anticonvulsants; Bile Duct Diseases; Carbamazepine; Epilepsy; Female; Humans; Middle Aged; Oxcarbaze | 2014 |
Does nephrotoxicity exist in pediatric epileptic patients on valproate or carbamazepine therapy?
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Creatinine; Cystatin C; Epi | 2015 |
[Effects of carbamazepine on plasma concentrations of valproic acid and its toxic metabolite in epileptic patients].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epi | 2014 |
Function of inhibitory micronetworks is spared by Na+ channel-acting anticonvulsant drugs.
Topics: Animals; Anticonvulsants; Biophysics; Carbamazepine; Convulsants; Disease Models, Animal; Electric S | 2014 |
Human leukocyte antigen genotypes and trial of desensitization in patients with oxcarbazepine-induced skin rash: a pilot study.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Desensitization, Immunologic; D | 2014 |
Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Female; Genetic Association Studie | 2014 |
Asymmetric dimethylarginine and vascular risk in patients treated with antiepileptic drugs.
Topics: Anticonvulsants; Aorta; Brachial Artery; Carbamazepine; Carotid Arteries; Epilepsy; Female; Humans; | 2014 |
Association of certain chronic maternal diseases with the risk of specific congenital heart defects: a population-based study.
Topics: Adult; Anticonvulsants; Aortic Coarctation; Carbamazepine; Case-Control Studies; Chronic Disease; Di | 2014 |
Population pharmacokinetics modeling of oxcarbazepine to characterize drug interactions in Chinese children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy; Fe | 2014 |
Carbamazepine-imatinib interaction in a child with chronic myeloid leukemia.
Topics: Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Humans; Imatinib Mesylate; Leuke | 2014 |
Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dried Blood Spot Testing; Drug Monitoring; Drug Therapy | 2014 |
A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models.
Topics: Animals; Anticonvulsants; Carbamazepine; Computers; Disease Models, Animal; Drug Delivery Systems; E | 2014 |
Validation of a multigenic model to predict seizure control in newly treated epilepsy.
Topics: Adult; Algorithms; Anticonvulsants; Artificial Intelligence; Australia; Biomarkers, Pharmacological; | 2014 |
[Convulsions due to an interaction between anti-epileptic drugs and rifampicin].
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Cytochrome P-450 Enzyme System; Drug Interactions; Epile | 2014 |
Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Femal | 2015 |
A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
Topics: Adolescent; Age Factors; Anticonvulsants; Body Weight; Carbamazepine; Child; Child, Preschool; Drug | 2015 |
Response to "Asymmetric dimethylarginine and vascular risk in patients treated with antiepileptic drugs".
Topics: Anticonvulsants; Aorta; Brachial Artery; Carbamazepine; Carotid Arteries; Epilepsy; Female; Humans; | 2014 |
Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.
Topics: Adaptor Proteins, Signal Transducing; Adult; ATP Binding Cassette Transporter, Subfamily B; Carbamaz | 2014 |
Effects of phenytoin and valproic acid on cognitive functions of Thai epileptic patients: a pilot study.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Cognition; Ep | 2014 |
IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Child Development; Epilepsy; Female; Humans; Intellige | 2015 |
Fine-tuning risk assessment with antiepileptic drug use in pregnancy.
Topics: Anticonvulsants; Carbamazepine; Child Development; Epilepsy; Female; Humans; Intelligence; Lamotrigi | 2015 |
[A case of focal epilepsy manifesting multiple psychiatric auras].
Topics: Carbamazepine; Consciousness; Diagnosis, Differential; Electroencephalography; Epilepsies, Partial; | 2015 |
Cardiac asystoles misdiagnosed as epileptic seizures.
Topics: Aged; Anticonvulsants; Carbamazepine; Diagnostic Errors; Electroencephalography; Epilepsy; Heart Arr | 2015 |
Valproate and pregnancy: think again.
Topics: Anticonvulsants; Carbamazepine; Child Development; Epilepsy; Female; Humans; Intelligence; Lamotrigi | 2015 |
Development of mania with carbamazepine for treatment of seizure disorder in a 7-year-old boy.
Topics: Anticonvulsants; Bipolar Disorder; Carbamazepine; Child; Epilepsy; Humans; Male | 2015 |
Osteomalacia: a forgotten cause of fractures in the elderly.
Topics: Aged; Anticonvulsants; Carbamazepine; Delayed Diagnosis; Diet; Epilepsy; Femoral Neck Fractures; Hum | 2015 |
Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Asian People; Carbamazepine; Child; Chi | 2016 |
A rare paroxysmal movement disorder: mixed type of paroxysmal dyskinesia.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Chorea; Clonazepam; Diagnosis, Differential; Drug Therap | 2014 |
Epilepsy in a boy with a developmental venous anomaly--case-based update.
Topics: Angiography, Digital Subtraction; Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epi | 2015 |
Endocrine Effects of Valproate versus Carbamazepine in Males with Epilepsy: A Prospective Study.
Topics: Adolescent; Anticonvulsants; Body Height; Body Weight; Carbamazepine; Child; Epilepsy; Humans; Male; | 2015 |
[Effects of topiramate on headache in children with epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Fructose; Hea | 2015 |
Antiepileptic drugs in Rett Syndrome.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Male | 2015 |
SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.
Topics: Adult; Alleles; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; | 2015 |
Case 1: Joint Pain, Weight Loss, Fatigue, and Persistent Pleural Effusions in 17-year-old Boy.
Topics: Adolescent; Anticonvulsants; Arthralgia; Asthma; Carbamazepine; Diabetes Mellitus, Type 2; Diagnosis | 2015 |
Case 3: Fever, Vomiting, and Increased Sleepiness in a 4-year-old Girl.
Topics: Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Child, Preschool; Diagnosis, | 2015 |
A prospective study of adverse drug reactions to antiepileptic drugs in children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cognition Disorders; Drug Thera | 2015 |
Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Decision Trees; Drug-Related Side Effe | 2015 |
Effect of Carbamazepine and Valproate Monotherapy on Cardiovascular Risks in Epileptic Children.
Topics: Anticonvulsants; Apolipoproteins A; Apolipoproteins B; Blood Chemical Analysis; Carbamazepine; Cardi | 2015 |
Practical guidance and considerations for transitioning patients from oxcarbazepine or carbamazepine to eslicarbazepine acetate--Expert opinion.
Topics: Anticonvulsants; Attitude of Health Personnel; Carbamazepine; Dibenzazepines; Drug Substitution; Dru | 2015 |
Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs.
Topics: Acetylcholinesterase; Adult; Anticonvulsants; Antioxidants; Aryldialkylphosphatase; Carbamazepine; C | 2015 |
Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery.
Topics: Adolescent; Adult; Aged; Attitude of Health Personnel; Carbamazepine; Epilepsy; Female; Genetic Test | 2015 |
Impact of epilepsy and antiepileptic medications on the metabolic profile in adults with autism spectrum disorder and intellectual disabilities.
Topics: Adult; Anticonvulsants; Autism Spectrum Disorder; Blood Glucose; Body Mass Index; Carbamazepine; Cho | 2015 |
Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Dibenzazepines; Dyslipidemias; Epilepsy; Female; | 2015 |
Cytochrome P450 2C19 polymorphisms and valproic acid-induced weight gain.
Topics: Adolescent; Anticonvulsants; Body Mass Index; Carbamazepine; Child; Cytochrome P-450 CYP2C19; Epilep | 2016 |
Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study.
Topics: Administration, Intravenous; Adult; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Therapy, Co | 2016 |
Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy.
Topics: Adult; Alleles; Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Dose-Response Relationship, | 2015 |
A LC-MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS.
Topics: Anticonvulsants; Calibration; Carbamazepine; Child; Chromatography, Liquid; Dried Blood Spot Testing | 2015 |
[Valproic acid responsible for low IQ].
Topics: Anticonvulsants; Carbamazepine; Child Development; Epilepsy; Female; Humans; Intelligence; Male; Pre | 2015 |
Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
Topics: Adolescent; Adult; Aged; Aging; Anticonvulsants; Carbamazepine; Child; Databases, Pharmaceutical; Dr | 2015 |
Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Prescriptions; Epilepsy; F | 2015 |
Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Hypersensitivity Syndrome; Eczema, Dyshidrotic; Eosinoph | 2016 |
Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy.
Topics: Adolescent; Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; Carbamazepine; Ch | 2015 |
Drug-induced systemic lupus erythematosus in a child after 3 years of treatment with carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Drug Eruptions; Epilepsy; Female; Humans; Lupus Erythematosus | 2017 |
Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Middle Age | 2016 |
Fine-tuning risk assessment with antiepileptic drug use in pregnancy.
Topics: Anticonvulsants; Carbamazepine; Child Development; Epilepsy; Female; Humans; Intelligence; Male; Pre | 2015 |
Delayed Intraparenchymal Hematoma Following Diagnostic Lumbar Puncture.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Magnetic Resonance Imaging; Male; Spinal Pu | 2015 |
A case of lichenoid drug eruption in a child treated with carbamazepine for idiopathic epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Contraindications; Drug Eruptions; Drug Substitution; Epileps | 2015 |
First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfamily B; Bio | 2015 |
Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
Topics: Adolescent; Adult; Albania; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Ep | 2015 |
Do HLA-A markers predict skin-reactions from aromatic antiepileptic drugs in a Norwegian population? A case control study.
Topics: Adult; Anticonvulsants; Carbamazepine; Case-Control Studies; Cross Reactions; Epilepsy; Female; Gene | 2015 |
Concomitant administration of rifampicin and oxcarbazepine results in a significant decrease of the active MHD metabolite of oxcarbazepine.
Topics: Acne Vulgaris; Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Drug Interactions; Epil | 2016 |
Application of Counter-propagation Artificial Neural Networks in Prediction of Topiramate Concentration in Patients with Epilepsy.
Topics: Adult; Algorithms; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Drug Intera | 2015 |
Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Depression; Drug-Related Side Effects and Adve | 2016 |
CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Cytochrome P-450 CYP1A2; Epilepsy; Female; Genot | 2016 |
Use of antiepileptic drugs during pregnancy and lactation: Type of information provided by searching Google.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans | 2016 |
Toxic epidermal necrolysis in patient with malignant astrocytoma.
Topics: Astrocytoma; Bacterial Outer Membrane Proteins; Brain Neoplasms; Carbamazepine; Epilepsy; Female; Hu | 2016 |
Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fructose; Humans; Male; M | 2016 |
Concentrations of carbamazepine and carbamazepine-10,11-epoxide in maternal and umbilical cord blood at birth: Influence of co-administration of valproic acid or enzyme-inducing antiepileptic drugs.
Topics: Adolescent; Adult; Anticonvulsants; Blood Chemical Analysis; Carbamazepine; Dose-Response Relationsh | 2016 |
Weight gain in children on oxcarbazepine monotherapy.
Topics: Adolescent; Anticonvulsants; Body Mass Index; Carbamazepine; Child; Child, Preschool; Epilepsy; Fema | 2016 |
The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
Topics: Adolescent; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Child, Preschool; Clobazam; Clon | 2016 |
Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Metabolic Syndrome; Mid | 2016 |
Comparative case-control study of homocysteine, vitamin B
Topics: Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Case-Control Studies; Epilepsy; Fema | 2017 |
Medication prescribing and patient-reported outcome measures in people with epilepsy in Bhutan.
Topics: Adult; Aged; Anticonvulsants; Bhutan; Carbamazepine; Drug Prescriptions; Electroencephalography; Epi | 2016 |
Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Topics: Adolescent; Anticonvulsants; Bone Remodeling; Carbamazepine; Case-Control Studies; Child; Child, Pre | 2016 |
Comparison of body composition in persons with epilepsy on conventional & new antiepileptic drugs.
Topics: Adult; Anticonvulsants; Benzodiazepines; Body Composition; Body Water; Body Weight; Carbamazepine; C | 2016 |
Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Drug Resistance; Epilepsy; Epoxide Hy | 2016 |
Reflections on monotherapy trials for epilepsy - Authors' reply.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans | 2016 |
Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.
Topics: Adult; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Epilep | 2016 |
EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Consensus; Delphi Technique; Dibenzazepines; Drug Substitution; Epil | 2018 |
Patterns of antiepileptic drugs use in epileptic pediatric patients in Jordan.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross-Sectional Studies; Drug T | 2016 |
Seizures triggered by pentylenetetrazol in marmosets made chronically epileptic with pilocarpine show greater refractoriness to treatment.
Topics: Animals; Anticonvulsants; Brain; Callithrix; Carbamazepine; Chronic Disease; Disease Models, Animal; | 2016 |
Comparative study of antiepileptic drug use during pregnancy over a period of 12 years in Spain. Efficacy of the newer antiepileptic drugs lamotrigine, levetiracetam, and oxcarbazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Levetiracetam; Longitu | 2018 |
Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90 mg in a patient with severe epilepsy on oxcarbazepine.
Topics: Anticonvulsants; Antiviral Agents; Carbamates; Carbamazepine; Drug Interactions; Drug Therapy, Combi | 2016 |
The consequences of valproate exposure in utero.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Prenatal Exposure Delayed Effects; Valproic Acid | 2016 |
Comparative persistence of antiepileptic drugs in patients with epilepsy: A STROBE-compliant retrospective cohort study.
Topics: Adolescent; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilep | 2016 |
HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; Carbamazepine; Drug Eruptions; Epilepsy; Female; G | 2016 |
Catamenial Epilepsy: The Menstrual Cycle as a Clue to Predict Future Refractory Seizures.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Menstrual Cycle; Seizures | 2017 |
Efficacy and tolerability of anti-epileptic drugs-an internet study.
Topics: Adult; Anticonvulsants; Carbamazepine; Depression; Epilepsy; Female; Humans; Internet; Lamotrigine; | 2017 |
Hyperhomocysteinaemia in children receiving phenytoin and carbamazepine monotherapy: a cross-sectional observational study.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Child, Preschool; Cross-Sectional Studi | 2017 |
Lacosamide monotherapy for newly diagnosed epilepsy.
Topics: Carbamazepine; Delayed-Action Preparations; Double-Blind Method; Epilepsy; Humans; Lacosamide | 2017 |
Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cohort Studies; Community Health Planning; | 2016 |
Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; China; Epilepsy; | 2017 |
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Asian People; Carbamazepine; Child; Chi | 2017 |
Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Humans; Male; Nige | 2017 |
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Carbamazepine; Cyanobacteria; Dip | 2017 |
Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therap | 2017 |
Prenatal exposure to antiepileptic drugs and use of primary healthcare during childhood: a population-based cohort study in Denmark.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Denmark; Epilepsy; Femal | 2017 |
[Therapeutic drug monitoring of three antiepileptic drugs - Back on twenty years of experience].
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Monitoring; Epilepsy; Humans; | 2016 |
Serum Homocysteine, Folate, and Vitamin B12 Levels in Carbamazepine Treated Epileptic Children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Folic Acid; H | 2016 |
Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Asian People; Body Weight; Carbamazepine; Child; Child, Pr | 2017 |
An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; China; Cross-Sectional Studies; Drug Combin | 2017 |
The effect of newer antiepileptic drugs in combination therapy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Drug Therapy, Combination; Epi | 2017 |
Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
Topics: Adult; Aged; Carbamazepine; Dibenzazepines; Drug Substitution; Epilepsy; Female; Follow-Up Studies; | 2017 |
A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy.
Topics: Anticonvulsants; Austria; Carbamazepine; Dose-Response Relationship, Drug; Drug Resistance; Epilepsy | 2008 |
States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
Topics: Adolescent; Age Factors; Anticonvulsants; Body Mass Index; Carbamazepine; Case-Control Studies; Chil | 2009 |
Antiepileptic drug utilization in children from 1997-2005--a study from the Netherlands.
Topics: Anticonvulsants; Carbamazepine; Child; Databases, Factual; Drug Utilization; Epilepsy; Female; Human | 2008 |
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Genetic Predisposition t | 2008 |
Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.
Topics: Adult; Anticonvulsants; Carbamazepine; Case-Control Studies; Cysteine; Dipeptides; Drug Evaluation; | 2008 |
Lack of valproic acid-associated weight gain in prepubertal children.
Topics: Adolescent; Anticonvulsants; Body Height; Body Mass Index; Body Weight; Carbamazepine; Child; Child, | 2008 |
Recovery of long-term anterograde amnesia, but not retrograde amnesia, after initiation of an anti-epileptic drug in a case of transient epileptic amnesia.
Topics: Amnesia, Anterograde; Amnesia, Retrograde; Amnesia, Transient Global; Anticonvulsants; Carbamazepine | 2007 |
Carbamazepine-induced drug-induced hypersensitivity syndrome in a 14-year-old Japanese boy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Drug Hypersensitivity; Epilepsy; Erythema; Herpesvirus 6 | 2008 |
Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Medical Records; | 2008 |
Joint modelling of longitudinal and competing risks data.
Topics: Carbamazepine; Computer Simulation; Epilepsy; Humans; Lamotrigine; Longitudinal Studies; Models, Sta | 2008 |
Quality of life in seizure-free patients with epilepsy on monotherapy.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; Male; Middle Age | 2009 |
Oculogyric crisis masquerading as ventriculoperitoneal shunt dysfunction.
Topics: Anticonvulsants; Carbamazepine; Diagnosis, Differential; Dystonia; Epilepsy; Female; Humans; Hydroce | 2008 |
Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate.
Topics: Anticonvulsants; Carbamazepine; Child; Drug Administration Schedule; Epilepsy; Female; Humans; Linea | 2009 |
First-drug treatment failures in children newly diagnosed with epilepsy.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; | 2009 |
Cyclic vomiting syndrome in adults: disregarding a possible epileptic component?
Topics: Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy; Humans; Male; Middle Aged; Syndrom | 2009 |
Combined EEG/fMRI recording in musicogenic epilepsy.
Topics: Adult; Anticonvulsants; Brain; Brain Mapping; Carbamazepine; Electroencephalography; Epilepsy; Femal | 2009 |
[New antiepileptic drugs].
Topics: Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsies, Partial; Epilepsy; | 2009 |
Bone metabolism alteration on antiepileptic drug therapy.
Topics: Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Carbamazepine; Child; Child, Preschool; Epile | 2009 |
Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
Topics: Adult; Age Factors; Algorithms; Anticonvulsants; Biological Availability; Carbamazepine; Child; Data | 2008 |
A case of carbamazepine intoxication in a young boy.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Male; Poisoning; Therapeutic Irrigation | 2010 |
Safety of an IV formulation of carbamazepine.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Injections | 2009 |
Changing trends in antiepileptic drug prescribing in girls of child-bearing potential.
Topics: Abnormalities, Drug-Induced; Adolescent; Anticonvulsants; Carbamazepine; Child; Contraceptive Agents | 2009 |
[When a seizure occurs...].
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Fructose; Humans | 2009 |
An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Dose-Response Relationship, Drug; Drug Dosage Cal | 2009 |
Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.
Topics: Adult; Anticonvulsants; Carbamazepine; Child, Preschool; Cognition; Developmental Disabilities; Dose | 2009 |
Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid.
Topics: 3-Mercaptopropionic Acid; Analysis of Variance; Animals; Anticonvulsants; ATP Binding Cassette Trans | 2009 |
Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract.
Topics: Animals; Anticonvulsants; Ataxia; Bacopa; Carbamazepine; Cerebellum; Down-Regulation; Drug Evaluatio | 2009 |
Pattern and presentation of epilepsy in Nigerian Africans: a study of trends in the southeast.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Black People; Carbamazepine; Child; Chi | 2009 |
Possible epileptic origin of symptoms in a case exemplifying the sleeper kind of 'limbic psychotic trigger reaction'.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Crime; Epilepsy; Female; Hallucinations | 2009 |
[Fetal malformations in women with epilepsy].
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Bulgaria; Carbamazepine; Epilepsy; Female; Humans; Inf | 2009 |
Effectiveness of the first antiepileptic drug in the treatment of pediatric epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Fructose; Humans; Retrospective S | 2009 |
Which is the best anti-convulsant drug for the treatment of epilepsy in psoriatic or other Th1 mediated skin disease patients?
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Interleukin-2; NF-kappa B; Psoriasis; Th1 Cells; T | 2009 |
Characterization of the time course of carbamazepine deinduction by an enzyme turnover model.
Topics: Adult; Carbamazepine; Cytochrome P-450 CYP3A; Epilepsy; Female; Humans; Male; Metabolic Clearance Ra | 2009 |
HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.
Topics: Adolescent; Adult; Alleles; Asian People; Carbamazepine; Child; Drug Eruptions; Drug Hypersensitivit | 2010 |
Upregulation of 5-HT2C receptors in hippocampus of pilocarpine-induced epileptic rats: antagonism by Bacopa monnieri.
Topics: Animals; Anticonvulsants; Bacopa; Carbamazepine; Disease Models, Animal; Epilepsy; Ergolines; Hippoc | 2009 |
Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
Topics: Anthropometry; Anticonvulsants; Body Composition; Body Height; Body Mass Index; Body Weight; Carbama | 2010 |
Is asymmetric dimethylarginine responsible for the vascular events in patients under antiepileptic drug treatment?
Topics: Adult; Anticonvulsants; Arginine; Arterial Occlusive Diseases; Carbamazepine; Drug Monitoring; Epile | 2009 |
Prevalence of epilepsy and seizure disorders as causes of apparent life- threatening event (ALTE) in children admitted to a tertiary hospital.
Topics: Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Emergency Service, Hospital; Epilepsy; Fema | 2009 |
Cardiac effects of carbamazepine treatment in childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Echocardiography; Electrocardio | 2009 |
Effect of CYP3A5*3 genotype on serum carbamazepine concentrations at steady-state in Korean epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Epi | 2009 |
Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
Topics: Age Factors; Anticonvulsants; Body Height; Body Mass Index; Carbamazepine; Child; Depression, Chemic | 2010 |
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Enzyme Induction; Epilepsy; Female; Folic Acid; F | 2010 |
A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy.
Topics: Analysis of Variance; Anticonvulsants; Carbamazepine; Child, Preschool; Cognition; Creativity; Epile | 2009 |
Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Chi-Square Distribution; | 2009 |
Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Follow-Up Studies; Fructo | 2009 |
Analytical interference of carbamazepine on the Abbott TDx and Abbott Axsym tricyclic antidepressant assays.
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Carbamazepine; Cross Reactions; Drug Monit | 2009 |
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Felbamate; Humans; I | 2010 |
Valproic acid: long-term effects on children exposed in utero.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Cohort Studies; Contraindications; Dose | 2009 |
Transient improvement after brief antiepileptic drug withdrawal in the epilepsy monitoring unit--possible relationship to AED tolerance.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Resistance; Drug Tolerance | 2010 |
Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; China; Drug Eruptions; Epilepsy; Female; Hu | 2010 |
Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow.
Topics: Analysis of Variance; Anticonvulsants; Blood-Brain Barrier; Carbamazepine; Cell Line, Transformed; C | 2010 |
Effects of the antiepileptic drugs on peripheral nerve function.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Fructose; Humans; Male; Median Nerve; Neural Condu | 2010 |
Dose-dependent oxcarbazepine-related anorgasmia.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Male; Oxc | 2010 |
Increased excitability and metabolism in pilocarpine induced epileptic rats: effect of Bacopa monnieri.
Topics: Acetylcholinesterase; Animals; Anticonvulsants; Bacopa; Carbamazepine; Epilepsy; Epinephrine; Insuli | 2010 |
Safety profile of oxcarbazepine: results from a prescription-event monitoring study.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Carbamazepine; | 2010 |
Behavioral deficit and decreased GABA receptor functional regulation in the cerebellum of epileptic rats: effect of Bacopa monnieri and bacoside A.
Topics: Animals; Anticonvulsants; Behavioral Symptoms; Bicuculline; Carbamazepine; Cerebellum; Disease Model | 2010 |
[Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy].
Topics: Adolescent; Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Bone Density; Calcium; Carbamazep | 2010 |
A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy.
Topics: Alleles; Anticonvulsants; Carbamazepine; Case-Control Studies; Cell Line; Central Nervous System; Dr | 2010 |
Growth hormone levels in children and adolescents with epilepsy.
Topics: Adolescent; Anthropometry; Body Weight; Carbamazepine; Chi-Square Distribution; Child; Developmental | 2010 |
The onset of acute oxcarbazepine toxicity related to prescription of clarithromycin in a child with refractory epilepsy.
Topics: Carbamazepine; Child; Clarithromycin; Dose-Response Relationship, Drug; Drug Interactions; Drug Ther | 2010 |
Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy.
Topics: Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dose-Response Rela | 2010 |
Antiepileptic drugs modify power of high EEG frequencies and their neural generators.
Topics: Adolescent; Adult; Anticonvulsants; Brain Waves; Carbamazepine; Electroencephalography; Epilepsy; Fe | 2010 |
The effect of antiepileptic drugs on mitochondrial activity: a pilot study.
Topics: Adenosine Triphosphate; Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electro | 2010 |
Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients.
Topics: Adolescent; Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Casse | 2010 |
Modification in body weight associated with antiepileptic drugs.
Topics: Adult; Anticonvulsants; Body Mass Index; Carbamazepine; Epilepsy; Female; Humans; Male; Valproic Aci | 2010 |
Prevalence of Epilepsy among Cataract Patients.
Topics: Aged; Anticonvulsants; Carbamazepine; Case-Control Studies; Cataract; Cataract Extraction; Clonazepa | 2010 |
BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alleles; Anticonvulsants; Bone Density; Calcium, Dietary; | 2011 |
Antioxidant potential of curcumin against oxidative insult induced by pentylenetetrazol in epileptic rats.
Topics: Alkaloids; Animals; Antioxidants; Benzodioxoles; Biological Availability; Carbamazepine; Catalase; C | 2010 |
[Change from original preparations to generics. A case example with oxcarbazepine].
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Drug Substitution; Drugs, Generic; Epilepsy; Humans; | 2010 |
Carbamazepine and lamotrigine plasma concentrations in epileptic patients during optimising therapy.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Humans; Lamotrigine; Triazines | 2010 |
HLA-B* 1502 screening: time to clinical practice.
Topics: Alleles; Anticonvulsants; Asian People; Carbamazepine; Epilepsy; Genetic Markers; Genetic Testing; G | 2010 |
Effects of valproate and carbamazepine monotherapy on neuroactive steroids, their precursors and metabolites in adult men with epilepsy.
Topics: Adult; Androstanes; Anticonvulsants; Carbamazepine; Epilepsy; Gas Chromatography-Mass Spectrometry; | 2010 |
Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Comorbidity; Epilepsy; F | 2010 |
Influence of carbamazepine on kindling grades in depressive and non-depressive rats.
Topics: Animals; Anticonvulsants; Carbamazepine; Depression; Disease Models, Animal; Electric Stimulation; E | 2010 |
Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.
Topics: Adolescent; Adult; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Carbamazepine; Case-Control Studi | 2010 |
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.
Topics: Anticonvulsants; Antineoplastic Agents; Brain Neoplasms; Carbamazepine; Combined Modality Therapy; C | 2010 |
Retrospective analysis of the effectiveness of first-line antiepileptic drugs for generalized onset and unclassified epileptic seizures in Chinese children.
Topics: Age of Onset; Anticonvulsants; Asian People; Carbamazepine; Child; Child, Preschool; Epilepsy; Femal | 2011 |
Carbamazepine does not alter the intrinsic cardiac function in rats with epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Heart Rate; Male; Rats; Rats, Wistar; Ventricular | 2010 |
Drug treatment failures and effectivity in children with newly diagnosed epilepsy.
Topics: Adolescent; Age of Onset; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Child, Pre | 2010 |
Epilepsy: drug trial design and epilepsy surgery: time for a change?
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Epilepsy; Humans; Randomized Controlled Tr | 2010 |
Behavioral deficit and decreased GABA receptor functional regulation in the hippocampus of epileptic rats: effect of Bacopa monnieri.
Topics: Animals; Anticonvulsants; Bacopa; Behavior, Animal; Carbamazepine; Epilepsy; Hippocampus; Male; Neur | 2011 |
Letter: HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India.
Topics: Alleles; Anticonvulsants; Asian People; Carbamazepine; Child; Drug Eruptions; Epilepsy; Female; HLA- | 2009 |
Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.
Topics: Adolescent; Adult; Aged, 80 and over; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child | 2010 |
Age and comedications influence levetiracetam pharmacokinetics in children.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; | 2010 |
Magnetic N-succinyl chitosan/alginate beads for carbamazepine delivery.
Topics: Alginates; Anticonvulsants; Carbamazepine; Chitosan; Delayed-Action Preparations; Drug Carriers; Dru | 2010 |
[A case report of monitoring on carbamazepine in breast feeding woman].
Topics: Adult; Breast Feeding; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Epileps | 2010 |
Factors influencing valproate pharmacokinetics in children and adults.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Body Weight; Carbamazepine; Child; Child, Pre | 2010 |
[Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
Topics: Adult; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Drug Therapy, Co | 2011 |
Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.
Topics: Adult; Aged; Anticonvulsants; Bayes Theorem; Carbamazepine; Chronic Disease; Databases, Factual; Dem | 2011 |
Having witnesses present.
Topics: Accidents, Occupational; Accidents, Traffic; Anticonvulsants; Automobile Driving; Carbamazepine; Dec | 2010 |
Nocturnal frontal lobe epilepsy presenting with restless leg syndrome-like symptoms.
Topics: Anticonvulsants; Brain Diseases; Carbamazepine; Electroencephalography; Epilepsy; Epilepsy, Frontal | 2011 |
Effects of breastfeeding in children of women taking antiepileptic drugs.
Topics: Adult; Anticonvulsants; Breast Feeding; Carbamazepine; Child, Preschool; Cognition; Epilepsy; Female | 2010 |
Carbamazepine in pregnancy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant, Newbo | 2010 |
Seizures due to water loading in a young epileptic woman preparing for full bladder ultrasound.
Topics: Adult; Anticonvulsants; Carbamazepine; Drinking; Epilepsy; Female; Humans; Hyponatremia; Seizures; U | 2011 |
Carbamazepine in pregnancy: Levetiracetam and lamotrigine are better options.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Contraindications; Epilepsy; Female; Hu | 2011 |
[Bilateral acute anterior uveitis and anticonvulsant hypersensitivity syndrome].
Topics: Acute Disease; Adult; Anticonvulsants; Carbamazepine; Drug Eruptions; Drug Hypersensitivity; Epileps | 2010 |
Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfamily B; ATP | 2011 |
Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine.
Topics: Acetamides; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lacosamide | 2011 |
Protein kinase inhibitor as a potential candidate for epilepsy treatment.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Carbamazepine; Carbenoxolone; Cerebral Cortex; Electroenc | 2011 |
Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Child, Preschool; Developmental Disabilities; | 2011 |
Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy.
Topics: Amino Acids; Animals; Carbamazepine; Convulsants; Drug Evaluation, Preclinical; Electroshock; Epilep | 2011 |
[Severe ethanol poisoning treated by haemodialysis].
Topics: Acidosis; Acute Disease; Alcoholism; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Coma; Em | 2011 |
Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Asian People; ATP Binding Cassette Transporter, Subfamily | 2011 |
Carbamazepine induced DRESS syndrome.
Topics: Adolescent; Anticonvulsants; Biopsy; Carbamazepine; Dermatitis, Exfoliative; Drug Eruptions; Drug Hy | 2010 |
Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy.
Topics: Alleles; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transp | 2011 |
A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: eslicarbazepine acetate, carbamazepine and main metabolites.
Topics: Animals; Anticonvulsants; Brain; Brain Chemistry; Carbamazepine; Chromatography, High Pressure Liqui | 2011 |
Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
Topics: Animals; Anticonvulsants; Carbamazepine; Curcumin; Disease Models, Animal; Drug Interactions; Drug T | 2011 |
Epilepsy: HLA alleles linked to carbamazepine hypersensitivity.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; HLA Antigens; Humans | 2011 |
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epile | 2011 |
Comparison of carbamazepine rash in multiple sclerosis and epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Exanthema; Female; H | 2012 |
Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Canada; Carbamazepine; Cohort Studies; Drug Therapy, C | 2011 |
Effects of oxcarbazepine treatment on serum lipids and carotid intima media thickness in children.
Topics: Anticonvulsants; Carbamazepine; Carotid Arteries; Carotid Intima-Media Thickness; Child; Child, Pres | 2012 |
Valproic Acid related metabolic syndrome in patients with epilepsy.
Topics: Adult; Anticonvulsants; Blood Glucose; Body Mass Index; Carbamazepine; Cholesterol, HDL; Epilepsy; F | 2011 |
Normal vitamin D and low free estradiol levels in women on enzyme-inducing antiepileptic drugs.
Topics: Adolescent; Adult; Anticonvulsants; Bone Density; Carbamazepine; Epilepsy; Estradiol; Female; Humans | 2011 |
Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Blood Platelets; Carbamazepine; Cross-Sectional Studies; Epileps | 2011 |
Factors influencing carbamazepine pharmacokinetics in children and adults: population pharmacokinetic analysis.
Topics: Adult; Aging; Anticonvulsants; Carbamazepine; Child; Chromatography, High Pressure Liquid; Drug Inte | 2011 |
Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Calcium; Carbamazepine; Drug Interactions; Epilepsy; Fruc | 2011 |
Antiepileptic drug use during pregnancy: perinatal outcomes.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anticonvulsants; Carbamazepine; Cohort Studies; Drug | 2011 |
Blocking out the real diagnosis.
Topics: Anticonvulsants; Atrioventricular Block; Bradycardia; Carbamazepine; Diagnostic Errors; Epilepsy; Hu | 2011 |
The future of psychiatric pharmacogenomics.
Topics: Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers, Pharmacological; Bipolar Disorder; Carbamaze | 2011 |
Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography/tandem mass spectrometry.
Topics: Anticonvulsants; Calibration; Carbamazepine; Chromatography, Liquid; Drug Monitoring; Drug Stability | 2011 |
Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life.
Topics: Adult; Aged; Anticonvulsants; Brain Neoplasms; Carbamazepine; Epilepsy; Female; Glioma; Humans; Male | 2012 |
Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Delayed-Action Preparati | 2012 |
Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans.
Topics: Adult; Aged; Anticonvulsants; Asian People; Carbamazepine; Drug Eruptions; Epilepsy; Female; Gene Fr | 2011 |
Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity.
Topics: Administration, Oral; Animals; Anticonvulsants; beta-Cyclodextrins; Calorimetry, Differential Scanni | 2011 |
[Clinical characteristics and treatment for new onset epilepsy in the elderly].
Topics: Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Diagnostic Imaging; Elect | 2010 |
[Epilepsy in elderly].
Topics: Aged; Aged, 80 and over; Aging; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, | 2011 |
Use of antiepileptic medications in pregnancy in relation to risks of birth defects.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Hu | 2011 |
Biomarkers for antiepileptic drug response.
Topics: Alleles; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily | 2011 |
Antiepleptic drug interactions: a clinical case demonstration.
Topics: Adolescent; Anticonvulsants; Brain; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epi | 2011 |
Frequency of the HLA-B*1502 allele contributing to carbamazepine-induced hypersensitivity reactions in a cohort of Malaysian epilepsy patients.
Topics: Adolescent; Adult; Alleles; Asian People; Carbamazepine; Child; Child, Preschool; Cohort Studies; Dr | 2011 |
Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Atherosclerosis; Blood Glucose; Carbamazepine; Carotid Art | 2012 |
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Hum | 2012 |
A once-per-day, drug-in-food protocol for prolonged administration of antiepileptic drugs in animal models.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; E | 2012 |
Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; C-Reactive Protein; Carbamazepine; Epilepsy; Female | 2012 |
The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy.
Topics: Anticonvulsants; Biomarkers; Bone Density; Bone Remodeling; Carbamazepine; Child; Child, Preschool; | 2011 |
Fasting insulin and HOMA-index changes in patients treated with valproic acid.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Carbamazepine; Cholesterol, HDL; Epilepsy; Female; | 2011 |
Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
Topics: Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transpor | 2012 |
Carbamazepine mucoadhesive nanoemulgel (MNEG) as brain targeting delivery system via the olfactory mucosa.
Topics: Adhesives; Administration, Intranasal; Animals; Anticonvulsants; Brain; Carbamazepine; Cattle; Drug | 2012 |
Kcna1-mutant rats dominantly display myokymia, neuromyotonia and spontaneous epileptic seizures.
Topics: Animals; Antiemetics; Biophysical Phenomena; Biotinylation; Body Weight; Carbamazepine; Cells, Cultu | 2012 |
CSF concentrations and serum protein binding of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Topics: Adolescent; Adult; Blood Proteins; Carbamazepine; Epilepsy; Humans; Male; Protein Binding; Young Adu | 1976 |
Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Carnitine; Child; Child, Preschool; Chromatography, High | 2011 |
Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.
Topics: Administration, Oral; Adult; Anticonvulsants; Biological Availability; Carbamazepine; Chemistry, Pha | 2012 |
Is carbamazepine safe to take during pregnancy?
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Neural Tube D | 2012 |
Parry-Romberg syndrome in an 11-year-old female with neurological manifestations without brain imaging abnormalities.
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Epilepsy; Facial Hemiatrophy; Female; Humans; Magnetic | 2012 |
A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.
Topics: Adult; Anticonvulsants; Biotransformation; Brain Chemistry; Carbamazepine; Child; Chromatography, Hi | 2012 |
Thyroid hormones may contribute to vascular risk factors and atherosclerosis.
Topics: Anticonvulsants; Atherosclerosis; Carbamazepine; Carotid Artery, Common; Epilepsy; Female; Humans; M | 2012 |
Influence of UDP-glucuronosyltransferase polymorphisms on valproic acid pharmacokinetics in Chinese epilepsy patients.
Topics: Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Epilepsy; Female; Glucuronosyltransfer | 2012 |
Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes.
Topics: Abnormalities, Drug-Induced; Adolescent; Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Epil | 2012 |
Assessing adherence-based quality measures in epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cohort Studies; Epilepsy; Female; Follow-Up | 2012 |
Seizure management at Auckland City Hospital Emergency Department between July and December 2009: time for a change?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Disease Management; Emer | 2012 |
[The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma].
Topics: Adult; Brain Injuries; Bromocriptine; Carbamazepine; Dopamine Agonists; Drug Interactions; Drug Ther | 2011 |
Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Databases, Factual; Epilepsy; German | 2012 |
The effect of combination therapy on the plasma concentrations of traditional antiepileptics: a retrospective study.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Anticonvulsants; Carbamazepine; Drug Int | 2012 |
A rat model for LGI1-related epilepsies.
Topics: Amino Acid Sequence; Animals; Anticonvulsants; Brain; Carbamazepine; Cells, Cultured; Chlorocebus ae | 2012 |
A case of fetal carbamazepine syndrome with right hemihypoplasia of the entire body.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Bone and Bones; Carbamazepine; Congenital Abnormalitie | 2012 |
B-vitamin deficiency in patients treated with antiepileptic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans | 2012 |
Severe consequences of carbamazepine exposure in utero.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant | 2011 |
Neurological picture. Transient high-intensity signal of heterotopia on DWI in an epilepsy patient.
Topics: Anticonvulsants; Brain; Carbamazepine; Choristoma; Consciousness Disorders; Diagnosis, Differential; | 2012 |
Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Chil | 2012 |
[A girl case of panayiotopoulos syndrome with encephalopathy-like manifestation].
Topics: Anticonvulsants; Autonomic Nervous System Diseases; Carbamazepine; Child, Preschool; Epilepsy; Femal | 2012 |
Randomised controlled monotherapy trials: which comparators to use?
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Humans; Seizures; Valproic Acid | 2012 |
Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore.
Topics: Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Cost-Benefit Analysis; Decision Making | 2012 |
A novel microextraction by packed sorbent-gas chromatography procedure for the simultaneous analysis of antiepileptic drugs in human plasma and urine.
Topics: Alprazolam; Anticonvulsants; Carbamazepine; Epilepsy; Gas Chromatography-Mass Spectrometry; Humans; | 2012 |
Asymmetric dimethylarginine may contribute to vascular risk factors in patients receiving antiepileptic drug treatment.
Topics: Anticonvulsants; Atherosclerosis; Carbamazepine; Carotid Artery, Common; Epilepsy; Female; Humans; M | 2012 |
Comparative stroke risk of antiepileptic drugs in patients with epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male | 2013 |
Oxcarbazepine-related retrograde ejaculation.
Topics: Adult; Anticonvulsants; Carbamazepine; Ejaculation; Epilepsy; Humans; Male; Oxcarbazepine; Sexual Dy | 2012 |
Epileptiform activity and cognitive deficits in SNAP-25(+/-) mice are normalized by antiepileptic drugs.
Topics: Animals; Anticonvulsants; Association Learning; Brain; Carbamazepine; Cognition Disorders; Epilepsy; | 2014 |
The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation.
Topics: Anticonvulsants; Asian People; Carbamazepine; China; Computer Simulation; Dose-Response Relationship | 2012 |
Signal-averaged and standard electrocardiography in patients with newly diagnosed epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Arrhythmias, Cardiac; Carbamazepine; Electrocardiography; Epilep | 2012 |
Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.
Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Kindling, Neurologic; | 2013 |
Ion chromatography combined with online electrochemical derivatization and fluorescence detection for the determination of carbamazepine in human plasma.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Ion Exchange; Electrochemical Techniques; Epilepsy; | 2012 |
How did phenobarbital's chemical structure affect the development of subsequent antiepileptic drugs (AEDs)?
Topics: Anticonvulsants; Carbamazepine; Drug Discovery; Epilepsy; Ethosuximide; History, 20th Century; Human | 2012 |
Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Benzodiazepines; Brain Neoplasms; Carbamazepine; Clobazam; Dr | 2012 |
Effect of carbamazepine therapy on homocysteine, vitamin B12 and folic acid levels in children with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Folic Acid; Homocysteine; | 2013 |
Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs.
Topics: Adolescent; Anticonvulsants; Arginine; Atherosclerosis; Biomarkers; Carbamazepine; Child; Epilepsy; | 2013 |
Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Anticonvulsants; Carbamazepine; Cross-S | 2012 |
Oxcarbazepine-induced jerky see-saw nystagmus.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Magnetic Resonance Imaging; Nystagm | 2013 |
Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Convulsants; Epilepsy; Hippocampus; Male; Pilocarpine; Rats | 2002 |
Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Insulin Resistance; Obesity; Polycy | 2002 |
Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Enzyme Induction; Epilepsy; | 2002 |
Effects of prenatal exposure to carbamazepine on brainstem auditory evoked potentials in infants of epileptic mothers.
Topics: Adult; Anticonvulsants; Carbamazepine; Embryonic and Fetal Development; Epilepsy; Evoked Potentials, | 2002 |
Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy.
Topics: Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Carbamazepine; Child; Child, Preschool; Epile | 2002 |
H(2)-histamine antagonist (famotidine) induced adverse CNS reactions with long-standing secondary mania and epileptic seizures.
Topics: Aged; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Carbamazepine; Epilepsy; Famotidine; Fema | 2002 |
The benzodiazepine partial inverse agonist Ro15-4513 alters anticonvulsant and lethal effects of carbamazepine in amygdala-kindled rats.
Topics: Affinity Labels; Amygdala; Animals; Anticonvulsants; Azides; Benzodiazepines; Carbamazepine; Drug In | 2002 |
Effects of antiepileptic drugs on induced epileptiform activity in a rat model of dysplasia.
Topics: 4-Aminopyridine; Action Potentials; Animals; Animals, Newborn; Anticonvulsants; Carbamazepine; Disea | 2002 |
Chondrodysplasia punctata (CDP) with features of the tibia-metacarpal type and maternal phenytoin treatment during pregnancy.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Chondrodysplasia Punctata; Craniofacial Abnormalit | 2002 |
Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Circadian Rhythm; Drug Therapy, Combination; Epi | 2002 |
Interaction of topiramate with carbamazepine: two case reports and a review of clinical experience.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Fr | 2002 |
Administration of Carbatrol to children with feeding tubes.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Delayed-Action Preparations; Dose-Response | 2002 |
Aggregate data meta-analysis with time-to-event outcomes.
Topics: Anticonvulsants; Carbamazepine; Cerebral Palsy; Cohort Studies; Epilepsy; Female; Humans; Life Table | 2002 |
Generalized pustulosis and severe tubulointerstitial nephropathy as manifestations of carbamazepine hypersensitivity syndrome.
Topics: Adult; Anticonvulsants; Carbamazepine; Combined Modality Therapy; Drug Eruptions; Drug Therapy, Comb | 2002 |
Effect of carbamazepine on sleep patterns disturbed by epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Electroencephalography; Electromyography; Epilepsy; Excitat | 2002 |
Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Oxcarbazepin | 2003 |
Bone health in epilepsy.
Topics: Adolescent; Anticonvulsants; Bone Diseases, Metabolic; Carbamazepine; Cytochrome P-450 Enzyme System | 2002 |
Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Biomarkers; Bone Diseases, Metabolic; Bone Resorpti | 2002 |
Effect of vigabatrin on the pharmacokinetics of carbamazepine.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Drug The | 2002 |
Carbamazepine poisoning: treatment with haemodialysis.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Renal Dialysis; Tablets | 2003 |
Carbamazepine-induced pemphigus.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Cytoskeletal Proteins; Desmoplakins; Drug Eruptions; Epi | 2003 |
Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Topics: Adolescent; Anticonvulsants; Arginine Vasopressin; Carbamazepine; Child; Child, Preschool; Dose-Resp | 2002 |
Misdiagnosis of epilepsy in patients prescribed anticonvulsant drugs for other reasons.
Topics: Adult; Anticonvulsants; Carbamazepine; Diagnostic Errors; Epilepsy; Humans; Male; Middle Aged; Seizu | 2003 |
Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Folic Acid; H | 2003 |
Carbamazepine-induced abnormal pitch perception.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; M | 2003 |
[Generic carbamazepine-induced subacute adrenal insufficiency?].
Topics: Addison Disease; Adrenal Insufficiency; Adult; Anti-Inflammatory Agents; Anticonvulsants; Carbamazep | 2002 |
Major malformations in offspring of women with epilepsy.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Comorbidity; Educational Status; | 2003 |
Clinically relevant reduction of lamotrigine concentrations by carbamazepine.
Topics: Aged; Anticonvulsants; Carbamazepine; Drug Antagonism; Drug Therapy, Combination; Epilepsy; Humans; | 2003 |
Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Chi-Square Distribution; Child; Ch | 2003 |
Favorable outcome of epileptic blindness in children.
Topics: Acute Disease; Adolescent; Anticonvulsants; Blindness, Cortical; Carbamazepine; Child; Electroenceph | 2003 |
Evaluation of therapeutic drug monitoring of antiepileptic drugs.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Rela | 2003 |
Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug T | 2003 |
Epilepsy, atherosclerosis, myocardial infarction, and carbamazepine.
Topics: Anticonvulsants; Autopsy; Carbamazepine; Child; Coronary Artery Disease; Epilepsy; Fatal Outcome; Hu | 2003 |
Langerhans cell histiocytosis presenting as adult onset epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Glucocorticoids; Histiocytosis, Langerhans-Cell; Hu | 2003 |
Effects of valproic acid, carbamazepine, and phenobarbitone on the fatty acid composition of erythrocyte membranes in children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Erythrocyte Membrane; | 2003 |
Population pharmacokinetics of carbamazepine in Chinese epilepsy patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbamazepine; Chi-Square Distribution; Child; Child, Pr | 2003 |
Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Topics: Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Case-Control Studies; Cytochrome P-450 CYP | 2003 |
Abnormal ALP isoenzyme in children with epilepsy treated with carbamazepine.
Topics: Alkaline Phosphatase; Anticonvulsants; Bone and Bones; Carbamazepine; Child; Child, Preschool; Enzym | 2003 |
Absence seizures in patients with localization-related epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Electroencephalogra | 2003 |
A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Epilepsy; Female; Follicle Stimulating Hormone | 2003 |
Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy.
Topics: Adult; Analysis of Variance; Carbamazepine; Epilepsy; Humans; Male; Semen; Sperm Count; Spermatozoa; | 2003 |
[Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epileps | 2003 |
The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Topics: Abortion, Induced; Anticonvulsants; Australia; Carbamazepine; Cohort Studies; Congenital Abnormaliti | 2003 |
Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Corpus Callosum; Electroencephalography; Epilepsy; Female; Hu | 2003 |
Serum carnitine levels during oxcarbazepine and carbamazepine monotherapies in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Carnitine; Child; Epilepsy; Female; Humans; Male | 2003 |
[THERAPEUTIC RESULTS WITH A NEW ANTIEPILEPTIC, TEGRETOL].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Humans; T | 1963 |
REPORT ON THE ANTI-EPILEPTIC ACTION OF TEGRETOL.
Topics: Acetazolamide; Adolescent; Anticonvulsants; Biomedical Research; Carbamazepine; Child; Chlordiazepox | 1964 |
[RESULTS AND CLINICAL OBSERVATIONS IN THE USE OF A NEW ANTIEPILEPTIC DRUG, TEGRETOL (G 32,883)].
Topics: Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy; Pharmacology; Toxicology | 1964 |
A CASE OF INTOXICATION WITH TEGRETOL.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy; Electroencephalography; Epilepsy; Epilepsy, Temporal L | 1964 |
[CLINICAL EXPERIENCES WITH TEGRETOL IN THE TREATMENT OF EPILEPSY].
Topics: Anticonvulsants; Carbamazepine; Drug Therapy; Epilepsy; Toxicology | 1965 |
[Oxcarbazepine-induced encephalopathy].
Topics: Adult; Anticonvulsants; Antimalarials; Carbamazepine; Chloroquine; Confusion; Epilepsy; Female; Huma | 2003 |
[Hyponatremic coma induced by oxcarbazepine: case report].
Topics: Anticonvulsants; Carbamazepine; Coma; Epilepsy; Female; Humans; Hyponatremia; Middle Aged; Oxcarbaze | 2003 |
Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3).
Topics: alpha-Linolenic Acid; Analysis of Variance; Animals; Anticonvulsants; Carbamazepine; Disease Models, | 2004 |
Langerhans cell histiocytosis presenting as adult onset epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Histiocytosis, Langerhans-Cell; Humans; Magnetic Re | 2003 |
Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
Topics: Amygdala; Animals; Anticonvulsants; Biological Availability; Blood-Brain Barrier; Carbamazepine; Cer | 2003 |
Anticonvulsant-hypersensitivity syndrome in a child.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Thrombocytopenia | 2003 |
Major malformations in offspring of women with epilepsy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Logistic Mode | 2003 |
Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic | 2004 |
Validated high performance liquid chromatographic method for simultaneous determination of phenytoin, phenobarbital and carbamazepine in human serum.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Indicators a | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Transcranial direct current stimulation (tDCS).
Topics: Animals; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electric Stimulation; Elect | 2003 |
Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy.
Topics: Adult; Aged; Autonomic Nervous System; Carbamazepine; Cardiovascular System; Epilepsy; Female; Heart | 2003 |
Normal intelligence in children with prenatal exposure to carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epilepsy; | 2004 |
Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Nitrates; Nitric Oxide; Nitri | 2004 |
Spotlight on oxcarbazepine in epilepsy.
Topics: Adolescent; Anticonvulsants; Area Under Curve; Carbamazepine; Child; Child, Preschool; Clinical Tria | 2004 |
Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Epileps | 2004 |
Effect of epilepsy and antiepileptic drugs on male reproductive health.
Topics: Adult; Androstenedione; Anticonvulsants; Carbamazepine; Dehydroepiandrosterone Sulfate; Epilepsies, | 2004 |
[Childhood-onset epileptic blindness--clinical correlates and outcomes].
Topics: Age of Onset; Anticonvulsants; Blindness; Carbamazepine; Child; Epilepsy; Follow-Up Studies; Humans; | 2004 |
Acute encephalopathy induced by oxcarbazepine and furosemide.
Topics: Anticonvulsants; Carbamazepine; Diuretics; Electroencephalography; Encephalitis; Epilepsy; Female; F | 2004 |
[Atypical epilepsy symptomatology as cause of a dementia like state in a mentally and physically retarded patient].
Topics: Anticonvulsants; Carbamazepine; Dementia; Electroencephalography; Epilepsy; Humans; Intellectual Dis | 2004 |
Cost of epilepsy in patients attending a secondary-level hospital in India.
Topics: Anticonvulsants; Carbamazepine; Efficiency, Organizational; Epilepsy; Hospital Costs; Hospitalizatio | 2004 |
[A case of polymyalgia rheumatica with improved steroid-responsibility after discontinuing carbamazepine].
Topics: Aged; Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Female; Humans; Methotrexate; Polym | 2004 |
The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Cholesterol; Cholesterol, HDL; Cholesterol, | 2004 |
Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.
Topics: Abnormalities, Multiple; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fetal Diseases; Hu | 2004 |
Modulation of antiepileptic effect of phenytoin and carbamazepine by melatonin in mice.
Topics: Animals; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, High Pressure Liquid; Dis | 2004 |
Valproate therapy and nonalcoholic fatty liver disease.
Topics: Adolescent; Adult; Carbamazepine; Chi-Square Distribution; Epilepsy; Fatty Liver; Female; Humans; Ma | 2004 |
Oxcarbazepine in pregnancy: clinical experience in Argentina.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Argentina; Carbamazepine; Drug Therapy, Combination; E | 2004 |
Feasibility and limitations of oxcarbazepine monitoring using salivary monohydroxycarbamazepine (MHD).
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Chromatography, High Pre | 2004 |
Serum androgen levels and testicular structure during pubertal maturation in male subjects with epilepsy.
Topics: Adolescent; Adult; Androgens; Androstenedione; Anticonvulsants; Carbamazepine; Child; Epilepsy; Huma | 2004 |
Hair analysis differentiates chronic from acute carbamazepine intoxication.
Topics: Acute Disease; Anticonvulsants; Carbamazepine; Child; Chronic Disease; Diagnosis, Differential; Epil | 2004 |
Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Drug Evaluation, Preclinical; Drug | 2004 |
Color vision in epileptic adolescents treated with valproate and carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Color Perception; Epilepsy; Female; Humans; Male; | 2004 |
Urinary 6beta-hydroxycortisol/17-hydroxycorticosteroids ratio as a measure of hepatic CYP3A4 capacity after enzyme induction.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Chromatography | 2004 |
Activation of serum aminotransferases by pyridoxal-5' -phosphate in epileptic patients treated with anticonvulsant drugs.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Carbamazepine; Drug Therapy, Combination; | 2004 |
The effects of oxcarbazepine on oxidative stress in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Catalase; Epilepsy; Erythrocytes; Female; Glutathione Peroxid | 2004 |
Severe overdosage with the antiepileptic drug oxcarbazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Overdose; Epilepsy; Humans; Male; Oxcarbazepine | 2004 |
Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Dehydroepiandrosterone; Epilepsy; Female; Growth; | 2004 |
[Carbamazepine or phenobarbitone monotherapy in epilepsy?].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Evidence-Based Medicine; Humans; Phenobarbital | 2004 |
Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Child; Cohort Studies; Confoundi | 2004 |
Effect of carbamazepine and valproate on bone mineral density.
Topics: Adolescent; Anticonvulsants; Bone Density; Carbamazepine; Case-Control Studies; Child; Cross-Section | 2004 |
The outcome of initiation of antiepileptic drug monotherapy in primary care: a UK database survey.
Topics: Aged; Anticonvulsants; Carbamazepine; Child, Preschool; Clinical Competence; Epilepsy; Family Practi | 2004 |
Assessment of the epilepsy treatment gap in two cities of south-east of Brazil.
Topics: Adult; Anticonvulsants; Brazil; Carbamazepine; Epilepsy; Health Services Accessibility; Health Servi | 2004 |
Longer term outcome of children born to mothers with epilepsy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Fema | 2004 |
Fracture risk associated with use of antiepileptic drugs.
Topics: Adult; Anticonvulsants; Bone Density; Carbamazepine; Case-Control Studies; Denmark; Epilepsy; Female | 2004 |
Kinesigenic attacks with ictal electroencephalographic abnormalities.
Topics: Adolescent; Anticonvulsants; Athetosis; Carbamazepine; Chorea; Electroencephalography; Epilepsy; Hum | 2004 |
[Hair analysis as a document of oxcarbazepine therapy in fatal levomepromazine poisoning].
Topics: Anticonvulsants; Antipsychotic Agents; Carbamazepine; Epilepsy; Fatal Outcome; Hair; Humans; Male; M | 2004 |
Serum amylase, pancreatic amylase and lipase concentrations in epileptic children treated with carbamazepine monotherapy.
Topics: Adolescent; Amylases; Carbamazepine; Child; Epilepsy; gamma-Glutamyltransferase; Humans; Lipase; Pan | 2004 |
Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093.
Topics: Animals; Anticonvulsants; Carbamazepine; Cell Survival; Cells, Cultured; Dibenzazepines; Epilepsy; H | 2004 |
Isoforms of serum gamma-glutamyltransferase in epileptic patients treated with enzyme-inducing anticonvulsant drugs.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; gamma-Glutamyltransferase; Humans; Isoenzym | 2004 |
Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Chil | 2004 |
[Influence of psychotropic drugs on thrombocytes aggregation in patients with epilepsy].
Topics: Adolescent; Adult; Barbiturates; Carbamazepine; Epilepsy; Humans; In Vitro Techniques; Lamotrigine; | 2004 |
Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy?
Topics: Adult; Anticonvulsants; Biopsy; Carbamazepine; Colitis; Colon; Colonoscopy; Diagnosis, Differential; | 2004 |
Initiation of treatment and selection of antiepileptic drugs in childhood epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; | 2004 |
Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics.
Topics: Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilep | 2005 |
Ro/SSA-positive cutaneous lupus erythematosus induced by carbamazepine.
Topics: Adult; Antibodies, Antinuclear; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lupus Erythematosu | 2005 |
Asthenozoospermia: possible association with long-term exposure to an anti-epileptic drug of carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Infertility, Male; Male; Sperm Motility | 2005 |
Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Bone and Bones; Bone Remodeling; Carbamazepine; Epilepsy; Female | 2005 |
Antiepileptic drugs alter reproductive endocrine hormones in men with epilepsy.
Topics: Adult; Age Factors; Androstenedione; Anticonvulsants; C-Peptide; Carbamazepine; Carnitine; Dihydrote | 2005 |
A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Hum | 2005 |
Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes.
Topics: Anticonvulsants; Carbamazepine; Computer Simulation; Epilepsy; Genetic Heterogeneity; Humans; Meta-A | 2005 |
Gingival enlargement in children treated with antiepileptics.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Cross-Sectional Studies; Dental Plaque | 2004 |
Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
Topics: Adult; Age Distribution; Age Factors; Aged; Aged, 80 and over; Aging; Algorithms; Anticonvulsants; B | 2005 |
Valproate-induced eosinophilia in children with epilepsy: role of interleukin-5.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Child, Preschool; Eosinophi | 2005 |
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
Topics: Adolescent; Adult; Aged; Alleles; Amino Acid Sequence; Anticonvulsants; Aryl Hydrocarbon Hydroxylase | 2005 |
Sodium valproate -- induced skeletal myopathy.
Topics: Anticonvulsants; Carbamazepine; Carnitine; Child, Preschool; Epilepsy; Humans; Male; Muscular Diseas | 2005 |
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
Topics: Anticonvulsants; Carbamazepine; Causality; Epilepsy; Germany; Humans; Incidence; Inpatients; Lamotri | 2005 |
Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Chromatography, High P | 2005 |
Gene variants affect response to antiepileptic drugs.
Topics: Alternative Splicing; Anticonvulsants; Carbamazepine; Cytochrome P-450 Enzyme System; Drug Resistanc | 2005 |
Carbamazepine induced osteomalacia: letter to the editor.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Middle Aged; Osteomalacia; Radionuclide Im | 2005 |
[Epilepsy in a school-aged child with refractory crises worsening despite medication].
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; Electroencephalography; Epilepsy; Humans; Male | 2005 |
Hyponatremia associated with repeated use of levetiracetam.
Topics: Aged; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Hyponatre | 2005 |
Antiepileptic drugs for the elderly: using the old to focus on the new.
Topics: Age Factors; Aged; Aged, 80 and over; Amines; Carbamazepine; Cyclohexanecarboxylic Acids; Epilepsy; | 2005 |
Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy.
Topics: Affect; Anticonvulsants; Carbamazepine; Epilepsy; Health Status; Humans; Lamotrigine; Mood Disorders | 2005 |
Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Bayes Theorem; Carbamazepine; Child; Child, Preschool; Delayed-A | 2005 |
Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Erectile Dysfunction; Humans; Male; Middle Aged; Oxcarbaze | 2005 |
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy.
Topics: Adult; Anticonvulsants; Biological Availability; Carbamazepine; Dose-Response Relationship, Drug; Dr | 2005 |
Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA).
Topics: Adult; Anticonvulsants; Carbamazepine; Cross Reactions; Drug Monitoring; Drug Overdose; Epilepsy; Hi | 2005 |
Effects of anticonvulsants on soman-induced epileptiform activity in the guinea-pig in vitro hippocampus.
Topics: Amines; Animals; Anticonvulsants; Carbamates; Carbamazepine; Chlormethiazole; Clozapine; Cyclohexane | 2005 |
Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7.
Topics: Carbamazepine; DNA, Viral; Drug Hypersensitivity; Epilepsy; Follow-Up Studies; Herpesvirus 7, Human; | 2005 |
Pharmacokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in children and adolescents.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Female; Fructose; Hu | 2005 |
Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
Topics: Animals; Anticonvulsants; Biomarkers; Carbamazepine; Dopamine; Dose-Response Relationship, Drug; Epi | 2005 |
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Dibenzazepines; Drug Monitorin | 2005 |
A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.
Topics: Adult; Aged; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain B | 2005 |
Failure of Implanon contraception in a patient taking carbamazepin for epilepsia.
Topics: Adult; Anticonvulsants; Carbamazepine; Contraceptive Agents, Female; Desogestrel; Drug Interactions; | 2006 |
Lower frequency variability in the alpha activity in EEG among patients with epilepsy.
Topics: Adult; Alpha Rhythm; Anticonvulsants; Brain; Carbamazepine; Case-Control Studies; Electroencephalogr | 2005 |
Nonconvulsive status epilepticus precipitated by carbamazepine presenting as dissociative and affective disorders in adolescents.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Depressive Disorder; Diagnosis, Differential; Dia | 2005 |
Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro.
Topics: 2-Amino-5-phosphonovalerate; 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Acetamides; Anim | 2006 |
Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
Topics: Abnormalities, Drug-Induced; Adolescent; Anthropometry; Anticonvulsants; Carbamazepine; Child; Child | 2006 |
Epilepsy and medication effects on the pattern visual evoked potential.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Evoked Potentials, Visual; Female; Follow-Up Studie | 2005 |
[Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Topics: Amino Acids; Anticonvulsants; Bone and Bones; Bone Density; Calcium, Dietary; Carbamazepine; Child; | 2005 |
The trials and tribulations of pediatric drug trials.
Topics: Age Factors; Anticonvulsants; Brain; Carbamazepine; Child; Clinical Trials as Topic; Drug-Related Si | 2005 |
[Anticonvulsive pharmacotherapy may aggravate epilepsy course].
Topics: Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Electroencephalography; Epilepsy; | 2005 |
Effect of plasma exchange on carbamazepine levels in a patient with myasthenia gravis and epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Comorbidity; Epilepsy; Female; Humans; Myasthenia Gravis; Pla | 2005 |
[The efficacy of topiramate (topamax) in the treatment of resistant epilepsy in children].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistance; Drug Therapy, | 2005 |
The use of lamotrigine and other antiepileptic drugs in paediatric patients at a Malaysian hospital.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cost-Benefit Analysis; D | 2005 |
Possible precipitation of myoclonic seizures with oxcarbazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Infant | 2006 |
Response to antiepileptic drug therapy: winners and losers.
Topics: Adult; Anticonvulsants; Carbamazepine; Cerebral Cortex; Drug Administration Schedule; Drug Resistanc | 2005 |
Hot water epilepsy occurring at temperature below the core temperature.
Topics: Anticonvulsants; Body Temperature; Brain; Carbamazepine; Child; Cognition Disorders; Electroencephal | 2006 |
Hyponatremia from oxcarbazepine and carbamazepine.
Topics: Adult; Age Factors; Aging; Anticonvulsants; Carbamazepine; Databases, Factual; Dose-Response Relatio | 2005 |
Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Femal | 2006 |
Visual defects associated with vigabatrin: a study of epileptic argentine patients.
Topics: Adult; Anticonvulsants; Argentina; Carbamazepine; Electroretinography; Epilepsy; Female; Humans; Mal | 2005 |
Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Case-Control Studies; Epilepsy; Female; Folic Aci | 2006 |
Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Disease Models, Animal; Dose-Respo | 2006 |
Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Epilepsy; Female; Humans; Male; Nerv | 2006 |
Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Administration Schedule; Electroencephalogra | 2006 |
Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; | 2006 |
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
Topics: Adult; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Dose-Response Relations | 2006 |
Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone and Bones; Bone Res | 2006 |
The cerebral form of toxocarosis in a seven-year-old patient.
Topics: Animals; Anticonvulsants; Antinematodal Agents; Brain Diseases; Carbamazepine; Child; Epilepsy; Fema | 2006 |
Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
Topics: Carbamazepine; Delayed-Action Preparations; Drug Tolerance; Epilepsy; Humans | 2006 |
Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Infant; Isox | 2006 |
Retinal nerve fiber layer and macular thickness in adolescents with epilepsy treated with valproate and carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Color Vision Defects; Epilepsy; Female; Follow-Up | 2006 |
Measuring the effects of antiepileptic medications on balance in older people.
Topics: Aged; Amines; Anticonvulsants; Ataxia; Carbamazepine; Cyclohexanecarboxylic Acids; Dizziness; Epilep | 2006 |
A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fetal Diseases | 2006 |
Effect of CYP3A5*3 on carbamazepine pharmacokinetics in Japanese patients with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; | 2006 |
Active control trials for epilepsy: avoiding bias in head-to-head trials.
Topics: Anticonvulsants; Bias; Carbamazepine; Control Groups; Dose-Response Relationship, Drug; Drug Adminis | 2006 |
Antiepileptic drug use and birth rate in patients with epilepsy--a population-based cohort study in Finland.
Topics: Adolescent; Adult; Anticonvulsants; Birth Rate; Carbamazepine; Cohort Studies; Epilepsy; Female; Fin | 2006 |
ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.
Topics: Adolescent; Adult; Alleles; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1 | 2006 |
[Rapid analysis of antiepileptic drugs in human plasma by micellar electrokinetic capillary chromatography].
Topics: Anticonvulsants; Buffers; Carbamazepine; Chromatography, Micellar Electrokinetic Capillary; Clonazep | 2006 |
Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Topics: Adult; Aged; Aging; Anticonvulsants; Bayes Theorem; Carbamazepine; Databases, Factual; Epilepsy; Fem | 2006 |
Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Folic Acid; H | 2006 |
Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Resistance; Epilepsy; Female; | 2006 |
Phenytoin-induced DRESS with cross-reactivity to carbamazepine in a 10-year-old Indian child.
Topics: Anticonvulsants; Blood Chemical Analysis; Carbamazepine; Child; Drug Eruptions; Eosinophilia; Epilep | 2006 |
Oxcarbazepine therapy in very young children: a single-center clinical experience.
Topics: Age Factors; Anticonvulsants; Carbamazepine; Child, Preschool; Epilepsy; Female; Follow-Up Studies; | 2006 |
Adverse effects of antiepileptic drugs on bone mineral density.
Topics: Adolescent; Anticonvulsants; Bone Density; Calcification, Physiologic; Carbamazepine; Case-Control S | 2006 |
[A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine].
Topics: Aged; Anticonvulsants; Antiemetics; Carbamazepine; Dopamine Antagonists; Epilepsy; Female; Follow-Up | 2006 |
Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.
Topics: Adolescent; Adult; Androgens; Androstenedione; Anticonvulsants; Carbamazepine; Comorbidity; Dehydroe | 2006 |
Bone metabolism and vitamin D levels in carbamazepine-treated patients.
Topics: Anticonvulsants; Bone and Bones; Bone Development; Bone Resorption; Carbamazepine; Dose-Response Rel | 2006 |
Carbamazepine protects against megencephaly and abnormal expression of BDNF and Nogo signaling components in the mceph/mceph mouse.
Topics: Animals; Anticonvulsants; Brain; Brain-Derived Neurotrophic Factor; Carbamazepine; Cell Differentiat | 2006 |
Capillary microscopy and hemorheology in children during antiepileptic monotherapy with carbamazepine and valproate.
Topics: Adolescent; Anticonvulsants; Blood Flow Velocity; Capillaries; Carbamazepine; Cerebellar Cortex; Chi | 2006 |
Antiepileptic TDM pattern at a tertiary care hospital in India.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Humans; India; Pharmacology, Clinical; Ph | 2006 |
[Carbamazepine intoxication in a HIV patient under artiretroviral therapy].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Retroviral Agents; Anticonvulsants; Antiretroviral T | 2006 |
The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
Topics: Anticonvulsants; Carbamazepine; Child; Cognition; Education, Special; Epilepsy; Female; Humans; Ment | 2006 |
Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
Topics: Analysis of Variance; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Dose-Res | 2006 |
Oxidative stress in children receiving valproic acid.
Topics: Adolescent; Age Factors; Anticonvulsants; Benzodiazepines; Biomarkers; Canada; Carbamazepine; Case-C | 2006 |
Kinetic changes and modulation by carbamazepine on voltage-gated sodium channels in rat CA1 neurons after epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Hippocampus; Kainic Acid; Male; Membrane Potentia | 2006 |
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine.
Topics: Adult; Aged; Anticonvulsants; ATP-Binding Cassette Transporters; Carbamazepine; Cytochrome P-450 Enz | 2006 |
Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Topics: Animals; Anticonvulsants; Brain Damage, Chronic; Carbamazepine; Convulsants; Disease Models, Animal; | 2006 |
The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate.
Topics: Antibodies; Anticonvulsants; Carbamazepine; Child; Drug Administration Schedule; Epilepsy; Humans; I | 2006 |
Serum lipid profile in children receiving anti-epileptic drug monotherapy: is it atherogenic?
Topics: Adolescent; Anticonvulsants; Apolipoproteins; Atherosclerosis; Carbamazepine; Child; Cholesterol, HD | 2006 |
Pharmacological management of a youth with ADHD and a seizure disorder.
Topics: Adrenergic Uptake Inhibitors; Anticonvulsants; Atomoxetine Hydrochloride; Attention Deficit Disorder | 2006 |
Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child.
Topics: Anticonvulsants; Antiparkinson Agents; Aspartic Acid; Basal Ganglia; Benzothiazoles; Carbamazepine; | 2006 |
The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children.
Topics: Anticonvulsants; Antioxidants; Bilirubin; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; | 2007 |
[Oxcarbazepine in the treatment of epilepsy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 2007 |
A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitriol; | 2007 |
Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Carnitine; Chemical and Drug Induced Liver Injury; Child | 2007 |
Ocular surface reconstruction.
Topics: Adolescent; Amnion; Carbamazepine; Conjunctival Diseases; Corneal Diseases; Cyclophosphamide; Deamin | 2007 |
Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Follow-Up Studies; Humans; Infant, Newborn; Matern | 2007 |
Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Monitoring; Drug Therapy, Combination; Epile | 2007 |
Hyponatremia due to an additive effect of carbamazepine and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Clarithromycin; Drug Synergism; Drug T | 2007 |
Intestinal expression of cytochrome P450 enzymes and ABC transporters and carbamazepine and phenytoin disposition.
Topics: Adult; Aged; Anticonvulsants; ATP-Binding Cassette Transporters; Carbamazepine; Cytochrome P-450 Enz | 2007 |
A survey of antiepileptic prescribing to women of childbearing potential in psychiatry.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Prescriptions; England; Epilepsy; Female; Ho | 2007 |
Antiepileptic drugs prevent changes induced by pilocarpine model of epilepsy in brain ecto-nucleotidases.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphatases; Adenosine Triphosphate; A | 2007 |
A pharmacoeconomic comparison of monotherapy with Tegretol, Finlepsin and Trileptal (preliminary data).
Topics: Adult; Anticonvulsants; Bulgaria; Carbamazepine; Cost-Benefit Analysis; Economics, Pharmaceutical; E | 2006 |
Stevens-Johnson syndrome due to concomitant use of lamotrigine and valproic acid.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Lamotrig | 2007 |
Thyroid dysfunction associated with increased low-density lipoprotein cholesterol in epileptic children treated with carbamazepine monotherapy: a causal relationship?
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol, LDL; Epilepsy; Fem | 2007 |
Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
Topics: Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Trans | 2007 |
Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy.
Topics: Action Potentials; Animals; Anticonvulsants; Carbamazepine; Chronic Disease; Dentate Gyrus; Disease | 2007 |
Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
Topics: Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Drug Costs; Drug Industry; Epilepsies, Partia | 2007 |
Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Female | 2007 |
[Long latency auditory evoked potentials in schoolchildren and adolescents with epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Cognition; Epilepsy; Event- | 2006 |
Rash from antiepileptic drugs: influence by gender, age, and learning disability.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Comorbidity; Drug Eruptions; Epileps | 2007 |
Road not taken: lessons to be learned from Queen v. Gillett.
Topics: Accident Prevention; Anticonvulsants; Automobile Driver Examination; Automobile Driving; Carbamazepi | 2007 |
[Saliva and plasma levels of carbamazepine have a poor correlation: a pilot study].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Drug Monitoring; Epilepsy; Humans; Pilot Projects | 2007 |
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.
Topics: Adolescent; Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Chil | 2007 |
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.
Topics: Adolescent; Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Chil | 2007 |
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.
Topics: Adolescent; Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Chil | 2007 |
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese.
Topics: Adolescent; Adult; Alleles; Anticonvulsants; Asian People; Carbamazepine; Case-Control Studies; Chil | 2007 |
Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Blood Glucose; Body Mass Index; Carbamazepine; Comorbidity; Epil | 2007 |
Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Topics: Acetamides; Algorithms; Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Disease | 2007 |
[Effect of carbamazepine on epilepsy with 1p36 deletion syndrome].
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Child, Preschool; Chromosome Deletion; Chromosomes, Hu | 2007 |
Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Child, Preschool; | 2007 |
Old versus new antiepileptic drugs: the SANAD study.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Lamotrigine; Triazines | 2007 |
Old versus new antiepileptic drugs: the SANAD study.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Lamotrigi | 2007 |
Old versus new antiepileptic drugs: the SANAD study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lamotrigine; Triazines; Valproic Acid | 2007 |
Effect of oxcarbazepine pretreatment on convulsive activity and brain damage induced by kainic acid administration in rats.
Topics: Animals; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Disease Models, Animal; Epilepsy; | 2008 |
[Immediate switching from carbamazepine to oxcarbazepine. Our experience in children and adolescents].
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Male; Oxcarbazepine; R | 2008 |
Relation of blood platelet count during carbamazepine and oxcarbazepine treatment with daily dose, and serum concentrations of carbamazepine, carbamazepine-10, 11-epoxide, and 10-hydroxycarbazepine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 2007 |
Anticonvulsant effects of carbamazepine on spontaneous seizures in rats with kainate-induced epilepsy: comparison of intraperitoneal injections with drug-in-food protocols.
Topics: Administration, Oral; Animals; Anticonvulsants; Carbamazepine; Cross-Over Studies; Disease Models, A | 2007 |
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy.
Topics: Anticonvulsants; Bias; Carbamazepine; Clinical Trials as Topic; Conflict of Interest; Disclosure; Dr | 2007 |
[Carbamazepine hepatoxicity--a case report].
Topics: Adolescent; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Hepatitis B Surface Ant | 2007 |
Carbamazepine and risk of hypothyroidism: a prospective study.
Topics: Adult; Anticonvulsants; Carbamazepine; Diabetic Neuropathies; Down-Regulation; Epilepsy; Humans; Hyp | 2007 |
Carbamazepine (Tegretol) in epilepsy. Nine year follow-up study with special emphasis on untoward reactions.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Carbamazepine; Child; Diplopia; Drug Overd | 1974 |
Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000-2005.
Topics: Adolescent; Adult; Age Distribution; Aged; Amines; Anticonvulsants; Carbamazepine; Catchment Area, H | 2007 |
Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine.
Topics: Adult; Anticonvulsants; Brain Diseases; Carbamazepine; Comorbidity; Epilepsy; Humans; Isoxazoles; Ma | 2007 |
Uncontrolled headache induced by oxcarbazepine.
Topics: Acute Disease; Adult; Anticonvulsants; Brain Neoplasms; Carbamazepine; Central Nervous System Vascul | 2007 |
Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Resistance; Drug Therapy, Combination; E | 2008 |
[Symptomatic secondary hyponatraemia due to combined treatment anticonvulsant and antidepressant: risk of sudden death in epilepsy?].
Topics: Adult; Anticonvulsants; Antidepressive Agents; Carbamazepine; Cyclohexanols; Death, Sudden; Drug Int | 2007 |
Long-term assessment of oxcarbazepine in a naturalistic setting: a retrospective study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Evaluation Studies as Topic; Female; Humans; Longit | 2008 |
[Carbamazepine and clarithromycin: a clinically relevant drug interaction].
Topics: Adult; Aged; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Clarithromycin; Cytochrome P-450 | 2007 |
An oxcarbazepine-related fatality with an overview of 26 oxcarbazepine postmortem cases.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Forensic Toxicolog | 2008 |
Switching from branded to generic antiepileptic drugs as a confounding factor and unpredictable diagnostic pitfall in epilepsy management.
Topics: Adult; Anticonvulsants; Ataxia; Carbamazepine; Drugs, Generic; Electroencephalography; Epilepsy; Fem | 2007 |
Homocysteine levels in epileptic children receiving antiepileptic drugs.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Folic Acid; Homocysteine; Human | 2007 |
Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
Topics: Adolescent; Adult; Age Factors; Algorithms; Anticonvulsants; Biological Availability; Carbamazepine; | 2007 |
Oxcarbazepine may induce psychotic symptoms in Parkinson's disease.
Topics: Aged; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Male; Oxcarbazepine; Parkinson Disease; Psyc | 2008 |
Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Child; Chromatography, High Pressu | 2008 |
Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cytochrome P-450 CYP3A; Epileps | 2008 |
Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Case-Control Studies; Electroencephalography; Epi | 2008 |
Cerebellar cognitive affective syndrome associated with topiramate.
Topics: Amines; Anticonvulsants; Carbamazepine; Cerebellar Diseases; Cerebellum; Cognition Disorders; Cycloh | 2008 |
New antiepileptic drugs in pediatric epilepsy.
Topics: Amines; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cyclohexanecarboxylic Acids; Epilep | 2008 |
Treatment of newly diagnosed epilepsies: the shortcomings of SANAD.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Follow-Up Studies; Humans; Lamotrigine; Randomized | 2008 |
DRESS: is oxcarbazepine safer than carbamazepine? An analysis of the French Pharmacovigilance database.
Topics: Adverse Drug Reaction Reporting Systems; Anticonvulsants; Carbamazepine; Databases, Factual; Epileps | 2008 |
Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, M | 2008 |
Association between SCN1A polymorphism and carbamazepine-resistant epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; Genotype; | 2008 |
Our work is still cut out for us...
Topics: Anticonvulsants; Carbamazepine; Child; Data Collection; Epilepsy; Expert Testimony; Guidelines as To | 2008 |
Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests.
Topics: Adult; Anticonvulsants; Carbamazepine; Eosinophilia; Epilepsy; Exanthema; Exanthema Subitum; Hematol | 2008 |
Generalized tonic-clonic seizures after acute oxcarbazepine withdrawal.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged; Oxca | 2008 |
Anticonvulsant therapy and its possible consequences on peripheral nervous system: a neurographic study.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Neural Conduction; Peripheral Nerves; Peripheral N | 1984 |
Anticonvulsant drug therapy in human pregnancy: effects on serum concentrations of vitamin D metabolites in maternal and cord blood.
Topics: 24,25-Dihydroxyvitamin D 3; Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Calcifediol; C | 1984 |
Psychiatric implications of anticonvulsant drugs.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Dose-Response Relationship, Dr | 1980 |
[Effect of barbexaclone treatment on thyroid function in epileptic children and juveniles (author's transl)].
Topics: Adolescent; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Humans; Phenobarbital; Phenyt | 1980 |
Choice of anticonvulsants in epilepsy.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Child, Preschool | 1981 |
New anticonvulsant drugs.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Epilepsy; gamma-Aminobutyric A | 1980 |
The influence of antiepileptic drugs on the electroencephalogram: a review of controlled clinical studies.
Topics: Anti-Anxiety Agents; Anticonvulsants; Brain; Carbamazepine; Clonazepam; Electroencephalography; Epil | 1982 |
Carbamazepine-induced non-hereditary acute porphyria.
Topics: 5-Aminolevulinate Synthetase; Acute Disease; Adult; Carbamazepine; Diagnosis, Differential; Epilepsy | 1983 |
[Rise in gamma-GT during anticonvulsive therapy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combinatio | 1982 |
Carbamazepine-induced non-hereditary acute porphyria.
Topics: Acute Disease; Carbamazepine; Epilepsy; Humans; Porphyrias | 1983 |
Possible hazard of valpromide-carbamazepine combination therapy in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Humans; Valproi | 1984 |
Pharmacokinetics of antiepileptic drugs.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Child; Child, Preschool | 1983 |
Carbamazepine-induced acute porphyria syndrome.
Topics: Acute Disease; Aged; Carbamazepine; Child; Epilepsy; Female; Humans; Middle Aged; Porphyrias; Syndro | 1984 |
Pharmacodynamic factors in the occurrence of psychiatric symptoms among patients with epilepsy.
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Epilepsy; Folic Acid; Humans; Kinetics; Mental Disorde | 1983 |
A rapid gas liquid chromatography method for simultaneous determination of various anticonvulsants.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Gas; Drug Therapy, Combination; Epilepsy; Humans; Ph | 1980 |
Transient global amnesia as an epileptic manifestation.
Topics: Amnesia; Carbamazepine; Child; Diagnosis, Differential; Electroencephalography; Epilepsy; Female; Hu | 1981 |
Plasma concentrations of valproate during maintenance therapy in epileptic children.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Epilepsy, A | 1982 |
Plasma arginine vasopressin concentrations in epileptics under monotherapy.
Topics: Adult; Anticonvulsants; Arginine Vasopressin; Carbamazepine; Epilepsy; Humans; Phenytoin; Primidone; | 1983 |
Interactions between primidone, carbamazepine, and nicotinamide.
Topics: Animals; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Epile | 1982 |
Serum anticonvulsant concentrations and the risk of drug induced skin eruptions.
Topics: Carbamazepine; Craniotomy; Drug Eruptions; Epilepsy; Humans; Phenytoin; Postoperative Complications | 1984 |
Limbic ictus and atypical psychoses.
Topics: Amphetamine; Animals; Carbamazepine; Cocaine; Electric Stimulation; Electroencephalography; Epilepsy | 1982 |
[Side-effects of phenytoin and carbamazepine on electrophysiologic functions of the peripheral and central nervous system].
Topics: Brain; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalog | 1983 |
Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients.
Topics: Adult; Aged; Bone and Bones; Carbamazepine; Cholecalciferol; Epilepsy; Ergocalciferols; Female; Huma | 1983 |
Carbamazepine and serum sodium levels.
Topics: Adolescent; Adult; Aged; Aging; Arginine Vasopressin; Carbamazepine; Child; Child, Preschool; Cyclic | 1984 |
Carbamazepine levels in breast milk.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Immunoenzyme Techniques; Milk, Human; Spectrophotome | 1984 |
The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol; Epilepsy; Humans; | 1983 |
Carbamazepine and valproic acid.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug In | 1983 |
Serum thyroid hormones and blood folic acid during monotherapy with carbamazepine or valproate. A controlled study.
Topics: Adolescent; Adult; Aged; Carbamazepine; Epilepsy; Folic Acid; Humans; Middle Aged; Thyroid Hormones; | 1983 |
[Ataractic treatment in psychiatry and general medicine. 2. Tranquillant = tranquilizers = daytime sedatives].
Topics: Anticonvulsants; Antidepressive Agents; Benzodiazepines; Carbamazepine; Chemistry, Pharmaceutical; C | 1983 |
Carbamazepine monotherapy in epileptic out-patients.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy; | 1983 |
Antiepileptic drugs and teratogenesis. How should patients, doctors and health authorities be counselled?
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant, Newbo | 1983 |
Active metabolites in antiepileptic therapy. Reflections on a pharmacological joker.
Topics: Anticonvulsants; Biotransformation; Carbamazepine; Diazepam; Epilepsy; Humans; Kinetics; Primidone; | 1983 |
[Monotherapy with carbamazepine in childhood epilepsies].
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Epileps | 1983 |
Serum folate concentrations during pregnancy in women with epilepsy: relation to antiepileptic drug concentrations, number of seizures, and fetal outcome.
Topics: Carbamazepine; Congenital Abnormalities; Epilepsy; Female; Fetal Death; Folic Acid; Humans; Phenobar | 1983 |
Drugs for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Humans; Phenobarbital; Phenytoin; Statu | 1983 |
Treatment of the nonconvulsive epilepsies.
Topics: Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Humans; Phenobarbi | 1983 |
[Pharmacotherapy of epilepsy--current problems and controversies].
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsies, Partial; Epilepsy; Epilepsy, | 1983 |
Unnecessary polypharmacy in patients with frequent seizures.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Clonazepam; Drug Therapy, Combination; Epi | 1984 |
Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy.
Topics: Abnormalities, Drug-Induced; Arousal; Benzodiazepinones; Carbamazepine; Chemical and Drug Induced Li | 1983 |
Hepatic toxicity of antiepileptic drugs: a review.
Topics: Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Energy Metabolism; Epilepsy; | 1983 |
Pituitary responsiveness to gonadotrophin-releasing and thyrotrophin-releasing hormones in epileptic patients receiving carbamazepine or phenytoin.
Topics: Adult; Carbamazepine; Epilepsy; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone | 1984 |
Rational use of valproate: indications and drug regimen in epilepsy.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, | 1984 |
Carbamazepine/valproic acid interaction in man and rhesus monkey.
Topics: Adolescent; Adult; Animals; Carbamazepine; Child; Dose-Response Relationship, Drug; Drug Interaction | 1984 |
Effect of anticonvulsant drugs on thalamo-cortical and hippocampo-cortical self-sustained after-discharges in the rat.
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebral Cortex; Electric Stimulation; Electroencephalograp | 1984 |
The effects of carbamazepine and valproate on folate metabolism in man.
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Female; Folic Acid; gamma-Glutamyl Hydrolase; Humans; In | 1984 |
Potentiation of the anticonvulsant effects of antiepileptic drugs by "nootropics"; a potential new therapeutic approach.
Topics: Animals; Anticonvulsants; Carbamazepine; Clonazepam; Dose-Response Relationship, Drug; Drug Synergis | 1984 |
Summing up of the success so far gained through choice of drugs or combinations of drugs.
Topics: Adult; Anticonvulsants; Carbamazepine; Cognition Disorders; Drug Therapy, Combination; Epilepsy; Hum | 1984 |
[The incidence of postoperative epilepsy and prophylactic anticonvulsants in patients with intracranial aneurysm].
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; In | 1984 |
[Clinical and electroencephalographic features of the action of the psychic stimulant sydnocarb in various forms of epilepsy].
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Electroencephalography; Epilepsy; Epileps | 1984 |
Nonsedative regimens in the treatment of epilepsy.
Topics: Carbamazepine; Epilepsy; Ethosuximide; Humans; Phenytoin; Seizures; Valproic Acid | 1983 |
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients.
Topics: Anticonvulsants; Antipyrine; Carbamazepine; Enzyme Induction; Epilepsy; Female; Glucaric Acid; Half- | 1984 |
[Plasma levels of antiepileptic agents in the treatment of epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Interac | 1984 |
[Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic].
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; | 1984 |
Anticonvulsant effects on the memory performance of epileptics.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Intelligence; Memory; Memory Di | 1984 |
Anticonvulsants, folic acid and memory dysfunction in epileptics.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Erythrocytes; Folic Acid; Humans; Memor | 1984 |
[Mono- or polytherapy of epilepsy?].
Topics: Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Long-Term Care; Phenytoin | 1984 |
Altered ratio of carbamazepine-10,11-epoxide/carbamazepine in plasma of children: evidence of anticonvulsant drug interaction.
Topics: Anticonvulsants; Carbamazepine; Child; Chromatography, Gas; Chromatography, High Pressure Liquid; Dr | 1984 |
Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epil | 1984 |
Epilepsy in children.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Diagnosis, Differential; Electroencephalogr | 1984 |
Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans | 1984 |
Carbamazepine in violent non-epileptic schizophrenics.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Schizophrenia | 1984 |
Biochemical mechanisms of action of carbamazepine in affective illness and epilepsy.
Topics: Carbamazepine; Epilepsy; Humans; Mood Disorders | 1984 |
Carbamazepine and bone mineral metabolism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Bone and Bones; Calcifediol; Calcium; Carbamazepine; | 1984 |
Excretion of organic acids associated with biotin deficiency in chronic anticonvulsant therapy.
Topics: Adult; Anticonvulsants; Biotin; Carbamazepine; Carboxy-Lyases; Carboxylic Acids; Epilepsy; Female; H | 1984 |
Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
Topics: Adult; Biotransformation; Carbamazepine; Child; Epilepsy; Female; Humans; Kinetics; Male | 1984 |
[Treatment of pregnant epileptics with carbamazepine. Preliminary report].
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pregnancy Co | 1984 |
Differential effect of antiepileptic and non-antiepileptic drugs on the reticular formation.
Topics: Action Potentials; Animals; Anticonvulsants; Baclofen; Carbamazepine; Cats; Dose-Response Relationsh | 1984 |
Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbama | 1984 |
High-dose monotherapy in treatment of intractable seizures.
Topics: Adult; Carbamazepine; Epilepsy; Humans; Middle Aged; Phenytoin; Seizures | 1984 |
Therapeutic plasma levels of phenytoin, phenobarbital, and carbamazepine: individual variation in relation to seizure frequency and type.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Middle Aged; Phenobar | 1984 |
Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
Topics: Adult; Aged; Carbamazepine; Child; Circadian Rhythm; Epilepsy; Female; Humans; Male; Middle Aged | 1984 |
Psychomotor status--a female case in the 34th week of pregnancy.
Topics: Adult; Carbamazepine; Clonazepam; Drugs, Chinese Herbal; Electroencephalography; Epilepsy; Epilepsy, | 1983 |
The relationship between seizures and amnesia in experimental epilepsy.
Topics: Amnesia; Animals; Carbamazepine; Epilepsy; Humans; Male; Memory Disorders; Rats; Rats, Inbred Strain | 1984 |
The influence of carbamazepine and phenytoin on memory and other aspects of cognitive function in new referrals with epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Cognition Disorders; Decision Making; Epilepsy; Fixation, Oc | 1984 |
Effects of phenobarbital, diphenylhydantoin and carbamazepine on thyroid function in epileptic children.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Phenobarbital; Phenytoin; Thyr | 1984 |
Transient hypogammaglobulinemia in the adult. Functional assessment of T and B lymphocytes.
Topics: Adult; Agammaglobulinemia; B-Lymphocytes; Carbamazepine; Epilepsy; Female; Humans; Immunoglobulin A; | 1983 |
Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?
Topics: Adolescent; Adult; Aged; Bone and Bones; Calcifediol; Calcium; Carbamazepine; Epilepsy; Female; Huma | 1983 |
Cardiac conduction disturbances during carbamazepine therapy.
Topics: Aged; Arrhythmias, Cardiac; Bundle-Branch Block; Carbamazepine; Epilepsy; Female; Heart Block; Heart | 1983 |
Drug effects on afterdischarge and seizure threshold in lissencephalic ferrets: an epilepsy model for drug evaluation.
Topics: Animals; Carbamazepine; Disease Models, Animal; Drug Evaluation; Epilepsy; Female; Ferrets; Male; Th | 1983 |
Fluctuations in salivary carbamazepine and carbamazepine-10,11-epoxide concentrations during the day in epileptic children.
Topics: Adolescent; Carbamazepine; Child; Circadian Rhythm; Epilepsy; Female; Humans; Male; Saliva | 1983 |
Carbamazepine, seizure disorders, and pregnancy.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pregnancy Complicat | 1983 |
A quantitative determination of anticonvulsant-induced bone demineralization by an improved X-ray densitometry technique.
Topics: Absorptiometry, Photon; Adolescent; Adult; Aged; Anticonvulsants; Bone and Bones; Carbamazepine; Dru | 1983 |
Reduction of polypharmacy for epilepsy in an institution for the retarded.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Huma | 1983 |
Carbamazepine--erythromycin interaction leading to carbamazepine toxicity in four epileptic children.
Topics: Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy; Erythromycin; Female; Humans; I | 1983 |
Carbamazepine and its major metabolites in plasma: a summary of eight years of therapeutic drug monitoring.
Topics: Black People; Carbamazepine; Epilepsy; Humans; White People | 1983 |
Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans | 1983 |
Long-term therapy with carbamazepine: effects on nerve conduction velocity.
Topics: Carbamazepine; Chronic Disease; Epilepsy; Female; Humans; Male; Motor Neurons; Neural Conduction; Ne | 1983 |
[Vomiting: symptom of an epileptic seizure].
Topics: Adult; Carbamazepine; Child; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Hu | 1983 |
Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Female; | 1983 |
[Alpha 1-acid glycoprotein and carbamazepine].
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Orosomucoid; Phenob | 1983 |
A design for the prospective evaluation of the efficacy and toxicity of antiepileptic drugs in adults.
Topics: Adult; Aged; Anticonvulsants; Behavior; Carbamazepine; Clinical Trials as Topic; Double-Blind Method | 1983 |
Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine).
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Drug Therapy, | 1984 |
Carbamazepine--erythromycin-base interaction.
Topics: Adult; Carbamazepine; Drug Interactions; Epilepsy; Erythromycin; Female; Humans | 1984 |
Protein binding of carbamazepine and its epoxide in maternal and fetal plasma at delivery: comparison to other anticonvulsants.
Topics: Adult; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Fatty Acids, | 1984 |
Together, phenobarbital and carbamazepine lower the alpha 1-acid glycoprotein concentration in plasma of epileptic patients.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Orosomucoid; Phenobarbital | 1984 |
Effect of carbamazepine & its combinations on thyroid functions in epileptics.
Topics: Adolescent; Adult; Carbamazepine; Child; Epilepsy; Female; Humans; Hypothyroidism; Male; Thyroid Hor | 1984 |
Prospective neurometric studies during the beginning of carbamazepine and phenytoin therapy.
Topics: Action Potentials; Adolescent; Adult; Carbamazepine; Cerebral Cortex; Electroencephalography; Electr | 1984 |
Comparison of fluorescence polarization immunoassay and enzyme immunoassay for free carbamazepine in serum or plasma ultrafiltrates from epileptic patients.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Immunoassay; Male; Ultrafiltration | 1984 |
Effect of viloxazine on serum carbamazepine levels in epileptic patients.
Topics: Adult; Carbamazepine; Depression; Drug Interactions; Epilepsy; Female; Humans; Male; Middle Aged; Mo | 1984 |
[Anticonvulsive combined therapy (author's transl)].
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epileps | 1980 |
[Differential treatment of epilepsy patients].
Topics: Anticonvulsants; Carbamazepine; Diagnosis, Differential; Drug Therapy, Combination; Epilepsy; Epilep | 1980 |
Pharmacokinetics of anticonvulsant drugs.
Topics: Anticonvulsants; Binding, Competitive; Brain; Carbamazepine; Drug Interactions; Drug Tolerance; Epil | 1980 |
Influence of carbamazepine on serum thyroxine and triiodothyronine in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Middle Aged; Thyroid | 1981 |
Drug treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Electroencephalography; Epilepsy; Ethosuximide; Female; | 1981 |
[A neuro-immunological hypothesis for some forms of epilepsy].
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Humans; Hydantoins; Immunoglobulins; Immunologic Deficie | 1981 |
Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients.
Topics: Adolescent; Adult; Binding, Competitive; Blood Proteins; Carbamazepine; Epilepsy; Female; Humans; Ma | 1981 |
Recent advances in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Huma | 1980 |
[A case of Pringle-Bourneville disease].
Topics: Adult; Carbamazepine; Epilepsy; Epilepsy, Absence; Female; Humans; Phenobarbital; Tuberous Sclerosis | 1981 |
Daily fluctuations of dipropylacetate (DPA) serum level in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle | 1980 |
Plasma levels and pharmacokinetics of antipileptic drugs in children.
Topics: Adolescent; Age Factors; Anticonvulsants; Biological Availability; Biotransformation; Carbamazepine; | 1981 |
Differentiating between organic and functional seizures: a common diagnostic problem.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Diagnosis, Differential; Dose-Response Relationsh | 1981 |
Carbamazepine intoxication caused by interaction with isoniazid.
Topics: Carbamazepine; Drug Interactions; Epilepsy; Humans; Isoniazid | 1982 |
The effects of anticonvulsants on memory function in epileptic patients: preliminary findings.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Memory; Memory, Short-Term; Mental Recall; Phenyto | 1981 |
[Clinical evaluation of certain modern antiepileptic preparations].
Topics: Anticonvulsants; Automatism; Carbamazepine; Child; Clonazepam; Diencephalon; Epilepsy; Epilepsy, Abs | 1982 |
Early prognosis of epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Female; Humans; Male; | 1982 |
Sodium valproate: monotherapy and polytherapy.
Topics: Adolescent; Adult; Carbamazepine; Drug Therapy, Combination; Epilepsies, Myoclonic; Epilepsies, Part | 1982 |
Therapeutic concentration of antiepileptic drugs and the severity of epileptogenesis.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Isoxazoles; Phenytoin; Valproic Acid; Zonisamide | 1982 |
[The effect of anticonvulsive therapy on the psychological achievements in epileptic children].
Topics: Achievement; Adolescent; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Valproic Acid | 1982 |
Reduced theophylline half-life induced by carbamazepine therapy.
Topics: Asthma; Carbamazepine; Child; Drug Interactions; Epilepsy; Female; Half-Life; Humans; Theophylline | 1983 |
[A side-effect of carbamazepine].
Topics: Carbamazepine; Diabetes Insipidus; Epilepsy; Humans; Water Intoxication | 1983 |
Motor and sensory conduction velocities and electromyographic findings in man before and after carbamazepine treatment.
Topics: Carbamazepine; Electromyography; Epilepsy; Humans; Neural Conduction; Peripheral Nerves; Phenytoin | 1983 |
Effect of dosage frequency of carbamazepine on drug serum levels in epileptic patients.
Topics: Adolescent; Behavior; Carbamazepine; Drug Administration Schedule; Electroencephalography; Epilepsy; | 1983 |
A retrospective study on epileptic patients treated with carbamazepine: interaction between age and co-medication on the drug disposition.
Topics: Adolescent; Adult; Aged; Aging; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy; | 1983 |
A study of the action of anticonvulsant drugs on an experimental model of epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Electric Stimulation; Epi | 1980 |
Anticonvulsant drugs, cognitive function and memory.
Topics: Anticonvulsants; Carbamazepine; Double-Blind Method; Epilepsy; Humans; Male; Memory Disorders; Menta | 1980 |
Further studies on anticonvulsant drugs and seizures.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Cognition; Epilepsy; Female; Humans; Male; Memory; | 1981 |
Carbamazepine. Pharmacology and clinical uses.
Topics: Adult; Alcohol Withdrawal Delirium; Arrhythmias, Cardiac; Behavior; Carbamazepine; Child; Diabetes I | 1981 |
Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Huma | 1980 |
Some immunological reactions during chronic treatment with antiepileptic drugs.
Topics: Adult; Antibody Formation; B-Lymphocytes; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; | 1981 |
Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants.
Topics: 24,25-Dihydroxyvitamin D 3; Adult; Aged; Alkaline Phosphatase; Calcifediol; Calcitriol; Calcium; Car | 1982 |
Value of saliva samples in monitoring carbamazepine concentrations in epileptic patients.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Immunoenzyme Techniques; Male; Saliva | 1980 |
Stability of antiepileptic drug level in serum. Reliability of enzyme immunoassay method.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Immunoenzyme Techniques; Phenobarbital; Phe | 1980 |
Carbamazepine determination in saliva of children: enzyme immunoassay (EMIT) versus high pressure liquid chromatography.
Topics: Carbamazepine; Child; Child, Preschool; Chromatography, High Pressure Liquid; Epilepsy; Humans; Immu | 1982 |
Fluorescent immunoassay for determining antiepileptic drug concentrations: clinical usefulness.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Fluorescent Antibody Technique; Humans; Immunoassay; Immun | 1982 |
Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; Epilepsy; | 1982 |
Respiratory disease in patients with epilepsy on single-drug therapy with carbamazepine or phenobarbital.
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immu | 1982 |
Differences between the concentrations of antiepileptic drugs in normal and pathological human brain.
Topics: Adolescent; Adult; Anticonvulsants; Brain; Carbamazepine; Child; Electroencephalography; Epilepsy; F | 1982 |
Epileptic seizures and lipoma of the corpus callosum.
Topics: Adult; Brain Neoplasms; Carbamazepine; Corpus Callosum; Epilepsy; Humans; Lipoma; Male | 1982 |
Simultaneous liquid-chromatographic determination of carbamazepine and its epoxide metabolite in plasma.
Topics: Carbamazepine; Child; Chromatography, High Pressure Liquid; Epilepsy; Evaluation Studies as Topic; H | 1982 |
A particular evolution of two cases of somatosensory spike epilepsy.
Topics: Carbamazepine; Child; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; Evoked Potentials, | 1982 |
Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction.
Topics: Adult; Carbamazepine; Drug Interactions; Epilepsy; Humans; Isoniazid; Liver; Male | 1982 |
The effect of carbamazepine on serum immunoglobulin concentrations.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Female; Humans; Immunoglobulin A; Immunoglo | 1982 |
Anticonvulsant drugs and cognitive functions.
Topics: Adult; Anticonvulsants; Carbamazepine; Cognition Disorders; Drug Therapy, Combination; Electroenceph | 1982 |
HLA antigens in epileptic patients with drug-induced immunodeficiency.
Topics: Adult; Anticonvulsants; Carbamazepine; Dysgammaglobulinemia; Epilepsy; Female; HLA Antigens; Humans; | 1982 |
Experience with carbamazepine (Mazetol) an analysis of 156 cases.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Male; Middle Ag | 1982 |
Nonlinear kinetics of phenytoin in children.
Topics: Adolescent; Adult; Age Factors; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, | 1982 |
Protein binding of carbamazepine in epileptic patients.
Topics: Carbamazepine; Epilepsy; Humans; Intellectual Disability; Protein Binding | 1982 |
Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction.
Topics: Adult; Carbamazepine; Drug Antagonism; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Mi | 1980 |
A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Double-Blind Method | 1981 |
[Measurements of nerve conduction velocity during decreasing toxic diphenylhydantoin levels and the beginning of carbamazepine medication. A clinical neurophysiological documentation (author's transl)].
Topics: Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Male; Middle Aged; Motor Neurons; | 1981 |
Serum carbamazepine concentration--dose dependency and daily fluctuations.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans | 1980 |
Quantitative assessment of smooth-pursuit eye movements in healthy and epileptic subjects.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electrooculography; Epilepsy; Eye Movements; Huma | 1980 |
Carbamazepine plasma levels in children and adults: influence of age, dose, and associated therapy.
Topics: Adolescent; Aging; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Fema | 1980 |
[Influence of anti-epileptic drugs on blood lipid parameters: preliminary data].
Topics: Anticonvulsants; Carbamazepine; Cholesterol; Epilepsy; Humans; Lipids; Phenobarbital; Phenytoin; Tri | 1981 |
Ictal effects of anticonvulsant medication withdrawal in epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy; Humans; Middle | 1981 |
Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
Topics: Blood Proteins; Carbamazepine; Epilepsy; Female; Humans; Male; Protein Binding; Saliva | 1981 |
Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome?
Topics: Adult; Aged; Carbamazepine; Child; Diagnosis, Differential; Dystonia; Electroencephalography; Epilep | 1981 |
Salivary anticonvulsant levels in children with epilepsy.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Infant; Phenytoin; Saliva | 1981 |
[A neuro-immunological theory for some forms of epilepsy].
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Humans; Hydantoins; IgA Deficiency; Immunoglobulins | 1981 |
Fatal carbamazepine-associated hepatitis. Report of two cases.
Topics: Adult; Alcoholism; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Female; Humans; | 1981 |
Dose-dependency of the ratio between carbamazepine serum level and dosage in patients with epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Carbamazepine; Child; Child, Preschool; Dose-Response Relation | 1981 |
Influence of disulfiram on the serum concentration of carbamazepine in patients with epilepsy.
Topics: Adult; Carbamazepine; Disulfiram; Drug Interactions; Epilepsy; Female; Humans; Male; Middle Aged | 1981 |
Role of carbamazepine in reducing polypharmacy in epilepsy.
Topics: Acetazolamide; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Ther | 1981 |
[Monotherapy or polytherapy in epilepsy?].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Combinations; Drug Evaluation; Drug I | 1981 |
[Diagnosis of osteopathy caused by antiepileptic drugs].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Bone Diseases; Carbamazepine; Epilepsy; Female; Femur; Han | 1981 |
Autoinduction of carbamazepine metabolism in children examined by a stable isotope technique.
Topics: Adolescent; Carbamazepine; Child; Deuterium; Epilepsy; Female; Humans; Kinetics; Male | 1980 |
Laughing seizures (gelastic seizures) in childhood.
Topics: Carbamazepine; Child; Electroencephalography; Epilepsy; Humans; Laughter; Male; Tomography, X-Ray Co | 1980 |
Improvement in antiepileptic drug levels following reduction of intervals between clinic visits.
Topics: Adolescent; Adult; Anticonvulsants; Appointments and Schedules; Carbamazepine; Epilepsy; Ethosuximid | 1980 |
Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Epilepsy; Female; Humans; Lipoproteins, HDL; Mal | 1980 |
Antiepileptic drug distribution in cerebral cortex, ammon's horn, and amygdala in man.
Topics: Adolescent; Adult; Amygdala; Anticonvulsants; Carbamazepine; Cerebral Cortex; Child; Epilepsy; Femal | 1980 |
Hyponatraemia and carbamazepine intoxication.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Hyponatre | 1980 |
Simultaneous liquid chromatographic analysis for carbamazepine and carbamazepine 10,11-epoxide in plasma and saliva by use of double internal standardization.
Topics: Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Saliva | 1980 |
Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Half-Life; H | 1980 |
Long-term experiences with carbamazepine (Tegretol) in children with seizures.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Time Factors | 1980 |
Monitoring 2-ethyl-2-phenylmalonamide in serum by gas-liquid chromatography: application to retrospective study in epilepsy patients dosed with primidone.
Topics: Adult; Carbamazepine; Chromatography, Gas; Drug Interactions; Epilepsy; Humans; Malonates; Middle Ag | 1980 |
Arrhythmogenic epilepsy: an hypothesis.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Carbamazepine; Digoxin; Electroencephalography; Electrophys | 1980 |
The auto-induction of carbamazepine during long-term therapy.
Topics: Adolescent; Adult; Biotransformation; Carbamazepine; Epilepsy; Female; Humans; Kinetics; Male; Middl | 1980 |
Rapid quantitative determination of underivatized carbamazepine, phenytoin, phenobarbital and p-hydroxyphenobarbital in biological fluids by packed column gas chromatography.
Topics: Adult; Carbamazepine; Chromatography, Gas; Epilepsy; Female; Gas Chromatography-Mass Spectrometry; H | 1980 |
Biochemical evidence for osteomalacia with carbamazepine therapy.
Topics: Adolescent; Adult; Alkaline Phosphatase; Bilirubin; Carbamazepine; Child; Enzyme Induction; Epilepsy | 1980 |
Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine.
Topics: Carbamazepine; Epilepsy; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Immun | 1980 |
[Dystonia and carbamazepine (author's transl)].
Topics: Carbamazepine; Child; Child, Preschool; Dystonia; Epilepsy; Female; Humans; Male | 1980 |
Power spectral analysis of EEG characteristics during sleep in epileptics.
Topics: Adolescent; Adult; Carbamazepine; Circadian Rhythm; Electroencephalography; Epilepsy; Ethosuximide; | 1981 |
9-Hydroxymethyl-10-carbamoylacridan in human serum is one of the major metabolites of carbamazepine.
Topics: Acridines; Biotransformation; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; | 1995 |
Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Erythrocytes; Female; | 1995 |
Menstrual disorders in women with epilepsy receiving carbamazepine.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Ep | 1995 |
Evaluation of equations for unbound serum concentration prediction of carbamazepine and carbamazepine-10,11-epoxide in polytherapy pediatric patients with epilepsy.
Topics: Adolescent; Binding, Competitive; Biological Availability; Carbamazepine; Child; Child, Preschool; E | 1995 |
[Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
Topics: Adolescent; Anticonvulsants; Brain Diseases; Carbamazepine; Child; Child, Preschool; Epilepsy; Femal | 1995 |
Automated analysis of free and total concentrations of three antiepileptic drugs in plasma with on-line dialysis and high-performance liquid chromatography.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Dialysis; Epilepsy; Humans; Ph | 1995 |
Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.
Topics: Anticonvulsants; Auditory Pathways; Brain Stem; Carbamazepine; Child; Child, Preschool; Epilepsies, | 1995 |
Red cell folate levels in pregnant epileptic women.
Topics: Adult; Carbamazepine; Epilepsy; Erythrocytes; Female; Folic Acid; Follow-Up Studies; Humans; Phenyto | 1995 |
Lamotrigine versus carbamazepine in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Administration Schedule; Epilepsy; Hu | 1995 |
Carbamazepine, phenytoin, sex hormones, and sexual function in men with epilepsy.
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Follow-Up Studies; Humans; Male; Middle Aged; Phenytoin; | 1995 |
Cytokine production in blood mononuclear cells from epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Cytokines; Epilepsy; Female; Humans; Interleukin-1; Interleukin-2; | 1995 |
Interactions of phenobarbital and phenytoin with carbamazepine and its metabolites' concentrations, concentration ratios, and level/dose ratios in epileptic children.
Topics: Biotransformation; Carbamazepine; Child; Chromatography, High Pressure Liquid; Dose-Response Relatio | 1995 |
Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy; Epoxide Hydr | 1995 |
Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine.
Topics: Adolescent; Adult; Anticonvulsants; Antipyrine; Carbamazepine; Cytochrome P-450 Enzyme System; Echoc | 1995 |
Effect of carbamazepine and valproate on bone mineral density.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Calcium, Dietary; Carbamazepine; Case-Control Stud | 1995 |
Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Phenytoi | 1995 |
Is there a pathophysiological and therapeutic link between panic disorder and epilepsy?
Topics: Adult; Brain; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Magnetic Resonance Im | 1995 |
Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.
Topics: Adolescent; Adult; Aged; Antibody Formation; B-Lymphocytes; Carbamazepine; Complement C3; Complement | 1994 |
Drugs for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Humans; Phenytoin | 1995 |
[Disorders of color perception and increase glare sensitivity in phenytoin and carbamazepine therapy. Ocular side effects of anticonvulsants].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Color Perception Tests; Color Vision Defec | 1995 |
Self-esteem and behavioural adjustment in children with epilepsy and children with diabetes.
Topics: Adolescent; Carbamazepine; Child; Child Behavior Disorders; Cross-Sectional Studies; Diabetes Mellit | 1994 |
Reduced carnitine and antiepileptic drugs: cause relationship or co-existence?
Topics: Adolescent; Anticonvulsants; Carbamazepine; Carnitine; Child; Child, Preschool; Epilepsy; Female; Hu | 1995 |
The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Epilepsy; Female; G | 1995 |
Lamotrigine versus carbamazepine in epilepsy.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans; Lamotrigine; Triazine | 1995 |
Lamotrigine versus carbamazepine in epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Lamotrigine; Research Design; Triazi | 1995 |
Signs and symptoms of carbamazepine overdose.
Topics: Adolescent; Adult; Carbamazepine; Cerebellar Diseases; Coma; Drug Overdose; Epilepsy; Female; Humans | 1995 |
[Sensitive physiologic perceptual tests for ocular side effects of drugs exemplified by various anticonvulsants].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Color Perception; Contrast Sensitivity; Da | 1995 |
Effects of antiepileptic drugs on EEG background activity in children with epilepsy: initial phase of therapy.
Topics: Alpha Rhythm; Anticonvulsants; Carbamazepine; Child; Delta Rhythm; Electroencephalography; Epilepsie | 1995 |
Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Delayed-Action Preparations; Dose-Response Relat | 1995 |
[Changes in drug therapy and in seizure frequency in an institution for epilepsy patients between 1971 and 1986].
Topics: Aged; Aged, 80 and over; Anticonvulsants; Barbiturates; Carbamazepine; Drug Therapy, Combination; Dr | 1994 |
Efficacy of carbamazepine with respect to distribution of carbamazepine and its metabolite 10,11-epoxide in cerebral tumours and paratumorous cortex.
Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Carbamazepine; Cerebral Cortex; Child; Epilepsy; F | 1994 |
Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 1994 |
Erythromycin-induced carbamazepine toxicity: a continuing problem.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Clarithromycin; Drug Interactions; Epilepsy; Ery | 1995 |
Mazetal, diplopia and epilepsy.
Topics: Carbamazepine; Diplopia; Epilepsy; Humans | 1994 |
Pediatric carbamazepine overdoses.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Overdose; | 1994 |
In vivo binding characteristics of carbamazepine and carbamazepine 10, 11-epoxide to serum proteins in monotherapy adult patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Ag | 1994 |
Six mutagenicity assays in exposure biomonitoring of patients receiving carbamazepine for epilepsy or trigeminal neuralgia.
Topics: Adolescent; Adult; Aged; Biotransformation; Carbamazepine; Case-Control Studies; Cell Division; Chil | 1995 |
Resistance to vecuronium.
Topics: Adult; Carbamazepine; Drug Resistance; Electroencephalography; Epilepsy; Female; Humans; Neostigmine | 1993 |
Lithium neurotoxicity at subtherapeutic serum levels.
Topics: Adult; Antipsychotic Agents; Ataxia; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, | 1994 |
Oxcarbazepine: Experience and Future Role. Proceedings of a satellite symposium at the 20th International Epilepsy Congress. Oslo, Norway, July 3-8, 1993.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine | 1994 |
Neuroleptic and antiepileptic treatment in the mentally retarded.
Topics: Adult; Aged; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Dose-Response Relationship, Drug; | 1993 |
A comparative study of serum F protein and other liver function tests as an index of hepatocellular damage in epileptic patients.
Topics: Adult; Alkaline Phosphatase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Chemical a | 1994 |
Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; H | 1994 |
Changes of thyroid hormone levels in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Phenytoin; Thyrotropin; Thyro | 1994 |
Diagnosis and treatment.
Topics: Adolescent; Carbamazepine; Child; Developing Countries; Diagnosis, Differential; Electroencephalogra | 1994 |
Epilepsy treatment in The Netherlands. Comparison of matched groups of two medical centres.
Topics: Adolescent; Adult; Carbamazepine; Diazepam; Epilepsy; Ethosuximide; Female; gamma-Aminobutyric Acid; | 1994 |
Use of saliva in home monitoring of carbamazepine levels.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Drug Monitoring; Epilepsy; Female; Humans; Male; | 1995 |
Improved therapeutic monitoring of drug interactions in epileptic children using carbamazepine polytherapy.
Topics: Adolescent; Biotransformation; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Monit | 1994 |
The influence of polytherapy on the relationships between serum carbamazepine and its metabolites in epileptic children.
Topics: Aging; Anticonvulsants; Body Weight; Carbamazepine; Child; Chromatography, High Pressure Liquid; Dru | 1994 |
Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cross Reactions; Drug Hypersens | 1994 |
New antiepileptic drugs already registered.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Approval; Drugs, Investigational; Epi | 1994 |
Oxcarbazepine: clinical development program.
Topics: Aged; Anticonvulsants; Carbamazepine; Child; Clinical Trials as Topic; Drug Administration Schedule; | 1994 |
A retrospective study of 113 epileptic patients treated with sustained-release valproate.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Drug Administration Schedule; Drug Ther | 1994 |
Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone Density; Bone Development; Bone Resorption | 1994 |
[Effects of carbamazepine on heart conduction in young patients: a serial study using ambulatory ECG].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Carbamazepine; Epilepsy; Female; Heart Conduction System; H | 1994 |
[Anxiety attacks and epileptic seizures. Determining similarities based on a case report].
Topics: Adult; Arousal; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; E | 1994 |
Concentrations of carbamazepine and carbamazepine-10, 11-epoxide in serum, brain tumors and paratumorous cortex: a prospective study of 37 neurosurgically treated epileptic patients.
Topics: Adolescent; Adult; Aged; Biological Availability; Biopsy; Brain Neoplasms; Carbamazepine; Cerebral C | 1994 |
Amino acid levels in the cerebrospinal fluid of newly diagnosed epileptic patients: effect of vigabatrin and carbamazepine monotherapies.
Topics: Adolescent; Adult; Amino Acids; Aminocaproates; Carbamazepine; Carnosine; Epilepsy; Female; gamma-Am | 1993 |
Serum lipid levels during carbamazepine medication. A prospective study.
Topics: Adolescent; Adult; Carbamazepine; Cholesterol, HDL; Cholesterol, LDL; Epilepsy; Female; gamma-Glutam | 1993 |
Carbamazepine hypersensitivity and rickettsiosis mimicking Kawasaki disease.
Topics: Blood Cell Count; Boutonneuse Fever; Carbamazepine; Child; Chloramphenicol; Diagnosis, Differential; | 1993 |
Clinical development outlook of oxcarbazepine.
Topics: Aged; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; | 1994 |
Practical aspects of oxcarbazepine treatment.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Drug Eruptions; Epilepsy; Humans; M | 1994 |
Carbamazepine offers no psychotropic advantage over phenytoin in adult epileptic subjects.
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; Humans; In | 1993 |
Pregnancy, epilepsy, management and outcome: a 10-year perspective.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Birth Weight; Carbamazepine; Cohort Studies; Drug Ther | 1993 |
Auditory event-related potentials in benign childhood epilepsy with centrotemporal spike: the effects of carbamazepine.
Topics: Acoustic Stimulation; Adolescent; Arousal; Attention; Carbamazepine; Cerebral Cortex; Child; Epileps | 1994 |
Psoriasiform eruption induced by anticonvulsants.
Topics: Adult; Carbamazepine; Drug Eruptions; Epilepsy; Female; Humans; Male; Middle Aged; Psoriasis; Valpro | 1994 |
Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Circadian Rhythm; Delayed-Action Preparatio | 1994 |
Population analysis of the dose-dependent pharmacokinetics of zonisamide in epileptic patients.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Biological Availability; Carbamazepine; Ch | 1994 |
[Repetitive serum determinations of anticonvulsants in epileptic patients].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsy; Female; Humans; Middle | 1993 |
The use of antiepileptic drug levels in children: a survey of Canadian pediatric neurologists.
Topics: Adolescent; Anticonvulsants; Attitude of Health Personnel; Carbamazepine; Child; Epilepsy; Ethosuxim | 1993 |
Calcium-antagonistic effects of carbamazepine in epilepsies and affective psychoses.
Topics: Animals; Caffeine; Calcium Channel Blockers; Carbamazepine; Epilepsy; Guinea Pigs; Hippocampus; In V | 1993 |
Carbamazepine withdrawal: effects of taper rate on seizure frequency.
Topics: Adult; Analysis of Variance; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Male; | 1993 |
Determination of total and free carbamazepine and the principal metabolites in serum by high-performance liquid chromatography with photodiode-array detection.
Topics: Carbamazepine; Child; Chromatography, High Pressure Liquid; Epilepsy; Humans; Spectrophotometry, Ult | 1993 |
Semen parameters among epileptic males treated with carbamazepine.
Topics: Adult; Carbamazepine; Epilepsy; Humans; Male; Semen; Sperm Motility | 1993 |
Nutritional factors and anticonvulsant therapies: effect on growth in children with epilepsy.
Topics: Carbamazepine; Child; Child Nutritional Physiological Phenomena; Child, Preschool; Cross-Sectional S | 1993 |
Bioequivalency revisited: epitol versus tegretol.
Topics: Carbamazepine; Clinical Trials as Topic; Drugs, Generic; Epilepsy; Humans; Therapeutic Equivalency | 1993 |
Skin rash caused by carbamazepine.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administr | 1993 |
Teratogenicity of antiepileptic drugs and drug specific malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug | 1993 |
Fluid retention and cardiomegaly associated with carbamazepine in an epileptic child.
Topics: Adolescent; Carbamazepine; Cardiomegaly; Epilepsy; Humans; Inappropriate ADH Syndrome; Male | 1993 |
Unmasking the significant enzyme-inducing effects of phenytoin on serum carbamazepine concentrations during phenytoin withdrawal.
Topics: Adult; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Enzyme Induction; Epilepsy; Huma | 1993 |
Carbamazepine and plasma levels of clozapine.
Topics: Adult; Carbamazepine; Clozapine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Mal | 1993 |
Daytime sleepiness in epileptic patients on long-term monotherapy: MSLT, clinical and psychometric assessment.
Topics: Adolescent; Adult; Analysis of Variance; Carbamazepine; Electroencephalography; Epilepsy; Humans; Ma | 1993 |
Practices of epilepsy during pregnancy: a survey of Canadian neurologists.
Topics: Anticonvulsants; Canada; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Neurolo | 1993 |
The 10,11-epoxide-10,11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, comedication, and relation to outcome of pregnancy.
Topics: Abnormalities, Drug-Induced; Amniotic Fluid; Carbamazepine; Cohort Studies; Dose-Response Relationsh | 1993 |
Investigation and management of loss of efficacy of an antiepileptic medication using carbamazepine as an example.
Topics: Algorithms; Carbamazepine; Contraindications; Drug Interactions; Drug Resistance; Epilepsy; Humans | 1993 |
Effects of carbamazepine and baclofen on 4-aminopyridine-induced epileptic activity in rat hippocampal slices.
Topics: 4-Aminopyridine; Animals; Baclofen; Carbamazepine; Electrophysiology; Epilepsy; Hippocampus; In Vitr | 1993 |
Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 1993 |
In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy.
Topics: Adolescent; Age Factors; Blood Proteins; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; H | 1993 |
[Stevens-Johnson syndrome secondary to carbamazepine].
Topics: Adult; Carbamazepine; Epilepsy; Humans; Male; Stevens-Johnson Syndrome | 1993 |
Five years of anticonvulsant monitoring on site at the epilepsy clinic.
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Humans; Outpatient Clinics, Hospital; Phe | 1993 |
Postmortem concentrations of phenobarbital, carbamazepine, and its metabolite carbamazepine-10,11-epoxide in different regions of the brain and in the serum: analysis of autoptic specimens from 51 epileptic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Autopsy; Brain Chemistry; Carbamazepine; Child; Child, P | 1993 |
Steady state pharmacokinetics of conventional versus controlled-release carbamazepine in patients with epilepsy.
Topics: Adolescent; Adult; Carbamazepine; Child; Circadian Rhythm; Delayed-Action Preparations; Epilepsy; Hu | 1993 |
Carbamazepine, serum thyroid hormones and myocardial function in epileptic patients.
Topics: Adult; Carbamazepine; Epilepsy; Female; Heart; Humans; Male; Systole; Thyroxine; Triiodothyronine | 1993 |
[Five cases of paroxysmal sleep disturbances].
Topics: Carbamazepine; Child; Child, Preschool; Diagnosis, Differential; Diazepam; Electroencephalography; E | 1993 |
An audit of therapeutic drug monitoring of anticonvulsants.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Drug Monitoring; Epilepsy; Humans; Medical Audit; Nort | 1995 |
Costing of antiepileptic drugs.
Topics: Acetates; Amines; Anticonvulsants; Argentina; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Costs | 1996 |
[Cardiac effects of carbamazepine therapy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Echocardiography; Electrocardiography; Electroencephalog | 1995 |
Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring?
Topics: Anticonvulsants; Carbamazepine; Drug Monitoring; Epilepsy; Gas Chromatography-Mass Spectrometry; Hai | 1995 |
A model for estimating individualized valproate clearance values in children.
Topics: Administration, Oral; Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Ther | 1995 |
Comparison of equations for predicting bound serum concentrations of carbamazepine and carbamazepine-10, 11-epoxide after polytherapy in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Blood Proteins; Carbamazepine; Child; C | 1995 |
[Current role of novel antiepileptics in the treatment of epilepsies].
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Resistance; Epil | 1996 |
Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide treatment of a patient with the MELAS syndrome.
Topics: Aged; Anticonvulsants; Carbamazepine; Cells, Cultured; Cerebrovascular Disorders; Epilepsy; Fibrobla | 1996 |
Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.
Topics: Administration, Oral; Adult; Carbamazepine; Drug Interactions; Enzyme Induction; Epilepsy; Female; F | 1996 |
Pharmacology of cortical epileptic afterdischarges in rats.
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebral Cortex; Dimethyl Sulfoxide; Disease Models, Animal | 1996 |
Carbamazepine-exacerbated epilepsy with multifocal shifting independent epileptiform discharges on electroencephalogram: a case report.
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Dose-Response Relationship, Drug; Electroencephalograp | 1995 |
Carbamazepine-induced thrombocytopenia and carbamazepine-10,11-epoxide: a case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Hemiplegia; Humans; Thrombocytopenia | 1995 |
Obesity and endocrine disorders in women taking valproate for epilepsy.
Topics: Adult; Body Weight; Carbamazepine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endocrine | 1996 |
Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study.
Topics: Adult; Brain; Carbamazepine; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, | 1996 |
Seizure control after chronic pharmacotherapy in epileptic disorders beginning after 40 years of age.
Topics: Adult; Age of Onset; Aged; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged; Phenobarbital | 1995 |
[Study of the influence of anticonvulsant treatment on thyroid function].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Enzyme-Linked Immunosorbent Assay; E | 1995 |
Influence of D-cycloserine on the anticonvulsant activity of phenytoin and carbamazepine against electroconvulsions in mice.
Topics: Animals; Anticonvulsants; Avoidance Learning; Behavior, Animal; Carbamazepine; Cycloserine; Disease | 1996 |
Catamenial epilepsy: gynecological and hormonal implications. Five case reports.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Estradiol; Female; Humans; Premenstrual | 1996 |
Chiral separation of 10,11-dihydro-10, 11-trans-dihydroxycarbamazepine, a metabolite of carbamazepine with two asymmetric carbons, in human serum.
Topics: Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Reproducibility of Results; S | 1996 |
Exfoliative dermatitis caused by carbamazepine in a patient with isolated IgA deficiency.
Topics: Anticonvulsants; Carbamazepine; Dermatitis, Exfoliative; Drug Eruptions; Epilepsy; Humans; IgA Defic | 1995 |
Quantitative pharmaco-EEG of carbamazepine in volunteers and epileptics.
Topics: Adult; Anticonvulsants; Brain Mapping; Carbamazepine; Cerebral Cortex; Electroencephalography; Epile | 1996 |
Paralytic ileus in a fetus-neonate after maternal intake of benzodiazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Clonazepam; Epilepsy; Female; Fetal Diseases; Humans; Infant, | 1995 |
Self mutilation and epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Self Mutilation | 1995 |
Severe carbamazepine toxicity induced by concurrent erythromycin therapy.
Topics: Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Drug Therapy, Combi | 1996 |
Comparing antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenobarbital; Valproic Acid | 1996 |
Modifications of diazepam binding inhibitor and peripheral benzodiazepine receptors in the lymphocytes of epileptic patients.
Topics: Adolescent; Carbamazepine; Child; Diazepam; Epilepsy; Female; Humans; Lymphocytes; Male; Receptors, | 1996 |
Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: a case study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Half-Life; Humans; Metabolic Clearance Rate | 1996 |
[The effects of phenobarbital, valproic acid and carbamazepine on the serum lipids and lipoproteins in a pediatric population].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infan | 1996 |
Dose-dependent metabolism of carbamazepine in humans.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combina | 1996 |
Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Huma | 1996 |
The effects of antiepileptic drugs on serum zinc and copper levels in children.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Copper; Drug Therapy, Combination; Epilepsy | 1995 |
Exquisite sensitivity of paroxysmal kinesigenic choreoathetosis to carbamazepine.
Topics: Adolescent; Age of Onset; Carbamazepine; Epilepsy; Female; Humans; Movement Disorders; Sensitivity a | 1996 |
Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Carbamazepine; Citalopram; Depressive Disorder; Drug | 1996 |
The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combinatio | 1996 |
Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; | 1996 |
Lack of influence of histopathological changes on carbamazepine and carbamazepine-10, 11-epoxide concentrations in the brain cortex of epileptic patients.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cerebral Cortex; Epilepsy; Female; H | 1996 |
Effects of high-dose antiepileptic drugs on event-related potentials in epileptic children.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Evoked Potentials; Female; Human | 1996 |
Salivary protein composition in epileptic patients on different medications.
Topics: Adult; Aged; Albumins; Amylases; Anticonvulsants; Carbamazepine; Cystatin C; Cystatins; Cysteine Pro | 1996 |
Fetal malformations in an epileptic pregnant woman treated with carbamazepine.
Topics: Abnormalities, Drug-Induced; Abortion, Eugenic; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Fem | 1996 |
Plasma tryptophan levels in children with epilepsy before and after antiepileptic treatment.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Tryptophan; Valpr | 1996 |
Steady state pharmacokinetics of carbamazepine-phenobarbital interaction in patients with epilepsy.
Topics: Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combin | 1996 |
[Epilepsy and pregnancy. Prospective study of 100 cases].
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Birth Weight; Carbamazepine; Epilepsy; Female; Hum | 1996 |
Resistance to rocuronium in an epileptic patient on long-term carbamazepine therapy--a case report.
Topics: Androstanols; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Resistance; Epilepsy; Humans; | 1996 |
Pharmacokinetics of oxcarbazepine in the dog.
Topics: Administration, Oral; Animals; Anticonvulsants; Blood Proteins; Carbamazepine; Dogs; Epilepsy; Femal | 1996 |
Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Child Development; Child, Preschool; Cr | 1996 |
The contribution of endogenous mono-ADP-ribosylation to kindling-induced epileptogenesis.
Topics: Adenosine Diphosphate Ribose; Amino Acid Sequence; Animals; Anticonvulsants; Carbamazepine; Electrop | 1997 |
Carbamazepine-associated acute tubulointerstitial nephritis.
Topics: Acute Disease; Aged; Anticonvulsants; Biopsy; Carbamazepine; Epilepsy; Female; Follow-Up Studies; Hu | 1997 |
Hair analysis as a potential index of therapeutic compliance in the treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Follow-Up Studies; H | 1997 |
Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta.
Topics: Anticonvulsants; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Epilepsy; Fe | 1997 |
Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Demography; Epilepsy; Fe | 1997 |
Clinical pharmacokinetics of carbamazepine and valproate in children and adolescents with epilepsy.
Topics: Adolescent; Antidepressive Agents; Brain; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; | 1996 |
Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1997 |
Color vision tests for early detection of antiepileptic drug toxicity.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Color Perception; Epilepsy; Humans; Osmolar Conce | 1997 |
[Sturge-Weber syndrome: experience with 14 cases].
Topics: Anticonvulsants; Brain; Carbamazepine; Epilepsy; Female; Humans; Infant; Magnetic Resonance Imaging; | 1997 |
Topiramate for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Int | 1997 |
Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dehydroepiandrosterone; Dehydroepiandrosterone Su | 1997 |
Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.
Topics: Adult; Anticonvulsants; Carbamazepine; Chromatography, Liquid; Epilepsy; Female; Glucuronates; Human | 1997 |
Motor impairments in children with epilepsy treated with carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Dyskinesia, Drug-Induced; Epilepsy; Female; Human | 1997 |
Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats: dose response relationships.
Topics: Analysis of Variance; Animals; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Dru | 1997 |
Pure red cell aplasia during carbamazepine monotherapy.
Topics: Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Red-Cell Aplasia, Pure | 1997 |
Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy.
Topics: Adolescent; Adult; Anticonvulsants; Blood Cell Count; Carbamazepine; Cytochrome P-450 Enzyme System; | 1997 |
Reversible MRI lesions after seizures.
Topics: Adult; Anticonvulsants; Carbamazepine; Cerebral Cortex; Epilepsy; Female; Frontal Lobe; Humans; Magn | 1997 |
[Current knowledge on epilepsy, schizophrenia and spastic conditions. Neuro-Forum, Dresden, 5 April 1997].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsies, Partial; Epilepsy; Humans; Remission In | 1997 |
[Current knowledge on epilepsy, schizophrenia and spastic conditions. Neuro-Forum, Dresden, 5 April 1997].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsies, Partial; Epilepsy; Humans; Remission In | 1997 |
Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Epilepsy; Fear; Female; Follow-Up Studies; Humans; Intel | 1996 |
Bone status after long-term anticonvulsant therapy in epileptic patients: evaluation using quantitative ultrasound of calcaneus and phalanges.
Topics: Adult; Anticonvulsants; Calcaneus; Carbamazepine; Case-Control Studies; Drug Therapy, Combination; E | 1997 |
The effects of long-term anticonvulsive treatment on serum lipid profile.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Fluorescence | 1997 |
Serum lipids in epileptic children treated with carbamazepine and valproate.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Apolipoproteins; Carbamazepine; Case-Control Stud | 1997 |
Carbamazepine levels in the hair of patients under long-term treatment: a preliminary study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Chromatography, Gas; Epi | 1997 |
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors.
Topics: Adolescent; Adult; Aged; Benzodiazepinones; Carbamazepine; Cells, Cultured; Chemotaxis, Leukocyte; C | 1997 |
AWD 140-190: a new anticonvulsant with a very good margin of safety.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Dose-Response Relationship, Drug; E | 1997 |
Predictions of carbamazepine concentrations using a Bayesian program (PKS System, Abbott): a retrospective evaluation in an outpatient population.
Topics: Administration, Oral; Adolescent; Adult; Anticonvulsants; Bayes Theorem; Carbamazepine; Child; Compu | 1997 |
Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Hyperlipidemias; Lipids | 1997 |
Auditory event related potentials in patients with epilepsy on sodium valproate monotherapy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Evoked Potentials, Auditory; Female; Humans; Male; | 1997 |
[Pharmacokinetic variations in anticonvulsants in Mexican epileptic women during different stages of the postpartum period].
Topics: Animals; Anticonvulsants; Carbamazepine; Cricetinae; Epilepsy; Female; Humans; Milk, Human; Phenytoi | 1997 |
Carbamazepine-phenprocoumon interaction.
Topics: Adult; Anticoagulants; Anticonvulsants; Carbamazepine; Cerebral Infarction; Cytochrome P-450 CYP3A; | 1997 |
Extrashot-ODS, a syringe-type minicolumn sample injector for a reversed-phase high-performance liquid chromatographic column. Application to antiepileptics in human sera.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Epi | 1997 |
Effect of lamotrigine on carbamazepine epoxide/carbamazepine serum concentration ratios in adult patients with epilepsy.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lamotrigine; | 1997 |
Response of obsessive compulsive disorder to carbamazepine in two patients with comorbid epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Obsessive-Compulsive Disorder | 1997 |
Ticlopidine-carbamazepine interaction in a coronary stent patient.
Topics: Aged; Anticonvulsants; Carbamazepine; Coronary Disease; Drug Interactions; Epilepsy; Humans; Male; P | 1997 |
Elevation of plasma carbamazepine concentrations by ketoconazole in patients with epilepsy.
Topics: Adult; Antifungal Agents; Carbamazepine; Drug Interactions; Drug Monitoring; Epilepsy; Female; Human | 1997 |
Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsant and antipsychotic drugs.
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Buspirone; Calcium Channel Blockers; Carbamazepine; | 1997 |
Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening.
Topics: Adolescent; Adult; Aging; Anticonvulsants; Body Weight; Carbamazepine; Child; Child, Preschool; Drug | 1997 |
Syndrome resembling systemic lupus erythematosus induced by carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lupus Erythematosus, Systemic | 1997 |
If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug?
Topics: Age of Onset; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cohort Studies; Drug Administ | 1997 |
Oxcarbazepine in the treatment of early childhood epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; | 1997 |
Weak blockade of AMPA receptor-mediated depolarisations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebral Cortex; Epilepsy; Evoked Potentials; Excitatory Am | 1997 |
[Carbamazepine and vigabatrin in epileptic pregnant woman and side effects in the newborn infant].
Topics: Alkaline Phosphatase; Anticonvulsants; Carbamazepine; Chlorine; Drug Therapy, Combination; Epilepsy; | 1997 |
BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.
Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Dose-Response R | 1997 |
Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath test.
Topics: Adolescent; Analgesics, Non-Narcotic; Breath Tests; Caffeine; Carbamazepine; Carbon Dioxide; Central | 1998 |
Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epile | 1997 |
[Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Chromatography, High Pressure Liquid; Electroencephalo | 1997 |
Studies of drugs in epilepsy cited by author are not evidence based.
Topics: Anticonvulsants; Carbamazepine; Drug Combinations; Epilepsy; Evidence-Based Medicine; GABA Agents; g | 1998 |
Treatment of the epileptic patient in the dental office.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Child; Dental Care for Chronically Ill; Emergencies; Ep | 1998 |
Epilepsy and Crohn's disease in children.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Carbamazepine; Child; Crohn Disease; Epilepsy; Humans; Int | 1998 |
[Acquired aphasic epilepsy (Landau-Kleffner syndrome). Report of 10 cases].
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Aphasia; Brain; Carbamazepine; Child; Child, Preschool | 1997 |
Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?
Topics: Anticonvulsants; Carbamazepine; Child; Diplopia; Dizziness; Dose-Response Relationship, Drug; Drug A | 1998 |
Teratogenic effects of antiepileptic drugs: what do we advise patients?
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Patient Advoc | 1997 |
Detection of a drug-drug interaction on population-based phenobarbitone clearance using nonlinear mixed-effects modeling.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Body Weight; Carbamazepine; Child; Child, Preschool | 1998 |
Carbamazepine responsive epileptic oral motor and ocular motor apraxia.
Topics: Anticonvulsants; Apraxias; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Male; O | 1998 |
Does antiepileptic therapy affect immune response?
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbama | 1998 |
Postmortem changes in blood concentrations of phenytoin and carbamazepine: an experimental study.
Topics: Animals; Anticonvulsants; Carbamazepine; Death, Sudden; Epilepsy; Humans; Phenytoin; Postmortem Chan | 1998 |
Hyponatremia induced by oxcarbazepine in children.
Topics: Anticonvulsants; Carbamazepine; Child; Chlorides; Electroencephalography; Epilepsy; Female; Humans; | 1998 |
Changes in arrhythmia profile and heart rate variability during abrupt withdrawal of antiepileptic drugs. Implications for sudden death.
Topics: Adult; Aged; Analysis of Variance; Anticonvulsants; Arrhythmias, Cardiac; Autonomic Nervous System; | 1997 |
Peripheral benzodiazepine receptor expression on leukocytes and neutrophil function during anticonvulsant monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Leukocytes; Lymph | 1998 |
Sudden unexpected death in epilepsy: is carbamazepine implicated?
Topics: Adult; Age Distribution; Aged; Anticonvulsants; Carbamazepine; Cause of Death; Death, Sudden; Epilep | 1998 |
[Changes in the blastogenic lymphocyte transformation during kindling induced by picrotoxin in rats].
Topics: Animals; Anticonvulsants; Carbamazepine; Convulsants; Delta Sleep-Inducing Peptide; Epilepsy; Kindli | 1998 |
Evaluation of bone mineral density in children receiving antiepileptic drugs.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Anticonvulsants; Bone Density; Calcium; Carbamazepine; | 1998 |
[A case of digestive epilepsy with late diagnosis: a disease not to be disregarded].
Topics: Abdominal Pain; Aged; Anticonvulsants; Carbamazepine; Digestive System Diseases; Epilepsy; Female; H | 1998 |
Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children.
Topics: Adolescent; Alanine Transaminase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Catal | 1998 |
Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use.
Topics: Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Carb | 1998 |
Carbamazepine intoxication with negative myoclonus after the addition of clobazam.
Topics: Aged; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Cloba | 1998 |
Changes of the EEG paroxysmal pattern during felbamate therapy in Lennox-Gastaut syndrome: a case report.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Carbamazepine; Clobazam; Drug Therapy, | 1998 |
Sudden death in two patients with epilepsy and the syndrome of inappropriate antidiuretic hormone secretion (SIADH).
Topics: Adolescent; Adult; Anticonvulsants; Autopsy; Carbamazepine; Death, Sudden; Epilepsy; gamma-Aminobuty | 1998 |
Carbamazepine-induced sinus node dysfunction and atrioventricular block in elderly women.
Topics: Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Anticonvulsants; Bradycardia; Carbamazepine; Card | 1998 |
Paroxysmal kinesigenic choreoathetosis in Singapore and its relationship to epilepsy.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Athetosis; Carbamazepine; Child; Chorea; Comorbidi | 1998 |
Seizure exacerbation and developmental regression with carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Devel | 1998 |
[Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Apolipoproteins; Carbamazepine; Cholesterol; Choles | 1998 |
Flow cytometry assay of peripheral benzodiazepine receptors (pBZrs) on leukocytes following carbamazepine treatment.
Topics: Carbamazepine; Epilepsy; Flow Cytometry; Humans; Leukocytes; Receptors, GABA-A | 1997 |
Kinetic profile of carbamazepine in an adult Portuguese outpatient population.
Topics: Adult; Anticonvulsants; Bayes Theorem; Carbamazepine; Drug Administration Schedule; Epilepsy; Female | 1998 |
Serum lipids and lipoproteins in patients treated with antiepileptic drugs.
Topics: Adolescent; Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Carbamazepine; Cholestero | 1998 |
Exacerbation of epileptic seizures by carbamazepine: report of 10 cases.
Topics: Age Factors; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cognition Disorders; Dose-Resp | 1998 |
Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Hospitalization; H | 1999 |
N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs.
Topics: Acetylglucosaminidase; Anticonvulsants; beta-Galactosidase; Biomarkers; Carbamazepine; Case-Control | 1999 |
The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.
Topics: Adolescent; Anthropometry; Anticonvulsants; Carbamazepine; Child; Cross-Sectional Studies; Epilepsy; | 1999 |
Carbamazepine hypersensitivity syndrome presenting as vasculitis of the CNS.
Topics: Carbamazepine; Central Nervous System Diseases; Drug Hypersensitivity; Epilepsy; Female; Humans; Mid | 1999 |
Elevated plasma concentrations of homocysteine in antiepileptic drug treatment.
Topics: Age Factors; Ambulatory Care; Anticonvulsants; Carbamazepine; Convulsants; Depression, Chemical; Epi | 1999 |
Outcome of pregnancies in epileptic women: a study in Saudi Arabia.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Middle Aged; Pregnancy; | 1999 |
Anticonvulsant and neurotoxic effects of intracerebroventricular injection of phenytoin, phenobarbital and carbamazepine in an amygdala-kindling model of epilepsy in the rat.
Topics: Amygdala; Animals; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Injec | 1999 |
Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Biotrans | 1999 |
Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study.
Topics: Adult; Age Factors; Ambulatory Care; Anticonvulsants; Blood Donors; Body Weight; Carbamazepine; Chol | 1999 |
Carbamazepine pharmacokinetics-pharmacodynamics in genetically epilepsy-prone rats.
Topics: Acoustic Stimulation; Animals; Anticonvulsants; Area Under Curve; Carbamazepine; Dose-Response Relat | 1999 |
[Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Folic Acid; Humans; Neural Tube Defects; Pregnancy | 1999 |
Carbamazepine induced eczematous eruption-clinically resembling atopic dermatitis.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Dermatitis, Atopic; Dermatitis, Exfoliative; Diagnosis, | 1999 |
The management of epilepsy in a hospital for people with a learning disability.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Drug Uti | 1999 |
Elimination of oxcarbazepine-induced oculogyric crisis following vagus nerve stimulation.
Topics: Adult; Anticonvulsants; Carbamazepine; Electric Stimulation; Epilepsy; Humans; Male; Ocular Motility | 1999 |
Comparative drug monitoring of carbamazepin suspension (TroyaPharm) and Tegretol syrup (Ciba Geigy) in epileptic children.
Topics: Administration, Oral; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Child, Preschool; | 1998 |
Malformations in offspring of women with epilepsy: a prospective study.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Comorbidity; Congenital Abnormalities; | 1999 |
Therapeutic serum levels for new antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans | 1999 |
Problem of managing patients with epilepsy in developing countries.
Topics: Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Developing Countries; Drug Costs; Economics, | 1999 |
Clinical experience with new antiepileptic drugs: antiepileptic drugs in Europe.
Topics: Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Cross-Cultural Comparison; Drug Approval; | 1999 |
Are carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis more common in nonepileptic patients?
Topics: Anticonvulsants; Carbamazepine; Comorbidity; Epilepsy; Humans; Prevalence; Stevens-Johnson Syndrome | 1999 |
Modulation of sodium currents in rat CA1 neurons by carbamazepine and valproate after kindling epileptogenesis.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Hippocampus; Kindling, Neurologic; Male; Neurons; | 1999 |
Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study.
Topics: Adult; Age Factors; Carbamazepine; Cholesterol, HDL; Epilepsy; Female; Humans; Hypercholesterolemia; | 1999 |
The effect of carbamazepine and sodium valproate on the blood and serum values of children from a third-world environment.
Topics: Adolescent; Anemia; Anticonvulsants; Black People; Carbamazepine; Child; Child, Preschool; Developin | 1999 |
Insights into the tetanus toxin model of early-onset epilepsy from long-term video monitoring during anticonvulsant therapy.
Topics: Age of Onset; Animals; Anticonvulsants; Behavior, Animal; Carbamazepine; Epilepsy; Hippocampus; Inje | 1999 |
Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism.
Topics: Adolescent; Age Factors; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Hypothyro | 1999 |
Importance of specifying the type of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Contraindications; Diagnosis, Differential; Epilepsies, Parti | 1999 |
Epileptogenic activity of folic acid.
Topics: Anticonvulsants; Carbamazepine; Dietary Supplements; Epilepsy; Female; Folic Acid; Humans; Lupus Ery | 2000 |
The anticonvulsant SGB-017 (ADCI) blocks voltage-gated sodium channels in rat and human neurons: comparison with carbamazepine.
Topics: Animals; Anticonvulsants; Carbamazepine; Cells, Cultured; Disease Models, Animal; Dizocilpine Maleat | 2000 |
Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy.
Topics: Analysis of Variance; Androstanols; Anesthesia Recovery Period; Anticonvulsants; Carbamazepine; Case | 2000 |
Anticonvulsant induced osteomalacia.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant; Male; Osteomalacia; Ph | 2000 |
[Therapeutic antiepileptic drug monitoring: thirteen years of experience in the Laboratory of Clinical Neuropharmacology in the Chair and Department of Developmental neurology].
Topics: Academic Medical Centers; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy | 2000 |
[Carbamazepine presence in plasma lipoproteins].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Fluore | 2000 |
[Bimodal evoked potentials during long-term therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and adolescents with epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Evoked Potentials; Evoked Potentials, A | 2000 |
[Oxcarbazepine in the treatment of drug-resistant epilepsy in children and adolescents: preliminary study].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistance; Epileps | 2000 |
Subjective improvement following treatment with carbamazepine (Tegretol) for a subpopulation of patients with traumatic brain injuries.
Topics: Accidents, Traffic; Brain Injuries; Carbamazepine; Dichotic Listening Tests; Epilepsy; Factor Analys | 2000 |
Homocysteine concentrations and methionine loading in patients on antiepileptic drugs.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Case-Control Studies; Cytochrome P-450 Enzyme System; E | 2000 |
Changes in bone turnover and deoxypyridinoline levels in epileptic patients.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Anticonvulsants; Bone and Bones; Calcium; Carbamazepine; C | 2000 |
[Drug resistant epilepsy in Senegal: therapeutic, clinical and socioeconomic factors].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Resistance; Epilepsy; Female; Humans; | 1999 |
Repeated acute testing of anticonvulsant drugs in amygdala kindled rats: increase in anticonvulsant but decrease in adverse effect potential.
Topics: Amygdala; Animals; Anticonvulsants; Ataxia; Behavior, Animal; Carbamazepine; Disease Models, Animal; | 2000 |
Two new drugs for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clinical Trials as Topic; Drug Inter | 2000 |
N(6)-2-(4-aminophenyl)ethyl-adenosine enhances the anticonvulsive action of conventional antiepileptic drugs in the kindling model of epilepsy in rats.
Topics: Adenosine; Amygdala; Animals; Anticonvulsants; Avoidance Learning; Carbamazepine; Disease Models, An | 2000 |
Plasma total glutathione concentrations in epileptic patients taking anticonvulsants.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cysteine; Epilepsy; Glutathione; Humans; Oxidatio | 2000 |
A clinical study of 57 children with fetal anticonvulsant syndromes.
Topics: Abnormalities, Drug-Induced; Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Ep | 2000 |
[Carbamazepine medication paralyzed the elderly man].
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Cerebrovascular Disorders; Epilepsy; Humans | 1998 |
Body dimensions of infants exposed to antiepileptic drugs in utero: observations spanning 25 years.
Topics: Anticonvulsants; Birth Weight; Body Height; Carbamazepine; Drug Therapy, Combination; Embryonic and | 2000 |
A 41-year-old woman with confusion and unsteady gait.
Topics: Adult; Anticonvulsants; Blood Chemical Analysis; Carbamazepine; Confusion; Diagnosis, Differential; | 2000 |
The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
Topics: Anticonvulsants; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Carbamazepine; Child; Chole | 2000 |
Re: Shorvon 'Oxcarbazepine, a review' Seizure 2000;9:75-79.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Hyponatremia; Oxcarbazepine; Sodium | 2000 |
Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women.
Topics: Adult; Amenorrhea; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Therapy, Combination; Epilep | 2000 |
Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Hypoglycemia; I | 2000 |
Population based, prospective study of the care of women with epilepsy in pregnancy.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fetal Death; Guidelin | 2000 |
Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs.
Topics: Animals; Anticonvulsants; Calcium; Carbamazepine; Clonazepam; Electrophysiology; Epilepsy; Evoked Po | 2000 |
Comparative stereoselective pharmacokinetic analysis of 10-hydroxycarbazepine after oral administration of its individual enantiomers and the racemic mixture to dogs.
Topics: Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Carbamazepine; Cross-Over Studies; | 2000 |
Carbamazepine and valproic acid: effects on the serum lipids and liver functions in children.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Chi-Square Distribution; Child; Ch | 2000 |
Renal tubular function in patients receiving anticonvulsant therapy: a long-term study.
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Follow-Up Studies; | 2000 |
Serum sex hormone levels in young male patients with epilepsy receiving carbamazepine and valproic acid and after their withdrawal.
Topics: Adolescent; Antidepressive Agents; Carbamazepine; Epilepsy; Gonadal Steroid Hormones; Humans; Male; | 2000 |
[Clinical utilization of new anti-epileptic agents].
Topics: Acetates; Amines; Anemia, Aplastic; Anticonvulsants; Carbamazepine; Cyclohexanecarboxylic Acids; Dru | 2000 |
Effects of antiepileptic drugs on evoked potentials in epileptic children.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Ep | 2000 |
Carbamazepine induced bradycardia.
Topics: Adult; Anticonvulsants; Bradycardia; Carbamazepine; Epilepsy; Female; Humans | 2000 |
Relation between dosage of carbamazepine and concentration in hair and plasma samples from a compliant inpatient epileptic population.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; Hai | 2001 |
Seizures in multiple sclerosis.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Anticonvulsants; Atrophy; Brain; Carbamazepine; | 2001 |
Independent short-term variability of spike-like (600 Hz) and postsynaptic (N20) cerebral SEP components.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Arousal; Carbamazepine; Cerebral Cortex; Epilepsy; Evoked | 2001 |
Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal.
Topics: Anticonvulsants; Carbamazepine; Child; Cognition; Epilepsy; Event-Related Potentials, P300; Female; | 2001 |
Increased urinary excretion of tubular enzymes and proteins in children with epilepsy.
Topics: Acetylglucosaminidase; Adolescent; Alpha-Globulins; Anticonvulsants; Carbamazepine; Child; Child, Pr | 2000 |
The teratogenicity of anticonvulsant drugs.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Case-Control Studies; Congenital Abnorm | 2001 |
Pharmacokinetic interactions among phenobarbital, carbamazepine, and valproic acid in pediatric Japanese patients: clinical considerations on steady-state serum concentration-dose ratios.
Topics: Adolescent; Anticonvulsants; Biological Availability; Carbamazepine; Child; Dose-Response Relationsh | 2000 |
Antiepileptic drug therapy and its management in sudden unexpected death in epilepsy: a case-control study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Case-Control Studies; Cohort Studies; Death, Sudd | 2001 |
Tooth brushing-induced seizures: a case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Cerebral Cortex; Electroencephalography; Epilepsy; Epilepsy, | 2001 |
Effect of Antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholester | 2001 |
Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Bayes Theorem; Carbamazepine; Child; Child | 2001 |
The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.
Topics: Adult; Aldosterone; Anticonvulsants; Carbamazepine; Creatinine; Epilepsy; Humans; Hyponatremia; Male | 2001 |
Effects of antiepileptic drugs on cognition.
Topics: Acetates; Amines; Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Cyclohexanecarboxy | 2001 |
Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage.
Topics: Adult; Algorithms; Anticonvulsants; Bayes Theorem; Carbamazepine; Child; Drug Monitoring; Epilepsy; | 2001 |
[Pharmacokinetic variability of oxcarbazepine in epileptic patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Chromatography, High Pre | 2000 |
Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug.
Topics: Adult; Anticonvulsants; Carbamazepine; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Drug | 2001 |
Severe, isolated thrombocytopenia under polytherapy with carbamazepine and valproate.
Topics: Aged; Anticonvulsants; Blood Platelets; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; | 2001 |
[Rett syndrome: retrospective and prospective study of 28 patients].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Follow | 2001 |
[Dementia and carbamazepine medication in an elderly man].
Topics: Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Dementia; Epilepsy; Humans; Hyponatremia; M | 1998 |
Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Pregna | 2001 |
Thyroid hormones in epileptic children receiving carbamazepine and valproic acid.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Case-Control Studies; Child; Drug Interactions; Drug The | 2001 |
Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Enzyme Induction; Epilepsy; gamma-Glutamyltransfe | 2001 |
Transient dystonias in three patients treated with tiagabine.
Topics: Acute Disease; Adult; Anticonvulsants; Basal Ganglia Diseases; Carbamazepine; Child; Dose-Response R | 2001 |
Early hormonal changes during valproate or carbamazepine treatment: a 3-month study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Hormones; Humans; Male; Time Fa | 2001 |
Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria.
Topics: Adult; Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Diagnosis, Differenti | 2001 |
Altered ovarian function and cardiovascular risk factors in valproate-treated women.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Case-Control S | 2001 |
Plasma concentration of topiramate correlates with cerebrospinal fluid concentration.
Topics: Adolescent; Adult; Anticonvulsants; Blood-Brain Barrier; Brain; Carbamazepine; Drug Monitoring; Drug | 2001 |
Informed consent for a prescription drug: impact of disclosed information on patient understanding and medical outcomes.
Topics: Adult; Age Factors; Altruism; Attitude; Baltimore; Beneficence; Carbamazepine; Child; Cognition; Com | 1990 |
Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients.
Topics: Anticonvulsants; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; | 2001 |
Change in oxcarbazepine (Trileptal) formulation is associated with more side effects and higher blood concentrations.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine | 2001 |
[Analogs of generic preparations for the treatment of epilepsy: is their use safe?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 2001 |
Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Anticonvulsants; Biomarkers; Bone Density; Bone Resor | 2001 |
Effectiveness of first antiepileptic drug.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Dose-Response Relationship, Drug; Electroe | 2001 |
[Oxcarbazepine].
Topics: Adult; Animals; Anticonvulsants; Carbamazepine; Child, Preschool; Clinical Trials as Topic; Drug Int | 2001 |
Effects of antiepileptic drugs on afterdischarge generation in rat hippocampal slices.
Topics: 4-Aminopyridine; Action Potentials; Animals; Anticonvulsants; Bicuculline; Carbamazepine; Dose-Respo | 2002 |
[The pharmacological and hormonal effects of carbamazepine and valproic acid in the treatment of reproductive age women with epilepsy].
Topics: Adult; Anticonvulsants; Carbamazepine; Endocrine System Diseases; Epilepsy; Estradiol; Female; Folli | 2001 |
Antenatal carbamazepine use associated with d-TGA and ASD.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Heart Septal Defects, Atrial; Humans; Infan | 2002 |
[Parietal theta rhythms in carbamazepine therapy of children with epilepsy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epileps | 2001 |
Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Copper; Epilepsy; Female; Glutathi | 2002 |
Effect of anticonvulsant drugs on interleukins-1, -2 and -6 and monocyte chemoattractant protein-1.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Chemokine CCL2; Child; Epilepsy; Female; Humans; Interle | 2001 |
[Pharmacokinetic aspects of carbamazepine and valproic acid using in reproductive-age women with epilepsy].
Topics: Adult; Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Female; Ferti | 2002 |
Serum lipid changes during anticonvulsive treatment serum lipids in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cholesterol; Cholesterol, HDL; | 2001 |
Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Flu | 2002 |
Differential effects of remacemide and desglycinyl-remacemide on epileptiform burst firing in the rat hippocampal slice.
Topics: 4-Aminopyridine; Acetamides; Action Potentials; Animals; Anticonvulsants; Carbamazepine; Dose-Respon | 2002 |
Transplacental passage of oxcarbazepine and its metabolites in vivo.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fetal Blood; Humans; Maternal-Fetal Exchang | 2001 |
Oxcarbazepine.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epil | 2002 |
[Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
Topics: Acetylglucosaminidase; Adolescent; Adult; Anticonvulsants; beta 2-Microglobulin; Carbamazepine; Case | 2001 |
Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Femal | 2002 |
Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding.
Topics: Breast Feeding; Carbamazepine; Chemical and Drug Induced Liver Injury; Cholestasis; Epilepsy; Female | 2002 |
[Treatment of newly diagnosed epileptic crises. A French experience].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Child; Child, Preschool; | 2001 |
Correlation of serum and salivary carbamazepine concentration in epileptic patients: implications for therapeutic drug monitoring.
Topics: Adolescent; Adult; Anticonvulsants; Blood; Carbamazepine; Drug Monitoring; Epilepsy; Humans; Middle | 2002 |
Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Topics: Absorptiometry, Photon; Adolescent; Anticonvulsants; Biomarkers; Bone Density; Bone Diseases, Metabo | 2002 |
[Visual field defect in a patient given sodium valporate then carbamazepine: possible effect of aminotransferase inhibition].
Topics: Adult; Amino Acid Metabolism, Inborn Errors; Anticonvulsants; Carbamazepine; Drug Therapy, Combinati | 2002 |
Ophthalmic findings in fetal anticonvulsant syndrome(s).
Topics: Abnormalities, Drug-Induced; Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Ep | 2002 |
The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests.
Topics: Adult; Anticonvulsants; Attitude to Health; Carbamazepine; Cognition Disorders; Epilepsy; Humans; Me | 2002 |
[Adverse effects of anti-epileptic drugs].
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Barbiturates; Carbamazepine; Diazepam; Epilepsy; Ethos | 1975 |
Resistant transitory epilepsy in children.
Topics: Adrenocorticotropic Hormone; Anticonvulsants; Carbamazepine; Child, Preschool; Encephalomyelitis, Ac | 1976 |
Epilepsy.
Topics: Automobile Driving; Barbiturates; Benzodiazepines; Carbamazepine; Diagnosis, Differential; Epilepsie | 1976 |
Anticonvulsant therapy and serum gamma-glutamyl-transferase.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Epilepsy; Female; gamma-Glutamyltran | 1978 |
Neuropsychological correlates of anticonvulsants and epileptiform discharges in adult epileptics.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Electroencephalography; Epilepsy; Humans; Phenyto | 1978 |
Cyclobarbital as a test substance for oxidative drug metabolism in man. Findings in neuropsychiatric patients.
Topics: Adult; Alcoholism; Barbiturates; Carbamazepine; Epilepsy; Female; Humans; Kinetics; Male; Mental Dis | 1979 |
Letter: Bioavailability of drugs after intramuscular injection.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Biotransformation; Carbamazepine; | 1975 |
Interaction between carbamazepine and triacetyloleandomycin.
Topics: Carbamazepine; Drug Interactions; Epilepsy; Humans; Infections; Troleandomycin | 1977 |
Interaction of propoxyphene with carbamazepine.
Topics: Carbamazepine; Dextropropoxyphene; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; T | 1977 |
[Carbamacepine induced changes of thyroid hormones in epileptic children and juveniles (author's transl)].
Topics: Carbamazepine; Child; Cholesterol; Epilepsy; Female; Humans; Long-Term Care; Male; Thyroid Function | 1977 |
Effects of anticonvulsant drugs on thyroid hormones in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Cholesterol; Dose-Response Relationship, Drug; Dr | 1978 |
[Time-dependency of serum carbamazepine concentration (author's transl)].
Topics: Adolescent; Adult; Age Factors; Aged; Carbamazepine; Child; Epilepsy; Epilepsy, Tonic-Clonic; Female | 1978 |
Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans.
Topics: Adult; Carbamazepine; Epilepsy; Humans; Phenobarbital; Phenytoin; Radioimmunoassay; Thyroid Hormones | 1978 |
Bone mineral content in epileptics.
Topics: Aged; Bone and Bones; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged; Minerals; Muscle C | 1979 |
[Tegretol in the treatment of epilepsy].
Topics: Carbamazepine; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Humans | 1979 |
Prophylactic effects of phenytoin, phenobarbital, and carbamazepine examined in kindling cat preparations.
Topics: Animals; Carbamazepine; Cats; Disease Models, Animal; Drug Evaluation, Preclinical; Electric Stimula | 1976 |
Blindness of cerebral origin in acute intermittent porphyria. Report of a case and postmortem examination.
Topics: Adult; Blindness; Brain; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Hypertensi | 1977 |
[Psychotropic drugs in the clinical picture of epilepsy (review of the literature)].
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Anticonvulsants; Antipsychotic Agents; Carbamazepine; C | 1975 |
[Drug therapy of epilepsy].
Topics: Anticonvulsants; Carbamazepine; Chlordiazepoxide; Clonazepam; Diazepam; Electroencephalography; Epil | 1975 |
[Effects of combination of anti-epileptic drugs].
Topics: Adrenergic beta-Antagonists; Anticonvulsants; Benzodiazepines; Carbamazepine; Digitoxin; Drug Intera | 1975 |
Antipyretic analgesics in patients on antiepileptic drug therapy.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Carbamazepine; Drug Interactions; Epilepsy; Female; | 1979 |
[Drug therapy of epilepsy].
Topics: Age Factors; Anticonvulsants; Barbiturates; Benzodiazepines; Bromides; Carbamazepine; Chlormethiazol | 1977 |
Drug interactions during anticonvulsant therapy in childhood: diphenylhydantoin, primidone, phenobarbitone, clonazepam, nitrazepam, carbamazepin and dipropylacetate.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Interactions; | 1977 |
Deposits of plasma proteins in the skin during treatment with carbamazepine and diphenylhydantoin.
Topics: Adult; Aged; Blood Proteins; Carbamazepine; Epilepsy; Female; Fluorescent Antibody Technique; Humans | 1977 |
Measurement of carbamazepine and its epoxide metabolite by high-performance liquid chromatography, and a comparison of assay techniques for the analysis of carbamazepine.
Topics: Carbamazepine; Chromatography, Gas; Chromatography, High Pressure Liquid; Epilepsy; Epoxy Compounds; | 1977 |
Epilepsy and IgA deficiency--the effect of sodium valproate.
Topics: Adult; Agammaglobulinemia; Carbamazepine; Epilepsy; Female; Humans; Immunoglobulin A; Male; Phenobar | 1977 |
Choice of drug therapy in epilepsy.
Topics: Acetazolamide; Anticonvulsants; Benzodiazepines; Carbamazepine; Clonazepam; Epilepsy; Ethosuximide; | 1977 |
[Plasma levels of anticonvulsants. Experiences with routine plasma level determination of 6 different anticonvulsants].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Ethos | 1978 |
Distribution of plasma carbamazepine in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Immunoenzyme | 1977 |
Long-term use of the major anticonvulsant drugs.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Ethosuximi | 1978 |
[Dipropylacetate (sodium valproate) and carbamazepine : a suspicious anticonvulsant combination].
Topics: Carbamazepine; Cognition Disorders; Confusion; Drug Therapy, Combination; Epilepsy; Humans; Male; Mi | 1978 |
Drugs for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Diazepam; Epilepsy; Ethosuximide; Humans; Phenobarbital; | 1979 |
Recent advances in drug therapy for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Drug Interactions; Epilepsy; Humans; Phenobarbital; Phen | 1979 |
The use of antiepileptic drugs.
Topics: Anticonvulsants; Benzodiazepines; Carbamazepine; Drug Interactions; Epilepsy; Ethosuximide; Humans; | 1979 |
Recent advances in drug therapy of some forms of childhood epilepsy.
Topics: Anticonvulsants; Carbamazepine; Child; Clonazepam; Diazepam; Drug Therapy, Combination; Epilepsy; Hu | 1979 |
[Changes in the thyroid hormone system with combined anticonvulsion treatment of epileptic children and adolescents (author's transl)].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Cholesterol; Drug Therapy, Combination; Enzyme In | 1977 |
Medical treatment of epilepsy: part I.
Topics: Anticonvulsants; Bromides; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Therapy, Combina | 1978 |
Anticonvulsant therapy. Approaches to some common clinical problems.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Eth | 1979 |
Pharmacokinetics of carbamazepine in the neonate and in the child.
Topics: Adult; Carbamazepine; Child; Child, Preschool; Chromatography, Gas; Epilepsy; Female; Half-Life; Hum | 1979 |
[Neutropenia in epilepsy patients].
Topics: Adolescent; Adult; Agranulocytosis; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epile | 1979 |
Biochemical variables related to calcium metabolism in epileptics.
Topics: Aged; Alkaline Phosphatase; Anticonvulsants; Calcium; Carbamazepine; Epilepsy; Female; Humans; Male; | 1979 |
One drug for epilepsy [proceedings].
Topics: Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Phenytoin | 1979 |
Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy.
Topics: Adult; Carbamazepine; Epilepsy; Estradiol; Female; Humans; Menstruation; Phenobarbital; Phenytoin; P | 1979 |
Schizophrenia-like psychosis associated with anticonvulsant toxicity.
Topics: Adult; Anticonvulsants; Athetosis; Carbamazepine; Chorea; Dose-Response Relationship, Drug; Drug The | 1979 |
[Drug therapy of epilepsy with control of the serum level of anti-epileptic agents].
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Ethosuximide; Humans; Phenobarbital; Phenytoin; Primidone; | 1979 |
Drugs for epilepsy.
Topics: Carbamazepine; Epilepsy; Humans; Phenytoin | 1979 |
Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Kinetics | 1979 |
A month-by-month long-term study on carbamazepine:clinical, EEG and pharmacological evaluation.
Topics: Adolescent; Adult; Carbamazepine; Child; Electroencephalography; Epilepsy; Female; Humans; Longitudi | 1979 |
[Psychiatric prognosis in epilepsies].
Topics: Affective Symptoms; Carbamazepine; Chronic Disease; Epilepsy; Humans; Intellectual Disability; Neuro | 1979 |
Tears as the best practical indicator of the unbound fraction of an anticonvulsant drug.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Phenobarbital; Protein | 1979 |
[Studies on the serum levels of the antiepileptic drugs-with particular reference to diphenylhydantoin, phenobarbital and carbamazepine-(author's transl)].
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Middle Aged; Phenobarbi | 1979 |
A simple procedure for the determination of carbamazepine in plasma by high pressure-liquid chromatography.
Topics: Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans | 1979 |
[Discussion of the contribution by W. Fröscher et al.: "Nocturnal decrease of the carbamazepine blood level"].
Topics: Carbamazepine; Circadian Rhythm; Epilepsy | 1979 |
Simultaneous determination of the anticonvulsants, cinromide (3-bromo-n-ethylcinnamamide), 3-bromocinnamamide, and carbamazepine in plasma by high-performance liquid chromatography.
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Cinnamates; Epilepsy; Female; | 1979 |
Carbamazepine in two pregnancies.
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Epilepsy; Female; Fetal Death; Humans; Maternal-F | 1979 |
The epoxide of carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Biotransformation; Carbamazepine; Child; Child, Preschool; | 1979 |
Carbamazepine as an anticonvulsant in children.
Topics: Adolescent; Age Factors; Carbamazepine; Child; Child, Preschool; Cognition; Dose-Response Relationsh | 1977 |
Saliva carbamazepine levels in children.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Kinetics; Male; Saliva | 1977 |
Interaction between carbamazepine and propoxyphene in man.
Topics: Adolescent; Adult; Carbamazepine; Dextropropoxyphene; Drug Interactions; Drug Therapy, Combination; | 1977 |
[Drug interaction between carbamazepine (Tegretol) and dextropropoxyphene (Albalgin, Doloxene)].
Topics: Adolescent; Adult; Carbamazepine; Dextropropoxyphene; Drug Interactions; Drug Therapy, Combination; | 1978 |
Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing.
Topics: Autonomic Nervous System; Carbamazepine; Catecholamines; Climacteric; Clonidine; Epilepsy; Epilepsy, | 1978 |
Carbamazepine in childhood seizures.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Infant | 1978 |
[Optimizing the therapeutic process in long-term antiepileptic therapy through the determination of drug levels in patients].
Topics: Anticonvulsants; Carbamazepine; Drug Therapy; Epilepsy; Ethosuximide; Germany, East; Humans; Methods | 1978 |
Time-dependency of serum carbamazepine concentration.
Topics: Adolescent; Carbamazepine; Child; Chromatography, Gas; Circadian Rhythm; Dose-Response Relationship, | 1978 |
Water intoxication in epileptic patients receiving carbamazepine.
Topics: Adolescent; Adult; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Hyponatremia; | 1978 |
Kinetics of drug interactions in the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Carbamazepine; Drug Interactions; Epilepsy; Ethanol; Female; Humans; Kinet | 1978 |
[Neonatal abstinence syndrome in children whose mothers were treated for epilepsy during pregnancy].
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant, Newborn; Infant, Newborn, D | 1978 |
[Study on carbamazepine serum level in epileptic patients treated only with carbamazepine: with special reference to its efficacy and side effects (author's transl)].
Topics: Adolescent; Adult; Carbamazepine; Child; Drug Administration Schedule; Epilepsy; Female; Humans; Mal | 1978 |
[Paroxysmal attacks of dysarthria and ataxia in multiple sclerosis].
Topics: Adult; Ataxia; Carbamazepine; Diagnosis, Differential; Dysarthria; Epilepsy; Humans; Male; Multiple | 1978 |
Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Topics: Adolescent; Brain; Carbamazepine; Child; Epilepsy; Epoxy Compounds; Female; Humans; Male; Phenobarbi | 1978 |
Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Dose-Response Relationship, Drug; Drug Evaluation; Ep | 1978 |
[Measurement of the blood concentration of antiepileptic drugs. II Special cases].
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Clonazepam; Epilepsy; Ethosuximide; Humans; Phenobarbi | 1975 |
IgA deficiency and systemic lupus erythematosus. Occurrence in an oriental woman with idiopathic epilepsy.
Topics: Adult; B-Lymphocytes; Carbamazepine; Chromosome Aberrations; Chromosome Disorders; Dysgammaglobuline | 1976 |
Proposals on antiepileptic pharmacotherapy for use in developing countries.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Clonazepam; Developing Countries; Diazepam | 1976 |
Systematic determination of the serum phenytoin level as an aid in the management of children with epilepsy.
Topics: Acetazolamide; Adolescent; Carbamazepine; Child; Child, Preschool; Contraceptives, Oral; Drug Intera | 1975 |
Carbamazepine in the management of seizure disorders.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Epilepsy, Temporal Lobe; Epilepsy, Tonic-Clonic; Humans | 1975 |
Seizures in adolescents.
Topics: Adolescent; Anticonvulsants; Automobile Driving; Benzodiazepines; Carbamazepine; Diagnosis, Differen | 1975 |
Sensible prescribing. XI.--Juvenile and adult epilepsy.
Topics: Adolescent; Adult; Age Factors; Carbamazepine; Child; Clonazepam; Epilepsy; Epilepsy, Absence; Epile | 1975 |
Perspectives in complex partial seizures.
Topics: Carbamazepine; Diagnosis, Differential; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Hist | 1975 |
[A discussion of the curability of childhood epilepsies (author's transl)].
Topics: Barbiturates; Benzodiazepines; Carbamazepine; Child; Drug Therapy, Combination; Epilepsies, Partial; | 1975 |
[Epileptic seizures with psychomotor symptoms and generalized spike-wave-pattern].
Topics: Adolescent; Adult; Carbamazepine; Child; Diagnosis, Differential; Drug Therapy, Combination; Electro | 1976 |
Carbamazepine and its 10,11-epoxide in children and adults with epilepsy.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Epilepsy; Ethers, Cyclic; Female; Humans; | 1977 |
Water intoxication due to carbamazepine.
Topics: Adult; Aged; Carbamazepine; Epilepsy; Female; Humans; Male; Trigeminal Neuralgia; Water Intoxication | 1977 |
The significance of the simultaneous determination of carbamazepine and its 10,11-epoxide from plasma and human erythrocytes.
Topics: Adolescent; Adult; Carbamazepine; Cell Membrane Permeability; Child; Child, Preschool; Epilepsy; Epo | 1977 |
Lack of effect of clonazepam on serum levels of diphenylhydantoin, phenobarbital and carbamazepine.
Topics: Adolescent; Adult; Benzodiazepinones; Carbamazepine; Child; Clonazepam; Drug Interactions; Drug Ther | 1977 |
The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
Topics: Adolescent; Adult; Biotransformation; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Fem | 1977 |
[The anti-epileptic drugs].
Topics: Age Factors; Anticonvulsants; Carbamazepine; Epilepsy; Ethosuximide; Humans; Phenobarbital; Phenytoi | 1977 |
Serum sodium and osmolality during carbamazepine treatment in children.
Topics: Adolescent; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Osmolar Concentration; Sodium | 1977 |
Use of saliva in monitoring carbamazepine medication in epileptic children.
Topics: Carbamazepine; Child; Epilepsy; Humans; Saliva | 1977 |
Fatal carbamazepine hepatitis.
Topics: Adolescent; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Female; Humans | 1977 |
Comparison of six procedures for the simultaneous determination of antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Gas; Epilepsy; Humans; Phenobarbital; Phenytoin; Pri | 1977 |
[Antiepileptics, pregnancy and breast feeding].
Topics: Anticonvulsants; Barbiturates; Benzodiazepines; Breast Feeding; Carbamazepine; Epilepsy; Female; Hum | 1976 |
Management of seizure disorders with anticonvulsant drugs: current concepts.
Topics: Adult; Animals; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Child; Epilepsy; Huma | 1976 |
[Brain stem seizures with circumscrbed elementary symptoms].
Topics: Adult; Amitriptyline; Ataxia; Brain Neoplasms; Brain Stem; Carbamazepine; Epilepsy; Female; Humans; | 1976 |
Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.
Topics: Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Epoxy Compounds; Humans; Phenytoin | 1976 |
Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects.
Topics: Adult; Age Factors; Carbamazepine; Child; Drug Therapy, Combination; Electroencephalography; Epileps | 1976 |
[Experience with tegretol treatment of epilepsy in school age children].
Topics: Adolescent; Carbamazepine; Child; Epilepsy; Humans; Psychopathology; Syndrome | 1976 |
Chromosomal damage in epileptics on monotherapy with carbamazepine and diphenylhydantoin.
Topics: Adolescent; Adult; Carbamazepine; Chromosome Aberrations; Chromosomes; Epilepsy; Female; Humans; Mal | 1976 |
Anticonvulsant drugs and mental symptoms: a review.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Ethosuximide; Folic Acid | 1976 |
Letter: Epanutin and isoniazid interaction.
Topics: Adult; Carbamazepine; Drug Interactions; Electroencephalography; Epilepsy; Ethambutol; Ethosuximide; | 1975 |
Ictal laughter: a case report with clinical, cinefilm, and EEG observations.
Topics: Adolescent; Brain; Carbamazepine; Diazepam; Drug Therapy, Combination; Electroencephalography; Epile | 1975 |
[Tegretol psyschoses in epileptic patients].
Topics: Adult; Automatism; Carbamazepine; Consciousness Disorders; Delusions; Epilepsy; Hallucinations; Huma | 1975 |
[Concentration of carbamazepine in plasma during long term anti-epilepsy treatment].
Topics: Carbamazepine; Epilepsy; Humans; Time Factors | 1975 |
[Carbamazepine--daily course in the serum during long term medication].
Topics: Adolescent; Adult; Carbamazepine; Child; Epilepsy; Female; Humans; Male; Time Factors | 1975 |
[Effects of anticonvulsive treatment on drug elimination in man. Induction of liver hydroxylating enzyme system by diphenylhydantoin and carbamazepine].
Topics: Adult; Antipyrine; Bilirubin; Carbamazepine; Creatinine; Epilepsy; Female; Half-Life; Humans; Hydrox | 1975 |
Photically induced epilepsy in Papio papio as a model for drug studies.
Topics: Acetylcholine; Animals; Carbamazepine; Clonazepam; Diazepam; Disease Models, Animal; Dopamine; Dose- | 1975 |
[Current viewpoints in drug treatment of epilepsy, with reference to the most common drugs in current use].
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Epilepsy; Ethosuximide; Humans; Phenobarbital; Phenytoin | 1975 |
Treatment with carbamazepine: children.
Topics: Age Factors; Carbamazepine; Child; Diagnosis, Differential; Epilepsy; Epilepsy, Temporal Lobe; Human | 1975 |
Treatment with carbamazepine: adults.
Topics: Adult; Age Factors; Carbamazepine; Epilepsy; Epilepsy, Temporal Lobe; Humans; Retrospective Studies | 1975 |
Carbamazepine: absorption, distribution, and excretion.
Topics: Administration, Oral; Animals; Carbamazepine; Epilepsy; Female; Humans; Injections, Intravenous; Int | 1975 |
Serum carbamazepine concentration and clinical control.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Pregnancy; Seizures; Substance-Related Disorde | 1975 |
Behavioral effects of carbamazepine.
Topics: Adult; Behavior; Carbamazepine; Chemical Phenomena; Chemistry; Child; Epilepsy; Humans; Neurocogniti | 1975 |
Neurotoxicity of carbamazepine.
Topics: Age Factors; Brain Diseases; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Trig | 1975 |
Hematologic toxicity of carbamazepine.
Topics: Adult; Aged; Anemia, Aplastic; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Female; Hu | 1975 |
Psychosocial management of patients with complex partial seizures.
Topics: Adult; Alcoholism; Carbamazepine; Delivery of Health Care; Drug Administration Schedule; Epilepsy; E | 1975 |
Disposition of placentally transferred carbamazepine (Tegretol) in the newborn.
Topics: Carbamazepine; Epilepsy; Female; Half-Life; Humans; Infant, Newborn; Kinetics; Maternal-Fetal Exchan | 1975 |
Drugs for epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Diazepam; Epilepsy; Ethosuximide; Humans; Phenobarbital; | 1976 |
Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, | 1976 |
Effects of epilepsy on daily functioning in northern Ecuador: summary of findings of a population-based research project.
Topics: Activities of Daily Living; Adaptation, Psychological; Adolescent; Adult; Carbamazepine; Cross-Secti | 1992 |
Treatment of epilepsy.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Phenytoin; Valproic Acid | 1992 |
Carbamazepine and episodic dyscontrol.
Topics: Adult; Aggression; Brain Damage, Chronic; Carbamazepine; Epilepsy; Humans; Male; Violence | 1992 |
Cognitive functions, epileptic syndromes and antiepileptic drugs.
Topics: Adolescent; Adult; Carbamazepine; Child; Cognition; Epilepsy; Female; Humans; Male; Middle Aged; Phe | 1992 |
Effects of phenobarbital, carbamazepine and a combination of both on corazol-induced changes in the bioelectric activity of rat brains.
Topics: Animals; Brain; Carbamazepine; Electroencephalography; Epilepsy; Male; Pentylenetetrazole; Phenobarb | 1992 |
Salivary concentrations of antiepileptic drugs, oestradiol and progesterone throughout pregnancy in epileptic women.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Estradiol; Female; Humans; Osmolar Concentration; P | 1992 |
What to do when the first anticonvulsant does not work.
Topics: Aminocaproates; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lamotrigine; Phenytoin; Treatment | 1992 |
Therapeutic drug monitoring improves seizure control and reduces anticonvulsant side-effects in patients with refractory epilepsy.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Monitoring; Electroencephalog | 1992 |
Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding.
Topics: Adult; Breast Feeding; Carbamazepine; Epilepsy; Female; gamma-Glutamyltransferase; Humans; Infant, N | 1992 |
Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Fema | 1992 |
EEG changes in patients during the introduction of carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Male; Midd | 1992 |
Distribution of carbamazepine and its epoxide in blood compartments in adolescent and adult epileptic patients.
Topics: Adolescent; Adult; Aged; Aging; Blood Proteins; Carbamazepine; Chromatography, High Pressure Liquid; | 1992 |
Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Cognition; Drug Interactions; Epilepsy; Female; Humans; Male; Midd | 1992 |
[Disseminated lupus erythematosus induced by carbamazepine (Tegretol)].
Topics: Adult; Antibodies, Antinuclear; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Lupus Erythematosu | 1992 |
The effect of anticonvulsants on EEG background activity in epileptic children with monopharmacy.
Topics: Adolescent; Analysis of Variance; Carbamazepine; Child; Electroencephalography; Epilepsy; Humans; Va | 1992 |
Changes in unbound and total valproic acid concentrations after replacement of carbamazepine with oxcarbazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combinat | 1992 |
Effect of carbamazepine treatment on EEG changes induced by different cortical activation patterns in newly referred epileptic patients.
Topics: Adult; Arousal; Carbamazepine; Cerebral Cortex; Electroencephalography; Epilepsy; Evoked Potentials; | 1992 |
Carbamazepine neurotoxic reaction after administration of diltiazem.
Topics: Carbamazepine; Diltiazem; Drug Interactions; Epilepsy; Female; Humans; Hypertension; Middle Aged; Ne | 1992 |
Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases.
Topics: Adolescent; Adult; Angiography; Brain Neoplasms; Carbamazepine; Cerebral Hemorrhage; Child; Epilepsy | 1992 |
Psychological effects of sodium valproate and carbamazepine in epilepsy.
Topics: Carbamazepine; Child; Child Behavior; Child, Preschool; Cognition; Epilepsy; Female; Humans; Intelli | 1992 |
"An analysis of epileptic patients nonresponsive to drugs".
Topics: Anticonvulsants; Carbamazepine; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combina | 1992 |
A within-subject analysis of carbamazepine disposition related to development in children with epilepsy.
Topics: Adolescent; Aging; Carbamazepine; Child; Child Development; Child, Preschool; Dose-Response Relation | 1992 |
Cognitive effects of antiepileptic drug discontinuation.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cognition; Cognition Disorders; Epilepsy; Humans; | 1992 |
Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies.
Topics: Animals; Calcium Channel Blockers; Carbamazepine; Epilepsy; Extracellular Space; Guinea Pigs; Hippoc | 1992 |
Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA/2 mice.
Topics: Animals; Carbamazepine; Cerebral Cortex; Dose-Response Relationship, Drug; Epilepsy; In Vitro Techni | 1992 |
Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbama | 1992 |
Mentally handicapped epileptic patients: psychiatric illness and personality disorder.
Topics: Carbamazepine; Disabled Persons; Epilepsy; Female; Humans; Male; Mental Disorders; Personality Disor | 1992 |
Rapid tolerance to acute psychomotor impairment with carbamazepine in epileptic patients.
Topics: Adolescent; Adult; Carbamazepine; Drug Tolerance; Epilepsy; Female; Humans; Male; Middle Aged; Psych | 1992 |
Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dextropropoxyphene; D | 1992 |
Phenytoin and carbamazepine decreased oral bioavailability of praziquantel.
Topics: Adult; Biological Availability; Carbamazepine; Epilepsy; Female; Humans; Male; Phenytoin; Praziquant | 1992 |
Glutathione adduct of hemoglobin (Hb ASSG) in hemolysates of patients on long-term antiepileptic therapy.
Topics: Carbamazepine; Epilepsy; Female; Glutathione; Glycated Hemoglobin; Humans; Isoelectric Focusing; Iso | 1992 |
Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Female; Humans; | 1992 |
Hyponatremic coma under oxcarbazepine therapy.
Topics: Anticonvulsants; Carbamazepine; Coma; Epilepsy; Female; Humans; Hyponatremia; Middle Aged; Oxcarbaze | 1992 |
Epilepsy--another cause of intermittent fever with confusion.
Topics: Aged; Aged, 80 and over; Carbamazepine; Confusion; Epilepsy; Fever of Unknown Origin; Humans; Male | 1992 |
Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Humans; Infant; Infant, | 1992 |
Antiepileptics and the development of congenital anomalies.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Apgar Score; Birth Weight; Carbamazepine; Epilepsy; Fe | 1992 |
Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Prescriptions; Epi | 1992 |
Clinical utility of unbound antiepileptic drug blood levels in the management of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Phenytoin; Valproic Aci | 1992 |
Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study.
Topics: Abnormalities, Drug-Induced; Analysis of Variance; Carbamazepine; Epilepsy; Female; Humans; Phenytoi | 1992 |
Reduction of frequency of seizures by carbamazepine during cobalt experimental epilepsy in the rat.
Topics: Animals; Carbamazepine; Cobalt; Disease Models, Animal; Epilepsy; Female; Rats; Rats, Inbred Strains | 1992 |
Anticonvulsant-induced chronic pancreatitis. A case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Chronic Disease; Cytochrome P-450 Enzyme System; Epilepsy; Fr | 1992 |
The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.
Topics: Carbamazepine; Child; Chronic Disease; Epilepsy; Female; Humans; Male; Tablets | 1992 |
Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats.
Topics: Animals; Carbamazepine; Drug Resistance; Electrodes; Epilepsy; Female; Kindling, Neurologic; Phenyto | 1991 |
Ralitoline (CI-946) and CI-953 block sustained repetitive sodium action potentials in cultured mouse spinal cord neurons and displace batrachotoxinin A 20-alpha-benzoate binding in vitro.
Topics: Action Potentials; Animals; Anticonvulsants; Batrachotoxins; Carbamazepine; Cells, Cultured; Electro | 1991 |
Teratogenesis with carbamazepine.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pregnancy Complicat | 1991 |
Serum gamma glutamyl transferase activities in epileptic patients receiving carbamazepine monotherapy.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Carbamazepine; Enzyme Induction; Epilepsy; Female; ga | 1991 |
Influence of antiepileptic drugs on sleep patterns.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Brain; Carbamazepine; Chil | 1991 |
Quantitative EEG analysis of carbamazepine effects on amygdaloid kindled seizures in cats.
Topics: Administration, Oral; Amygdala; Animals; Behavior, Animal; Carbamazepine; Cats; Electric Stimulation | 1990 |
[Unclear cerebral fits].
Topics: Carbamazepine; Diagnosis, Differential; Electroencephalography; Epilepsies, Partial; Epilepsy; Femal | 1992 |
Influence of concurrent administration of sodium valproate on the plasma concentrations of carbamazepine and its epoxide and diol metabolites.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Fema | 1991 |
[Evaluation of the effectiveness of monotherapy in the treatment of epilepsy].
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Drug Evaluation; Epilepsy; Humans; Middle Aged; Pheno | 1991 |
Effects of carbamazepine on bicuculline- and pentylenetetrazol-induced seizures in developing rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Bicuculline; Carbamazepine; Epilepsy; Female; Pentylene | 1991 |
A prospective study of serum sex hormones during carbamazepine therapy.
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Mal | 1991 |
Limbic system dysrhythmia: a diagnostic electroencephalogram procedure utilizing procaine activation.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Diagnosis, D | 1991 |
Mycosis fungoides-like lesions associated with phenytoin and carbamazepine therapy.
Topics: Adult; Aged; Aged, 80 and over; Carbamazepine; Diagnosis, Differential; Drug Eruptions; Epilepsy; Fe | 1991 |
Common epileptic syndromes in children.
Topics: Adolescent; Adrenocorticotropic Hormone; Carbamazepine; Child; Child, Preschool; Electroencephalogra | 1991 |
Spina bifida in infants of women taking carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Comp | 1991 |
Effects of seizures and carbamazepine on interictal spiking in amygdala kindled cats.
Topics: Action Potentials; Amygdala; Animals; Carbamazepine; Cats; Electric Stimulation; Electroencephalogra | 1991 |
Comparison of gabapentin with other antiepileptic and GABAergic drugs.
Topics: Acetates; Action Potentials; Amines; Animals; Anticonvulsants; Carbamazepine; Cats; Cyclohexanecarbo | 1991 |
Plasma uric acid in patients receiving anticonvulsant monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Phenobarbital; Phenytoin; Prosp | 1991 |
Sleep spindles in epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Drug Therapy, Combination; Electroencephalography; Epilepsy; | 1991 |
[Effects of antiepileptic drugs on delivery and early childhood--comparison among mono-therapies of valproic acid, phenytoin, carbamazepine and phenobarbital].
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Birth Weight; Carbamazepine; Embryonic and Feta | 1991 |
Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy.
Topics: Action Potentials; Analysis of Variance; Animals; Anticonvulsants; Carbamazepine; Epilepsy; Kindling | 1991 |
Patients with recurrent blackouts on carbamazepine therapy.
Topics: Aged; Carbamazepine; Diagnosis, Differential; Epilepsy; Humans; Male; Middle Aged; Pacemaker, Artifi | 1991 |
Epileptic patients refractory to drug therapy.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Immunoglobulin G; Immunoglobulins; Male; Middle Aged | 1991 |
Measurement of phenytoin and carbamazepine in an ultrafiltrate of saliva.
Topics: Adolescent; Adult; Aged; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Drug | 1991 |
Weight reduction and epilepsy.
Topics: Carbamazepine; Diet, Reducing; Electrolytes; Epilepsy; Humans | 1991 |
Antiepileptic medication in pregnancy: late effects on the children's central nervous system development.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Central Nervous System; Child; Child De | 1991 |
Methsuximide for intractable childhood seizures.
Topics: Adolescent; Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dr | 1991 |
Seizures: introduction and commentary.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Humans; Phenobarbital; Phenytoin; Valpr | 1991 |
4-aminopyridine and barium chloride attenuate the anti-epileptic effect of carbamazepine in hippocampal slices.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Barium; Barium Compounds; Carbamazepine; Chlorides; Depre | 1991 |
Effects of carbamazepine and valproate on immunological assessment in young epileptic patients.
Topics: Adolescent; Carbamazepine; Epilepsy; Female; Humans; Immunoglobulins; Lymphocyte Subsets; Male; Refe | 1991 |
Electrophysiologic effects and clinical hazards of carbamazepine treatment for neurologic disorders in patients with abnormalities of the cardiac conduction system.
Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Carbamazepine; Cardiac Pacing, Artificial; Electrocar | 1991 |
Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Topics: Adolescent; Carbamazepine; Child; Chromatography, High Pressure Liquid; Epilepsy; Female; Humans; Ma | 1991 |
Epilepsy after craniotomy and the place of prophylactic anticonvulsant drugs: discussion paper.
Topics: Carbamazepine; Craniotomy; Epilepsy; Humans; Phenytoin; Postoperative Complications; Retrospective S | 1991 |
Cerebral effects of carbamazepine capsules and Divitabs in psychiatric patients.
Topics: Adult; Brain; Capsules; Carbamazepine; Cognition Disorders; Delayed-Action Preparations; Depressive | 1991 |
Teratogenic effect of carbamazepine.
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Epilepsy; Facial Bones; Female; Humans; Infant, N | 1991 |
[Bradyarrhythmias induced by antiepileptics increase frequency of epileptic seizures].
Topics: Aged; Bradycardia; Carbamazepine; Epilepsy; Humans; Male; Phenytoin | 1991 |
[Aplastic anemia in carbamazepine therapy].
Topics: Aged; Anemia, Aplastic; Carbamazepine; Epilepsy; Humans; Male; Pancytopenia; Seizures; Sick Sinus Sy | 1991 |
Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenobarbital.
Topics: Adolescent; Adult; Analysis of Variance; Apolipoproteins A; Apolipoproteins B; Carbamazepine; Child; | 1991 |
Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
Topics: Adult; Biological Availability; Carbamazepine; Drug Interactions; Epilepsy; Humans; Male; Middle Age | 1991 |
Isoenzymes of alkaline phosphatase in epileptic patients receiving carbamazepine monotherapy.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Carbamazepine; Epilepsy; Female; Humans; Isoenzym | 1991 |
Weight gain, increased appetite, and excessive food intake induced by carbamazepine.
Topics: Adolescent; Appetite; Carbamazepine; Child; Eating; Epilepsy; Female; Humans; Male; Weight Gain | 1991 |
The effects of phenytoin and carbamazepine on serum concentrations of mono-unsaturated metabolites of valproic acid.
Topics: Adult; Aged; Biotransformation; Carbamazepine; Drug Interactions; Epilepsy; Female; Humans; Male; Mi | 1990 |
Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy.
Topics: Adolescent; Adult; Anesthesia, Intravenous; Anticonvulsants; Carbamazepine; Craniotomy; Drug Interac | 1990 |
Pilot study to determine the interaction of oxiracetam with antiepileptic drugs.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Clob | 1990 |
Valproic acid-induced carbamazepine-10,11-epoxide toxicity in children and adolescents.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epile | 1990 |
Carbamazepine metabolism in humans: effect of concurrent anticonvulsant therapy.
Topics: Administration, Oral; Adolescent; Adult; Carbamazepine; Chromatography, High Pressure Liquid; Drug I | 1990 |
Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine.
Topics: Adolescent; Blood Proteins; Carbamazepine; Child; Epilepsy; Epoxide Hydrolases; Female; Humans; Male | 1990 |
Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Epilepsy; Female; Humans; Male; Menstrua | 1990 |
[High-dose monotherapy in intractable epilepsy].
Topics: Adolescent; Adult; Carbamazepine; Epilepsies, Myoclonic; Epilepsies, Partial; Epilepsy; Female; Huma | 1990 |
Treatment of epilepsy in people with multiple handicap.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Disabled Persons; Epilepsy; Hum | 1990 |
Antiepileptic medications.
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Dental Care for Disabled; Epilepsy; Humans; Hydantoins | 1990 |
Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epi | 1990 |
[The use of phenobarbital and carbamazepine (finlepsin) in children with epilepsy and cerebral spastic palsy with epileptic syndrome].
Topics: Adolescent; Carbamazepine; Cerebral Palsy; Child; Dose-Response Relationship, Drug; Drug Therapy, Co | 1990 |
Direct serum injection high-performance liquid chromatographic method for the simultaneous determination of phenobarbital, carbamazepine and phenytoin.
Topics: Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Immunoenzyme Techniques; Phen | 1990 |
Pattern-reversal visual evoked potentials recorded in children with generalized epilepsy.
Topics: Adolescent; Analysis of Variance; Anticonvulsants; Carbamazepine; Child; Epilepsy; Evoked Potentials | 1990 |
Rapid anti-epileptic drug assay.
Topics: Anticonvulsants; Carbamazepine; Child; Dose-Response Relationship, Drug; Epilepsy; Ethosuximide; Hum | 1990 |
When epilepsy masquerades as heart disease. Awareness is key to avoiding misdiagnosis.
Topics: Adrenal Gland Neoplasms; Arrhythmias, Cardiac; Carbamazepine; Diagnostic Errors; Epilepsy; Humans; P | 1990 |
Acne keloidalis-like lesions on the scalp associated with antiepileptic drugs.
Topics: Acne Keloid; Adult; Carbamazepine; Epilepsy; Humans; Male; Phenytoin; Scalp Dermatoses | 1990 |
[Computerized analysis of EEG background activity in mono-therapeutic patients with epilepsy--relationships between antiepileptic drugs and types of seizures].
Topics: Adult; Anticonvulsants; Brain Mapping; Carbamazepine; Electroencephalography; Epilepsy; Female; Huma | 1990 |
Effects of age and antiepileptic drugs on plasma levels and kinetics of clobazam and N-desmethylclobazam.
Topics: Adolescent; Adult; Age Factors; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepin | 1990 |
Postmortem serum protein binding and brain concentrations of antiepileptic drugs in autoptic specimens from 45 epileptic patients.
Topics: Anticonvulsants; Blood Proteins; Brain; Carbamazepine; Epilepsy; Female; Humans; Male; Phenobarbital | 1990 |
Side-effects of drugs in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male | 1990 |
Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding.
Topics: Breast Feeding; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Female; Humans; Inf | 1990 |
Chewable carbamazepine for children with epilepsy.
Topics: Acetazolamide; Adolescent; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilep | 1990 |
Comparative experimental study of antiepileptics--regional specificity of antiepileptic action of carbamazepine, phenobarbital and valproate sodium.
Topics: Animals; Anticonvulsants; Carbamazepine; Epilepsy; Hippocampus; Male; Motor Cortex; Phenobarbital; R | 1990 |
Cognitive function in adult epileptic patients established on anticonvulsant monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cognition; Epilepsy; Female; Humans; Intelligence | 1990 |
Factors influencing plasma level/dose ratios of carbamazepine and its major metabolites in epileptic children.
Topics: Adolescent; Age Factors; Carbamazepine; Child; Epilepsy; Humans; Regression Analysis; Time Factors | 1990 |
No effect of thioridazine on plasma concentrations of carbamazepine and its active metabolite carbamazepine-10,11-epoxide.
Topics: Adult; Carbamazepine; Epilepsy; Female; Homeostasis; Humans; Male; Middle Aged; Thioridazine | 1990 |
Carbamazapine for behavioral disorders.
Topics: Carbamazepine; Electroencephalography; Epilepsy; Humans; Intellectual Disability; Neurocognitive Dis | 1990 |
The development of independent foci in epileptic patients.
Topics: Carbamazepine; Electroencephalography; Epilepsy; Humans; Nervous System; Time Factors | 1990 |
Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system.
Topics: Age Factors; Carbamazepine; Chemical and Drug Induced Liver Injury; Epilepsy; Female; Hematologic Di | 1990 |
[Epilepsy research: three important working areas].
Topics: Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans | 1990 |
Phenobarbital treatment and major depressive disorder in children with epilepsy: a naturalistic follow-up.
Topics: Adolescent; Analysis of Variance; Carbamazepine; Child; Depressive Disorder; Epilepsy; Follow-Up Stu | 1990 |
A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.
Topics: Adult; Biological Availability; Carbamazepine; Epilepsy; Female; Humans; Male; Tablets | 1990 |
Epileptic transient amnesia.
Topics: Aged; Amnesia; Carbamazepine; Epilepsy; Female; Humans; Memory, Short-Term | 1990 |
Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours.
Topics: Adult; Anticonvulsants; Brain Neoplasms; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged; | 1990 |
Serum protein binding of antiepileptic drugs in Sri Lankans.
Topics: Adolescent; Adult; Anticonvulsants; Blood Proteins; Carbamazepine; Drug Therapy, Combination; Epilep | 1990 |
Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Male; Middle Aged; | 1990 |
The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Chromatogra | 1990 |
Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background.
Topics: Adult; Anticonvulsants; Carbamazepine; Child, Preschool; Epilepsy; Female; Humans; Intelligence Test | 1990 |
Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding.
Topics: Adult; Anticonvulsants; Blood Proteins; Carbamazepine; Epilepsy; Female; Humans; Maternal-Fetal Exch | 1990 |
The efficacy and tolerability of chewable carbamazepine compared to conventional carbamazepine in patients with epilepsy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carbamazepine; Dose-Response Relationship, Dru | 1990 |
Simple and rapid micro-analytical high-performance liquid chromatographic technique for the assay of oxcarbazepine and its primary active metabolite 10-hydroxycarbazepine.
Topics: Autoanalysis; Carbamazepine; Chromatography, High Pressure Liquid; Epilepsy; Humans; Microchemistry; | 1990 |
Carbamazepine, epilepsy, and optic nerve hypoplasia.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Epilepsy; Female; Humans; Infant, Newborn; Optic Nerve | 1990 |
The effects of carbamazepine and sodium valproate on SEPs and BAEPs.
Topics: Adult; Aged; Brain Stem; Carbamazepine; Epilepsy; Evoked Potentials, Auditory; Evoked Potentials, So | 1987 |
Drugs for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Humans; Phenytoin; Valpro | 1989 |
Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid.
Topics: Adult; Anticonvulsants; Aspirin; Carbamazepine; Epilepsy; Esterases; Female; Humans; Male; Phenobarb | 1989 |
The prevalence of adverse reactions to anticonvulsants in children with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Clonazepam; Drug Therapy, Combi | 1989 |
[Medical treatment of epilepsy].
Topics: Aminocaproates; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Oxcarbazepine; Valproic Acid; Viga | 1989 |
Protoporphyrinaemia and decreased activities of 5-aminolevulinic acid dehydrase and uroporphyrinogen I synthetase in erythrocytes of a Vitamin B6-deficient epileptic boy given valproic acid and carbamazepine.
Topics: Ammonia-Lyases; Carbamazepine; Chromatography, Ion Exchange; Epilepsy; Erythrocytes; Folic Acid; Hum | 1989 |
Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
Topics: Adolescent; Adult; Aged; Antipyrine; Caffeine; Carbamazepine; Cytochrome P-450 Enzyme System; Enzyme | 1989 |
[Reye syndrome treated with valproic acid in association with varicella infection].
Topics: Adult; Aspirin; Carbamazepine; Chickenpox; Drug Therapy, Combination; Epilepsy; Humans; Male; Reye S | 1989 |
Thyroid hormone concentrations in epileptic patients.
Topics: Anticonvulsants; Carbamazepine; Drug Combinations; Epilepsy; Humans; Phenytoin; Thyrotropin; Thyroxi | 1989 |
Epilepsy in women of childbearing age.
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Child; Epilepsy; Female; Humans; Pregnancy; Pregn | 1989 |
Thyroid function in epileptic patients treated with carbamazepine.
Topics: Adolescent; Adult; Aged; Carbamazepine; Epilepsy; Female; Follow-Up Studies; Humans; Male; Middle Ag | 1989 |
Epilepsy in women of childbearing age.
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Epilepsy; Female; Humans; Pregnancy; Pregnancy Co | 1989 |
Probable pseudocholinesterase induction by valproic acid, carbamazepine and phenytoin leading to increased serum aspirin-esterase activity in epileptics.
Topics: Adolescent; Adult; Analysis of Variance; Carbamazepine; Carboxylic Ester Hydrolases; Cholinesterases | 1989 |
Sustained attention during the interictal period of mentally normal children with epilepsy or febrile convulsions, and the influence of anticonvulsants and seizures on attention.
Topics: Anticonvulsants; Attention; Carbamazepine; Child; Drug Therapy, Combination; Epilepsies, Partial; Ep | 1989 |
Patch testing with carbamazepine: reinduction of an exfoliative dermatitis.
Topics: Adolescent; Carbamazepine; Drug Eruptions; Epilepsy; Female; Humans; Patch Tests; Skin Tests; Time F | 1989 |
Carbamazepine update.
Topics: Carbamazepine; Diuresis; Drug Evaluation; Drug Interactions; Epilepsy; Humans; Trigeminal Neuralgia | 1989 |
Effects of anticonvulsants on spontaneous epileptiform activity which develops in the absence of chemical synaptic transmission in hippocampal slices.
Topics: Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Cell Membrane Permeability; Epilepsy; Hipp | 1985 |
Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Outpatients; Phenobarbital; Phenytoin | 1989 |
Predicting the range of plasma carbamazepine concentrations in patients with epilepsy.
Topics: Carbamazepine; Delayed-Action Preparations; Epilepsy; Humans; Models, Statistical | 1989 |
Bone marrow suppression secondary to carbamazepine.
Topics: Adult; Bone Marrow; Bone Marrow Cells; Carbamazepine; Colony-Forming Units Assay; Epilepsy; Female; | 1989 |
Daily salivary anticonvulsant monitoring in patients with intractable epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Monitoring, Physiologic; Phenobarbi | 1989 |
Phenytoin withdrawal and seizure frequency.
Topics: Adult; Carbamazepine; Diazepam; Drug Therapy, Combination; Epilepsy; Epilepsy, Temporal Lobe; Female | 1989 |
Pregnancy and epilepsy.
Topics: Abnormalities, Drug-Induced; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Estrogens; Female; Hum | 1989 |
The effect of anticonvulsants on the dexamethasone suppression test.
Topics: Adult; Anticonvulsants; Bipolar Disorder; Carbamazepine; Depressive Disorder; Dexamethasone; Epileps | 1989 |
Hematologic monitoring in children with epilepsy treated with carbamazepine.
Topics: Agranulocytosis; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Follow-Up Studies; Humans | 1989 |
Carbamazepine clearance in paediatric epilepsy patients. Influence of body mass, dose, sex and co-medication.
Topics: Biological Availability; Black People; Body Weight; Carbamazepine; Child; Child, Preschool; Drug Int | 1989 |
Teratogenic effects of carbamazepine.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Epilepsy; Female; Fetus; Humans; Pregnancy; Pregnancy Co | 1989 |
Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Topics: Adolescent; Adult; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Male | 1989 |
Valpromide/carbamazepine and risk of teratogenicity.
Topics: Abnormalities, Drug-Induced; Animals; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Hu | 1985 |
Serum 5'-nucleotidase in patients receiving anti-epileptic drugs.
Topics: 5'-Nucleotidase; Adolescent; Adult; Age Factors; Aged; Alkaline Phosphatase; Carbamazepine; Child; C | 1985 |
[Bilateral shoulder dislocation fractures, femoral neck and vertebral fractures: a remarkable combination of injuries during an epileptic seizure].
Topics: Adult; Bone Screws; Bone Wires; Carbamazepine; Diabetes Complications; Epilepsy; Epilepsy, Tonic-Clo | 1985 |
Alcohol withdrawal: clinical symptoms and management of the syndrome.
Topics: Alcohol Withdrawal Delirium; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Chlormethiazole; | 1986 |
The influence of long-term anticonvulsant therapy with diphenylhydantoin and carbamazepine on serum gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Carbamazepine; Chemi | 1988 |
[Altered gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase serum activities in long-term anticonvulsive therapy--comparison of diphenylhydantoin and carbamazepine].
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Carbamazepine; Cytoc | 1988 |
[The effect of carbamazepine on water metabolism in epileptics].
Topics: Carbamazepine; Diuretics; Epilepsy; Humans; Hyponatremia; Water Intoxication; Water-Electrolyte Bala | 1989 |
Influence of valproate and carbamazepine on symmetrical cortical penicillin foci in the rat.
Topics: Animals; Carbamazepine; Dose-Response Relationship, Drug; Electrocardiography; Epilepsy; Male; Penic | 1985 |
[Systemic lupus erythematosus and hyper-IgE syndrome in a 13-year-old child].
Topics: Adolescent; Carbamazepine; Epilepsy; Glomerulonephritis; Humans; Hypergammaglobulinemia; Immune Comp | 1986 |
Valproate-associated hyperammonemia and DL-carnitine supplement.
Topics: Adolescent; Adult; Ammonia; Carbamazepine; Carnitine; Child; Child, Preschool; Disabled Persons; Dru | 1987 |
Effect of isotretinoin on carbamazepine pharmacokinetics.
Topics: Acne Vulgaris; Adult; Carbamazepine; Epilepsy; Humans; Isotretinoin; Male | 1988 |
Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine.
Topics: Adult; Aged; Carbamazepine; Cholecalciferol; Epilepsy; Ergocalciferols; Female; Humans; Male; Middle | 1985 |
Potent depressant action of baclofen on hippocampal epileptiform activity in vitro: possible use in the treatment of epilepsy.
Topics: Animals; Anticonvulsants; Baclofen; Carbamazepine; Diazepam; Epilepsy; gamma-Aminobutyric Acid; Guin | 1986 |
Impact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic.
Topics: Carbamazepine; Epilepsy; Humans; Immunoenzyme Techniques; Outpatient Clinics, Hospital; Pharmacology | 1988 |
Carbamazepine, phenytoin and sodium valproate monotherapy.
Topics: Carbamazepine; Epilepsy; Humans; Phenytoin; Valproic Acid | 1986 |
The influence of seizure type and medication on psychiatric symptoms in epileptic patients.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Epilepsies, Myoclonic; Epilepsy; Epilepsy, Tempora | 1986 |
Phenylethylmalonamide serum levels in patients treated with primidone and the effects of other antiepileptic drugs.
Topics: Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Malonates; Phenobarbita | 1986 |
Drugs for epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Epilepsy; Humans; Phenytoin; Status | 1986 |
[Single evening administration of slow release carbamazepine].
Topics: Adolescent; Adult; Biotransformation; Carbamazepine; Drug Administration Schedule; Epilepsies, Parti | 1986 |
A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy.
Topics: Adult; Calcium; Carbamazepine; Diet; Epilepsy; Female; Humans; Male; Phenobarbital; Phenytoin; Ultra | 1986 |
[Various matters concerning the improvement of therapeutic tactics in epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Drug Therapy, Comb | 1986 |
Memory disturbances in epileptic patients.
Topics: Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Memory Disorders; Phenytoin; Valproic Ac | 1986 |
Synergistic effects of oxiracetam and piracetam in combination with antiepileptic drugs.
Topics: Animals; Anticonvulsants; Carbamazepine; Clonazepam; Drug Synergism; Drug Therapy, Combination; Epil | 1986 |
[Epilepsy with continuous discharges during slow-wave sleep. Treatment with clobazam].
Topics: Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Carbamazepine; Child; Child, Preschool; Clo | 1986 |
Forced normalization. Acute psychosis after seizure control in seven patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Haloperidol; Humans; Male; Psychotic Disord | 1987 |
Clinically significant danazol-carbamazepine interaction.
Topics: Adult; Carbamazepine; Danazol; Drug Interactions; Epilepsy; Female; Fibrocystic Breast Disease; Huma | 1987 |
[Modification of psychophysical performance of the human by anticonvulsants].
Topics: Anticonvulsants; Arousal; Carbamazepine; Diazepam; Epilepsy; Ethosuximide; Humans; Mental Processes; | 1987 |
Barbiturate-refractory epilepsy: safe schedule for therapeutic substitution.
Topics: Adolescent; Adult; Anticonvulsants; Barbiturates; Carbamazepine; Drug Tolerance; Epilepsy; Female; H | 1986 |
Anticonvulsant drugs in monotherapy. Effect on the fetus.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Fe | 1987 |
[Cognitive effects of antiepileptic drugs].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Cognition Disorders; Epilepsy; | 1987 |
An interaction between cytostatic and anticonvulsant drugs.
Topics: Adenocarcinoma, Papillary; Adult; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carba | 1988 |
The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Midd | 1987 |
[Etiologic factors in epilepsy as a predictor of response to anticonvulsive drug therapy].
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Elec | 1988 |
Zinc concentrations in leucocytes of patients receiving antiepileptic drugs.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Neutrophils; Valproic Acid; Zinc | 1988 |
Kawasaki-like syndrome caused by carbamazepine.
Topics: Carbamazepine; Child, Preschool; Drug Hypersensitivity; Epilepsy; Humans; Male; Mucocutaneous Lymph | 1988 |
A comparative study of the relative effects of anticonvulsant drugs and dietary folate on the red cell folate status of patients with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Diet; Drug Therapy, Combination; Epilepsy; Erythrocytes; Fema | 1987 |
Congenital abnormalities in two sibs exposed to valproic acid in utero.
Topics: Abnormalities, Drug-Induced; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infan | 1988 |
Variability of phenytoin, carbamazepine and valproate concentrations in a clinic population.
Topics: Carbamazepine; Epilepsy; Female; Humans; Male; Minnesota; Outpatient Clinics, Hospital; Patient Comp | 1988 |
[Clinical treatment of resistant epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Resistance; Electroencephalography; E | 1988 |
Changes in clearance of sodium valproate with changes in dose.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; M | 1987 |
[Pharmacokinetic aspects of anticonvulsant therapy with benzonal].
Topics: Anticonvulsants; Barbiturates; Brain Chemistry; Carbamazepine; Chromatography, Gas; Dose-Response Re | 1988 |
Generic vs. branded carbamazepine.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Nebraska; Therapeutic Equivalency | 1988 |
Intra- and interindividual relationship between serum levels and dose in epileptic patients treated with carbamazepine monotherapy.
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans | 1988 |
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; | 1988 |
Free drug levels monitoring as a detector of false metabolic refractory epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged | 1988 |
[Monotherapy of epileptic seizures with carbamazepine and monitoring its blood levels].
Topics: Carbamazepine; Chromatography, Gas; Epilepsy; Humans | 1988 |
Comparison of methods of carbamazepine dosage, individualization in epileptic patients.
Topics: Adolescent; Adult; Aged; Carbamazepine; Epilepsy; Humans; Middle Aged; Models, Statistical; Predicti | 1988 |
Influence of concurrent administration of carbamazepine on the plasma concentrations of clonazepam.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Clonazepam; Dose-Response Relationship, Drug; Dr | 1988 |
[Serum levels of triiodothyronine, thyroxine and thyrotropin in children with epilepsy treated with amizepine, luminal and mizodine in a monotherapy system. Preliminary report].
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Male; Phenobarbit | 1988 |
Relevance of poor compliance for seizure control.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Middle Aged; Patient Compliance | 1988 |
Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Male; Oxcarbazepine | 1987 |
A dry-reagent strip for quantifying carbamazepine evaluated.
Topics: Adolescent; Adult; Anticoagulants; Carbamazepine; Child; Epilepsy; Fluorescence Polarization; Humans | 1988 |
Disseminated cysticercosis. New observations, including CT scan findings and experience with treatment by praziquantel.
Topics: Adolescent; Adult; Brain; Carbamazepine; Child; Cysticercosis; Dexamethasone; Drug Therapy, Combinat | 1988 |
Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance.
Topics: Adult; Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Male; Middle Aged; Phenytoin; Tim | 1988 |
Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal.
Topics: Carbamazepine; Cognition; Epilepsy; Humans; Intelligence Tests; Neuropsychological Tests; Phenytoin | 1988 |
Impaired visual contrast sensitivity in epileptic patients treated with carbamazepine.
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Flicker Fusion; Humans; Middle Aged; Osmolar Concentrati | 1988 |
Carbamazepine malabsorption: a case report.
Topics: Biological Availability; Carbamazepine; Child; Epilepsy; Humans; Male; Tablets | 1988 |
[Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment].
Topics: Adult; Carbamazepine; Chromatography, Gas; Drug Evaluation; Epilepsy; Female; Half-Life; Humans; Mal | 1987 |
[Loading-doses of carbamazepine and diphenylhydantoin: use in high-risk patients].
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Humans; Middle Aged; Phenytoin; Risk | 1987 |
[Cursive and gelastic manifestations of epilepsies].
Topics: Adolescent; Adult; Carbamazepine; Child; Electroencephalography; Epilepsy; Epilepsy, Temporal Lobe; | 1987 |
Piracetam potentiates the antiepileptic action of carbamazepine in chronic experimental limbic epilepsy.
Topics: Animals; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Epilepsy; Limbic System; Male; Pi | 1986 |
Carbamazepine effects on mononuclear blood cells in epileptic patients.
Topics: Adolescent; Adult; B-Lymphocytes; Carbamazepine; Child; Complement System Proteins; Epilepsy; Humans | 1986 |
Minor additive inducing effects of phenobarbital on carbamazepine clearance in patients on combined carbamazepine-phenytoin therapy.
Topics: Aged; Carbamazepine; Drug Interactions; Epilepsy; Humans; Male; Middle Aged; Phenobarbital; Phenytoi | 1987 |
Can a single measurement of carbamazepine suffice for therapeutic monitoring?
Topics: Carbamazepine; Child; Child, Preschool; Epilepsy; Humans; Monitoring, Physiologic; Saliva | 1987 |
Effects of josamycin on carbamazepine kinetics.
Topics: Adult; Aged; Carbamazepine; Drug Interactions; Epilepsy; Female; Humans; Leucomycins; Male; Middle A | 1987 |
Phenytoin and carbamazepine, alone and in combination: anticonvulsant and neurotoxic effects.
Topics: Animals; Brain; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Co | 1987 |
Your CE topic this month (No. 20). Antiepileptic pharmacotherapy.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Ethosuximide; Humans; Nu | 1986 |
Carbamazepine-induced facial burns caused by a photocopier.
Topics: Adult; Burns; Carbamazepine; Epilepsy; Face; Female; Humans; Photosensitivity Disorders; Ultraviolet | 1987 |
Carbamazepine up-regulates the binding of [3H]PK 11195 to platelets of epileptic patients.
Topics: Adolescent; Adult; Blood Platelets; Carbamazepine; Cell Membrane; Epilepsy; Female; Humans; Isoquino | 1987 |
Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination | 1987 |
Phenobarbital treatment and major depressive disorder in children with epilepsy.
Topics: Adolescent; Carbamazepine; Child; Depressive Disorder; Epilepsy; Humans; Phenobarbital; Suicide, Att | 1987 |
How to initiate and maintain carbamazepine therapy in children and adults.
Topics: Adult; Anemia, Aplastic; Carbamazepine; Child; Drug Administration Schedule; Epilepsy; Humans; Leuko | 1987 |
Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Intellectual Disability; Kinetics; Male; Phenytoin; | 1986 |
Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Female; Huma | 1986 |
Measuring anti-convulsant levels in the accident and emergency department.
Topics: Adult; Carbamazepine; Emergencies; Epilepsy; Humans; Patient Compliance; Phenobarbital; Phenytoin; P | 1986 |
Carbamazepine, clonazepam use during pregnancy.
Topics: Abnormalities, Drug-Induced; Benzodiazepinones; Carbamazepine; Clonazepam; Epilepsy; Female; Humans; | 1986 |
Carbamazepine/MAOI interaction.
Topics: Carbamazepine; Drug Interactions; Epilepsy; Humans; Monoamine Oxidase Inhibitors | 1986 |
Decision-making in refractory epilepsy: an analysis based on computer simulation.
Topics: Carbamazepine; Computers; Epilepsy; Humans; Models, Theoretical; Patient Compliance; Phenytoin | 1986 |
Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy.
Topics: Adolescent; Adult; Age Factors; Carbamazepine; Child; Child, Preschool; Dose-Response Relationship, | 1986 |
Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy.
Topics: Adolescent; Adult; Anticonvulsants; Body Weight; Carbamazepine; Drug Therapy, Combination; Epilepsy; | 1986 |
[Phenomenon of "paradoxical poisoning" during antiepileptic therapy].
Topics: Adult; Anticonvulsants; Barbiturates; Carbamazepine; Child; Drug Synergism; Drug Therapy, Combinatio | 1986 |
[Drug interactions with phenytoin and carbamazepine].
Topics: Carbamazepine; Drug Therapy, Combination; Epilepsy; Humans; Phenytoin | 1986 |
Total and free serum concentrations of carbamazepine and carbamazepine-10,11-epoxide in children with epilepsy.
Topics: Adolescent; Carbamazepine; Child; Epilepsy; Female; Humans; Male | 1986 |
Differences in antiepileptic drug efficacy in hippocampally kindled normal and microcephalic rats.
Topics: Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Drug Evaluation, Preclinical; Elect | 1986 |
Effect of influenza vaccine on serum anticonvulsant concentrations.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Influenza Vaccines; Inf | 1986 |
Use of saliva for monitoring oxcarbazepine therapy in epileptic patients.
Topics: Adult; Anticonvulsants; Blood Proteins; Carbamazepine; Chromatography, High Pressure Liquid; Epileps | 1986 |
Carbamazepine-viloxazine interaction in patients with epilepsy.
Topics: Adult; Carbamazepine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Epilepsy; F | 1986 |
Phenytoin vs carbamazepine in seizure disorder.
Topics: Carbamazepine; Epilepsy; Humans; Phenytoin | 1986 |
[Determination of carbamazepine in serum by the thin-layer fluorescence scanner].
Topics: Carbamazepine; Chromatography, Thin Layer; Epilepsy; Humans | 1986 |
Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives.
Topics: Adult; Carbamazepine; Contraceptives, Oral, Hormonal; Drug Interactions; Epilepsy; Ethinyl Estradiol | 1986 |
Carbamazepine suppresses synchronized afterdischarging in disinhibited immature rat hippocampus in vitro.
Topics: Animals; Animals, Newborn; Carbamazepine; Dose-Response Relationship, Drug; Electric Stimulation; Ep | 1987 |
Availability of drug assay results and dosage advice improves antiepileptic care in a specialist neurology outpatient clinic.
Topics: Adolescent; Adult; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Outpatient Cli | 1985 |
The effects of long-term anticonvulsant drug therapy on vitamin D metabolites and mineral homeostasis in pregnant epileptic women and their newborns.
Topics: Adolescent; Adult; Anticonvulsants; Calcifediol; Calcitriol; Carbamazepine; Dihydroxycholecalciferol | 1985 |
Effect of chronic anticonvulsant monotherapy on lymphocyte subpopulations in adult epileptic patients.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Complement System Proteins; Epilepsy; Femal | 1985 |
[Determination of antiepileptic serum levels in patients with mono- and polytherapy in correlation with the clinical picture of the disease].
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; | 1985 |
[Side effects of anticonvulsants on the peripheral nervous system and vestibulo-ocular functions].
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Therapy, Combination; Epilepsy; Epilepsy, Temporal Lobe; | 1985 |
Effects of pregnancy on antiepileptic drug utilization.
Topics: Anticonvulsants; Biological Availability; Carbamazepine; Epilepsy; Female; Humans; Kinetics; Metabol | 1985 |
Lack of effect of carbamazepine on serum alpha 1-acid glycoprotein concentration.
Topics: Carbamazepine; Epilepsy; Humans; Immunodiffusion; Male; Orosomucoid; Rifampin; Sex Hormone-Binding G | 1985 |
Anticonvulsant drugs and the genetically epilepsy-prone rat.
Topics: Acoustic Stimulation; Amitriptyline; Animals; Anticonvulsants; Carbamazepine; Desipramine; Disease M | 1985 |
Drug compliance and seizure control in epileptic children.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infan | 1985 |
Monotherapy and polytherapy for intractable epilepsies.
Topics: Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Benzodiazepinones; Carbamazepine; Clobazam; D | 1985 |
Sub-normal serum thyroxine levels associated with carbamazepine and valproic acid treatment.
Topics: Carbamazepine; Child; Diabetes Complications; Drug Therapy, Combination; Epilepsy; Humans; Male; Thy | 1985 |
Interictal EEG prediction of response to antiepileptic drug monotherapy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Electroencephalogr | 1985 |
Evaluation of the effects of antiepileptic drugs on sleep-wakefulness patterns following 1 night total sleep deprivation in epileptic patients.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Epilepsy; Human | 1985 |
Chronic valproic acid therapy and incidence of increases in venous plasma ammonia.
Topics: Adolescent; Adult; Aged; Ammonia; Carbamazepine; Child; Child, Preschool; Drug Interactions; Epileps | 1985 |
The optimum use of anticonvulsants.
Topics: Anticonvulsants; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Phen | 1985 |
Mortality from ischaemic heart disease among patients using anticonvulsive drugs: a case-control study.
Topics: Aged; Anticonvulsants; Barbiturates; Carbamazepine; Cardiovascular Diseases; Cerebrovascular Disorde | 1985 |
Where, why, and what type of therapy.
Topics: Carbamazepine; Child; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; Epilepsy, Temporal Lobe; Hum | 1985 |
Monitoring: the most important role of the pediatrician.
Topics: Activities of Daily Living; Anticonvulsants; Carbamazepine; Child, Preschool; Environmental Monitori | 1985 |
Serum concentrations of valproic acid: influence of dose and comedication.
Topics: Adolescent; Adult; Body Weight; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epileps | 1985 |
Use of total and free anticonvulsant serum levels in clinical practice.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Humans; Immunoenzyme Techniques; Phenobarbital; Phenytoin; | 1985 |
Persistent right umbilical vein--case report and review of literature.
Topics: Abnormalities, Multiple; Carbamazepine; Ectromelia; Epilepsy; Female; Heart Septal Defects, Atrial; | 1986 |
Alternative single anticonvulsant drug therapy for refractory epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsy; Humans; Phenobarbital; Phenytoin; | 1986 |
The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Middle Aged; Phenobarbital; Phenytoin | 1986 |
Childhood seizures after carbamazepine.
Topics: Carbamazepine; Child; Epilepsy; Humans | 1986 |
High alpha 1-acid glycoprotein concentrations in serum of epileptic children being treated with carbamazepine.
Topics: Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Male; Orosomucoid | 1985 |
Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
Topics: Adolescent; Age Factors; Carbamazepine; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy | 1985 |
Differential effect of cimetidine on serum concentrations of carbamazepine and phenytoin.
Topics: Adolescent; Adult; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Hu | 1985 |
Carbamazepine-phenytoin interaction: elevation of plasma phenytoin concentrations due to carbamazepine comedication.
Topics: Adult; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; | 1985 |
Epilepsy in a community--management and social impact.
Topics: Adolescent; Adult; Aged; Ambulatory Care Facilities; Carbamazepine; Craniocerebral Trauma; Epilepsy; | 1985 |
Effect of antiepileptic drugs on short-latency somatosensory evoked potentials.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Drug Therapy, Combination; Electroencephal | 1985 |
Hyponatremia during carbamazepine therapy.
Topics: Adult; Age Factors; Carbamazepine; Child; Epilepsy; Female; Humans; Hyponatremia; Male; Risk; Sodium | 1985 |
Gas chromatographic determination of m- and p-hydroxyphenytoin in the urine of epileptic patients.
Topics: Adult; Aged; Carbamazepine; Chromatography, Gas; Epilepsy; Female; Humans; Hydrolysis; Male; Phenyto | 1985 |
Epileptic amnesic attacks: benefit from antiepileptic drugs.
Topics: Aged; Amnesia; Anticonvulsants; Carbamazepine; Epilepsy; Humans; Male; Middle Aged; Neuropsychologic | 1985 |
Psychotic syndromes in epilepsy.
Topics: Brain; Carbamazepine; Confusion; Delusions; Electroencephalography; Epilepsy; Epilepsy, Temporal Lob | 1985 |
Failure of prednisolone to suppress carbamazepine hypersensitivity.
Topics: Adult; Carbamazepine; Drug Hypersensitivity; Epilepsy; Female; Humans; Prednisolone | 1985 |
Antiepileptic and antiamnesic effect of carbamazepine in experimental limbic epilepsy.
Topics: Amnesia; Animals; Avoidance Learning; Carbamazepine; Electroshock; Epilepsy; Hippocampus; Humans; Li | 1985 |
Hypnogenic paroxysmal dystonia: epilepsy or sleep disorder? A case report.
Topics: Adult; Carbamazepine; Diazepam; Dystonia; Epilepsy; Humans; Male; Sleep; Sleep Wake Disorders; Syndr | 1985 |
Finger- and toenail hypoplasia after carbamazepine monotherapy in late pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Carbamazepine; Epilepsy; Female; Humans; Infant, Newborn; Nails, | 1985 |
Lateral gaze nystagmus in carbamazepine-treated epileptic patients: correlation with total and free plasma concentrations of parent drug and its 10,11-epoxide metabolite.
Topics: Adult; Carbamazepine; Epilepsy; Female; Humans; Male; Nystagmus, Pathologic; Phenobarbital | 1985 |
Acute hepatitis in a patient treated with carbamazepine.
Topics: Acute Disease; Carbamazepine; Chemical and Drug Induced Liver Injury; Child, Preschool; Epilepsy; Hu | 1985 |
Serum concentrations of carbamazepine.
Topics: Carbamazepine; Child; Epilepsy; Humans | 1985 |
Increased frequency of goitre in epileptic patients on long-term phenytoin or carbamazepine treatment.
Topics: Adolescent; Adult; Aged; Carbamazepine; Epilepsy; Female; Goiter; Humans; Male; Middle Aged; Phenyto | 1985 |
Alpha 1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy.
Topics: Carbamazepine; Child; Child, Preschool; Epilepsy; Female; Humans; Infant; Male; Orosomucoid; Protein | 1985 |
The role of antiepileptics in sudden death in epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Death, Sudden; Epilepsy; Female; Humans; Male; Patient Compli | 1985 |
Carbamazepine-induced hair loss.
Topics: Alopecia; Carbamazepine; Child; Epilepsy; Female; Headache; Humans | 1985 |
Comparative safety of carbamazepine & phenytoin in the treatment of epilepsy.
Topics: Carbamazepine; Cells, Cultured; Epilepsy; Humans; Lymphocytes; Phenytoin; Sister Chromatid Exchange | 1985 |
Coarse features in epilepsy as a consequence of anticonvulsant therapy. Report of cases in two pairs of identical twins.
Topics: Acromegaly; Adult; Anticonvulsants; Carbamazepine; Child; Diazepam; Diseases in Twins; Epilepsy; Epi | 1973 |
Effect of clonazepam (Ro 5-4023) on epileptic seizures.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepinones; Carbamazepine; Chlorobenzenes; Drug Evaluatio | 1973 |
Choreo-athetosis and encephalopathy induced by phenytoin.
Topics: Adolescent; Adult; Ataxia; Athetosis; Carbamazepine; Chorea; Diplopia; Electroencephalography; Epile | 1974 |
Epilepsy.
Topics: Adrenocorticotropic Hormone; Carbamazepine; Diazepam; Drug Hypersensitivity; Drug-Related Side Effec | 1974 |
Falsely high fluorescence in cortisol determinations due to the carbamazepine.
Topics: 17-Ketosteroids; Carbamazepine; Diabetes Insipidus; Diabetic Ketoacidosis; Epilepsy; Fluorescence; F | 1973 |
Pharmacokinetic evaluation of anticonvulsants prior to efficacy testing exemplified by carbamazepine in epileptic monkey model.
Topics: Administration, Oral; Animals; Carbamazepine; Delayed-Action Preparations; Disease Models, Animal; D | 1974 |
Radiologic bone changes and hypocalcemia with anticonvulsant therapy in epilepsy.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Anticonvulsants; Back Pain; Calcium; Carbamazepine; D | 1972 |
Carbamazepine as an anticonvulsant: a pilot study.
Topics: Administration, Oral; Adult; Anticonvulsants; Carbamazepine; Drug Eruptions; Epilepsy; Eye Movements | 1974 |
The effect of tegretol on some elementary neuronal mechanisms.
Topics: Animals; Carbamazepine; Cats; Dibenzazepines; Epilepsy; Phenytoin; Synapses; Synaptic Transmission; | 1969 |
Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
Topics: Adult; Aged; Carbamazepine; Electric Stimulation; Electromyography; Epilepsy; Ethosuximide; Evoked P | 1974 |
"Dilatin" overdosage.
Topics: Anticonvulsants; Ataxia; Brain Neoplasms; Carbamazepine; Diagnosis, Differential; Dibenzazepines; Ep | 1968 |
Drug treatment of epilepsy in childhood.
Topics: Anticonvulsants; Carbamazepine; Child; Child, Preschool; Diazepam; Epilepsy; Epilepsy, Absence; Epil | 1969 |
Diphenylhydantoin.
Topics: Affective Symptoms; Arrhythmias, Cardiac; Ataxia; Carbamazepine; Central Nervous System Diseases; Ch | 1971 |
A comprehensive scheme for the evaluation of anticonvulsant concentrations in blood using thin-layer chromatography.
Topics: Acetazolamide; Anticonvulsants; Benzazepines; Carbamazepine; Chlordiazepoxide; Chromatography, Thin | 1971 |
[Medical treatment of epilepsy].
Topics: Acetazolamide; Anticonvulsants; Carbamazepine; Diazepam; Epilepsy; Ethosuximide; Humans; Hydantoins; | 1971 |
[Therapy of epilepsy. The causes and consequences of inadequate treatment].
Topics: Acridines; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Barbiturates; Carbamazepine; Child | 1972 |
Anticonvulsant drugs. I. Patho-physiological and pharmacological aspects.
Topics: Acetates; Acetazolamide; Anticonvulsants; Carbamazepine; Diazepam; Dibenzazepines; Electroencephalog | 1972 |
The concentration of carbamazepine (Tegretol R) in serum and in cerebrospinal fluid in patients with epilepsy.
Topics: Adult; Body Weight; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Protein Bindi | 1972 |
A clinical trial with clonazepam (Ro 5-4023).
Topics: Adolescent; Adult; Anticonvulsants; Barbiturates; Benzodiazepinones; Carbamazepine; Child; Chloroben | 1973 |
Concentration of carbamazepine (Tegretol) in serum and in cerebrospinal fluid in patients with epilepsy.
Topics: Adolescent; Adult; Carbamazepine; Cerebrospinal Fluid Proteins; Colorimetry; Epilepsy; Female; Human | 1973 |
[Effect of anticonvulsive drugs on the intelligence in children].
Topics: Anticonvulsants; Brain; Carbamazepine; Child; Child, Preschool; Electroencephalography; Epilepsy; Fe | 1974 |
The action of some anticonvulsant drugs on cobalt-induced epilepsy and on the bemegride threshold in alert cats.
Topics: Animals; Anticonvulsants; Bemegride; Carbamazepine; Cats; Cobalt; Diazepam; Electroencephalography; | 1972 |
[Treatment of character disorders and subcritical epilepsy in adolescents].
Topics: Adolescent; Adult; Aggression; Carbamazepine; Epilepsy; Female; Humans; Male; Mental Disorders; Soci | 1973 |
Dystonic seizures induced by movement.
Topics: Adolescent; Adult; Athetosis; Basal Ganglia Diseases; Carbamazepine; Child; Chorea; Diagnosis, Diffe | 1973 |
Abdominal epilepsy.
Topics: Abdomen; Carbamazepine; Colic; Diagnosis, Differential; Electroencephalography; Epilepsy; Humans; Ma | 1973 |
Preliminary observations of serum carbamazepine concentration in epileptic patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Epilepsy; Humans; Male; Mid | 1973 |
Carbamazepine (tegretol)--trigeminal neuralgia and other uses.
Topics: Carbamazepine; Epilepsy; Facial Neuralgia; Female; Glossopharyngeal Nerve; Humans; Multiple Sclerosi | 1973 |
A rapid method for the estimation of anti-epileptic drugs in blood serum by gas-liquid chromatography.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Gas; Epilepsy; Ethosuximide; Evaluation Studies as T | 1973 |
The teratological effects of anticonvulsants and the effects on pregnancy and birth.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Child; Cleft Lip; Cleft Palate; Cyclohe | 1973 |
Antiparoxysmal and psychotropic effect of carbamazepine in the pharmacotherapy of epilepsy.
Topics: Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Male | 1973 |
Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy.
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Depression, Chemical; Drug Therapy, Combination; Epil | 1973 |
Effect of anticonvulsive drugs on folate absorption and the cerebrospinal folate pump.
Topics: Adolescent; Adult; Aged; Carbamazepine; Depression, Chemical; Epilepsy; Female; Folic Acid; Folic Ac | 1973 |
Medicine in old age. Disturbances of the special senses and other functions.
Topics: Aged; Carbamazepine; Deafness; Dementia; Epilepsy; Female; Geriatrics; Headache; Hematoma, Subdural; | 1974 |
[Letter: Teratogenic hazards in antiepileptic therapy].
Topics: Abnormalities, Drug-Induced; Carbamazepine; Epilepsy; Female; Humans; Phenobarbital; Phenytoin; Preg | 1974 |
Comparison of two generically equivalent carbamazepine preparations.
Topics: Adolescent; Adult; Biopharmaceutics; Blood-Brain Barrier; Carbamazepine; Child; Epilepsy; Half-Life; | 1974 |
[Effects of tegretol therapy in different groups of epileptic patients in a psychiatric hospital].
Topics: Adolescent; Adult; Carbamazepine; Dibenzazepines; Electroencephalography; Epilepsies, Partial; Epile | 1968 |
[Successful results with carbamazepine (tegretol) in the treatment of severe epilepsy and its characteriopathic manifestations].
Topics: Adult; Carbamazepine; Character; Dibenzazepines; Epilepsies, Partial; Epilepsy; Epilepsy, Absence; E | 1968 |
[Tegretol treatment of epilepsy].
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Dibenzazepines; Epilepsy; Epilepsy, Temporal Lobe; Ep | 1970 |
[Carbamazepine in the therapy of childhood epilepsy].
Topics: Adolescent; Anticonvulsants; Behavior; Body Weight; Carbamazepine; Child; Child, Preschool; Chronic | 1970 |
[Basic principles of epilepsy therapy].
Topics: Anticonvulsants; Barbiturates; Benzazepines; Carbamazepine; Epilepsy; Epilepsy, Absence; Epilepsy, T | 1970 |
[Clinical and electroencephalographic evaluation of the action of Tegretol in cases of epilepsy].
Topics: Adolescent; Adult; Aged; Carbamazepine; Drug Tolerance; Electroencephalography; Epilepsy; Epilepsy, | 1971 |
[In cerebral attacks: Tegretal].
Topics: Adolescent; Adult; Carbamazepine; Epilepsy; Epilepsy, Tonic-Clonic; Humans; Middle Aged; Trigeminal | 1970 |
[Therapy of epilepsy].
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Diazepam; Epilepsy; Humans; Hydantoins; Primidone; Suc | 1972 |
Antiepileptic drug concentrations in plasma. Clinical evaluation of 321 estimations in 237 unselected patients.
Topics: Carbamazepine; Chromatography, Gas; Chromatography, Thin Layer; Epilepsy; Humans; Methods; Phenobarb | 1972 |
[Catamnestic studies over a period of 9 years on the therapy of epilepsy using carbamazepine].
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Epilepsy; Female; Germany, West; Humans; Male; Middle | 1972 |
[Speech disorders in children with cerebral convulsions].
Topics: Adolescent; Barbiturates; Carbamazepine; Drug Hypersensitivity; Electroencephalography; Epilepsy; Et | 1972 |
Epilepsy in multiple sclerosis.
Topics: Adolescent; Adult; Barbiturates; Basal Ganglia; Carbamazepine; Cerebral Cortex; Demyelinating Diseas | 1972 |
Bone density in patients receiving long-term anticonvulsant therapy.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Anticonvulsants; Calcium; Carbamazepine; Epilep | 1971 |
[Carbamazepine--an antiepileptic agent with broad applicability, also in psychiatry. An introductory report with cases].
Topics: Adolescent; Adult; Carbamazepine; Diagnosis, Differential; Epilepsy; Female; Humans; Male; Neurotic | 1971 |
[Our experiences with Tegretol in the treatment of epilepsy].
Topics: Adolescent; Adult; Aged; Carbamazepine; Child; Drug Synergism; Epilepsy; Female; Headache; Humans; M | 1971 |
[Tegretol in the treatment of children's epilepsy].
Topics: Blood Cell Count; Carbamazepine; Child; Epilepsy; Female; Humans; Lymphocytes; Male; Neutrophils | 1971 |
[Anticonvulsants. 2. Pharmacodynamics].
Topics: Anticonvulsants; Barbiturates; Carbamazepine; Diazepam; Epilepsy; Humans; Hydantoins; Oxazoles; Prim | 1971 |
Simultaneous quantitative determination of anti-epileptic drugs, including carbamazepine, in body fluids.
Topics: Anticonvulsants; Carbamazepine; Chromatography, Gas; Epilepsy; Humans; Temperature | 1971 |
Anticonvulsant drugs and folic acid in young mentally retarded epileptic patients. A study of serum folate, fit frequency and I.Q.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Ethosuximide; Female; Folic Acid; Human | 1971 |
[Clinical evaluation with G 32. 883].
Topics: Carbamazepine; Dibenzazepines; Epilepsy; Humans; Trigeminal Neuralgia | 1967 |
[Carbamazepine in the treatment of epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy; Humans | 1969 |
[Experience with long-term administration of Tegretal in polygraphic sleep--EEG. 2].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Dysautonomia, Familial; Electroen | 1969 |
[Tegretal: problems of psychotropic action].
Topics: Adolescent; Adult; Anticonvulsants; Behavior; Carbamazepine; Central Nervous System; Epilepsy; Femal | 1970 |
[Drug treatment of chronic epilepsy].
Topics: Anticonvulsants; Carbamazepine; Chronic Disease; Epilepsy; Ethosuximide; Humans; Hydantoins; Primido | 1970 |
Gas chromatographic assay of underivatized 5,5-diphenylhydantoin (dilantin) in plasma extracts.
Topics: Carbamazepine; Chloroform; Chromatography, Gas; Coma; Epilepsy; Humans; Hydrogen-Ion Concentration; | 1971 |
[2 years of experience in the treatment of epilepsy with tegretol].
Topics: Carbamazepine; Child; Dibenzazepines; Electroencephalography; Epilepsy; Humans | 1967 |
[The anti-epileptic and psychotropic properties of carbamazepine (Tegretol)].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Epilepsy; Female; Humans; Male; M | 1967 |
[Contribution to the treatment of mental states of epileptic origin. Value of Tegretol].
Topics: Carbamazepine; Dibenzazepines; Epilepsy; Humans; Mental Disorders | 1967 |
[About a new anticonvulsant psychotropic. Preliminary results with carbamazepine].
Topics: Adult; Carbamazepine; Child; Dibenzazepines; Epilepsy; Female; Humans; Male | 1967 |
[Treatment of epilepsy with G 32 883].
Topics: Carbamazepine; Dibenzazepines; Epilepsy; Humans | 1967 |
[Action of Tegretol (G. 32.883) in certain severe forms of epilepsy].
Topics: Adult; Carbamazepine; Dibenzazepines; Electroencephalography; Epilepsy; Female; Humans; Male | 1968 |
[On the antiepileptic mechanism of action of 5-carbamyl-5H-dibenzo(b,f)azepine. Neurophysiologic studies on cats].
Topics: Action Potentials; Amygdala; Animals; Brain; Carbamazepine; Cats; Cerebral Cortex; Depression, Chemi | 1969 |